
<html lang="en"     class="pb-page"  data-request-id="2a1b318e-19c4-4d11-999f-37c726d6590b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b01668;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-12"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives" /></meta><meta name="dc.Creator" content="Hui  Cong" /></meta><meta name="dc.Creator" content="Lijuan  Xu" /></meta><meta name="dc.Creator" content="Yougen  Wu" /></meta><meta name="dc.Creator" content="Zhuo  Qu" /></meta><meta name="dc.Creator" content="Tengfei  Bian" /></meta><meta name="dc.Creator" content="Wannian  Zhang" /></meta><meta name="dc.Creator" content="Chengguo  Xing" /></meta><meta name="dc.Creator" content="Chunlin  Zhuang" /></meta><meta name="dc.Description" content="Apoptosis, an important form of programmed cell death (PCD), is a tightly regulated cellular process to eliminate unwanted or damaged cells. Resistance of apoptosis is a hallmark of cancer cells. I..." /></meta><meta name="Description" content="Apoptosis, an important form of programmed cell death (PCD), is a tightly regulated cellular process to eliminate unwanted or damaged cells. Resistance of apoptosis is a hallmark of cancer cells. I..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 24, 2019" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01668" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01668" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01668" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01668" /></link>
        
    
    

<title>Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01668" /></meta><meta property="og:title" content="Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0016.jpeg" /></meta><meta property="og:description" content="Apoptosis, an important form of programmed cell death (PCD), is a tightly regulated cellular process to eliminate unwanted or damaged cells. Resistance of apoptosis is a hallmark of cancer cells. Inhibitor of apoptosis proteins (IAPs) is a class of key apoptosis regulators that promote cancer cell resistant to apoptosis, particularly in cancer treatment. Disrupting the binding of IAPs with their functional partners therefore is a promising strategy to restore the apoptotic response to proapoptotic stimuli, particularly those introduced by standard cancer therapies. The most successful example is the use of small molecules to mimic the IAP-binding motif of an endogenous IAP antagonist, second mitochondria-derived activator of caspase (SMAC). Here we will review the functions of IAPs, the structural interactions of IAPs with SMAC, four generations of SMAC-mimetic IAP antagonists, and representative antagonists in clinical evaluations, focusing on research articles over the past 15 years. Outlooks and perspectives on the associated challenges are provided as well." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01668"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01668">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01668&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01668&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01668&amp;href=/doi/10.1021/acs.jmedchem.8b01668" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5750-5772</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01596" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b00322" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Hui Cong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hui Cong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</div><div class="loa-info-affiliations-info">School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hui++Cong">Hui Cong</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lijuan Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lijuan Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</div><div class="loa-info-affiliations-info">School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lijuan++Xu">Lijuan Xu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yougen Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yougen Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Tropical Agriculture and Forestry, Hainan University, 58 Renmin Avenue, Haikou 570228, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yougen++Wu">Yougen Wu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhuo Qu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhuo Qu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhuo++Qu">Zhuo Qu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tengfei Bian</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tengfei Bian</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tengfei++Bian">Tengfei Bian</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wannian Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wannian Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</div><div class="loa-info-affiliations-info">School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wannian++Zhang">Wannian Zhang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chengguo Xing</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chengguo Xing</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</div></div><span class="conrtib-corresp"><strong>*</strong>C.X.: e-mail, <a href="/cdn-cgi/l/email-protection#c3a0aba6ada4a4b6acbbaaada483a0acb3edb6a5afeda6a7b6"><span class="__cf_email__" data-cfemail="d1b2b9b4bfb6b6a4bea9b8bfb691b2bea1ffa4b7bdffb4b5a4">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chengguo++Xing">Chengguo Xing</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath7">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4266-6236" title="Orcid link">http://orcid.org/0000-0002-4266-6236</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Chunlin Zhuang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chunlin Zhuang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</div><div class="loa-info-affiliations-info">School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><span class="conrtib-corresp"><strong>*</strong>C.Z.: e-mail, <a href="/cdn-cgi/l/email-protection#4238212e2c23362a232c027374716c212d2f"><span class="__cf_email__" data-cfemail="403a232c2e213428212e007176736e232f2d">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chunlin++Zhuang">Chunlin Zhuang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath8">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0569-5708" title="Orcid link">http://orcid.org/0000-0002-0569-5708</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01668&amp;href=/doi/10.1021%2Facs.jmedchem.8b01668" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5750–5772</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 24, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 October 2018</li><li><span class="item_label"><b>Published</b> online</span>24 January 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 June 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01668" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01668</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5750%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHui%2BCong%252C%2BLijuan%2BXu%252C%2BYougen%2BWu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D12%26contentID%3Dacs.jmedchem.8b01668%26title%3DInhibitor%2Bof%2BApoptosis%2BProtein%2B%2528IAP%2529%2BAntagonists%2Bin%2BAnticancer%2BAgent%2BDiscovery%253A%2BCurrent%2BStatus%2Band%2BPerspectives%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5772%26publicationDate%3DJune%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01668"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3734</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">33</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01668" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hui&quot;,&quot;last_name&quot;:&quot;Cong&quot;},{&quot;first_name&quot;:&quot;Lijuan&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Yougen&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Zhuo&quot;,&quot;last_name&quot;:&quot;Qu&quot;},{&quot;first_name&quot;:&quot;Tengfei&quot;,&quot;last_name&quot;:&quot;Bian&quot;},{&quot;first_name&quot;:&quot;Wannian&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Chengguo&quot;,&quot;last_name&quot;:&quot;Xing&quot;},{&quot;first_name&quot;:&quot;Chunlin&quot;,&quot;last_name&quot;:&quot;Zhuang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;5750-5772&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01668&quot;},&quot;abstract&quot;:&quot;Apoptosis, an important form of programmed cell death (PCD), is a tightly regulated cellular process to eliminate unwanted or damaged cells. Resistance of apoptosis is a hallmark of cancer cells. Inhibitor of apoptosis proteins (IAPs) is a class of key apoptosis regulators that promote cancer cell resistant to apoptosis, particularly in cancer treatment. Disrupting the binding of IAPs with their functional partners therefore is a promising strategy to restore the apoptotic response to proapoptotic stimuli, particularly those introduced by standard cancer therapies. The most successful example is the use of small molecules to mimic the IAP-binding motif of an endogenous IAP antagonist, second mitochondria-derived activator of caspase (SMAC). Here we will review the functions of IAPs, the structural interactions of IAPs with SMAC, four generations of SMAC-mimetic IAP antagonists, and representative antagonists in clinical evaluations, focusing on research articles over the past 15 years. Outlooks and perspectiv&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01668&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01668" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01668&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01668" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01668&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01668" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01668&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01668&amp;href=/doi/10.1021/acs.jmedchem.8b01668" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01668" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01668" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01668%26sid%3Dliteratum%253Aachs%26pmid%3D30676015%26genre%3Darticle%26aulast%3DCong%26date%3D2019%26atitle%3DInhibitor%2Bof%2BApoptosis%2BProtein%2B%2528IAP%2529%2BAntagonists%2Bin%2BAnticancer%2BAgent%2BDiscovery%253A%2BCurrent%2BStatus%2Band%2BPerspectives%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D12%26spage%3D5750%26epage%3D5772%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/jmcmar.2019.62.issue-12/20190627/jmcmar.2019.62.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Apoptosis, an important form of programmed cell death (PCD), is a tightly regulated cellular process to eliminate unwanted or damaged cells. Resistance of apoptosis is a hallmark of cancer cells. Inhibitor of apoptosis proteins (IAPs) is a class of key apoptosis regulators that promote cancer cell resistant to apoptosis, particularly in cancer treatment. Disrupting the binding of IAPs with their functional partners therefore is a promising strategy to restore the apoptotic response to proapoptotic stimuli, particularly those introduced by standard cancer therapies. The most successful example is the use of small molecules to mimic the IAP-binding motif of an endogenous IAP antagonist, second mitochondria-derived activator of caspase (SMAC). Here we will review the functions of IAPs, the structural interactions of IAPs with SMAC, four generations of SMAC-mimetic IAP antagonists, and representative antagonists in clinical evaluations, focusing on research articles over the past 15 years. Outlooks and perspectives on the associated challenges are provided as well.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  IAPs Are Key Regulators of Apoptosis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00004" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00004" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Apoptosis, a form of programmed cell death (PCD), is an essential cellular process for normal development and homeostasis, which maintains a balance between cell death and growth.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Dysregulated apoptosis is involved in the pathological etiology of a variety of diseases, including neurodegenerative diseases, viral infections, and cancers.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> Resistance to apoptosis in cancer cells is a major challenge that limits the success of cancer treatment.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Therefore, restoring the proapoptotic pathway in cancer cells is a promising strategy for anticancer drug discovery.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Inhibitors of apoptosis proteins (IAPs) are a class of negative apoptotic regulators in mammalian cells.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> IAP family proteins, which were first identified in baculoviruses, are characterized by the presence of one or more of the 70–80-amino-acid zinc-binding baculoviral IAP repeat (BIR) domains.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> To date, eight members of the mammalian IAP family have been identified: neuronal IAP (NIAP), cellular IAP1 (c-IAP1), cellular IAP2 (c-IAP2), X-chromosome-linked IAP (XIAP), survivin, ubiquitin-conjugating BIR domain enzyme (BRUCE), melanoma IAP (ML-IAP), and IAP-like protein 2 (ILP2).<a onclick="showRef(event, 'ref6 ref10'); return false;" href="javascript:void(0);" class="ref ref6 ref10">(6,10)</a> These proteins are frequently overexpressed in cancer cells and are associated with poor prognoses.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> In this review, we focus on c-IAP1, c-IAP2, and XIAP, which play a predominant role in regulating apoptosis in cells, particularly malignant cells.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, a typical IAP commonly contains two kinds of BIR domains (types 1 and 2), a ubiquitin-associated (UBA) domain and a RING domain. BIR1, a type 1 BIR domain, interacts with tumor necrosis factor receptor-associated factors 1 and 2 (TRAF1 and TRAF2),<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> which may regulate TRAF-mediated NF-κB and MAPK activation.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> BIR2 and BIR3 of IAPs are type 2 BIR domains. The BIR2 domain of XIAP binds to and inhibits the activation of caspase-3 and caspase-7, and the BIR3 domain specifically binds to and inhibits caspase 9.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Unlike XIAP, c-IAP1 and c-IAP2 can bind to caspase-3 and caspase-9 but do not inhibit these enzymes.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> All three members have one UBA domain, which can bind to ubiquitin chains and thus participate in downstream biochemical processes.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The RING domain enables E3 ubiquitin ligase activity to the IAPs.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> An additional caspase recruitment domain (CARD) is presented in c-IAPs, but the function of this domain is unclear with one study suggesting that this domain contributes to the autoinhibition of RING domain activity.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Functional domains of mammalian IAPs: typical IAP structure and the structures of XIAP, c-IAP1, and c-IAP2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Extensive studies demonstrate that XIAP, c-IAP1, and c-IAP2 regulate apoptosis through a number of pathways (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> XIAP is a key regulator in inhibiting both forms of apoptosis: the death receptor-mediated pathway and the mitochondria-mediated pathway. It functionally binds to and inhibits caspase-3, caspase-7, and caspase-9. c-IAP1 and c-IAP2 mediate TRAF2 and receptor-interacting protein 1 (RIP1) ubiquitination. Through the interaction of cIAPs and TRAF2, TNF factor receptor 1 (TNFR1)-mediated caspase-8 activation and apoptosis are triggered.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Regulation of caspase-dependent apoptosis and NF-κB signaling by IAP and SMAC proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In many cancers, IAPs bind to and inhibit activated caspases and high levels of IAP result in resistance to apoptosis. BIR domains of IAPs are required for such protein–protein interactions (PPIs) to inhibit apoptosis. Therefore, the discovery of PPI inhibitors for IAPs in cancer cells is hypothesized to be a potential strategy to overcome the resistance of cancers to chemotherapy.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  SMAC Is an Endogenous IAP Antagonist, and the Binding Interactions between SMAC and IAPs Provide Concrete Insights for Drug Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41606" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41606" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Second mitochondria-derived activator of caspase (SMACs), also known as direct IAP-binding protein with low pI (DIABLO), is well-defined as the endogenous antagonist of IAPs and was first discovered by Dr. Xiaodong Wang and Dr. David Vaux in 2000.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> SMAC is a mitochondrial protein, which is released from the mitochondria into the cytosol during apoptotic induction. Subsequently, SMAC interacts with the BIR2 and BIR3 domains of IAPs at the IAP-binding motif (IBM), thereby antagonizing IAPs and resulting in caspase-3/7/9 activation and apoptosis.<a onclick="showRef(event, 'ref6 ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref6 ref25 ref26 ref27 ref28 ref29">(6,25−29)</a></div><div class="NLM_p">Determination of the structures of XIAP BIR3 with the SMAC protein (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1G73">1G73</a>)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> or a nine-residue peptide from SMAC (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1G3F">1G3F</a>)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> has provided concrete insights for designing small-molecule SMAC mimetics. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, two units of SMAC, each consisting of a three-helix bundle, generate a homodimeric tertiary structure. The four N-terminal residues (Ala1-Val2-Pro3-Ile4, abbreviated as AVPI) of SMAC bind to a surface groove on XIAP BIR3 via a combination of intermolecular hydrogen bonds and van der Waals interactions. The amino group (−NH<sub>2</sub>) of the Ala1 residue forms four strong hydrogen bonds with the neighboring residues in BIR3 (Glu314, Gln319, Trp310), and the backbone carbonyl group (−C═O) forms an additional hydrogen bond with the indole NH group of Trp323. The methyl group (−CH<sub>3</sub>) of Ala1 fits into a small hydrophobic pocket that might be important for binding activity. The amino and carbonyl groups of Val2 form hydrogen bonds with Thr308, while its isopropyl side chain is solvent exposed, making this position suitable for further optimization. van der Waals interactions have been demonstrated between the pyrrole ring of Pro3 and the Trp323-Tyr324 loop. Another hydrogen bond is formed between Ile4 and the carbonyl group of Gly306, and the isobutyl side chain of Ile4 forms hydrophobic interactions with the region containing Leu292, Lys297, and Lys299.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1G73">1G73</a>) and detailed interactions of SMAC, XIAP-BIR3 (presented as a surface model and the carbons in gray), and the AVPI peptide (carbons in yellow, nitrogens in blue, and oxygens in red). Blue dashed lines represent hydrogen bonds. The figures were generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The N-terminal residues of known binding partners of this groove with high sequence homology, such as Grim (AIAY), Hid (AVPF), and Reaper (AVAF), have been demonstrated to be essential for maintaining strong binding affinities with BIR3-containing proteins.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> Therefore, compounds mimicking this binding motif might serve as prototypical IAP antagonist therapeutic candidates. Four generations of such antagonists will be discussed herein, including peptides and peptidomimetics based on AVPI, nonpeptidic conformation-constrained monovalent IAP antagonists, bivalent IAP antagonists, and nonalanine IAP antagonists.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3.  Four Generations of SMAC-Mimetic IAP Antagonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74205" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74205" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">3.1.  First-Generation SMAC-Based Peptides and Peptidomimetics Designed Based on AVPI</h3><div class="NLM_p">The length and variety of amino acids in SMAC were first evaluated for the interaction to the BIR3 domain, and a structure–activity relationship (SAR) was demonstrated (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref27 ref28 ref29 ref32'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref32">(27−29,32)</a> The mature SMAC (59–239 residues) exhibits a binding affinity with a <i>K</i><sub>d</sub> of approximately 420 nM. The activity almost remains when the C terminus is shortened to the 9-mer AVPIAQKSE. Further shortening the C terminus to the 5-mer AVPIA (<i>K</i><sub>d</sub> = 640 nM) and 4-mer AVPI (<i>K</i><sub>d</sub> = 480 nM) results in no loss of binding affinity to the BIR3 domain of XIAP, indicating that the C terminus of SMAC is not essential for BIR3 binding. The role of each amino acid in the 4-mer peptide is also determined. (1) The binding affinity decreases or is completely lost when the alanine residue is replaced with glycine, serine, or methionine, while a 2-fold improvement is observed with 2-aminobutyric acid (a non-natural amino acid), indicating a hydrophobic interaction between the methyl group of the alanine and the BIR3 domain. However, a larger hydrophobic side chain is not suitable in this pocket. Acetylated peptides or a replacement with propionic or isobutyric acid at the N terminus leads to a complete loss of binding affinity, suggesting the importance of the positive charge and hydrogen bonds for binding. (2) Many amino acid residues could be tolerated at the valine position, in agreement with the crystal structure of the SMAC-BIR3 complex that no close interactions with valine are observed. Replacement with arginine shows an approximately 3-fold increase in binding affinity while replacement with glycine, proline, or aspartate at this position leads to nearly complete loss of activity, indicating that the positive charge may be important to the binding affinity. Methylation of the imino group between alanine and valine leads to complete loss of binding, highlighting the importance of the hydrogen bond with Thr308. (3) The van der Waals interaction between the proline residue of the peptide and the Trp323-Tyr324 loop plays an important role in binding. Proline or substituted pyrrolidine is typically used in peptides and peptidomimetics to constrain the compound in an appropriate configuration, which is discussed in the following sections. (4) At the isoleucine position, a relatively large pocket for hydrophobic interaction is observed in the crystal structure of the complex. Therefore, a hydrophobic residue at this position, for instance, tryptophan, leucine, valine, or phenylalanine, is favorable for binding, but a charged or polar residue such as arginine, glutamate, aspartate, histidine, glutamine, and asparagine is not favorable for binding. N-Methylation of isoleucine also decreases the binding affinity, due to the loss of the hydrogen bond, but the effect is much weaker than that observed with the imino group between alanine and valine. Simultaneous replacement of valine and isoleucine to arginine and phenylalanine, ARPF leads to a 24-fold increase in affinity (<i>K</i><sub>d</sub> = 20 nM) compared with that of the SMAC AVPI peptide.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Systematic summary for the different regions of the first-generation SMAC-based AVPI peptides and peptidomimetics. Structures with asterisks (∗) contain non-natural substituents. Chemical structures of representative potent and cell-permeable SMAC peptidomimetics as IAP antagonists. Substituents in different regions are colored as follows: alanine (blue), valine (pink), proline (black), and isoleucine (red). # indicates that the compound has been advanced into clinical evaluations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although they exhibit very high binding affinities, these peptides have a common drawback, i.e., poor cell permeability, similar to other peptidic compounds.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Therefore, extensive modifications using non-natural amino acids or substituents were carried out to identify potent and cell-permeable peptidomimetics (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Only a few optimizations were performed at the alanine and valine positions. Monomethylation of the terminal free amino group is well tolerated, but dimethylation significantly decreases the protein binding activity, indicating the importance of the intermolecular hydrogen bonds formed by the amino group. As observed in the crystal structure, the isopropyl group of valine is solvent exposed. A <i>tert</i>-leucine or cyclohexyl group would be suitable at this position without compromising the loss of binding affinity. At the proline position, replacement with a variety of amino acids leads to dramatic loss in binding affinity.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Azetidine, bearing a four-membered ring, and piperidine, bearing a six-membered ring, exhibit a 2- and 10-fold decreases in the <i>K</i><sub>d</sub> value, respectively. The <i>R</i>-4-hydroxyproline analog exhibits decreased binding affinity, which is consistent with the hydrophobicity of the Trp323-Tyr324 loop. Herein, the introduction of a phenyl group improves the binding affinity by 2-fold compared with the nonsubstituted analog. The <i>R</i>-tetrahydronaphthylamide peptidomimetic (<b>1</b>) and <i>R</i>-indane amide peptidomimetic (<b>2</b>) at the isoleucine position have <i>K</i><sub>d</sub> values of 12 and 29 nM, respectively, with XIAP-BIR3 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The configuration is important for the activity, as the <i>S</i>-diastereomeric analogs markedly reduce the binding affinities. In addition to exhibiting biochemical potency, these compounds also show decent cell permeability. Compounds <b>1</b>, <b>3</b>, and <b>4</b> could rescue BIR3-mediated caspase inhibition with EC<sub>50</sub> values of 290, 310, and 240 nM, respectively. Compounds <b>1</b> and <b>3</b> can also inhibit MDA-MB-231 cancer cell growth with IC<sub>50</sub> values of 68 and 13 nM, respectively, and they exhibit modest inhibition of tumor growth in an MDA-MB-231 xenograft mouse model, suggesting the therapeutic potential of these compounds in cancer treatment.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">A c-IAP-selective peptidomimetic antagonist (<b>5</b>) was developed by Genentech.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> This compound exhibits high affinity for the BIR3 domains of c-IAP1 and c-IAP2 and more than 2000-fold selectivity over XIAP. This antagonist is mostly used as a tool compound because c-IAP-selective antagonists are less potent than other antagonists in inducing apoptosis in cancer cells.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Compound <b>6</b> (also known as GDC-0152), a pan-IAP antagonist that has been advanced into a phase I clinic trial (NCT00977067), binds to c-IAP1, c-IAP2, XIAP-BIR3, and ML-IAP with <i>K</i><sub>d</sub> values of 17, 43, 28, and 14 nM, respectively.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> This compound promotes cIAP1 degradation, induces caspase-3/7 activation, inhibits MDA-MB-231 breast cancer cell growth without affecting normal mammary epithelial cells, regresses tumor growth in a mouse model, and has excellent preclinical predictions of pharmacokinetics, mean plasma clearance, and distribution.</div><div class="NLM_p">Compound <b>7</b> (also known as LCL161) is another peptidomimetic that is in several clinical trials, but sufficient data are unavailable currently.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> A recent study, using a dissociation-enhanced lanthanide fluorescent immunoassay (DELFIA), determined the binding affinity of this compound with the BIR3 domains of XIAP, c-IAP1, and c-IAP2 with IC<sub>50</sub> values of 52.7, 10.4, and 12.9 nM, respectively.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In this study, a thermodynamics-driven approach was used to first identify compound <b>8</b> as a Lys-covalent XIAP-BIR3-selective inhibitor with an IC<sub>50</sub> value of 16.6 nM and more than a 12-fold selectivity toward c-IAPs. This compound also exhibits anticancer activity in multiple cancer cell lines, especially those that are resistant to LCL161.</div><div class="NLM_p last">Takeda Pharmaceutical developed a series of bicyclic octahydropyrrolo[1,2-<i>a</i>]pyrazine peptidomimetics using a bioisostere-based strategy to replace the proline.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> The proline ring is expanded to a six-membered piperazine ring, and a fused five-membered ring is introduced onto the piperazine to hydrophobically interact with the Trp23-Tyr324 region. Further optimization leads to the development of compound <b>9</b> (also named T-3256336), which exhibits potent c-IAP1 (IC<sub>50</sub> = 1.3 nM) and XIAP-BIR3 (IC<sub>50</sub> = 200 nM) inhibitory activity and cancer cell growth inhibition (GI<sub>50</sub> = 1.8 nM) against MDA-MB-231 breast cancer cells. This compound has good metabolic stability and an oral bioavailability of 50% and causes complete tumor regression in an MDA-MB-231 tumor xenograft model.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> However, this compound has low membrane permeability (1.0 nm/s, the membrane width permeabilized per second) into cells expressing multidrug resistance 1 (MDR1), which mediates drug efflux (efflux ratio of 24).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Therefore, a tricyclic hexahydropyrazino[1,2-<i>a</i>]indole scaffold was developed to enhance the membrane permeability into MDR1-expressing cells. Compound <b>10</b>, with an electron-withdrawing chloride group that decreases the electron density of the bridgehead nitrogen, exhibits significantly improved membrane permeability (64 nm/s) and decreases the MDR1 substrate activity (efflux ratio of 1.4). Moreover, this compound exhibits strong biochemical activity and tumor growth inhibition (TGI) in MDA-MB-231 cells, representing a suitable lead for further evaluation.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">3.2.  Second-Generation Conformation-Constrained Monovalent IAP Antagonists</h3><div class="NLM_p">Dr. Shaomeng Wang and colleagues first published bicyclic lactam structures as IAP antagonists in 2004 to mimic the geometry of the AVPI peptide.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> A representative structure optimization workflow is summarized in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. First, optimization of the isoleucine position of compound <b>11</b> results in compound <b>12</b>, which has a <i>K</i><sub>d</sub> value of 290 nM, showing a 2-fold improvement over the <i>K</i><sub>d</sub> value of compound <b>11</b>. Then, cyclization of valine and proline forms [6,5] bicyclic compound <b>13</b> and its diastereoisomer. The binding affinities of these compounds to the XIAP BIR3 protein are determined, with <i>K</i><sub>d</sub> values of 4470 nM and higher than 100 μM, respectively, indicating the importance of the conformational constraint to binding.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> An analog (<b>14</b>) optimized at the alanine and isoleucine positions using ethyl and diphenylmethyl groups exhibits the best <i>K</i><sub>d</sub> values (350 nM) with XIAP BIR3 in [6,5] bicyclic series and can enhance apoptosis induced by cisplatin in PC-3 human prostate cancer cells.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Next, one or two additional carbon atoms are inserted into the six-membered ring to afford [7.5] or [8.5] bicyclic analogs to better mimic the binding conformation of the AVPI peptide.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> A [7.5] bicyclic compound (<b>15</b>) exhibits a <i>K</i><sub>d</sub> value of 150 nM with XIAP BIR3. Further optimization by introduction of a diphenylmethyl group and methylation of its primary amino group obtains compound <b>16</b> with an excellent binding affinity, a <i>K</i><sub>d</sub> value of 61 nM.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> This compound biochemically suppresses the inhibition of caspase-9 activity by XIAP-BIR3 and exhibits an IC<sub>50</sub> of 100 nM in the inhibition of MDA-MB-231 cancer cell growth. The cellular activity of these SMAC mimetics is affected by methylation of the amino group at the alanine position.<a onclick="showRef(event, 'ref33 ref42'); return false;" href="javascript:void(0);" class="ref ref33 ref42">(33,42)</a> The [8.5] bicyclic series are another class of highly potent and cell-permeable SMAC mimetics.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Among these compounds, those with diphenylmethyl (<b>17</b> and <b>18</b>), <i>R</i>-indane amide (<b>19</b>), and <i>R</i>-tetrahydronaphthyl amide (<b>20</b>) groups exhibit high biochemical potency toward the XIAP BIR3 domain, with <i>K</i><sub>d</sub> values of 67, 26, 15, and 14 nM, respectively. Cocrystallization of compound <b>17</b> with the XIAP BIR3 protein (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JK7">2JK7</a>) provides the structural basis for further design of bicyclic monovalent SMAC mimetics. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, six hydrogen bonds are observed with Glu314, Asp309, Trp323, Thr308, and Gly306 residues. The ethyl group at the N terminus fits into the small hydrophobic pocket, mimicking the methyl group in the SMAC AVPI peptide. The diphenylmethyl group inserts into the hydrophobic pocket formed by the Leu292-Lys297-Lys299 region. The eight-membered lactam constrains the molecule in the correct configuration and forms weak contacts with Trp323, leaving space for further optimization at the ring region. Considering the modest area under the curve (AUC) and oral bioavailability of compound <b>18</b> (also known as SM-122, <i>K</i><sub>d</sub> = 26 nM),<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> multiple optimizations were carried out on the bicyclic rings to improve druggability.<a onclick="showRef(event, 'ref44 ref45 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46 ref47 ref48">(44−48)</a> Replacement of the original [8.5] bicyclic core with a diazabicyclic core (structure not shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) results in a compound with similar binding affinity to that of compound <b>17</b>.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Introduction of substituents on the nitrogen leads to various feasible derivatives. Among these derivatives, compound <b>21</b> (also known as SM-337) shows high binding potencies with XIAP-BIR3, c-IAP1, and c-IAP2, with <i>K</i><sub>d</sub> values of 8.4, 1.5, and 4.2 nM, respectively. This compound inhibits MDA-MB-231 cancer cell growth with an IC<sub>50</sub> value of 31 nM, which is 17-fold more potent than that of compound <b>18</b>. The pharmacokinetic (PK) profile of this compound is also much better than that of compound <b>18</b>, with an oral bioavailability of 24% at a dose of 30 mg/kg in rats, compared with 14% observed for compound <b>18</b>. Furthermore, an isovaleryl analog (<b>22</b>, also named SM-406 or AT-406 or Debio-1143) exhibits potent binding to XIAP-BIR3, c-IAP1, and c-IAP2 with <i>K</i><sub>d</sub> values of 66.4, 1.9, and 5.1 nM, respectively. Preclinical evaluations have shown that this compound has an excellent drug profile, with good PK properties observed in four different species (mice, rats, nonhuman primates, and dogs), high effectiveness in the induction of apoptosis in MDA-MB-231 xenograft tumors, and complete TGI using the regimen of oral gavage daily, 5 days a week for 2 weeks at 100 mg/kg. This compound has been evaluated as an oral agent alone or in combination with other agents in five phase I trials (NCT03270176, NCT01930292, NCT01265199, NCT02022098, and NCT01078649). Similarly, a phenylacetylamino group (<b>23</b>) is introduced at the carbon of the eight-membered lactam to generate a new chiral center.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> A fluorescence polarization (FP)-based binding assay shows that the <i>R</i> configuration was 2–3 times more potent than the corresponding <i>S</i> isomer. Compound <b>23</b> binds to XIAP-BIR3, c-IAP1, and c-IAP2 proteins with <i>K</i><sub>d</sub> values of 36, < 1, and <1.9 nM, respectively. In a cell-free caspase-9 functional assay, this compound efficiently induces c-IAP1 degradation at a concentration of 10 nM. The IC<sub>50</sub> value against MDA-MB-231 cancer cells is 200 nM, which is 9-fold more potent than that of compound <b>18</b>. Hydrophobic substituents could also be tolerated on the proline ring, similar to compound <b>4</b>.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Compound <b>24</b>, with a benzyl group, has <i>K</i><sub>d</sub> values of 3.9, 0.37, and 0.25 nM toward XIAP-BIR3, c-IAP1, and c-IAP2, respectively. In MDA-MB-231 cells, this compound has an IC<sub>50</sub> of 8.9 nM, making this compound >25 times more potent than that of compound <b>18</b>. Tricyclization is another strategy to control the conformation in SMAC mimetics.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Compound <b>25</b>, with a fused phenyl ring, is demonstrated to bind to XIAP-BIR3, c-IAP1, and c-IAP2 with <i>K</i><sub>d</sub> values of 18, 1.1, and 4.2 nM, respectively, and potently inhibits MDA-MB-231 cancer cell growth. In this bicyclic series, some compounds show good selectivity toward XIAP-BIR3 or c-IAPs.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Compound <b>26</b> (also named SM-1295) is reported to be greater than 1000-fold more potent toward cIAP1 than toward XIAP-BIR3, providing a powerful chemical tool for investigating the function of these IAPs.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structure optimization workflow for the bicyclic monovalent IAP antagonists developed by Dr. Shaomeng Wang and colleagues. The bicyclic parts are colored in orange, and the side chains are colored in black. # indicates that the compound has been advanced into clinical evaluations. The crystal structure of the complex is generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Genentech also published a series of conformationally constrained SMAC mimetics (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> The [7.5] bicyclic compound <b>27</b>, constrained at the valine–proline position, exhibits binding to the XIAP-BIR3, c-IAP1-BIR3, c-IAP2-BIR3, and ML-IAP-BIR domains with <i>K</i><sub>d</sub> values of 770, 50, 130, and 50 nM, respectively, and effectively inhibits MDA-MB-231 breast cancer and A2058 melanoma cell growth.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Compound <b>28</b>, which is bicyclized at the proline–isoleucine position to form a [5.5] azabicyclooctane scaffold, exhibits potent binding to XIAP-BIR3, c-IAP1, and ML-IAP with <i>K</i><sub>d</sub> values of 140, 33, and 38 nM, respectively. This compound promotes c-IAP1 degradation, activates caspases, inhibits breast cancer cell growth without affecting normal mammary epithelial cells, and effectively inhibits tumor growth in a breast cancer xenograft model when orally administered.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Compound <b>29</b> (also named LBW242, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), developed by Novartis, is cyclized at the proline–isoleucine position and binds to XIAP BIR3 with an IC<sub>50</sub> of 280 nM.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> LBW242 can induce apoptosis and overcome drug resistance in multiple myeloma (MM) cells while not affecting normal lymphocytes.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Other representative bicyclic monovalent IAP antagonists obtained using different cyclization strategies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.3.  Third-Generation Bivalent IAP Antagonists</h3><div class="NLM_p">Most monovalent compounds are pan-IAP inhibitors that bind to the BIR3 domains of XIAP, c-IAP1, and/or c-IAP2. Most of them exhibit selectivity for BIR3 over BIR2, while some do not exhibit BIR2 binding affinity or have not been tested for this activity. The binding of the BIR3 domain to caspase-9 and the binding of the BIR2 domain to caspase-3 and caspase-7 are two pathways that concurrently inhibit cell death.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Therefore, the X-ray crystal structure (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) of homodimeric SMAC with the BIR3 domain of XIAP is used to design bivalent SMAC mimetics containing two AVPI mimics with a linker, mimicking the mode of action of SMAC by targeting both the BIR2 and the BIR3 domains of XIAP. Dr. Xiaodong Wang and Dr. Patrick Harran published the first bivalent SMAC mimetic (<b>30</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A) in 2004, initiating a new generation of IAP antagonists.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> This compound, which is an unexpected product of a copper-mediated reaction, exhibits a comparable binding affinity toward the XIAP BIR3 domain (<i>K</i><sub>d</sub> = 120 nM) and a greatly increased affinity with XIAP that contains both BIR2 and BIR3 domains (an estimated <i>K</i><sub>d</sub> value of 0.3 nM).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) First reported bivalent SMAC mimetic. The corresponding monovalent mimetic is highlighted in blue. (B) Common design strategies of the bivalent IAP antagonists, highlighted in different colors. Ala = P1, Val = P2, Pro = P3, Ile = P4. Linker 1: P4–P4 strategy. Linker 2: P2–P2 strategy. Linker 3: P3–P3 strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Given that the alanine group is located in a small hydrophobic pocket without enough space for linkage (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), there are three ways in which the two molecules of the monovalent antagonists are commonly tethered (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). Herein, we provide representative cases of these three strategies (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>, and <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). In addition, there have been many other successful cases in patents, which are not included in this review.<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53,54)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Bivalent antagonists linked using the P4–P4 strategy, highlighted in red. # indicates that the compound has been advanced into clinical evaluations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Bivalent antagonists linked using the P2–P2 strategy, highlighted in pink.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Bivalent antagonists linked using the P3–P3 strategy, highlighted in orange.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of their monovalent SMAC mimetics, the Wang group published a series of bivalent IAP antagonists.<a onclick="showRef(event, 'ref55 ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref55 ref56 ref57 ref58">(55−58)</a> Compound <b>18</b> is designed to target XIAP BIR3, and molecular modeling predicts that this compound also binds to XIAP BIR2 with an experimental IC<sub>50</sub> of 5600 nM.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Tethering site determination is the first step performed before the synthesis of the bivalent molecules (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). The pro-<i>R</i> phenyl ring is retained in compound <b>31</b> (also named SM-157), and the pro-<i>S</i> phenyl ring of SM-122, exposed to solvent, is replaced by a [1,2,3]-triazole structure without detrimental effects. The IC<sub>50</sub> value of this compound toward XIAP-BIR2-BIR3 protein is 376 nM, which is comparable to that of SM-122 (IC<sub>50</sub> = 438 nM). Next, based on the linker region between BIR2 and BIR3, which contains roughly 25 residues (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), compound <b>32</b> (also known as SM-164) is designed and synthesized by using “click chemistry” to tether two monovalent compounds together via a flexible linker between the two triazole rings with a distance of approximately 15 Å. The binding affinity against the XIAP-BIR2-BIR3 protein increases significantly to 1.4 nM, making this compound around 300 times more potent than the monovalent SM-122 and >7000 times more potent than the AVPI peptide (IC<sub>50</sub> = 10 396 nM).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> SM-164 is 1000 times more potent than SM-122 as an apoptosis inducer in HL60 tumor cells. In the MDA-MB-231 xenograft model, this compound induces rapid c-IAP1 degradation and strong apoptosis in tumor tissues, and the tumors completely regress with no obvious toxicity observed in normal mouse tissues.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> In addition, a follow-up study described in detail that the linker has a major effect on intracellular concentrations, cell permeability, and overall cellular activity.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><div class="NLM_p">Compound <b>33</b> (also known as AZD5582) is designed from peptidomimetic <b>2</b> using the P4–P4 strategy with 1,3-bisacetylene linkage.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> This compound exhibits potent bindings to the BIR2 domain of XIAP (IC<sub>50</sub> = 21 nM) and the BIR3 domains of c-IAP1, c-IAP2, and XIAP (IC<sub>50</sub> = 15, 21, and 15 nM, respectively); causes c-IAP1 degradation (IC<sub>50</sub> = 0.1 nM); and significantly inhibits MDA-MB-231 cell growth (IC<sub>50</sub> < 0.06 nM). Compound <b>34</b> (also named as TL32711 and birinapant), manufactured by TetraLogic Pharmaceuticals, interacts with the BIR3 domains of XIAP, c-IAP1, c-IAP2 and the single BIR domain of ML-IAP with <i>K</i><sub>d</sub> values of 50, ∼1, 36 and ∼1 nM, respectively.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> This compound potently induces c-IAP1 and c-IAP2 degradation (5 and 151 nM, respectively) and inhibits TNF-mediated NF-κB activation. Compound <b>34</b> also promotes the degradation of cIAP1 and inhibits the TNF-mediated NF-κB signal transduction pathway more effectively than its monovalent counterpart (highlighted in blue box). These results indicate that specific bivalent IAP antagonists but not monovalent compounds are capable of effectively degrading cIAP1 and are preferred for the targeting of TNF-dependent signaling for diseases.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> This compound has been advanced into several clinical trials.<a onclick="showRef(event, 'ref13 ref63'); return false;" href="javascript:void(0);" class="ref ref13 ref63">(13,63)</a></div><div class="NLM_p">The Wang group also reported the synthesis of bivalent antagonists starting from compound <b>22</b> using the P2–P2 strategy (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64,65)</a> This compound exhibits high affinity to the BIR2 and BIR3 domains in XIAP, and computational model predicts that the solvent-exposed amide group in the eight-membered ring might be suitable for tethering. Therefore, compound <b>35</b> was designed using a linker similar to SM-164, exhibiting a <i>K</i><sub>d</sub> value of 2 nM with XIAP containing the BIR2 and BIR3 domains. This compound is also cell permeable, with an IC<sub>50</sub> value of 3.4 nM against MDA-MB-231 cells, and efficiently induces the degradation of c-IAP1 and c-IAP2 in cancer cells at concentrations as low as 1 nM; it also activates caspase-3 and caspase-8 and cleaves PARP at single-digit nanomolar concentrations.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Further SAR studies of this tethering strategy leads to the potent compound <b>36</b> (SM-1200). Compared with SM-164, the major advantage of this compound is its PK profile, exhibiting a 17-fold increase in the AUC in rat plasma and an 8-fold decrease in clearance. In addition, compound <b>36</b> exhibits 99% tumor regression at 10 mg/kg (iv) in the MDA-MB-231 xenograft model when administered weekly for 4 weeks with 6 out of 7 mice remaining tumor free 27 days after the final dose.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Compound <b>38</b> (AEG40730) is a peptidomimetic generated by tethering two molecules of compound <b>37</b> (AEG40599).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> It potently binds to the BIR3 domains of the XIAP, c-IAP1, and c-IAP2 proteins, but the potency of BIR2 binding has not been reported.</div><div class="NLM_p last">Bristol-Myers Squibb published tetrahydroisoquinoline-based heterodimeric bivalent compounds tethered at the proline site (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67,68)</a> Tethering of compounds <b>1</b> and <b>39</b> using a carboxybenzamide linker results in compound <b>40</b>, which exhibits a high binding affinity with the XIAP and c-IAP1 proteins containing BIR2 and BIR3 domains. This compound also exhibits a TGI value of 100% in the A875 tumor xenograft model, while monovalent inhibitors (e.g., GDC-0152, compound <b>6</b>) are inactive.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Subsequent studies examined a series of highly potent analogs with truncated linkers.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Compound <b>41,</b> obtained by directly tethering <b>1</b> and <b>39</b>, exhibits improved biochemical and cell-based activity. In addition, complete tumor regression is demonstrated without substantial weight loss in both the A875 melanoma and H1703 lung xenograft models.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.4.  Fourth-Generation Non-Alanine IAP Antagonists Identified by Fragment-Based Drug Discovery (FBDD)</h3><div class="NLM_p">Instead of using the AVPI peptide as a starting point, four nonalanine fragments of millimolar binding affinities with XIAP BIR3 were identified by Astex Pharmaceuticals using an FBDD-based strategy.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Among these fragments, fragment <b>42</b> (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A) exhibits a promising binding mode with XIAP BIR3 despite weak binding and low ligand efficiency (LE), leading to further fragment optimizations. Fragment <b>43</b> was then designed based on the AVPI peptide with greatly improved IC<sub>50</sub> values toward the XIAP BIR3 and c-IAP1 BIR3 proteins. On the basis of the cocrystal structure of the complex (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B), this fragment locates at the AVP positions of the BIR3 protein but the binding pocket is not fully occupied. Structure-based drug design (SBDD) was then utilized to obtain an early lead compound <b>44</b>, exhibiting dual inhibition of the XIAP and c-IAP1 BIR3 proteins (IC<sub>50</sub> = 160 and 10 nM). The LE is higher than the benchmark level of 0.3. At the cell level, this compound is also active in MDA-MB-231 and EVSA-T cancer cells, with EC<sub>50</sub> values of 590 and 100 nM, respectively. In the MDA-MB-231 xenograft model, this compound significantly reduces the tumor size when administered intraperitoneally. Further optimization results in the potent, orally bioavailable compound <b>45</b> (also named AT-IAP), which is a dual antagonist of XIAP and c-IAP1 (IC<sub>50</sub> = 5.1 and 0.32 nM).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>C, the morpholine mimics the isopropyl group of the valine amino acid of SMAC and occupies the valine-binding pocket. In addition to common hydrogen bonds labeled in the figure, a water molecule is observed in the cocrystal structure, mediating an H-bond interaction between the tertiary amine of the piperazine ring and the NH of Trp323. The piperazine-indoline forms a suitable conformation, with the fluorinated phenyl group located on the hydrophobic side of the binding pocket. Although AT-IAP has acceptable oral bioavailability in mice (<i>F</i> = 22%) and antitumor growth activity in mouse MDA-MB-231 xenograft models, the oral bioavailability at 5 mg/kg is only 2% in cynomolgus monkeys, and the hERG inhibition rate at 30 μM is 70%. Therefore, in order to improve the metabolic stability and cardiac safety profile, further optimization was performed and results in the IAP antagonist clinical candidate <b>46</b> (also named ASTX660). The X-ray cocrystal structure (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>D) reveals that <b>46</b> binds to XIAP in a manner similar to AT-IAP. This compound exhibits a favorable preclinical profile and is currently being evaluated in a phase I/II clinical trial (NCT02503423).<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71,72)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structure optimization workflow of nonalanine IAP antagonists (A) and their cocrystal complexes with the XIAP BIR3 protein: (B) fragment <b>43</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5C7B">5C7B</a>); (C) AT-IAP (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M6L">5M6L</a>); (D) ASTX660 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQW">5OQW</a>). The red dots represent water molecules in the crystal complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">4.  Other Representative IAP Antagonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75865" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75865" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">4.1.  Benzoxazepinones and Benzodiazepinones Are Identified as XIAP BIR2 Selective Antagonists</h3><div class="NLM_p">Hoffmann-La Roche published a series of benzoxazepinones and benzodiazepinones that selectively target BIR2 over BIR3 (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>A).<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a> The benzazepinone <b>47</b> is an initial hit from a high-throughput screening and has selective binding affinity for XIAP BIR2.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> A peptidomimetics SAR study shows that N-methylation of the <span class="smallcaps smallerCapital">l</span>-alanine moiety and substituents containing aromatic groups on the azepinone N-substituent are preferred. Compound <b>48</b> exhibits high BIR2-selective binding affinity, unacceptably high in vivo clearance (521 mL min<sup>–1</sup> kg<sup>–1</sup>), and low blood stability (7%). The introduction of substituents onto the azepinone ring was thought to be a suitable approach to improve the PK profile. Compound <b>49</b>, with a spiro-tetrahydropyran moiety, significantly improves the blood stability (88%) and clearance (60 mL min<sup>–1</sup> kg<sup>–1</sup>) but remains unsatisfactory. In addition, replacement of the bromine with a carboxylic acid (<b>50</b>) improves BIR2 potency, although unfavorable clearance is observed. To guide further design of new analogs, a cocrystal structure of compound <b>50</b> with the XIAP BIR2 domain is obtained revealing features that might contribute to the selectivity for BIR2 over BIR3 (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>B).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The left side of the figure shows four hydrogen bonds, similar to the structure of the BIR3 domain with other antagonists. In contrast, the fused benzene ring of benzoxazepinone locates in the His223 region, where a tryptophan residue is located in the BIR3 protein. The naphthyl ring system is inserted into the Lys206-Lys208 hydrophobic pocket and forms a hydrogen bond with Lys206 backbone NH. The methoxy group of this residue is inserted into the narrow loop between His223 and Phe224. The other part of the naphthyl moiety locates at the solvent-exposed edge, indicating that relatively bulky groups can be tolerated at this site. Compound <b>51</b>, with an indole moiety, exhibits excellent selective BIR2 potency, an acceptable clearance rate (41 mL min<sup>–1</sup> kg<sup>–1</sup>), and good oral bioavailability (<i>F</i> = 53%). However, this compound has some safety issues that make it unfavorable as a clinical lead.<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a> This compound is a potent inhibitor (IC<sub>50</sub> = 1.8 μM) of CYP3A4 and demonstrates a time-dependent inhibition (TDI). The potential of CYP3A4 induction (CYP3A4 mRNA > 40% of control at 10 μM) is also unacceptable.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structure optimization workflow for benzoxazepinone and benzodiazepinone synthesis (A) and the cocrystal complexes of these compounds with the XIAP BIR2 protein: (B) compound <b>50</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJV">4KJV</a>); (C) compound <b>52</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJU">4KJU</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Subsequent efforts focused on safety optimization using a related benzodiazepinone scaffold to overcome the above drawbacks.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Compound <b>52</b> is designed to have a substituent on the new nitrogen atom oriented toward a solvent-exposed area in the cocrystal complex (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>C). The substituted phenyl compound retains high selectivity over BIR3 and low CYP3A4 inhibition. Similar to the spiro-tetrahydropyran compound, introduction of a trans methyl group at the 4 position of the benzodiazepinone core might lead to a compound with improved metabolic stability as well. Compound <b>53</b> was developed using this strategy to retain potent BIR2 activity and excellent clearance. The CYP3A4 inhibition also decreases compared to compound <b>51</b> to an acceptable value of 16 μM. Moreover, no induction is observed at concentrations up to 10 μM.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">4.2.  Macrocyclic Antagonists</h3><div class="NLM_p">In addition to the above antagonists, macrocyclic molecules are another series of compounds that act as IAP antagonists (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>). Compound <b>54</b>, also developed by the Wang group, is a cyclic, bivalent SMAC mimetic that simultaneously modifies the valine and isoleucine positions.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> This compound is much more potent than the AVPI peptide, with <i>K</i><sub>d</sub> values of 4 or 4400 nM toward XIAPs containing the BIR3 or BIR2 domain alone. For the XIAP containing both BIR2 and BIR3 domains, this compound exhibits a biphasic dose–response curve, with IC<sub>50</sub> values of 0.5 and 406 nM for the two binding sites. This compound is also cell permeable and effectively inhibits MDA-MB-231 cell growth (IC<sub>50</sub> = 2200 nM). The amide linker is later replaced with two triazoles to reduce the peptidic characteristics of the compound.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Compound <b>55</b> (also known as SM-162) is more potent than compound <b>54</b> at binding to XIAP, c-IAP1, and c-IAP2. This compound is 5–8 times more potent than compound <b>54</b> in inhibiting the growth of MDA-MB-231 breast cancer and SK-OV-3 ovarian cancer cells.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Macrocyclic molecules as IAP antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Bristol-Myers Squibb and Ensemble Therapeutics together screened macrocycle libraries obtained by DNA-programmed chemistry and identified antagonists that exhibited binding to XIAP BIR2 and BIR3 domains.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Compound <b>56</b> is obtained after structural optimization, with similar affinities for XIAP and c-IAP1 proteins containing both BIR2 and BIR3 domains. This compound also exhibits potent proapoptotic activity in several cancer cell lines and causes complete tumor regression at a dose of 50 mg/kg in an A875 xenograft model. Further optimization of the linkers and the side chains of the macrocyclic compounds results in compound <b>57</b>, with a cyclopropylacylsulfonamide group and a propyl linker.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> This compound exhibits high binding affinities to XIAP and c-IAPs. In addition, both in vitro and in vivo antitumor activities are significantly improved compared with those of the initial lead compound <b>56</b>. Complete tumor regression (TGI > 100%) is observed upon intraperitoneal administration of the compound at 5 mg/kg in the A875 xenograft model. The PK profile shows that this compound has a short to moderate half-life and very low clearance in mice, rats, and dogs.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">5.  IAP Antagonists in Clinical Development</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76267" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76267" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Currently, there are at least eight small-molecule IAP antagonists in clinical trials (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>).<a onclick="showRef(event, 'ref63 ref80'); return false;" href="javascript:void(0);" class="ref ref63 ref80">(63,80)</a> Among these trials, the phase I trial using compound <b>6</b> (GDC-0512) for the treatment of solid cancers has been terminated early by the sponsor for reasons unrelated to patient safety or antitumor activity (NCT00977067). Compound <b>58</b> (GDC-0917/CUDC427) completed phase I trials on refractory solid tumors or lymphomas, but the results have not been reported (NCT01226277).</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. IAP antagonists with disclosed structures that have been advanced into clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>7</b> (LCL161), developed by Novartis, completed phase II trials on triple-negative breast cancer in combination with paclitaxel (NCT01617668) and on relapsed or refractory multiple myeloma (NCT01955434). The pathologic complete response (pCR) rate after 12 weeks of therapy was measured. The results showed that LCL161 with paclitaxel had a pCR rate of 24.9%, compared with the value of 23.4% observed for paclitaxel alone, in patients with positive gene expression signatures, while a value of less than 10% was observed in participants with negative expression signatures. The overall response rate was 0% when LCL161 was used alone to treat myeloma and 17.4% when LCL161 was used in combination with cyclophosphamide. There are at least four phase I or II trials recruiting patients with other indications to test LCL161 in combination with other drugs (NCT02098161, NCT02649673, NCT03111992, and NCT02890069).</div><div class="NLM_p">Compound <b>22</b> (SM-406/AT-406) from Ascenta, now partnered with Debiopharm (Debio-1143), is in phase I/II trials for dose finding and efficacy evaluation (NCT02022098). Another phase I trial of this compound in combination with avelumab is recruiting participants with advanced solid malignancies and advanced or metastatic NSCLC after platinum-based therapy (NCT03270176).</div><div class="NLM_p">Compound <b>34</b> (TL32711/Birinapant), a bivalent SMAC mimetic developed by TetraLogic, has been advanced into several phase I or II trials as a single agent (NCT00993239, NCT01681368, NCT01486784, and NCT01681368). The first human phase I trial with birinapant as a single agent in 50 patients with advanced solid tumors or lymphoma (NCT00993239) determined the maximum tolerated dose (MTD) of 47 mg/m<sup>2</sup> with favorable pharmacodynamics (PD) and PK properties. However, toxicities including headache, nausea, and vomiting and two cases of Bell’s palsy (grade 2) were observed at 63 mg/m<sup>2</sup>.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> In a phase II trial, the effectiveness of birinapant for ovarian, primary peritoneal, or fallopian tube cancer was evaluated (NCT01681368). Eleven patients received birinapant at 47 mg/m<sup>2</sup> on days 1, 8, and 15 of 28-day cycles. However, accrual was terminated for lack of a clinical benefit as a single agent in this small population.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Combinations with gemcitabine (NCT01573780), 5-azacitidine (NCT02147873, NCT01828346), or other standard chemotherapeutics such as irinotecan or docetaxel (NCT01188499), carboplatin (NCT02756130), conatumumab (NCT01940172), and pembrolizumab (NCT02587962) are also in progress to identify optimal synergistic combinations.</div><div class="NLM_p">Compound <b>59</b> (also named APG-1387), a bivalent compound developed by Ascentage, has been advanced into two phase I trials to test the safety, tolerability, and PK and PD profile.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The first indication was advanced solid tumors or hematologic malignancies, and the compound was used as a single agent or in combination with systemic anticancer agents (NCT03386526). Another study indicates a dismal prognosis in hepatocellular carcinoma (HCC) patients with copy number alterations of cIAP1, cIAP2, and XIAP.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Therefore, the use of APG-1387 has been attempted for the treatment of HBV-positive HCC. The result shows that this compound directly induced cancer cell apoptosis and promoted innate antitumor immunity, suggesting that APG1387 could be a good candidate for combination with immune checkpoint inhibitor anti-PD1 antibody treatment to overcome low responses of checkpoint inhibitors in HBV-positive HCC.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Several phase Ib/II studies will be implemented to further assess the antitumor effects of APG-1387 in combination with pembrolizumab.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Another trial will explore the tolerability, safety, and PK/PD of APG-1387 in chronic hepatitis B patients (NCT03585322, see discussion in <a class="ref internalNav" href="#sec6_4_4" aria-label="section 6.4.4">section 6.4.4</a>).</div><div class="NLM_p last">An open-label, dose-escalation phase I/II study (NCT02503423) of compound <b>46</b> (ASTX660) from Astex Pharmaceuticals is recruiting participants with advanced solid tumors and lymphomas to determine MTD, recommended phase II dose (RP2D), and recommended dosing regimen and to obtain preliminary efficacy, PK, and target engagement data. AEG40826 (HGS1029), the hydrochloride salt of a small-molecule inhibitor of IAP with an undisclosed structure (proposed to be a bivalent SMAC mimetic), was found to be tolerated for the treatment of advanced solid tumors in a phase I trial (NCT00708006), but no further trials have been reported.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">6.  Outlook and Future Strategies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57705" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57705" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">6.1.  Advantages and Disadvantages of Monovalent and Bivalent IAP Antagonists</h3><div class="NLM_p">As drug candidates, both monovalent and bivalent SMAC mimetics have their advantages and disadvantages.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Monovalent antagonists are potent toward XIAP-BIR3 (i.e., <b>18</b>, <i>K</i><sub>d</sub> = 26 nM) but much weaker binders of XIAP containing the BIR2 and BIR3 domains (i.e., <b>18</b>, IC<sub>50</sub> = 438 nM) and thus generally less effective at inhibiting XIAP compared to the corresponding bivalent antagonists (i.e., <b>32</b>, IC<sub>50</sub> = 1.4 nM). Although monovalent mimetics are approximately 100–1000 times less potent than the corresponding bivalent compounds at the cellular level, these compounds exhibit superior pharmacological properties when administered orally due to their significantly lower molecular weight. Monovalent compounds <b>21</b> (SM-337) and <b>22</b> (SM-406) have oral bioavailability of 24% and 46%, respectively, in rats.<a onclick="showRef(event, 'ref44 ref48'); return false;" href="javascript:void(0);" class="ref ref44 ref48">(44,48)</a> Bivalent mimetics, including macrocyclic antagonists, are mainly administered intravenously, such as compounds <b>32</b> (SM-164), <b>36</b> (SM-1200), <b>40</b>, <b>41</b>, and <b>59</b> (APG-1387), or intraperitoneally, such as compounds <b>55</b> and <b>56</b>, which is a disadvantage for further clinical development.</div><div class="NLM_p last">In terms of mechanism, monovalent and bivalent SMAC mimetics have their own potential advantages. As discussed, the intrinsic apoptotic pathway is activated in response to intracellular damage, leading to activation of caspase-9.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> The extrinsic apoptotic pathway is activated by the binding of death ligands, such as TNFα, resulting in the activation of caspase-8. Both caspase-8 and caspase-9 can activate the terminal caspase-3 and caspase-7.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Both pathways are inhibited by XIAP via binding of the BIR3 domain to caspase-9 and the BIR2 domain to the terminal caspase-3 and caspase-7.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Most monovalent mimetics are pan-IAP inhibitors that bind to the BIR3 domains of XIAP, c-IAP1, and/or c-IAP2, such as the SM series, and some of these compounds exhibit selectivity for BIR2 over BIR3, such as compounds <b>47</b>–<b>53</b>. Bivalent compounds mirror the mode of action of SMAC by targeting both the BIR2 and BIR3 domains of XIAP and blocking the inhibition of the activity of caspase-9, caspase-3, and caspase-7 using a single molecule. Thus, selectively targeting the BIR2 domain of XIAP using monovalent mimetics via a distinct mechanism from that of pan-IAP inhibitors and bivalent compounds could result in different PD properties.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Collectively, the advantages and disadvantages of monovalent and bivalent inhibitors cannot be ignored in clinical studies, and further research is required to obtain detailed insight.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">6.2.  Challenges in the Development of SMAC Mimetics in the Future</h3><div class="NLM_p">Currently, most SMAC mimetics are pan-IAP antagonists that nonselectively inhibit XIAP, c-IAP1, and c-IAP2, while only a few compounds are selective for XIAP, c-IAP1, or c-IAP1/2.<a onclick="showRef(event, 'ref35 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref37">(35,37)</a> Almost all IAP antagonists contain the alanine motif derived from the natural AVPI peptide. Recently, a non-alanine monovalent mimetic is considered for the first time as a clinical candidate (<b>46</b>, ASTX660), providing a novel idea for future design of selective IAP antagonists with promising chemical space in this area.<a onclick="showRef(event, 'ref69 ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref69 ref71 ref72">(69,71,72)</a> A covalent antagonist (<b>8</b>) selectively targeting the BIR3 domain of XIAP, not c-IAP1/2, indicates that covalent binding with specific residues on the IAP could provide insight into the relative selectivity potentials.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">To date, eight IAP inhibitors have been advanced into clinical trials. These compounds, however, demonstrate minimal to moderate efficacy alone, and most of them are now being re-evaluated in combination with additional standard therapies, such as paclitaxel and gemcitabine (see <a class="ref internalNav" href="#sec5" aria-label="section 5">section 5</a> and <a class="ref internalNav" href="#sec6_3" aria-label="section 6.3">section 6.3</a>). In addition, SMAC mimetics also stimulate TNFα-dependent apoptosis.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Mechanistically, the SMAC mimetic stimulates NF-κB activation, inducing elevated levels of cytokines and chemokines in normal tissues, which might have potential adverse effects in clinical studies. For instance, the phase I trial of compound <b>6</b> (GDC-0152) was terminated while it was reported to cause acute induction of TNFα in the plasma of dogs and rats that may result in TNFα-mediated toxicity.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> On the other hand, in several phase I studies of SMAC mimetics, including GDC-0152, no severe TNFα-driven systemic inflammatory response or severe cytokine release syndrome was observed in humans.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> It remains to be determined what may have contributed to such differences. It has also been reported that a bivalent SMAC mimetic, BV6,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> can affect the host microenvironment to increase bone metastasis via unexpected osteoclast activation.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></div><div class="NLM_p last">On the basis of the apoptotic pathway, any cancer cell expressing TNFR1 should respond to SMAC mimetic treatment because TNFR1 expression is ubiquitous among various cancer cell types. However, screening of a panel of 50 human NSCLC cell lines shows that only 22% are sensitive to SMAC mimetics treatment.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Therefore, insensitivity to SMAC mimetics is expected to be common, and utilization of combination therapies is likely required to minimize this limit.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">6.3.  Combinatorial Therapies with Other Agents for the Treatment of Cancers</h3><div class="NLM_p">On the basis of the above challenges, IAP antagonists have been extensively evaluated in combination with other cytotoxic agents, kinase-targeted agents, death receptor ligands, and radiation therapy.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Several formulations using combinatorial therapies have been evaluated in clinical trials because of the moderate efficacy of IAP antagonists as single therapies (see <a class="ref internalNav" href="#sec4" aria-label="section 4">section 4</a>).</div><div class="NLM_p">Many cytotoxic drugs, such as gemcitabine, doxorubicin, etoposide, cisplatin, 5-fluorouracil, vinorelbine, irinotecan, and cytarabine, have been tested in combination with IAP antagonists, and synergistic effects on various cancers, including pancreatic, lung, colon, prostate, breast, and skin cancer as well as acute leukemia, have been detected, mostly in vitro that require further validation.<a onclick="showRef(event, 'ref91 ref93 ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref91 ref93 ref94 ref95">(91,93−95)</a></div><div class="NLM_p">IAP antagonists have also been reported to potentiate the effects of kinase-targeting agents. For instance, phosphatidyl inositol 3-kinase (PI3K) has been reported to potentially upregulate c-IAP2 by inhibition of caspase-3.<a onclick="showRef(event, 'ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref96 ref97">(96,97)</a> Inhibition of the PI3K pathway by a PI3K inhibitor, LY294002, could regulate c-IAP2 and sensitize resistant cancer cells to a SMAC mimetic and TNFα.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Fms-like tyrosine kinase 3 (FLT3), which is mutated in approximately 30% of acute myelogenous leukemia (AML) patients, is a promising therapeutic target.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> The SMAC mimetics LCL161 and LBW242 enhance the proapoptotic effects of a FLT3 inhibitor, PKC412, against leukemia both in vitro and in vivo.<a onclick="showRef(event, 'ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref100 ref101">(100,101)</a> In addition, SMAC mimetics have been shown to exhibit enhanced effects in combination with BCR-ABL inhibitors, such as nilotinib and imatinib, and epidermal growth factor receptor (EGFR) inhibitors, such as trastuzumab, lapatinib, and gefitinib.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div><div class="NLM_p">TNF-related apoptosis-inducing ligand (TRAIL), a death receptor ligand, is used to treat various cancers. Debatin et al. first reported a proof-of-concept study to show that a SMAC peptide could strongly enhance the antitumor activity of TRAIL in an intracranial malignant glioma xenograft model.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> The bivalent SMAC mimetic (<b>32</b>, SM-164) exhibits a highly synergistic effect with TRAIL in both TRAIL-sensitive and TRAIL-resistant breast, prostate, and colon cancer cell lines. In a breast cancer (cell name 2LMP) xenograft model, the agents are ineffective alone, but a combination of SM-164 with TRAIL induces rapid and consistent tumor regression.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p last">The use of SMAC mimetics in combination with radiation is also an effective strategy,<a onclick="showRef(event, 'ref103 ref104'); return false;" href="javascript:void(0);" class="ref ref103 ref104">(103,104)</a> such as the treatment of pancreatic cancer,<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> prostate cancer,<a onclick="showRef(event, 'ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref106 ref107">(106,107)</a> gliblastoma,<a onclick="showRef(event, 'ref108 ref109'); return false;" href="javascript:void(0);" class="ref ref108 ref109">(108,109)</a> head and neck squamous cell carcinoma,<a onclick="showRef(event, 'ref110 ref111'); return false;" href="javascript:void(0);" class="ref ref110 ref111">(110,111)</a> and breast cancer.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">6.4.  Future Directions and New Applications of IAP Antagonists</h3><div id="sec6_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">6.4.1.  Selective IAP Inhibitors</h4><div class="NLM_p last">As presented in <a class="ref internalNav" href="#sec3" aria-label="sections 3">sections 3</a> and <a class="ref internalNav" href="#sec4" aria-label="4">4</a>, most of the SMAC mimetics exhibit nonselective binding to XIAP, c-IAP1, and c-IAP2, with a few exceptions. Genentech reported the design of SMAC mimetics, such as compound <b>5</b>, that selectively target c-IAP1 and c-IAP2 over XIAP.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Compound <b>8</b> forms a covalent bond with a lysine residue of XIAP, exhibiting promising selectivity for XIAP over c-IAP1/2.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The bicyclic (compound <b>9</b>) and tricyclic (<b>10</b>) mimetics selectively bind to c-IAP1 BIR3 over XIAP BIR3.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> Second-generation monovalent mimetics <b>47</b>–<b>53</b> exhibit selectivity for BIR2 over BIR3, disrupting the interaction with the terminal caspase-3 and caspase-7 and exhibiting different PD properties in mice.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> In addition, selective targeting of other family members, such as ML-IAP and survivin, has also demonstrated promising therapeutic potential.<a onclick="showRef(event, 'ref113 ref114'); return false;" href="javascript:void(0);" class="ref ref113 ref114">(113,114)</a> Notably, most of the activity of the current IAP antagonists is likely attributed to their antagonism of cIAP1. A study showed that monovalent and bivalent IAP antagonists activate the E3 ligase activity of cIAP1 by promoting RING domain dimerization, leading to caspase-8-mediated apoptosis.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> In other words, XIAP is not required. However, most IAP antagonists have been designed based on the XIAP-BIR3/SMAC interaction and the homology between XIAP and cIAP1 BIR3 domains. Therefore, what is the true role of cIAPs versus XIAP in the activity of pan-IAP or “selective” IAP antagonists? The development of truly selective, i.e., not BIR-directed, IAP antagonists will help address this issue. Given the sufficient structural differences of the IAP family, selective IAP antagonists can be developed. These selective agents at least could be applied as useful tool compounds or chemical probes to characterize the biological functions of individual IAP members and may be further evaluated as therapeutic agents if they happen to have clinical advantages.</div></div><div id="sec6_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">6.4.2.  Induction of Protein Degradation by Incorporating IAP Ligands into Conjugates</h4><div class="NLM_p">The occupation of a binding site is a mainstream strategy for small-molecule drug discovery. Alternatively, the target protein can be tagged for elimination by protein degradation.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Proteolysis-targeting chimeras (PROTACs) and specific and nongenetic IAP-dependent protein erasers (SNIPERs) are two protein degradation strategies.<a onclick="showRef(event, 'ref116 ref117 ref118 ref119 ref120 ref121 ref122 ref123 ref124 ref125 ref126 ref127 ref128 ref129 ref130 ref131'); return false;" href="javascript:void(0);" class="ref ref116 ref117 ref118 ref119 ref120 ref121 ref122 ref123 ref124 ref125 ref126 ref127 ref128 ref129 ref130 ref131">(116−131)</a> These strategies share a mechanism for degradation of the protein of interest (POI) using hybrid molecules or conjugates of two different ligands and a linker (three examples are shown in <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>). These molecules contain one ligand for the POI and another for the ubiquitin–proteasome system (UPS) to degrade the protein. By use of this mechanism, several protein degradation inducers have been designed for several POIs,<a onclick="showRef(event, 'ref116 ref119 ref120 ref121 ref122 ref123 ref124 ref125 ref126 ref127 ref128 ref129 ref130 ref131'); return false;" href="javascript:void(0);" class="ref ref116 ref119 ref120 ref121 ref122 ref123 ref124 ref125 ref126 ref127 ref128 ref129 ref130 ref131">(116,119−131)</a> such as androgen receptor (AR),<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> BCR-ABL protein,<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> and estrogen receptor α (ERα).<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> For instance, compound <b>60</b>, with a LCL161 moiety, is developed with effective proteasomal degradation of AR at 3 μM, and AR-mediated gene expression and proliferation of androgen-dependent prostate cancer cells were suppressed. Caspase activation and apoptosis are also observed but not in cells treated with AR antagonists alone.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> BCR-ABL allosteric ligands are incorporated in the SNIPER using LCL161 as an IAP antagonist moiety to obtain compound <b>61</b>, which exhibits potent BCR-ABL degradation activity.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Compound <b>62</b> is an example associated with ERα degradation and is synthesized by connecting the ERα ligand 4-hydroxy-tamoxifen with an analog of compound <b>4</b> by a PEG linker. This compound exhibits high binding affinity for IAPs and potently induces the degradation of ERα at concentrations lower than 3 nM with the simultaneous degradation of c-IAP1 and XIAP.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Collectively, instead of traditional small-molecule-based strategies, emerging technologies based on IAP degradation, such as SNIPER technology, are attracting considerable attention in drug discovery. Highly potent IAP antagonists, monovalent and bivalent SMAC mimetics, might be used as tool compounds for assembly into conjugates for degradation as an alternative strategy for drug development.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Representative conjugates with an IAP antagonist moiety for target protein degradation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">6.4.3.  Beyond Apoptosis: Inflammation, Cell Migration, Immunity, Necroptosis, and Pyroptosis</h4><div class="NLM_p">In addition to apoptosis, XIAP and c-IAP1/2 proteins play critical roles in many other cellular processes.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> For instance, the activation of NF-κB is regulated by IAPs. The NF-κB pathway controls the expression of genes in regulating inflammation, cell migration, and immunity as well as cell survival. c-IAP1 and c-IAP2 cause cancer cells resistant to apoptosis induced by TNFα, which is one key mediator of cancer-related inflammation.<a onclick="showRef(event, 'ref132 ref133'); return false;" href="javascript:void(0);" class="ref ref132 ref133">(132,133)</a> IAPs are shown to interact with other substrates, leading to either a positive or negative influence on cell movement.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> XIAP can negatively regulate the activity of the Rho GDP dissociation inhibitor by modulating the SUMOylation of this protein to increase actin polymerization and cell motility.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Ubiquitin-dependent proteasomal degradation of XIAP and c-IAP1 limits cell migration.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> IAP antagonists can also modulate the immune system.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> A recent work indicates that IAP antagonists induce antitumor activity by modulating innate and adaptive immunity via activation of the NF-κB pathway.<a onclick="showRef(event, 'ref19 ref137 ref138 ref139'); return false;" href="javascript:void(0);" class="ref ref19 ref137 ref138 ref139">(19,137−139)</a> Mouse models exhibit synergism between IAP antagonists, such as LCL161, and anti-PD-1 immunotherapy.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Another report shows that IAP antagonists could enhance cytokine production in iNKT cells.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> These results suggest that IAP antagonists may also be useful as novel immunomodulation therapies for the treatment of human cancers.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">In addition to the above roles of IAPs, SMAC mimetics are also widely applied to promote necroptosis, another important form of PCD.<a onclick="showRef(event, 'ref141 ref142 ref143 ref144'); return false;" href="javascript:void(0);" class="ref ref141 ref142 ref143 ref144">(141−144)</a> A necroptosis model has been established by Yuan et al. A standard stimulus, such as TNF or FasL, is used to activate TNFR1 signaling resulting in both apoptosis and necroptosis. Then, IAPs are inhibited by a SMAC mimetic (such as SM-164, BV6, or birinapant) to further promote TNF-induced cell death.<a onclick="showRef(event, 'ref144 ref145 ref146'); return false;" href="javascript:void(0);" class="ref ref144 ref145 ref146">(144−146)</a> Finally, a caspase inhibitor, usually Z-VAD-FMK, is used to block caspase-8 to inhibit the apoptotic pathway and stimuli the necroptotic signaling. SMAC mimetics here are used as tool compounds to consume/inhibit IAPs and facilitate the formation of a necrosome. Therefore, it is possible to use SMAC mimetics to treat apoptosis-resistant cancers by inducing necroptosis.<a onclick="showRef(event, 'ref146 ref147 ref148 ref149 ref150 ref151 ref152 ref153 ref154'); return false;" href="javascript:void(0);" class="ref ref146 ref147 ref148 ref149 ref150 ref151 ref152 ref153 ref154">(146−154)</a></div><div class="NLM_p last">IAP inhibition using SMAC mimetics or genetic deletion triggers cleavage of IL-1β mediated by the NLRP3-caspase-1 inflammasome and caspase-8 in a caspase-1-independent manner.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> A mouse model study shows that c-IAP1 is tightly linked to caspase-11.<a onclick="showRef(event, 'ref156 ref157'); return false;" href="javascript:void(0);" class="ref ref156 ref157">(156,157)</a> IAPs, in theory, may be associated with pyroptosis, a lytic form of PCD induced by the inflammatory caspase-1 and caspase-11.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Elucidation of the mechanism by which IAP family proteins are involved in pyroptosis requires further research.</div></div><div id="sec6_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">6.4.4.  Beyond Cancer: Hepatitis B Virus (HBV)</h4><div class="NLM_p">A recent study shows that antagonizing the function of c-IAPs might promote the clearance of HBV infection by preventing TNF-mediated killing/death of infected cells.<a onclick="showRef(event, 'ref159 ref160'); return false;" href="javascript:void(0);" class="ref ref159 ref160">(159,160)</a> The SMAC mimetic birinapant (<b>34</b>) rapidly reduces serum HBV DNA levels and hepatitis B surface and core antigens in animal models.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> In addition, compound <b>59</b> (APG-1387) is in phase I trials in patients with chronic hepatitis B (NCT03585322). This is a new strategy for the treatment of HBV, and the effectiveness of this strategy in the clearance of HBV in patients requires further clinical research.</div><div class="NLM_p last">In summary, evading apoptosis and other type of programmed cell death is a key hallmark for cancer development. It also introduces a major barrier to cancer treatment. Antagonizing IAPs is a promising and logical strategy to restore the defected death pathway in cancer cells to improve the outcome of therapeutic treatment. To some extent, the science of IAPs, SMAC, and IAP antagonists, as well as how these proteins and compounds interact to mediate inflammation, apoptosis, and necroptosis, remains in its infancy. With additional progress in the preclinical and clinical stages of IAP antagonists and better understanding of the biological functions of IAPs, the clinical future is promising for IAP antagonists.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01668" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64642" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64642" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chengguo Xing</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4266-6236" title="Orcid link">http://orcid.org/0000-0002-4266-6236</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bbd8d3ded5dcdcced4c3d2d5dcfbd8d4cb95ceddd795dedfce"><span class="__cf_email__" data-cfemail="2c4f4449424b4b59435445424b6c4f435c02594a4002494859">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunlin Zhuang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0569-5708" title="Orcid link">http://orcid.org/0000-0002-0569-5708</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c8b2aba4a6a9bca0a9a688f9fefbe6aba7a5"><span class="__cf_email__" data-cfemail="3a405956545b4e525b547a0b0c0914595557">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hui Cong</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lijuan Xu</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yougen Wu</span> - <span class="hlFld-Affiliation affiliation">College
of Tropical Agriculture and Forestry, Hainan
University, 58 Renmin
Avenue, Haikou 570228, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhuo Qu</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tengfei Bian</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, University of Florida, 1345 Center Drive, Gainesville, Florida 32610, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wannian Zhang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>H.C. and L.X. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34428" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34428" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Hui Cong</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=BIO-d7e1987-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Hui Cong</b> received her Bachelor’s degree from Bengbu Medical College, China (2016). She is now a graduate student at Ningxia Medical University under the supervision of Prof. Chengguo Xing. In 2018, she joined Second Military Medical University as a joint graduate student. Her research interests focus on drug discovery for the treatment of antimultidrug resistant cancers.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Lijuan Xu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=BIO-d7e1992-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lijuan Xu</b> received her Bachelor’s degree from Bengbu Medical University, China (2017). She worked as a technician at the School of Pharmacy, Second Military Medical University (2017–2018). She is now a graduate student at Ningxia Medical University. Her research interests focus on inhibitors of programmed cell death.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Yougen Wu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=BIO-d7e1997-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yougen Wu</b> received his Bachelor’s degree from Jiangxi Agricultural University (2000) and a Ph.D. in Medicinal Plants from Nanjing Agricultural University (2009). He worked in the College of Pharmacy, University of Hawaii at Hilo as a postdoctoral researcher (2012–2013, 2015). He was sponsored by the China Scholarship Council to work under the supervision of Prof. Chengguo Xing at the University of Florida (2018). Currently, he is a Professor at the College of Tropical Agriculture and Forestry, Hainan University. His research interests focus on the isolation and identification of active ingredients from traditional Chinese medicine and their formation mechanisms.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Zhuo Qu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=BIO-d7e2002-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Zhuo Qu</b> received her Bachelor’s degree from Tianjin Medical University (2012) and a Ph.D. in Applied Chemistry from Tianjin University (2017). Currently, she is an Associate Professor at the School of Pharmacy, Ningxia Medical University. Her research interests focus on the neuropharmacology of traditional Chinese medicine, especially active ingredients and their mechanisms of action in the treatment of Alzheimer’s disease.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Tengfei Bian</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=BIO-d7e2007-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Tengfei Bian</b> received his Bachelor’s degree from Harbin Engineering University, China (2008) and a Ph.D. in Chemical Engineering from Dalian University of Technology (2016). He was sponsored by the China Scholarship Council’s Ph.D. Abroad Training Plan to work under the supervision of Prof. Chengguo Xing at University of Minnesota (2013–2014). He also worked as a Visiting Scholar in Prof. Chengguo Xing’s lab at University of Minnesota (2016.1–2016.3). He is currently a Postdoctoral Associate in Prof. Chengguo Xing’s lab in the Department of Medicinal Chemistry, University of Florida. His research interests focus on the effect of carcinogens and cocarcinogens from cigarette smoking on the development of lung cancer.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Wannian Zhang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=BIO-d7e2012-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Wannian Zhang</b> received his Bachelor’s degree in Pharmacy (1968) and M.S. in Medicinal Chemistry (1981) from Second Military Medical University. He has been a Professor of Medicinal Chemistry since 1992 and served as the Dean of the School of Pharmacy from 1994 to 2001. Currently, Prof. Zhang is the Chief of the State’s Key Discipline of Medicinal Chemistry, Second Military Medical University. He has held a joint professorship with Ningxia Medical University and served as Dean of the School of Pharmacy since 2011. His research interests focus on antifungal and antitumor drug design and development. He has published more than 100 scientific articles and has developed four compounds that have been certificated by the CFDA.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Chengguo Xing</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=BIO-d7e2017-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Chengguo Xing</b> received his Bachelor’s degree from Dalian University of Technology (1996) and his Ph.D. in Organic Chemistry from Arizona State University under the supervision of Prof. Edward Skibo (2001). After 2 years of postdoctoral training with Prof. Andrew G. Myers at Harvard University, he joined the University of Minnesota as a faculty member in 2003. Currently, he is a Professor and the Frank A. Duckworth Eminent Scholar Chair in Drug Research and Development at the University of Florida. His research interests focus on the isolation, identification, design, and synthesis of biologically active small molecules, employing candidates such as probes to tackle health-related biological questions and evaluating the clinical potential of these compounds in relevant animal models.</p></figure></div><div class="bio" rid="ath8"><figure id="ath8" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Chunlin Zhuang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=BIO-d7e2022-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Chunlin Zhuang</b> received his Bachelor’s degree from Nanjing Medical University, China (2009) and a Ph.D. in Medicinal Chemistry from Second Military Medical University (2014). He was sponsored by the China Scholarship Council’s Ph.D. Abroad Training Plan to work under the supervision of Prof. Chengguo Xing at the University of Minnesota (2012). He is currently a faculty member at the School of Pharmacy, Second Military Medical University, China. He has held a joint professorship with Ningxia Medical University. His research interests focus on structure-based drug design of inhibitors of protein–protein interactions.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40447" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40447" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Gunda I. Georg and Dr. Nicholas Meanwell for their kind invitation to write this Perspective. This work was funded by grants from the National Natural Science Foundation of China (Grants 81872791 and 81502978 to C.Z.); the Young Elite Scientists Sponsorship Program by the China Association for Science and Technology (Grant 2017QNRC061 to C.Z.); the Shanghai Municipal Commission of Health and Family Planning (Grant 2017YQ052 to C.Z.); the Key Research and Development Program of Ningxia (Grant 2018BFH02001 to W.Z. and Grant 2018BFH02001-01 to C.Z.); the Shanghai “ChenGuang” Project (Grant 16CG42 to C.Z.); the National Cancer Institute, National Institutes of Health, U.S. (Grant R01CA193278 to C.X.); the College of Pharmacy, University of Florida (C.X.); the University of Florida Health Cancer Center (C.X.); and the Harry T. Mangurian, Jr. Foundation (C.X.).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myelogenous leukemia</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BIR</td><td class="NLM_def"><p class="first last">baculoviral IAP repeat</p></td></tr><tr><td class="NLM_term">BRUCE</td><td class="NLM_def"><p class="first last">ubiquitin-conjugating BIR domain enzyme</p></td></tr><tr><td class="NLM_term">CARD</td><td class="NLM_def"><p class="first last">caspase recruitment domain</p></td></tr><tr><td class="NLM_term">c-IAP1</td><td class="NLM_def"><p class="first last">cellular IAP1</p></td></tr><tr><td class="NLM_term">c-IAP2</td><td class="NLM_def"><p class="first last">cellular IAP2</p></td></tr><tr><td class="NLM_term">DELFIA</td><td class="NLM_def"><p class="first last">dissociation-enhanced lanthanide fluorescent immunoassay</p></td></tr><tr><td class="NLM_term">DIABLO</td><td class="NLM_def"><p class="first last">direct IAP-binding protein with low pI</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">ERα</td><td class="NLM_def"><p class="first last">estrogen receptor α</p></td></tr><tr><td class="NLM_term">FBDD</td><td class="NLM_def"><p class="first last">fragment-based drug discovery</p></td></tr><tr><td class="NLM_term">FLT3</td><td class="NLM_def"><p class="first last">Fms-like tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">HBV</td><td class="NLM_def"><p class="first last">hepatitis B virus</p></td></tr><tr><td class="NLM_term">IAP</td><td class="NLM_def"><p class="first last">inhibitor of apoptosis protein</p></td></tr><tr><td class="NLM_term">IBM</td><td class="NLM_def"><p class="first last">IAP-binding motif</p></td></tr><tr><td class="NLM_term">ILP2</td><td class="NLM_def"><p class="first last">IAP-like protein 2</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">MDR1</td><td class="NLM_def"><p class="first last">multidrug resistance 1</p></td></tr><tr><td class="NLM_term">ML-IAP</td><td class="NLM_def"><p class="first last">melanoma IAP</p></td></tr><tr><td class="NLM_term">MM</td><td class="NLM_def"><p class="first last">multiple myeloma</p></td></tr><tr><td class="NLM_term">MTD</td><td class="NLM_def"><p class="first last">maximum tolerated dose</p></td></tr><tr><td class="NLM_term">NIAP</td><td class="NLM_def"><p class="first last">neuronal IAP</p></td></tr><tr><td class="NLM_term">NIK</td><td class="NLM_def"><p class="first last">NF-κB-inducing kinase</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">non-small-cell lung cancer</p></td></tr><tr><td class="NLM_term">PCD</td><td class="NLM_def"><p class="first last">programmed cell death</p></td></tr><tr><td class="NLM_term">pCR</td><td class="NLM_def"><p class="first last">pathologic complete response</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamic</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidyl inositol 3-kinase</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">POI</td><td class="NLM_def"><p class="first last">protein of interest</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">PROTAC</td><td class="NLM_def"><p class="first last">proteolysis-targeting chimera</p></td></tr><tr><td class="NLM_term">RIP1</td><td class="NLM_def"><p class="first last">receptor-interacting protein 1</p></td></tr><tr><td class="NLM_term">RP2D</td><td class="NLM_def"><p class="first last">recommended phase II dose</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SBDD</td><td class="NLM_def"><p class="first last">structure-based drug design</p></td></tr><tr><td class="NLM_term">SMAC</td><td class="NLM_def"><p class="first last">second mitochondria-derived activator of caspase</p></td></tr><tr><td class="NLM_term">SNIPER</td><td class="NLM_def"><p class="first last">specific and nongenetic IAP-dependent protein eraser</p></td></tr><tr><td class="NLM_term">TDI</td><td class="NLM_def"><p class="first last">time-dependent inhibitor</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibition</p></td></tr><tr><td class="NLM_term">TNFR1</td><td class="NLM_def"><p class="first last">TNF factor receptor 1</p></td></tr><tr><td class="NLM_term">TRAF1</td><td class="NLM_def"><p class="first last">tumor necrosis factor receptor-associated factors 1</p></td></tr><tr><td class="NLM_term">TRAF2</td><td class="NLM_def"><p class="first last">tumor necrosis factor receptor-associated factor 2</p></td></tr><tr><td class="NLM_term">TRAIL</td><td class="NLM_def"><p class="first last">TNF-related apoptosis-inducing ligand</p></td></tr><tr><td class="NLM_term">UBA</td><td class="NLM_def"><p class="first last">ubiquitin-associated</p></td></tr><tr><td class="NLM_term">UPS</td><td class="NLM_def"><p class="first last">ubiquitin-proteasome system</p></td></tr><tr><td class="NLM_term">XIAP</td><td class="NLM_def"><p class="first last">X chromosome-linked IAP</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 160 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, A. R.</span></span> <span> </span><span class="NLM_article-title">Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1038/bjc.1972.33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fbjc.1972.33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=4561027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADyaE3s%252FgsFSksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1972&pages=239-257&author=J.+F.+Kerrauthor=A.+H.+Wyllieauthor=A.+R.+Currie&title=Apoptosis%3A+a+basic+biological+phenomenon+with+wide-ranging+implications+in+tissue+kinetics&doi=10.1038%2Fbjc.1972.33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics</span></div><div class="casAuthors">Kerr J F; Wyllie A H; Currie A R</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-57</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">The term apoptosis is proposed for a hitherto little recognized mechanism of controlled cell deletion, which appears to play a complementary but opposite role to mitosis in the regulation of animal cell populations.  Its morphological features suggest that it is an active, inherently programmed phenomenon, and it has been shown that it can be initiated or inhibited by a variety of environmental stimuli, both physiological and pathological.The structural changes take place in two discrete stages.  The first comprises nuclear and cytoplasmic condensation and breaking up of the cell into a number of membrane-bound, ultrastructurally well-preserved fragments.  In the second stage these apoptotic bodies are shed from epithelial-lined surfaces or are taken up by other cells, where they undergo a series of changes resembling in vitro autolysis within phagosomes, and are rapidly degraded by lysosomal enzymes derived from the ingesting cells.Apoptosis seems to be involved in cell turnover in many healthy adult tissues and is responsible for focal elimination of cells during normal embryonic development.  It occurs spontaneously in untreated malignant neoplasms, and participates in at least some types of therapeutically induced tumour regression.  It is implicated in both physiological involution and atrophy of various tissues and organs.  It can also be triggered by noxious agents, both in the embryo and adult animal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNWEBcjRkVZzW1zwg2yUK5fW6udTcc2ebn4BXjNI86Jbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3s%252FgsFSksw%253D%253D&md5=60211d4b22f18156fa64206b2cad983d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1972.33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1972.33%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DJ.%2BF.%26aulast%3DWyllie%26aufirst%3DA.%2BH.%26aulast%3DCurrie%26aufirst%3DA.%2BR.%26atitle%3DApoptosis%253A%2520a%2520basic%2520biological%2520phenomenon%2520with%2520wide-ranging%2520implications%2520in%2520tissue%2520kinetics%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1972%26volume%3D26%26spage%3D239%26epage%3D257%26doi%3D10.1038%2Fbjc.1972.33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, J. M.</span></span> <span> </span><span class="NLM_article-title">Apoptosis and disease</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1254</span>, <span class="refDoi"> DOI: 10.1016/0140-6736(93)91154-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2F0140-6736%2893%2991154-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=8098400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADyaK3s3mtFSqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1993&pages=1251-1254&author=D.+A.+Carsonauthor=J.+M.+Ribeiro&title=Apoptosis+and+disease&doi=10.1016%2F0140-6736%2893%2991154-E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis and disease</span></div><div class="casAuthors">Carson D A; Ribeiro J M</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">8855</span>),
    <span class="NLM_cas:pages">1251-4</span>
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    </div><div class="casAbstract">The intercellular connections that characterise advanced forms of life would not be possible without a mechanism to remove individual cells that are no longer needed, or that function abnormally.  Such physiological cell death, in the absence of inflammation, is achieved by apoptosis, a structurally distinct programmed cell death pathway.  Defective regulation of programmed cell death may play a part in the aetiology of cancer, AIDS, autoimmune diseases, and degenerative diseases of the central nervous system.  The pharmacological manipulation of apoptosis offers new possibilities for the prevention and treatment of these illnesses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5_BzorppnLgxyojvcjibhfW6udTcc2ebn4BXjNI86Jbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s3mtFSqsQ%253D%253D&md5=c163cc42fac31d9c0d2b17afcc351109</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0140-6736%2893%2991154-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0140-6736%252893%252991154-E%26sid%3Dliteratum%253Aachs%26aulast%3DCarson%26aufirst%3DD.%2BA.%26aulast%3DRibeiro%26aufirst%3DJ.%2BM.%26atitle%3DApoptosis%2520and%2520disease%26jtitle%3DLancet%26date%3D1993%26volume%3D341%26spage%3D1251%26epage%3D1254%26doi%3D10.1016%2F0140-6736%2893%2991154-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solary, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubrez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eymin, B.</span></span> <span> </span><span class="NLM_article-title">The role of apoptosis in the pathogenesis and treatment of diseases</span>. <i>Eur. Respir. J.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1293</span>– <span class="NLM_lpage">1305</span>, <span class="refDoi"> DOI: 10.1183/09031936.96.09061293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1183%2F09031936.96.09061293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=8804951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADyaK28zpvVSltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1996&pages=1293-1305&author=E.+Solaryauthor=L.+Dubrezauthor=B.+Eymin&title=The+role+of+apoptosis+in+the+pathogenesis+and+treatment+of+diseases&doi=10.1183%2F09031936.96.09061293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The role of apoptosis in the pathogenesis and treatment of diseases</span></div><div class="casAuthors">Solary E; Dubrez L; Eymin B</div><div class="citationInfo"><span class="NLM_cas:title">The European respiratory journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1293-305</span>
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    </div><div class="casAbstract">In adult multicellular organisms, homeostasis is determined in each cell lineage by a balance between cell death and cell growth.  Dysregulation of cell death mechanisms is involved in the pathogenesis of an increasing number of diseases.  Defective apoptosis can participate in malignant transformation, viral latency and autoimmune diseases.  Excessive apoptotic cell death is involved in CD4+ T-cell depletion observed in acquired immune deficiency syndrome, in fulminant hepatitis associated with infection by hepatitis B and C viruses, in some neurodegenerative disorders and haematological diseases, in polycystic kidney disease and ischaemia.  Three steps can be distinguished in the pathway that leads to cell death.  The first step involves interactions between the extracellular and intracellular signals that decide whether a cell should live or die.  When death is chosen, a common pathway that involves at least the Bcl-2- family of proteins and the interleukin-1 beta (IL-1 beta)-converting enzyme-related cysteine proteases confirms whether or not the cell should die.  Finally, if death is allowed to occur, the apoptotic process itself is characterized by deoxyribonucleic acid (DNA) fragmentation, proteolysis and morphological changes that precede the engulfment of apoptotic cells by neighbouring cells and phagocytes.  Several inducers and inhibitors of apoptosis acting on one or several of these three steps that characterize the apoptotic process have been identified in vitro.  Their potential usefulness in improving the current therapeutic strategies and designing new strategies in several different diseases is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSstdFlp_TrSMyail4HZd-ifW6udTcc2eYG3FFpfVsj0bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zpvVSltQ%253D%253D&md5=d297625b8ca78684e2fa14dc36e24605</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1183%2F09031936.96.09061293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.96.09061293%26sid%3Dliteratum%253Aachs%26aulast%3DSolary%26aufirst%3DE.%26aulast%3DDubrez%26aufirst%3DL.%26aulast%3DEymin%26aufirst%3DB.%26atitle%3DThe%2520role%2520of%2520apoptosis%2520in%2520the%2520pathogenesis%2520and%2520treatment%2520of%2520diseases%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D1996%26volume%3D9%26spage%3D1293%26epage%3D1305%26doi%3D10.1183%2F09031936.96.09061293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of cancer: the next generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+the+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0ljDXBo6b6WtdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520the%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span> <span> </span><span class="NLM_article-title">The inhibitor of apoptosis proteins as therapeutic targets in cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">5995</span>– <span class="NLM_lpage">6000</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-07-0729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1078-0432.CCR-07-0729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=17947460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFygs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=5995-6000&author=D.+Vucicauthor=W.+J.+Fairbrother&title=The+inhibitor+of+apoptosis+proteins+as+therapeutic+targets+in+cancer&doi=10.1158%2F1078-0432.CCR-07-0729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer</span></div><div class="casAuthors">Vucic, Domagoj; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5995-6000</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Apoptosis is a cell suicide process with a major role in development and homeostasis in vertebrates and invertebrates.  Inhibition of apoptosis enhances the survival of cancer cells and facilitates their escape from immune surveillance and cytotoxic therapies.  Among the principal mols. contributing to this phenomenon are the inhibitor of apoptosis (IAP) proteins, a family of antiapoptotic regulators that block cell death in response to diverse stimuli through interactions with inducers and effectors of apoptosis.  IAP proteins are expressed in the majority of human malignancies at elevated levels and play an active role in promoting tumor maintenance through the inhibition of cellular death and participation in signaling pathways assocd. with malignancies.  Here, we discuss the role of IAP proteins in cancer and options for targeting IAP proteins for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosUyky7YXEnLVg90H21EOLACvtfcHk0ljDXBo6b6WtdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFygs7vP&md5=bff042bce2006a510abb6814d43c6dc5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-0729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-0729%26sid%3Dliteratum%253Aachs%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520inhibitor%2520of%2520apoptosis%2520proteins%2520as%2520therapeutic%2520targets%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D5995%26epage%3D6000%26doi%3D10.1158%2F1078-0432.CCR-07-0729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, C. S.</span></span> <span> </span><span class="NLM_article-title">IAP proteins: blocking the road to death’s door</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1038/nrm830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnrm830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=12042762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=401-410&author=G.+S.+Salvesenauthor=C.+S.+Duckett&title=IAP+proteins%3A+blocking+the+road+to+death%E2%80%99s+door&doi=10.1038%2Fnrm830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: IAP proteins: blocking the road to death's door</span></div><div class="casAuthors">Salvesen, Guy S.; Duckett, Colin S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-410</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The 'inhibitor of apoptosis' (IAP) gene family, which was discovered less than a decade ago, encodes a group of structurally related proteins that, in addn. to their ability to suppress apoptotic cell death, are involved in an increasing no. of seemingly unrelated cellular functions.  Here, we review the functional and structural properties of this fascinating group of proteins, and of several recently identified IAP-binding factors that regulate IAP function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofMWLW8mAr_LVg90H21EOLACvtfcHk0ljDXBo6b6WtdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D&md5=0f967aad318a34d988ad40486950ed62</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm830%26sid%3Dliteratum%253Aachs%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26atitle%3DIAP%2520proteins%253A%2520blocking%2520the%2520road%2520to%2520death%25E2%2580%2599s%2520door%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2002%26volume%3D3%26spage%3D401%26epage%3D410%26doi%3D10.1038%2Fnrm830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deveraux, Q.
L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span> <span> </span><span class="NLM_article-title">IAP family proteins--suppressors of apoptosis</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1101/gad.13.3.239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1101%2Fgad.13.3.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=9990849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADyaK1MXht1KgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=239-252&author=Q.%0AL.+Deverauxauthor=J.+C.+Reed&title=IAP+family+proteins%2D%2Dsuppressors+of+apoptosis&doi=10.1101%2Fgad.13.3.239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">IAP family proteins-suppressors of apoptosis</span></div><div class="casAuthors">Deveraux, Quinn L.; Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-252</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review with 98 refs.  Apoptosis is a physiol. cell suicide program that is crit. for the development and maintenance of healthy tissues.  Dysregulation of cell death pathways occur in cancer, autoimmune and immunodeficiency diseases, reperfusion injury after ischemic episodes, and in neurodegenerative disorders.  Thus, proteins involved in apoptosis regulation are of intense biol. interest and many are attractive therapeutic targets.  This review discusses the Inhibitor of Apoptosis (IAP) family of proteins.  First discovered in baculoviruses, IAPs were shown to be involved in suppressing the host cell death response to viral infection.  Interestingly, ectopic expression of some baculoviral IAPs blocks apoptosis in mammalian cells, suggesting conservation of the cell death program among diverse species and commonalities in the mechanism used by the IAPs to inhibit apoptosis.  Although the mechanism used by the IAPs to suppress cell death remains debated, several studies have provided insights into the biochem. functions of these intriguing proteins.  Moreover, a variety of reports have suggested an important role for the IAPs in some human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSDPMG453K_LVg90H21EOLACvtfcHk0li54yRU-enjww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1KgsL0%253D&md5=a1a71b281cb401c9580e48a7e8f1ccee</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.3.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.3.239%26sid%3Dliteratum%253Aachs%26aulast%3DDeveraux%26aufirst%3DQ.%2BL.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DIAP%2520family%2520proteins--suppressors%2520of%2520apoptosis%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D239%26epage%3D252%26doi%3D10.1101%2Fgad.13.3.239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clem, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. K.</span></span> <span> </span><span class="NLM_article-title">An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">2521</span>– <span class="NLM_lpage">2528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=8139034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADyaK2cXksFSqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1994&pages=2521-2528&author=M.+J.+Birnbaumauthor=R.+J.+Clemauthor=L.+K.+Miller&title=An+apoptosis-inhibiting+gene+from+a+nuclear+polyhedrosis+virus+encoding+a+polypeptide+with+Cys%2FHis+sequence+motifs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs</span></div><div class="casAuthors">Birnbaum, Mark J.; Clem, Rollie J.; Miller, Lois K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2521-8</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    </div><div class="casAbstract">Two different baculovirus genes are known to be able to block apoptosis triggered upon infection of Spodoptera frugiperda cells with p35 mutants of the insect baculovirus Autographa californica nuclear polyhedrosis virus (AcMNPV):p35 (P35-encoding gene) of AcMNPV and iap (inhibitor of apoptosis gene) of Cydia pomonella granulosis virus (CpGV).  Using a genetic complementation assay to identify addnl. genes which inhibit apoptosis during infection with a p35 mutant, the authors have isolated a gene from Orgyia pseudotsugata NPV (OpMNPV) that was able to functionally substitute for AcMPNV p35.  The nucleotide sequence of this gene, Op-iap, predicted a 30-kDa polypeptide product with approx. 58% amino acid sequence identity to the product of CpGV iap, Cp-IAP.  Like Cp-IAP, the predicted product of Op-iap has a carboxy-terminal C3HC4 zinc finger-like motif.  In addn., a pair of addnl. cysteine/histidine motifs were found in the N-terminal regions of both polypeptide sequences.  Recombinant p35 mutant viruses carrying either Op-iap or Cp-iap appeared to have a normal phenotype in S. frugiperda cells.  Thus, Cp-IAP and Op-IAP appear to be functionally analogous to P35 but are likely to block apoptosis by a different mechanism which may involve direct interaction with DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOzymcROFQ6LVg90H21EOLACvtfcHk0li54yRU-enjww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksFSqurg%253D&md5=e391d3cedb2dbdff2c8b7a584cd92293</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirnbaum%26aufirst%3DM.%2BJ.%26aulast%3DClem%26aufirst%3DR.%2BJ.%26aulast%3DMiller%26aufirst%3DL.%2BK.%26atitle%3DAn%2520apoptosis-inhibiting%2520gene%2520from%2520a%2520nuclear%2520polyhedrosis%2520virus%2520encoding%2520a%2520polypeptide%2520with%2520Cys%252FHis%2520sequence%2520motifs%26jtitle%3DJ.%2520Virol%26date%3D1994%26volume%3D68%26spage%3D2521%26epage%3D2528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crook, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clem, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. K.</span></span> <span> </span><span class="NLM_article-title">An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">2168</span>– <span class="NLM_lpage">2174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=8445726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADyaK3sXisVyqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1993&pages=2168-2174&author=N.+E.+Crookauthor=R.+J.+Clemauthor=L.+K.+Miller&title=An+apoptosis-inhibiting+baculovirus+gene+with+a+zinc+finger-like+motif"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif</span></div><div class="casAuthors">Crook, Norman E.; Clem, Rollie J.; Miller, Lois K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2168-74</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    </div><div class="casAbstract">Spodoptera frugiperda SF-21 cells infected with Autographa californica nuclear polyhedrosis virus mutants which lack a functional p35 gene undergo apoptosis, a type of programmed cell death.  To identify p35-homologous genes in other baculoviruses, A. californica nuclear polyhedrosis virus DNA contg. a deletion in p35 was contransfected into SF-21 cells along with genomic DNAs from other baculoviruses.  One of the viral DNAs which were able to rescue wild-type infection was from Cydia pomonella granulosis virus (CpGV).  The CpGV gene responsible for the effect was mapped to a 1.6-kb SalI-SstI subclone of the SalI B fragment of CpGV.  The sequence of the SalI-SstI subclone revealed an open reading frame capable of encoding a polypeptide of 31 kDa which was sufficient to rescue wild-type infection; this gene was thus called iap (inhibitor of apoptosis).  The predicted sequence of the IAP polypeptide exhibited no significant homol. to P35 but contained a zinc finger-like motif which is also found in other genes with the potential to regulate apoptosis, including several mammalian proto-oncogenes and two insect genes involved in embryonic development.  In the context of the viral genome, both iap and p35 were able to block apoptosis induced by actinomycin D, indicating that these genes act by blocking cellular apoptosis rather than by preventing viral stimulation of apoptosis.  Several independent recombinant viruses derived from cotransfections with either the entire CpGV genome or the 1.6-kb subclone were characterized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9wL9F0FrRUbVg90H21EOLACvtfcHk0li54yRU-enjww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXisVyqtbg%253D&md5=cdd2b2488b2416f2ec84e79a4311ec92</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrook%26aufirst%3DN.%2BE.%26aulast%3DClem%26aufirst%3DR.%2BJ.%26aulast%3DMiller%26aufirst%3DL.%2BK.%26atitle%3DAn%2520apoptosis-inhibiting%2520baculovirus%2520gene%2520with%2520a%2520zinc%2520finger-like%2520motif%26jtitle%3DJ.%2520Virol%26date%3D1993%26volume%3D67%26spage%3D2168%26epage%3D2174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varfolomeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span> <span> </span><span class="NLM_article-title">Targeting inhibitor of apoptosis proteins for therapeutic intervention</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1509</span>– <span class="NLM_lpage">1525</span>, <span class="refDoi"> DOI: 10.4155/fmc.09.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.4155%2Ffmc.09.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21426063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFSit7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1509-1525&author=C.+Ndubakuauthor=F.+Cohenauthor=E.+Varfolomeevauthor=D.+Vucic&title=Targeting+inhibitor+of+apoptosis+proteins+for+therapeutic+intervention&doi=10.4155%2Ffmc.09.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting inhibitor of apoptosis proteins for therapeutic intervention</span></div><div class="casAuthors">Ndubaku, Chudi; Cohen, Frederick; Varfolomeev, Eugene; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1509-1525</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The inhibitors of apoptosis (IAP) proteins have emerged over the last decade as important targets for therapeutic intervention in human malignancies.  Overexpression of IAPs was implicated in cell survival and resistance against stress-induced apoptosis brought on by radiation and/or chemotherapeutics (currently the std.-of-care in a variety of different cancer diseases).  In addn., evasion from death receptor-mediated apoptosis and regulation of NF-κB pathways and cell division were also assocd. with IAP proteins.  Efforts to target IAP proteins in tumors have focused mainly on designing small mols. that mimic the IAP-binding motif of the endogenous IAP antagonist, second mitochondrial activator of caspases.  In addn., several other IAP-targeting strategies, including antisense oligonucleotides and transcriptional repression, were also initiated, with the hope of providing therapeutic benefit to cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZV1K372WKh7Vg90H21EOLACvtfcHk0li54yRU-enjww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFSit7%252FI&md5=40f037c635256749e6a78a71a98c7d9d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.116%26sid%3Dliteratum%253Aachs%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DTargeting%2520inhibitor%2520of%2520apoptosis%2520proteins%2520for%2520therapeutic%2520intervention%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D1509%26epage%3D1525%26doi%3D10.4155%2Ffmc.09.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, W. C.</span></span> <span> </span><span class="NLM_article-title">Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">6815</span>– <span class="NLM_lpage">6824</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=14583479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosVGnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=6815-6824&author=L.+Yangauthor=Z.+Caoauthor=H.+Yanauthor=W.+C.+Wood&title=Coexistence+of+high+levels+of+apoptotic+signaling+and+inhibitor+of+apoptosis+proteins+in+human+tumor+cells%3A+implication+for+cancer+specific+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Coexistence of High Levels of Apoptotic Signaling and Inhibitor of Apoptosis Proteins in Human Tumor Cells: Implication for Cancer Specific Therapy</span></div><div class="casAuthors">Yang, Lily; Cao, Zehong; Yan, Hui; Wood, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6815-6824</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">It is well known that dysfunction of the apoptotic pathway confers apoptosis resistance and results in a low sensitivity of human cancer cells to therapeutic agents.  A novel strategy to overcome the resistance is to target the apoptotic pathway directly.  To identify mol. targets in the apoptotic pathway that are differentially regulated in cancer and normal cells, we have examd. the levels of apoptotic effectors and inhibitors in human tumor and normal cell lines as well as in cancer and normal tissues.  These include three pancreatic cancer lines (BXPC-3, MIA PaCa-2, and Panc-1), four breast cancer cell lines (MDA-MB-231, MDA-MB-435, MDA-MB-361, and MCF-7), and colon carcinoma line (SW620).  Addnl., breast carcinoma tissue specimens were examd.  Compared with normal human fibroblast and mammary epithelial cell lines, we detected high basal levels of caspase-3 and caspase-8 activities and active caspase-3 fragments in the tumor cell lines and cancer tissues in the absence of apoptotic stimuli.  Furthermore, the tumor cells expressed high levels of survivin and XIAP, two members of the inhibitor of apoptosis (IAP) protein family.  When the activity of these IAPs was blocked by expression of dominant-neg. mutant survivin (survivinT34A) and XIAP-assocd. factor 1, resp., apoptosis was induced in tumor but not normal cell lines.  Moreover, down-regulation of both survivin and XIAP significantly enhanced tumor-cell apoptosis as compared with inhibition of either survivin or XIAP alone.  These results suggest that up-regulated IAP expression counteracts the high basal caspase-3 activity obsd. in these tumor cells and that apoptosis in tumor cells but not normal cells can be induced by blocking IAP activity.  Therefore, IAPs are important mol. targets for the development of cancer-specific therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrnkSWDJOSCbVg90H21EOLACvtfcHk0lh3i0voHeaY8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosVGnsrk%253D&md5=f8b94616c5ddba25d9ac4ecd1e17eba8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DWood%26aufirst%3DW.%2BC.%26atitle%3DCoexistence%2520of%2520high%2520levels%2520of%2520apoptotic%2520signaling%2520and%2520inhibitor%2520of%2520apoptosis%2520proteins%2520in%2520human%2520tumor%2520cells%253A%2520implication%2520for%2520cancer%2520specific%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D6815%26epage%3D6824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornblau, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segall, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scudiero, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudor, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qui, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monks, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreeff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span> <span> </span><span class="NLM_article-title">Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1796</span>– <span class="NLM_lpage">1803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10815900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktVWis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=1796-1803&author=I.+Tammauthor=S.+M.+Kornblauauthor=H.+Segallauthor=S.+Krajewskiauthor=K.+Welshauthor=S.+Kitadaauthor=D.+A.+Scudieroauthor=G.+Tudorauthor=Y.+H.+Quiauthor=A.+Monksauthor=M.+Andreeffauthor=J.+C.+Reed&title=Expression+and+prognostic+significance+of+IAP-family+genes+in+human+cancers+and+myeloid+leukemias"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias</span></div><div class="casAuthors">Tamm, Ingo; Kornblau, Steven M.; Segall, Harry; Krajewski, Stanislaw; Welsh, Kate; Kitada, Shinichi; Scudiero, Dominic A.; Tudor, Gabriela; Qui, Yi Hua; Monks, Anne; Andreeff, Michael; Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1796-1803</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Expression of several inhibitor of apoptosis proteins (IAPs) was investigated in the National Cancer Institute panel of 60 human tumor cell lines, and the expression and prognostic significance of one of these, XIAP, was evaluated in 78 previously untreated patients with acute myelogenous leukemia (AML).  XIAP and cIAP1 were expressed in most cancer lines analyzed, with substantial variability in their relative levels.  In contrast, NAIP mRNA was not detectable, and cIAP2 was found at the mRNA and protein levels in only 34 (56%) and 5 (8%) of the 60 tumor cell lines analyzed, resp.  Interestingly, XIAP, cIAP1, and cIAP2 mRNA levels did not correlate with protein levels in the tumor lines, indicating posttranscriptional regulation of expression.  High levels of XIAP protein in tumor cell lines were unexpectedly correlated with sensitivity to some anticancer drugs, particularly cytarabine and other nucleosides, whereas higher levels of cIAP1 protein levels were assocd. with resistance to several anticancer drugs.  The relevance of XIAP to in vivo responses to cytarabine was explored in AML, making correlations with patient outcome.  Patients with lower levels of XIAP protein had longer survival and a tendency toward longer remission duration than those with higher levels of XIAP.  Altogether, IAPs are widely but differentially expressed in human cancers and leukemias, and higher XIAP protein levels may have adverse prognostic significance for patients with AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPBpTFu0KAgrVg90H21EOLACvtfcHk0lh3i0voHeaY8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVWis7k%253D&md5=08ea4dd16cfe6106339fbe7ee7e47a77</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamm%26aufirst%3DI.%26aulast%3DKornblau%26aufirst%3DS.%2BM.%26aulast%3DSegall%26aufirst%3DH.%26aulast%3DKrajewski%26aufirst%3DS.%26aulast%3DWelsh%26aufirst%3DK.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DTudor%26aufirst%3DG.%26aulast%3DQui%26aufirst%3DY.%2BH.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DAndreeff%26aufirst%3DM.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DExpression%2520and%2520prognostic%2520significance%2520of%2520IAP-family%2520genes%2520in%2520human%2520cancers%2520and%2520myeloid%2520leukemias%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D1796%26epage%3D1803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Small-molecule SMAC mimetics as new cancer therapeutics</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2014.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.pharmthera.2014.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=24841289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosl2ju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2014&pages=82-95&author=L.+Baiauthor=D.+C.+Smithauthor=S.+Wang&title=Small-molecule+SMAC+mimetics+as+new+cancer+therapeutics&doi=10.1016%2Fj.pharmthera.2014.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule SMAC mimetics as new cancer therapeutics</span></div><div class="casAuthors">Bai, Longchuan; Smith, David C.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-95</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Apoptosis is a tightly regulated cellular process and faulty regulation of apoptosis is a hallmark of human cancers.  Targeting key apoptosis regulators with the goal to restore apoptosis in tumor cells has been pursued as a new cancer therapeutic strategy.  XIAP, cIAP1, and cIAP2, members of inhibitor of apoptosis (IAP) proteins, are crit. regulators of cell death and survival and are attractive targets for new cancer therapy.  The SMAC/DIABLO protein is an endogenous antagonist of XIAP, cIAP1, and cIAP2.  In the last decade, intense research efforts have resulted in the design and development of several small-mol. SMAC mimetics now in clin. trials for cancer treatment.  In this review, we will discuss the roles of XIAP, cIAP1, and cIAP2 in regulation of cell death and survival, and the design and development of small-mol. SMAC mimetics as novel cancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLJ1zuCJO_xrVg90H21EOLACvtfcHk0lh3i0voHeaY8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosl2ju7k%253D&md5=92404daa1b37f65bee87fa699858a5bf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DSmall-molecule%2520SMAC%2520mimetics%2520as%2520new%2520cancer%2520therapeutics%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D144%26spage%3D82%26epage%3D95%26doi%3D10.1016%2Fj.pharmthera.2014.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lober, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Togo, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zapata, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span> <span> </span><span class="NLM_article-title">Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">1080</span>– <span class="NLM_lpage">1090</span>, <span class="refDoi"> DOI: 10.1074/jbc.M509381200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.M509381200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=16282325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD28XitF2kug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=1080-1090&author=T.+Samuelauthor=K.+Welshauthor=T.+Loberauthor=S.+H.+Togoauthor=J.+M.+Zapataauthor=J.+C.+Reed&title=Distinct+BIR+domains+of+cIAP1+mediate+binding+to+and+ubiquitination+of+tumor+necrosis+factor+receptor-associated+factor+2+and+second+mitochondrial+activator+of+caspases&doi=10.1074%2Fjbc.M509381200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct BIR Domains of cIAP1 Mediate Binding to and Ubiquitination of Tumor Necrosis Factor Receptor-associated Factor 2 and Second Mitochondrial Activator of Caspases</span></div><div class="casAuthors">Samuel, Temesgen; Welsh, Kate; Lober, Thomas; Togo, Summanuna H.; Zapata, Juan M.; Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1080-1090</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis proteins (IAPs) regulate apoptosis primarily by inhibiting caspase-family proteases.  However, many IAPs also possess E3 ligase (ubiquitin-protein isopeptide ligase) activities implicated in both caspase-dependent and -independent functions of these proteins.  Here, the authors compared the structural features of cIAP1 responsible for its interactions with two known target proteins, TRAF2 and SMAC.  The N-terminal (BIR1) and C-terminal (BIR3) BIR domains of cIAP1 were detd. to be necessary and sufficient for binding TRAF2 and SMAC, resp.  Mutational anal. of the BIR1 and BIR3 domains identified crit. residues required for TRAF2 and SMAC binding.  Using these mutants, cIAP1-mediated ubiquitination of TRAF2 and SMAC in vitro was detd. to be correspondingly dependent on intact binding sites on BIR1 and BIR3.  Because TRAF2 regulates NF-κB activation, the effects of cIAP1 on TRAF2-mediated induction of NF-κB transcriptional activity were studied using reporter gene assays.  Expression of a fragment of cIAP1 encompassing the three BIR domains (but not full-length cIAP1) greatly enhanced TRAF2-induced increases in NF-κB activity, providing a convenient assay for monitoring BIR-dependent effects of cIAP1 on TRAF2 in cells.  BIR1 mutants of the BIR1-3 fragment of cIAP1 that failed to bind TRAF2 lost the ability to modulate NF-κB activity, demonstrating a requirement for BIR1-mediated interactions with TRAF2.  Altogether, these findings demonstrate the modularity and diversification of BIR domains, showing that a single cIAP can direct its E3 ligase activity toward different substrates and can alter the cellular functions of different protein targets in accordance with differences in the specificity of individual BIR domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_mIKWzl6NzLVg90H21EOLACvtfcHk0ljjwe34-gyULw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitF2kug%253D%253D&md5=6c675e45e0175fa52e2eeaed19fdd805</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M509381200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M509381200%26sid%3Dliteratum%253Aachs%26aulast%3DSamuel%26aufirst%3DT.%26aulast%3DWelsh%26aufirst%3DK.%26aulast%3DLober%26aufirst%3DT.%26aulast%3DTogo%26aufirst%3DS.%2BH.%26aulast%3DZapata%26aufirst%3DJ.%2BM.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DDistinct%2520BIR%2520domains%2520of%2520cIAP1%2520mediate%2520binding%2520to%2520and%2520ubiquitination%2520of%2520tumor%2520necrosis%2520factor%2520receptor-associated%2520factor%25202%2520and%2520second%2520mitochondrial%2520activator%2520of%2520caspases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D1080%26epage%3D1090%26doi%3D10.1074%2Fjbc.M509381200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varfolomeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wayson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span> <span> </span><span class="NLM_article-title">The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">29022</span>– <span class="NLM_lpage">29029</span>, <span class="refDoi"> DOI: 10.1074/jbc.M605116200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.M605116200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=16891304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFamsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=29022-29029&author=E.+Varfolomeevauthor=S.+M.+Waysonauthor=V.+M.+Dixitauthor=W.+J.+Fairbrotherauthor=D.+Vucic&title=The+inhibitor+of+apoptosis+protein+fusion+c-IAP2.MALT1+stimulates+NF-kappaB+activation+independently+of+TRAF1+AND+TRAF2&doi=10.1074%2Fjbc.M605116200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-κB activation independently of TRAF1 AND TRAF2</span></div><div class="casAuthors">Varfolomeev, Eugene; Wayson, Sarah M.; Dixit, Vishva M.; Fairbrother, Wayne J.; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">29022-29029</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The inhibitors of apoptosis (IAPs) are a family of cell death inhibitors found in viruses and metazoans.  All members of the IAP family have at least one baculovirus IAP repeat (BIR) motif that is essential for their anti-apoptotic activity.  The t(11, 18)(q21;q21) translocation fuses the BIR domains of c-IAP2 with the paracaspase/MALT1 (mucosa-assocd. lymphoid tissue) protein, a crit. mediator of T cell receptor-stimulated activation of NF-κB.  The c-IAP2.MALT1 fusion protein constitutively activates the NF-κB pathway, and this is considered crit. to malignant B cell transformation and lymphoma progression.  The BIR domains of c-IAP1 and c-IAP2 interact with tumor necrosis factor receptor-assocd. factors 1 and 2 (TRAF1 and TRAF2).  Here we investigated the importance of TRAF1 and TRAF2 for c-IAP2.MALT1-stimulated NF-κB activation.  We identified a novel epitope within the BIR1 domains of c-IAP1 and c-IAP2 that is crucial for their phys. interaction with TRAF1 and TRAF2.  The c-IAP2.MALT1 fusion protein assocs. with TRAF1 and TRAF2 using the same binding site.  We explored the functional relevance of this interaction and established that binding to TRAF1 and TRAF2 is not required for c-IAP2.MALT1-stimulated NF-κB activation.  Furthermore, gene ablation of TRAF2 or combined down-regulation of TRAF1 and TRAF2 did not affect c-IAP2.MALT1-stimulated signaling.  However, TRAF1/2-binding mutants of c-IAP2.MALT1 still oligomerize and activate NF-κB, suggesting that oligomerization might be important for signaling of the fusion protein.  Therefore, the t(11, 18)(q21;q21) translocation creating the c-IAP2.MALT1 fusion protein activates NF-κB and contributes to human malignancy in the absence of signaling adaptors that might otherwise regulate its activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrt_4xav-jLrVg90H21EOLACvtfcHk0ljjwe34-gyULw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFamsrw%253D&md5=79aa3ec008da4e8d5b05854ed04ed2bf</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M605116200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M605116200%26sid%3Dliteratum%253Aachs%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DWayson%26aufirst%3DS.%2BM.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DThe%2520inhibitor%2520of%2520apoptosis%2520protein%2520fusion%2520c-IAP2.MALT1%2520stimulates%2520NF-kappaB%2520activation%2520independently%2520of%2520TRAF1%2520AND%2520TRAF2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D29022%26epage%3D29029%26doi%3D10.1074%2Fjbc.M605116200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, K. L.</span></span> <span> </span><span class="NLM_article-title">A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">37297</span>– <span class="NLM_lpage">37305</span>, <span class="refDoi"> DOI: 10.1074/jbc.M303389200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.M303389200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=12867425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2mu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=37297-37305&author=E.+D.+Tangauthor=C.+Y.+Wangauthor=Y.+Xiongauthor=K.+L.+Guan&title=A+role+for+NF-kappaB+essential+modifier%2FIkappaB+kinase-gamma+%28NEMO%2FIKKgamma%29+ubiquitination+in+the+activation+of+the+IkappaB+kinase+complex+by+tumor+necrosis+factor-alpha&doi=10.1074%2Fjbc.M303389200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A Role for NF-κB Essential Modifier/IκB Kinase-γ (NEMO/IKKγ) Ubiquitination in the Activation of the IκB Kinase Complex by Tumor Necrosis Factor-α</span></div><div class="casAuthors">Tang, Eric D.; Wang, Cun-Yu; Xiong, Yue; Guan, Kun-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">37297-37305</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">NEMO (NF-κB essential modifier)/IKKγ (IκB kinase-γ) is required for the activation of the IκB kinase complex (IKK) by inflammatory stimuli such as tumor necrosis factor (TNF-α).  Here we show that TNF-α stimulates the ubiquitination of NEMO in a manner that does not appear to target it for degrdn. and that is impaired by mutations in the NEMO zinc finger.  Mutations of the zinc finger are found in patients with hypohidrotic ectodermal dysplasia with immunodeficiency (HED-ID) and lead to the impairment of TNF-α-stimulated IKK phosphorylation and activation.  In addn., the ubiquitination of NEMO is mediated by c-IAP1, an inhibitor of apoptosis protein that is a component of the TNF receptor signaling complex.  Thus, the ubiquitination of NEMO mediated by c-IAP1 likely plays an important role in the activation of IKK by TNF-α.  Also, defective NEMO ubiquitination may be responsible for the impaired cellular NF-κB signaling found in patients with HED-ID.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX7WoCOLR0gbVg90H21EOLACvtfcHk0ljjwe34-gyULw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2mu7g%253D&md5=2cb7eea0ca7f100822190d36a9a81a26</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M303389200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M303389200%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DE.%2BD.%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26atitle%3DA%2520role%2520for%2520NF-kappaB%2520essential%2520modifier%252FIkappaB%2520kinase-gamma%2520%2528NEMO%252FIKKgamma%2529%2520ubiquitination%2520in%2520the%2520activation%2520of%2520the%2520IkappaB%2520kinase%2520complex%2520by%2520tumor%2520necrosis%2520factor-alpha%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D37297%26epage%3D37305%26doi%3D10.1074%2Fjbc.M303389200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eckelman, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, F. L.</span></span> <span> </span><span class="NLM_article-title">Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">988</span>– <span class="NLM_lpage">994</span>, <span class="refDoi"> DOI: 10.1038/sj.embor.7400795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fsj.embor.7400795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=17016456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVajtr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=988-994&author=B.+P.+Eckelmanauthor=G.+S.+Salvesenauthor=F.+L.+Scott&title=Human+inhibitor+of+apoptosis+proteins%3A+why+XIAP+is+the+black+sheep+of+the+family&doi=10.1038%2Fsj.embor.7400795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family</span></div><div class="casAuthors">Eckelman, Brendan P.; Salvesen, Guy S.; Scott, Fiona L.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">988-994</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Several of the inhibitor of apoptosis protein (IAP) family members regulate apoptosis in response to various cellular assaults.  Some members are also involved in cell signaling, mitosis and targeting proteins to the ubiquitin-proteasome degrdn. machinery.  The most intensively studied family member, X-linked IAP (XIAP), is a potent inhibitor of caspase activity; hence, it is generally assumed that direct caspase inhibition is an important conserved function of most members of the family.  Biochem. and structural studies have precisely mapped the elements of XIAP required for caspase inhibition.  Intriguingly, these elements are not conserved among IAPs.  Here, we review current knowledge of the caspase-inhibitory potential of the human IAPs and show that XIAP is probably the only bona fide caspase inhibitor, suggesting that the other family members never gained the ability to directly inhibit caspase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi2WCkDI8Vs7Vg90H21EOLACvtfcHk0ljXNDKSBMnNOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVajtr7K&md5=7db7a68e171e0303dd25ba6e2a97be34</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsj.embor.7400795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.embor.7400795%26sid%3Dliteratum%253Aachs%26aulast%3DEckelman%26aufirst%3DB.%2BP.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DScott%26aufirst%3DF.%2BL.%26atitle%3DHuman%2520inhibitor%2520of%2520apoptosis%2520proteins%253A%2520why%2520XIAP%2520is%2520the%2520black%2520sheep%2520of%2520the%2520family%26jtitle%3DEMBO%2520Rep.%26date%3D2006%26volume%3D7%26spage%3D988%26epage%3D994%26doi%3D10.1038%2Fsj.embor.7400795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eckelman, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span> <span> </span><span class="NLM_article-title">The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">3254</span>– <span class="NLM_lpage">3260</span>, <span class="refDoi"> DOI: 10.1074/jbc.M510863200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.M510863200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=16339151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=3254-3260&author=B.+P.+Eckelmanauthor=G.+S.+Salvesen&title=The+human+anti-apoptotic+proteins+cIAP1+and+cIAP2+bind+but+do+not+inhibit+caspases&doi=10.1074%2Fjbc.M510863200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Anti-apoptotic Proteins cIAP1 and cIAP2 Bind but Do Not Inhibit Caspases</span></div><div class="casAuthors">Eckelman, Brendan P.; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3254-3260</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">CIAPs (cellular inhibitor of apoptosis proteins) 1 and 2 are able to regulate apoptosis when ectopically expressed in recipient cells and probably also in vivo.  Previous work suggested that this is at least partially due to direct caspase inhibition, mediated by two of the three baculovirus IAP repeat (BIR) domains that are contained in these proteins.  In support of this we show that the BIR domains 2 and 3 of the two cIAPs are able to bind caspases-7 and -9.  However, we demonstrate that neither of these BIR domains is able to inhibit caspases because of crit. substitutions in the regions that target caspase inhibition in the X-linked IAP, a tight binding caspase inhibitor.  The cIAP BIR domains can be converted to tight binding caspase inhibitors by substituting these crit. residues with XIAP residues.  Thus, cIAPs maintain protein scaffolds suitable for direct caspase inhibition but have lost or never acquired specific caspase inhibitory interaction sites.  Consequently, although the binding function of the cIAP BIRs may be important for their physiol. function, caspase inhibition is not.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7nmRzBWNlZrVg90H21EOLACvtfcHk0ljXNDKSBMnNOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSmsrk%253D&md5=b7375d7fb6c76c0a4ce99b9a9dc14972</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M510863200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M510863200%26sid%3Dliteratum%253Aachs%26aulast%3DEckelman%26aufirst%3DB.%2BP.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DThe%2520human%2520anti-apoptotic%2520proteins%2520cIAP1%2520and%2520cIAP2%2520bind%2520but%2520do%2520not%2520inhibit%2520caspases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D3254%26epage%3D3260%26doi%3D10.1074%2Fjbc.M510863200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gyrd-Hansen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miasari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoro, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zender, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Fonseca, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvelebil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bujnicki, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, P.</span></span> <span> </span><span class="NLM_article-title">IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1309</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1038/ncb1789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fncb1789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18931663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlais7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=1309-1317&author=M.+Gyrd-Hansenauthor=M.+Dardingauthor=M.+Miasariauthor=M.+M.+Santoroauthor=L.+Zenderauthor=W.+Xueauthor=T.+Tenevauthor=P.+C.+da+Fonsecaauthor=M.+Zvelebilauthor=J.+M.+Bujnickiauthor=S.+Loweauthor=J.+Silkeauthor=P.+Meier&title=IAPs+contain+an+evolutionarily+conserved+ubiquitin-binding+domain+that+regulates+NF-kappaB+as+well+as+cell+survival+and+oncogenesis&doi=10.1038%2Fncb1789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-κB as well as cell survival and oncogenesis</span></div><div class="casAuthors">Gyrd-Hansen, Mads; Darding, Maurice; Miasari, Maria; Santoro, Massimo M.; Zender, Lars; Xue, Wen; Tenev, Tencho; da Fonseca, Paula C. A.; Zvelebil, Marketa; Bujnicki, Janusz M.; Lowe, Scott; Silke, John; Meier, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1309-1317</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The covalent attachment of ubiquitin to target proteins influences various cellular processes, including DNA repair, NF-κB signaling and cell survival.  The most common mode of regulation by ubiquitin-conjugation involves specialized ubiquitin-binding proteins that bind to ubiquitylated proteins and link them to downstream biochem. processes.  Unravelling how the ubiquitin-message is recognized is essential because aberrant ubiquitin-mediated signaling contributes to tumor formation.  Recent evidence indicates that inhibitor of apoptosis (IAP) proteins are frequently overexpressed in cancer and their expression level is implicated in contributing to tumorigenesis, chemoresistance, disease progression and poor patient-survival.  Here, we have identified an evolutionarily conserved ubiquitin-assocd. (UBA) domain in IAPs, which enables them to bind to Lys 63-linked polyubiquitin.  We found that the UBA domain is essential for the oncogenic potential of cIAP1, to maintain endothelial cell survival and to protect cells from TNF-α-induced apoptosis.  Moreover, the UBA domain is required for XIAP and cIAP2-MALT1 to activate NF-κB.  Our data suggest that the UBA domain of cIAP2-MALT1 stimulates NF-κB signaling by binding to polyubiquitylated NEMO.  Significantly, 98% of all cIAP2-MALT1 fusion proteins retain the UBA domain, suggesting that ubiquitin-binding contributes to the oncogenic potential of cIAP2-MALT1 in MALT lymphoma.  Our data identify IAPs as ubiquitin-binding proteins that contribute to ubiquitin-mediated cell survival, NF-κB signaling and oncogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1bPlCkVUl3LVg90H21EOLACvtfcHk0ljXNDKSBMnNOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlais7jJ&md5=ad243bd52582b4e40f58eccd369bc2d4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fncb1789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1789%26sid%3Dliteratum%253Aachs%26aulast%3DGyrd-Hansen%26aufirst%3DM.%26aulast%3DDarding%26aufirst%3DM.%26aulast%3DMiasari%26aufirst%3DM.%26aulast%3DSantoro%26aufirst%3DM.%2BM.%26aulast%3DZender%26aufirst%3DL.%26aulast%3DXue%26aufirst%3DW.%26aulast%3DTenev%26aufirst%3DT.%26aulast%3Dda%2BFonseca%26aufirst%3DP.%2BC.%26aulast%3DZvelebil%26aufirst%3DM.%26aulast%3DBujnicki%26aufirst%3DJ.%2BM.%26aulast%3DLowe%26aufirst%3DS.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DIAPs%2520contain%2520an%2520evolutionarily%2520conserved%2520ubiquitin-binding%2520domain%2520that%2520regulates%2520NF-kappaB%2520as%2520well%2520as%2520cell%2520survival%2520and%2520oncogenesis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2008%26volume%3D10%26spage%3D1309%26epage%3D1317%26doi%3D10.1038%2Fncb1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaux, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span> <span> </span><span class="NLM_article-title">IAPs, RINGs and ubiquitylation</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1038/nrm1621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnrm1621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=15803136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVaktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=287-297&author=D.+L.+Vauxauthor=J.+Silke&title=IAPs%2C+RINGs+and+ubiquitylation&doi=10.1038%2Fnrm1621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">IAPs, RINGs and ubiquitylation</span></div><div class="casAuthors">Vaux, David L.; Silke, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">287-297</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Here, the authors review the function of the RING domain of inhibitor of apoptosis proteins (IAPs), provide an overview of the biol. of E3 ubiquitin ligases, the enzymes which conjugate ubiquitin to substrate proteins, and its application to IAPs, and examine evidence for substrate ubiquitination by IAPs and for the importance of these ubiquitination events in the prevention of apoptosis.  The IAPs all contain one or more baculoviral IAP repeat motifs, through which they interact with various other proteins.  Many IAPs also have another Zn-binding motif, the RING domain, which can recruit E2 ubiquitin-conjugating enzymes and catalyze the transfer of ubiquitin onto target proteins.  The no. of targets of IAP-mediated ubiquitination is increasing, and recent results indicate that outcomes following ubiquitination are tantalizingly complex.  As well as regulating other proteins, the IAPs themselves are controlled by ubiquitin-mediated degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8gh0_du1aY7Vg90H21EOLACvtfcHk0ljXNDKSBMnNOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVaktb8%253D&md5=4d3040429bbac085dd33b46c8c74d955</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrm1621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1621%26sid%3Dliteratum%253Aachs%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DIAPs%252C%2520RINGs%2520and%2520ubiquitylation%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2005%26volume%3D6%26spage%3D287%26epage%3D297%26doi%3D10.1038%2Fnrm1621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rautureau, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francalanci, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broemer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoro, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, P.</span></span> <span> </span><span class="NLM_article-title">CARD-mediated autoinhibition of cIAP1’s E3 ligase activity suppresses cell proliferation and migration</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">569</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2011.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.molcel.2011.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21549626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsV2jtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2011&pages=569-583&author=J.+Lopezauthor=S.+W.+Johnauthor=T.+Tenevauthor=G.+J.+Rautureauauthor=M.+G.+Hindsauthor=F.+Francalanciauthor=R.+Wilsonauthor=M.+Broemerauthor=M.+M.+Santoroauthor=C.+L.+Dayauthor=P.+Meier&title=CARD-mediated+autoinhibition+of+cIAP1%E2%80%99s+E3+ligase+activity+suppresses+cell+proliferation+and+migration&doi=10.1016%2Fj.molcel.2011.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">CARD-Mediated Autoinhibition of cIAP1's E3 Ligase Activity Suppresses Cell Proliferation and Migration</span></div><div class="casAuthors">Lopez, Juanita; John, Sidonie Wicky; Tenev, Tencho; Rautureau, Gilles J. P.; Hinds, Mark G.; Francalanci, Floriana; Wilson, Rebecca; Broemer, Meike; Santoro, Massimo M.; Day, Catherine L.; Meier, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">569-583</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">E3 ligases mediate the covalent attachment of ubiquitin to target proteins thereby enabling ubiquitin-dependent signaling.  Unraveling how E3 ligases are regulated is important because miscontrolled ubiquitylation can lead to disease.  Cellular inhibitor of apoptosis (cIAP) proteins are E3 ligases that modulate diverse biol. processes such as cell survival, proliferation, and migration.  Here, the authors have solved the structure of the caspase recruitment domain (CARD) of cIAP1 and identified that it is required for cIAP1 autoregulation.  The CARD inhibits activation of cIAP1's E3 activity by preventing RING dimerization, E2 binding, and E2 activation.  Moreover, the CARD is required to suppress cell proliferation and migration.  Further, CARD-mediated autoregulation is also necessary to maximally suppress caspase-8-dependent apoptosis and vascular tree degeneration in vivo.  Taken together, the authors' data reveal mechanisms by which the E3 ligase activity of cIAP1 is controlled, and how its deregulation impacts on cell proliferation, migration and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEuBA3RY1Np7Vg90H21EOLACvtfcHk0lhvHEPsPzGYgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsV2jtb0%253D&md5=5ffa96aa585d6c4468951d01b1f76d52</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DJ.%26aulast%3DJohn%26aufirst%3DS.%2BW.%26aulast%3DTenev%26aufirst%3DT.%26aulast%3DRautureau%26aufirst%3DG.%2BJ.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DFrancalanci%26aufirst%3DF.%26aulast%3DWilson%26aufirst%3DR.%26aulast%3DBroemer%26aufirst%3DM.%26aulast%3DSantoro%26aufirst%3DM.%2BM.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DCARD-mediated%2520autoinhibition%2520of%2520cIAP1%25E2%2580%2599s%2520E3%2520ligase%2520activity%2520suppresses%2520cell%2520proliferation%2520and%2520migration%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D42%26spage%3D569%26epage%3D583%26doi%3D10.1016%2Fj.molcel.2011.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varfolomeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blankenship, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wayson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorova, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayagaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dynek, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span> <span> </span><span class="NLM_article-title">IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">681</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.cell.2007.10.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18022362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSgurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=669-681&author=E.+Varfolomeevauthor=J.+W.+Blankenshipauthor=S.+M.+Waysonauthor=A.+V.+Fedorovaauthor=N.+Kayagakiauthor=P.+Gargauthor=K.+Zobelauthor=J.+N.+Dynekauthor=L.+O.+Elliottauthor=H.+J.+Wallweberauthor=J.+A.+Flygareauthor=W.+J.+Fairbrotherauthor=K.+Deshayesauthor=V.+M.+Dixitauthor=D.+Vucic&title=IAP+antagonists+induce+autoubiquitination+of+c-IAPs%2C+NF-kappaB+activation%2C+and+TNFalpha-dependent+apoptosis&doi=10.1016%2Fj.cell.2007.10.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis</span></div><div class="casAuthors">Varfolomeev, Eugene; Blankenship, John W.; Wayson, Sarah M.; Fedorova, Anna V.; Kayagaki, Nobuhiko; Garg, Parie; Zobel, Kerry; Dynek, Jasmin N.; Elliott, Linda O.; Wallweber, Heidi J. A.; Flygare, John A.; Fairbrother, Wayne J.; Deshayes, Kurt; Dixit, Vishva M.; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">669-681</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis (IAP) proteins are antiapoptotic regulators that block cell death in response to diverse stimuli.  They are expressed at elevated levels in human malignancies and are attractive targets for the development of novel cancer therapeutics.  Herein, the authors demonstrate that small-mol. IAP antagonists bind to select baculovirus IAP repeat (BIR) domains resulting in dramatic induction of autoubiquitination activity and rapid proteasomal degrdn. of c-IAPs.  The IAP antagonists also induce cell death that is dependent on TNF signaling and de novo protein biosynthesis.  Addnl., the c-IAP proteins were found to function as regulators of NF-κB signaling.  Through their ubiquitin E3 ligase activities c-IAP1 and c-IAP2 promote proteasomal degrdn. of NIK, the central ser/thr kinase in the noncanonical NF-κB pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV7cKeBeR_hrVg90H21EOLACvtfcHk0lhvHEPsPzGYgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSgurzF&md5=c9a255030cc26db0519680d170ba91f9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DBlankenship%26aufirst%3DJ.%2BW.%26aulast%3DWayson%26aufirst%3DS.%2BM.%26aulast%3DFedorova%26aufirst%3DA.%2BV.%26aulast%3DKayagaki%26aufirst%3DN.%26aulast%3DGarg%26aufirst%3DP.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DDynek%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DIAP%2520antagonists%2520induce%2520autoubiquitination%2520of%2520c-IAPs%252C%2520NF-kappaB%2520activation%252C%2520and%2520TNFalpha-dependent%2520apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D669%26epage%3D681%26doi%3D10.1016%2Fj.cell.2007.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holcik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korneluk, R. G.</span></span> <span> </span><span class="NLM_article-title">XIAP: apoptotic brake and promising therapeutic target</span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1023/A:1011379307472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1023%2FA%3A1011379307472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=11445667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsF2qu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=253-261&author=M.+Holcikauthor=H.+Gibsonauthor=R.+G.+Korneluk&title=XIAP%3A+apoptotic+brake+and+promising+therapeutic+target&doi=10.1023%2FA%3A1011379307472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">XIAP: apoptotic brake and promising therapeutic target</span></div><div class="casAuthors">Holcik, Martin; Gibson, Hilary; Korneluk, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-261</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  The X-linked Inhibitor of Apoptosis, XIAP, is a key member of the newly discovered family of intrinsic inhibitors of apoptosis (IAP) proteins.  IAPs block cell death both in vitro and in vivo by virtue of inhibition of distinct caspases.  Although other proteins were identified which inhibit upstream caspases, only the IAPs were demonstrated to be endogenous repressors of the terminal caspase cascade.  In turn, the caspase inhibiting activity of XIAP is neg. regulated by at least 2 XIAP-interacting proteins, XAF1 and Smac/DIABLO.  In addn. to the inhibition of caspases, recent discoveries from several labs. suggest that XIAP is also involved in a no. of other biol. significant cellular activities including modulation of receptor-mediated signal transduction and protein ubiquitination.  XIAP is also translated by a rare cap-independent mechanism mediated by a specific sequence called IRES (for Internal Ribosome Entry Site) which is found in the XIAP 5' UTR.  XIAP protein is thus synthesized under various conditions of cellular stress such as serum starvation and low dose γ-irradn. induced apoptosis, conditions that lead to the inhibition of cellular protein synthesis.  The multiple biol. activities of XIAP, its unique translational and post-translational control and the centrality of the caspase cascade make the control of XIAP expression an exceptionally promising mol. target for modulating apoptosis.  Therapeutic benefits can be derived from both the suppression of inappropriate cell death such as in neurodegenerative disorders and ischemic injury or in the activation of latent cell death pathways such as in autoimmune disease and cancer where apoptosis induction is the desired outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqewyDCMlelK7Vg90H21EOLACvtfcHk0lhvHEPsPzGYgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsF2qu7g%253D&md5=fa50ae4bab9721c40942d0268085e5a4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1023%2FA%3A1011379307472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1011379307472%26sid%3Dliteratum%253Aachs%26aulast%3DHolcik%26aufirst%3DM.%26aulast%3DGibson%26aufirst%3DH.%26aulast%3DKorneluk%26aufirst%3DR.%2BG.%26atitle%3DXIAP%253A%2520apoptotic%2520brake%2520and%2520promising%2520therapeutic%2520target%26jtitle%3DApoptosis%26date%3D2001%26volume%3D6%26spage%3D253%26epage%3D261%26doi%3D10.1023%2FA%3A1011379307472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Brabander, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harran, P. G.</span></span> <span> </span><span class="NLM_article-title">A small molecule SMAC mimic potentiates TRAIL- and TNFalpha-mediated cell death</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>305</i></span>,  <span class="NLM_fpage">1471</span>– <span class="NLM_lpage">1474</span>, <span class="refDoi"> DOI: 10.1126/science.1098231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1126%2Fscience.1098231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=15353805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFartL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1471-1474&author=L.+Liauthor=R.+M.+Thomasauthor=H.+Suzukiauthor=J.+K.+De+Brabanderauthor=X.+Wangauthor=P.+G.+Harran&title=A+small+molecule+SMAC+mimic+potentiates+TRAIL-+and+TNFalpha-mediated+cell+death&doi=10.1126%2Fscience.1098231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death</span></div><div class="casAuthors">Li, Lin; Thomas, Ranny Mathew; Suzuki, Hidetaka; De Brabander, Jef K.; Wang, Xiaodong; Harran, Patrick G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">5689</span>),
    <span class="NLM_cas:pages">1471-1474</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We describe the synthesis and properties of a small mol. mimic of Smac, a pro-apoptotic protein that functions by relieving inhibitor-of-apoptosis protein (IAP)-mediated suppression of caspase activity.  The compd. binds to X chromosome-encoded IAP (XIAP), cellular IAP 1 (cIAP-1), and cellular IAP 2 (cIAP-2) and synergizes with both tumor necrosis factor α (TNFα) and TNF-related apoptosis-inducing ligand (TRAIL) to potently induce caspase activation and apoptosis in human cancer cells.  The mol. has allowed a temporal, unbiased evaluation of the roles that IAP proteins play during signaling from TRAIL and TNF receptors.  The compd. is also a lead structure for the development of IAP antagonists potentially useful as therapy for cancer and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri19S7A9uW8bVg90H21EOLACvtfcHk0lgjLrcFmnnPsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFartL8%253D&md5=75945f9e8637c8ce303e15f95395f449</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscience.1098231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1098231%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DR.%2BM.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DDe%2BBrabander%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHarran%26aufirst%3DP.%2BG.%26atitle%3DA%2520small%2520molecule%2520SMAC%2520mimic%2520potentiates%2520TRAIL-%2520and%2520TNFalpha-mediated%2520cell%2520death%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1471%26epage%3D1474%26doi%3D10.1126%2Fscience.1098231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">SMAC, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)00008-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2FS0092-8674%2800%2900008-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10929711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=33-42&author=C.+Duauthor=M.+Fangauthor=Y.+Liauthor=L.+Liauthor=X.+Wang&title=SMAC%2C+a+mitochondrial+protein+that+promotes+cytochrome+c-dependent+caspase+activation+by+eliminating+IAP+inhibition&doi=10.1016%2FS0092-8674%2800%2900008-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition</span></div><div class="casAuthors">Du, Chunying; Fang, Min; Li, Yucheng; Li, Lily; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-42</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We report here the identification of a novel protein, Smac, which promotes caspase activation in the cytochrome c/Apaf-1/caspase-9 pathway.  Smac promotes caspase-9 activation by binding to inhibitor of apoptosis proteins, IAPs, and removing their inhibitory activity.  Smac is normally a mitochondrial protein but is released into the cytosol when cells undergo apoptosis.  Mitochondrial import and cleavage of its signal peptide are required for Smac to gain its apoptotic activity.  Overexpression of Smac increases cells' sensitivity to apoptotic stimuli.  Smac is the second mitochondrial protein, along with cytochrome c, that promotes apoptosis by activating caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEUyaGmAsnprVg90H21EOLACvtfcHk0lgjLrcFmnnPsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCrsbc%253D&md5=8321d44bed77ff7c2da398e1b02f9e20</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900008-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900008-8%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DC.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DSMAC%252C%2520a%2520mitochondrial%2520protein%2520that%2520promotes%2520cytochrome%2520c-dependent%2520caspase%2520activation%2520by%2520eliminating%2520IAP%2520inhibition%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D33%26epage%3D42%26doi%3D10.1016%2FS0092-8674%2800%2900008-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verhagen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekert, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pakusch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritz, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaux, D. L.</span></span> <span> </span><span class="NLM_article-title">Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)00009-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2FS0092-8674%2800%2900009-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10929712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=43-53&author=A.+M.+Verhagenauthor=P.+G.+Ekertauthor=M.+Pakuschauthor=J.+Silkeauthor=L.+M.+Connollyauthor=G.+E.+Reidauthor=R.+L.+Moritzauthor=R.+J.+Simpsonauthor=D.+L.+Vaux&title=Identification+of+DIABLO%2C+a+mammalian+protein+that+promotes+apoptosis+by+binding+to+and+antagonizing+IAP+proteins&doi=10.1016%2FS0092-8674%2800%2900009-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins</span></div><div class="casAuthors">Verhagen, Anne M.; Ekert, Paul G.; Pakusch, Miha; Silke, John; Connolly, Lisa M.; Reid, Gavin E.; Moritz, Robert L.; Simpson, Richard J.; Vaux, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">To identify proteins that bind mammalian IAP homolog A (MIHA, also known as XIAP), we used coimmunopptn. and 2D immobilized pH gradient/SDS-PAGE, followed by electrospray ionization tandem mass spectrometry.  DIABLO (direct IAP binding protein with low pI) is a novel protein that can bind MIHA and can also interact with MIHB and MIHC and the baculoviral IAP, OpIAP.  The N-terminally processed, IAP-interacting form of DIABLO is concd. in membrane fractions in healthy cells but released into the MIHA-contg. cytosolic fractions upon UV irradn.  As transfection of cells with DIABLO was able to counter the protection afforded by MIHA against UV irradn., DIABLO may promote apoptosis by binding to IAPs and preventing them from inhibiting caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-TYWHjxeE7Vg90H21EOLACvtfcHk0lgjLrcFmnnPsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr4%253D&md5=475519bd43e9d625b06b0293895d9693</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900009-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900009-X%26sid%3Dliteratum%253Aachs%26aulast%3DVerhagen%26aufirst%3DA.%2BM.%26aulast%3DEkert%26aufirst%3DP.%2BG.%26aulast%3DPakusch%26aufirst%3DM.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DConnolly%26aufirst%3DL.%2BM.%26aulast%3DReid%26aufirst%3DG.%2BE.%26aulast%3DMoritz%26aufirst%3DR.%2BL.%26aulast%3DSimpson%26aufirst%3DR.%2BJ.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26atitle%3DIdentification%2520of%2520DIABLO%252C%2520a%2520mammalian%2520protein%2520that%2520promotes%2520apoptosis%2520by%2520binding%2520to%2520and%2520antagonizing%2520IAP%2520proteins%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D43%26epage%3D53%26doi%3D10.1016%2FS0092-8674%2800%2900009-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structural and biochemical basis of apoptotic activation by SMAC/DIABLO</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>406</i></span>,  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1038/35022514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2F35022514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10972280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVCrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2000&pages=855-862&author=J.+Chaiauthor=C.+Duauthor=J.+W.+Wuauthor=S.+Kyinauthor=X.+Wangauthor=Y.+Shi&title=Structural+and+biochemical+basis+of+apoptotic+activation+by+SMAC%2FDIABLO&doi=10.1038%2F35022514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and biochemical basis of apoptotic activation by Smac/DIABLO</span></div><div class="casAuthors">Chai, Jijie; Du, Chunying; Wu, Jia-Wei; Kyin, Saw; Wang, Xiaodong; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">406</span>
        (<span class="NLM_cas:issue">6798</span>),
    <span class="NLM_cas:pages">855-862</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis (programmed cell death), an essential process in the development and homeostasis of metazoans, is carried out by caspases.  The mitochondrial protein Smac/DIABLO performs a crit. function in apoptosis by eliminating the inhibitory effect of IAPs (inhibitor of apoptosis proteins) on caspases.  Here we show that Smac/DIABLO promotes not only the proteolytic activation of procaspase-3 but also the enzymic activity of mature caspase-3, both of which depend upon its ability to interact phys. with IAPs.  The crystal structure of Smac/DIABLO at 2.2Å resoln. reveals that it homodimerizes through an extensive hydrophobic interface.  Missense mutations inactivating this dimeric interface significantly compromise the function of Smac/DIABLO.  As in the Drosophila proteins Reaper, Grim and Hid, the amino-terminal amino acids of Smac/DIABLO are indispensable for its function, and a seven-residue peptide derived from the amino terminus promotes procaspase-3 activation in vitro.  These results establish an evolutionarily conserved structural and biochem. basis for the activation of apoptosis by Smac/DIABLO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ4zPSamJORbVg90H21EOLACvtfcHk0lhaFOXIDA-4Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVCrsLk%253D&md5=e3e65405a679b11556fa875b7c5dc9fa</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2F35022514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35022514%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%2BW.%26aulast%3DKyin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520and%2520biochemical%2520basis%2520of%2520apoptotic%2520activation%2520by%2520SMAC%252FDIABLO%26jtitle%3DNature%26date%3D2000%26volume%3D406%26spage%3D855%26epage%3D862%26doi%3D10.1038%2F35022514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oost, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Structural basis for binding of SMAC/DIABLO to the XIAP BIR3 domain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">1004</span>– <span class="NLM_lpage">1008</span>, <span class="refDoi"> DOI: 10.1038/35050006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2F35050006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=11140637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1004-1008&author=Z.+Liuauthor=C.+Sunauthor=E.+T.+Olejniczakauthor=R.+P.+Meadowsauthor=S.+F.+Betzauthor=T.+Oostauthor=J.+Herrmannauthor=J.+C.+Wuauthor=S.+W.+Fesik&title=Structural+basis+for+binding+of+SMAC%2FDIABLO+to+the+XIAP+BIR3+domain&doi=10.1038%2F35050006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain</span></div><div class="casAuthors">Liu, Zhlhong; Sun, Chaohong; Olejniczak, Edward T.; Meadows, Robert P.; Betz, Stephen F.; Oost, Thorsten; Hemnann, Julia; Wu, Joe C.; Feslk, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1004-1008</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The inhibitor-of-apoptosis proteins (IAPs) regulate programmed cell death by inhibiting members of the caspase family of enzymes.  Recently, a mammalian protein called Smac (also named DIABLO) was identified that binds to the LAPs and promotes caspase activation.  Although undefined in the x-ray structure, the amino-terminal residues of Smac are crit. for its function.  To understand the structural basis for mol. recognition between Smac and the IAPs, we detd. the soln. structure of the BIR3 domain of X-linked IAP (XIAP) complexed with a functionally active nine-residue peptide derived from the N terminus of Smac.  The peptide binds across the third β-strand of the BIR3 domain in an extended conformation with only the first four residues contacting the protein.  The complex is stabilized by four intermol. hydrogen bonds, an electrostatic interaction involving the N terminus of the peptide, and several hydrophobic interactions.  This structural information, along with the binding data from BIR3 and Smac peptide mutants reported here, should aid in the design of small mols. that may be used for the treatment of cancers that overexpress IAPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM4pZbM96xmrVg90H21EOLACvtfcHk0lhaFOXIDA-4Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D&md5=d81bd94ecd9cf9c11d96ee228ff371aa</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2F35050006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DBetz%26aufirst%3DS.%2BF.%26aulast%3DOost%26aufirst%3DT.%26aulast%3DHerrmann%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DStructural%2520basis%2520for%2520binding%2520of%2520SMAC%252FDIABLO%2520to%2520the%2520XIAP%2520BIR3%2520domain%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1004%26epage%3D1008%26doi%3D10.1038%2F35050006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suber, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis of IAP recognition by SMAC/DIABLO</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">1008</span>– <span class="NLM_lpage">1012</span>, <span class="refDoi"> DOI: 10.1038/35050012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2F35050012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=11140638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1008-1012&author=G.+Wuauthor=J.+Chaiauthor=T.+L.+Suberauthor=J.+W.+Wuauthor=C.+Duauthor=X.+Wangauthor=Y.+Shi&title=Structural+basis+of+IAP+recognition+by+SMAC%2FDIABLO&doi=10.1038%2F35050012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of IAP recognition by Smac/DIABLO</span></div><div class="casAuthors">Wu, Geng; Chai, Jijie; Suber, Tomeka L.; Wu, Jia-Wel; Du, Chunying; Wang, Xiaodong; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1008-1012</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is an essential process in the development and homeostasis of all metazoans.  The inhibitor-of-apoptosis (IAP) proteins suppress cell death by inhibiting the activity of caspases; this inhibition is performed by the zinc-binding BIR domains of the IAP proteins.  The mitochondrial protein Smac/DIABLO promotes apoptosis by eliminating the inhibitory effect of IAPs through phys. interactions.  Amino-terminal sequences in Smac/DIABLO are required for this function, as mutation of the very first amino acid leads to loss of interaction with LAPs and concomitant loss of Smac/DIABLO function.  Here we report the high-resoln. crystal structure of Smac/DIABLO complexed with the third BIR domain (BIR3) of XIAP.  Our results show that the N-terminal four residues (Ala-Val-Pro-Ile) in Smac/DIABLO recognize a surface groove on BIR3, with the first residue Ala binding a hydrophobic pocket and making five hydrogen bonds to neighboring residues on BIR3.  These observations provide a structural explanation for the roles of the Smac N terminus as well as the conserved N-terminal sequences in the Drosophila proteins Hid/Grim/Reaper.  In conjunction with other observations, our results reveal how Smac may relieve IAP inhibition of caspase-9 activity.  In addn. to explaining a no. of biol. observations, our structural anal. identifies potential targets for drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3qy8uKazsrVg90H21EOLACvtfcHk0lhaFOXIDA-4Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D&md5=fab609edfb1833053eeb78dd2d4ed536</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2F35050012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DSuber%26aufirst%3DT.%2BL.%26aulast%3DWu%26aufirst%3DJ.%2BW.%26aulast%3DDu%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520IAP%2520recognition%2520by%2520SMAC%252FDIABLO%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1008%26epage%3D1012%26doi%3D10.1038%2F35050012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocina, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structural analysis of a functional DIAP1 fragment bound to grim and hid peptides</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(01)00282-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2FS1097-2765%2801%2900282-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=11511363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1Wnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=95-104&author=J.+W.+Wuauthor=A.+E.+Cocinaauthor=J.+Chaiauthor=B.+A.+Hayauthor=Y.+Shi&title=Structural+analysis+of+a+functional+DIAP1+fragment+bound+to+grim+and+hid+peptides&doi=10.1016%2FS1097-2765%2801%2900282-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analysis of a functional DIAP1 fragment bound to grim and hid peptides</span></div><div class="casAuthors">Wu, Jia-Wei; Cocina, Amy E.; Chai, Jijie; Hay, Bruce A.; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-104</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis protein DIAP1 suppresses apoptosis in Drosophila, with the second BIR domain (BIR2) playing an important role.  Three proteins, Hid, Grim, and Reaper, promote apoptosis, in part by binding to DIAP1 through their conserved N-terminal sequences.  The crystal structures of DIAP1-BIR2 by itself and in complex with the N-terminal peptides from Hid and Grim reveal that these peptides bind a surface groove on DIAP1, with the first four amino acids mimicking the binding of the Smac tetrapeptide to XIAP.  The next 3 residues also contribute to binding through hydrophobic interactions.  Interestingly, peptide binding induces the formation of an addnl. α helix in DIAP1.  Our study reveals the structural conservation and diversity necessary for the binding of IAPs by the Drosophila Hid/Grim/Reaper and the mammalian Smac proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK8y5_Rd5rLrVg90H21EOLACvtfcHk0lgCrknJDQKVMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1Wnu70%253D&md5=7f65cfee4e8ff7e5cff9ee603117a522</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2801%2900282-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252801%252900282-9%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%2BW.%26aulast%3DCocina%26aufirst%3DA.%2BE.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DHay%26aufirst%3DB.%2BA.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520analysis%2520of%2520a%2520functional%2520DIAP1%2520fragment%2520bound%2520to%2520grim%2520and%2520hid%2520peptides%26jtitle%3DMol.%2520Cell%26date%3D2001%26volume%3D8%26spage%3D95%26epage%3D104%26doi%3D10.1016%2FS1097-2765%2801%2900282-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">A structural view of mitochondria-mediated apoptosis</span>. <i>Nat. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">394</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1038/87548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2F87548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=11323712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1ersbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=394-401&author=Y.+Shi&title=A+structural+view+of+mitochondria-mediated+apoptosis&doi=10.1038%2F87548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A structural view of mitochondria-mediated apoptosis</span></div><div class="casAuthors">Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">394-401</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A review, with 87 refs.  Mitochondria-mediated apoptosis plays a central role in animal development and tissue homeostasis, and its alteration results in a range of malignant disorders including cancer.  Upon apoptotic stimuli, the mitochondrial proteins cytochrome c and Smac/DIABLO are released into the cytosol, where they synergistically activate caspases by activating Apaf-1 and relieving the apoptotic inhibition by IAPs.  Recent biochem. and structural studies reveal a mol. basis for these important events and identify an evolutionarily conserved mechanism of apoptosis from fruit flies to mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4gpcowzOjsbVg90H21EOLACvtfcHk0lgCrknJDQKVMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1ersbY%253D&md5=c052658166d2b7a0b35d7eb00a02bc6d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2F87548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F87548%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.%26atitle%3DA%2520structural%2520view%2520of%2520mitochondria-mediated%2520apoptosis%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D394%26epage%3D401%26doi%3D10.1038%2F87548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kipp, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wist, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cresson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albiniak, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semmelhack, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLendon, G. L.</span></span> <span> </span><span class="NLM_article-title">Molecular targeting of inhibitor of apoptosis proteins based on small molecule mimics of natural binding partners</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">7344</span>– <span class="NLM_lpage">7349</span>, <span class="refDoi"> DOI: 10.1021/bi0121454</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0121454" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjs1egsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=7344-7349&author=R.+A.+Kippauthor=M.+A.+Caseauthor=A.+D.+Wistauthor=C.+M.+Cressonauthor=M.+Carrellauthor=E.+Grinerauthor=A.+Wiitaauthor=P.+A.+Albiniakauthor=J.+Chaiauthor=Y.+Shiauthor=M.+F.+Semmelhackauthor=G.+L.+McLendon&title=Molecular+targeting+of+inhibitor+of+apoptosis+proteins+based+on+small+molecule+mimics+of+natural+binding+partners&doi=10.1021%2Fbi0121454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Targeting of Inhibitor of Apoptosis Proteins Based on Small Molecule Mimics of Natural Binding Partners</span></div><div class="casAuthors">Kipp, Rachael A.; Case, Martin A.; Wist, Aislyn D.; Cresson, Catherine M.; Carrell, Maria; Griner, Erin; Wiita, Arun; Albiniak, Philip A.; Chai, Jijie; Shi, Yigong; Semmelhack, Martin F.; McLendon, George L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7344-7349</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An assay based on a solvent-sensitive fluorogenic dye mol., badan, is used to test the binding affinity of a library of tetrapeptide mols. for the BIR3 (baculovirus IAP repeat) domain of XIAP (X-linked inhibitor of apoptosis protein).  The fluorophore is attached to a tetrapeptide, Ala-Val-Pro-Cys-NH2, through a thiol linkage and, upon binding to XIAP, undergoes a solvatochromic shift in fluorescence emission.  When a mol. (e.g., a natural protein known to bind to XIAP or a tetrapeptide mimic) displaces the dye, the emission shifts back to the spectrum obsd. in water.  As emission intensity is related to the binding of the tetrapeptide, the intensity can be used to det. the equil. const., K, for the displacement of the dye by the tetrapeptide.  The results permit residue-specific anal. of the interaction.  Furthermore, we show that hydrophobic effects in the fourth position are general and can effectively increase overall affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2jRD1J251H7Vg90H21EOLACvtfcHk0lgCrknJDQKVMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjs1egsL4%253D&md5=ce6f8ed9b3a195523b98dc4943142312</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fbi0121454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0121454%26sid%3Dliteratum%253Aachs%26aulast%3DKipp%26aufirst%3DR.%2BA.%26aulast%3DCase%26aufirst%3DM.%2BA.%26aulast%3DWist%26aufirst%3DA.%2BD.%26aulast%3DCresson%26aufirst%3DC.%2BM.%26aulast%3DCarrell%26aufirst%3DM.%26aulast%3DGriner%26aufirst%3DE.%26aulast%3DWiita%26aufirst%3DA.%26aulast%3DAlbiniak%26aufirst%3DP.%2BA.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSemmelhack%26aufirst%3DM.%2BF.%26aulast%3DMcLendon%26aufirst%3DG.%2BL.%26atitle%3DMolecular%2520targeting%2520of%2520inhibitor%2520of%2520apoptosis%2520proteins%2520based%2520on%2520small%2520molecule%2520mimics%2520of%2520natural%2520binding%2520partners%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D7344%26epage%3D7349%26doi%3D10.1021%2Fbi0121454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design of small-molecule SMAC mimetics as IAP antagonists</span>. <i>Curr. Top. Microbiol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1007/82_2010_111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1007%2F82_2010_111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2010&pages=89-113&author=S.+Wang&title=Design+of+small-molecule+SMAC+mimetics+as+IAP+antagonists&doi=10.1007%2F82_2010_111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2F82_2010_111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F82_2010_111%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%2520of%2520small-molecule%2520SMAC%2520mimetics%2520as%2520IAP%2520antagonists%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2010%26volume%3D348%26spage%3D89%26epage%3D113%26doi%3D10.1007%2F82_2010_111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oost, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Assaad, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deckwerth, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oltersdorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaselli, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">4417</span>– <span class="NLM_lpage">4426</span>, <span class="refDoi"> DOI: 10.1021/jm040037k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040037k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFOltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4417-4426&author=T.+K.+Oostauthor=C.+Sunauthor=R.+C.+Armstrongauthor=A.+S.+Al-Assaadauthor=S.+F.+Betzauthor=T.+L.+Deckwerthauthor=H.+Dingauthor=S.+W.+Elmoreauthor=R.+P.+Meadowsauthor=E.+T.+Olejniczakauthor=A.+Oleksijewauthor=T.+Oltersdorfauthor=S.+H.+Rosenbergauthor=A.+R.+Shoemakerauthor=K.+J.+Tomaselliauthor=H.+Zouauthor=S.+W.+Fesik&title=Discovery+of+potent+antagonists+of+the+antiapoptotic+protein+XIAP+for+the+treatment+of+cancer&doi=10.1021%2Fjm040037k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer</span></div><div class="casAuthors">Oost, Thorsten K.; Sun, Chaohong; Armstrong, Robert C.; Al-Assaad, Ali-Samer; Betz, Stephen F.; Deckwerth, Thomas L.; Ding, Hong; Elmore, Steven W.; Meadows, Robert P.; Olejniczak, Edward T.; Oleksijew, Andrew; Oltersdorf, Tilman; Rosenberg, Saul H.; Shoemaker, Alexander R.; Tomaselli, Kevin J.; Zou, Hua; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4417-4426</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis (IAP) proteins are overexpressed in many cancers and have been implicated in tumor growth, pathogenesis, and resistance to chemo- or radiotherapy.  On the basis of the NMR structure of a SMAC peptide complexed with the BIR3 domain of X-linked IAP (XIAP), a novel series of XIAP antagonists was discovered.  The most potent compds. in this series bind to the baculovirus IAP repeat 3 (BIR3) domain of XIAP with single-digit nanomolar affinity and promote cell death in several human cancer cell lines.  In a MDA-MB-231 breast cancer mouse xenograft model, these XIAP antagonists inhibited the growth of tumors.  Close structural analogs that showed only weak binding to the XIAP-BIR3 domain were inactive in the cellular assays and showed only marginal in vivo activity.  Our results are consistent with a mechanism in which ligands for the BIR3 domain of XIAP induce apoptosis by freeing up caspases.  The present study validates the BIR3 domain of XIAP as a target and supports the use of small mol. XIAP antagonists as a potential therapy for cancers that overexpress XIAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzSXHFufBtZbVg90H21EOLACvtfcHk0ljmyL1r8AkyTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFOltbo%253D&md5=ccd77135a42ab84cd36f221abdb4fee7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm040037k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040037k%26sid%3Dliteratum%253Aachs%26aulast%3DOost%26aufirst%3DT.%2BK.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DAl-Assaad%26aufirst%3DA.%2BS.%26aulast%3DBetz%26aufirst%3DS.%2BF.%26aulast%3DDeckwerth%26aufirst%3DT.%2BL.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DTomaselli%26aufirst%3DK.%2BJ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520potent%2520antagonists%2520of%2520the%2520antiapoptotic%2520protein%2520XIAP%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4417%26epage%3D4426%26doi%3D10.1021%2Fjm040037k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varfolomeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorova, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dynek, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span> <span> </span><span class="NLM_article-title">Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1021/cb900083m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb900083m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Sjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=557-566&author=C.+Ndubakuauthor=E.+Varfolomeevauthor=L.+Wangauthor=K.+Zobelauthor=K.+Lauauthor=L.+O.+Elliottauthor=B.+Maurerauthor=A.+V.+Fedorovaauthor=J.+N.+Dynekauthor=M.+Koehlerauthor=S.+G.+Hymowitzauthor=V.+Tsuiauthor=K.+Deshayesauthor=W.+J.+Fairbrotherauthor=J.+A.+Flygareauthor=D.+Vucic&title=Antagonism+of+c-IAP+and+XIAP+proteins+is+required+for+efficient+induction+of+cell+death+by+small-molecule+IAP+antagonists&doi=10.1021%2Fcb900083m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of c-IAP and XIAP Proteins Is Required for Efficient Induction of Cell Death by Small-Molecule IAP Antagonists</span></div><div class="casAuthors">Ndubaku, Chudi; Varfolomeev, Eugene; Wang, Lan; Zobel, Kerry; Lau, Kevin; Elliott, Linda O.; Maurer, Brigitte; Fedorova, Anna V.; Dynek, Jasmin N.; Koehler, Michael; Hymowitz, Sarah G.; Tsui, Vickie; Deshayes, Kurt; Fairbrother, Wayne J.; Flygare, John A.; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">557-566</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins are crit. regulators of cancer cell survival, which makes them attractive targets for therapeutic intervention in cancers.  Herein, the structure-based design of IAP antagonists with high affinities and selectivity (>2000-fold) for c-IAP1 over XIAP and their functional characterization as activators of apoptosis in tumor cells are described.  Although capable of inducing cell death and preventing clonogenic survival, c-IAP-selective antagonists are significantly less potent in promoting apoptosis when compared to pan-selective compds.  However, both pan-IAP- and c-IAP-selective antagonists stimulate c-IAP1 and c-IAP2 degrdn. and activation of NF-κB pathways with comparable potencies.  Therefore, although compds. that specifically target c-IAP1 and c-IAP2 are capable of inducing apoptosis, antagonism of the c-IAP proteins and XIAP is required for efficient induction of cancer cell death by IAP antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7xO3yZNCyz7Vg90H21EOLACvtfcHk0ljmyL1r8AkyTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Sjur4%253D&md5=f1c82b7c5632453ba36e039441f039c9</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fcb900083m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb900083m%26sid%3Dliteratum%253Aachs%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DMaurer%26aufirst%3DB.%26aulast%3DFedorova%26aufirst%3DA.%2BV.%26aulast%3DDynek%26aufirst%3DJ.%2BN.%26aulast%3DKoehler%26aufirst%3DM.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DAntagonism%2520of%2520c-IAP%2520and%2520XIAP%2520proteins%2520is%2520required%2520for%2520efficient%2520induction%2520of%2520cell%2520death%2520by%2520small-molecule%2520IAP%2520antagonists%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2009%26volume%3D4%26spage%3D557%26epage%3D566%26doi%3D10.1021%2Fcb900083m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheeti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisner, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazzard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halladay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoRusso, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Um, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varfolomeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ware, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4101</span>– <span class="NLM_lpage">4113</span>, <span class="refDoi"> DOI: 10.1021/jm300060k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300060k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4101-4113&author=J.%0AA.+Flygareauthor=M.+Beresiniauthor=N.+Budhaauthor=H.+Chanauthor=I.+T.+Chanauthor=S.+Cheetiauthor=F.+Cohenauthor=K.+Deshayesauthor=K.+Doernerauthor=S.+G.+Eckhardtauthor=L.+O.+Elliottauthor=B.+Fengauthor=M.+C.+Franklinauthor=S.+F.+Reisnerauthor=L.+Gazzardauthor=J.+Halladayauthor=S.+G.+Hymowitzauthor=H.+Laauthor=P.+LoRussoauthor=B.+Maurerauthor=L.+Murrayauthor=E.+Pliseauthor=C.+Quanauthor=J.+P.+Stephanauthor=S.+G.+Youngauthor=J.+Tomauthor=V.+Tsuiauthor=J.+Umauthor=E.+Varfolomeevauthor=D.+Vucicauthor=A.+J.+Wagnerauthor=H.+J.+Wallweberauthor=L.+Wangauthor=J.+Wareauthor=Z.+Wenauthor=H.+Wongauthor=J.+M.+Wongauthor=M.+Wongauthor=S.+Wongauthor=R.+Yuauthor=K.+Zobelauthor=W.+J.+Fairbrother&title=Discovery+of+a+potent+small-molecule+antagonist+of+inhibitor+of+apoptosis+%28IAP%29+proteins+and+clinical+candidate+for+the+treatment+of+cancer+%28GDC-0152%29&doi=10.1021%2Fjm300060k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)</span></div><div class="casAuthors">Flygare, John A.; Beresini, Maureen; Budha, Nageshwar; Chan, Helen; Chan, Iris T.; Cheeti, Sravanthi; Cohen, Frederick; Deshayes, Kurt; Doerner, Karl; Eckhardt, S. Gail; Elliott, Linda O.; Feng, Bainian; Franklin, Matthew C.; Reisner, Stacy Frankovitz; Gazzard, Lewis; Halladay, Jason; Hymowitz, Sarah G.; La, Hank; LoRusso, Patricia; Maurer, Brigitte; Murray, Lesley; Plise, Emile; Quan, Clifford; Stephan, Jean-Philippe; Young, Shin G.; Tom, Jeffrey; Tsui, Vickie; Um, Joanne; Varfolomeev, Eugene; Vucic, Domagoj; Wagner, Andrew J.; Wallweber, Heidi J. A.; Wang, Lan; Ware, Joseph; Wen, Zhaoyang; Wong, Harvey; Wong, Jonathan M.; Wong, Melisa; Wong, Susan; Yu, Ron; Zobel, Kerry; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4101-4113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of compds. were designed and synthesized as antagonists of cIAP1/2, ML-IAP, and XIAP based on the N-terminus, AVPI, of mature Smac.  Compd. (I) (GDC-0152) has the best profile of these compds.; it binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domains of cIAP1 and cIAP2 with Ki values of 28, 14, 17, and 43 nM, resp.  These compds. promote degrdn. of cIAP1, induce activation of caspase-3/7, and lead to decreased viability of breast cancer cells without affecting normal mammary epithelial cells.  Compd. I inhibits tumor growth when dosed orally in the MDA-MB-231 breast cancer xenograft model.  Compd. I was advanced to human clin. trials, and it exhibited linear pharmacokinetics over the dose range (0.049 to 1.48 mg/kg) tested.  Mean plasma clearance in humans was 9 ± 3 mL/min/kg, and the vol. of distribution was 0.6 ± 0.2 L/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZSPNVJ5gVWrVg90H21EOLACvtfcHk0lj4KctJnGeaiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D&md5=19452878ea834d3c324d567b39a78fb2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm300060k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300060k%26sid%3Dliteratum%253Aachs%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DBudha%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DI.%2BT.%26aulast%3DCheeti%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDoerner%26aufirst%3DK.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DReisner%26aufirst%3DS.%2BF.%26aulast%3DGazzard%26aufirst%3DL.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLoRusso%26aufirst%3DP.%26aulast%3DMaurer%26aufirst%3DB.%26aulast%3DMurray%26aufirst%3DL.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DStephan%26aufirst%3DJ.%2BP.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DTom%26aufirst%3DJ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DUm%26aufirst%3DJ.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWare%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DJ.%2BM.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520small-molecule%2520antagonist%2520of%2520inhibitor%2520of%2520apoptosis%2520%2528IAP%2529%2520proteins%2520and%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520cancer%2520%2528GDC-0152%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4101%26epage%3D4113%26doi%3D10.1021%2Fjm300060k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baggio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udompholkul, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salem, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aronson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dona, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troadec, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichiorri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">Design of potent pan-IAP and Lys-covalent XIAP selective inhibitors using a thermodynamics driven approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6350</span>– <span class="NLM_lpage">6363</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00810</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00810" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6350-6363&author=C.+Baggioauthor=L.+Gambiniauthor=P.+Udompholkulauthor=A.+F.+Salemauthor=A.+Aronsonauthor=A.+Donaauthor=E.+Troadecauthor=F.+Pichiorriauthor=M.+Pellecchia&title=Design+of+potent+pan-IAP+and+Lys-covalent+XIAP+selective+inhibitors+using+a+thermodynamics+driven+approach&doi=10.1021%2Facs.jmedchem.8b00810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach</span></div><div class="casAuthors">Baggio, Carlo; Gambini, Luca; Udompholkul, Parima; Salem, Ahmed F.; Aronson, Alexander; Dona, Ada; Troadec, Estelle; Pichiorri, Flavia; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6350-6363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently we reported that rapid detn. of enthalpy of binding can be achieved for a large no. of congeneric agents or in combinatorial libraries fairly efficiently.  We show that using a thermodn. Craig plot can be very useful in dissecting the enthalpy and entropy contribution of different substituents on a common scaffold, in order to design potent, selective, or pan-active compds.  In our implementation, the approach identified a crit. Lys residue in the BIR3 domain of XIAP.  We report for the first time that it is possible to target such residue covalently to attain potent and selective agents.  Preliminary cellular studies in various models of leukemia, multiple myeloma, and pancreatic cancers suggest that the derived agents possess a potentially intriguing pattern of activity, esp. for cell lines that are resistant to the pan-IAP antagonist and clin. candidate LCL161.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHXO3jixcQVbVg90H21EOLACvtfcHk0lj4KctJnGeaiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7nJ&md5=825ecb56c2a2e7d7b92ef9f1601f3df8</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00810%26sid%3Dliteratum%253Aachs%26aulast%3DBaggio%26aufirst%3DC.%26aulast%3DGambini%26aufirst%3DL.%26aulast%3DUdompholkul%26aufirst%3DP.%26aulast%3DSalem%26aufirst%3DA.%2BF.%26aulast%3DAronson%26aufirst%3DA.%26aulast%3DDona%26aufirst%3DA.%26aulast%3DTroadec%26aufirst%3DE.%26aulast%3DPichiorri%26aufirst%3DF.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DDesign%2520of%2520potent%2520pan-IAP%2520and%2520Lys-covalent%2520XIAP%2520selective%2520inhibitors%2520using%2520a%2520thermodynamics%2520driven%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6350%26epage%3D6363%26doi%3D10.1021%2Facs.jmedchem.8b00810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiokawa, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oguro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosugi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">7938</span>– <span class="NLM_lpage">7954</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.09.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.bmc.2013.09.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=24169315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs12ltb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=7938-7954&author=Z.+Shiokawaauthor=K.+Hashimotoauthor=B.+Saitoauthor=Y.+Oguroauthor=H.+Sumiauthor=M.+Yabukiauthor=M.+Yoshimatsuauthor=Y.+Kosugiauthor=Y.+Deboriauthor=N.+Morishitaauthor=D.+R.+Douganauthor=G.+P.+Snellauthor=S.+Yoshidaauthor=T.+Ishikawa&title=Design%2C+synthesis%2C+and+biological+activities+of+novel+hexahydropyrazino%5B1%2C2-a%5Dindole+derivatives+as+potent+inhibitors+of+apoptosis+%28IAP%29+proteins+antagonists+with+improved+membrane+permeability+across+MDR1+expressing+cells&doi=10.1016%2Fj.bmc.2013.09.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells</span></div><div class="casAuthors">Shiokawa, Zenyu; Hashimoto, Kentaro; Saito, Bunnai; Oguro, Yuya; Sumi, Hiroyuki; Yabuki, Masato; Yoshimatsu, Mie; Kosugi, Yohei; Debori, Yasuyuki; Morishita, Nao; Dougan, Douglas R.; Snell, Gyorgy P.; Yoshida, Sei; Ishikawa, Tomoyasu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7938-7954</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors previously reported octahydropyrrolo[1,2-a]pyrazine deriv. (T-3256336) as a potent antagonist for inhibitors of apoptosis (IAP) proteins.  Because compd. T-3256336 was susceptible to MDR1 mediated efflux, the authors developed another scaffold, hexahydropyrazino[1,2-a]indole, using structure-based drug design.  The fused benzene ring of this scaffold was aimed at increasing the lipophilicity and decreasing the basicity of the scaffold to improve the membrane permeability across MDR1 expressing cells.  The authors established a chiral pool synthetic route to yield the desired tricyclic chiral isomers.  Chem. modification of the core scaffold led to a representative compd. I, which showed strong inhibition of IAP binding (X chromosome-linked IAP [XIAP]: IC50 23 nM and cellular IAP [cIAP]: IC50 1.1 nM) and cell growth inhibition (MDA-MB-231 cells: GI50 2.8 nM) with high permeability and low potential of MDR1 substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMPcB0ZZBVPLVg90H21EOLACvtfcHk0lj4KctJnGeaiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs12ltb3J&md5=9287b57136ba62eaf138e12b1fdb6af4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.09.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.09.067%26sid%3Dliteratum%253Aachs%26aulast%3DShiokawa%26aufirst%3DZ.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DB.%26aulast%3DOguro%26aufirst%3DY.%26aulast%3DSumi%26aufirst%3DH.%26aulast%3DYabuki%26aufirst%3DM.%26aulast%3DYoshimatsu%26aufirst%3DM.%26aulast%3DKosugi%26aufirst%3DY.%26aulast%3DDebori%26aufirst%3DY.%26aulast%3DMorishita%26aufirst%3DN.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activities%2520of%2520novel%2520hexahydropyrazino%255B1%252C2-a%255Dindole%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520apoptosis%2520%2528IAP%2529%2520proteins%2520antagonists%2520with%2520improved%2520membrane%2520permeability%2520across%2520MDR1%2520expressing%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D7938%26epage%3D7954%26doi%3D10.1016%2Fj.bmc.2013.09.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oguro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiokawa, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosugi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of potent inhibitor of apoptosis (IAP) proteins antagonists bearing an octahydropyrrolo[1,2-a]pyrazine scaffold as a novel proline mimetic</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1228</span>– <span class="NLM_lpage">1246</span>, <span class="refDoi"> DOI: 10.1021/jm301674z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301674z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkt1Okug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1228-1246&author=K.+Hashimotoauthor=B.+Saitoauthor=N.+Miyamotoauthor=Y.+Oguroauthor=D.+Tomitaauthor=Z.+Shiokawaauthor=M.+Asanoauthor=H.+Kakeiauthor=N.+Tayaauthor=M.+Kawasakiauthor=H.+Sumiauthor=M.+Yabukiauthor=K.+Iwaiauthor=S.+Yoshidaauthor=M.+Yoshimatsuauthor=K.+Aoyamaauthor=Y.+Kosugiauthor=T.+Kojimaauthor=N.+Morishitaauthor=D.+R.+Douganauthor=G.+P.+Snellauthor=S.+Imamuraauthor=T.+Ishikawa&title=Design+and+synthesis+of+potent+inhibitor+of+apoptosis+%28IAP%29+proteins+antagonists+bearing+an+octahydropyrrolo%5B1%2C2-a%5Dpyrazine+scaffold+as+a+novel+proline+mimetic&doi=10.1021%2Fjm301674z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of potent inhibitor of apoptosis (IAP) proteins antagonists bearing an octahydropyrrolo[1,2-a]pyrazine scaffold as a novel proline mimetic</span></div><div class="casAuthors">Hashimoto, Kentaro; Saito, Bunnai; Miyamoto, Naoki; Oguro, Yuya; Tomita, Daisuke; Shiokawa, Zenyu; Asano, Moriteru; Kakei, Hiroyuki; Taya, Naohiro; Kawasaki, Masanori; Sumi, Hiroyuki; Yabuki, Masato; Iwai, Kenichi; Yoshida, Sei; Yoshimatsu, Mie; Aoyama, Kazunobu; Kosugi, Yohei; Kojima, Takashi; Morishita, Nao; Dougan, Douglas R.; Snell, Gyorgy P.; Imamura, Shinichi; Ishikawa, Tomoyasu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1228-1246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To develop novel inhibitor of apoptosis (IAP) proteins antagonists, we designed a bicyclic octahydropyrrolo[1,2-a]pyrazine scaffold as a novel proline bioisostere.  This design was based on the X-ray co-crystal structure of four N-terminal amino acid residues (AVPI) of the second mitochondria-derived activator of caspase (Smac) with the X-chromosome-linked IAP (XIAP) protein.  Lead optimization of this scaffold to improve oral absorption yielded compd. (I), which showed potent cellular IAP1 (cIAP1 IC50: 1.3 nM) and XIAP (IC50: 200 nM) inhibitory activity, in addn. to potent tumor growth inhibitory activity (GI50: 1.8 nM) in MDA-MB-231 breast cancer cells.  X-ray crystallog. anal. of compd. I bound to XIAP and to cIAP1 was achieved, revealing the various key interactions that contribute to the higher cIAPI affinity of compd. I over XIAP.  Because of its potent IAP inhibitory activities, compd. I (T-3256336) caused tumor regression in a MDA-MB-231 tumor xenograft model (T/C: -53% at 30 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0yTXJd7mdobVg90H21EOLACvtfcHk0lgIusWbCKIsog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkt1Okug%253D%253D&md5=e015021a842d92ceca267ab2ef78f752</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301674z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301674z%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DB.%26aulast%3DMiyamoto%26aufirst%3DN.%26aulast%3DOguro%26aufirst%3DY.%26aulast%3DTomita%26aufirst%3DD.%26aulast%3DShiokawa%26aufirst%3DZ.%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DKakei%26aufirst%3DH.%26aulast%3DTaya%26aufirst%3DN.%26aulast%3DKawasaki%26aufirst%3DM.%26aulast%3DSumi%26aufirst%3DH.%26aulast%3DYabuki%26aufirst%3DM.%26aulast%3DIwai%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DYoshimatsu%26aufirst%3DM.%26aulast%3DAoyama%26aufirst%3DK.%26aulast%3DKosugi%26aufirst%3DY.%26aulast%3DKojima%26aufirst%3DT.%26aulast%3DMorishita%26aufirst%3DN.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DImamura%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520inhibitor%2520of%2520apoptosis%2520%2528IAP%2529%2520proteins%2520antagonists%2520bearing%2520an%2520octahydropyrrolo%255B1%252C2-a%255Dpyrazine%2520scaffold%2520as%2520a%2520novel%2520proline%2520mimetic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1228%26epage%3D1246%26doi%3D10.1021%2Fjm301674z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of potent, conformationally constrained SMAC mimetics</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">16686</span>– <span class="NLM_lpage">16687</span>, <span class="refDoi"> DOI: 10.1021/ja047438+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja047438%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCru7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=16686-16687&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=C.+Y.+Yangauthor=L.+Xuauthor=M.+Liuauthor=Y.+Tomitaauthor=H.+Panauthor=Y.+Yoshiokaauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=S.+Wang&title=Structure-based+design+of+potent%2C+conformationally+constrained+SMAC+mimetics&doi=10.1021%2Fja047438%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of potent, conformationally constrained Smac mimetics</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Yang, Chao-Yie; Xu, Liang; Liu, Meilan; Tomita, York; Pan, Hongguang; Yoshioka, Yoshiko; Krajewski, Krzysztof; Roller, Peter P.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">16686-16687</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A successful structure-based design and synthesis of a class of highly potent conformationally constrained Smac mimetics is described.  The most potent compd. has a Ki value of 25 nM binding to the XIAP BIR3 protein and is 23 times more potent than natural Smac peptides.  These potent Smac mimetics can serve as powerful chem. and pharmacol. tools to further elucidate the role of Smac and its cellular binding partners in apoptosis regulation and may be developed as a new class of anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVqjV4v0Bp27Vg90H21EOLACvtfcHk0lgIusWbCKIsog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCru7zJ&md5=3b29591968a51e0b5fdfc42c81aae5de</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja047438%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja047438%252B%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DYoshioka%26aufirst%3DY.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520of%2520potent%252C%2520conformationally%2520constrained%2520SMAC%2520mimetics%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D16686%26epage%3D16687%26doi%3D10.1021%2Fja047438%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">4147</span>– <span class="NLM_lpage">4150</span>, <span class="refDoi"> DOI: 10.1021/jm0499108</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0499108" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1Kqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4147-4150&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=C.+Y.+Yangauthor=L.+Xuauthor=Y.+Tomitaauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=S.+Wang&title=Structure-based+design%2C+synthesis%2C+and+evaluation+of+conformationally+constrained+mimetics+of+the+second+mitochondria-derived+activator+of+caspase+that+target+the+X-linked+inhibitor+of+apoptosis+protein%2Fcaspase-9+interaction+site&doi=10.1021%2Fjm0499108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design, Synthesis, and Evaluation of Conformationally Constrained Mimetics of the Second Mitochondria-Derived Activator of Caspase That Target the X-Linked Inhibitor of Apoptosis Protein/Caspase-9 Interaction Site</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Yang, Chao-Yie; Xu, Liang; Tomita, York; Krajewski, Krzysztof; Roller, Peter P.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4147-4150</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A successful structure-based design of conformationally constrained second mitochondria-derived activator of caspase (Smac) mimetics that target the XIAP/caspase-9 interaction site is described.  The most potent Smac mimetic (12d) has a Ki of 350 nM for binding to the XIAP BIR3 domain protein.  The compd. 12d is found to be effective in enhancing apoptosis induced by cisplatin in PC-3 human prostate cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmBYVDWMeKvrVg90H21EOLACvtfcHk0lhKKA0_G51Qig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1Kqsbc%253D&md5=e64491c5a63afbdc6832334034692c99</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm0499108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0499108%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520conformationally%2520constrained%2520mimetics%2520of%2520the%2520second%2520mitochondria-derived%2520activator%2520of%2520caspase%2520that%2520target%2520the%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%252Fcaspase-9%2520interaction%2520site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4147%26epage%3D4150%26doi%3D10.1021%2Fjm0499108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of a potent, cell-permeable, conformationally constrained second mitochondria derived activator of caspase (SMAC) mimetic</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">7916</span>– <span class="NLM_lpage">7920</span>, <span class="refDoi"> DOI: 10.1021/jm061108d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061108d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Ghs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7916-7920&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=J.+Luauthor=S.+Qiuauthor=C.+Y.+Yangauthor=W.+Gaoauthor=J.+Meagherauthor=J.+Stuckeyauthor=S.+Wang&title=Design%2C+synthesis%2C+and+evaluation+of+a+potent%2C+cell-permeable%2C+conformationally+constrained+second+mitochondria+derived+activator+of+caspase+%28SMAC%29+mimetic&doi=10.1021%2Fjm061108d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of a Potent, Cell-Permeable, Conformationally Constrained Second Mitochondria Derived Activator of Caspase (Smac) Mimetic</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Lu, Jianfeng; Qiu, Su; Yang, Chao-Yie; Gao, Wei; Meagher, Jennifer; Stuckey, Jeanne; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7916-7920</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A potent, cell-permeable, conformationally constrained second mitochondria derived activator of caspase mimetic (SM-131, 2) has been designed, synthesized, and evaluated.  Compd. 2 binds to X-linked inhibitors of apoptosis proteins (XIAP) with a Ki of 61 nM in a competitive binding assay and directly antagonizes the XIAP inhibition of caspase-9 activity in a cell-free functional assay.  Compd. 2 achieves an IC50 of 100 nM in inhibition of cell growth and effectively induces cell death in the MDA-MB-231 human breast cancer cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxw5s6_ZlkCrVg90H21EOLACvtfcHk0lhKKA0_G51Qig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Ghs7rF&md5=6964976131c6fbb1ae76d89885538e8c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm061108d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061108d%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DMeagher%26aufirst%3DJ.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520a%2520potent%252C%2520cell-permeable%252C%2520conformationally%2520constrained%2520second%2520mitochondria%2520derived%2520activator%2520of%2520caspase%2520%2528SMAC%2529%2520mimetic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7916%26epage%3D7920%26doi%3D10.1021%2Fjm061108d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis, evaluation, and crystallographic studies of conformationally constrained SMAC mimetics as inhibitors of the X-linked inhibitor of apoptosis protein (XIAP)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7169</span>– <span class="NLM_lpage">7180</span>, <span class="refDoi"> DOI: 10.1021/jm8006849</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8006849" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWgsr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7169-7180&author=H.+Sunauthor=J.+A.+Stuckeyauthor=Z.+Nikolovska-Coleskaauthor=D.+Qinauthor=J.+L.+Meagherauthor=S.+Qiuauthor=J.+Luauthor=C.+Y.+Yangauthor=N.+G.+Saitoauthor=S.+Wang&title=Structure-based+design%2C+synthesis%2C+evaluation%2C+and+crystallographic+studies+of+conformationally+constrained+SMAC+mimetics+as+inhibitors+of+the+X-linked+inhibitor+of+apoptosis+protein+%28XIAP%29&doi=10.1021%2Fjm8006849"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design, Synthesis, Evaluation, and Crystallographic Studies of Conformationally Constrained Smac Mimetics as Inhibitors of the X-linked Inhibitor of Apoptosis Protein (XIAP)</span></div><div class="casAuthors">Sun, Haiying; Stuckey, Jeanne A.; Nikolovska-Coleska, Zaneta; Qin, Dongguang; Meagher, Jennifer L.; Qiu, Su; Lu, Jianfeng; Yang, Chao-Yie; Saito, Naoyuki G.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7169-7180</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small mols. designed to mimic the binding of Smac protein to X-linked inhibitor of apoptosis protein (XIAP) are being pursued as a promising new class of anticancer drugs.  Herein, we report the design, synthesis, and comprehensive structure-activity relationship studies of a series of conformationally constrained bicyclic Smac mimetics.  Our studies led to the discovery of a no. of highly potent and cell-permeable Smac mimetics and yielded important new insights into their structure-activity relationship for their binding to XIAP and for their activity in inhibition of cancer cell growth.  Detn. of the crystal structure of one potent Smac mimetic, compd. 21, in complex with XIAP BIR3 provides the structural basis for its high-affinity binding to XIAP and for the design of highly potent Smac mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgt5ivzgNCObVg90H21EOLACvtfcHk0lhKKA0_G51Qig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWgsr7J&md5=515d5c4e791d37f83d2e32b6234aa66b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm8006849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8006849%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DSaito%26aufirst%3DN.%2BG.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520evaluation%252C%2520and%2520crystallographic%2520studies%2520of%2520conformationally%2520constrained%2520SMAC%2520mimetics%2520as%2520inhibitors%2520of%2520the%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528XIAP%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7169%26epage%3D7180%26doi%3D10.1021%2Fjm8006849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Potent, orally bioavailable diazabicyclic small-molecule mimetics of second mitochondria-derived activator of caspases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">8158</span>– <span class="NLM_lpage">8162</span>, <span class="refDoi"> DOI: 10.1021/jm801254r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801254r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOjs7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=8158-8162&author=Y.+Pengauthor=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=S.+Qiuauthor=C.+Y.+Yangauthor=J.+Luauthor=Q.+Caiauthor=H.+Yiauthor=S.+Kangauthor=D.+Yangauthor=S.+Wang&title=Potent%2C+orally+bioavailable+diazabicyclic+small-molecule+mimetics+of+second+mitochondria-derived+activator+of+caspases&doi=10.1021%2Fjm801254r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Potent, Orally Bioavailable Diazabicyclic Small-Molecule Mimetics of Second Mitochondria-Derived Activator of Caspases</span></div><div class="casAuthors">Peng, Yuefeng; Sun, Haiying; Nikolovska-Coleska, Zaneta; Qiu, Su; Yang, Chao-Yie; Lu, Jianfeng; Cai, Qian; Yi, Han; Kang, Sanmao; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8158-8162</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of small-mol. Smac mimetics contg. a diazabicyclic core structure have been designed, synthesized, and evaluated.  The most potent compd. I binds to XIAP, cIAP-1, and cIAP-2 with Ki values of 8.4, 1.5, and 4.2 nM, resp., directly antagonizes XIAP in a cell-free functional assay and induces cIAP-1 degrdn. in cancer cells.  It inhibits cell growth with an IC50 value of 31 nM, effectively induces apoptosis in the MDA-MB-231 cancer cell line, and has a good oral bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsvyGFa0RL1rVg90H21EOLACvtfcHk0ljkHp5Pfqz5vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOjs7vF&md5=21d7e471c3e97eeef3413294bdc9e779</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm801254r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801254r%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPotent%252C%2520orally%2520bioavailable%2520diazabicyclic%2520small-molecule%2520mimetics%2520of%2520second%2520mitochondria-derived%2520activator%2520of%2520caspases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D8158%26epage%3D8162%26doi%3D10.1021%2Fjm801254r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of tricyclic, conformationally constrained small-molecule mimetics of second mitochondria-derived activator of caspases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7352</span>– <span class="NLM_lpage">7355</span>, <span class="refDoi"> DOI: 10.1021/jm801146d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801146d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2jsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7352-7355&author=B.+Zhangauthor=Z.+Nikolovska-Coleskaauthor=Y.+Zhangauthor=L.+Baiauthor=S.+Qiuauthor=C.+Y.+Yangauthor=H.+Sunauthor=S.+Wangauthor=Y.+Wu&title=Design%2C+synthesis%2C+and+evaluation+of+tricyclic%2C+conformationally+constrained+small-molecule+mimetics+of+second+mitochondria-derived+activator+of+caspases&doi=10.1021%2Fjm801146d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Tricyclic, Conformationally Constrained Small-Molecule Mimetics of Second Mitochondria-Derived Activator of Caspases</span></div><div class="casAuthors">Zhang, Bin; Nikolovska-Coleska, Zaneta; Zhang, Yan; Bai, Longchuan; Qiu, Su; Yang, Chao-Yie; Sun, Haiying; Wang, Shaomeng; Wu, Yikang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7352-7355</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of tricyclic, conformationally constrained Smac mimetics have been designed, synthesized, and evaluated.  The most potent compd. 6 (WS-5) binds to XIAP, cIAP-1, and cIAP-2 with Ki of 18, 1.1, and 4.2 nM, resp.  Compd. 6 antagonizes XIAP in a functional assay, induces cIAP-1 degrdn., inhibits cell growth with an IC50 of 68 nM in the MDA-MB-231 cancer cell line, and effectively induces cancer cells to undergo apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojd9U5P-xipLVg90H21EOLACvtfcHk0ljkHp5Pfqz5vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2jsLnK&md5=b6a69cd39881fd868e822042261090a5</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm801146d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801146d%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520tricyclic%252C%2520conformationally%2520constrained%2520small-molecule%2520mimetics%2520of%2520second%2520mitochondria-derived%2520activator%2520of%2520caspases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7352%26epage%3D7355%26doi%3D10.1021%2Fjm801146d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of potent, nonpeptidic mimetics of second mitochondria-derived activator of caspases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">593</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1021/jm801101z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801101z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksV2juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=593-596&author=W.+Sunauthor=Z.+Nikolovska-Coleskaauthor=D.+Qinauthor=H.+Sunauthor=C.+Y.+Yangauthor=L.+Baiauthor=S.+Qiuauthor=Y.+Wangauthor=D.+Maauthor=S.+Wang&title=Design%2C+synthesis%2C+and+evaluation+of+potent%2C+nonpeptidic+mimetics+of+second+mitochondria-derived+activator+of+caspases&doi=10.1021%2Fjm801101z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Potent, Nonpeptidic Mimetics of Second Mitochondria-Derived Activator of Caspases</span></div><div class="casAuthors">Sun, Wei; Nikolovska-Coleska, Zaneta; Qin, Dongguang; Sun, Haiying; Yang, Chao-Yie; Bai, Longchuang; Qiu, Su; Wang, You; Ma, Dawei; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">593-596</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of new Smac mimetics have been designed, synthesized, and evaluated.  The most potent compd. 10 (I) binds to XIAP, cIAP-1, and cIAP-2 BIR3 proteins with Ki of 3.9, 0.37, and 0.25 nM, resp.  Compd. 10 antagonizes XIAP in a cell-free functional assay and induces rapid cIAP-1 degrdn. in cancer cells.  Compd. 10 inhibits cell growth in the MDA-MB-231 cancer cell line with an IC50 of 8.9 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcSkEaskJVSbVg90H21EOLACvtfcHk0ljkHp5Pfqz5vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksV2juw%253D%253D&md5=d2318c41357a62386273a82986222e9f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm801101z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801101z%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DW.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520potent%252C%2520nonpeptidic%2520mimetics%2520of%2520second%2520mitochondria-derived%2520activator%2520of%2520caspases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D593%26epage%3D596%26doi%3D10.1021%2Fjm801101z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deschamps, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Nonpeptidic and potent small-molecule inhibitors of cIAP-1/2 and XIAP proteins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6361</span>– <span class="NLM_lpage">6367</span>, <span class="refDoi"> DOI: 10.1021/jm100487z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100487z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslCgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6361-6367&author=H.+Sunauthor=J.+Luauthor=L.+Liuauthor=H.+Yiauthor=S.+Qiuauthor=C.+Y.+Yangauthor=J.+R.+Deschampsauthor=S.+Wang&title=Nonpeptidic+and+potent+small-molecule+inhibitors+of+cIAP-1%2F2+and+XIAP+proteins&doi=10.1021%2Fjm100487z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptidic and Potent Small-Molecule Inhibitors of cIAP-1/2 and XIAP Proteins</span></div><div class="casAuthors">Sun, Haiying; Lu, Jianfeng; Liu, Liu; Yi, Han; Qiu, Su; Yang, Chao-Yie; Deschamps, Jeffrey R.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6361-6367</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of compds. were designed and synthesized as antagonists of cIAP-1/2 and XIAP based upon our previously identified lead compd. SM-122 (I).  The most potent of these II binds to XIAP, cIAP-1, and cIAP-2 proteins with Ki values of 36, <1, and <1.9 nM, resp.  Consistent with its potent binding affinities to IAPs, II effectively antagonizes XIAP in a cell-free caspase-9 functional assay, efficiently induces cIAP-1 degrdn. in cells at concns. as low as 10 nM, and triggers activation of caspases and PARP cleavage in the MDA-MB-231 breast cancer cell line.  Compd. II potently inhibits cell growth in the MDA-MB-231 cancer cell line with an IC50 value of 200 nM and is 9 times more potent than compd. I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJAD9rnga8p7Vg90H21EOLACvtfcHk0ljStMwA7TTrjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslCgsr4%253D&md5=0b38acbc17c4ba3dcd5b81eeaef9e1a2</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm100487z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100487z%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DNonpeptidic%2520and%2520potent%2520small-molecule%2520inhibitors%2520of%2520cIAP-1%252F2%2520and%2520XIAP%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6361%26epage%3D6367%26doi%3D10.1021%2Fjm100487z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leopold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2714</span>– <span class="NLM_lpage">2726</span>, <span class="refDoi"> DOI: 10.1021/jm101505d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101505d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2714-2726&author=Q.+Caiauthor=H.+Sunauthor=Y.+Pengauthor=J.+Luauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=L.+Liuauthor=S.+Qiuauthor=C.+Y.+Yangauthor=R.+Millerauthor=H.+Yiauthor=T.+Zhangauthor=D.+Sunauthor=S.+Kangauthor=M.+Guoauthor=L.+Leopoldauthor=D.+Yangauthor=S.+Wang&title=A+potent+and+orally+active+antagonist+%28SM-406%2FAT-406%29+of+multiple+inhibitor+of+apoptosis+proteins+%28IAPs%29+in+clinical+development+for+cancer+treatment&doi=10.1021%2Fjm101505d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span></div><div class="casAuthors">Cai, Qian; Sun, Haiying; Peng, Yuefeng; Lu, Jianfeng; Nikolovska-Coleska, Zaneta; McEachern, Donna; Liu, Liu; Qiu, Su; Yang, Chao-Yie; Miller, Rebecca; Yi, Han; Zhang, Tao; Sun, Duxin; Kang, Sanmao; Guo, Ming; Leopold, Lance; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2714-2726</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery and characterization of SM-406 (compd. 2), a potent and orally bioavailable Smac mimetic and an antagonist of the inhibitor of apoptosis proteins (IAPs).  This compd. binds to XIAP, cIAP1, and cIAP2 proteins with Ki of 66.4, 1.9, and 5.1 nM, resp.  Compd. 2 effectively antagonizes XIAP BIR3 protein in a cell-free functional assay, induces rapid degrdn. of cellular cIAP1 protein, and inhibits cancer cell growth in various human cancer cell lines.  It has good oral bioavailability in mice, rats, non-human primates, and dogs, is highly effective in induction of apoptosis in xenograft tumors, and is capable of complete inhibition of tumor growth.  Compd. 2 is currently in phase I clin. trials for the treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgYOZBCwfnLrVg90H21EOLACvtfcHk0ljStMwA7TTrjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D&md5=5b73a2ea1a5a2a6b3e3f4c978b49706f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm101505d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101505d%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DLeopold%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520potent%2520and%2520orally%2520active%2520antagonist%2520%2528SM-406%252FAT-406%2529%2520of%2520multiple%2520inhibitor%2520of%2520apoptosis%2520proteins%2520%2528IAPs%2529%2520in%2520clinical%2520development%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2714%26epage%3D2726%26doi%3D10.1021%2Fjm101505d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Potent and selective small-molecule inhibitors of cIAP1/2 proteins reveal that the binding of Smac mimetics to XIAP BIR3 is not required for their effective induction of cell death in tumor cells</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">994</span>– <span class="NLM_lpage">1002</span>, <span class="refDoi"> DOI: 10.1021/cb400889a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400889a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2cXit1yls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=994-1002&author=H.+Sunauthor=J.+Luauthor=L.+Liuauthor=C.+Y.+Yangauthor=S.+Wang&title=Potent+and+selective+small-molecule+inhibitors+of+cIAP1%2F2+proteins+reveal+that+the+binding+of+Smac+mimetics+to+XIAP+BIR3+is+not+required+for+their+effective+induction+of+cell+death+in+tumor+cells&doi=10.1021%2Fcb400889a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective Small-Molecule Inhibitors of cIAP1/2 Proteins Reveal That the Binding of Smac Mimetics to XIAP BIR3 Is Not Required for Their Effective Induction of Cell Death in Tumor Cells</span></div><div class="casAuthors">Sun, Haiying; Lu, Jianfeng; Liu, Liu; Yang, Chao-Yie; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">994-1002</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cellular inhibitor of apoptosis protein 1 and 2 (cIAP1/2) and X-linked inhibitor of apoptosis protein (XIAP) are key apoptosis regulators and promising new cancer therapeutic targets.  This study describes a set of non-peptide, small-mol. Smac (second mitochondria-derived activator of caspases) mimetics that are selective inhibitors of cIAP1/2 over XIAP.  The most potent and most selective compds. bind to cIAP1/2 with affinities in the low nanomolar range and show >1,000-fold selectivity for cIAP1 over XIAP.  These selective cIAP inhibitors effectively induce degrdn. of the cIAP1 protein in cancer cells at low nanomolar concns. and do not antagonize XIAP in a cell-free functional assay.  They potently inhibit cell growth and effectively induce apoptosis at low nanomolar concns. in cancer cells with a mechanism of action similar to that of other known Smac mimetics.  Our study shows that binding of Smac mimetics to XIAP BIR3 is not required for effective induction of apoptosis in tumor cells by Smac mimetics.  These potent and highly selective cIAP1/2 inhibitors are powerful tools in the investigation of the role of these IAP proteins in the regulation of apoptosis and other cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVFuPpODQgO7Vg90H21EOLACvtfcHk0ljStMwA7TTrjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXit1yls74%253D&md5=c0aadbda28ed4e14aa31b58cb995b8af</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fcb400889a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400889a%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPotent%2520and%2520selective%2520small-molecule%2520inhibitors%2520of%2520cIAP1%252F2%2520proteins%2520reveal%2520that%2520the%2520binding%2520of%2520Smac%2520mimetics%2520to%2520XIAP%2520BIR3%2520is%2520not%2520required%2520for%2520their%2520effective%2520induction%2520of%2520cell%2520death%2520in%2520tumor%2520cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D994%26epage%3D1002%26doi%3D10.1021%2Fcb400889a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varfolomeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okawa, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of a potent SMAC mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">533</span>, <span class="refDoi"> DOI: 10.1021/cb600276q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb600276q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps12jsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=525-533&author=K.+Zobelauthor=L.+Wangauthor=E.+Varfolomeevauthor=M.+C.+Franklinauthor=L.+O.+Elliottauthor=H.+J.+Wallweberauthor=D.+C.+Okawaauthor=J.+A.+Flygareauthor=D.+Vucicauthor=W.+J.+Fairbrotherauthor=K.+Deshayes&title=Design%2C+synthesis%2C+and+biological+activity+of+a+potent+SMAC+mimetic+that+sensitizes+cancer+cells+to+apoptosis+by+antagonizing+IAPs&doi=10.1021%2Fcb600276q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs</span></div><div class="casAuthors">Zobel, Kerry; Wang, Lan; Varfolomeev, Eugene; Franklin, Matthew C.; Elliott, Linda O.; Wallweber, Heide J. A.; Okawa, David C.; Flygare, John A.; Vucic, Domagoj; Fairbrother, Wayne J.; Deshayes, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">525-533</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Designed second mitochondrial activator of caspases (Smac) mimetics based on an accessible [7,5]-bicyclic scaffold bind to and antagonize protein interactions involving the inhibitor of apoptosis (IAP) proteins, X-chromosome-linked IAP (XIAP), melanoma IAP (ML-IAP), and c-IAPs 1 and 2 (cIAP2 and cIAP2).  The design rationale is based on a combination of phage-panning data, peptide binding studies, and a survey of potential isosteres.  The synthesis of two scaffolds is described.  These compds. bind the XIAP-baculoviral IAP repeat 3 (BIR3), cIAP1-BIR3, cIAP2-BIR3, and ML-IAP-BIR domains with submicromolar affinities.  The most potent Smac mimetic binds the cIAP-1-BIR3 and ML-IAP-BIR domains with a Ki of 5 nM.  THe X-ray crystal structure of this compd. bound to an ML-IAP/XIAP chimeric BIR domain protein is compared with that of a complex with a phage-derived tetrapeptide, AVPW.  The structures show that these compds. bind to the Smac-binding site on ML0IAP with identical hydrogen-bonding patterns and similar hydrophobic interactions.  Consistent with the structural data, coimmunopptn. expts. demonstrate that the compds. can effectively block Smac interactions with ML0IAP.  The compds. are further demonstrated to activate caspase-3 and -7, to reduce cell viability in assays using MDA-MB-231 breast cancer cells and A2058 melanoma cells, and to enhance doxorubicin-induced apoptosis in MDA-MB-231 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxz4Cro0vW9rVg90H21EOLACvtfcHk0li6buY3RyCfoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps12jsbk%253D&md5=48b9613b3bbde6a1164281919e00e173</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fcb600276q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb600276q%26sid%3Dliteratum%253Aachs%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DOkawa%26aufirst%3DD.%2BC.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DDeshayes%26aufirst%3DK.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520a%2520potent%2520SMAC%2520mimetic%2520that%2520sensitizes%2520cancer%2520cells%2520to%2520apoptosis%2520by%2520antagonizing%2520IAPs%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2006%26volume%3D1%26spage%3D525%26epage%3D533%26doi%3D10.1021%2Fcb600276q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncharov, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keteltas, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankovitz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span> <span> </span><span class="NLM_article-title">Orally bioavailable antagonists of inhibitor of apoptosis proteins based on an azabicyclooctane scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1723</span>– <span class="NLM_lpage">1730</span>, <span class="refDoi"> DOI: 10.1021/jm801450c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801450c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1ektb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1723-1730&author=F.+Cohenauthor=B.+Alickeauthor=L.+O.+Elliottauthor=J.+A.+Flygareauthor=T.+Goncharovauthor=S.+F.+Keteltasauthor=M.+C.+Franklinauthor=S.+Frankovitzauthor=J.+P.+Stephanauthor=V.+Tsuiauthor=D.+Vucicauthor=H.+Wongauthor=W.+J.+Fairbrother&title=Orally+bioavailable+antagonists+of+inhibitor+of+apoptosis+proteins+based+on+an+azabicyclooctane+scaffold&doi=10.1021%2Fjm801450c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Bioavailable Antagonists of Inhibitor of Apoptosis Proteins Based on an Azabicyclooctane Scaffold</span></div><div class="casAuthors">Cohen, Frederick; Alicke, Bruno; Elliott, Linda O.; Flygare, John A.; Goncharov, Tatiana; Keteltas, Stephen F.; Franklin, Matthew C.; Frankovitz, Stacy; Stephan, Jean-Philippe; Tsui, Vickie; Vucic, Domagoj; Wong, Harvey; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1723-1730</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of IAP antagonists based on an azabicyclooctane scaffold was designed and synthesized.  The most potent of these compds., I, binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domain of c-IAP1 with Ki values of 140, 38, and 33 nM, resp.  These compds. promote degrdn. of c-IAP1, activate caspases, and lead to decreased viability of breast cancer cells without affecting normal mammary epithelial cells.  Finally, I inhibits tumor growth when dosed orally in a breast cancer xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkDNRJcxvb2bVg90H21EOLACvtfcHk0li6buY3RyCfoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1ektb4%253D&md5=f6f414daa4174a3449c44442cb944a4a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm801450c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801450c%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DGoncharov%26aufirst%3DT.%26aulast%3DKeteltas%26aufirst%3DS.%2BF.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DFrankovitz%26aufirst%3DS.%26aulast%3DStephan%26aufirst%3DJ.%2BP.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DOrally%2520bioavailable%2520antagonists%2520of%2520inhibitor%2520of%2520apoptosis%2520proteins%2520based%2520on%2520an%2520azabicyclooctane%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1723%26epage%3D1730%26doi%3D10.1021%2Fjm801450c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velankar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulciniti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tassone, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raje, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsiades, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsiades, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span> <span> </span><span class="NLM_article-title">Targeting mitochondrial factor SMAC/DIABLO as therapy for multiple myeloma (MM)</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">1220</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.1182/blood-2006-04-015149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1182%2Fblood-2006-04-015149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=17032924" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2006&pages=1220-1227&author=D.+Chauhanauthor=P.+Neriauthor=M.+Velankarauthor=K.+Podarauthor=T.+Hideshimaauthor=M.+Fulcinitiauthor=P.+Tassoneauthor=N.+Rajeauthor=C.+Mitsiadesauthor=N.+Mitsiadesauthor=P.+Richardsonauthor=L.+Zawelauthor=M.+Tranauthor=N.+Munshiauthor=K.+C.+Anderson&title=Targeting+mitochondrial+factor+SMAC%2FDIABLO+as+therapy+for+multiple+myeloma+%28MM%29&doi=10.1182%2Fblood-2006-04-015149"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-04-015149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-04-015149%26sid%3Dliteratum%253Aachs%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DNeri%26aufirst%3DP.%26aulast%3DVelankar%26aufirst%3DM.%26aulast%3DPodar%26aufirst%3DK.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DFulciniti%26aufirst%3DM.%26aulast%3DTassone%26aufirst%3DP.%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DMitsiades%26aufirst%3DC.%26aulast%3DMitsiades%26aufirst%3DN.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DZawel%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DTargeting%2520mitochondrial%2520factor%2520SMAC%252FDIABLO%2520as%2520therapy%2520for%2520multiple%2520myeloma%2520%2528MM%2529%26jtitle%3DBlood%26date%3D2006%26volume%3D109%26spage%3D1220%26epage%3D1227%26doi%3D10.1182%2Fblood-2006-04-015149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hird, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquila, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennessy, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasbinder, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitor of apoptosis proteins antagonists: a patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1517/13543776.2015.1041922</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1517%2F13543776.2015.1041922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=25980951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSru7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=755-774&author=A.+W.+Hirdauthor=B.+M.+Aquilaauthor=E.+J.+Hennessyauthor=M.+M.+Vasbinderauthor=B.+Yang&title=Small+molecule+inhibitor+of+apoptosis+proteins+antagonists%3A+a+patent+review&doi=10.1517%2F13543776.2015.1041922"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitor of apoptosis proteins antagonists: a patent review</span></div><div class="casAuthors">Hird, Alexander W.; Aquila, Brian M.; Hennessy, Edward J.; Vasbinder, Melissa M.; Yang, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">755-774</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The family of inhibitor of apoptosis proteins (IAPs) plays a key role in the suppression of proapoptotic signaling; hence, a small mol. that disrupts the binding of IAPs with their functional partner should restore apoptotic response to proapoptotic stimuli in cells.  The continued publication of new patent applications of IAP antagonists over the past 4 years is a testament to the continued interest surrounding the IAP family of proteins.  Areas covered: This review summarizes the IAP antagonist patent literature from 2010 to 2014.  Monovalent and bivalent Smac mimetics will be covered as well as two new developments in the field: IAP antagonists coupled to or merged with other targeted agents and new BIR2 selective IAP antagonists.  Expert opinion: In addn. to the well-explored scaffolds for monovalent and bivalent Smac-mimetics, some companies have taken more drastic approaches to explore new chem. space - for example, fragment-based approaches and macrocyclic inhibitors.  Furthermore, other companies have designed compds. with alternative biol. profiles - tethering to known kinase binding structures, trying to target to the mitochondria or introducing selective binding to the BIR2 domain.  An overview of the status for the four small mol. IAP antagonists being evaluated in active human clin. trials is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5iwIpEHoA9LVg90H21EOLACvtfcHk0ljzUru_kS-Wrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSru7jM&md5=318208dc0a860b64cc385c32ff4b8bf0</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1517%2F13543776.2015.1041922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2015.1041922%26sid%3Dliteratum%253Aachs%26aulast%3DHird%26aufirst%3DA.%2BW.%26aulast%3DAquila%26aufirst%3DB.%2BM.%26aulast%3DHennessy%26aufirst%3DE.%2BJ.%26aulast%3DVasbinder%26aufirst%3DM.%2BM.%26aulast%3DYang%26aufirst%3DB.%26atitle%3DSmall%2520molecule%2520inhibitor%2520of%2520apoptosis%2520proteins%2520antagonists%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2015%26volume%3D25%26spage%3D755%26epage%3D774%26doi%3D10.1517%2F13543776.2015.1041922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span> <span> </span><span class="NLM_article-title">Small-molecule pan-IAP antagonists: a patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1517/13543770903567077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1517%2F13543770903567077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=20100005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=251-267&author=J.+A.+Flygareauthor=W.+J.+Fairbrother&title=Small-molecule+pan-IAP+antagonists%3A+a+patent+review&doi=10.1517%2F13543770903567077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule pan-IAP antagonists: a patent review</span></div><div class="casAuthors">Flygare, John A.; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-267</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The inhibitor of apoptosis (IAP) proteins are crit. regulators of cancer cell survival that have become important targets for therapeutic intervention in human malignancies.  One strategy for targeting IAP proteins involves agents that mimic the amino terminus of the endogenous IAP protein antagonist second mitochondria-derived activator of caspases (Smac)/direct IAP-binding protein with low pI (DIABLO) and thus block crit. IAP protein interactions.  Areas covered in this review: This review of the IAP antagonist patent literature covers the period from 2000 to mid-2009.  Over 50 patents and patent applications pertaining to IAP antagonists have been published over the past 10 years.  In the case of several filings, only the original source is reviewed in this anal.  What the reader will gain: Readers will gain an overview of IAP protein antagonist scaffolds, with representative examples including monovalent and bivalent Smac mimetics, and an understanding of their structure-activity relationships.  Take home message: The feasibility of disrupting IAP protein interactions with pro-apoptotic proteins using monovalent and bivalent Smac-derived peptidomimetic compds. has been broadly established.  Four such compds. have entered or been approved to enter human clin. trials, which will hopefully allow the utility of this potential therapeutic approach to be evaluated in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN1K-xLSDlXrVg90H21EOLACvtfcHk0ljzUru_kS-Wrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb0%253D&md5=9017c8266da17502a6c081d5ca2955ac</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1517%2F13543770903567077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903567077%26sid%3Dliteratum%253Aachs%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DSmall-molecule%2520pan-IAP%2520antagonists%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D251%26epage%3D267%26doi%3D10.1517%2F13543770903567077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent SMAC mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">15279</span>– <span class="NLM_lpage">15294</span>, <span class="refDoi"> DOI: 10.1021/ja074725f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja074725f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1yrur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=15279-15294&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=J.+Luauthor=J.+L.+Meagherauthor=C.+Y.+Yangauthor=S.+Qiuauthor=Y.+Tomitaauthor=Y.+Uedaauthor=S.+Jiangauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Design%2C+synthesis%2C+and+characterization+of+a+potent%2C+nonpeptide%2C+cell-permeable%2C+bivalent+SMAC+mimetic+that+concurrently+targets+both+the+BIR2+and+BIR3+domains+in+XIAP&doi=10.1021%2Fja074725f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Characterization of a Potent, Nonpeptide, Cell-Permeable, Bivalent Smac Mimetic That Concurrently Targets Both the BIR2 and BIR3 Domains in XIAP</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Lu, Jianfeng; Meagher, Jennifer L.; Yang, Chao-Yie; Qiu, Su; Tomita, York; Ueda, Yumi; Jiang, Sheng; Krajewski, Krzysztof; Roller, Peter P.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">15279-15294</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">XIAP is a central apoptosis regulator that inhibits apoptosis by binding to and inhibiting the effectors caspase-3/-7 and an initiator caspase-9 through its BIR2 and BIR3 domains, resp.  Smac protein in its dimeric form effectively antagonizes XIAP by concurrently targeting both its BIR2 and BIR3 domains.  We report the design, synthesis, and characterization of a nonpeptide, cell-permeable, bivalent small-mol. (SM-164) which mimics Smac protein for targeting XIAP.  Our study shows that SM-164 binds to XIAP contg. both BIR domains with an IC50 value of 1.39 nM, being 300 and 7000 times more potent than its monovalent counterparts and the natural Smac AVPI peptide, resp.  SM-164 concurrently interacts with both BIR domains in XIAP and functions as an ultrapotent antagonist of XIAP in both cell-free functional and cell-based assays.  SM-164 targets cellular XIAP and effectively induces apoptosis at concns. as low as 1 nM in the HL-60 leukemia cell line.  The potency of bivalent SM-164 in binding, functional, and cellular assays is 2-3 orders of magnitude higher than its corresponding monovalent Smac mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNGBGUOFcArLVg90H21EOLACvtfcHk0ljzUru_kS-Wrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1yrur%252FI&md5=11b7028aa71b875e07b80f7a3d952b46</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fja074725f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja074725f%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520a%2520potent%252C%2520nonpeptide%252C%2520cell-permeable%252C%2520bivalent%2520SMAC%2520mimetic%2520that%2520concurrently%2520targets%2520both%2520the%2520BIR2%2520and%2520BIR3%2520domains%2520in%2520XIAP%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D15279%26epage%3D15294%26doi%3D10.1021%2Fja074725f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design of small-molecule peptidic and nonpeptidic SMAC mimetics</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1264</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1021/ar8000553</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar8000553" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kiur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=1264-1277&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=C.+Y.+Yangauthor=D.+Qianauthor=J.+Luauthor=S.+Qiuauthor=L.+Baiauthor=Y.+Pengauthor=Q.+Caiauthor=S.+Wang&title=Design+of+small-molecule+peptidic+and+nonpeptidic+SMAC+mimetics&doi=10.1021%2Far8000553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Small-Molecule Peptidic and Nonpeptidic Smac Mimetics</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Yang, Chao-Yie; Qian, Dongguang; Lu, Jianfeng; Qiu, Su; Bai, Longchuan; Peng, Yuefeng; Cai, Qian; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1264-1277</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Smac/DIABLO is a protein released from mitochondria into the cytosol in response to apoptotic stimuli.  Smac promotes apoptosis at least in part through antagonizing inhibitor of apoptosis proteins (IAPs), including XIAP, cIAP-1, and cIAP-2.  Smac interacts with these IAPs via its N-terminal AVPI binding motif.  There has been an enormous interest in academic labs. and pharmaceutical companies in the design of small-mol. Smac mimetics as potential anticancer agents.  This task is particularly challenging because it involves targeting protein-protein interactions.  Nevertheless, intense research has now generated potent, specific, cell-permeable small-mol. peptidomimetics and nonpeptidic mimetics.  To date, two types of Smac mimetics have been reported, namely, monovalent and bivalent Smac mimetics.  The monovalent compds. are designed to mimic the binding of a single AVPI binding motif to IAP proteins, whereas the bivalent compds. contain two AVPI binding motif mimetics tethered together through a linker.  Studies from several groups have clearly demonstrated that both monovalent and bivalent Smac mimetics not only enhance the antitumor activity of other anticancer agents but also can induce apoptosis as single agents in a subset of human cancer cell lines in vitro and are capable of achieving tumor regression in animal models of human cancer.  In general, bivalent Smac mimetics are 100-1000 times more potent than their corresponding monovalent Smac mimetics in induction of apoptosis in tumor cells.  However, properly designed monovalent Smac mimetics can achieve oral bioavailability and may have major advantages over bivalent Smac mimetics as potential drug candidates.  In-depth insights on the mol. mechanism of action of Smac mimetics have been provided by several independent studies.  It was shown that Smac mimetics induce apoptosis in tumor cells by targeting cIAP-1/-2 for the rapid degrdn. of these proteins, which leads to activation of nuclear factor κB (NF-κB) and prodn. and secretion of tumor necrosis factor α (TNFα).  TNFα promotes formation of a receptor-interacting serine-threonine kinase 1 (RIPK1)-dependent caspase-8-activating complex, leading to activation of caspase-8 and -3/-7 and ultimately to apoptosis.  For the most efficient apoptosis induction, Smac mimetics also need to remove the inhibition of XIAP to caspase-3/-7.  Hence, Smac mimetics induce apoptosis in tumor cells by targeting not only cIAP-1/-2 but also XIAP.  The employment of potent, cell-permeable, small-mol. Smac mimetics has yielded important insights into the regulation of apoptosis by IAP proteins.  To date, at least one Smac mimetic has been advanced into clin. development.  Several other Smac mimetics are in an advanced preclin. development stage and are expected to enter human clin. testing for the treatment of cancer in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF2ORbmgx5q7Vg90H21EOLACvtfcHk0ljzUru_kS-Wrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kiur3L&md5=434530329024b75e59f7f88e29ea0de1</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Far8000553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far8000553%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DQian%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%2520of%2520small-molecule%2520peptidic%2520and%2520nonpeptidic%2520SMAC%2520mimetics%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D1264%26epage%3D1277%26doi%3D10.1021%2Far8000553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shangary, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1/2 and XIAP</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">9384</span>– <span class="NLM_lpage">9393</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-2655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F0008-5472.CAN-08-2655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=19010913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOmt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=9384-9393&author=J.+Luauthor=L.+Baiauthor=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=S.+Qiuauthor=R.+S.+Millerauthor=H.+Yiauthor=S.+Shangaryauthor=Y.+Sunauthor=J.+L.+Meagherauthor=J.+A.+Stuckeyauthor=S.+Wang&title=SM-164%3A+a+novel%2C+bivalent+Smac+mimetic+that+induces+apoptosis+and+tumor+regression+by+concurrent+removal+of+the+blockade+of+cIAP-1%2F2+and+XIAP&doi=10.1158%2F0008-5472.CAN-08-2655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">SM-164: A Novel, Bivalent Smac Mimetic That Induces Apoptosis and Tumor Regression by Concurrent Removal of the Blockade of cIAP-1/2 and XIAP</span></div><div class="casAuthors">Lu, Jianfeng; Bai, Longchuan; Sun, Haiying; Nikolovska-Coleska, Zaneta; McEachern, Donna; Qiu, Su; Miller, Rebecca S.; Yi, Han; Shangary, Sanjeev; Sun, Yi; Meagher, Jennifer L.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9384-9393</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Small-mol. Smac mimetics are being developed as a novel class of anticancer drugs.  Recent studies have shown that Smac mimetics target cellular inhibitor of apoptosis protein (cIAP)-1/2 for degrdn. and induce tumor necrosis factor-α (TNFα)-dependent apoptosis in tumor cells.  In this study, we have investigated the mechanism of action and therapeutic potential of two different types of novel Smac mimetics, monovalent SM-122 and bivalent SM-164.  Our data showed that removal of cIAP-1/2 by Smac mimetics or small interfering RNA is not sufficient for robust TNFα-dependent apoptosis induction, and X-linked inhibitor of apoptosis protein (XIAP) plays a crit. role in inhibiting apoptosis induction.  Although SM-164 is modestly more effective than SM-122 in induction of cIAP-1/2 degrdn., SM-164 is 1,000 times more potent than SM-122 as an inducer of apoptosis in tumor cells, which is attributed to its much higher potency in binding to and antagonizing XIAP.  SM-164 induces rapid cIAP-1 degrdn. and strong apoptosis in the MDA-MB-231 xenograft tumor tissues and achieves tumor regression, but has no toxicity in normal mouse tissues.  Our study provides further insights into the mechanism of action for Smac mimetics and regulation of apoptosis by inhibitor of apoptosis proteins.  Furthermore, our data provide evidence that SM-164 is a promising new anticancer drug for further evaluation and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlLbn79J0ygLVg90H21EOLACvtfcHk0lhxem68HhlljA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOmt7vE&md5=2d33887357ef44ef9aa997c8021814ec</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-2655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-2655%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DR.%2BS.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DSM-164%253A%2520a%2520novel%252C%2520bivalent%2520Smac%2520mimetic%2520that%2520induces%2520apoptosis%2520and%2520tumor%2520regression%2520by%2520concurrent%2520removal%2520of%2520the%2520blockade%2520of%2520cIAP-1%252F2%2520and%2520XIAP%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D9384%26epage%3D9393%26doi%3D10.1158%2F0008-5472.CAN-08-2655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellail, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, SMAC mimetic SM-164 in combination with TRAIL for cancer treatment</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">902</span>– <span class="NLM_lpage">914</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-10-0864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1535-7163.MCT-10-0864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21372226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlslKgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=902-914&author=J.+Luauthor=D.+McEachernauthor=H.+Sunauthor=L.+Baiauthor=Y.+Pengauthor=S.+Qiuauthor=R.+Millerauthor=J.+Liaoauthor=H.+Yiauthor=M.+Liuauthor=A.+Bellailauthor=C.+Haoauthor=S.+Y.+Sunauthor=A.+T.+Tingauthor=S.+Wang&title=Therapeutic+potential+and+molecular+mechanism+of+a+novel%2C+potent%2C+nonpeptide%2C+SMAC+mimetic+SM-164+in+combination+with+TRAIL+for+cancer+treatment&doi=10.1158%2F1535-7163.MCT-10-0864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment</span></div><div class="casAuthors">Lu, Jianfeng; McEachern, Donna; Sun, Haiying; Bai, Longchuan; Peng, Yuefeng; Qiu, Su; Miller, Rebecca; Liao, Jinhui; Yi, Han; Liu, Meilan; Bellail, Anita; Hao, Chunhai; Sun, Shi-Yong; Ting, Adrian T.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">902-914</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Smac mimetics are being developed as a new class of anticancer therapies.  Because the single-agent activity of Smac mimetics is very limited, rational combinations represent a viable strategy for their clin. development.  The combination of Smac mimetics with TNF-related apoptosis inducing ligand (TRAIL) may be particularly attractive because of the low toxicity of TRAIL to normal cells and the synergistic antitumor activity obsd. for the combination.  In this study, we have investigated the combination synergy between TRAIL and a potent Smac mimetic, SM-164, in vitro and in vivo and the underlying mol. mechanism of action for the synergy.  Our study shows that SM-164 is highly synergistic with TRAIL in vitro in both TRAIL-sensitive and TRAIL-resistant cancer cell lines of breast, prostate, and colon cancer.  Furthermore, the combination of SM-164 with TRAIL induces rapid tumor regression in vivo in a breast cancer xenograft model in which either agent is ineffective.  Our data show that X-linked IAP (XIAP) and cellular IAP 1 (cIAP1), but not cIAP2, work in concert to attenuate the activity of TRAIL; SM-164 strongly enhances TRAIL activity by concurrently targeting XIAP and cIAP1.  Moreover, although RIP1 plays a minimal role in the activity of TRAIL as a single agent, it is required for the synergistic interaction between TRAIL and SM-164.  This study provides a strong rationale to develop the combination of SM-164 and TRAIL as a new therapeutic strategy for the treatment of human cancer.  Mol Cancer Ther; 10(5); 902-14.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ3TvDUPiQaLVg90H21EOLACvtfcHk0lhxem68HhlljA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlslKgt7Y%253D&md5=4c6f2df52cdcd0d4ad87d39b36ff9ddd</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0864%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DBellail%26aufirst%3DA.%26aulast%3DHao%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DS.%2BY.%26aulast%3DTing%26aufirst%3DA.%2BT.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DTherapeutic%2520potential%2520and%2520molecular%2520mechanism%2520of%2520a%2520novel%252C%2520potent%252C%2520nonpeptide%252C%2520SMAC%2520mimetic%2520SM-164%2520in%2520combination%2520with%2520TRAIL%2520for%2520cancer%2520treatment%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D902%26epage%3D914%26doi%3D10.1158%2F1535-7163.MCT-10-0864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Potent bivalent SMAC mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">3306</span>– <span class="NLM_lpage">3318</span>, <span class="refDoi"> DOI: 10.1021/jm101651b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101651b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3306-3318&author=H.+Sunauthor=L.+Liuauthor=J.+Luauthor=L.+Baiauthor=X.+Liauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=C.+Y.+Yangauthor=S.+Qiuauthor=H.+Yiauthor=D.+Sunauthor=S.+Wang&title=Potent+bivalent+SMAC+mimetics%3A+effect+of+the+linker+on+binding+to+inhibitor+of+apoptosis+proteins+%28IAPs%29+and+anticancer+activity&doi=10.1021%2Fjm101651b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Bivalent Smac Mimetics: Effect of the Linker on Binding to Inhibitor of Apoptosis Proteins (IAPs) and Anticancer Activity</span></div><div class="casAuthors">Sun, Haiying; Liu, Liu; Lu, Jianfeng; Bai, Longchuan; Li, Xiaoqin; Nikolovska-Coleska, Zaneta; McEachern, Donna; Yang, Chao-Yie; Qiu, Su; Yi, Han; Sun, Duxin; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3306-3318</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized and evaluated a series of nonpeptidic, bivalent Smac mimetics as antagonists of the inhibitor of apoptosis proteins and new anticancer agents.  All these bivalent Smac mimetics bind to full-length XIAP with low nanomolar affinities and function as ultrapotent antagonists of XIAP.  While these Smac mimetics bind to cIAP1/2 with similar low nanomolar affinities, their potencies to induce degrdn. of cIAP1/2 proteins in cells differ by more than 100-fold.  The most potent bivalent Smac mimetics inhibit cell growth with IC50 from 1 to 3 nM in the MDA-MB-231 breast cancer cell line and are 100 times more potent than the least potent compds.  Detn. of intracellular concns. for several representative compds. showed that the linkers in these bivalent Smac mimetics significantly affect their intracellular concns. and hence the overall cellular activity.  Compd. 27 completely inhibits tumor growth in the MDA-MB-231 xenografts while causing no signs of toxicity in the animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHDLE3fRizsbVg90H21EOLACvtfcHk0liXY566GPdlRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSqs74%253D&md5=cff3236e7f91333d13edd4093aa6f634</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm101651b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101651b%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPotent%2520bivalent%2520SMAC%2520mimetics%253A%2520effect%2520of%2520the%2520linker%2520on%2520binding%2520to%2520inhibitor%2520of%2520apoptosis%2520proteins%2520%2528IAPs%2529%2520and%2520anticancer%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3306%26epage%3D3318%26doi%3D10.1021%2Fjm101651b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hennessy, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquila, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castriotta, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattersley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hird, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huntington, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamhi, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laing, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oza, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeh, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sha, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasbinder, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitston, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9897</span>– <span class="NLM_lpage">9919</span>, <span class="refDoi"> DOI: 10.1021/jm401075x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401075x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9897-9919&author=E.+J.+Hennessyauthor=A.+Adamauthor=B.+M.+Aquilaauthor=L.+M.+Castriottaauthor=D.+Cookauthor=M.+Hattersleyauthor=A.+W.+Hirdauthor=C.+Huntingtonauthor=V.+M.+Kamhiauthor=N.+M.+Laingauthor=D.+Liauthor=T.+MacIntyreauthor=C.+A.+Omerauthor=V.+Ozaauthor=T.+Pattersonauthor=G.+Repikauthor=M.+T.+Rooneyauthor=J.+C.+Saehauthor=L.+Shaauthor=M.+M.+Vasbinderauthor=H.+Wangauthor=D.+Whitston&title=Discovery+of+a+novel+class+of+dimeric+Smac+mimetics+as+potent+IAP+antagonists+resulting+in+a+clinical+candidate+for+the+treatment+of+cancer+%28AZD5582%29&doi=10.1021%2Fjm401075x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582)</span></div><div class="casAuthors">Hennessy, Edward J.; Adam, Ammar; Aquila, Brian M.; Castriotta, Lillian M.; Cook, Donald; Hattersley, Maureen; Hird, Alexander W.; Huntington, Christopher; Kamhi, Victor M.; Laing, Naomi M.; Li, Danyang; MacIntyre, Terry; Omer, Charles A.; Oza, Vibha; Patterson, Troy; Repik, Galina; Rooney, Michael T.; Saeh, Jamal C.; Sha, Li; Vasbinder, Melissa M.; Wang, Haiyun; Whitston, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9897-9919</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of dimeric compds. based on the AVPI motif of Smac (second mitochondrial activator of caspases) were designed and prepd. as antagonists of the inhibitor of apoptosis proteins (IAPs).  Optimization of cellular potency, phys. properties, and pharmacokinetic parameters led to the identification of compd. 14 (AZD5582), which binds potently to the BIR3 domains of cIAP1, cIAP2, and XIAP (IC50 = 15, 21, and 15 nM, resp.).  This compd. causes cIAP1 degrdn. and induces apoptosis in the MDA-MB-231 breast cancer cell line at subnanomolar concns. in vitro.  When administered i.v. to MDA-MB-231 xenograft-bearing mice, 14 results in cIAP1 degrdn. and caspase-3 cleavage within tumor cells and causes substantial tumor regressions following two weekly doses of 3.0 mg/kg.  Antiproliferative effects are obsd. with 14 in only a small subset of the over 200 cancer cell lines examd., consistent with other published IAP inhibitors.  As a result of its in vitro and in vivo profile, 14 was nominated as a candidate for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppmeDH06Y5lLVg90H21EOLACvtfcHk0liXY566GPdlRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltrjM&md5=9b4a5f7b89ebf74737d86c86acdf9c77</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm401075x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401075x%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DE.%2BJ.%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DAquila%26aufirst%3DB.%2BM.%26aulast%3DCastriotta%26aufirst%3DL.%2BM.%26aulast%3DCook%26aufirst%3DD.%26aulast%3DHattersley%26aufirst%3DM.%26aulast%3DHird%26aufirst%3DA.%2BW.%26aulast%3DHuntington%26aufirst%3DC.%26aulast%3DKamhi%26aufirst%3DV.%2BM.%26aulast%3DLaing%26aufirst%3DN.%2BM.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DOza%26aufirst%3DV.%26aulast%3DPatterson%26aufirst%3DT.%26aulast%3DRepik%26aufirst%3DG.%26aulast%3DRooney%26aufirst%3DM.%2BT.%26aulast%3DSaeh%26aufirst%3DJ.%2BC.%26aulast%3DSha%26aufirst%3DL.%26aulast%3DVasbinder%26aufirst%3DM.%2BM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWhitston%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520dimeric%2520Smac%2520mimetics%2520as%2520potent%2520IAP%2520antagonists%2520resulting%2520in%2520a%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520cancer%2520%2528AZD5582%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9897%26epage%3D9919%26doi%3D10.1021%2Fjm401075x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Condon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPorte, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rippin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haimowitz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendi, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benetatos, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neiman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seipel, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinlay, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feltham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettjeman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vince, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunduru, S. K.</span></span> <span> </span><span class="NLM_article-title">Birinapant, a SMAC-mimetic with improved tolerability for the treatment of solid tumors and hematological malignancies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3666</span>– <span class="NLM_lpage">3677</span>, <span class="refDoi"> DOI: 10.1021/jm500176w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500176w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltF2msrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3666-3677&author=S.+M.+Condonauthor=Y.+Mitsuuchiauthor=Y.+Dengauthor=M.+G.+LaPorteauthor=S.+R.+Rippinauthor=T.+Haimowitzauthor=M.+D.+Alexanderauthor=P.+T.+Kumarauthor=M.+S.+Hendiauthor=Y.+H.+Leeauthor=C.+A.+Benetatosauthor=G.+Yuauthor=G.+S.+Kapoorauthor=E.+Neimanauthor=M.+E.+Seipelauthor=J.+M.+Burnsauthor=M.+A.+Grahamauthor=M.+A.+McKinlayauthor=X.+Liauthor=J.+Wangauthor=Y.+Shiauthor=R.+Felthamauthor=B.+Bettjemanauthor=M.+H.+Cummingauthor=J.+E.+Vinceauthor=N.+Khanauthor=J.+Silkeauthor=C.+L.+Dayauthor=S.+K.+Chunduru&title=Birinapant%2C+a+SMAC-mimetic+with+improved+tolerability+for+the+treatment+of+solid+tumors+and+hematological+malignancies&doi=10.1021%2Fjm500176w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Birinapant, a Smac-Mimetic with Improved Tolerability for the Treatment of Solid Tumors and Hematological Malignancies</span></div><div class="casAuthors">Condon, Stephen M.; Mitsuuchi, Yasuhiro; Deng, Yijun; LaPorte, Matthew G.; Rippin, Susan R.; Haimowitz, Thomas; Alexander, Matthew D.; Kumar, Pavan Tirunahari; Hendi, Mukta S.; Lee, Yu-Hua; Benetatos, Christopher A.; Yu, Guangyao; Kapoor, Gurpreet Singh; Neiman, Eric; Seipel, Martin E.; Burns, Jennifer M.; Graham, Martin A.; McKinlay, Mark A.; Li, Xiaochun; Wang, Jiawei; Shi, Yigong; Feltham, Rebecca; Bettjeman, Bodhi; Cumming, Mathew H.; Vince, James E.; Khan, Nufail; Silke, John; Day, Catherine L.; Chunduru, Srinivas K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3666-3677</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Birinapant (1) is a second-generation bivalent antagonist of IAP proteins that is currently undergoing clin. development for the treatment of cancer.  Using a range of assays that evaluated cIAP1 stability and oligomeric state, we demonstrated that 1 stabilized the cIAP1-BUCR (BIR3-UBA-CARD-RING) dimer and promoted autoubiquitylation of cIAP1 in vitro.  Smac-mimetic 1-induced loss of cIAPs correlated with inhibition of TNF-mediated NF-κB activation, caspase activation, and tumor cell killing.  Many first-generation Smac-mimetics such as compd. A (2) were poorly tolerated.  Notably, animals that lack functional cIAP1, cIAP2, and XIAP are not viable, and 2 mimicked features of triple IAP knockout cells in vitro.  The improved tolerability of 1 was assocd. with (i) decreased potency against cIAP2 and affinity for XIAP BIR3 and (ii) decreased ability to inhibit XIAP-dependent signaling pathways.  The P2' position of 1 was crit. to this differential activity, and this improved tolerability has allowed 1 to proceed into clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMoeegQjyMH7Vg90H21EOLACvtfcHk0liXY566GPdlRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltF2msrc%253D&md5=585857357c81b517de327eed450421b0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm500176w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500176w%26sid%3Dliteratum%253Aachs%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DMitsuuchi%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DLaPorte%26aufirst%3DM.%2BG.%26aulast%3DRippin%26aufirst%3DS.%2BR.%26aulast%3DHaimowitz%26aufirst%3DT.%26aulast%3DAlexander%26aufirst%3DM.%2BD.%26aulast%3DKumar%26aufirst%3DP.%2BT.%26aulast%3DHendi%26aufirst%3DM.%2BS.%26aulast%3DLee%26aufirst%3DY.%2BH.%26aulast%3DBenetatos%26aufirst%3DC.%2BA.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DKapoor%26aufirst%3DG.%2BS.%26aulast%3DNeiman%26aufirst%3DE.%26aulast%3DSeipel%26aufirst%3DM.%2BE.%26aulast%3DBurns%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DMcKinlay%26aufirst%3DM.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DBettjeman%26aufirst%3DB.%26aulast%3DCumming%26aufirst%3DM.%2BH.%26aulast%3DVince%26aufirst%3DJ.%2BE.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26atitle%3DBirinapant%252C%2520a%2520SMAC-mimetic%2520with%2520improved%2520tolerability%2520for%2520the%2520treatment%2520of%2520solid%2520tumors%2520and%2520hematological%2520malignancies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3666%26epage%3D3677%26doi%3D10.1021%2Fjm500176w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benetatos, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haimowitz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnone, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seipel, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunduru, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinlay, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condon, S. M.</span></span> <span> </span><span class="NLM_article-title">Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-kappaB signaling by degrading TRAF2-associated cIAP1 in cancer cells</span>. <i>Cell Death Discov</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">16046</span>, <span class="refDoi"> DOI: 10.1038/cddiscovery.2016.46</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fcddiscovery.2016.46" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=28149532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADC%252BC1c3hvFCmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=16046&author=Y.+Mitsuuchiauthor=C.+A.+Benetatosauthor=Y.+Dengauthor=T.+Haimowitzauthor=S.+C.+Beckauthor=M.+R.+Arnoneauthor=G.+S.+Kapoorauthor=M.+E.+Seipelauthor=S.+K.+Chunduruauthor=M.+A.+McKinlayauthor=C.+G.+Begleyauthor=S.+M.+Condon&title=Bivalent+IAP+antagonists%2C+but+not+monovalent+IAP+antagonists%2C+inhibit+TNF-mediated+NF-kappaB+signaling+by+degrading+TRAF2-associated+cIAP1+in+cancer+cells&doi=10.1038%2Fcddiscovery.2016.46"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-κB signaling by degrading TRAF2-associated cIAP1 in cancer cells</span></div><div class="casAuthors">Mitsuuchi Y; Benetatos C A; Deng Y; Haimowitz T; Beck S C; Arnone M R; Kapoor G S; Seipel M E; Chunduru S K; McKinlay M A; Begley C G; Condon S M</div><div class="citationInfo"><span class="NLM_cas:title">Cell death discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16046</span>
        ISSN:<span class="NLM_cas:issn">2058-7716</span>.
    </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins have pivotal roles in cell proliferation and differentiation, and antagonizing IAPs in certain cancer cell lines results in induction of cell death.  A variety of IAP antagonist compounds targeting the baculovirus IAP protein repeat 3 (BIR3) domain of cIAP1have advanced into clinical trials.  Here we sought to compare and contrast the biochemical activities of selected monovalent and bivalent IAP antagonists with the intent of identifying functional differences between these two classes of IAP antagonist drug candidates.  The anti-cellular IAP1 (cIAP1) and pro-apoptotic activities of monovalent IAP antagonists were increased by using a single covalent bond to combine the monovalent moieties at the P4 position.  In addition, regardless of drug concentration, treatment with monovalent compounds resulted in consistently higher levels of residual cIAP1 compared with that seen following bivalent compound treatment.  We found that the remaining residual cIAP1 following monovalent compound treatment was predominantly tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2)-associated cIAP1.  As a consequence, bivalent compounds were more effective at inhibiting TNF-induced activation of p65/NF-κB compared with monovalent compounds.  Moreover, extension of the linker chain at the P4 position of bivalent compounds resulted in a decreased ability to degrade TRAF2-associated cIAP1 in a manner similar to monovalent compounds.  This result implied that specific bivalent IAP antagonists but not monovalent compounds were capable of inducing formation of a cIAP1 E3 ubiquitin ligase complex with the capacity to effectively degrade TRAF2-associated cIAP1.  These results further suggested that only certain bivalent IAP antagonists are preferred for the targeting of TNF-dependent signaling for the treatment of cancer or infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTweo5XuUOxT4YPsCkJIw00fW6udTcc2ebt9NZNqd4qJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3hvFCmsg%253D%253D&md5=d451111fb7d800e0207454ec4309bbce</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fcddiscovery.2016.46&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddiscovery.2016.46%26sid%3Dliteratum%253Aachs%26aulast%3DMitsuuchi%26aufirst%3DY.%26aulast%3DBenetatos%26aufirst%3DC.%2BA.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DHaimowitz%26aufirst%3DT.%26aulast%3DBeck%26aufirst%3DS.%2BC.%26aulast%3DArnone%26aufirst%3DM.%2BR.%26aulast%3DKapoor%26aufirst%3DG.%2BS.%26aulast%3DSeipel%26aufirst%3DM.%2BE.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DMcKinlay%26aufirst%3DM.%2BA.%26aulast%3DBegley%26aufirst%3DC.%2BG.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26atitle%3DBivalent%2520IAP%2520antagonists%252C%2520but%2520not%2520monovalent%2520IAP%2520antagonists%252C%2520inhibit%2520TNF-mediated%2520NF-kappaB%2520signaling%2520by%2520degrading%2520TRAF2-associated%2520cIAP1%2520in%2520cancer%2520cells%26jtitle%3DCell%2520Death%2520Discov%26date%3D2017%26volume%3D3%26spage%3D16046%26doi%3D10.1038%2Fcddiscovery.2016.46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayly, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skidmore, J.</span></span> <span> </span><span class="NLM_article-title">Small molecules, big targets: drug discovery faces the protein-protein interaction challenge</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnrd.2016.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27050677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=533-550&author=D.+E.+Scottauthor=A.+R.+Baylyauthor=C.+Abellauthor=J.+Skidmore&title=Small+molecules%2C+big+targets%3A+drug+discovery+faces+the+protein-protein+interaction+challenge&doi=10.1038%2Fnrd.2016.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules, big targets: drug discovery faces the protein-protein interaction challenge</span></div><div class="casAuthors">Scott, Duncan E.; Bayly, Andrew R.; Abell, Chris; Skidmore, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">533-550</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein-protein interactions (PPIs) are of pivotal importance in the regulation of biol. systems and are consequently implicated in the development of disease states.  Recent work has begun to show that, with the right tools, certain classes of PPI can yield to the efforts of medicinal chemists to develop inhibitors, and the first PPI inhibitors have reached clin. development.  In this Review, we describe the research leading to these breakthroughs and highlight the existence of groups of structurally related PPIs within the PPI target class.  For each of these groups, we use examples of successful discovery efforts to illustrate the research strategies that have proved most useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK-aGzHa9mP7Vg90H21EOLACvtfcHk0liyYm46Aio6Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D&md5=9f0953567ae9338b8b36aa78b8160655</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.29%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BE.%26aulast%3DBayly%26aufirst%3DA.%2BR.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DSkidmore%26aufirst%3DJ.%26atitle%3DSmall%2520molecules%252C%2520big%2520targets%253A%2520drug%2520discovery%2520faces%2520the%2520protein-protein%2520interaction%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D533%26epage%3D550%26doi%3D10.1038%2Fnrd.2016.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Bivalent SMAC mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1021/jm201072x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201072x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=106-114&author=Y.+Pengauthor=H.+Sunauthor=J.+Luauthor=L.+Liuauthor=Q.+Caiauthor=R.+Shenauthor=C.+Y.+Yangauthor=H.+Yiauthor=S.+Wang&title=Bivalent+SMAC+mimetics+with+a+diazabicyclic+core+as+highly+potent+antagonists+of+XIAP+and+cIAP1%2F2+and+novel+anticancer+agents&doi=10.1021%2Fjm201072x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Bivalent Smac Mimetics with a Diazabicyclic Core as Highly Potent Antagonists of XIAP and cIAP1/2 and Novel Anticancer Agents</span></div><div class="casAuthors">Peng, Yuefeng; Sun, Haiying; Lu, Jianfeng; Liu, Liu; Cai, Qian; Shen, Rong; Yang, Chao-Yie; Yi, Han; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">106-114</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonpeptidic, bivalent Smac mimetics designed based upon monovalent Smac mimetics with a diazabicyclic core structure bind to XIAP, cIAP1, and cIAP2 with low to subnanomolar affinities and are highly effective in antagonizing XIAP in cell-free functional assays.  They efficiently induce the degrdn. of cIAP1 and cIAP2 in cancer cells at concns. as low as 1 nM, activate caspase-3 and -8, and cleave PARP at 3-10 nM.  The most potent compds. in the series have IC50 of 3-5 nM in inhibition of cell growth in both MDA-MB-231 and SK-OV-3 cell lines and are promising lead compds. for the development of a new class of cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF3qkUBx1I87Vg90H21EOLACvtfcHk0liyYm46Aio6Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurvI&md5=217458cb832862fa7fbd09262f6f7b2f</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm201072x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201072x%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DBivalent%2520SMAC%2520mimetics%2520with%2520a%2520diazabicyclic%2520core%2520as%2520highly%2520potent%2520antagonists%2520of%2520XIAP%2520and%2520cIAP1%252F2%2520and%2520novel%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D106%26epage%3D114%26doi%3D10.1021%2Fjm201072x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">A potent bivalent SMAC mimetic (SM-1200) achieving rapid, complete, and durable tumor regression in mice</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3969</span>– <span class="NLM_lpage">3979</span>, <span class="refDoi"> DOI: 10.1021/jm400216d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400216d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3969-3979&author=R.+Shengauthor=H.+Sunauthor=L.+Liuauthor=J.+Luauthor=D.+McEachernauthor=G.+Wangauthor=J.+Wenauthor=P.+Minauthor=Z.+Duauthor=H.+Luauthor=S.+Kangauthor=M.+Guoauthor=D.+Yangauthor=S.+Wang&title=A+potent+bivalent+SMAC+mimetic+%28SM-1200%29+achieving+rapid%2C+complete%2C+and+durable+tumor+regression+in+mice&doi=10.1021%2Fjm400216d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent Bivalent Smac Mimetic (SM-1200) Achieving Rapid, Complete, and Durable Tumor Regression in Mice</span></div><div class="casAuthors">Sheng, Rong; Sun, Haiying; Liu, Liu; Lu, Jianfeng; McEachern, Donna; Wang, Guanfeng; Wen, Jianfeng; Min, Ping; Du, Zhenyun; Lu, Huirong; Kang, Sanmao; Guo, Ming; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3969-3979</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors have designed, synthesized, and evaluated a series of new compds. based upon the authors' previously reported bivalent Smac mimetics.  This led to the identification of compd. SM-1200, which binds to XIAP, cIAP1, and cIAP2 with Ki values of 0.5, 3.7, and 5.4 nM, resp., inhibits cell growth in the MDA-MB-231 breast cancer and SK-OV-3 ovarian cancer cell lines with IC50 values of 11.0 and 28.2 nM, resp.  Compd. SM-1200 has a much improved pharmacokinetic profile over the authors' previously reported bivalent Smac mimetics and is highly effective in induction of rapid and durable tumor regression in the MDA-MB-231 xenograft model.  These data indicate that compd. SM-1200 is a promising Smac mimetic and warrants extensive evaluation as a potential candidate for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlWWEgSvmyrVg90H21EOLACvtfcHk0lgHcLWbgr7UAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtr0%253D&md5=5610e9a8cc40939434a77e5840a50110</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm400216d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400216d%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DMin%26aufirst%3DP.%26aulast%3DDu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520potent%2520bivalent%2520SMAC%2520mimetic%2520%2528SM-1200%2529%2520achieving%2520rapid%252C%2520complete%252C%2520and%2520durable%2520tumor%2520regression%2520in%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3969%26epage%3D3979%26doi%3D10.1021%2Fjm400216d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milutinovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudreault, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillard, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaquith, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, P. A.</span></span> <span> </span><span class="NLM_article-title">cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">700</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2008.05.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.molcel.2008.05.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18570872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFWnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=689-700&author=M.+J.+Bertrandauthor=S.+Milutinovicauthor=K.+M.+Dicksonauthor=W.+C.+Hoauthor=A.+Boudreaultauthor=J.+Durkinauthor=J.+W.+Gillardauthor=J.+B.+Jaquithauthor=S.+J.+Morrisauthor=P.+A.+Barker&title=cIAP1+and+cIAP2+facilitate+cancer+cell+survival+by+functioning+as+E3+ligases+that+promote+RIP1+ubiquitination&doi=10.1016%2Fj.molcel.2008.05.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination</span></div><div class="casAuthors">Bertrand, Mathieu J. M.; Milutinovic, Snezana; Dickson, Kathleen M.; Ho, Wai Chi; Boudreault, Alain; Durkin, Jon; Gillard, John W.; Jaquith, James B.; Morris, Stephen J.; Barker, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">689-700</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) family of proteins enhances cell survival through mechanisms that remain uncertain.  In this report, we show that cIAP1 and cIAP2 promote cancer cell survival by functioning as E3 ubiquitin ligases that maintain constitutive ubiquitination of the RIP1 adaptor protein.  We demonstrate that AEG40730, a compd. modeled on BIR-binding tetrapeptides, binds to cIAP1 and cIAP2, facilitates their autoubiquitination and proteosomal degrdn., and causes a dramatic redn. in RIP1 ubiquitination.  We show that cIAP1 and cIAP2 directly ubiquitinate RIP1 and induce constitutive RIP1 ubiquitination in cancer cells and demonstrate that constitutively ubiquitinated RIP1 assocs. with the prosurvival kinase TAK1.  When deubiquitinated by AEG40730 treatment, RIP1 binds caspase-8 and induces apoptosis.  These findings provide insights into the function of the IAPs and provide new therapeutic opportunities in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd_y6j1lTyc7Vg90H21EOLACvtfcHk0lgHcLWbgr7UAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFWnt74%253D&md5=89f7538f6a7f253b5ca1e80bd7b11d8b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2008.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2008.05.014%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DM.%2BJ.%26aulast%3DMilutinovic%26aufirst%3DS.%26aulast%3DDickson%26aufirst%3DK.%2BM.%26aulast%3DHo%26aufirst%3DW.%2BC.%26aulast%3DBoudreault%26aufirst%3DA.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DGillard%26aufirst%3DJ.%2BW.%26aulast%3DJaquith%26aufirst%3DJ.%2BB.%26aulast%3DMorris%26aufirst%3DS.%2BJ.%26aulast%3DBarker%26aufirst%3DP.%2BA.%26atitle%3DcIAP1%2520and%2520cIAP2%2520facilitate%2520cancer%2520cell%2520survival%2520by%2520functioning%2520as%2520E3%2520ligases%2520that%2520promote%2520RIP1%2520ubiquitination%26jtitle%3DMol.%2520Cell%26date%3D2008%26volume%3D30%26spage%3D689%26epage%3D700%26doi%3D10.1016%2Fj.molcel.2008.05.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbott, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of tetrahydroisoquinoline-based bivalent heterodimeric IAP antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5022</span>– <span class="NLM_lpage">5029</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.09.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.bmcl.2014.09.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=25278234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOltbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5022-5029&author=K.+S.+Kimauthor=L.+Zhangauthor=D.+Williamsauthor=H.+L.+Perezauthor=E.+Stangauthor=R.+M.+Borzilleriauthor=S.+Posyauthor=M.+Leiauthor=C.+Chaudhryauthor=S.+Emanuelauthor=R.+Talbott&title=Discovery+of+tetrahydroisoquinoline-based+bivalent+heterodimeric+IAP+antagonists&doi=10.1016%2Fj.bmcl.2014.09.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of tetrahydroisoquinoline-based bivalent heterodimeric IAP antagonists</span></div><div class="casAuthors">Kim, Kyoung Soon; Zhang, Liping; Williams, David; Perez, Heidi L.; Stang, Erik; Borzilleri, Robert M.; Posy, Shana; Lei, Ming; Chaudhry, Charu; Emanuel, Stuart; Talbott, Randy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5022-5029</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bivalent heterodimeric IAP antagonists that incorporate (R)-tetrahydroisoquinoline in the P3' subunit show high affinity for the BIR2 domain and demonstrated potent IAP inhibitory activities in biochem. and cellular assays.  Potent in vivo efficacy was obsd. in a variety of human tumor xenograft models.  The bivalent heterodimeric mol. I with a P3-P3' benzamide linker induced pharmacodynamic markers of apoptosis and was efficacious when administered i.v. at a dose of 1 mg/kg to mice harboring A875 human melanoma tumors.  An analog with a polyamine group incorporated at the P2' thiovaline side chain of I exhibited antiproliferative activity against the P-gp expressing HCT116/VM46 cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGmx42606d97Vg90H21EOLACvtfcHk0lgHcLWbgr7UAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOltbvN&md5=63b2a7041057d80aeddd4ef08ad2d599</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.09.022%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DD.%26aulast%3DPerez%26aufirst%3DH.%2BL.%26aulast%3DStang%26aufirst%3DE.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DPosy%26aufirst%3DS.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DChaudhry%26aufirst%3DC.%26aulast%3DEmanuel%26aufirst%3DS.%26aulast%3DTalbott%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520tetrahydroisoquinoline-based%2520bivalent%2520heterodimeric%2520IAP%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5022%26epage%3D5029%26doi%3D10.1016%2Fj.bmcl.2014.09.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuel, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanslau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fargnoli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naglich, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traeger, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuppugalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vite, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbott, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, R. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent heterodimeric antagonists of inhibitor of apoptosis proteins (IAPs) with sustained antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1556</span>– <span class="NLM_lpage">1562</span>, <span class="refDoi"> DOI: 10.1021/jm501482t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501482t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVygsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1556-1562&author=H.+L.+Perezauthor=C.+Chaudhryauthor=S.+L.+Emanuelauthor=C.+Fanslauauthor=J.+Fargnoliauthor=J.+Ganauthor=K.+S.+Kimauthor=M.+Leiauthor=J.+G.+Naglichauthor=S.+C.+Traegerauthor=R.+Vuppugallaauthor=D.+D.+Weiauthor=G.+D.+Viteauthor=R.+L.+Talbottauthor=R.+M.+Borzilleri&title=Discovery+of+potent+heterodimeric+antagonists+of+inhibitor+of+apoptosis+proteins+%28IAPs%29+with+sustained+antitumor+activity&doi=10.1021%2Fjm501482t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Heterodimeric Antagonists of Inhibitor of Apoptosis Proteins (IAPs) with Sustained Antitumor Activity</span></div><div class="casAuthors">Perez, Heidi L.; Chaudhry, Charu; Emanuel, Stuart L.; Fanslau, Caroline; Fargnoli, Joseph; Gan, Jinping; Kim, Kyoung S.; Lei, Ming; Naglich, Joseph G.; Traeger, Sarah C.; Vuppugalla, Ragini; Wei, Donna D.; Vite, Gregory D.; Talbott, Randy L.; Borzilleri, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1556-1562</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The prominent role of IAPs in controlling cell death and their overexpression in a variety of cancers has prompted the development of IAP antagonists as potential antitumor therapies.  The authors describe the identification of a series of heterodimeric antagonists with highly potent antiproliferative activities in cIAP- and XIAP-dependent cell lines.  Compds. I (L = none) and I (L = NH) further demonstrate curative efficacy in human melanoma and lung cancer xenograft models and are promising candidates for advanced studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9jI4A3_S8CbVg90H21EOLACvtfcHk0lh_j6qpwBobNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVygsQ%253D%253D&md5=890b77928df9afc7d03ba0a50724d430</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm501482t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501482t%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DH.%2BL.%26aulast%3DChaudhry%26aufirst%3DC.%26aulast%3DEmanuel%26aufirst%3DS.%2BL.%26aulast%3DFanslau%26aufirst%3DC.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DGan%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DNaglich%26aufirst%3DJ.%2BG.%26aulast%3DTraeger%26aufirst%3DS.%2BC.%26aulast%3DVuppugalla%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DD.%2BD.%26aulast%3DVite%26aufirst%3DG.%2BD.%26aulast%3DTalbott%26aufirst%3DR.%2BL.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520potent%2520heterodimeric%2520antagonists%2520of%2520inhibitor%2520of%2520apoptosis%2520proteins%2520%2528IAPs%2529%2520with%2520sustained%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1556%26epage%3D1562%26doi%3D10.1021%2Fjm501482t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamanini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitorino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsher, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.</span></span> <span> </span><span class="NLM_article-title">Fragment-based drug discovery targeting inhibitor of apoptosis proteins: discovery of a non-alanine lead series with dual activity against cIAP1 and XIAP</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6574</span>– <span class="NLM_lpage">6588</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00706</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00706" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1CitLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6574-6588&author=G.+Chessariauthor=I.+M.+Buckauthor=J.+E.+Dayauthor=P.+J.+Dayauthor=A.+Iqbalauthor=C.+N.+Johnsonauthor=E.+J.+Lewisauthor=V.+Martinsauthor=D.+Millerauthor=M.+Readerauthor=D.+C.+Reesauthor=S.+J.+Richauthor=E.+Tamaniniauthor=M.+Vitorinoauthor=G.+A.+Wardauthor=P.+A.+Williamsauthor=G.+Williamsauthor=N.+E.+Wilsherauthor=A.+J.+Woolford&title=Fragment-based+drug+discovery+targeting+inhibitor+of+apoptosis+proteins%3A+discovery+of+a+non-alanine+lead+series+with+dual+activity+against+cIAP1+and+XIAP&doi=10.1021%2Facs.jmedchem.5b00706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAP</span></div><div class="casAuthors">Chessari, Gianni; Buck, Ildiko M.; Day, James E. H.; Day, Philip J.; Iqbal, Aman; Johnson, Christopher N.; Lewis, Edward J.; Martins, Vanessa; Miller, Darcey; Reader, Michael; Rees, David C.; Rich, Sharna J.; Tamanini, Emiliano; Vitorino, Marc; Ward, George A.; Williams, Pamela A.; Williams, Glyn; Wilsher, Nicola E.; Woolford, Alison J.-A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6574-6588</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis proteins (IAPs) are important regulators of apoptosis and pro-survival signaling pathways whose deregulation is often assocd. with tumor genesis and tumor growth.  IAPs have been proposed as targets for anticancer therapy, and a no. of peptidomimetic IAP antagonists have entered clin. trials.  Using the fragment-based screening approach, the authors identified nonpeptidic fragments binding with millimolar affinities to both cellular inhibitor of apoptosis protein 1 (cIAP1) and X-linked inhibitor of apoptosis protein (XIAP).  Structure-based hit optimization together with an anal. of protein-ligand electrostatic potential complementarity allowed us to significantly increase binding affinity of the starting hits.  Subsequent optimization gave a potent nonalanine IAP antagonist I structurally distinct from all IAP antagonists previously reported.  The lead compd. had activity in cell-based assays and in a mouse xenograft efficacy model and represents a highly promising start point for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXRpw0ZQNug7Vg90H21EOLACvtfcHk0ljiPruivp5xPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1CitLrL&md5=70a9c10527791ce2cedd0a74e0bbeebb</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00706%26sid%3Dliteratum%253Aachs%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DBuck%26aufirst%3DI.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DIqbal%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMiller%26aufirst%3DD.%26aulast%3DReader%26aufirst%3DM.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DTamanini%26aufirst%3DE.%26aulast%3DVitorino%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DG.%2BA.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DWilsher%26aufirst%3DN.%2BE.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26atitle%3DFragment-based%2520drug%2520discovery%2520targeting%2520inhibitor%2520of%2520apoptosis%2520proteins%253A%2520discovery%2520of%2520a%2520non-alanine%2520lead%2520series%2520with%2520dual%2520activity%2520against%2520cIAP1%2520and%2520XIAP%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6574%26epage%3D6588%26doi%3D10.1021%2Facs.jmedchem.5b00706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamanini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths-Jones, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsher, N. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent Nonpeptidomimetic, small-molecule antagonist of cellular inhibitor of apoptosis protein 1 (cIAP1) and X-linked inhibitor of apoptosis protein (XIAP)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4611</span>– <span class="NLM_lpage">4625</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01877</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01877" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Wntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4611-4625&author=E.+Tamaniniauthor=I.+M.+Buckauthor=G.+Chessariauthor=E.+Chiarparinauthor=J.+E.+H.+Dayauthor=M.+Fredericksonauthor=C.+M.+Griffiths-Jonesauthor=K.+Hearnauthor=T.+D.+Heightmanauthor=A.+Iqbalauthor=C.+N.+Johnsonauthor=E.+J.+Lewisauthor=V.+Martinsauthor=T.+Peakmanauthor=M.+Readerauthor=S.+J.+Richauthor=G.+A.+Wardauthor=P.+A.+Williamsauthor=N.+E.+Wilsher&title=Discovery+of+a+Potent+Nonpeptidomimetic%2C+small-molecule+antagonist+of+cellular+inhibitor+of+apoptosis+protein+1+%28cIAP1%29+and+X-linked+inhibitor+of+apoptosis+protein+%28XIAP%29&doi=10.1021%2Facs.jmedchem.6b01877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP)</span></div><div class="casAuthors">Tamanini, Emiliano; Buck, Ildiko M.; Chessari, Gianni; Chiarparin, Elisabetta; Day, James E. H.; Frederickson, Martyn; Griffiths-Jones, Charlotte M.; Hearn, Keisha; Heightman, Tom D.; Iqbal, Aman; Johnson, Christopher N.; Lewis, Edward J.; Martins, Vanessa; Peakman, Torren; Reader, Michael; Rich, Sharna J.; Ward, George A.; Williams, Pamela A.; Wilsher, Nicola E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4611-4625</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">XIAP and cIAP1 are members of the inhibitor of apoptosis protein (IAP) family and are key regulators of anti-apoptotic and pro-survival signaling pathways.  Overexpression of IAPs occurs in various cancers and has been assocd. with tumor progression and resistance to treatment.  Structure-based drug design (SBDD) guided by structural information from X-ray crystallog., computational studies, and NMR soln. conformational anal. was successfully applied to a fragment-derived lead resulting in AT-IAP, a potent, orally bioavailable, dual antagonist of XIAP and cIAP1 and a structurally novel chem. probe for IAP biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMIPJYPfW1ubVg90H21EOLACvtfcHk0ljiPruivp5xPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Wntb0%253D&md5=2e00e53298df3ebe16bc02ad7cd7bf65</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01877%26sid%3Dliteratum%253Aachs%26aulast%3DTamanini%26aufirst%3DE.%26aulast%3DBuck%26aufirst%3DI.%2BM.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DDay%26aufirst%3DJ.%2BE.%2BH.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DGriffiths-Jones%26aufirst%3DC.%2BM.%26aulast%3DHearn%26aufirst%3DK.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DIqbal%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DPeakman%26aufirst%3DT.%26aulast%3DReader%26aufirst%3DM.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DWard%26aufirst%3DG.%2BA.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DWilsher%26aufirst%3DN.%2BE.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520Nonpeptidomimetic%252C%2520small-molecule%2520antagonist%2520of%2520cellular%2520inhibitor%2520of%2520apoptosis%2520protein%25201%2520%2528cIAP1%2529%2520and%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528XIAP%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4611%26epage%3D4625%26doi%3D10.1021%2Facs.jmedchem.6b01877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsher, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span> <span> </span><span class="NLM_article-title">ASTX660, a novel non-peptidomimetic antagonist of cIAP1/2 and XIAP, potently induces TNFalpha-dependent apoptosis in cancer cell lines and inhibits tumor growth</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1381</span>– <span class="NLM_lpage">1391</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-17-0848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1535-7163.MCT-17-0848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=29695633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1alur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=1381-1391&author=G.+A.+Wardauthor=E.+J.+Lewisauthor=J.+S.+Ahnauthor=C.+N.+Johnsonauthor=J.+F.+Lyonsauthor=V.+Martinsauthor=J.+M.+Munckauthor=S.+J.+Richauthor=T.+Smythauthor=N.+T.+Thompsonauthor=P.+A.+Williamsauthor=N.+E.+Wilsherauthor=N.+G.+Wallisauthor=G.+Chessari&title=ASTX660%2C+a+novel+non-peptidomimetic+antagonist+of+cIAP1%2F2+and+XIAP%2C+potently+induces+TNFalpha-dependent+apoptosis+in+cancer+cell+lines+and+inhibits+tumor+growth&doi=10.1158%2F1535-7163.MCT-17-0848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth</span></div><div class="casAuthors">Ward, George A.; Lewis, Edward J.; Ahn, Jong Sook; Johnson, Christopher N.; Lyons, John F.; Martins, Vanessa; Munck, Joanne M.; Rich, Sharna J.; Smyth, Tomoko; Thompson, Neil T.; Williams, Pamela A.; Wilsher, Nicola E.; Wallis, Nicola G.; Chessari, Gianni</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1381-1391</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Because of their roles in the evasion of apoptosis, inhibitor of apoptosis proteins (IAP) are considered attractive targets for anticancer therapy.  Antagonists of these proteins have the potential to switch prosurvival signaling pathways in cancer cells toward cell death.  Various SMAC-peptidomimetics with inherent cIAP selectivity have been tested clin. and demonstrated minimal single-agent efficacy.  ASTX660 is a potent, non-peptidomimetic antagonist of cIAP1/2 and XIAP, discovered using fragment-based drug design.  The antagonism of XIAP and cIAP1 by ASTX660 was demonstrated on purified proteins, cells, and in vivo in xenograft models.  The compd. binds to the isolated BIR3 domains of both XIAP and cIAP1 with nanomolar potencies.  In cells and xenograft tissue, direct antagonism of XIAP was demonstrated by measuring its displacement from caspase-9 or SMAC.  Compd.-induced proteasomal degrdn. of cIAP1 and 2, resulting in downstream effects of NIK stabilization and activation of noncanonical NF-κB signaling, demonstrated cIAP1/2 antagonism.  Treatment with ASTX660 led to TNFα-dependent induction of apoptosis in various cancer cell lines in vitro, whereas dosing in mice bearing breast and melanoma tumor xenografts inhibited tumor growth.  ASTX660 is currently being tested in a phase I-II clin. trial (NCT02503423), and we propose that its antagonism of cIAP1/2 and XIAP may offer improved efficacy over first-generation antagonists that are more cIAP1/2 selective.  Mol Cancer Ther; 17(7); 1381-91. ©2018 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA6bD-2Q28tLVg90H21EOLACvtfcHk0lgAE-hEi4xCag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1alur7J&md5=0fad3f7bf0870ef4566b182d4719a5d6</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-17-0848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-17-0848%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DG.%2BA.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DAhn%26aufirst%3DJ.%2BS.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DLyons%26aufirst%3DJ.%2BF.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMunck%26aufirst%3DJ.%2BM.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DSmyth%26aufirst%3DT.%26aulast%3DThompson%26aufirst%3DN.%2BT.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DWilsher%26aufirst%3DN.%2BE.%26aulast%3DWallis%26aufirst%3DN.%2BG.%26aulast%3DChessari%26aufirst%3DG.%26atitle%3DASTX660%252C%2520a%2520novel%2520non-peptidomimetic%2520antagonist%2520of%2520cIAP1%252F2%2520and%2520XIAP%252C%2520potently%2520induces%2520TNFalpha-dependent%2520apoptosis%2520in%2520cancer%2520cell%2520lines%2520and%2520inhibits%2520tumor%2520growth%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26spage%3D1381%26epage%3D1391%26doi%3D10.1158%2F1535-7163.MCT-17-0848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millemaggi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsher, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span> <span> </span><span class="NLM_article-title">A fragment-derived clinical candidate for antagonism of X-linked and cellular inhibitor of apoptosis proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1 H,2 H,3 H-pyrrolo[3,2- b]pyridin-1-yl)-2-[(2 R,5 R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7314</span>– <span class="NLM_lpage">7329</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00900</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00900" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVKhtr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7314-7329&author=C.+N.+Johnsonauthor=J.+S.+Ahnauthor=I.+M.+Buckauthor=E.+Chiarparinauthor=J.+E.+H.+Dayauthor=A.+Hopkinsauthor=S.+Howardauthor=E.+J.+Lewisauthor=V.+Martinsauthor=A.+Millemaggiauthor=J.+M.+Munckauthor=L.+W.+Pageauthor=T.+Peakmanauthor=M.+Readerauthor=S.+J.+Richauthor=G.+Saxtyauthor=T.+Smythauthor=N.+T.+Thompsonauthor=G.+A.+Wardauthor=P.+A.+Williamsauthor=N.+E.+Wilsherauthor=G.+Chessari&title=A+fragment-derived+clinical+candidate+for+antagonism+of+X-linked+and+cellular+inhibitor+of+apoptosis+proteins%3A+1-%286-%5B%284-Fluorophenyl%29methyl%5D-5-%28hydroxymethyl%29-3%2C3-dimethyl-1+H%2C2+H%2C3+H-pyrrolo%5B3%2C2-+b%5Dpyridin-1-yl%29-2-%5B%282+R%2C5+R%29-5-methyl-2-%28%5B%283R%29-3-methylmorpholin-4-yl%5Dmethyl%29piperazin-1-yl%5Dethan-1-one+%28ASTX660%29&doi=10.1021%2Facs.jmedchem.8b00900"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1H,2H,3H-pyrrolo[3,2-b]pyridin-1-yl)-2-[(2R,5R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660)</span></div><div class="casAuthors">Johnson, Christopher N.; Ahn, Jong Sook; Buck, Ildiko M.; Chiarparin, Elisabetta; Day, James E. H.; Hopkins, Anna; Howard, Steven; Lewis, Edward J.; Martins, Vanessa; Millemaggi, Alessia; Munck, Joanne M.; Page, Lee W.; Peakman, Torren; Reader, Michael; Rich, Sharna J.; Saxty, Gordon; Smyth, Tomoko; Thompson, Neil T.; Ward, George A.; Williams, Pamela A.; Wilsher, Nicola E.; Chessari, Gianni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7314-7329</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis proteins (IAPs) are promising anticancer targets, given their roles in the evasion of apoptosis.  Several peptidomimetic IAP antagonists, with inherent selectivity for cellular IAP (cIAP) over X-linked IAP (XIAP), have been tested in the clinic.  A fragment screening approach followed by structure-based optimization has previously been reported that resulted in a low-nanomolar cIAP1 and XIAP antagonist lead mol. with a more balanced cIAP-XIAP profile.  We now report the further structure-guided optimization of the lead, with a view to improving the metabolic stability and cardiac safety profile, to give the nonpeptidomimetic antagonist clin. candidate (ASTX660), currently being tested in a phase 1/2 clin. trial (NCT02503423).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBj2OOs5EG-7Vg90H21EOLACvtfcHk0lgAE-hEi4xCag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVKhtr7P&md5=9c7ca5775f42441c971ad8459bb129c2</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00900%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DAhn%26aufirst%3DJ.%2BS.%26aulast%3DBuck%26aufirst%3DI.%2BM.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DDay%26aufirst%3DJ.%2BE.%2BH.%26aulast%3DHopkins%26aufirst%3DA.%26aulast%3DHoward%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMillemaggi%26aufirst%3DA.%26aulast%3DMunck%26aufirst%3DJ.%2BM.%26aulast%3DPage%26aufirst%3DL.%2BW.%26aulast%3DPeakman%26aufirst%3DT.%26aulast%3DReader%26aufirst%3DM.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DSmyth%26aufirst%3DT.%26aulast%3DThompson%26aufirst%3DN.%2BT.%26aulast%3DWard%26aufirst%3DG.%2BA.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DWilsher%26aufirst%3DN.%2BE.%26aulast%3DChessari%26aufirst%3DG.%26atitle%3DA%2520fragment-derived%2520clinical%2520candidate%2520for%2520antagonism%2520of%2520X-linked%2520and%2520cellular%2520inhibitor%2520of%2520apoptosis%2520proteins%253A%25201-%25286-%255B%25284-Fluorophenyl%2529methyl%255D-5-%2528hydroxymethyl%2529-3%252C3-dimethyl-1%2520H%252C2%2520H%252C3%2520H-pyrrolo%255B3%252C2-%2520b%255Dpyridin-1-yl%2529-2-%255B%25282%2520R%252C5%2520R%2529-5-methyl-2-%2528%255B%25283R%2529-3-methylmorpholin-4-yl%255Dmethyl%2529piperazin-1-yl%255Dethan-1-one%2520%2528ASTX660%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7314%26epage%3D7329%26doi%3D10.1021%2Facs.jmedchem.8b00900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donnell, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michoud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupert, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fretland, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kester, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukacs, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mischke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moliterni, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polonskaia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutt, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solis, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Specian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiszewski, S. W.</span></span> <span> </span><span class="NLM_article-title">Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7772</span>– <span class="NLM_lpage">7787</span>, <span class="refDoi"> DOI: 10.1021/jm400731m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400731m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFGku7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7772-7787&author=A.+F.+Donnellauthor=C.+Michoudauthor=K.+C.+Rupertauthor=X.+Hanauthor=D.+Aguilarauthor=K.+B.+Frankauthor=A.+J.+Fretlandauthor=L.+Gaoauthor=B.+Gogginauthor=J.+H.+Hoggauthor=K.+Hongauthor=C.+A.+Jansonauthor=R.+F.+Kesterauthor=N.+Kongauthor=K.+Leauthor=S.+Liauthor=W.+Liangauthor=L.+J.+Lombardoauthor=Y.+Louauthor=C.+M.+Lukacsauthor=S.+Mischkeauthor=J.+A.+Moliterniauthor=A.+Polonskaiaauthor=A.+D.+Schuttauthor=D.+S.+Solisauthor=A.+Specianauthor=R.+T.+Taylorauthor=M.+Weiselauthor=S.+W.+Remiszewski&title=Benzazepinones+and+benzoxazepinones+as+antagonists+of+inhibitor+of+apoptosis+proteins+%28IAPs%29+selective+for+the+second+baculovirus+IAP+repeat+%28BIR2%29+domain&doi=10.1021%2Fjm400731m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Benzazepinones and Benzoxazepinones as Antagonists of Inhibitor of Apoptosis Proteins (IAPs) Selective for the Second Baculovirus IAP Repeat (BIR2) Domain</span></div><div class="casAuthors">Donnell, Andrew F.; Michoud, Christophe; Rupert, Kenneth C.; Han, Xiaochun; Aguilar, Douglas; Frank, Karl B.; Fretland, Adrian J.; Gao, Lin; Goggin, Barry; Hogg, J. Heather; Hong, Kyoungja; Janson, Cheryl A.; Kester, Robert F.; Kong, Norman; Le, Kang; Li, Shirley; Liang, Weiling; Lombardo, Louis J.; Lou, Yan; Lukacs, Christine M.; Mischke, Steven; Moliterni, John A.; Polonskaia, Ann; Schutt, Andrew D.; Solis, Dave S.; Specian, Anthony; Taylor, Robert T.; Weisel, Martin; Remiszewski, Stacy W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7772-7787</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">XIAP is a key regulator of apoptosis, and its overexpression in cancer cells may contribute to their survival.  The antiapoptotic function of XIAP derives from its BIR domains, which bind to and inhibit pro-apoptotic caspases.  Most known IAP inhibitors are selective for the BIR3 domain and bind to cIAP1 and cIAP2 as well as XIAP.  Pathways activated upon cIAP binding contribute to the function of these compds.  Inhibitors selective for XIAP should exert pro-apoptotic effects through competition with the terminal caspases.  This paper details our synthetic explorations of a novel XIAP BIR2-selective benzazepinone screening hit with a focus on increasing BIR2 potency and overcoming high in vivo clearance.  These efforts led to the discovery of benzoxazepinone 40, a potent BIR2-selective inhibitor with good in vivo pharmacokinetic properties which potentiates apoptotic signaling in a manner mechanistically distinct from that of known pan-IAP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqR1SV1L6CSrVg90H21EOLACvtfcHk0lgAE-hEi4xCag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFGku7rM&md5=7ae7bebecf9f779ce42bd29b7312652b</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm400731m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400731m%26sid%3Dliteratum%253Aachs%26aulast%3DDonnell%26aufirst%3DA.%2BF.%26aulast%3DMichoud%26aufirst%3DC.%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DAguilar%26aufirst%3DD.%26aulast%3DFrank%26aufirst%3DK.%2BB.%26aulast%3DFretland%26aufirst%3DA.%2BJ.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DGoggin%26aufirst%3DB.%26aulast%3DHogg%26aufirst%3DJ.%2BH.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DKester%26aufirst%3DR.%2BF.%26aulast%3DKong%26aufirst%3DN.%26aulast%3DLe%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DW.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DLukacs%26aufirst%3DC.%2BM.%26aulast%3DMischke%26aufirst%3DS.%26aulast%3DMoliterni%26aufirst%3DJ.%2BA.%26aulast%3DPolonskaia%26aufirst%3DA.%26aulast%3DSchutt%26aufirst%3DA.%2BD.%26aulast%3DSolis%26aufirst%3DD.%2BS.%26aulast%3DSpecian%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DR.%2BT.%26aulast%3DWeisel%26aufirst%3DM.%26aulast%3DRemiszewski%26aufirst%3DS.%2BW.%26atitle%3DBenzazepinones%2520and%2520benzoxazepinones%2520as%2520antagonists%2520of%2520inhibitor%2520of%2520apoptosis%2520proteins%2520%2528IAPs%2529%2520selective%2520for%2520the%2520second%2520baculovirus%2520IAP%2520repeat%2520%2528BIR2%2529%2520domain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7772%26epage%3D7787%26doi%3D10.1021%2Fjm400731m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kester, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnell, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiszewski, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moliterni, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michoud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupert, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mischke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukacs, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fretland, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polonskaia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solis, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tardell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvorozniak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutt, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggin, B.</span></span> <span> </span><span class="NLM_article-title">Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7788</span>– <span class="NLM_lpage">7803</span>, <span class="refDoi"> DOI: 10.1021/jm400732v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400732v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOjur3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7788-7803&author=R.+F.+Kesterauthor=A.+F.+Donnellauthor=Y.+Louauthor=S.+W.+Remiszewskiauthor=L.+J.+Lombardoauthor=S.+Chenauthor=N.+T.+Leauthor=J.+Loauthor=J.+A.+Moliterniauthor=X.+Hanauthor=J.+H.+Hoggauthor=W.+Liangauthor=C.+Michoudauthor=K.+C.+Rupertauthor=S.+Mischkeauthor=K.+Leauthor=M.+Weiselauthor=C.+A.+Jansonauthor=C.+M.+Lukacsauthor=A.+J.+Fretlandauthor=K.+Hongauthor=A.+Polonskaiaauthor=L.+Gaoauthor=S.+Liauthor=D.+S.+Solisauthor=D.+Aguilarauthor=C.+Tardellauthor=M.+Dvorozniakauthor=S.+Tannuauthor=E.+C.+Leeauthor=A.+D.+Schuttauthor=B.+Goggin&title=Optimization+of+benzodiazepinones+as+selective+inhibitors+of+the+X-linked+inhibitor+of+apoptosis+protein+%28XIAP%29+second+baculovirus+IAP+repeat+%28BIR2%29+domain&doi=10.1021%2Fjm400732v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Benzodiazepinones as Selective Inhibitors of the X-Linked Inhibitor of Apoptosis Protein (XIAP) Second Baculovirus IAP Repeat (BIR2) Domain</span></div><div class="casAuthors">Kester, Robert F.; Donnell, Andrew F.; Lou, Yan; Remiszewski, Stacy W.; Lombardo, Louis J.; Chen, Shaoqing; Le, Nam T.; Lo, Jennifer; Moliterni, John A.; Han, Xiaochun; Hogg, J. Heather; Liang, Weiling; Michoud, Christophe; Rupert, Kenneth C.; Mischke, Steven; Le, Kang; Weisel, Martin; Janson, Cheryl A.; Lukacs, Christine M.; Fretland, Adrian J.; Hong, Kyoungja; Polonskaia, Ann; Gao, Lin; Li, Shirley; Solis, Dave S.; Aguilar, Doug; Tardell, Christine; Dvorozniak, Mark; Tannu, Shahid; Lee, Edmund C.; Schutt, Andy D.; Goggin, Barry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7788-7803</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The IAPs are key regulators of the apoptotic pathways and are commonly overexpressed in many cancer cells.  IAPs contain one to three BIR domains that are crucial for their inhibitory function.  The pro-survival properties of XIAP come from binding of the BIR domains to the pro-apoptotic caspases.  The BIR3 domain of XIAP binds and inhibits caspase 9, while the BIR2 domain binds and inhibits the terminal caspases 3 and 7.  While XIAP BIR3 inhibitors have previously been reported, they also inhibit cIAP1/2 and promote the release of TNFα, potentially limiting their therapeutic utility.  This paper will focus on the optimization of selective XIAP BIR2 inhibitors leading to the discovery of highly potent benzodiazepinone 36 (IC50 = 45 nM), which has high levels of selectivity over XIAP BIR3 and cIAP1 BIR2/3 and shows efficacy in a xenograft pharmacodynamic model monitoring caspase activity while not promoting the release of TNFα in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGkZy4tzatPrVg90H21EOLACvtfcHk0lg1Lkh8GfK9ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOjur3M&md5=5260aeb14bf75a3754bd1720c2512a8a</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm400732v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400732v%26sid%3Dliteratum%253Aachs%26aulast%3DKester%26aufirst%3DR.%2BF.%26aulast%3DDonnell%26aufirst%3DA.%2BF.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DRemiszewski%26aufirst%3DS.%2BW.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLe%26aufirst%3DN.%2BT.%26aulast%3DLo%26aufirst%3DJ.%26aulast%3DMoliterni%26aufirst%3DJ.%2BA.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DHogg%26aufirst%3DJ.%2BH.%26aulast%3DLiang%26aufirst%3DW.%26aulast%3DMichoud%26aufirst%3DC.%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DMischke%26aufirst%3DS.%26aulast%3DLe%26aufirst%3DK.%26aulast%3DWeisel%26aufirst%3DM.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DLukacs%26aufirst%3DC.%2BM.%26aulast%3DFretland%26aufirst%3DA.%2BJ.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DPolonskaia%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DSolis%26aufirst%3DD.%2BS.%26aulast%3DAguilar%26aufirst%3DD.%26aulast%3DTardell%26aufirst%3DC.%26aulast%3DDvorozniak%26aufirst%3DM.%26aulast%3DTannu%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DE.%2BC.%26aulast%3DSchutt%26aufirst%3DA.%2BD.%26aulast%3DGoggin%26aufirst%3DB.%26atitle%3DOptimization%2520of%2520benzodiazepinones%2520as%2520selective%2520inhibitors%2520of%2520the%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528XIAP%2529%2520second%2520baculovirus%2520IAP%2520repeat%2520%2528BIR2%2529%2520domain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7788%26epage%3D7803%26doi%3D10.1021%2Fjm400732v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lukacs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belunis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowther, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danho, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiszewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamath, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span> <span> </span><span class="NLM_article-title">The structure of XIAP BIR2: understanding the selectivity of the BIR domains</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1717</span>– <span class="NLM_lpage">1725</span>, <span class="refDoi"> DOI: 10.1107/S0907444913016284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1107%2FS0907444913016284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=23999295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlKrsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1717-1725&author=C.+Lukacsauthor=C.+Belunisauthor=R.+Crowtherauthor=W.+Danhoauthor=L.+Gaoauthor=B.+Gogginauthor=C.+A.+Jansonauthor=S.+Liauthor=S.+Remiszewskiauthor=A.+Schuttauthor=M.+K.+Thakurauthor=S.+K.+Singhauthor=S.+Swaminathanauthor=R.+Pandeyauthor=R.+Tyagiauthor=R.+Gosuauthor=A.+V.+Kamathauthor=A.+Kuglstatter&title=The+structure+of+XIAP+BIR2%3A+understanding+the+selectivity+of+the+BIR+domains&doi=10.1107%2FS0907444913016284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of XIAP BIR2: understanding the selectivity of the BIR domains</span></div><div class="casAuthors">Lukacs, Christine; Belunis, Charles; Crowther, Robert; Danho, Waleed; Gao, Lin; Goggin, Barry; Janson, Cheryl A.; Li, Shirley; Remiszewski, Stacy; Schutt, Andrew; Thakur, Manish K.; Singh, Saroj K.; Swaminathan, Srinivasan; Pandey, Rajat; Tyagi, Rajiv; Gosu, Ramachandraiah; Kamath, Ajith V.; Kuglstatter, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1717-1725</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">XIAP, a member of the inhibitor of apoptosis family of proteins, is a crit. regulator of apoptosis.  Inhibition of the BIR domain-caspase interaction is a promising approach towards treating cancer.  Previous work has been directed towards inhibiting the BIR3-caspase-9 interaction, which blocks the intrinsic apoptotic pathway; selectively inhibiting the BIR2-caspase-3 interaction would also block the extrinsic pathway.  The BIR2 domain of XIAP has successfully been crystd.; peptides and small-mol. inhibitors can be soaked into these crystals, which diffract to high resoln.  Here, the BIR2 apo crystal structure and the structures of five BIR2-tetrapeptide complexes are described.  The structural flexibility obsd. on comparing these structures, along with a comparison with XIAP BIR3, affords an understanding of the structural elements that drive selectivity between BIR2 and BIR3 and which can be used to design BIR2-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6-upk5-drzbVg90H21EOLACvtfcHk0lg1Lkh8GfK9ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlKrsLnK&md5=deebf6694f2e53929d7c6ec4e763cf14</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1107%2FS0907444913016284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913016284%26sid%3Dliteratum%253Aachs%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DBelunis%26aufirst%3DC.%26aulast%3DCrowther%26aufirst%3DR.%26aulast%3DDanho%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DGoggin%26aufirst%3DB.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DRemiszewski%26aufirst%3DS.%26aulast%3DSchutt%26aufirst%3DA.%26aulast%3DThakur%26aufirst%3DM.%2BK.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DPandey%26aufirst%3DR.%26aulast%3DTyagi%26aufirst%3DR.%26aulast%3DGosu%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%2BV.%26aulast%3DKuglstatter%26aufirst%3DA.%26atitle%3DThe%2520structure%2520of%2520XIAP%2520BIR2%253A%2520understanding%2520the%2520selectivity%2520of%2520the%2520BIR%2520domains%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1717%26epage%3D1725%26doi%3D10.1107%2FS0907444913016284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Interaction of a cyclic, bivalent SMAC mimetic with the x-linked inhibitor of apoptosis protein</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">9811</span>– <span class="NLM_lpage">9824</span>, <span class="refDoi"> DOI: 10.1021/bi800785y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi800785y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=9811-9824&author=Z.+Nikolovska-Coleskaauthor=J.+L.+Meagherauthor=S.+Jiangauthor=C.+Y.+Yangauthor=S.+Qiuauthor=P.+P.+Rollerauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Interaction+of+a+cyclic%2C+bivalent+SMAC+mimetic+with+the+x-linked+inhibitor+of+apoptosis+protein&doi=10.1021%2Fbi800785y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of a Cyclic, Bivalent Smac Mimetic with the X-Linked Inhibitor of Apoptosis Protein</span></div><div class="casAuthors">Nikolovska-Coleska, Zaneta; Meagher, Jennifer L.; Jiang, Sheng; Yang, Chao-Yie; Qiu, Su; Roller, Peter P.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">9811-9824</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed and synthesized a cyclic, bivalent Smac mimetic (compd. 3) and characterized its interaction with the X-linked inhibitor of apoptosis protein (XIAP).  Compd. 3 binds to XIAP contg. both BIR2 and BIR3 domains with a biphasic dose-response curve representing two binding sites with IC50 values of 0.5 and 406 nM, resp.  Compd. 3 binds to XIAPs contg. the BIR3-only and BIR2-only domain with Ki values of 4 nM and 4.4 μM, resp.  Gel filtration expts. using wild-type and mutated XIAPs showed that 3 forms a 1:2 stoichiometric complex with XIAP contg. the BIR3-only domain.  However, it forms a 1:1 stoichiometric complex with XIAP contg. both BIR2 and BIR3 domains, and both BIR domains are involved in the binding.  Compd. 3 efficiently antagonizes inhibition of XIAP in a cell-free functional assay and is >200 times more potent than its corresponding monovalent compd. 2.  Detn. of the crystal structure of 3 in complex with the XIAP BIR3 domain confirms that 3 induces homodimerization of the XIAP BIR3 domain and provides a structural basis for the cooperative binding of one mol. of compd. 3 to two XIAP BIR3 mols.  On the basis of this crystal structure, a binding model of XIAP contg. both BIR2 and BIR3 domains and 3 was constructed, which sheds light on the ability of 3 to relieve the inhibition of XIAP with not only caspase-9 but also caspase-3/-7.  Compd. 3 is cell-permeable, effectively activates caspases in whole cells, and potently inhibits cancer cell growth.  Compd. 3 is a useful biochem. and pharmacol. tool for further elucidating the role of XIAP in regulation of apoptosis and represents a promising lead compd. for the design of potent, cell-permeable Smac mimetics for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSEyxJPGLGNLVg90H21EOLACvtfcHk0ljwn6Ey4-Cysw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmu7vK&md5=e4bc922befd427c343f908017286d6f7</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fbi800785y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi800785y%26sid%3Dliteratum%253Aachs%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DInteraction%2520of%2520a%2520cyclic%252C%2520bivalent%2520SMAC%2520mimetic%2520with%2520the%2520x-linked%2520inhibitor%2520of%2520apoptosis%2520protein%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D9811%26epage%3D9824%26doi%3D10.1021%2Fbi800785y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Cyclopeptide SMAC mimetics as antagonists of IAP proteins</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3043</span>– <span class="NLM_lpage">3046</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.bmcl.2010.03.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=20443226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFGnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3043-3046&author=H.+Sunauthor=L.+Liuauthor=J.+Luauthor=S.+Qiuauthor=C.+Y.+Yangauthor=H.+Yiauthor=S.+Wang&title=Cyclopeptide+SMAC+mimetics+as+antagonists+of+IAP+proteins&doi=10.1016%2Fj.bmcl.2010.03.114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclopeptide Smac mimetics as antagonists of IAP proteins</span></div><div class="casAuthors">Sun, Haiying; Liu, Liu; Lu, Jianfeng; Qiu, Su; Yang, Chao-Yie; Yi, Han; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3043-3046</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two cyclopeptidic Smac mimetics (I) (R1 = Ph and CH2Ph) were designed and synthesized.  These two compds. bind to XIAP and cIAP-1/2 with low nanomolar affinities, and restore the activities of caspase-9 and caspase-3/-7 inhibited by XIAP.  Compd. I (R1 = Ph) potently inhibits cancer cell growth and is 5-8 times more potent than the initial lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbEjNhyQ7ZgbVg90H21EOLACvtfcHk0ljwn6Ey4-Cysw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFGnsrs%253D&md5=e32ead150e03ba70be0c41ecd82fa6e7</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.114%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DCyclopeptide%2520SMAC%2520mimetics%2520as%2520antagonists%2520of%2520IAP%2520proteins%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3043%26epage%3D3046%26doi%3D10.1016%2Fj.bmcl.2010.03.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seigal, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connors, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuel, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fargnoli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naglich, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokross, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbott, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrett, N. K.</span></span> <span> </span><span class="NLM_article-title">The discovery of macrocyclic XIAP antagonists from a DNA-programmed chemistry library, and their optimization to give lead compounds with in vivo antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2855</span>– <span class="NLM_lpage">2861</span>, <span class="refDoi"> DOI: 10.1021/jm501892g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501892g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivF2qu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2855-2861&author=B.+A.+Seigalauthor=W.+H.+Connorsauthor=A.+Fraleyauthor=R.+M.+Borzilleriauthor=P.+H.+Carterauthor=S.+L.+Emanuelauthor=J.+Fargnoliauthor=K.+Kimauthor=M.+Leiauthor=J.+G.+Naglichauthor=M.+E.+Pokrossauthor=S.+L.+Posyauthor=H.+Shenauthor=N.+Surtiauthor=R.+Talbottauthor=Y.+Zhangauthor=N.+K.+Terrett&title=The+discovery+of+macrocyclic+XIAP+antagonists+from+a+DNA-programmed+chemistry+library%2C+and+their+optimization+to+give+lead+compounds+with+in+vivo+antitumor+activity&doi=10.1021%2Fjm501892g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of Macrocyclic XIAP Antagonists from a DNA-Programmed Chemistry Library, and Their Optimization To Give Lead Compounds with in Vivo Antitumor Activity</span></div><div class="casAuthors">Seigal, Benjamin A.; Connors, William H.; Fraley, Andrew; Borzilleri, Robert M.; Carter, Percy H.; Emanuel, Stuart L.; Fargnoli, Joseph; Kim, Kyoung; Lei, Ming; Naglich, Joseph G.; Pokross, Matthew E.; Posy, Shana L.; Shen, Henry; Surti, Neha; Talbott, Randy; Zhang, Yong; Terrett, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2855-2861</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Affinity selection screening of macrocycle libraries derived from DNA-programmed chem. identified XIAP BIR2 and BIR3 domain inhibitors that displace bound pro-apoptotic caspases.  X-ray cocrystal structures of key compds. with XIAP BIR2 suggested potency-enhancing structural modifications.  Optimization of dimeric macrocycles with similar affinity for both domains were potent pro-apoptotic agents in cancer cell lines and efficacious in shrinking tumors in a mouse xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlB6i1KOFJjrVg90H21EOLACvtfcHk0ljwn6Ey4-Cysw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivF2qu78%253D&md5=9bd53cc3ed014796248e8048cecea0d1</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm501892g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501892g%26sid%3Dliteratum%253Aachs%26aulast%3DSeigal%26aufirst%3DB.%2BA.%26aulast%3DConnors%26aufirst%3DW.%2BH.%26aulast%3DFraley%26aufirst%3DA.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DEmanuel%26aufirst%3DS.%2BL.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DNaglich%26aufirst%3DJ.%2BG.%26aulast%3DPokross%26aufirst%3DM.%2BE.%26aulast%3DPosy%26aufirst%3DS.%2BL.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DSurti%26aufirst%3DN.%26aulast%3DTalbott%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTerrett%26aufirst%3DN.%2BK.%26atitle%3DThe%2520discovery%2520of%2520macrocyclic%2520XIAP%2520antagonists%2520from%2520a%2520DNA-programmed%2520chemistry%2520library%252C%2520and%2520their%2520optimization%2520to%2520give%2520lead%2520compounds%2520with%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2855%26epage%3D2861%26doi%3D10.1021%2Fjm501892g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seigal, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrett, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbott, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fargnoli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naglich, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuppugalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vite, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, R. M.</span></span> <span> </span><span class="NLM_article-title">Dimeric macrocyclic antagonists of inhibitor of apoptosis proteins for the treatment of cancer</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">770</span>– <span class="NLM_lpage">775</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00091</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00091" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVGlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=770-775&author=Y.+Zhangauthor=B.+A.+Seigalauthor=N.+K.+Terrettauthor=R.+L.+Talbottauthor=J.+Fargnoliauthor=J.+G.+Naglichauthor=C.+Chaudhryauthor=S.+L.+Posyauthor=R.+Vuppugallaauthor=G.+Corneliusauthor=M.+Leiauthor=C.+Wangauthor=Y.+Zhangauthor=R.+J.+Schmidtauthor=D.+D.+Weiauthor=M.+M.+Millerauthor=M.+P.+Allenauthor=L.+Liauthor=P.+H.+Carterauthor=G.+D.+Viteauthor=R.+M.+Borzilleri&title=Dimeric+macrocyclic+antagonists+of+inhibitor+of+apoptosis+proteins+for+the+treatment+of+cancer&doi=10.1021%2Facsmedchemlett.5b00091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Dimeric Macrocyclic Antagonists of Inhibitor of Apoptosis Proteins for the Treatment of Cancer</span></div><div class="casAuthors">Zhang, Yong; Seigal, Benjamin A.; Terrett, Nicholas K.; Talbott, Randy L.; Fargnoli, Joseph; Naglich, Joseph G.; Chaudhry, Charu; Posy, Shana L.; Vuppugalla, Ragini; Cornelius, Georgia; Lei, Ming; Wang, Chunlei; Zhang, Yingru; Schmidt, Robert J.; Wei, Donna D.; Miller, Michael M.; Allen, Martin P.; Li, Ling; Carter, Percy H.; Vite, Gregory D.; Borzilleri, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">770-775</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of dimeric macrocyclic compds. were prepd. and evaluated as antagonists for inhibitor of apoptosis proteins.  The most potent analog I, which binds to XIAP and c-IAP proteins with high affinity and induces caspase-3 activation and ultimately cell apoptosis, inhibits growth of human melanoma and colorectal cell lines at low nanomolar concns.  Furthermore, compd. I demonstrated significant antitumor activity in the A875 human melanoma xenograft model at doses as low as 2 mg/kg on a q3d schedule.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBzbs9VSlJ47Vg90H21EOLACvtfcHk0lgIisjJiG1RfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVGlsLs%253D&md5=0e734d3be3ee9f36d4d3f0f10686b978</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00091%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSeigal%26aufirst%3DB.%2BA.%26aulast%3DTerrett%26aufirst%3DN.%2BK.%26aulast%3DTalbott%26aufirst%3DR.%2BL.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DNaglich%26aufirst%3DJ.%2BG.%26aulast%3DChaudhry%26aufirst%3DC.%26aulast%3DPosy%26aufirst%3DS.%2BL.%26aulast%3DVuppugalla%26aufirst%3DR.%26aulast%3DCornelius%26aufirst%3DG.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSchmidt%26aufirst%3DR.%2BJ.%26aulast%3DWei%26aufirst%3DD.%2BD.%26aulast%3DMiller%26aufirst%3DM.%2BM.%26aulast%3DAllen%26aufirst%3DM.%2BP.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DVite%26aufirst%3DG.%2BD.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDimeric%2520macrocyclic%2520antagonists%2520of%2520inhibitor%2520of%2520apoptosis%2520proteins%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D770%26epage%3D775%26doi%3D10.1021%2Facsmedchemlett.5b00091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span>U.S.
National Library of Medicine. Clinicaltrials.gov. <a href="https://www.clinicaltrials.gov/" class="extLink">https://www.clinicaltrials.gov/</a> (accessed Oct 15, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=U.S.%0ANational+Library+of+Medicine.+Clinicaltrials.gov.+https%3A%2F%2Fwww.clinicaltrials.gov%2F+%28accessed+Oct+15%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amaravadi, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilder, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adjei, A. A.</span></span> <span> </span><span class="NLM_article-title">A phase I study of the SMAC-mimetic birinapant in adults with refractory solid tumors or lymphoma</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2569</span>– <span class="NLM_lpage">2575</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-15-0475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1535-7163.MCT-15-0475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=26333381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOgt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=2569-2575&author=R.+K.+Amaravadiauthor=R.+J.+Schilderauthor=L.+P.+Martinauthor=M.+Levinauthor=M.+A.+Grahamauthor=D.+E.+Wengauthor=A.+A.+Adjei&title=A+phase+I+study+of+the+SMAC-mimetic+birinapant+in+adults+with+refractory+solid+tumors+or+lymphoma&doi=10.1158%2F1535-7163.MCT-15-0475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma</span></div><div class="casAuthors">Amaravadi, Ravi K.; Schilder, Russell J.; Martin, Lainie P.; Levin, Myron; Graham, Martin A.; Weng, David E.; Adjei, Alex A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2569-2575</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) family of antiapoptotic proteins has been identified as a target for small mol. inhibitors in cancer.  Second mitochondrial-derived activator of caspases (SMAC) efficiently and naturally antagonizes IAPs, and preclin. studies have detd. that SMAC mimetics have potent anticancer properties.  Here, we report a first-in-human trial designed to det. the max. tolerated dose (MTD), safety, and pharmacokinetics/pharmacodynamics (PK/PD) of birinapant, a novel SMAC mimetic.  Patients with advanced solid tumors or lymphoma were enrolled in a 3+3 dose escalation design with birinapant administered i.v. from 0.18 to 63 mg/m2 once weekly every 3 of 4 wk.  Fifty patients were enrolled to 12 dose cohorts.  Birinapant 47 mg/m2 was detd. to be the MTD.  At 63 mg/m2, dose-limiting toxicities included headache, nausea, and vomiting.  Two cases of Bell's palsy (grade 2) also occurred at 63 mg/m2.  Birinapant had a plasma half-life of 30 to 35 h and accumulated in tumor tissue.  Birinapant suppressed cIAP1 and increased apoptosis in peripheral blood mononuclear cells and tumor tissue.  Prolonged stable disease was obsd. in 3 patients: non-small cell lung cancer (5 mo), colorectal cancer (5 mo), and liposarcoma (9 mo).  Two patients with colorectal cancer had radiog. evidence of tumor shrinkage.  In conclusion, birinapant was well tolerated with an MTD of 47 mg/m2 and exhibited favorable PK and PD properties.  Several patients demonstrated stable disease and evidence of antitumor activity.  These results support the ongoing clin. trials of birinapant in patients with cancer.  Mol Cancer Ther; 14(11); 2569-75. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5J9EHx3GGObVg90H21EOLACvtfcHk0lgIisjJiG1RfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOgt7zI&md5=f40e5be7890545adbe2ff475a8d43d1d</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0475%26sid%3Dliteratum%253Aachs%26aulast%3DAmaravadi%26aufirst%3DR.%2BK.%26aulast%3DSchilder%26aufirst%3DR.%2BJ.%26aulast%3DMartin%26aufirst%3DL.%2BP.%26aulast%3DLevin%26aufirst%3DM.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DWeng%26aufirst%3DD.%2BE.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520the%2520SMAC-mimetic%2520birinapant%2520in%2520adults%2520with%2520refractory%2520solid%2520tumors%2520or%2520lymphoma%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D2569%26epage%3D2575%26doi%3D10.1158%2F1535-7163.MCT-15-0475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noonan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunch, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, C.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takebe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinders, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annunziata, C. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer</span>. <i>Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">588</span>– <span class="NLM_lpage">597</span>, <span class="refDoi"> DOI: 10.1002/cncr.29783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1002%2Fcncr.29783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=26566079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XitF2kurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2016&pages=588-597&author=A.+M.+Noonanauthor=K.+P.+Bunchauthor=J.+Q.+Chenauthor=M.+A.+Herrmannauthor=J.+M.+Leeauthor=E.+C.+Kohnauthor=C.%0AC.+O%E2%80%99Sullivanauthor=E.+Jordanauthor=N.+Houstonauthor=N.+Takebeauthor=R.+J.+Kindersauthor=L.+Caoauthor=C.+J.+Peerauthor=W.+D.+Figgauthor=C.+M.+Annunziata&title=Pharmacodynamic+markers+and+clinical+results+from+the+phase+2+study+of+the+SMAC+mimetic+birinapant+in+women+with+relapsed+platinum-resistant+or+-refractory+epithelial+ovarian+cancer&doi=10.1002%2Fcncr.29783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer</span></div><div class="casAuthors">Noonan, Anne M.; Bunch, Kristen P.; Chen, Jin-Qiu; Herrmann, Michelle A.; Lee, Jung-Min; Kohn, Elise C.; O'Sullivan, Ciara C.; Jordan, Elizabeth; Houston, Nicole; Takebe, Naoko; Kinders, Robert J.; Cao, Liang; Peer, Cody J.; Figg, W. Douglas; Annunziata, Christina M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">588-597</span>CODEN:
                <span class="NLM_cas:coden">CANCAR</span>;
        ISSN:<span class="NLM_cas:issn">0008-543X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">BACKGROUND : Inhibitors of apoptosis proteins (IAPs) are key regulators of apoptosis and are frequently dysregulated in ovarian cancer.  It was hypothesized that blocking IAPs with birinapant would increase tumor cell death and result in objective responses for women with platinum-refractory and -resistant ovarian cancer.  METHODS : In this phase 2, Cancer Therapy Evaluation Program-sponsored study, patients received birinapant at 47 mg/m2 on days 1, 8, and 15 of 28-day cycles.  Pharmacokinetics were obtained during cycle 1.  Plasma, peripheral blood mononuclear cells (PBMCs), and percutaneous tumor biopsy samples were collected before cycle 1 and after 6 wk.  The primary endpoint was an objective response or progression-free survival lasting greater than 6 mo in a mini-max design.  RESULTS : Eleven patients received birinapant; after this, accrual was terminated for lack of a clin. benefit.  Birinapant was well tolerated, with predominantly grade 2 adverse events and 1 case of grade 3 lymphopenia.  Pretreatment biopsy samples and PBMCs were collected; paired posttreatment biopsy samples and PBMCs were collected from 7 and 10 patients, resp.  There was consistent downregulation of cellular inhibitor of apoptosis protein 1 in tumors (P = .016) and PBMCs (P < .01).  Procaspase 3 also decreased in tumors (P = .031) and PBMCs (P < .01); cleaved caspase 3 colocalized with H2A histone family member X (γ-H2AX) in tumors after birinapant exposure.  Peripheral T and B cells decreased significantly after treatment, but natural killer cells did not (P = .04, P = .05, and P = .43, resp.).  CONCLUSIONS : Birinapant shows consistent target suppression in vivo without single-agent antitumor activity in this small population.  Single-agent pharmacodynamics are necessary to understand the drug's mechanism of action and set the stage for rational combination therapy.  Preclin. studies are ongoing to identify optimal synergistic combinations for future clin. trials.  Cancer 2016;122:588-597. © 2015 American Cancer Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHWiFa-PLcgbVg90H21EOLACvtfcHk0lhF0B8Lp5xvdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitF2kurg%253D&md5=2fa896daa52417c39dcda0e3b6d5aeed</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fcncr.29783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcncr.29783%26sid%3Dliteratum%253Aachs%26aulast%3DNoonan%26aufirst%3DA.%2BM.%26aulast%3DBunch%26aufirst%3DK.%2BP.%26aulast%3DChen%26aufirst%3DJ.%2BQ.%26aulast%3DHerrmann%26aufirst%3DM.%2BA.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DKohn%26aufirst%3DE.%2BC.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DC.%2BC.%26aulast%3DJordan%26aufirst%3DE.%26aulast%3DHouston%26aufirst%3DN.%26aulast%3DTakebe%26aufirst%3DN.%26aulast%3DKinders%26aufirst%3DR.%2BJ.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DPeer%26aufirst%3DC.%2BJ.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DAnnunziata%26aufirst%3DC.%2BM.%26atitle%3DPharmacodynamic%2520markers%2520and%2520clinical%2520results%2520from%2520the%2520phase%25202%2520study%2520of%2520the%2520SMAC%2520mimetic%2520birinapant%2520in%2520women%2520with%2520relapsed%2520platinum-resistant%2520or%2520-refractory%2520epithelial%2520ovarian%2520cancer%26jtitle%3DCancer%26date%3D2016%26volume%3D122%26spage%3D588%26epage%3D597%26doi%3D10.1002%2Fcncr.29783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Q. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Y. X.</span></span> <span> </span><span class="NLM_article-title">A novel SMAC mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.canlet.2016.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27424523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFyms7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2016&pages=14-22&author=N.+Liauthor=L.+Fengauthor=H.+Q.+Hanauthor=J.+Yuanauthor=X.+K.+Qiauthor=Y.+F.+Lianauthor=B.+H.+Kuangauthor=Y.+C.+Zhangauthor=C.+C.+Dengauthor=H.+J.+Zhangauthor=Y.+Y.+Yaoauthor=M.+Xuauthor=G.+P.+Heauthor=B.+C.+Zhaoauthor=L.+Gaoauthor=Q.+S.+Fengauthor=L.+Z.+Chenauthor=L.+Yangauthor=D.+Yangauthor=Y.+X.+Zeng&title=A+novel+SMAC+mimetic+APG-1387+demonstrates+potent+antitumor+activity+in+nasopharyngeal+carcinoma+cells+by+inducing+apoptosis&doi=10.1016%2Fj.canlet.2016.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis</span></div><div class="casAuthors">Li, Ning; Feng, Lin; Han, Hui-Qiong; Yuan, Jing; Qi, Xue-Kang; Lian, Yi-Fan; Kuang, Bo-Hua; Zhang, Yu-Chen; Deng, Cheng-Cheng; Zhang, Hao-Jiong; Yao, You-Yuan; Xu, Miao; He, Gui-Ping; Zhao, Bing-Chun; Gao, Ling; Feng, Qi-Sheng; Chen, Li-Zhen; Yang, Lu; Yang, Dajun; Zeng, Yi-Xin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-22</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Despite advances in the development of radiation against nasopharyngeal carcinoma (NPC), the management of advanced NPC remains a challenge.  Smac mimetics are designed to neutralize inhibitor of apoptosis (IAP) proteins, thus reactivating the apoptotic program in cancer cells.  In this study, we investigated the effect of a novel bivalent Smac mimetic APG-1387 in NPC.  In vitro, APG-1387 in combination with TNF-α potently decreased NPC cell viability by inducing apoptosis in majority of NPC cell lines.  The in vitro antitumor effect was RIPK1-dependent, whereas it was independent on IAPs, USP11, or EBV.  Of note, the inhibition of NF-κB or AKT pathway rendered resistant NPC cells responsive to the treatment of APG-1387/TNF-α.  In vivo, APG-1387 displayed antitumor activity as a single agent at well-tolerated doses, even in an in vitro resistant cell line.  In summary, our results demonstrate that APG-1387 exerts a potent antitumor effect on NPC.  These findings support clin. evaluation of APG-1387 as a potential treatment for advanced NPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxgw98S18Ux7Vg90H21EOLACvtfcHk0lhF0B8Lp5xvdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFyms7zJ&md5=06a99be3d888ddacea48da463055e625</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DH.%2BQ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DQi%26aufirst%3DX.%2BK.%26aulast%3DLian%26aufirst%3DY.%2BF.%26aulast%3DKuang%26aufirst%3DB.%2BH.%26aulast%3DZhang%26aufirst%3DY.%2BC.%26aulast%3DDeng%26aufirst%3DC.%2BC.%26aulast%3DZhang%26aufirst%3DH.%2BJ.%26aulast%3DYao%26aufirst%3DY.%2BY.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DG.%2BP.%26aulast%3DZhao%26aufirst%3DB.%2BC.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DQ.%2BS.%26aulast%3DChen%26aufirst%3DL.%2BZ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DZeng%26aufirst%3DY.%2BX.%26atitle%3DA%2520novel%2520SMAC%2520mimetic%2520APG-1387%2520demonstrates%2520potent%2520antitumor%2520activity%2520in%2520nasopharyngeal%2520carcinoma%2520cells%2520by%2520inducing%2520apoptosis%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D381%26spage%3D14%26epage%3D22%26doi%3D10.1016%2Fj.canlet.2016.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D. J.</span></span> <span> </span><span class="NLM_article-title">A novel SMAC mimetic APG-1387 exhibits dual antitumor effect on HBV-positive hepatocellular carcinoma with high expression of cIAP2 by inducing apoptosis and enhancing innate anti-tumor immunity</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2018.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.bcp.2018.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=29679556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotlGjsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2018&pages=127-135&author=W.+Panauthor=Q.+Luoauthor=X.+Yanauthor=L.+Yuanauthor=H.+Yiauthor=L.+Zhangauthor=B.+Liauthor=Y.+Zhangauthor=J.+Sunauthor=M.+Z.+Qiuauthor=D.+J.+Yang&title=A+novel+SMAC+mimetic+APG-1387+exhibits+dual+antitumor+effect+on+HBV-positive+hepatocellular+carcinoma+with+high+expression+of+cIAP2+by+inducing+apoptosis+and+enhancing+innate+anti-tumor+immunity&doi=10.1016%2Fj.bcp.2018.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">A novel SMAC mimetic APG-1387 exhibits dual antitumor effect on HBV-positive hepatocellular carcinoma with high expression of cIAP2 by inducing apoptosis and enhancing innate anti-tumor immunity</span></div><div class="casAuthors">Pan, Wentao; Luo, Qiuyun; Yan, Xianglei; Yuan, Luping; Yi, Hanjie; Zhang, Lin; Li, Baoxia; Zhang, Yuxin; Sun, Jian; Qiu, Miao-Zhen; Yang, Da-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-135</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Check point inhibitor anti-PD1 antibody produced some efficacy in Hepatocellular Carcinoma (HCC) patients previously treated with sorafenib.  Unfortunately, HCC patients with hepatitis B virus (HBV) infection did not respond as well as uninfected patients.  Previously, Second mitochondria-derived activator of caspases (SMAC) mimetics-the antagonist for inhibitor of apoptosis proteins (IAPs) can rapidly reduce serum hepatitis B virus DNA in animal model.  APG-1387 is a novel SMAC-mimetic, small mol. inhibitor targeting inhibitor of apoptosis proteins (IAPs).  In our study, firstly, we found that HCC patients with copy no. alteration of cIAP1, cIAP2, and XIAP had a dismal prognosis.  Then, we discovered that APG-1387 alone could induce apoptosis of PLC/PRF/5 which was HBV pos. both in-vitro and in-vivo.  Furthermore, we found that APG-1387 significantly up-regulated the expression of calreticulin and HLA-DR in PLC/PRF/5 via activating non-classic NF-κB pathway.  Also, compared to vehicle group, APG-1387 increased NK cell counts by 5 folds in PLC/PRF/5 xenograft model.  In-vitro, APG-1387 pos. regulated T cells by reducing Treg differentiation and down-regulating PD1 expression in CD4 T cell.  Moreover, APG-1387 had no impact on memory T cells.  Consequently, our results suggest that APG1387 could be a good candidate to combine with anti-PD1 antibody treatment to overcome low responds of check point inhibitors in HBV pos. HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdnVcQu-xYbbVg90H21EOLACvtfcHk0lhF0B8Lp5xvdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotlGjsLk%253D&md5=0f3fa0b8ddaa67243bb3b0c8be88b7f7</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2018.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2018.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DM.%2BZ.%26aulast%3DYang%26aufirst%3DD.%2BJ.%26atitle%3DA%2520novel%2520SMAC%2520mimetic%2520APG-1387%2520exhibits%2520dual%2520antitumor%2520effect%2520on%2520HBV-positive%2520hepatocellular%2520carcinoma%2520with%2520high%2520expression%2520of%2520cIAP2%2520by%2520inducing%2520apoptosis%2520and%2520enhancing%2520innate%2520anti-tumor%2520immunity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D154%26spage%3D127%26epage%3D135%26doi%3D10.1016%2Fj.bcp.2018.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sikic, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallant, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camidge, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colevas, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messersmith, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakelee, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminker, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J. R.</span></span> <span> </span><span class="NLM_article-title">Safety, pharmacokinetics (PK), and pharmacodynamics (PD) of HGS1029, an inhibitor of apoptosis protein (IAP) inhibitor, in patients (Pts) with advanced solid tumors: Results of a phase I study</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">3008</span>– <span class="NLM_lpage">3008</span>, <span class="refDoi"> DOI: 10.1200/jco.2011.29.15_suppl.3008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1200%2Fjco.2011.29.15_suppl.3008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21709188" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=3008-3008&author=B.+I.+Sikicauthor=S.+G.+Eckhardtauthor=G.+Gallantauthor=H.+A.+Burrisauthor=D.+R.+Camidgeauthor=A.+D.+Colevasauthor=S.+F.+Jonesauthor=W.+A.+Messersmithauthor=H.+A.+Wakeleeauthor=H.+Liauthor=P.+G.+Kaminkerauthor=S.+Morrisauthor=J.+R.+Infante&title=Safety%2C+pharmacokinetics+%28PK%29%2C+and+pharmacodynamics+%28PD%29+of+HGS1029%2C+an+inhibitor+of+apoptosis+protein+%28IAP%29+inhibitor%2C+in+patients+%28Pts%29+with+advanced+solid+tumors%3A+Results+of+a+phase+I+study&doi=10.1200%2Fjco.2011.29.15_suppl.3008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1200%2Fjco.2011.29.15_suppl.3008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252Fjco.2011.29.15_suppl.3008%26sid%3Dliteratum%253Aachs%26aulast%3DSikic%26aufirst%3DB.%2BI.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DGallant%26aufirst%3DG.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DCamidge%26aufirst%3DD.%2BR.%26aulast%3DColevas%26aufirst%3DA.%2BD.%26aulast%3DJones%26aufirst%3DS.%2BF.%26aulast%3DMessersmith%26aufirst%3DW.%2BA.%26aulast%3DWakelee%26aufirst%3DH.%2BA.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DKaminker%26aufirst%3DP.%2BG.%26aulast%3DMorris%26aufirst%3DS.%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26atitle%3DSafety%252C%2520pharmacokinetics%2520%2528PK%2529%252C%2520and%2520pharmacodynamics%2520%2528PD%2529%2520of%2520HGS1029%252C%2520an%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528IAP%2529%2520inhibitor%252C%2520in%2520patients%2520%2528Pts%2529%2520with%2520advanced%2520solid%2520tumors%253A%2520Results%2520of%2520a%2520phase%2520I%2520study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3D3008%26epage%3D3008%26doi%3D10.1200%2Fjco.2011.29.15_suppl.3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Cytochrome C-mediated apoptosis</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.73.011303.073706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1146%2Fannurev.biochem.73.011303.073706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=15189137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslagsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2004&pages=87-106&author=X.+Jiangauthor=X.+Wang&title=Cytochrome+C-mediated+apoptosis&doi=10.1146%2Fannurev.biochem.73.011303.073706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome C-mediated apoptosis</span></div><div class="casAuthors">Jiang, Xuejun; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-106</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Apoptosis, or programmed cell death, is involved in development, elimination of damaged cells, and maintenance of cell homeostasis.  Deregulation of apoptosis may cause diseases, such as cancers, immune diseases, and neurodegenerative disorders.  Apoptosis is executed by a subfamily of cysteine proteases known as caspases.  In mammalian cells, a major caspase activation pathway is the cytochrome c-initiated pathway.  In this pathway, a variety of apoptotic stimuli cause cytochrome c release from mitochondria, which in turn induces a series of biochem. reactions that result in caspase activation and subsequent cell death.  This review focused on the recent progress in understanding the biochem. mechanisms and regulation of the pathway, the roles of the pathway in physiol. and disease, and their potential therapeutic values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaXd15zPESYLVg90H21EOLACvtfcHk0lgerDLP3FxD0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslagsrY%253D&md5=a8e668a41a4b4d0994a128019967f28d</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.73.011303.073706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.73.011303.073706%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DCytochrome%2520C-mediated%2520apoptosis%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2004%26volume%3D73%26spage%3D87%26epage%3D106%26doi%3D10.1146%2Fannurev.biochem.73.011303.073706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashkenazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Death receptors: signaling and modulation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">1305</span>– <span class="NLM_lpage">1308</span>, <span class="refDoi"> DOI: 10.1126/science.281.5381.1305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1126%2Fscience.281.5381.1305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=9721089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADyaK1cXlvVegsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=1305-1308&author=A.+Ashkenaziauthor=V.+M.+Dixit&title=Death+receptors%3A+signaling+and+modulation&doi=10.1126%2Fscience.281.5381.1305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Death receptors: Signaling and modulation</span></div><div class="casAuthors">Ashkenazi, Avi; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">5381</span>),
    <span class="NLM_cas:pages">1305-1308</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review, with 61 refs.  Apoptosis is a cell suicide mechanism that enables metazoans to control cell no. in tissues and to eliminate individual cells that threaten the animal's survival.  Certain cells have unique sensors, termed death receptors, on their surface.  Death receptors detect the presence of extracellular death signals and, in response, they rapidly ignite the cell's intrinsic apoptosis machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql5qJid4f9QLVg90H21EOLACvtfcHk0lgerDLP3FxD0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvVegsL0%253D&md5=9bd9f0e6b358e7cfa3b509dec7fbbe8f</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1126%2Fscience.281.5381.1305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.281.5381.1305%26sid%3Dliteratum%253Aachs%26aulast%3DAshkenazi%26aufirst%3DA.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DDeath%2520receptors%253A%2520signaling%2520and%2520modulation%26jtitle%3DScience%26date%3D1998%26volume%3D281%26spage%3D1305%26epage%3D1308%26doi%3D10.1126%2Fscience.281.5381.1305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tchoghandjian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennewein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajalingam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Identification of non-canonical NF-kappaB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e564</span> <span class="refDoi"> DOI: 10.1038/cddis.2013.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fcddis.2013.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=23538445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVykur%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&author=A.+Tchoghandjianauthor=C.+Jenneweinauthor=I.+Eckhardtauthor=K.+Rajalingamauthor=S.+Fulda&title=Identification+of+non-canonical+NF-kappaB+signaling+as+a+critical+mediator+of+Smac+mimetic-stimulated+migration+and+invasion+of+glioblastoma+cells&doi=10.1038%2Fcddis.2013.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells</span></div><div class="casAuthors">Tchoghandjian, A.; Jennewein, C.; Eckhardt, I.; Rajalingam, K.; Fulda, S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">March</span>),
    <span class="NLM_cas:pages">e564</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">As inhibitor of apoptosis (IAP) proteins can regulate addnl. signaling pathways beyond apoptosis, we investigated the effect of the second mitochondrial activator of caspases (Smac) mimetic BV6, which antagonizes IAP proteins, on non-apoptotic functions in glioblastoma (GBM).  Here, we identify non-canonical nuclear factor-κB (NF-κB) signaling and a tumor necrosis factor-α (TNFα)/TNF receptor 1 (TNFR1) autocrine/paracrine loop as crit. mediators of BV6-stimulated migration and invasion of GBM cells.  In addn. to GBM cell lines, BV6 triggers cell elongation, migration and invasion in primary, patient-derived GBM cells at non-toxic concns., which do not affect cell viability or proliferation, and also increases infiltrative tumor growth in vivo underscoring the relevance of these findings.  Mol. studies reveal that BV6 causes rapid degrdn. of cellular IAP proteins, accumulation of NIK, processing of p100 to p52, translocation of p52 into the nucleus, increased NF-κB DNA binding and enhanced NF-κB transcriptional activity.  Electrophoretic mobility shift assay supershift shows that the NF-κB DNA-binding subunits consist of p50, p52 and RelB further confirming the activation of the non-canonical NF-κB pathway.  BV6-stimulated NF-κB activation leads to elevated mRNA levels of TNFα and addnl. NF-κB target genes involved in migration (i.e., interleukin 8, monocyte chemoattractant protein 1, CXC chemokine receptor 4) and invasion (i.e., matrix metalloproteinase-9).  Importantly, inhibition of NF-κB by overexpression of dominant-neg. IκBα superrepressor prevents the BV6-stimulated cell elongation, migration and invasion.  Similarly, specific inhibition of non-canonical NF-κB signaling by RNA interference-mediated silencing of NIK suppresses the BV6-induced cell elongation, migration and invasion as well as upregulation of NF-κB target genes.  Intriguingly, pharmacol. or genetic inhibition of the BV6-stimulated TNFα autocrine/paracrine loop by the TNFα-blocking antibody Enbrel or by knockdown of TNFR1 abrogates BV6-induced cell elongation, migration and invasion.  By demonstrating that the Smac mimetic BV6 at non-toxic concns. promotes migration and invasion of GBM cells via non-canonical NF-κB signaling, our findings have important implications for the use of Smac mimetics as cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrnI_do1XXrbVg90H21EOLACvtfcHk0lgerDLP3FxD0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVykur%252FE&md5=76b270768bd9b2f54644cf5482e788d8</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.70%26sid%3Dliteratum%253Aachs%26aulast%3DTchoghandjian%26aufirst%3DA.%26aulast%3DJennewein%26aufirst%3DC.%26aulast%3DEckhardt%26aufirst%3DI.%26aulast%3DRajalingam%26aufirst%3DK.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520non-canonical%2520NF-kappaB%2520signaling%2520as%2520a%2520critical%2520mediator%2520of%2520Smac%2520mimetic-stimulated%2520migration%2520and%2520invasion%2520of%2520glioblastoma%2520cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26doi%3D10.1038%2Fcddis.2013.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarrant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin-Koh, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dybdal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steigerwalt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamounas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amemiya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dambach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span> <span> </span><span class="NLM_article-title">Toxicity profile of small-molecule IAP antagonist GDC-0152 is linked to TNF-alpha pharmacology</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfs265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1093%2Ftoxsci%2Fkfs265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=22956632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFamsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2013&pages=247-258&author=R.+I.+Ericksonauthor=J.+Tarrantauthor=G.+Cainauthor=S.+C.+Lewin-Kohauthor=N.+Dybdalauthor=H.+Wongauthor=E.+Blackwoodauthor=K.+Westauthor=R.+Steigerwaltauthor=M.+Mamounasauthor=J.+A.+Flygareauthor=K.+Amemiyaauthor=D.+Dambachauthor=W.+J.+Fairbrotherauthor=D.+Diaz&title=Toxicity+profile+of+small-molecule+IAP+antagonist+GDC-0152+is+linked+to+TNF-alpha+pharmacology&doi=10.1093%2Ftoxsci%2Fkfs265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity Profile of Small-Molecule IAP Antagonist GDC-0152 Is Linked to TNF-α Pharmacology</span></div><div class="casAuthors">Erickson, Rebecca I.; Tarrant, Jacqueline; Cain, Gary; Lewin-Koh, Sock-Cheng; Dybdal, Noel; Wong, Harvey; Blackwood, Elizabeth; West, Kristina; Steigerwalt, Ronald; Mamounas, Michael; Flygare, John A.; Amemiya, Kenjie; Dambach, Donna; Fairbrother, Wayne J.; Diaz, Dolores</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">247-258</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-0929</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Inhibitor-of-apoptosis (IAP) proteins suppress apoptosis and are overexpressed in a variety of cancers.  Small-mol. IAP antagonists are currently being tested in clin. trials as novel cancer therapeutics.  GDC-0152 is a small-mol. drug that triggers tumor cell apoptosis by selectively antagonizing IAPs.  GDC-0152 induces NF-κB transcriptional activity leading to expression of several chemokines and cytokines, of which tumor necrosis factor alpha (TNF-α) is the most important for single-agent tumor activity.  TNF-α is a pleiotropic cytokine that drives a variety of cellular responses, comprising inflammation, proliferation, and cell survival or death depending on the cellular context.  As malignant and normal cells produce TNF-α upon IAP antagonism, increased TNF-α could drive both efficacy and toxicity.  The toxicity profile of GDC-0152 in dogs and rats was characterized after iv dose administration once every 2 wk for four doses.  Findings in both species consisted of a dose-related, acute, systemic inflammatory response, and hepatic injury.  Lab. findings included elevated plasma cytokines, an inflammatory leukogram, and increased liver transaminases with histopathol. findings of inflammatory infiltrates and apoptosis/necrosis in multiple tissues; a toxicol. profile consistent with TNF-α-mediated toxicity.  Dogs exhibited more severe findings than rats, and humans did not exhibit these findings, at comparable exposures across species.  Furthermore, elevations in blood neutrophil count, serum monocyte chemoattractant protein-1, and other markers of inflammation corresponded to GDC-0152 exposure and toxicity and thus may have utility as safety biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoC4-WYAFUa7Vg90H21EOLACvtfcHk0lgqgGQeRpZwTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFamsg%253D%253D&md5=78209395dfc2e757baf6a3f91c45c4dc</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfs265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfs265%26sid%3Dliteratum%253Aachs%26aulast%3DErickson%26aufirst%3DR.%2BI.%26aulast%3DTarrant%26aufirst%3DJ.%26aulast%3DCain%26aufirst%3DG.%26aulast%3DLewin-Koh%26aufirst%3DS.%2BC.%26aulast%3DDybdal%26aufirst%3DN.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DBlackwood%26aufirst%3DE.%26aulast%3DWest%26aufirst%3DK.%26aulast%3DSteigerwalt%26aufirst%3DR.%26aulast%3DMamounas%26aufirst%3DM.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DAmemiya%26aufirst%3DK.%26aulast%3DDambach%26aufirst%3DD.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DDiaz%26aufirst%3DD.%26atitle%3DToxicity%2520profile%2520of%2520small-molecule%2520IAP%2520antagonist%2520GDC-0152%2520is%2520linked%2520to%2520TNF-alpha%2520pharmacology%26jtitle%3DToxicol.%2520Sci.%26date%3D2013%26volume%3D131%26spage%3D247%26epage%3D258%26doi%3D10.1093%2Ftoxsci%2Fkfs265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vora, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vangveravong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwnica-Worms, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weilbaecher, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faccio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novack, D. V.</span></span> <span> </span><span class="NLM_article-title">Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-12-0271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F2159-8290.CD-12-0271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=23269702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Wktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=212-223&author=C.+Yangauthor=J.+L.+Davisauthor=R.+Zengauthor=P.+Voraauthor=X.+Suauthor=L.+I.+Collinsauthor=S.+Vangveravongauthor=R.+H.+Machauthor=D.+Piwnica-Wormsauthor=K.+N.+Weilbaecherauthor=R.+Faccioauthor=D.+V.+Novack&title=Antagonism+of+inhibitor+of+apoptosis+proteins+increases+bone+metastasis+via+unexpected+osteoclast+activation&doi=10.1158%2F2159-8290.CD-12-0271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of Inhibitor of Apoptosis Proteins Increases Bone Metastasis via Unexpected Osteoclast Activation</span></div><div class="casAuthors">Yang, Chang; Davis, Jennifer L.; Zeng, Rong; Vora, Paras; Su, Xinming; Collins, Lynne I.; Vangveravong, Suwanna; Mach, Robert H.; Piwnica-Worms, David; Weilbaecher, Katherine N.; Faccio, Roberta; Veis Novack, Deborah</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-223</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis (IAP) proteins play a central role in many types of cancer, and IAP antagonists are in development as anticancer agents.  IAP antagonists cause apoptosis in many cells, but they also activate alternative NF-κB signaling through NF-ΚB-inducing kinase (NIK), which regulates osteoclasts.  In bone metastasis, a pos. feedback loop between tumors and osteoclasts promotes tumor growth and osteolysis.  We therefore tested the effect of IAP antagonists on the bone microenvironment for metastasis.  In both drug-sensitive and drug-resistant tumors, growth in bone was favored, as compared with other sites during IAP antagonist treatment.  These drugs also caused osteoporosis and increased osteoclastogenesis, mediated by NIK, and enhanced tumor-assocd. osteolysis.  Cotreatment with zoledronic acid, a potent osteoclast inhibitor, reduced IAP antagonist-enhanced tumor growth in bone and osteolysis.  Thus, IAP antagonist-based cancer treatment may be compromised by osteoporosis and enhanced skeletal metastasis, which may be prevented by antiresorptive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2R6FAPQouhrVg90H21EOLACvtfcHk0lgqgGQeRpZwTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Wktrs%253D&md5=8fcc317509bf6008b705d8b769f1edb7</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-12-0271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-12-0271%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DJ.%2BL.%26aulast%3DZeng%26aufirst%3DR.%26aulast%3DVora%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DCollins%26aufirst%3DL.%2BI.%26aulast%3DVangveravong%26aufirst%3DS.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DPiwnica-Worms%26aufirst%3DD.%26aulast%3DWeilbaecher%26aufirst%3DK.%2BN.%26aulast%3DFaccio%26aufirst%3DR.%26aulast%3DNovack%26aufirst%3DD.%2BV.%26atitle%3DAntagonism%2520of%2520inhibitor%2520of%2520apoptosis%2520proteins%2520increases%2520bone%2520metastasis%2520via%2520unexpected%2520osteoclast%2520activation%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D212%26epage%3D223%26doi%3D10.1158%2F2159-8290.CD-12-0271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalcin-Chin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Autocrine TNFalpha signaling renders human cancer cells susceptible to SMAC-mimetic-induced apoptosis</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">456</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2007.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.ccr.2007.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=17996648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtl2nurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=445-456&author=S.+L.+Petersenauthor=L.+Wangauthor=A.+Yalcin-Chinauthor=L.+Liauthor=M.+Peytonauthor=J.+Minnaauthor=P.+Harranauthor=X.+Wang&title=Autocrine+TNFalpha+signaling+renders+human+cancer+cells+susceptible+to+SMAC-mimetic-induced+apoptosis&doi=10.1016%2Fj.ccr.2007.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Autocrine TNFα signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis</span></div><div class="casAuthors">Petersen, Sean L.; Wang, Lai; Yalcin-Chin, Asligul; Li, Lin; Peyton, Michael; Minna, John; Harran, Patrick; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">445-456</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A small-mol. mimetic of Smac/Diablo that specifically counters the apoptosis-inhibiting activity of IAP proteins has been shown to enhance apoptosis induced by cell surface death receptors as well as chemotherapeutic drugs.  Survey of a panel of 50 human non-small-cell lung cancer cell lines has revealed, surprisingly, that roughly one-quarter of these lines are sensitive to the treatment of Smac mimetic alone, suggesting that an apoptotic signal has been turned on in these cells and is held in check by IAP proteins.  This signal has now been identified as the autocrine-secreted cytokine tumor necrosis factor alpha (TNFα).  In response to autocrine TNFα signaling, the Smac mimetic promotes formation of a RIPK1-dependent caspase-8-activating complex, leading to apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_J544Om3crLVg90H21EOLACvtfcHk0lgqgGQeRpZwTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtl2nurrN&md5=c5bf1e83b408cf61e8413dce35d0cc59</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2007.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2007.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYalcin-Chin%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%26aulast%3DHarran%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DAutocrine%2520TNFalpha%2520signaling%2520renders%2520human%2520cancer%2520cells%2520susceptible%2520to%2520SMAC-mimetic-induced%2520apoptosis%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D445%26epage%3D456%26doi%3D10.1016%2Fj.ccr.2007.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span> <span> </span><span class="NLM_article-title">Targeting IAP proteins for therapeutic intervention in cancer</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1038/nrd3627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnrd3627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=22293567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=109-124&author=S.+Fuldaauthor=D.+Vucic&title=Targeting+IAP+proteins+for+therapeutic+intervention+in+cancer&doi=10.1038%2Fnrd3627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IAP proteins for therapeutic intervention in cancer</span></div><div class="casAuthors">Fulda, Simone; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-124</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Evasion of apoptosis is one of the crucial acquired capabilities used by cancer cells to fend off anticancer therapies.  Inhibitor of apoptosis (IAP) proteins exert a range of biol. activities that promote cancer cell survival and proliferation.  X chromosome-linked IAP is a direct inhibitor of caspases - pro-apoptotic executioner proteases - whereas cellular IAP proteins block the assembly of pro-apoptotic protein signalling complexes and mediate the expression of anti-apoptotic mols.  Furthermore, mutations, amplifications and chromosomal translocations of IAP genes are assocd. with various malignancies.  Among the therapeutic strategies that have been designed to target IAP proteins, the most widely used approach is based on mimicking the IAP-binding motif of second mitochondria-derived activator of caspase (SMAC), which functions as an endogenous IAP antagonist.  Alternative strategies include transcriptional repression and the use of antisense oligonucleotides.  This Review provides an update on IAP protein biol. as well as current and future perspectives on targeting IAP proteins for therapeutic intervention in human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-R51O_sZcdLVg90H21EOLACvtfcHk0lhlyFpn3HO2Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GgsLo%253D&md5=219506817f8526ba0bbd27117ed4f290</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1038%2Fnrd3627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3627%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DTargeting%2520IAP%2520proteins%2520for%2520therapeutic%2520intervention%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D109%26epage%3D124%26doi%3D10.1038%2Fnrd3627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoeneberger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristofanon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanlangenakker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeremias, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1020</span>– <span class="NLM_lpage">1029</span>, <span class="refDoi"> DOI: 10.1038/leu.2011.353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fleu.2011.353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=22173242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADC%252BC38zovFagsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1020-1029&author=S.+Loderauthor=M.+Faklerauthor=H.+Schoenebergerauthor=S.+Cristofanonauthor=J.+Leibacherauthor=N.+Vanlangenakkerauthor=M.+J.+Bertrandauthor=P.+Vandenabeeleauthor=I.+Jeremiasauthor=K.+M.+Debatinauthor=S.+Fulda&title=RIP1+is+required+for+IAP+inhibitor-mediated+sensitization+of+childhood+acute+leukemia+cells+to+chemotherapy-induced+apoptosis&doi=10.1038%2Fleu.2011.353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis</span></div><div class="casAuthors">Loder S; Fakler M; Schoeneberger H; Cristofanon S; Leibacher J; Vanlangenakker N; Bertrand M J M; Vandenabeele P; Jeremias I; Debatin K-M; Fulda S</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1020-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Evasion of apoptosis may contribute to poor treatment response in pediatric acute lymphoblastic leukemia (ALL), calling for novel treatment strategies.  Here, we report that inhibitors of apoptosis (IAPs) at subtoxic concentrations cooperate with various anticancer drugs (that is, AraC, Gemcitabine, Cyclophosphamide, Doxorubicin, Etoposide, Vincristine and Taxol) to induce apoptosis in ALL cells in a synergistic manner as calculated by combination index and to reduce long-term clonogenic survival.  Importantly, we identify RIP1 as a critical regulator of this synergism of IAP inhibitors and AraC that mediates the formation of a RIP1/FADD/caspase-8 complex via an autocrine/paracrine loop of tumor necrosis factor-α (TNFα).  Knockdown of RIP1 abolishes formation of this complex and subsequent activation of caspase-8 and -3, mitochondrial perturbations and apoptosis.  Similarly, inhibition of RIP1 kinase activity by Necrostatin-1 or blockage of TNFα by Enbrel inhibits IAP inhibitor- and AraC-triggered interaction of RIP1, FADD and caspase-8 and apoptosis.  In contrast to malignant cells, IAP inhibitors and AraC at equimolar concentrations are non-toxic to normal peripheral blood lymphocytes or mesenchymal stromal cells.  Thus, our findings provide first evidence that IAP inhibitors present a promising strategy to prime childhood ALL cells for chemotherapy-induced apoptosis in a RIP1-dependent manner.  These data have important implications for developing apoptosis-targeted therapies in childhood leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTa70MZXGWiVYqdXsLcGTEUfW6udTcc2ebtcgytIq5FUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zovFagsg%253D%253D&md5=04c10a36ff79b391c2ac597725b2fc67</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1038%2Fleu.2011.353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2011.353%26sid%3Dliteratum%253Aachs%26aulast%3DLoder%26aufirst%3DS.%26aulast%3DFakler%26aufirst%3DM.%26aulast%3DSchoeneberger%26aufirst%3DH.%26aulast%3DCristofanon%26aufirst%3DS.%26aulast%3DLeibacher%26aufirst%3DJ.%26aulast%3DVanlangenakker%26aufirst%3DN.%26aulast%3DBertrand%26aufirst%3DM.%2BJ.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DJeremias%26aufirst%3DI.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DRIP1%2520is%2520required%2520for%2520IAP%2520inhibitor-mediated%2520sensitization%2520of%2520childhood%2520acute%2520leukemia%2520cells%2520to%2520chemotherapy-induced%2520apoptosis%26jtitle%3DLeukemia%26date%3D2012%26volume%3D26%26spage%3D1020%26epage%3D1029%26doi%3D10.1038%2Fleu.2011.353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Probst, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetics increase cancer cell response to chemotherapeutics in a TNF-alpha-dependent manner</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1645</span>– <span class="NLM_lpage">1654</span>, <span class="refDoi"> DOI: 10.1038/cdd.2010.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fcdd.2010.44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=20431601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFChsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1645-1654&author=B.+L.+Probstauthor=L.+Liuauthor=V.+Rameshauthor=L.+Liauthor=H.+Sunauthor=J.+D.+Minnaauthor=L.+Wang&title=SMAC+mimetics+increase+cancer+cell+response+to+chemotherapeutics+in+a+TNF-alpha-dependent+manner&doi=10.1038%2Fcdd.2010.44"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent manner</span></div><div class="casAuthors">Probst, B. L.; Liu, L.; Ramesh, V.; Li, L.; Sun, H.; Minna, J. D.; Wang, L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1645-1654</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Second mitochondria-derived activator of caspase (Smac) is a mitochondrial protein released into the cytosol during apoptosis.  Smac mimetics have recently been touted as a novel therapeutic to induce apoptosis in cancer cells.  The ability of Smac mimetics to induce apoptosis in vitro has been shown to be dependent upon both XIAP neutralization and cancer cell autocrine tumor necrosis factor-α (TNF-α) prodn.  In this study we provide new evidence for the utility of Smac mimetics in combination with conventional chemotherapy agents to exacerbate caspase activation and induce cancer cell death.  Furthermore, we find that the combination effect is because of a multifaceted mechanism involving both inhibition of cell proliferation by the chemotherapy agents and an enhanced autocrine TNF-α feedback loop by the Smac mimetic/chemotherapy agent combination.  Surprisingly, although genotoxic agents typically induce apoptosis through the mitochondrial intrinsic pathway, we show that this synergism is mediated through a TNF-α/RIP1-dependent pathway, leading to activation of the extrinsic apoptotic pathway.  Finally, we report that autocrine TNF-α contributes to Smac mimetic-induced tumor regression as a single agent or in combination with chemotherapeutics in xenograft mouse models.  Collectively, we provide mechanistic and applicable data to support translational studies in the use of a Smac mimetic/chemotherapy antineoplasm modality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTaxGVjKencLVg90H21EOLACvtfcHk0lhlyFpn3HO2Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFChsLnO&md5=10924e8e08d725d40270cd663cbcc744</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2010.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2010.44%26sid%3Dliteratum%253Aachs%26aulast%3DProbst%26aufirst%3DB.%2BL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DRamesh%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DWang%26aufirst%3DL.%26atitle%3DSMAC%2520mimetics%2520increase%2520cancer%2520cell%2520response%2520to%2520chemotherapeutics%2520in%2520a%2520TNF-alpha-dependent%2520manner%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2010%26volume%3D17%26spage%3D1645%26epage%3D1654%26doi%3D10.1038%2Fcdd.2010.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fandy, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, R. K.</span></span> <span> </span><span class="NLM_article-title">SMAC/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">60</span>, <span class="refDoi"> DOI: 10.1186/1476-4598-7-60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1186%2F1476-4598-7-60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18590557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADC%252BD1cvlsFWrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=60&author=T.+E.+Fandyauthor=S.+Shankarauthor=R.+K.+Srivastava&title=SMAC%2FDIABLO+enhances+the+therapeutic+potential+of+chemotherapeutic+drugs+and+irradiation%2C+and+sensitizes+TRAIL-resistant+breast+cancer+cells&doi=10.1186%2F1476-4598-7-60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells</span></div><div class="casAuthors">Fandy Tamer E; Shankar Sharmila; Srivastava Rakesh K</div><div class="citationInfo"><span class="NLM_cas:title">Molecular cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Drug resistance is a major concern in cancer therapy.  Here, we investigate the clinical potential of the second mitochondria-derived activator of caspase (Smac/DIABLO) in enhancing the apoptosis-inducing potential of commonly used anticancer drugs (paclitaxel, doxorubicin, etoposide, tamoxifen), irradiation and TRAIL in breast carcinoma.  METHODS:  Breast cancer cells were overexpressed with Smac/DIABLO gene (full-length or Delta55 Smac/DIABLO) or treated with Smac/DIABLO peptide to enhance the apoptosis-inducing potential of chemotherapeutic drugs and irradiation, and sensitize TRAIL-resistant cells.  Cell viability and apoptosis were measured by XTT assay and DAPI staining, respectively.  Protein-protein interaction was determined by immunoprecipitation followed by the Western blot analysis.  RESULTS:  Overexpression of Smac/DIABLO gene (full-length or Delta55 Smac/DIABLO) or treatment with Smac/DIABLO peptide enhances apoptosis induced by paclitaxel, doxorubicin, etoposide, tamoxifen, and irradiation in breast cancer cells.  Overexpression of Smac/DIABLO resulted in an increased interaction of Smac/DIABLO with IAPs, which correlated with an increase in caspase-3 activity and apoptosis.  Furthermore, Smac/DIABLO sensitized TRAIL-resistant breast cancer cell lines to undergo apoptosis through caspase-3 activation.  These data suggest that apoptotic events down-stream of mitochondria were intact in TRAIL-resistant cells since ectopic expression of Smac/DIABLO or pretreatment of cells with Smac/DIABLO peptide completely restored TRAIL sensitivity.  CONCLUSION:  The ability of Smac/DIABLO agonists to enhance the apoptosis-inducing potential of chemotherapeutic drugs and irradiation, and sensitize TRAIL-resistant tumor cells suggests that Smac/DIABLO may induce fundamental alterations in cell signaling pathways.  Thus, Smac/DIABLO agonists can be used as promising new candidates for cancer treatment by potentiating cytotoxic therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVDgSbnz1HggHqQV89nF-2fW6udTcc2eYxbBNGGI7S07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvlsFWrtg%253D%253D&md5=e64d7666130d6893668b449fc085d8fb</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-7-60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-7-60%26sid%3Dliteratum%253Aachs%26aulast%3DFandy%26aufirst%3DT.%2BE.%26aulast%3DShankar%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DR.%2BK.%26atitle%3DSMAC%252FDIABLO%2520enhances%2520the%2520therapeutic%2520potential%2520of%2520chemotherapeutic%2520drugs%2520and%2520irradiation%252C%2520and%2520sensitizes%2520TRAIL-resistant%2520breast%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%26date%3D2008%26volume%3D7%26spage%3D60%26doi%3D10.1186%2F1476-4598-7-60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terragni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffer, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tullai, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, G. M.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factors</span>. <i>BMC Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">6</span>, <span class="refDoi"> DOI: 10.1186/1471-2121-9-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1186%2F1471-2121-9-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18226221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADC%252BD1c3gslentQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=6&author=J.+Terragniauthor=J.+R.+Grahamauthor=K.+W.+Adamsauthor=M.+E.+Schafferauthor=J.+W.+Tullaiauthor=G.+M.+Cooper&title=Phosphatidylinositol+3-kinase+signaling+in+proliferating+cells+maintains+an+anti-apoptotic+transcriptional+program+mediated+by+inhibition+of+FOXO+and+non-canonical+activation+of+NFkappaB+transcription+factors&doi=10.1186%2F1471-2121-9-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factors</span></div><div class="casAuthors">Terragni Jolyon; Graham Julie R; Adams Kenneth W; Schaffer Michael E; Tullai John W; Cooper Geoffrey M</div><div class="citationInfo"><span class="NLM_cas:title">BMC cell biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Phosphatidylinositol (PI) 3-kinase is activated by a variety of growth factor receptors and the PI 3-kinase/Akt signaling pathway is a key regulator of cell proliferation and survival.  The downstream targets of PI 3-kinase/Akt signaling include direct regulators of cell cycle progression and apoptosis as well as a number of transcription factors.  Growth factor stimulation of quiescent cells leads to robust activation of PI 3-kinase, induction of immediate-early genes, and re-entry into the cell cycle.  A lower level of PI 3-kinase signaling is also required for the proliferation and survival of cells maintained in the presence of growth factors, but the gene expression program controlled by PI 3-kinase signaling in proliferating cells has not been elucidated.  RESULTS:  We used microarray analyses to characterize the changes in gene expression resulting from inhibition of PI 3-kinase in proliferating cells.  The genes regulated by inhibition of PI 3-kinase in proliferating cells were distinct from genes induced by growth factor stimulation of quiescent cells and highly enriched in genes that regulate programmed cell death.  Computational analyses followed by chromatin immunoprecipitations demonstrated FOXO binding to both previously known and novel sites in promoter regions of approximately one-third of the up-regulated genes, consistent with activation of FOXO1 and FOXO3a in response to inhibition of PI 3-kinase.  NFkappaB binding sites were similarly identified in promoter regions of over one-third of the down-regulated genes.  RelB was constitutively bound to promoter regions in cells maintained in serum, however binding decreased following PI 3-kinase inhibition, indicating that PI 3-kinase signaling activates NFkappaB via the non-canonical pathway in proliferating cells.  Approximately 70% of the genes targeted by FOXO and NFkappaB regulate cell proliferation and apoptosis, including several regulators of apoptosis that were not previously known to be targeted by these transcription factors.  CONCLUSION:  PI 3-kinase signaling in proliferating cells regulates a novel transcriptional program that is highly enriched in genes that regulate apoptosis.  At least one-third of these genes are regulated either by FOXO transcription factors, which are activated following PI 3-kinase inhibition, or by RelB, which is activated by PI 3-kinase via the non-canonical pathway in proliferating cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkhXGPmX20psyail4HZd-ifW6udTcc2eYxbBNGGI7S07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3gslentQ%253D%253D&md5=342cfd9cf9842f1316eb89d642cf3d05</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1186%2F1471-2121-9-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2121-9-6%26sid%3Dliteratum%253Aachs%26aulast%3DTerragni%26aufirst%3DJ.%26aulast%3DGraham%26aufirst%3DJ.%2BR.%26aulast%3DAdams%26aufirst%3DK.%2BW.%26aulast%3DSchaffer%26aufirst%3DM.%2BE.%26aulast%3DTullai%26aufirst%3DJ.%2BW.%26aulast%3DCooper%26aufirst%3DG.%2BM.%26atitle%3DPhosphatidylinositol%25203-kinase%2520signaling%2520in%2520proliferating%2520cells%2520maintains%2520an%2520anti-apoptotic%2520transcriptional%2520program%2520mediated%2520by%2520inhibition%2520of%2520FOXO%2520and%2520non-canonical%2520activation%2520of%2520NFkappaB%2520transcription%2520factors%26jtitle%3DBMC%2520Cell%2520Biol.%26date%3D2008%26volume%3D9%26spage%3D6%26doi%3D10.1186%2F1471-2121-9-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seol, D. W.</span></span> <span> </span><span class="NLM_article-title">Up-regulation of IAPs by PI-3K: a cell survival signal-mediated anti-apoptotic mechanism</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>377</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2008.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.bbrc.2008.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18929542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlykt7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2008&pages=508-511&author=D.+W.+Seol&title=Up-regulation+of+IAPs+by+PI-3K%3A+a+cell+survival+signal-mediated+anti-apoptotic+mechanism&doi=10.1016%2Fj.bbrc.2008.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of IAPs by PI-3K: A cell survival signal-mediated anti-apoptotic mechanism</span></div><div class="casAuthors">Seol, Dai-Wu</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">508-511</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Under normal cell physiol., a balance between cell survival and apoptosis is crucial for homeostasis.  Many studies have demonstrated that apoptosis is modulated by cell survival stimuli.  Active Akt, a common mediator of cell survival signals, has been shown to inhibit apoptosis by attenuating activity of pro-apoptotic factors Bad and caspase-9.  However, the anti-apoptotic mechanisms mediated by various cell survival signals are poorly understood.  Human prostate cancer LNCaP cells, known to contain constitutively activated Akt as a result of a frame-shift mutation in PTEN, an inhibitor of PI-3K/Akt pathway, were obsd. to be completely resistant to TRAIL-induced apoptosis.  In agreement with the known action of Akt, blockade of the PI-3K/Akt pathway rendered LNCaP cells highly susceptible to TRAIL.  Importantly, active PI-3K/Akt prevented processing/activation of caspase-3, a phenomenon assocd. with the function of inhibitor of apoptosis proteins (IAPs).  In fact, inhibition of PI-3K activity using Wortmannin significantly decreased the protein levels of IAPs, concomitantly promoting processing/activation of caspase-3 and TRAIL-induced apoptosis.  My data indicate that in addn. to blocking Bad and caspase-9 through Akt, PI-3K also inhibits caspase-3 through up-regulating IAPs, thereby attenuates apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoasoEra137nLVg90H21EOLACvtfcHk0li7N-FIPy-4nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlykt7vK&md5=d2e1f79043702e3d66b2a15d3076b0ee</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2008.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2008.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DSeol%26aufirst%3DD.%2BW.%26atitle%3DUp-regulation%2520of%2520IAPs%2520by%2520PI-3K%253A%2520a%2520cell%2520survival%2520signal-mediated%2520anti-apoptotic%2520mechanism%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D377%26spage%3D508%26epage%3D511%26doi%3D10.1016%2Fj.bbrc.2008.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Overcoming cancer cell resistance to SMAC mimetic induced apoptosis by modulating cIAP-2 expression</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">11936</span>– <span class="NLM_lpage">11941</span>, <span class="refDoi"> DOI: 10.1073/pnas.1005667107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1073%2Fpnas.1005667107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=20547836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVartLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=11936-11941&author=S.+L.+Petersenauthor=M.+Peytonauthor=J.+D.+Minnaauthor=X.+Wang&title=Overcoming+cancer+cell+resistance+to+SMAC+mimetic+induced+apoptosis+by+modulating+cIAP-2+expression&doi=10.1073%2Fpnas.1005667107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression</span></div><div class="casAuthors">Petersen, Sean L.; Peyton, Michael; Minna, John D.; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">11936-11941, S11936/1-S11936/3</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Smac mimetics target cancer cells in a TNFα-dependent manner, partly via proteasome degrdn. of cellular inhibitor of apoptosis 1 (cIAP1) and cIAP2.  Degrdn. of cIAPs triggers the release of receptor interacting protein kinase (RIPK1) from TNF receptor 1 (TNFR1) to form a caspase-8 activating complex together with the adaptor protein Fas-assocd. death domain (FADD).  We report here a means through which cancer cells mediate resistance to Smac mimetic/TNFα-induced apoptosis and corresponding strategies to overcome such resistance.  These human cancer cell lines evades Smac mimetic-induced apoptosis by up-regulation of cIAP2, which although initially degraded, rebounds and is refractory to subsequent degrdn. clAP2 is induced by TNFa via NF-κB and modulation of the NF-κB signal renders otherwise resistant cells sensitive to Smac mimetics.  In addn., other signaling pathways, including phosphatidyl inositol-3 kinase (PI3K), have the potential to concurrently regulate cIAP2.  Using the P13K inhibitor, LY294002, dAP2 up-regulation was suppressed and resistance to Smac mimetics-induced apoptosis was also overcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp5NQOxkS-wLVg90H21EOLACvtfcHk0lhUZTbhRxo7xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVartLg%253D&md5=278c84b651abd7af0357a7023977d54b</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1005667107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1005667107%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DS.%2BL.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DOvercoming%2520cancer%2520cell%2520resistance%2520to%2520SMAC%2520mimetic%2520induced%2520apoptosis%2520by%2520modulating%2520cIAP-2%2520expression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D11936%26epage%3D11941%26doi%3D10.1073%2Fpnas.1005667107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stirewalt, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radich, J. P.</span></span> <span> </span><span class="NLM_article-title">The role of FLT3 in haematopoietic malignancies</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">665</span>, <span class="refDoi"> DOI: 10.1038/nrc1169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnrc1169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=12951584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVWlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=650-665&author=D.+L.+Stirewaltauthor=J.+P.+Radich&title=The+role+of+FLT3+in+haematopoietic+malignancies&doi=10.1038%2Fnrc1169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">The role of FLT3 in hematopoietic malignancies</span></div><div class="casAuthors">Stirewalt, Derek L.; Radich, Jerald P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">650-665</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Normal haematopoietic cells use complex systems to control proliferation, differentiation and cell death.  The control of proliferation is, in part, accomplished through the ligand-induced stimulation of receptor tyrosine kinases, which signal to downstream effectors through the RAS pathway.  Recently, mutations in the FMS-like tyrosine kinase 3 (FLT3) gene, which encodes a receptor tyrosine kinase, have been found to be the most common genetic lesion in acute myeloid leukemia (AML), occurring in ∼25% of cases.  Exploring the mechanism by which these FLT3 mutations cause uncontrolled proliferation might lead to a better understanding of how cells become cancerous and provide insights for the development of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRONPQkpemorVg90H21EOLACvtfcHk0lhUZTbhRxo7xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVWlu7c%253D&md5=97183b7a6087fafe20bfc695f403825b</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1038%2Fnrc1169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1169%26sid%3Dliteratum%253Aachs%26aulast%3DStirewalt%26aufirst%3DD.%2BL.%26aulast%3DRadich%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520role%2520of%2520FLT3%2520in%2520haematopoietic%2520malignancies%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D650%26epage%3D665%26doi%3D10.1038%2Fnrc1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weisberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cools, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsiades, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMillin, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall-Meyers, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, J. D.</span></span> <span> </span><span class="NLM_article-title">Potentiation of antileukemic therapies by SMAC mimetic, LBW242: effects on mutant FLT3-expressing cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1951</span>– <span class="NLM_lpage">1961</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-06-0810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1535-7163.MCT-06-0810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=17620426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsV2jsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1951-1961&author=E.+Weisbergauthor=A.+L.+Kungauthor=R.+D.+Wrightauthor=D.+Morenoauthor=L.+Catleyauthor=A.+Rayauthor=L.+Zawelauthor=M.+Tranauthor=J.+Coolsauthor=G.+Gillilandauthor=C.+Mitsiadesauthor=D.+W.+McMillinauthor=J.+Jiangauthor=E.+Hall-Meyersauthor=J.+D.+Griffin&title=Potentiation+of+antileukemic+therapies+by+SMAC+mimetic%2C+LBW242%3A+effects+on+mutant+FLT3-expressing+cells&doi=10.1158%2F1535-7163.MCT-06-0810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells</span></div><div class="casAuthors">Weisberg, Ellen; Kung, Andrew L.; Wright, Renee D.; Moreno, Daisy; Catley, Laurie; Ray, Arghya; Zawel, Leigh; Tran, Mary; Cools, Jan; Gilliland, Gary; Mitsiades, Constantine; McMillin, Douglas W.; Jiang, Jingrui; Hall-Meyers, Elizabeth; Griffin, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1951-1961</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Members of the inhibitor of apoptosis protein (IAP) family play a role in mediating apoptosis.  Studies suggest that these proteins may be a viable target in leukemia because they have been found to be variably expressed in acute leukemias and are assocd. with chemosensitivity, chemoresistance, disease progression, remission, and patient survival.  Another promising therapeutic target, FLT3, is mutated in about one third of acute myelogenous leukemia (AML) patients; promising results have recently been achieved in clin. trials investigating the effects of the protein tyrosine kinase inhibitor PKC412 on AML patients harboring mutations in the FLT3 protein.  Of growing concern, however, is the development of drug resistance resulting from the emergence of point mutations in targeted tyrosine kinases used for treatment of acute leukemia patients.  One approach to overriding resistance is to combine structurally unrelated inhibitors and/or inhibitors of different signaling pathways.  The proapoptotic IAP inhibitor, LBW242, was shown in proliferation studies done in vitro to enhance the killing of PKC412-sensitive and PKC412-resistant cell lines expressing mutant FLT3 when combined with either PKC412 or std. cytotoxic agents (doxorubicin and Ara-c).  In addn., in an in vivo imaging assay using bioluminescence as a measure of tumor burden, a total of 12 male NCr-nude mice were treated for 10 days with p.o. administration of vehicle, LBW242 (50 mg/kg/day), PKC412 (40 mg/kg/day), or a combination of LBW242 and PKC412; the lowest tumor burden was obsd. in the drug combination group.  Finally, the combination of LBW242 and PKC412 was sufficient to override stromal-mediated viability signaling conferring resistance to PKC412.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqob_oR49wsRbVg90H21EOLACvtfcHk0lhUZTbhRxo7xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsV2jsr8%253D&md5=7c4baf35a3a07a29c59fdb18294922af</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0810%26sid%3Dliteratum%253Aachs%26aulast%3DWeisberg%26aufirst%3DE.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DWright%26aufirst%3DR.%2BD.%26aulast%3DMoreno%26aufirst%3DD.%26aulast%3DCatley%26aufirst%3DL.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DZawel%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DM.%26aulast%3DCools%26aufirst%3DJ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DMitsiades%26aufirst%3DC.%26aulast%3DMcMillin%26aufirst%3DD.%2BW.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DHall-Meyers%26aufirst%3DE.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26atitle%3DPotentiation%2520of%2520antileukemic%2520therapies%2520by%2520SMAC%2520mimetic%252C%2520LBW242%253A%2520effects%2520on%2520mutant%2520FLT3-expressing%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1951%26epage%3D1961%26doi%3D10.1158%2F1535-7163.MCT-06-0810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weisberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straub, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazo-Kallanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galinsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, J. D.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetics: implications for enhancement of targeted therapies in leukemia</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2100</span>– <span class="NLM_lpage">2109</span>, <span class="refDoi"> DOI: 10.1038/leu.2010.212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fleu.2010.212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=20844561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FivF2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=2100-2109&author=E.+Weisbergauthor=A.+Rayauthor=R.+Barrettauthor=E.+Nelsonauthor=A.+L.+Christieauthor=D.+Porterauthor=C.+Straubauthor=L.+Zawelauthor=J.+F.+Daleyauthor=S.+Lazo-Kallanianauthor=R.+Stoneauthor=I.+Galinskyauthor=D.+Frankauthor=A.+L.+Kungauthor=J.+D.+Griffin&title=SMAC+mimetics%3A+implications+for+enhancement+of+targeted+therapies+in+leukemia&doi=10.1038%2Fleu.2010.212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Smac mimetics: implications for enhancement of targeted therapies in leukemia</span></div><div class="casAuthors">Weisberg E; Ray A; Barrett R; Nelson E; Christie A L; Porter D; Straub C; Zawel L; Daley J F; Lazo-Kallanian S; Stone R; Galinsky I; Frank D; Kung A L; Griffin J D</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2100-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Drug resistance is a growing concern with clinical use of tyrosine kinase inhibitors.  Utilizing in vitro models of intrinsic drug resistance and stromal-mediated chemoresistance, as well as functional mouse models of progressive and residual disease, we attempted to develop a potential therapeutic approach designed to suppress leukemia recurrence following treatment with selective kinase inhibitors.  The novel IAP inhibitor, LCL161, [corrected] was observed to potentiate the effects of tyrosine kinase inhibition against leukemic disease both in the absence and presence of a stromal-protected [corrected] environment.  LCL161 enhanced the proapoptotic effects of nilotinib and PKC412, against leukemic disease in vitro and potentiated the activity of both kinase inhibitors against leukemic disease in vivo.  In addition, LCL161 synergized in vivo with nilotinib to reduce leukemia burden significantly below the baseline level suppression exhibited by a moderate-to-high dose of nilotinib.  Finally, LCL161 displayed antiproliferative effects against cells characterized by intrinsic resistance to tyrosine kinase inhibitors as a result of expression of point mutations in the protein targets of drug inhibition.  These results support the idea of using IAP inhibitors in conjunction with targeted tyrosine kinase inhibition to override drug resistance and suppress or eradicate residual disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXlc9eyWdycoUSrryheKE6fW6udTcc2eZ6q-RPybgF4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FivF2htA%253D%253D&md5=b0305435b043feacfbe32df84b094ccd</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1038%2Fleu.2010.212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2010.212%26sid%3Dliteratum%253Aachs%26aulast%3DWeisberg%26aufirst%3DE.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DBarrett%26aufirst%3DR.%26aulast%3DNelson%26aufirst%3DE.%26aulast%3DChristie%26aufirst%3DA.%2BL.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DStraub%26aufirst%3DC.%26aulast%3DZawel%26aufirst%3DL.%26aulast%3DDaley%26aufirst%3DJ.%2BF.%26aulast%3DLazo-Kallanian%26aufirst%3DS.%26aulast%3DStone%26aufirst%3DR.%26aulast%3DGalinsky%26aufirst%3DI.%26aulast%3DFrank%26aufirst%3DD.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26atitle%3DSMAC%2520mimetics%253A%2520implications%2520for%2520enhancement%2520of%2520targeted%2520therapies%2520in%2520leukemia%26jtitle%3DLeukemia%26date%3D2010%26volume%3D24%26spage%3D2100%26epage%3D2109%26doi%3D10.1038%2Fleu.2010.212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wick, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span> <span> </span><span class="NLM_article-title">Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">808</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.1038/nm735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnm735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=12118245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls12msbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=808-815&author=S.+Fuldaauthor=W.+Wickauthor=M.+Wellerauthor=K.+M.+Debatin&title=Smac+agonists+sensitize+for+Apo2L%2FTRAIL-+or+anticancer+drug-induced+apoptosis+and+induce+regression+of+malignant+glioma+in+vivo&doi=10.1038%2Fnm735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo</span></div><div class="casAuthors">Fulda, Simone; Wick, Wolfgang; Weller, Michael; Debatin, Klaus-Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">808-815</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A major concern in cancer therapy is resistance of tumors such as glioblastoma to current treatment protocols.  Here, we report that transfer of the gene encoding second mitochondria-derived activator of caspase (Smac) or Smac peptides sensitized various tumor cells in vitro and malignant glioma cells in vivo for apoptosis induced by death-receptor ligation or cytotoxic drugs.  Expression of a cytosolic active form of Smac or cell-permeable Smac peptides bypassed the Bcl-2 block, which prevented the release of Smac from mitochondria, and also sensitized resistant neuroblastoma or melanoma cells and patient-derived primary neuroblastoma cells ex vivo.  Most importantly, Smac peptides strongly enhanced the antitumor activity of Apo-2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in an intracranial malignant glioma xenograft model in vivo.  Complete eradication of established tumors and survival of mice was only achieved upon combined treatment with Smac peptides and Apo2L/TRAIL without detectable toxicity to normal brain tissue.  Thus, Smac agonists are promising candidates for cancer therapy by potentiating cytotoxic therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAiJY7qJmypLVg90H21EOLACvtfcHk0ljqGkxyFUm0sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls12msbw%253D&md5=6718e2999db2730ad0cdf51046e718ef</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1038%2Fnm735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm735%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26atitle%3DSmac%2520agonists%2520sensitize%2520for%2520Apo2L%252FTRAIL-%2520or%2520anticancer%2520drug-induced%2520apoptosis%2520and%2520induce%2520regression%2520of%2520malignant%2520glioma%2520in%2520vivo%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D808%26epage%3D815%26doi%3D10.1038%2Fnm735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giagkousiklidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westhoff, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperczyk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspase</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">10502</span>– <span class="NLM_lpage">10513</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-0866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F0008-5472.CAN-05-0866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=16288043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Wgu7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=10502-10513&author=S.+Giagkousiklidisauthor=M.+Voglerauthor=M.+A.+Westhoffauthor=H.+Kasperczykauthor=K.+M.+Debatinauthor=S.+Fulda&title=Sensitization+for+gamma-irradiation-induced+apoptosis+by+second+mitochondria-derived+activator+of+caspase&doi=10.1158%2F0008-5472.CAN-05-0866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitization for γ-Irradiation-Induced Apoptosis by Second Mitochondria-Derived Activator of Caspase</span></div><div class="casAuthors">Giagkousiklidis, Stavros; Vogler, Meike; Westhoff, Mike-Andrew; Kasperczyk, Hubert; Debatin, Klaus-Michael; Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10502-10513</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Resistance to current treatment regimens, such as radiation therapy, remains a major concern in oncol. and may be caused by defects in apoptosis programs.  Because inhibitor of apoptosis proteins (IAPs), which are expressed at high levels in many tumors, block apoptosis at the core of the apoptotic machinery by inhibiting caspases, therapeutic modulation of IAPs could target a key control point in resistance.  Here, we report for the first time that full-length or mature second mitochondria-derived activator of caspase (Smac), an inhibitor of IAPs, significantly enhanced γ-irradn.-induced apoptosis and reduced clonogenic survival in neuroblastoma, glioblastoma, or pancreatic carcinoma cells.  Notably, Smac had no effect on DNA damage/DNA repair, activation of nuclear factor-κB, up-regulation of p53 and p21 proteins, or cell cycle arrest following γ-irradn., indicating that Smac did not alter the initial damage and/or cellular stress response.  Smac enhanced activation of caspase-2, caspase-3, caspase-8, and caspase-9, loss of mitochondrial membrane potential, and cytochrome c release on γ-irradn.  Inhibition of caspases also blocked γ-irradn.-induced mitochondrial perturbations, indicating that Smac facilitated caspase activation, which in turn triggered a mitochondrial amplification loop.  Interestingly, mitochondrial perturbations were completely blocked by the broad-range caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone or the relatively selective caspase-2 inhibitor N-benzyloxycarbonyl-Val-Asp-Val-Ala-Asp-fluoromethylketone, whereas caspase-8 or caspase-3 inhibitors only inhibited the increased drop of mitochondrial membrane potential provided by Smac, suggesting that caspase-2 was acting upstream of mitochondria after γ-irradn.  In conclusion, our findings provide evidence that targeting IAPs (e.g., by Smac agonists) is a promising strategy to enhance radiosensitivity in human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPnrHw079U5LVg90H21EOLACvtfcHk0ljqGkxyFUm0sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Wgu7%252FF&md5=5395fd5ac885392c07ae68b0dd3a3cc7</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-0866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-0866%26sid%3Dliteratum%253Aachs%26aulast%3DGiagkousiklidis%26aufirst%3DS.%26aulast%3DVogler%26aufirst%3DM.%26aulast%3DWesthoff%26aufirst%3DM.%2BA.%26aulast%3DKasperczyk%26aufirst%3DH.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DSensitization%2520for%2520gamma-irradiation-induced%2520apoptosis%2520by%2520second%2520mitochondria-derived%2520activator%2520of%2520caspase%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D10502%26epage%3D10513%26doi%3D10.1158%2F0008-5472.CAN-05-0866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holcik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korneluk, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, T.</span></span> <span> </span><span class="NLM_article-title">Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4174</span>– <span class="NLM_lpage">4177</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1203765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fsj.onc.1203765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10962579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVKlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=4174-4177&author=M.+Holcikauthor=C.+Yehauthor=R.+G.+Kornelukauthor=T.+Chow&title=Translational+upregulation+of+X-linked+inhibitor+of+apoptosis+%28XIAP%29+increases+resistance+to+radiation+induced+cell+death&doi=10.1038%2Fsj.onc.1203765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death</span></div><div class="casAuthors">Holcik, Martin; Yeh, Chiaoli; Korneluk, Robert G.; Chow, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">4174-4177</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibitory regulators of apoptosis play a crit. role in the responsiveness of tumor cells to cytotoxic agents.  The X-linked inhibitor of apoptosis protein (XIAP) is a member of a novel family of Inhibitor of Apoptosis (IAP) proteins.  Here we show that acute low dose ionizing irradn. results in the translational upregulation of XIAP that correlates with an increased resistance to radiation in non-small cell lung carcinoma.  This upregulation is mediated by an internal ribosome binding mechanism via an IRES element located within a XIAP 5' UTR.  Transient overexpression of XIAP rendered human carcinoma cells resistant to low dose γ-irradn.  By contrast, the antisense targeting of XIAP resulted in increased cell death following irradn. advocating a distinct role for XIAP in radiation resistant phenotype of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLacZN8mYro7Vg90H21EOLACvtfcHk0ljqGkxyFUm0sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVKlsLc%253D&md5=3caa8ba6c997cb3750e50b96970c7c99</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1203765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1203765%26sid%3Dliteratum%253Aachs%26aulast%3DHolcik%26aufirst%3DM.%26aulast%3DYeh%26aufirst%3DC.%26aulast%3DKorneluk%26aufirst%3DR.%2BG.%26aulast%3DChow%26aufirst%3DT.%26atitle%3DTranslational%2520upregulation%2520of%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520%2528XIAP%2529%2520increases%2520resistance%2520to%2520radiation%2520induced%2520cell%2520death%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D4174%26epage%3D4177%26doi%3D10.1038%2Fsj.onc.1203765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giagkousiklidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellanki, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Sensitization of pancreatic carcinoma cells for gamma-irradiation-induced apoptosis by XIAP inhibition</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">7006</span>– <span class="NLM_lpage">7016</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1210502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fsj.onc.1210502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=17471230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Wgt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=7006-7016&author=S.+Giagkousiklidisauthor=S.+H.+Vellankiauthor=K.+M.+Debatinauthor=S.+Fulda&title=Sensitization+of+pancreatic+carcinoma+cells+for+gamma-irradiation-induced+apoptosis+by+XIAP+inhibition&doi=10.1038%2Fsj.onc.1210502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitization of pancreatic carcinoma cells for γ-irradiation-induced apoptosis by XIAP inhibition</span></div><div class="casAuthors">Giagkousiklidis, S.; Vellanki, S. H.; Debatin, K-M.; Fulda, S.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">7006-7016</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Resistance of pancreatic cancer to current treatments including radiotherapy remains a major challenge in oncol. and may be caused by defects in apoptosis programs.  Since 'inhibitor of apoptosis proteins' (IAPs) block apoptosis at the core of the apoptotic machinery by inhibiting caspases, therapeutic modulation of IAPs could tackle a key resistance mechanism.  Here, we report that targeting X-linked inhibitor of apoptosis (XIAP) by RNA-interference-mediated knockdown or overexpression of second mitochondria-derived activator of caspase significantly enhanced apoptosis and markedly reduced clonogenic growth of pancreatic carcinoma cells upon γ-irradn.  Anal. of signaling pathways revealed that antagonizing XIAP increased activation of caspase-2, -3, -8 and -9 and loss of mitochondrial membrane potential upon γ-irradn.  Interestingly, inhibition of caspases also reduced the cooperative effect of XIAP targeting and γ-irradn. to trigger mitochondrial perturbations, suggesting that XIAP controls a feedback mitochondrial amplification loop by regulating caspase activity.  Importantly, our data demonstrate for the first time that small mol. XIAP inhibitors sensitized pancreatic carcinoma cells for γ-irradn.-induced apoptosis, whereas they had no effect on γ-irradn.-mediated apoptosis of non-malignant fibroblasts indicating some tumor specificity.  In conclusion, targeting XIAP, for example by small mols., is a promising novel approach to enhance radiosensitivity of pancreatic cancer that warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocEFY0jlGoJ7Vg90H21EOLACvtfcHk0lhZID9n4s5Wzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Wgt7rF&md5=84f692e7521dfe4140e383c8dfd6e67a</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210502%26sid%3Dliteratum%253Aachs%26aulast%3DGiagkousiklidis%26aufirst%3DS.%26aulast%3DVellanki%26aufirst%3DS.%2BH.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DSensitization%2520of%2520pancreatic%2520carcinoma%2520cells%2520for%2520gamma-irradiation-induced%2520apoptosis%2520by%2520XIAP%2520inhibition%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D7006%26epage%3D7016%26doi%3D10.1038%2Fsj.onc.1210502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span> <span> </span><span class="NLM_article-title">Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21804946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXms1Knsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=128-143&author=Y.+Daiauthor=J.+Desanoauthor=Y.+Quauthor=W.+Tangauthor=Y.+Mengauthor=T.+S.+Lawrenceauthor=L.+Xu&title=Natural+IAP+inhibitor+Embelin+enhances+therapeutic+efficacy+of+ionizing+radiation+in+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Natural IAP inhibitor embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer</span></div><div class="casAuthors">Dai, Yao; DeSano, Jeffrey; Qu, Yang; Tang, Wenhua; Meng, Yang; Lawrence, Theodore S.; Xu, Liang</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">128-143</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Embelin is an active ingredient of traditional herbal medicine that exhibits anti-tumor effects in human prostate cancer cells.  However, therapeutic effect of embelin in combination with conventional radiation therapy is not yet detd.  In this study, we evaluate the sensitizing potential of embelin on ionizing radiation (IR) in a human prostate cancer model.  In vitro, embelin combined with radiation potently suppressed prostate cancer PC-3 cell proliferation that was assocd. with S and G2/M arrest in cell cycle.  Moreover, the combination treatment promoted caspase-independent apoptosis, as evidenced by the increased apoptotic cell death without caspase-3 activation, but not autophagy.  Clonogenic survival assay showed that S-phase arrest was required for embelin-mediated radiosensitization.  In vivo, embelin significantly improved tumor response to X-ray radiation in the PC-3 xenograft model.  Combination therapy produced enhanced tumor growth delay and prolonged time to progression, with minimal systemic toxicity.  Immunohistochem. studies showed that embelin plus IR significantly inhibited cell proliferation, induced apoptosis, and decreased microvessel d. in tumors as compared with either treatment alone, suggesting an enhanced combinatory inhibition on tumor suppression and angiogenesis.  Our results demonstrate that embelin significantly facilitates tumor suppression by radiation therapy both in vitro and in vivo in the prostate cancer model.  This finding warrants embelin as a novel adjuvant therapeutic candidate for the treatment of hormone-refractory prostate cancer that is resistant to radiation therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaR72PSf0Ix7Vg90H21EOLACvtfcHk0lhZID9n4s5Wzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXms1Knsbo%253D&md5=4a4c379504790fb542eda1f04b406ae5</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DDesano%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DMeng%26aufirst%3DY.%26aulast%3DLawrence%26aufirst%3DT.%2BS.%26aulast%3DXu%26aufirst%3DL.%26atitle%3DNatural%2520IAP%2520inhibitor%2520Embelin%2520enhances%2520therapeutic%2520efficacy%2520of%2520ionizing%2520radiation%2520in%2520prostate%2520cancer%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2011%26volume%3D1%26spage%3D128%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeSano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burstein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pienta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span> <span> </span><span class="NLM_article-title">Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7701</span>– <span class="NLM_lpage">7710</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-0188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1078-0432.CCR-08-0188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=19047096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVegtrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=7701-7710&author=Y.+Daiauthor=M.+Liuauthor=W.+Tangauthor=J.+DeSanoauthor=E.+Bursteinauthor=M.+Davisauthor=K.+Pientaauthor=T.+Lawrenceauthor=L.+Xu&title=Molecularly+targeted+radiosensitization+of+human+prostate+cancer+by+modulating+inhibitor+of+apoptosis&doi=10.1158%2F1078-0432.CCR-08-0188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Molecularly Targeted Radiosensitization of Human Prostate Cancer by Modulating Inhibitor of Apoptosis</span></div><div class="casAuthors">Dai, Yao; Liu, Meilan; Tang, Wenhua; DeSano, Jeffrey; Burstein, Ezra; Davis, Mary; Pienta, Kenneth; Lawrence, Theodore; Xu, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7701-7710</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The inhibitor of apoptosis proteins (IAP) are overexpressed in hormone-refractory prostate cancer, rendering the cancer cells resistant to radiation.  This study aims to investigate the radiosensitizing effect of small-mol. IAP inhibitor both in vitro and in vivo in androgen-independent prostate cancer and the possible mechanism of radiosensitization.  Exptl. Design: Radiosensitization of SH-130 in human prostate cancer DU-145 cells was detd. by clonogenic survival assay.  Combination effect of SH-130 and ionizing radiation was evaluated by apoptosis assays.  Pull-down and immunopptn. assays were employed to investigate the interaction between SH-130 and IAPs.  DU-145 xenografts in nude mice were treated with SH-130, radiation, or combination, and tumor suppression effect was detd. by caliper measurement or bioluminescence imaging.  Nuclear factor-κB activation was detected by luciferase reporter assay and quant. real-time PCR.  RESULTS: SH-130 potently enhanced radiation-induced caspase activation and apoptosis in DU-145 cells.  Both X-linked IAP and cIAP-1 can be pulled down by SH-130 but not by inactive SH-123.  Moreover, SH-130 interrupted interaction between X-linked IAP/cIAP-1 and Smac.  In a nude mouse xenograft model, SH-130 potently sensitized the DU-145 tumors to X-ray radiation without increasing systemic toxicity.  The combination therapy suppressed tumor growth more significantly than either treatment alone, with over 80% of complete tumor regression.  Furthermore, SH-130 partially blocked tumor necrosis factor-α- and radiation-induced nuclear factor-κB activation in DU-145 cells.  CONCLUSIONS: Our results show that small-mol. inhibitors of IAPs can overcome apoptosis resistance and radiosensitize human prostate cancer with high levels of IAPs.  Mol. modulation of IAPs may improve the outcome of prostate cancer radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMkV6mpPRNdrVg90H21EOLACvtfcHk0lhZID9n4s5Wzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVegtrbI&md5=e17e9cc73ae39e2505b06ddc9c300e83</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0188%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DDeSano%26aufirst%3DJ.%26aulast%3DBurstein%26aufirst%3DE.%26aulast%3DDavis%26aufirst%3DM.%26aulast%3DPienta%26aufirst%3DK.%26aulast%3DLawrence%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DL.%26atitle%3DMolecularly%2520targeted%2520radiosensitization%2520of%2520human%2520prostate%2520cancer%2520by%2520modulating%2520inhibitor%2520of%2520apoptosis%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D7701%26epage%3D7710%26doi%3D10.1158%2F1078-0432.CCR-08-0188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vellanki, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabrucker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proepper, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eramo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeckers, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Small-molecule XIAP inhibitors enhance gamma-irradiation-induced apoptosis in glioblastoma</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1593/neo.09436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1593%2Fneo.09436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=19649204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1MXoslKiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=743-752&author=S.+H.+Vellankiauthor=A.+Grabruckerauthor=S.+Liebauauthor=C.+Proepperauthor=A.+Eramoauthor=V.+Braunauthor=T.+Boeckersauthor=K.+M.+Debatinauthor=S.+Fulda&title=Small-molecule+XIAP+inhibitors+enhance+gamma-irradiation-induced+apoptosis+in+glioblastoma&doi=10.1593%2Fneo.09436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule XIAP inhibitors enhance γ-irradiation-induced apoptosis in glioblastoma</span></div><div class="casAuthors">Vellanki, Sri Hari Krishna; Grabrucker, Andreas; Liebau, Stefan; Proepper, Christian; Eramo, Adriana; Braun, Veit; Boeckers, Tobias; Debatin, Klaus-Michael; Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Ann Arbor, MI, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">743-752</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">Because evasion of apoptosis can cause radioresistance of glioblastoma, there is a need to design rational strategies that counter apoptosis resistance.  In the present study, we investigated the potential of targeting the antiapoptotic protein XIAP for the radiosensitization of glioblastoma.  Here, we report that small-mol. XIAP inhibitors significantly enhance γ-irradn.-induced loss of viability and apoptosis and cooperate with γ-irradn. to suppress clonogenic survival of glioblastoma cells.  Anal. of mol. mechanisms reveals that XIAP inhibitors act in concert with γ-irradn. to cause mitochondrial outer membrane permeabilization, caspase activation, and caspase-dependent apoptosis.  Importantly, XIAP inhibitors also sensitize primary cultured glioblastoma cells derived from surgical specimens as well as glioblastoma-initiating stemlike cancer stem cells for γ-irradn.  In contrast, they do not increase the toxicity of γ-irradn. on some nonmalignant cells of the central nervous system, including rat neurons or glial cells, pointing to some tumor selectivity.  In conclusion, by demonstrating for the first time that small-mol. XIAP inhibitors increase the radiosensitivity of glioblastoma cells while sparing normal cells of the central nervous system, our findings build the rationale for further (pre)clin. development of XIAP inhibitors in combination with γ-irradn. in glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHqZM_Mi9OOLVg90H21EOLACvtfcHk0lhmSzo0WVPaHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXoslKiur4%253D&md5=903abf6952c79563b01bf32211c81cee</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1593%2Fneo.09436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.09436%26sid%3Dliteratum%253Aachs%26aulast%3DVellanki%26aufirst%3DS.%2BH.%26aulast%3DGrabrucker%26aufirst%3DA.%26aulast%3DLiebau%26aufirst%3DS.%26aulast%3DProepper%26aufirst%3DC.%26aulast%3DEramo%26aufirst%3DA.%26aulast%3DBraun%26aufirst%3DV.%26aulast%3DBoeckers%26aufirst%3DT.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DSmall-molecule%2520XIAP%2520inhibitors%2520enhance%2520gamma-irradiation-induced%2520apoptosis%2520in%2520glioblastoma%26jtitle%3DNeoplasia%26date%3D2009%26volume%3D11%26spage%3D743%26epage%3D752%26doi%3D10.1593%2Fneo.09436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennewein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marschall, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristofanon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellanki, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hehlgans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludolph, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">NF-kappaB is required for Smac mimetic-mediated sensitization of glioblastoma cells for gamma-irradiation-induced apoptosis</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1867</span>– <span class="NLM_lpage">1875</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1535-7163.MCT-11-0218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21859841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yls77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=1867-1875&author=R.+Bergerauthor=C.+Jenneweinauthor=V.+Marschallauthor=S.+Karlauthor=S.+Cristofanonauthor=L.+Wagnerauthor=S.+H.+Vellankiauthor=S.+Hehlgansauthor=F.+Rodelauthor=K.+M.+Debatinauthor=A.+C.+Ludolphauthor=S.+Fulda&title=NF-kappaB+is+required+for+Smac+mimetic-mediated+sensitization+of+glioblastoma+cells+for+gamma-irradiation-induced+apoptosis&doi=10.1158%2F1535-7163.MCT-11-0218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB Is Required for Smac Mimetic-Mediated Sensitization of Glioblastoma Cells for γ-Irradiation-Induced Apoptosis</span></div><div class="casAuthors">Berger, Rebecca; Jennewein, Claudia; Marschall, Viola; Karl, Sabine; Cristofanon, Silvia; Wagner, Liane; Vellanki, Sri Hari Krishna; Hehlgans, Stephanie; Roedel, Franz; Debatin, Klaus-Michael; Ludolph, Albert C.; Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1867-1875</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Evasion of apoptosis contributes to radioresistance of glioblastoma, calling for novel strategies to overcome apoptosis resistance.  In this study, we investigated the potential of the small mol. Smac mimetic BV6 to modulate radiosensitivity of glioblastoma cells.  Here, we identify a novel proapoptotic function of NF-κB in γ-irradn.-induced apoptosis of glioblastoma cells by showing, for the first time, that NF-κB is critically required for Smac mimetic-mediated radiosensitization.  BV6 significantly increases γ-irradn.-triggered apoptosis in several glioblastoma cell lines in a dose- and time-dependent manner.  Calcn. of combination index (CI) reveals that the interaction of BV6 and γ-irradn. is highly synergistic (CI < 0.3).  Mol. studies show that BV6 stimulates NF-κB activation, which is crit. for radiosensitization, because genetic inhibition of NF-κB by overexpression of the dominant-neg. superrepressor IκBα-SR significantly decreases BV6- and γ-irradn.-induced apoptosis.  Also, the BV6-mediated enhancement of γ-irradn.-triggered caspase activation, drop of mitochondrial membrane potential, and cytochrome c release is abolished in cells overexpressing IκBα-SR.  Similarly, NF-κB inhibition by ectopic expression of a kinase dead mutant of IKKβ prevents the BV6-mediated sensitization for γ-irradn.  The clin. relevance is underscored by expts. with primary tumor samples showing that BV6 sensitizes primary cultured glioma cells as well as glioblastoma-initiating cancer stem cells derived from surgical specimens for γ-irradn.  In conclusion, we identify NF-κB as a crit. mediator of Smac mimetic-conferred radiosensitization of glioblastoma cells.  These results have important implications for the development of Smac mimetic-based combination protocols for radiosensitization of glioblastoma.  Mol Cancer Ther; 10(10); 1867-75.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDgz47LnLOQ7Vg90H21EOLACvtfcHk0lhmSzo0WVPaHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yls77J&md5=35bf683c1a4316871b29b41848f5fadb</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0218%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DJennewein%26aufirst%3DC.%26aulast%3DMarschall%26aufirst%3DV.%26aulast%3DKarl%26aufirst%3DS.%26aulast%3DCristofanon%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DL.%26aulast%3DVellanki%26aufirst%3DS.%2BH.%26aulast%3DHehlgans%26aufirst%3DS.%26aulast%3DRodel%26aufirst%3DF.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26aulast%3DLudolph%26aufirst%3DA.%2BC.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DNF-kappaB%2520is%2520required%2520for%2520Smac%2520mimetic-mediated%2520sensitization%2520of%2520glioblastoma%2520cells%2520for%2520gamma-irradiation-induced%2520apoptosis%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D1867%26epage%3D1875%26doi%3D10.1158%2F1535-7163.MCT-11-0218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebolt, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span> <span> </span><span class="NLM_article-title">Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-10-0643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1535-7163.MCT-10-0643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21282353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=658-669&author=J.+Yangauthor=D.+McEachernauthor=W.+Liauthor=M.+A.+Davisauthor=H.+Liauthor=M.+A.+Morganauthor=L.+Baiauthor=J.+T.+Seboltauthor=H.+Sunauthor=T.+S.+Lawrenceauthor=S.+Wangauthor=Y.+Sun&title=Radiosensitization+of+head+and+neck+squamous+cell+carcinoma+by+a+SMAC-mimetic+compound%2C+SM-164%2C+requires+activation+of+caspases&doi=10.1158%2F1535-7163.MCT-10-0643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosensitization of Head and Neck Squamous Cell Carcinoma by a SMAC-Mimetic Compound, SM-164, Requires Activation of Caspases</span></div><div class="casAuthors">Yang, Jie; McEachern, Donna; Li, Wenyan; Davis, Mary A.; Li, Hua; Morgan, Meredith A.; Bai, Longchuan; Sebolt, Jonathan T.; Sun, Haiying; Lawrence, Theodore S.; Wang, Shaomeng; Sun, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-669</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Chemoradiation is the treatment of choice for locally advanced head and neck squamous cell carcinoma (HNSCC).  However, radioresistance, which contributes to local recurrence, remains a significant therapeutic problem.  In this study, we characterized SM-164, a small second mitochondria-derived activator of caspase -mimetic compd. that promotes degrdn. of cellular inhibitor of apoptosis-1 (cIAP-1; also known as baculoviral IAP repeat-contg. protein 2, BIRC2) and releases active caspases from the X-linked inhibitor of apoptosis inhibitory binding as a radiosensitizing agent in HNSCC cells.  We found that SM-164 at nanomolar concns. induced radiosensitization in some HNSCC cell lines in a manner dependent on intrinsic sensitivity to caspase activation and apoptosis induction.  Blockage of caspase activation via short interfering RNA knockdown or a pan-caspase inhibitor, z-VAD-fmk, largely abrogated SM-164 radiosensitization.  On the other hand, the resistant lines with a high level of Bcl-2 that blocks caspase activation and apoptosis induction became sensitive to radiation on Bcl-2 knockdown.  Mechanistic studies revealed that SM-164 radiosensitization in sensitive cells was assocd. with NF-κB activation and TNFα secretion, followed by activation of caspase-8 and -9, leading to enhanced apoptosis.  Finally, SM-164 also radiosensitized human tumor xenograft while causing minimal toxicity.  Thus, SM-164 is a potent radiosensitizer via a mechanism involving caspase activation and holds promise for future clin. development as a novel class of radiosensitizer for the treatment of a subset of head and neck cancer patients.  Mol Cancer Ther; 10(4); 658-69.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNverk0aII4rVg90H21EOLACvtfcHk0lhmSzo0WVPaHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSrtLg%253D&md5=956ac9aa378b66847abb94bd8f1911be</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0643%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DDavis%26aufirst%3DM.%2BA.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMorgan%26aufirst%3DM.%2BA.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DSebolt%26aufirst%3DJ.%2BT.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLawrence%26aufirst%3DT.%2BS.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DRadiosensitization%2520of%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%2520by%2520a%2520SMAC-mimetic%2520compound%252C%2520SM-164%252C%2520requires%2520activation%2520of%2520caspases%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D658%26epage%3D669%26doi%3D10.1158%2F1535-7163.MCT-10-0643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matzinger, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viertl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsoutsou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedemann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vozenin, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuagniaux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourhis, J.</span></span> <span> </span><span class="NLM_article-title">The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFalpha-mediated in head and neck squamous cell carcinoma</span>. <i>Radiother. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1016/j.radonc.2015.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.radonc.2015.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=26096848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVegs7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2015&pages=495-503&author=O.+Matzingerauthor=D.+Viertlauthor=P.+Tsoutsouauthor=L.+Kadiauthor=S.+Rigottiauthor=C.+Zannaauthor=N.+Wiedemannauthor=M.+C.+Vozeninauthor=G.+Vuagniauxauthor=J.+Bourhis&title=The+radiosensitizing+activity+of+the+SMAC-mimetic%2C+Debio+1143%2C+is+TNFalpha-mediated+in+head+and+neck+squamous+cell+carcinoma&doi=10.1016%2Fj.radonc.2015.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma</span></div><div class="casAuthors">Matzinger, Oscar; Viertl, David; Tsoutsou, Pelagia; Kadi, Linda; Rigotti, Stefania; Zanna, Claudio; Wiedemann, Norbert; Vozenin, Marie-Catherine; Vuagniaux, Gregoire; Bourhis, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Radiotherapy and Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">495-503</span>CODEN:
                <span class="NLM_cas:coden">RAONDT</span>;
        ISSN:<span class="NLM_cas:issn">0167-8140</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Second mitochondria-derived activator of caspase (SMAC)-mimetics are a new class of targeted drugs that specifically induce apoptotic cancer cell death and block pro-survival signaling by antagonizing selected members of the inhibitor of apoptosis protein (IAP) family.  The present study was designed to investigate the radiosensitizing effect and optimal sequence of administration of the novel SMAC-mimetic Debio 1143 in vitro and in vivo.  Apoptosis, alteration of DNA damage repair (DDR), and tumor necrosis factor-alpha (TNF-α) signaling were examd.  In vitro, Debio 1143 displayed anti-proliferative activity and enhanced intrinsic radiation sensitivity in 5/6 head and neck squamous cell carcinoma (HNSCC) cell lines in a synergistic manner.  In vivo, Debio 1143 dose-dependently radio-sensitized FaDu and SQ20B xenografts, resulting in complete tumor regression in 8/10 FaDu-xenografted mice at the high dose level.  At the mol. level, Debio 1143 combined with radiotherapy (RT) induced enhancement of caspase-3 activity, increase in Annexin V-pos. cells and karyopyknosis, and increase in TNF-α mRNA levels.  Finally, in a neutralization expt. using a TNF-α-blocking antibody and a caspase inhibitor, it was shown that the radiosensitizing effect of Debio 1143 is mediated by caspases and TNF-α.  These results demonstrate that the novel SMAC-mimetic Debio 1143 is a radiosensitizing agent that is worthy of further investigation in clin. trials in combination with radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDXg5haORedrVg90H21EOLACvtfcHk0ljQ46xYte3V3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVegs7rM&md5=632f084b345194b4140826f076162f1d</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.radonc.2015.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.radonc.2015.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DMatzinger%26aufirst%3DO.%26aulast%3DViertl%26aufirst%3DD.%26aulast%3DTsoutsou%26aufirst%3DP.%26aulast%3DKadi%26aufirst%3DL.%26aulast%3DRigotti%26aufirst%3DS.%26aulast%3DZanna%26aufirst%3DC.%26aulast%3DWiedemann%26aufirst%3DN.%26aulast%3DVozenin%26aufirst%3DM.%2BC.%26aulast%3DVuagniaux%26aufirst%3DG.%26aulast%3DBourhis%26aufirst%3DJ.%26atitle%3DThe%2520radiosensitizing%2520activity%2520of%2520the%2520SMAC-mimetic%252C%2520Debio%25201143%252C%2520is%2520TNFalpha-mediated%2520in%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%26jtitle%3DRadiother.%2520Oncol.%26date%3D2015%26volume%3D116%26spage%3D495%26epage%3D503%26doi%3D10.1016%2Fj.radonc.2015.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span> <span> </span><span class="NLM_article-title">SMAC-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis</span>. <i>Breast Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1007/s10549-011-1752-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1007%2Fs10549-011-1752-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21901386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlOlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2012&pages=189-199&author=D.+Yangauthor=Y.+Zhaoauthor=A.+Y.+Liauthor=S.+Wangauthor=G.+Wangauthor=Y.+Sun&title=SMAC-mimetic+compound+SM-164+induces+radiosensitization+in+breast+cancer+cells+through+activation+of+caspases+and+induction+of+apoptosis&doi=10.1007%2Fs10549-011-1752-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Smac-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis</span></div><div class="casAuthors">Yang, Dong; Zhao, Yongchao; Li, Amy Y.; Wang, Shaomeng; Wang, Gongxian; Sun, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">189-199</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Radiotherapy is a treatment choice for local control of breast cancer, particularly after the removal of tumor tissues by surgery.  However, intrinsic radioresistance of cancer cells limits therapeutic efficacy.  Here, we detd. in breast cancer cells the potential radiosensitizing activity of SM-164, a small mol. compd., that mimics the activity of SMAC, a mitochondrial protein released during apoptosis to activate caspases by inhibiting cellular inhibitor of apoptosis proteins, cIAP-1, and XIAP.  We found that SM-164 at nanomolar concns. promoted degrdn. of cIAP-1, disrupted the inhibitory binding of XIAP to active caspase-9, and sensitized breast cancer cells to radiation with a sensitization enhancement ratio (SER) of 1.7-1.8.  In one line of breast cancer cells resistant to SM-164 as a single agent, SM-164 radiosensitization was mediated by intrinsic apoptosis pathway through activation of caspases-9 and -3.  In a line of breast cancer cells sensitive to SM-164 as a single agent, SM-164 radiosensitization was mediated by both extrinsic and intrinsic apoptosis pathways through activation of caspases-9, -8, and -3.  Consistently, blockage of caspase activation, through siRNA knockdown or treatment with a pan-caspase inhibitor z-VAD-fmk, inhibited apoptosis and abrogated SM-164 radiosensitization.  Our study demonstrates that IAPs are valid radiosensitizing targets in breast cancer cells and SM-164 could be further developed as a novel class of radiosensitizers for the treatment of radioresistant breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQN0rWHmKu-LVg90H21EOLACvtfcHk0ljQ46xYte3V3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlOlu7k%253D&md5=61941e8b55a1a5dca83c836a19188558</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1007%2Fs10549-011-1752-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-011-1752-3%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DA.%2BY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DSMAC-mimetic%2520compound%2520SM-164%2520induces%2520radiosensitization%2520in%2520breast%2520cancer%2520cells%2520through%2520activation%2520of%2520caspases%2520and%2520induction%2520of%2520apoptosis%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2012%26volume%3D133%26spage%3D189%26epage%3D199%26doi%3D10.1007%2Fs10549-011-1752-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peery, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. T.</span></span> <span> </span><span class="NLM_article-title">Targeting survivin for therapeutic discovery: past, present, and future promises</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1466</span>– <span class="NLM_lpage">1477</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2017.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.drudis.2017.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=28577912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlSgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1466-1477&author=R.+C.+Peeryauthor=J.+Y.+Liuauthor=J.+T.+Zhang&title=Targeting+survivin+for+therapeutic+discovery%3A+past%2C+present%2C+and+future+promises&doi=10.1016%2Fj.drudis.2017.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting survivin for therapeutic discovery: past, present, and future promises</span></div><div class="casAuthors">Peery, Robert C.; Liu, Jing-Yuan; Zhang, Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1466-1477</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Survivin, the smallest member of the inhibitor of apoptosis protein (IAP) family, is overexpressed in cells of almost all cancers but not in most normal tissues in adults.  Survivin expression is required for cancer cell survival and knocking down its expression or inhibiting its function using mol. approaches results in spontaneous apoptosis.  Thus, survivin is an attractive and perhaps ideal target for cancer drug discovery.  However, a US Food and Drug Administration (FDA)-approved drug targeting survivin has yet to emerge.  In this Foundation Review, we examine and evaluate various strategies that have been used to target survivin and the stages of each survivin inhibitor to help understand this lack of success.  We also provide future perspectives moving forward in targeting survivin for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAjdIclTWikbVg90H21EOLACvtfcHk0ljQ46xYte3V3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlSgsrk%253D&md5=e0c67912f0c8fbd96ba9bd3d454dc879</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2017.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2017.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DPeery%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DZhang%26aufirst%3DJ.%2BT.%26atitle%3DTargeting%2520survivin%2520for%2520therapeutic%2520discovery%253A%2520past%252C%2520present%252C%2520and%2520future%2520promises%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2017%26volume%3D22%26spage%3D1466%26epage%3D1477%26doi%3D10.1016%2Fj.drudis.2017.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">Livin/ML-IAP as a new target for cancer treatment</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>250</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2006.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.canlet.2006.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=17218055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=2007&pages=168-176&author=B.+Liuauthor=M.+Hanauthor=J.+K.+Wenauthor=L.+Wang&title=Livin%2FML-IAP+as+a+new+target+for+cancer+treatment&doi=10.1016%2Fj.canlet.2006.09.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Livin/ML-IAP as a new target for cancer treatment</span></div><div class="casAuthors">Liu, Bin; Han, Mei; Wen, Jin-Kun; Wang, Ling</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">250</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-176</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Livin is a member of the inhibitors of apoptosis protein (IAP) gene family, which encodes neg. regulatory proteins that prevent cell apoptosis.  Livin is selectively expressed in the most common human neoplasms and appears to be involved in tumor cell resistance to chemotherapeutic agents.  Several studies in vitro and in vivo have demonstrated that down-regulation of Livin expression increases the apoptotic rate, reduces tumor growth potential and sensitized tumor cells to chemotherapeutic drugs.  This review will focus on the role of this protein during cancer development and progression and will demonstrate possible targets for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4SSDnWWgHJLVg90H21EOLACvtfcHk0ljQ46xYte3V3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLk%253D&md5=7af14b77b7c348e8d39bdfc3d9c74e2c</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2006.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2006.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DM.%26aulast%3DWen%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DL.%26atitle%3DLivin%252FML-IAP%2520as%2520a%2520new%2520target%2520for%2520cancer%2520treatment%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D250%26spage%3D168%26epage%3D176%26doi%3D10.1016%2Fj.canlet.2006.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feltham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettjeman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budhidarmo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mace, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunduru, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinlay, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaux, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">17015</span>– <span class="NLM_lpage">17028</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.222919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.M111.222919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21393245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlslKlur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=17015-17028&author=R.+Felthamauthor=B.+Bettjemanauthor=R.+Budhidarmoauthor=P.+D.+Maceauthor=S.+Shirleyauthor=S.+M.+Condonauthor=S.+K.+Chunduruauthor=M.+A.+McKinlayauthor=D.+L.+Vauxauthor=J.+Silkeauthor=C.+L.+Day&title=SMAC+mimetics+activate+the+E3+ligase+activity+of+cIAP1+protein+by+promoting+RING+domain+dimerization&doi=10.1074%2Fjbc.M111.222919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Smac Mimetics Activate the E3 Ligase Activity of cIAP1 Protein by Promoting RING Domain Dimerization</span></div><div class="casAuthors">Feltham, Rebecca; Bettjeman, Bodhi; Budhidarmo, Rhesa; Mace, Peter D.; Shirley, Sarah; Condon, Stephen M.; Chunduru, Srinivas K.; McKinlay, Mark A.; Vaux, David L.; Silke, John; Day, Catherine L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">17015-17028</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins are important ubiquitin E3 ligases that regulate cell survival and oncogenesis.  The cIAP1 and cIAP2 paralogs bear three N-terminal baculoviral IAP repeat (BIR) domains and a C-terminal E3 ligase RING domain.  IAP antagonist compds., also known as Smac mimetics, bind the BIR domains of IAPs and trigger rapid RING-dependent autoubiquitylation, but the mechanism is unknown.  We show that RING dimerization is essential for the E3 ligase activity of cIAP1 and cIAP2 because monomeric RING mutants could not interact with the ubiquitin-charged E2 enzyme and were resistant to Smac mimetic-induced autoubiquitylation.  Unexpectedly, the BIR domains inhibited cIAP1 RING dimerization, and cIAP1 existed predominantly as an inactive monomer.  However, addn. of either mono- or bivalent Smac mimetics relieved this inhibition, thereby allowing dimer formation and promoting E3 ligase activation.  In contrast, the cIAP2 dimer was more stable, had higher intrinsic E3 ligase activity, and was not highly activated by Smac mimetics.  These results explain how Smac mimetics promote rapid destruction of cIAP1 and suggest mechanisms for activating cIAP1 in other pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4sfaFqS3EFbVg90H21EOLACvtfcHk0lhcA1KEL0yqMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlslKlur4%253D&md5=94c17984105fe3a51bb9c797c82702fa</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.222919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.222919%26sid%3Dliteratum%253Aachs%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DBettjeman%26aufirst%3DB.%26aulast%3DBudhidarmo%26aufirst%3DR.%26aulast%3DMace%26aufirst%3DP.%2BD.%26aulast%3DShirley%26aufirst%3DS.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DMcKinlay%26aufirst%3DM.%2BA.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DC.%2BL.%26atitle%3DSMAC%2520mimetics%2520activate%2520the%2520E3%2520ligase%2520activity%2520of%2520cIAP1%2520protein%2520by%2520promoting%2520RING%2520domain%2520dimerization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D17015%26epage%3D17028%26doi%3D10.1074%2Fjbc.M111.222919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Induced protein degradation: an emerging drug discovery paradigm</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnrd.2016.211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27885283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCit7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=101-114&author=A.+C.+Laiauthor=C.+M.+Crews&title=Induced+protein+degradation%3A+an+emerging+drug+discovery+paradigm&doi=10.1038%2Fnrd.2016.211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Induced protein degradation: an emerging drug discovery paradigm</span></div><div class="casAuthors">Lai, Ashton C.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-114</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. drug discovery has traditionally focused on occupancy of a binding site that directly affects protein function, and this approach typically precludes targeting proteins that lack such amenable sites.  Furthermore, high systemic drug exposures may be needed to maintain sufficient target inhibition in vivo, increasing the risk of undesirable off-target effects.  Induced protein degrdn. is an alternative approach that is event-driven: upon drug binding, the target protein is tagged for elimination.  Emerging technologies based on proteolysis-targeting chimaeras (PROTACs) that exploit cellular quality control machinery to selectively degrade target proteins are attracting considerable attention in the pharmaceutical industry owing to the advantages they could offer over traditional small-mol. strategies.  These advantages include the potential to reduce systemic drug exposure, the ability to counteract increased target protein expression that often accompanies inhibition of protein function and the potential ability to target proteins that are not currently therapeutically tractable, such as transcription factors, scaffolding and regulatory proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj-O7zXGOpXLVg90H21EOLACvtfcHk0lhcA1KEL0yqMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCit7rP&md5=a01ff43e9b696fe4dc03f0815158a98f</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.211%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DA.%2BC.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DInduced%2520protein%2520degradation%253A%2520an%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D101%26epage%3D114%26doi%3D10.1038%2Fnrd.2016.211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Development of protein degradation inducers of androgen receptor by conjugation of androgen receptor ligands and inhibitor of apoptosis protein ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">575</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00168</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00168" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslSlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=543-575&author=N.+Shibataauthor=K.+Nagaiauthor=Y.+Moritaauthor=O.+Ujikawaauthor=N.+Ohokaauthor=T.+Hattoriauthor=R.+Koyamaauthor=O.+Sanoauthor=Y.+Imaedaauthor=H.+Naraauthor=N.+Choauthor=M.+Naito&title=Development+of+protein+degradation+inducers+of+androgen+receptor+by+conjugation+of+androgen+receptor+ligands+and+inhibitor+of+apoptosis+protein+ligands&doi=10.1021%2Facs.jmedchem.7b00168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands</span></div><div class="casAuthors">Shibata, Norihito; Nagai, Katsunori; Morita, Yoko; Ujikawa, Osamu; Ohoka, Nobumichi; Hattori, Takayuki; Koyama, Ryokichi; Sano, Osamu; Imaeda, Yasuhiro; Nara, Hiroshi; Cho, Nobuo; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">543-575</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeted protein degrdn. using small mols. is a novel strategy for drug development.  The authors have developed hybrid mols. named specific and nongenetic inhibitor of apoptosis protein [IAP]-dependent protein erasers (SNIPERs) that recruit IAP ubiquitin ligases to degrade target proteins.  Here, the authors show novel SNIPERs capable of inducing proteasomal degrdn. of the androgen receptor (AR).  Through derivatization of the SNIPER(AR) mol. at the AR ligand and IAP ligand and linker, the authors developed SNIPER(AR)-51 (I), which shows effective protein knockdown activity against AR.  Consistent with the degrdn. of the AR protein, I inhibits AR-mediated gene expression and proliferation of androgen-dependent prostate cancer cells.  In addn., I efficiently induces caspase activation and apoptosis in prostate cancer cells, which was not obsd. in the cells treated with AR antagonists.  These results suggest that SNIPER(AR)s could be leads for an anticancer drug against prostate cancers that exhibit AR-dependent proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW6OG4BZYg1rVg90H21EOLACvtfcHk0lhcA1KEL0yqMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslSlu7k%253D&md5=eeefbe187f2f93ca32518f6a3258b903</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00168%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DNagai%26aufirst%3DK.%26aulast%3DMorita%26aufirst%3DY.%26aulast%3DUjikawa%26aufirst%3DO.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DKoyama%26aufirst%3DR.%26aulast%3DSano%26aufirst%3DO.%26aulast%3DImaeda%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DH.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520protein%2520degradation%2520inducers%2520of%2520androgen%2520receptor%2520by%2520conjugation%2520of%2520androgen%2520receptor%2520ligands%2520and%2520inhibitor%2520of%2520apoptosis%2520protein%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D543%26epage%3D575%26doi%3D10.1021%2Facs.jmedchem.7b00168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sameshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the allosteric site of oncoprotein BCR-ABL as an alternative strategy for effective target protein degradation</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1042</span>– <span class="NLM_lpage">1047</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00247</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00247" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2js7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1042-1047&author=K.+Shimokawaauthor=N.+Shibataauthor=T.+Sameshimaauthor=N.+Miyamotoauthor=O.+Ujikawaauthor=H.+Naraauthor=N.+Ohokaauthor=T.+Hattoriauthor=N.+Choauthor=M.+Naito&title=Targeting+the+allosteric+site+of+oncoprotein+BCR-ABL+as+an+alternative+strategy+for+effective+target+protein+degradation&doi=10.1021%2Facsmedchemlett.7b00247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Allosteric Site of Oncoprotein BCR-ABL as an Alternative Strategy for Effective Target Protein Degradation</span></div><div class="casAuthors">Shimokawa, Kenichiro; Shibata, Norihito; Sameshima, Tomoya; Miyamoto, Naoki; Ujikawa, Osamu; Nara, Hiroshi; Ohoka, Nobumichi; Hattori, Takayuki; Cho, Nobuo; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1042-1047</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein degrdn. technol. based on hybrid small mols. is an emerging drug modality that has significant potential in drug discovery and as a unique method of post-translational protein knockdown in the field of chem. biol.  Here, we report the first example of a novel and potent protein degrdn. inducer that binds to an allosteric site of the oncogenic BCR-ABL protein.  BCR-ABL allosteric ligands were incorporated into the SNIPER (Specific and Nongenetic inhibitor of apoptosis protein [IAP]-dependent Protein Erasers) platform, and a series of in vitro biol. assays of binding affinity, target protein modulation, signal transduction, and growth inhibition were carried out.  One of the designed compds., I (SNIPER(ABL)-062), showed desirable binding affinities against ABL1, cIAP1/2, and XIAP and consequently caused potent BCR-ABL degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH-F9T_RIbVbVg90H21EOLACvtfcHk0ljA-tvfjfBfuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2js7fI&md5=2500e7d9129934033f969721141a8c1b</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00247%26sid%3Dliteratum%253Aachs%26aulast%3DShimokawa%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DSameshima%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DN.%26aulast%3DUjikawa%26aufirst%3DO.%26aulast%3DNara%26aufirst%3DH.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520allosteric%2520site%2520of%2520oncoprotein%2520BCR-ABL%2520as%2520an%2520alternative%2520strategy%2520for%2520effective%2520target%2520protein%2520degradation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1042%26epage%3D1047%26doi%3D10.1021%2Facsmedchemlett.7b00247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span> <span> </span><span class="NLM_article-title">Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">5820</span>– <span class="NLM_lpage">5826</span>, <span class="refDoi"> DOI: 10.1021/ja100691p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja100691p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1Gktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=5820-5826&author=Y.+Itohauthor=M.+Ishikawaauthor=M.+Naitoauthor=Y.+Hashimoto&title=Protein+knockdown+using+methyl+bestatin-ligand+hybrid+molecules%3A+design+and+synthesis+of+inducers+of+ubiquitination-mediated+degradation+of+cellular+retinoic+acid-binding+proteins&doi=10.1021%2Fja100691p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Knockdown Using Methyl Bestatin-Ligand Hybrid Molecules: Design and Synthesis of Inducers of Ubiquitination-Mediated Degradation of Cellular Retinoic Acid-Binding Proteins</span></div><div class="casAuthors">Itoh, Yukihiro; Ishikawa, Minoru; Naito, Mikihiko; Hashimoto, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5820-5826</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Induction of selective degrdn. of target proteins by small mols. (protein knockdown) would be useful for biol. research and treatment of various diseases.  To achieve protein knockdown, we utilized the ubiquitin ligase activity of cellular inhibitor of apoptosis protein 1 (cIAP1), which is activated by Me bestatin (MeBS, 2).  We speculated that formation of an artificial (nonphysiol.) complex of cIAP1 and a target protein would be induced by a hybrid mol. consisting of MeBS (2) linked to a ligand of the target protein, and this would lead to cIAP1-mediated ubiquitination and subsequent proteasomal degrdn. of the target protein.  To verify this hypothesis, we focused on cellular retinoic acid-binding proteins (CRABP-I and -II) and designed hybrid mols. (compds. 4) consisting of MeBS (2) coupled via spacers of various lengths to all-trans retinoic acid (ATRA, 3), a ligand of CRABPs.  Compds. 4 induced selective loss of CRABP-I and -II proteins in cells.  We confirmed that 4b induced formation of a complex of cIAP1 and CRABP-II in vitro and induced proteasomal degrdn. of CRABP-II in cells.  When neuroblastoma IMR-32 cells were treated with 4b, the level of CRABP-II was reduced and cell migration was inhibited, suggesting potential value of CRABP-II-targeting therapy for controlling tumor metastasis.  Our results indicate that 4b possesses sufficient activity, permeability, and stability in cells to be employed in cellular assays.  Hybrid mols. such as 4 should be useful not only as chem. tools for studying the biol./physiol. functions of CRABPs but also as candidate therapeutic agents targeting CRABPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUZurgNT02VLVg90H21EOLACvtfcHk0ljA-tvfjfBfuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1Gktb0%253D&md5=96c56bb081695a00b6fa6c269aaeef1b</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fja100691p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja100691p%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DNaito%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26atitle%3DProtein%2520knockdown%2520using%2520methyl%2520bestatin-ligand%2520hybrid%2520molecules%253A%2520design%2520and%2520synthesis%2520of%2520inducers%2520of%2520ubiquitination-mediated%2520degradation%2520of%2520cellular%2520retinoic%2520acid-binding%2520proteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D5820%26epage%3D5826%26doi%3D10.1021%2Fja100691p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okuhira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimaki-Mogami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>585</i></span>,  <span class="NLM_fpage">1147</span>– <span class="NLM_lpage">1152</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2011.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.febslet.2011.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21414315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVGjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2011&pages=1147-1152&author=K.+Okuhiraauthor=N.+Ohokaauthor=K.+Saiauthor=T.+Nishimaki-Mogamiauthor=Y.+Itohauthor=M.+Ishikawaauthor=Y.+Hashimotoauthor=M.+Naito&title=Specific+degradation+of+CRABP-II+via+cIAP1-mediated+ubiquitylation+induced+by+hybrid+molecules+that+crosslink+cIAP1+and+the+target+protein&doi=10.1016%2Fj.febslet.2011.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein</span></div><div class="casAuthors">Okuhira, Keiichiro; Ohoka, Nobumichi; Sai, Kimie; Nishimaki-Mogami, Tomoko; Itoh, Yukihiro; Ishikawa, Minoru; Hashimoto, Yuichi; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1147-1152</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Manipulation of protein stability with small mols. is a challenge in the field of drug discovery.  Here we show that cellular retinoic acid binding protein-II (CRABP-II) can be specifically degraded by a novel compd., SNIPER-4, consisting of (-)-N-[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butyryl]-L-leucine Me ester and all-trans retinoic acid that are ligands for cellular inhibitor of apoptosis protein 1 (cIAP1) and CRABP-II, resp.  Mechanistic anal. revealed that SNIPER-4 induces cIAP1-mediated ubiquitylation of CRABP-II, resulting in the proteasomal degrdn.  The protein knockdown strategy employing the structure of SNIPER-4 could be applicable to other target proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5g-lBn9EFJrVg90H21EOLACvtfcHk0ljA-tvfjfBfuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVGjtLk%253D&md5=5f56939c9c2a68efb08283b68a570af1</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2011.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2011.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DOkuhira%26aufirst%3DK.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DSai%26aufirst%3DK.%26aulast%3DNishimaki-Mogami%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DSpecific%2520degradation%2520of%2520CRABP-II%2520via%2520cIAP1-mediated%2520ubiquitylation%2520induced%2520by%2520hybrid%2520molecules%2520that%2520crosslink%2520cIAP1%2520and%2520the%2520target%2520protein%26jtitle%3DFEBS%2520Lett.%26date%3D2011%26volume%3D585%26spage%3D1147%26epage%3D1152%26doi%3D10.1016%2Fj.febslet.2011.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okuhira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimaki-Mogami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">1492</span>– <span class="NLM_lpage">1498</span>, <span class="refDoi"> DOI: 10.1111/cas.12272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1111%2Fcas.12272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=23992566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ylu7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2013&pages=1492-1498&author=K.+Okuhiraauthor=Y.+Demizuauthor=T.+Hattoriauthor=N.+Ohokaauthor=N.+Shibataauthor=T.+Nishimaki-Mogamiauthor=H.+Okudaauthor=M.+Kuriharaauthor=M.+Naito&title=Development+of+hybrid+small+molecules+that+induce+degradation+of+estrogen+receptor-alpha+and+necrotic+cell+death+in+breast+cancer+cells&doi=10.1111%2Fcas.12272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells</span></div><div class="casAuthors">Okuhira, Keiichiro; Demizu, Yosuke; Hattori, Takayuki; Ohoka, Nobumichi; Shibata, Norihito; Nishimaki-Mogami, Tomoko; Okuda, Haruhiro; Kurihara, Masaaki; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1492-1498</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Manipulation of protein stability with small mols. has a great potential for both basic research and clin. therapy.  Recently, we have developed a series of hybrid small mols. named SNIPER (Specific and Non-genetic IAP-dependent Protein ERaser) that induces degrdn. of target proteins via ubiquitin-proteasome system.  Here we report the activities of SNIPER(ER) that targets estrogen receptor alpha (ERα) for degrdn.  SNIPER(ER) induced degrdn. of ERα and inhibited estrogen-dependent expression of pS2 gene in an estrogen-dependent breast cancer cell line MCF-7.  A proteasome inhibitor MG132 and siRNA-mediated downregulation of cIAP1 abrogated the SNIPER(ER)-induced ERα degrdn., suggesting that the ERα is degraded by proteasome subsequent to cIAP1-mediated ubiquitylation.  Intriguingly, after the ERα degrdn., the SNIPER(ER)-treated MCF-7 cells undergo rapid cell death.  Detailed anal. indicated that SNIPER(ER) caused necrotic cell death accompanied by a release of HMGB1, a marker of necrosis, from the cells.  Following the ERα degrdn., reactive oxygen species (ROS) was produced in the SNIPER(ER)-treated MCF-7 cells, and an anti-oxidant N-acetylcysteine inhibited the necrotic cell death.  These results indicate that SNIPER(ER) induces ERα degrdn., ROS prodn. and necrotic cell death, implying a therapeutic potential of SNIPER(ER) as a lead for the treatment of ERα-pos. breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpckyKeS1C4ZrVg90H21EOLACvtfcHk0lh7Ceok7CHmUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ylu7fM&md5=dc35aee47ea4cd9554a663eb077137b5</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1111%2Fcas.12272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12272%26sid%3Dliteratum%253Aachs%26aulast%3DOkuhira%26aufirst%3DK.%26aulast%3DDemizu%26aufirst%3DY.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DNishimaki-Mogami%26aufirst%3DT.%26aulast%3DOkuda%26aufirst%3DH.%26aulast%3DKurihara%26aufirst%3DM.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520hybrid%2520small%2520molecules%2520that%2520induce%2520degradation%2520of%2520estrogen%2520receptor-alpha%2520and%2520necrotic%2520cell%2520death%2520in%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Sci.%26date%3D2013%26volume%3D104%26spage%3D1492%26epage%3D1498%26doi%3D10.1111%2Fcas.12272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuhira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e1513</span> <span class="refDoi"> DOI: 10.1038/cddis.2014.471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fcddis.2014.471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=25375378" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=N.+Ohokaauthor=K.+Nagaiauthor=T.+Hattoriauthor=K.+Okuhiraauthor=N.+Shibataauthor=N.+Choauthor=M.+Naito&title=Cancer+cell+death+induced+by+novel+small+molecules+degrading+the+TACC3+protein+via+the+ubiquitin-proteasome+pathway&doi=10.1038%2Fcddis.2014.471"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.471%26sid%3Dliteratum%253Aachs%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DNagai%26aufirst%3DK.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DOkuhira%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DCancer%2520cell%2520death%2520induced%2520by%2520novel%2520small%2520molecules%2520degrading%2520the%2520TACC3%2520protein%2520via%2520the%2520ubiquitin-proteasome%2520pathway%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26doi%3D10.1038%2Fcddis.2014.471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Protein knockdown technology: application of ubiquitin ligase to cancer therapy</span>. <i>Curr. Cancer Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.2174/1568009616666151112122502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.2174%2F1568009616666151112122502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=26560118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFOqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=136-146&author=N.+Ohokaauthor=N.+Shibataauthor=T.+Hattoriauthor=M.+Naito&title=Protein+knockdown+technology%3A+application+of+ubiquitin+ligase+to+cancer+therapy&doi=10.2174%2F1568009616666151112122502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy</span></div><div class="casAuthors">Ohoka, Nobumichi; Shibata, Norihito; Hattori, Takayuki; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">136-146</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Selective degrdn. of pathogenic proteins by small mols. in cells is a novel approach for development of therapeutic agents against various diseases, including cancer.  We and others have developed a protein knockdown technol. with a series of hybrid small compds., called SNIPERs (Specific and Nongenetic IAP-dependent Protein ERasers); and peptidic chimeric mols., called PROTACs (proteolysis-targeting chimeric mols.), which induce selective degrdn. of target proteins via the ubiquitin-proteasome pathway.  These compds. include two different ligands connected by a linker; one is a ligand for a ubiquitin ligase and the other is a ligand for the target protein, which are expected to crosslink these proteins in cells.  Theor., any cytosolic protein can be targeted for degrdn. by this technol.  To date, several SNIPERs and PROTACs against various oncogenic proteins have been developed, which specifically induce polyubiquitylation and proteasomal degrdn. of the oncogenic proteins, resulting in cell death, growth arrest, or impaired migration of cancer cells.  Thus, this protein knockdown technol. has a great potential for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmS_kGOWfeuLVg90H21EOLACvtfcHk0lh7Ceok7CHmUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFOqtw%253D%253D&md5=d78f1ae70ea89843d9f946454cc95058</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.2174%2F1568009616666151112122502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009616666151112122502%26sid%3Dliteratum%253Aachs%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DProtein%2520knockdown%2520technology%253A%2520application%2520of%2520ubiquitin%2520ligase%2520to%2520cancer%2520therapy%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2016%26volume%3D16%26spage%3D136%26epage%3D146%26doi%3D10.2174%2F1568009616666151112122502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okuhira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Molecular design, synthesis, and evaluation of SNIPER(ER) that induces proteasomal degradation of ERalpha</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1366</i></span>,  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-3127-9_42</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1007%2F978-1-4939-3127-9_42" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=26585163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntV2iuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1366&publication_year=2016&pages=549-560&author=K.+Okuhiraauthor=Y.+Demizuauthor=T.+Hattoriauthor=N.+Ohokaauthor=N.+Shibataauthor=M.+Kuriharaauthor=M.+Naito&title=Molecular+design%2C+synthesis%2C+and+evaluation+of+SNIPER%28ER%29+that+induces+proteasomal+degradation+of+ERalpha&doi=10.1007%2F978-1-4939-3127-9_42"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Design, Synthesis, and Evaluation of SNIPER(ER) That Induces Proteasomal Degradation of ERα</span></div><div class="casAuthors">Okuhira, Keiichiro; Demizu, Yosuke; Hattori, Takayuki; Ohoka, Nobumichi; Shibata, Norihito; Kurihara, Masaaki; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1366</span>
        (<span class="NLM_cas:issue">Estrogen Receptors</span>),
    <span class="NLM_cas:pages">549-560</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Manipulation of protein stability using small mols. has a great potential for both basic research and clin. therapy.  Based on our protein knockdown technol., we recently developed a novel small mol. SNIPER(ER) that targets the estrogen receptor alpha (ERα) for degrdn. via the ubiquitin-proteasome system.  This chapter describes the design and synthesis of SNIPER(ER) compds., and methods for the evaluation of their activity in cellular system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw8q6LETjkkLVg90H21EOLACvtfcHk0lh7Ceok7CHmUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntV2iuro%253D&md5=ece40d5d502601cdd67d104533d497bc</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-3127-9_42&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-3127-9_42%26sid%3Dliteratum%253Aachs%26aulast%3DOkuhira%26aufirst%3DK.%26aulast%3DDemizu%26aufirst%3DY.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DKurihara%26aufirst%3DM.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DMolecular%2520design%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520SNIPER%2528ER%2529%2520that%2520induces%2520proteasomal%2520degradation%2520of%2520ERalpha%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2016%26volume%3D1366%26spage%3D549%26epage%3D560%26doi%3D10.1007%2F978-1-4939-3127-9_42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motoi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, M.</span></span> <span> </span><span class="NLM_article-title">Development of BCR-ABL degradation inducers via the conjugation of an imatinib derivative and a cIAP1 ligand</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4865</span>– <span class="NLM_lpage">4869</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.bmcl.2016.09.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27666635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOntbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4865-4869&author=Y.+Demizuauthor=N.+Shibataauthor=T.+Hattoriauthor=N.+Ohokaauthor=H.+Motoiauthor=T.+Misawaauthor=T.+Shodaauthor=M.+Naitoauthor=M.+Kurihara&title=Development+of+BCR-ABL+degradation+inducers+via+the+conjugation+of+an+imatinib+derivative+and+a+cIAP1+ligand&doi=10.1016%2Fj.bmcl.2016.09.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Development of BCR-ABL degradation inducers via the conjugation of an imatinib derivative and a cIAP1 ligand</span></div><div class="casAuthors">Demizu, Yosuke; Shibata, Norihito; Hattori, Takayuki; Ohoka, Nobumichi; Motoi, Hiromi; Misawa, Takashi; Shoda, Takuji; Naito, Mikihiko; Kurihara, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4865-4869</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The manipulation of protein stability with small mols. has great potential as a technique for aiding the development of clin. therapies, including treatments for cancer.  In this study, BCR-ABL protein degrdn. inducers called SNIPER(ABL) (Specific and Nongenetic inhibitors of apoptosis protein [IAP]-dependent Protein Erasers) were developed.  The designed mols. contained two biol. active scaffolds: one was an imatinib deriv. that binds to BCL-ABL and the other was a Me bestatin that binds to cellular IAP 1 (cIAP1).  The hybrid mols., SNIPER(ABL), were expected to recruit BCR-ABL to cIAP1 for removal by proteasomes.  In fact, SNIPER(ABL) induced the degrdn. of BCR-ABL protein and a subsequent redn. in cell growth.  Thus, the degrdn. of BCR-ABL by SNIPER(ABL) is one potential strategy for treating BCR-ABL driven chronic myelogenous leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLT6dtmVPL47Vg90H21EOLACvtfcHk0ljzUJhNXEoTYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOntbnK&md5=31c045087293acf60932a9d6c4f38504</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DDemizu%26aufirst%3DY.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DMotoi%26aufirst%3DH.%26aulast%3DMisawa%26aufirst%3DT.%26aulast%3DShoda%26aufirst%3DT.%26aulast%3DNaito%26aufirst%3DM.%26aulast%3DKurihara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520BCR-ABL%2520degradation%2520inducers%2520via%2520the%2520conjugation%2520of%2520an%2520imatinib%2520derivative%2520and%2520a%2520cIAP1%2520ligand%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4865%26epage%3D4869%26doi%3D10.1016%2Fj.bmcl.2016.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okuhira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawahara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Targeted degradation of proteins localized in subcellular compartments by hybrid small molecules</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1124/mol.116.105569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1124%2Fmol.116.105569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27965304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsFajtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2017&pages=159-166&author=K.+Okuhiraauthor=T.+Shodaauthor=R.+Omuraauthor=N.+Ohokaauthor=T.+Hattoriauthor=N.+Shibataauthor=Y.+Demizuauthor=R.+Sugiharaauthor=A.+Ichinoauthor=H.+Kawaharaauthor=Y.+Itohauthor=M.+Ishikawaauthor=Y.+Hashimotoauthor=M.+Kuriharaauthor=S.+Itohauthor=H.+Saitoauthor=M.+Naito&title=Targeted+degradation+of+proteins+localized+in+subcellular+compartments+by+hybrid+small+molecules&doi=10.1124%2Fmol.116.105569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted degradation of proteins localized in subcellular compartments by hybrid small molecules</span></div><div class="casAuthors">Okuhira, Keiichiro; Shoda, Takuji; Omura, Risa; Ohoka, Nobumichi; Hattori, Takayuki; Shibata, Norihito; Demizu, Yosuke; Sugihara, Ryo; Ichino, Asato; Kawahara, Haruka; Itoh, Yukihiro; Ishikawa, Minoru; Hashimoto, Yuichi; Kurihara, Masaaki; Itoh, Susumu; Saito, Hiroyuki; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-169</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Development of novel small mols. that selectively degrade pathogenic proteins would provide an important advance in targeted therapy.  Recently, we have devised a series of hybrid small mols. named SNIPER (specific and nongenetic IAPdependent protein ERaser) that induces the degrdn. of target proteins via the ubiquitin-proteasome system.  To understand the localization of proteins that can be targeted by this protein knockdown technol., we examd. whether SNIPER mols. are able to induce degrdn. of cellular retinoic acid binding protein II (CRABP-II) proteins localized in subcellular compartments of cells.  CRABP-II is genetically fused with subcellular localization signals, and they are expressed in the cells.  SNIPER(CRABP) with different IAP-ligands, SNIPER(CRABP)- 4 with bestatin and SNIPER(CRABP)-11 with MV1 compd., induce the proteasomal degrdn. of wild-type (WT), cytosolic, nuclear, and membrane-localized CRABP-II proteins, whereas only SNIPER(CRABP)-11 displayed degrdn. activity toward the mitochondrial CRABP-II protein.  The small interfering RNA- mediated silencing of cIAP1 expression attenuated the knockdown activity of SNIPER(CRABP) against WT and cytosolic CRABP-II proteins, indicating that cIAP1 is the E3 ligase responsible for degrdn. of these proteins.  Against membrane-localized CRABP- II protein, cIAP1 is also a primary E3 ligase in the cells, but another E3 ligase distinct from cIAP2 and X-linked inhibitor of apoptosis protein (XIAP) could also be involved in the SNIPER(CRABP)-11- induced degrdn.  However, for the degrdn. of nuclear and mitochondrial CRABP-II proteins, E3 ligases other than cIAP1, cIAP2, and XIAP play a role in the SNIPER-mediated protein knockdown.  These results indicate that SNIPER can target cytosolic, nuclear, membrane-localized, and mitochondrial proteins for degrdn., but the responsible E3 ligase is different, depending on the localization of the target protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhA3S1phDgcbVg90H21EOLACvtfcHk0ljzUJhNXEoTYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsFajtbw%253D&md5=640d098e0247d9241e3eca20a1491126</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1124%2Fmol.116.105569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.116.105569%26sid%3Dliteratum%253Aachs%26aulast%3DOkuhira%26aufirst%3DK.%26aulast%3DShoda%26aufirst%3DT.%26aulast%3DOmura%26aufirst%3DR.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DDemizu%26aufirst%3DY.%26aulast%3DSugihara%26aufirst%3DR.%26aulast%3DIchino%26aufirst%3DA.%26aulast%3DKawahara%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DKurihara%26aufirst%3DM.%26aulast%3DItoh%26aufirst%3DS.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DTargeted%2520degradation%2520of%2520proteins%2520localized%2520in%2520subcellular%2520compartments%2520by%2520hybrid%2520small%2520molecules%26jtitle%3DMol.%2520Pharmacol.%26date%3D2017%26volume%3D91%26spage%3D159%26epage%3D166%26doi%3D10.1124%2Fmol.116.105569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuhira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teratani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">In vivo knockdown of pathogenic proteins via specific and nongenetic inhibitor of apoptosis protein (IAP)-dependent protein erasers (SNIPERs)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">4556</span>– <span class="NLM_lpage">4570</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.768853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.M116.768853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=28154167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksVClur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=4556-4570&author=N.+Ohokaauthor=K.+Okuhiraauthor=M.+Itoauthor=K.+Nagaiauthor=N.+Shibataauthor=T.+Hattoriauthor=O.+Ujikawaauthor=K.+Shimokawaauthor=O.+Sanoauthor=R.+Koyamaauthor=H.+Fujitaauthor=M.+Terataniauthor=H.+Matsumotoauthor=Y.+Imaedaauthor=H.+Naraauthor=N.+Choauthor=M.+Naito&title=In+vivo+knockdown+of+pathogenic+proteins+via+specific+and+nongenetic+inhibitor+of+apoptosis+protein+%28IAP%29-dependent+protein+erasers+%28SNIPERs%29&doi=10.1074%2Fjbc.M116.768853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs)</span></div><div class="casAuthors">Ohoka, Nobumichi; Okuhira, Keiichiro; Ito, Masahiro; Nagai, Katsunori; Shibata, Norihito; Hattori, Takayuki; Ujikawa, Osamu; Shimokawa, Kenichiro; Sano, Osamu; Koyama, Ryokichi; Fujita, Hisashi; Teratani, Mika; Matsumoto, Hirokazu; Imaeda, Yasuhiro; Nara, Hiroshi; Cho, Nobuo; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4556-4570</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Many diseases, esp. cancers, result from aberrant or overexpression of pathogenic proteins.  Specific inhibitors against these proteins have shown remarkable therapeutic effects, but these are limited mainly to enzymes.  An alternative approach that may have utility in drug development relies on selective degrdn. of pathogenic proteins via small chimeric mols. linking an E3 ubiquitin ligase to the targeted protein for proteasomal degrdn.  To this end, the authors recently developed a protein knockdown system based on hybrid small mol. SNIPERs (Specific and Nongenetic IAP-dependent Protein Erasers) that recruit inhibitor of the apoptosis protein (IAP) ubiquitin ligases to specifically degrade targeted proteins.  Here, the authors extend the authors' previous study to show a proof of concept of the SNIPER technol. in vivo.  By incorporating a high affinity IAP ligand, the authors developed a novel SNIPER against estrogen receptor α (ERα), SNIPER(ER)-87, that has a potent protein knockdown activity.  The SNIPER(ER) reduced ERα levels in tumor xenografts and suppressed the growth of ERα-pos. breast tumors in mice.  Mechanistically, it preferentially recruits X-linked IAP (XIAP) rather than cellular IAP1, to degrade ERα via the ubiquitin-proteasome pathway.  With this IAP ligand, potent SNIPERs against other pathogenic proteins, BCR-ABL, bromodomain-contg. protein 4 (BRD4), and phosphodiesterase-4 (PDE4) could also be developed.  These results indicate that forced ubiquitylation by SNIPERs is a useful method to achieve efficient protein knockdown with potential therapeutic activities and could also be applied to study the role of ubiquitylation in many cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEzH5uNeAFabVg90H21EOLACvtfcHk0ljzUJhNXEoTYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksVClur8%253D&md5=b09264d53c47c54343ed92d5a6d0eb79</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.768853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.768853%26sid%3Dliteratum%253Aachs%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DOkuhira%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DNagai%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DUjikawa%26aufirst%3DO.%26aulast%3DShimokawa%26aufirst%3DK.%26aulast%3DSano%26aufirst%3DO.%26aulast%3DKoyama%26aufirst%3DR.%26aulast%3DFujita%26aufirst%3DH.%26aulast%3DTeratani%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DH.%26aulast%3DImaeda%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DH.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DIn%2520vivo%2520knockdown%2520of%2520pathogenic%2520proteins%2520via%2520specific%2520and%2520nongenetic%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528IAP%2529-dependent%2520protein%2520erasers%2520%2528SNIPERs%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D4556%26epage%3D4570%26doi%3D10.1074%2Fjbc.M116.768853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1041</span>, <span class="refDoi"> DOI: 10.1111/cas.13198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1111%2Fcas.13198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=28192613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFGkt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2017&pages=1032-1041&author=N.+Ohokaauthor=K.+Nagaiauthor=N.+Shibataauthor=T.+Hattoriauthor=H.+Naraauthor=N.+Choauthor=M.+Naito&title=SNIPER%28TACC3%29+induces+cytoplasmic+vacuolization+and+sensitizes+cancer+cells+to+Bortezomib&doi=10.1111%2Fcas.13198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib</span></div><div class="casAuthors">Ohoka, Nobumichi; Nagai, Katsunori; Shibata, Norihito; Hattori, Takayuki; Nara, Hiroshi; Cho, Nobuo; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1032-1041</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">We previously developed a hybrid small mol. SNIPER (Specific and Nongenetic IAP-dependent Protein ERaser) against transforming acidic coiled-coil-3 (TACC3), SNIPER(TACC3), that induces proteasomal degrdn. of TACC3 protein.  In this study, we found that SNIPER(TACC3) induces cytoplasmic vacuolization derived from endoplasmic reticulum (ER) and paraptosis-like cell death selectively in cancer cells.  Mechanistic anal. suggests that accumulation of ubiquitylated protein aggregates that requires X-linked inhibitor of apoptosis protein (XIAP) induces ER stress, which results in ER-stress responses involving X-box binding protein-1 (XBP-1) and ER-derived vacuolization in cancer cells.  Importantly, inhibition of proteasome enhanced the SNIPER(TACC3)-induced vacuolization, and the combination treatment of SNIPER(TACC3) and bortezomib exhibited a synergistic anticancer activity in several cancer cell lines.  The induction of paraptosis-like cell death in cancer cells by SNIPER(TACC3) could be applied to treat cancer cells resistant to undergo apoptosis by overexpression of XIAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzpVKQdkRrQrVg90H21EOLACvtfcHk0lhz6Sh0HaDrAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFGkt7g%253D&md5=8cadd012e1983f47ff426289a33e92cb</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1111%2Fcas.13198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13198%26sid%3Dliteratum%253Aachs%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DNagai%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DNara%26aufirst%3DH.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DSNIPER%2528TACC3%2529%2520induces%2520cytoplasmic%2520vacuolization%2520and%2520sensitizes%2520cancer%2520cells%2520to%2520Bortezomib%26jtitle%3DCancer%2520Sci.%26date%3D2017%26volume%3D108%26spage%3D1032%26epage%3D1041%26doi%3D10.1111%2Fcas.13198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sameshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Development of protein degradation inducers of oncogenic BCR-ABL protein by conjugation of ABL kinase inhibitors and IAP ligands</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1657</span>– <span class="NLM_lpage">1666</span>, <span class="refDoi"> DOI: 10.1111/cas.13284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1111%2Fcas.13284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=28556300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVWmt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2017&pages=1657-1666&author=N.+Shibataauthor=N.+Miyamotoauthor=K.+Nagaiauthor=K.+Shimokawaauthor=T.+Sameshimaauthor=N.+Ohokaauthor=T.+Hattoriauthor=Y.+Imaedaauthor=H.+Naraauthor=N.+Choauthor=M.+Naito&title=Development+of+protein+degradation+inducers+of+oncogenic+BCR-ABL+protein+by+conjugation+of+ABL+kinase+inhibitors+and+IAP+ligands&doi=10.1111%2Fcas.13284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Development of protein degradation inducers of oncogenic BCR-ABL protein by conjugation of ABL kinase inhibitors and IAP ligands</span></div><div class="casAuthors">Shibata, Norihito; Miyamoto, Naoki; Nagai, Katsunori; Shimokawa, Kenichiro; Sameshima, Tomoya; Ohoka, Nobumichi; Hattori, Takayuki; Imaeda, Yasuhiro; Nara, Hiroshi; Cho, Nobuo; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1657-1666</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Chromosomal translocation occurs in some cancer cells, which results in the expression of aberrant oncogenic fusion proteins that include BCR-ABL in chronic myelogenous leukemia (CML).  Inhibitors of ABL tyrosine kinase, such as imatinib and dasatinib, exhibit remarkable therapeutic effects, although emergence of drug resistance hampers the therapy during long-term treatment.  An alternative approach to treat CML is to downregulate the BCR-ABL protein.  We have devised a protein knockdown system by hybrid mols. named Specific and Non-genetic inhibitor of apoptosis protein [IAP]-dependent Protein Erasers (SNIPER), which is designed to induce IAP-mediated ubiquitylation and proteasomal degrdn. of target proteins, and a couple of SNIPER(ABL) against BCR-ABL protein have been developed recently.  In this study, we tested various combinations of ABL inhibitors and IAP ligands, and the linker was optimized for protein knockdown activity of SNIPER(ABL).  The resulting SNIPER(ABL)-39, in which dasatinib is conjugated to an IAP ligand LCL161 deriv. by polyethylene glycol (PEG) × 3 linker, shows a potent activity to degrade the BCR-ABL protein.  Mechanistic anal. suggested that both cellular inhibitor of apoptosis protein 1 (cIAP1) and X-linked inhibitor of apoptosis protein (XIAP) play a role in the degrdn. of BCR-ABL protein.  Consistent with the degrdn. of BCR-ABL protein, the SNIPER(ABL)-39 inhibited the phosphorylation of signal transducer and activator of transcription 5 (STAT5) and Crk like proto-oncogene (CrkL), and suppressed the growth of BCR-ABL-pos. CML cells.  These results suggest that SNIPER(ABL)-39 could be a candidate for a degrdn.-based novel anti-cancer drug against BCR-ABL-pos. CML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwfgAQFIWa0LVg90H21EOLACvtfcHk0lhz6Sh0HaDrAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVWmt7fP&md5=ac6370b8855fb6a0a53c2e0506eb4491</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1111%2Fcas.13284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13284%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DMiyamoto%26aufirst%3DN.%26aulast%3DNagai%26aufirst%3DK.%26aulast%3DShimokawa%26aufirst%3DK.%26aulast%3DSameshima%26aufirst%3DT.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DImaeda%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DH.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520protein%2520degradation%2520inducers%2520of%2520oncogenic%2520BCR-ABL%2520protein%2520by%2520conjugation%2520of%2520ABL%2520kinase%2520inhibitors%2520and%2520IAP%2520ligands%26jtitle%3DCancer%2520Sci.%26date%3D2017%26volume%3D108%26spage%3D1657%26epage%3D1666%26doi%3D10.1111%2Fcas.13284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshaies, R. J.</span></span> <span> </span><span class="NLM_article-title">Development of PROTACS to target cancer-promoting proteins for ubiquitination and degradation</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1358</span>, <span class="refDoi"> DOI: 10.1074/mcp.T300009-MCP200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fmcp.T300009-MCP200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=14525958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVShu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=1350-1358&author=K.+M.+Sakamotoauthor=K.+B.+Kimauthor=R.+Vermaauthor=A.+Ransickauthor=B.+Steinauthor=C.+M.+Crewsauthor=R.+J.+Deshaies&title=Development+of+PROTACS+to+target+cancer-promoting+proteins+for+ubiquitination+and+degradation&doi=10.1074%2Fmcp.T300009-MCP200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Protacs to target cancer-promoting proteins for ubiquitination and degradation</span></div><div class="casAuthors">Sakamoto, Kathleen M.; Kim, Kyung B.; Verma, Rati; Ransick, Andy; Stein, Bernd; Crews, Craig M.; Deshaies, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Proteomics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1350-1358</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9476</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The proteome contains hundreds of proteins that in theory could be excellent therapeutic targets for the treatment of human diseases.  However, many of these proteins are from functional classes that have never been validated as viable candidates for the development of small mol. inhibitors.  Thus, to exploit fully the potential of the Human Genome Project to advance human medicine, there is a need to develop generic methods of inhibiting protein activity that do not rely on the target protein's function.  The authors previously demonstrated that a normally stable protein, methionine aminopeptidase-2 or MetAP-2, could be artificially targeted to an Skp1-Cullin-F-box (SCF) ubiquitin ligase complex for ubiquitination and degrdn. through a chimeric bridging mol. or Protac (proteolysis targeting chimeric mol.).  This Protac consisted of an SCFβ-TRCP-binding phosphopeptide derived from IκBα linked to ovalicin, which covalently binds MetAP-2.  In this study, the authors employed this approach to target two different proteins, the estrogen (ER) and androgen (AR) receptors, which have been implicated in the progression of breast and prostate cancer, resp.  The authors show here that an estradiol-based Protac can enforce the ubiquitination and degrdn. of the α isoform of ER in vitro, and a dihydroxytestosterone-based Protac introduced into cells promotes the rapid disappearance of AR in a proteasome-dependent manner.  Future improvements to this technol. may yield a general approach to treat a no. of human diseases, including cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3SZSMptsCorVg90H21EOLACvtfcHk0lhz6Sh0HaDrAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVShu7jE&md5=5a9f4cf5d5cc1d990bf59ac824902111</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1074%2Fmcp.T300009-MCP200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.T300009-MCP200%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DK.%2BM.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DVerma%26aufirst%3DR.%26aulast%3DRansick%26aufirst%3DA.%26aulast%3DStein%26aufirst%3DB.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26atitle%3DDevelopment%2520of%2520PROTACS%2520to%2520target%2520cancer-promoting%2520proteins%2520for%2520ubiquitination%2520and%2520degradation%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2003%26volume%3D2%26spage%3D1350%26epage%3D1358%26doi%3D10.1074%2Fmcp.T300009-MCP200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimori, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuhira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sameshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor alpha degradation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">6776</span>– <span class="NLM_lpage">6790</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA117.001091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.RA117.001091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=29545311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVOktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2018&pages=6776-6790&author=N.+Ohokaauthor=Y.+Moritaauthor=K.+Nagaiauthor=K.+Shimokawaauthor=O.+Ujikawaauthor=I.+Fujimoriauthor=M.+Itoauthor=Y.+Hayaseauthor=K.+Okuhiraauthor=N.+Shibataauthor=T.+Hattoriauthor=T.+Sameshimaauthor=O.+Sanoauthor=R.+Koyamaauthor=Y.+Imaedaauthor=H.+Naraauthor=N.+Choauthor=M.+Naito&title=Derivatization+of+inhibitor+of+apoptosis+protein+%28IAP%29+ligands+yields+improved+inducers+of+estrogen+receptor+alpha+degradation&doi=10.1074%2Fjbc.RA117.001091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor α degradation</span></div><div class="casAuthors">Ohoka, Nobumichi; Morita, Yoko; Nagai, Katsunori; Shimokawa, Kenichiro; Ujikawa, Osamu; Fujimori, Ikuo; Ito, Masahiro; Hayase, Youji; Okuhira, Keiichiro; Shibata, Norihito; Hattori, Takayuki; Sameshima, Tomoya; Sano, Osamu; Koyama, Ryokichi; Imaeda, Yasuhiro; Nara, Hiroshi; Cho, Nobuo; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6776-6790</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aberrant expression of proteins often underlies many diseases, including cancer.  A recently developed approach in drug development is small mol.-mediated, selective degrdn. of dysregulated proteins.  The authors have devised a protein-knockdown system that utilizes chimeric mols. termed specific and nongenetic IAP-dependent protein erasers (SNIPERs) to induce ubiquitylation and proteasomal degrdn. of various target proteins.  SNIPER(ER)-87 consists of an inhibitor of apoptosis protein (IAP) ligand LCL161 deriv. that is conjugated to the estrogen receptor α (ERα) ligand 4-hydroxytamoxifen by a PEG linker, and the authors have previously reported that this SNIPER efficiently degrades the ERα protein.  Here, the authors report that derivatization of the IAP ligand module yields SNIPER(ER)s with superior protein-knockdown activity.  These improved SNIPER(ER)s exhibited higher binding affinities to IAPs and induced more potent degrdn. of ERα than does SNIPER(ER)-87.  Further, they induced simultaneous degrdn. of cellular inhibitor of apoptosis protein 1 (cIAP1) and delayed degrdn. of X-linked IAP (XIAP).  Notably, these reengineered SNIPER(ER)s efficiently induced apoptosis in MCF-7 human breast cancer cells that require IAPs for continued cellular survival.  The authors found that one of these mols., SNIPER(ER)-110, inhibits the growth of MCF-7 tumor xenografts in mice more potently than the previously characterized SNIPER(ER)-87.  Mechanistic anal. revealed that the authors' novel SNIPER(ER)s preferentially recruit XIAP, rather than cIAP1, to degrade ERα.  The authors' results suggest that derivatized IAP ligands could facilitate further development of SNIPERs with potent protein-knockdown and cytocidal activities against cancer cells requiring IAPs for survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj30BS7yI2dLVg90H21EOLACvtfcHk0lg5dA-fyozfJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVOktb4%253D&md5=5800916097e83ecb4692cdc0e0c13525</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA117.001091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA117.001091%26sid%3Dliteratum%253Aachs%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DMorita%26aufirst%3DY.%26aulast%3DNagai%26aufirst%3DK.%26aulast%3DShimokawa%26aufirst%3DK.%26aulast%3DUjikawa%26aufirst%3DO.%26aulast%3DFujimori%26aufirst%3DI.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DHayase%26aufirst%3DY.%26aulast%3DOkuhira%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DSameshima%26aufirst%3DT.%26aulast%3DSano%26aufirst%3DO.%26aulast%3DKoyama%26aufirst%3DR.%26aulast%3DImaeda%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DH.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DDerivatization%2520of%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528IAP%2529%2520ligands%2520yields%2520improved%2520inducers%2520of%2520estrogen%2520receptor%2520alpha%2520degradation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26spage%3D6776%26epage%3D6790%26doi%3D10.1074%2Fjbc.RA117.001091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasula, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashwell, J. D.</span></span> <span> </span><span class="NLM_article-title">IAPs: what’s in a name?</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2008.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.molcel.2008.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18439892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsFentLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=123-135&author=S.+M.+Srinivasulaauthor=J.+D.+Ashwell&title=IAPs%3A+what%E2%80%99s+in+a+name%3F&doi=10.1016%2Fj.molcel.2008.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">IAPs: What's in a name?</span></div><div class="casAuthors">Srinivasula, Srinivasa M.; Ashwell, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-135</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Originally described in insect viruses, cellular proteins with baculoviral IAP repeat (BIR) motifs have been thought to function primarily as inhibitors of apoptosis.  The subsequent finding that a subset of inhibitor of apoptosis proteins (IAPs) that contain a RING domain have ubiquitin protein ligase (E3) activity implied the presence of other functions.  It is now known that IAPs are involved in mitotic chromosome segregation, cellular morphogenesis, Cu homeostasis, and intracellular signaling.  Here, the authors review the current understanding of the roles of IAPs in apoptotic and nonapoptotic processes and explore the notion that the latter represents the primary physiol. activities of IAPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWWLYuSWt6U7Vg90H21EOLACvtfcHk0lg5dA-fyozfJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsFentLY%253D&md5=762b696e69868dcd7714f63a0f622e3a</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2008.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2008.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DSrinivasula%26aufirst%3DS.%2BM.%26aulast%3DAshwell%26aufirst%3DJ.%2BD.%26atitle%3DIAPs%253A%2520what%25E2%2580%2599s%2520in%2520a%2520name%253F%26jtitle%3DMol.%2520Cell%26date%3D2008%26volume%3D30%26spage%3D123%26epage%3D135%26doi%3D10.1016%2Fj.molcel.2008.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uegaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mon, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohbayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of IAP (inhibitor of apoptosis) proteins represses inflammatory status via nuclear factor-kappa B pathway in murine endometriosis lesions</span>. <i>Am. J. Reprod. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">e12780</span>, <span class="refDoi"> DOI: 10.1111/aji.12780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1111%2Faji.12780" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2018&pages=e12780&author=F.+Taniguchiauthor=T.+Uegakiauthor=K.+Nakamuraauthor=K.+Y.+Monauthor=T.+Haradaauthor=T.+Ohbayashiauthor=T.+Harada&title=Inhibition+of+IAP+%28inhibitor+of+apoptosis%29+proteins+represses+inflammatory+status+via+nuclear+factor-kappa+B+pathway+in+murine+endometriosis+lesions&doi=10.1111%2Faji.12780"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1111%2Faji.12780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Faji.12780%26sid%3Dliteratum%253Aachs%26aulast%3DTaniguchi%26aufirst%3DF.%26aulast%3DUegaki%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DMon%26aufirst%3DK.%2BY.%26aulast%3DHarada%26aufirst%3DT.%26aulast%3DOhbayashi%26aufirst%3DT.%26aulast%3DHarada%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520IAP%2520%2528inhibitor%2520of%2520apoptosis%2529%2520proteins%2520represses%2520inflammatory%2520status%2520via%2520nuclear%2520factor-kappa%2520B%2520pathway%2520in%2520murine%2520endometriosis%2520lesions%26jtitle%3DAm.%2520J.%2520Reprod.%2520Immunol.%26date%3D2018%26volume%3D79%26spage%3De12780%26doi%3D10.1111%2Faji.12780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenneth, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, C. S.</span></span> <span> </span><span class="NLM_article-title">IAP proteins: regulators of cell migration and development</span>. <i>Curr. Opin. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">871</span>– <span class="NLM_lpage">875</span>, <span class="refDoi"> DOI: 10.1016/j.ceb.2012.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.ceb.2012.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=23219152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhsl2ju7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=871-875&author=N.+S.+Kennethauthor=C.+S.+Duckett&title=IAP+proteins%3A+regulators+of+cell+migration+and+development&doi=10.1016%2Fj.ceb.2012.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">IAP proteins: regulators of cell migration and development</span></div><div class="casAuthors">Kenneth, Niall S.; Duckett, Colin S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">871-875</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The cytoprotective properties of vertebrate inhibitor of apoptosis (IAP) proteins have been the subject of much study.  These proteins have, however, emerged as key signaling intermediates modulating a variety of cellular functions through their ability to act as E3 ubiquitin ligases.  This review will focus on the cell death-independent roles of the IAP proteins, focusing on recent reports indicating that c-IAPs and XIAP are key mols. involved in modulating cell migration and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEHaeAe_26qbVg90H21EOLACvtfcHk0lhd5rdQqRnChA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhsl2ju7jI&md5=bc7cc2a38c5a577b9e308339a82a5324</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2012.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2012.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DKenneth%26aufirst%3DN.%2BS.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26atitle%3DIAP%2520proteins%253A%2520regulators%2520of%2520cell%2520migration%2520and%2520development%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2012%26volume%3D24%26spage%3D871%26epage%3D875%26doi%3D10.1016%2Fj.ceb.2012.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosas-Acosta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span> <span> </span><span class="NLM_article-title">X-linked inhibitor of apoptosis protein (XIAP) mediates cancer cell motility via Rho GDP dissociation inhibitor (RhoGDI)-dependent regulation of the cytoskeleton</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">15630</span>– <span class="NLM_lpage">15640</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.176982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.M110.176982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21402697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVWjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=15630-15640&author=J.+Liuauthor=D.+Zhangauthor=W.+Luoauthor=Y.+Yuauthor=J.+Yuauthor=J.+Liauthor=X.+Zhangauthor=B.+Zhangauthor=J.+Chenauthor=X.+R.+Wuauthor=G.+Rosas-Acostaauthor=C.+Huang&title=X-linked+inhibitor+of+apoptosis+protein+%28XIAP%29+mediates+cancer+cell+motility+via+Rho+GDP+dissociation+inhibitor+%28RhoGDI%29-dependent+regulation+of+the+cytoskeleton&doi=10.1074%2Fjbc.M110.176982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">X-linked inhibitor of apoptosis protein (XIAP) mediates cancer cell motility via Rho GDP dissociation inhibitor (RhoGDI)-dependent regulation of the cytoskeleton</span></div><div class="casAuthors">Liu, Jin-Yi; Zhang, Dong-Yun; Luo, Wen-Jing; Yu, Yong-Hui; Yu, Jian-Xiu; Li, Jing-Xia; Zhang, Xin-Hai; Zhang, Bao-Lin; Chen, Jing-Yuan; Wu, Xue-Ru; Rosas-Acosta, German; Huang, Chuan-Shu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">15630-15640</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">X-linked inhibitor of apoptosis protein (XIAP) overexpression has been found to be assocd. with malignant cancer progression and aggression in individuals with many types of cancers.  However, the mol. basis of XIAP in the regulation of cancer cell biol. behavior remains largely unknown.  In this study, we found that a deficiency of XIAP expression in human cancer cells by either knock-out or knockdown leads to a marked redn. in β-actin polymn. and cytoskeleton formation.  Consistently, cell migration and invasion were also decreased in XIAP-deficient cells compared with parental wild-type cells.  Subsequent studies demonstrated that the regulation of cell motility by XIAP depends on its interaction with the Rho GDP dissocn. inhibitor (RhoGDI) via the XIAP RING domain.  Furthermore, XIAP was found to neg. regulate RhoGDI SUMOylation, which might affect its activity in controlling cell motility.  Collectively, our studies provide novel insights into the mol. mechanisms by which XIAP regulates cancer invasion and offer a further theor. basis for setting XIAP as a potential prognostic marker and specific target for treatment of cancers with metastatic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKnYyFLCELwLVg90H21EOLACvtfcHk0lhd5rdQqRnChA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVWjtL4%253D&md5=d595cd4a97c0b13801be94ca938483bd</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.176982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.176982%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%2BR.%26aulast%3DRosas-Acosta%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DC.%26atitle%3DX-linked%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528XIAP%2529%2520mediates%2520cancer%2520cell%2520motility%2520via%2520Rho%2520GDP%2520dissociation%2520inhibitor%2520%2528RhoGDI%2529-dependent%2520regulation%2520of%2520the%2520cytoskeleton%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D15630%26epage%3D15640%26doi%3D10.1074%2Fjbc.M110.176982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oberoi, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocking, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholz, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mooz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karreman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer zu
Heringdorf, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruonala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macek, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koster, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajalingam, K.</span></span> <span> </span><span class="NLM_article-title">IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1038/emboj.2011.423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Femboj.2011.423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=22117219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeit7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=14-28&author=T.+K.+Oberoiauthor=T.+Doganauthor=J.+C.+Hockingauthor=R.+P.+Scholzauthor=J.+Moozauthor=C.+L.+Andersonauthor=C.+Karremanauthor=D.+Meyer+zu%0AHeringdorfauthor=G.+Schmidtauthor=M.+Ruonalaauthor=K.+Namikawaauthor=G.+S.+Harmsauthor=A.+Carpyauthor=B.+Macekauthor=R.+W.+Kosterauthor=K.+Rajalingam&title=IAPs+regulate+the+plasticity+of+cell+migration+by+directly+targeting+Rac1+for+degradation&doi=10.1038%2Femboj.2011.423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation</span></div><div class="casAuthors">Oberoi, Tripat Kaur; Dogan, Taner; Hocking, Jennifer C.; Scholz, Rolf-Peter; Mooz, Juliane; Anderson, Carrie L.; Karreman, Christiaan; Meyer zu Heringdorf, Dagmar; Schmidt, Gudula; Ruonala, Mika; Namikawa, Kazuhiko; Harms, Gregory S.; Carpy, Alejandro; Macek, Boris; Koester, Reinhard W.; Rajalingam, Krishnaraj</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-28</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibitors of apoptosis proteins (IAPs) are a highly conserved class of multifunctional proteins.  Rac1 is a well-studied Rho GTPase that controls numerous basic cellular processes.  While the regulation of nucleotide binding to Rac1 is well understood, the mol. mechanisms controlling Rac1 degrdn. are not known.  Here, the authors demonstrate X-linked IAP (XIAP) and cellular IAP1 (c-IAP1), which function as E3 ubiquitin ligases, directly bind to Rac1 in a nucleotide-independent manner to promote its polyubiquitination at Lys-147 and proteasomal degrdn.  These IAPs were also required for the degrdn. of Rac1 upon CNF1 toxin treatment or RhoGDI depletion.  Consistently, down-regulation of XIAP or c-IAP1 by various strategies led to an increase in Rac1 protein levels in primary and tumor cells, leading to an elongated morphol. and enhanced cell migration.  Further, XIAP counteracted Rac1-dependent cellular polarization in the developing zebrafish hindbrain and promoted the delamination of neurons from the normal tissue architecture.  These observations unveiled an evolutionarily conserved role of IAPs in controlling Rac1 stability, thereby regulating the plasticity of cell migration and morphogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdklbqF_Nl9bVg90H21EOLACvtfcHk0lhd5rdQqRnChA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeit7rO&md5=8e71e043f962700c411bd61a77ecd6a7</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1038%2Femboj.2011.423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2011.423%26sid%3Dliteratum%253Aachs%26aulast%3DOberoi%26aufirst%3DT.%2BK.%26aulast%3DDogan%26aufirst%3DT.%26aulast%3DHocking%26aufirst%3DJ.%2BC.%26aulast%3DScholz%26aufirst%3DR.%2BP.%26aulast%3DMooz%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DC.%2BL.%26aulast%3DKarreman%26aufirst%3DC.%26aulast%3DMeyer%2Bzu%2BHeringdorf%26aufirst%3DD.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DRuonala%26aufirst%3DM.%26aulast%3DNamikawa%26aufirst%3DK.%26aulast%3DHarms%26aufirst%3DG.%2BS.%26aulast%3DCarpy%26aufirst%3DA.%26aulast%3DMacek%26aufirst%3DB.%26aulast%3DKoster%26aufirst%3DR.%2BW.%26aulast%3DRajalingam%26aufirst%3DK.%26atitle%3DIAPs%2520regulate%2520the%2520plasticity%2520of%2520cell%2520migration%2520by%2520directly%2520targeting%2520Rac1%2520for%2520degradation%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D14%26epage%3D28%26doi%3D10.1038%2Femboj.2011.423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slisz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanneman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draganov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacohen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dranoff, G.</span></span> <span> </span><span class="NLM_article-title">IAP inhibitors enhance co-stimulation to promote tumor immunity</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">2195</span>– <span class="NLM_lpage">2206</span>, <span class="refDoi"> DOI: 10.1084/jem.20101123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1084%2Fjem.20101123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=20837698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Cms73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2010&pages=2195-2206&author=M.+Douganauthor=S.+Douganauthor=J.+Sliszauthor=B.+Firestoneauthor=M.+Vannemanauthor=D.+Draganovauthor=G.+Goyalauthor=W.+Liauthor=D.+Neubergauthor=R.+Blumbergauthor=N.+Hacohenauthor=D.+Porterauthor=L.+Zawelauthor=G.+Dranoff&title=IAP+inhibitors+enhance+co-stimulation+to+promote+tumor+immunity&doi=10.1084%2Fjem.20101123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">IAP inhibitors enhance co-stimulation to promote tumor immunity</span></div><div class="casAuthors">Dougan, Michael; Dougan, Stephanie; Slisz, Joanna; Firestone, Brant; Vanneman, Matthew; Draganov, Dobrin; Goyal, Girija; Li, Weibo; Neuberg, Donna; Blumberg, Richard; Hacohen, Nir; Porter, Dale; Zawel, Leigh; Dranoff, Glenn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2195-2206</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis proteins (IAPs) have recently been shown to modulate nuclear factor κB (NF-κB) signaling downstream of tumor necrosis factor (TNF) family receptors, positioning them as essential survival factors in several cancer cell lines, as indicated by the cytotoxic activity of several novel small mol. IAP antagonists.  In addn. to roles in cancer, increasing evidence suggests that IAPs have an important function in immunity; however, the impact of IAP antagonists on antitumor immune responses is unknown.  In this study, the authors examine the consequences of IAP antagonism on T cell function in vitro and in the context of a tumor vaccine in vivo.  The authors find that IAP antagonists can augment human and mouse T cell responses to physiol. relevant stimuli.  The activity of IAP antagonists depends on the activation of NF-κB2 signaling, a mechanism paralleling that responsible for the cytotoxic activity in cancer cells.  The authors further show that IAP antagonists can augment both prophylactic and therapeutic antitumor vaccines in vivo.  These findings indicate an important role for the IAPs in regulating T cell-dependent responses and suggest that targeting IAPs using small mol. antagonists may be a strategy for developing novel immunomodulating therapies against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmv-vLXjlFDbVg90H21EOLACvtfcHk0lh-3tBuuwSaiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Cms73P&md5=6e49336c9cac37d0f1be08f65014cd0f</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1084%2Fjem.20101123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20101123%26sid%3Dliteratum%253Aachs%26aulast%3DDougan%26aufirst%3DM.%26aulast%3DDougan%26aufirst%3DS.%26aulast%3DSlisz%26aufirst%3DJ.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DVanneman%26aufirst%3DM.%26aulast%3DDraganov%26aufirst%3DD.%26aulast%3DGoyal%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DNeuberg%26aufirst%3DD.%26aulast%3DBlumberg%26aufirst%3DR.%26aulast%3DHacohen%26aufirst%3DN.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DZawel%26aufirst%3DL.%26aulast%3DDranoff%26aufirst%3DG.%26atitle%3DIAP%2520inhibitors%2520enhance%2520co-stimulation%2520to%2520promote%2520tumor%2520immunity%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2010%26volume%3D207%26spage%3D2195%26epage%3D2206%26doi%3D10.1084%2Fjem.20101123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, M.</span></span> <span> </span><span class="NLM_article-title">Regulation of innate and adaptive antitumor immunity by IAP antagonists</span>. <i>Immunotherapy</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.2217/imt-2017-0185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.2217%2Fimt-2017-0185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=29807457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlWqsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=787-796&author=S.+K.+Douganauthor=M.+Dougan&title=Regulation+of+innate+and+adaptive+antitumor+immunity+by+IAP+antagonists&doi=10.2217%2Fimt-2017-0185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of innate and adaptive antitumor immunity by IAP antagonists</span></div><div class="casAuthors">Dougan, Stephanie K.; Dougan, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Immunotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">787-796</span>CODEN:
                <span class="NLM_cas:coden">IMMUCO</span>;
        ISSN:<span class="NLM_cas:issn">1750-7448</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Inhibition of the T-cell co-inhibitory checkpoint receptors or their ligands CTLA-4, PD-1 and PD-L1 using monoclonal antibodies has proven to be highly effective against many cancers.  Yet many cancers remain resistant to checkpoint blockade, and durable remissions occur in only a minority of patients.  Novel approaches to enhancing antitumor responses are thus necessary in order to expand the reach of these treatments.  The inhibitor of apoptosis (IAP) protein family comprises a diverse group of proteins, many of which have immunoregulatory roles.  Small mol. IAP antagonists have been developed and are undergoing early phase clin. testing.  These drugs were initially developed to promote tumor cell apoptosis; however, a considerable body of work now indicates that IAP antagonists induce antitumor activity through modulation of innate and adaptive immunity.  Primarily through inhibition of cellular (c)-IAP1 and c-IAP2, IAP antagonists can activate alternative NF-κB signaling, promoting B-cell survival, activation of dendritic cells and delivering a broad co-stimulatory signal to T cells.  At the same time, IAP antagonists can promote tumor cell intrinsic sensitization to innate immune signals, and enhance tumor cell killing by inflammatory cytokines and phagocytic macrophages.  These drugs thus represent an attractive investigational approach to immunotherapy, providing a pos. signaling counterpart to the relief of signal inhibition conferred by checkpoint blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCDoHKW4B6TbVg90H21EOLACvtfcHk0lh-3tBuuwSaiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlWqsrzE&md5=98f73cd2f999007630043823f6ea38c0</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.2217%2Fimt-2017-0185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fimt-2017-0185%26sid%3Dliteratum%253Aachs%26aulast%3DDougan%26aufirst%3DS.%2BK.%26aulast%3DDougan%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520innate%2520and%2520adaptive%2520antitumor%2520immunity%2520by%2520IAP%2520antagonists%26jtitle%3DImmunotherapy%26date%3D2018%26volume%3D10%26spage%3D787%26epage%3D796%26doi%3D10.2217%2Fimt-2017-0185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbitt, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharik, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dueck, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asmann, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhmetzyanova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosiorek, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calcinotto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggs, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keane, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmann, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacy, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ailawadhi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dispenzieri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buadi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeder, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanan-Khan, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fooksman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergsagel, P. L.</span></span> <span> </span><span class="NLM_article-title">IAP antagonists induce anti-tumor immunity in multiple myeloma</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1411</span>– <span class="NLM_lpage">1420</span>, <span class="refDoi"> DOI: 10.1038/nm.4229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnm.4229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27841872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVGgtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=1411-1420&author=M.+Chesiauthor=N.+N.+Mirzaauthor=V.+M.+Garbittauthor=M.+E.+Sharikauthor=A.+C.+Dueckauthor=Y.+W.+Asmannauthor=I.+Akhmetzyanovaauthor=H.+E.+Kosiorekauthor=A.+Calcinottoauthor=D.+L.+Riggsauthor=N.+Keaneauthor=G.+J.+Ahmannauthor=K.+M.+Morrisonauthor=R.+Fonsecaauthor=M.+Q.+Lacyauthor=D.+Dingliauthor=S.+K.+Kumarauthor=S.+Ailawadhiauthor=A.+Dispenzieriauthor=F.+Buadiauthor=M.+A.+Gertzauthor=C.+B.+Reederauthor=Y.+Linauthor=A.+A.+Chanan-Khanauthor=A.+K.+Stewartauthor=D.+Fooksmanauthor=P.+L.+Bergsagel&title=IAP+antagonists+induce+anti-tumor+immunity+in+multiple+myeloma&doi=10.1038%2Fnm.4229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">IAP antagonists induce anti-tumor immunity in multiple myeloma</span></div><div class="casAuthors">Chesi, Marta; Mirza, Noweeda N.; Garbitt, Victoria M.; Sharik, Meaghen E.; Dueck, Amylou C.; Asmann, Yan W.; Akhmetzyanova, Ilseyar; Kosiorek, Heidi E.; Calcinotto, Arianna; Riggs, Daniel L.; Keane, Niamh; Ahmann, Gregory J.; Morrison, Kevin M.; Fonseca, Rafael; Lacy, Martha Q.; Dingli, David; Kumar, Shaji K.; Ailawadhi, Sikander; Dispenzieri, Angela; Buadi, Francis; Gertz, Morie A.; Reeder, Craig B.; Lin, Yi; Chanan-Khan, Asher A.; Stewart, A. Keith; Fooksman, David; Bergsagel, P. Leif</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1411-1420</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The cellular inhibitors of apoptosis (cIAP) 1 and 2 are amplified in about 3% of cancers and have been identified in multiple malignancies as being potential therapeutic targets as a result of their role in the evasion of apoptosis.  Consequently, small-mol. IAP antagonists, such as LCL161, have entered clin. trials for their ability to induce tumor necrosis factor (TNF)-mediated apoptosis of cancer cells.  However, cIAP1 and cIAP2 are recurrently homozygously deleted in multiple myeloma (MM), resulting in constitutive activation of the noncanonical nuclear factor (NF)-κB pathway.  To our surprise, we obsd. robust in vivo anti-myeloma activity of LCL161 in a transgenic myeloma mouse model and in patients with relapsed-refractory MM, where the addn. of cyclophosphamide resulted in a median progression-free-survival of 10 mo.  This effect was not a result of direct induction of tumor cell death, but rather of upregulation of tumor-cell-autonomous type I interferon (IFN) signaling and a strong inflammatory response that resulted in the activation of macrophages and dendritic cells, leading to phagocytosis of tumor cells.  Treatment of a MM mouse model with LCL161 established long-term anti-tumor protection and induced regression in a fraction of the mice.  Notably, combination of LCL161 with the immune-checkpoint inhibitor anti-PD1 was curative in all of the treated mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLwOgDYr44NbVg90H21EOLACvtfcHk0lh-3tBuuwSaiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVGgtL3N&md5=cb7f2d3f3cc01efe48ed29cfd281ef57</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1038%2Fnm.4229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4229%26sid%3Dliteratum%253Aachs%26aulast%3DChesi%26aufirst%3DM.%26aulast%3DMirza%26aufirst%3DN.%2BN.%26aulast%3DGarbitt%26aufirst%3DV.%2BM.%26aulast%3DSharik%26aufirst%3DM.%2BE.%26aulast%3DDueck%26aufirst%3DA.%2BC.%26aulast%3DAsmann%26aufirst%3DY.%2BW.%26aulast%3DAkhmetzyanova%26aufirst%3DI.%26aulast%3DKosiorek%26aufirst%3DH.%2BE.%26aulast%3DCalcinotto%26aufirst%3DA.%26aulast%3DRiggs%26aufirst%3DD.%2BL.%26aulast%3DKeane%26aufirst%3DN.%26aulast%3DAhmann%26aufirst%3DG.%2BJ.%26aulast%3DMorrison%26aufirst%3DK.%2BM.%26aulast%3DFonseca%26aufirst%3DR.%26aulast%3DLacy%26aufirst%3DM.%2BQ.%26aulast%3DDingli%26aufirst%3DD.%26aulast%3DKumar%26aufirst%3DS.%2BK.%26aulast%3DAilawadhi%26aufirst%3DS.%26aulast%3DDispenzieri%26aufirst%3DA.%26aulast%3DBuadi%26aufirst%3DF.%26aulast%3DGertz%26aufirst%3DM.%2BA.%26aulast%3DReeder%26aufirst%3DC.%2BB.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DChanan-Khan%26aufirst%3DA.%2BA.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26aulast%3DFooksman%26aufirst%3DD.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26atitle%3DIAP%2520antagonists%2520induce%2520anti-tumor%2520immunity%2520in%2520multiple%2520myeloma%26jtitle%3DNat.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D1411%26epage%3D1420%26doi%3D10.1038%2Fnm.4229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clancy-Thompson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruck, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Exley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumberg, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dranoff, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, S. K.</span></span> <span> </span><span class="NLM_article-title">IAP antagonists enhance cytokine production from mouse and human iNKT cells</span>. <i>Cancer Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1158/2326-6066.CIR-17-0490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F2326-6066.CIR-17-0490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=29187357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVSltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=25-35&author=E.+Clancy-Thompsonauthor=L.+Aliauthor=P.+T.+Bruckauthor=M.+A.+Exleyauthor=R.+S.+Blumbergauthor=G.+Dranoffauthor=M.+Douganauthor=S.+K.+Dougan&title=IAP+antagonists+enhance+cytokine+production+from+mouse+and+human+iNKT+cells&doi=10.1158%2F2326-6066.CIR-17-0490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells</span></div><div class="casAuthors">Clancy-Thompson, Eleanor; Ali, Lestat; Bruck, Patrick T.; Exley, Mark A.; Blumberg, Richard S.; Dranoff, Glenn; Dougan, Michael; Dougan, Stephanie K.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-35</span>CODEN:
                <span class="NLM_cas:coden">CIRACV</span>;
        ISSN:<span class="NLM_cas:issn">2326-6066</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis protein (IAP) antagonists are in clin. trials for a variety of cancers, and mouse models show synergism between IAP antagonists and anti-PD-1 immunotherapy.  Although IAP antagonists affect the intrinsic signaling of tumor cells, their most pronounced effects are on immune cells and the generation of antitumor immunity.  Here, we examd. the effects of IAP antagonism on T-cell development using mouse fetal thymic organ culture and obsd. a selective loss of iNKT cells, an effector cell type of potential importance for cancer immunotherapy.  Thymic iNKT-cell development probably failed due to increased strength of TCR signal leading to neg. selection, given that mature iNKT cells treated with IAP antagonists were not depleted, but had enhanced cytokine prodn. in both mouse and human ex vivo cultures.  Consistent with this, mature mouse primary iNKT cells and iNKT hybridomas increased prodn. of effector cytokines in the presence of IAP antagonists.  In vivo administration of IAP antagonists and α-GalCer resulted in increased IFNγ and IL-2 prodn. from iNKT cells and decreased tumor burden in a mouse model of melanoma lung metastasis.  Human iNKT cells also proliferated and increased IFNγ prodn. dramatically in the presence of IAP antagonists, demonstrating the utility of these compds. in adoptive therapy of iNKT cells.  Cancer Immunol Res; 6(1); 25-35. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ZRHeL8HNz7Vg90H21EOLACvtfcHk0lgqd8VCBcKqxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVSltQ%253D%253D&md5=e0979ec634d8723cfaa43063c6074dc5</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1158%2F2326-6066.CIR-17-0490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2326-6066.CIR-17-0490%26sid%3Dliteratum%253Aachs%26aulast%3DClancy-Thompson%26aufirst%3DE.%26aulast%3DAli%26aufirst%3DL.%26aulast%3DBruck%26aufirst%3DP.%2BT.%26aulast%3DExley%26aufirst%3DM.%2BA.%26aulast%3DBlumberg%26aufirst%3DR.%2BS.%26aulast%3DDranoff%26aufirst%3DG.%26aulast%3DDougan%26aufirst%3DM.%26aulast%3DDougan%26aufirst%3DS.%2BK.%26atitle%3DIAP%2520antagonists%2520enhance%2520cytokine%2520production%2520from%2520mouse%2520and%2520human%2520iNKT%2520cells%26jtitle%3DCancer%2520Immunol.%2520Res.%26date%3D2018%26volume%3D6%26spage%3D25%26epage%3D35%26doi%3D10.1158%2F2326-6066.CIR-17-0490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vince, J.</span></span> <span> </span><span class="NLM_article-title">IAPs and cell death</span>. <i>Curr. Top. Microbiol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>403</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1007/82_2016_507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1007%2F82_2016_507" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=2016&pages=95-117&author=J.+Silkeauthor=J.+Vince&title=IAPs+and+cell+death&doi=10.1007%2F82_2016_507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1007%2F82_2016_507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F82_2016_507%26sid%3Dliteratum%253Aachs%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DVince%26aufirst%3DJ.%26atitle%3DIAPs%2520and%2520cell%2520death%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2016%26volume%3D403%26spage%3D95%26epage%3D117%26doi%3D10.1007%2F82_2016_507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of necroptosis: an ordered cellular explosion</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">700</span>– <span class="NLM_lpage">714</span>, <span class="refDoi"> DOI: 10.1038/nrm2970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnrm2970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=20823910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFajsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=700-714&author=P.+Vandenabeeleauthor=L.+Galluzziauthor=T.+Vanden+Bergheauthor=G.+Kroemer&title=Molecular+mechanisms+of+necroptosis%3A+an+ordered+cellular+explosion&doi=10.1038%2Fnrm2970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of necroptosis: an ordered cellular explosion</span></div><div class="casAuthors">Vandenabeele, Peter; Galluzzi, Lorenzo; Vanden Berghe, Tom; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">700-714</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  For a long time, apoptosis was considered the sole form of programmed cell death during development, homeostasis and disease, whereas necrosis was regarded as an unregulated and uncontrollable process.  Evidence now reveals that necrosis can also occur in a regulated manner.  The initiation of programmed necrosis, 'necroptosis', by death receptors (such as tumor necrosis factor receptor 1) requires the kinase activity of receptor-interacting protein 1 (RIP1; also known as RIPK1) and RIP3 (also known as RIPK3), and its execution involves the active disintegration of mitochondrial, lysosomal and plasma membranes.  Necroptosis participates in the pathogenesis of diseases, including ischemic injury, neurodegeneration and viral infection, thereby representing an attractive target for the avoidance of unwarranted cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvEe8vjo9AoLVg90H21EOLACvtfcHk0lgqd8VCBcKqxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFajsL7P&md5=bc7798f807de31771d8e620acf754b92</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1038%2Fnrm2970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2970%26sid%3Dliteratum%253Aachs%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMolecular%2520mechanisms%2520of%2520necroptosis%253A%2520an%2520ordered%2520cellular%2520explosion%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D700%26epage%3D714%26doi%3D10.1038%2Fnrm2970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Small molecule probes for cellular death machines</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2017.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.cbpa.2017.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=28628894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVWqsb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2017&pages=74-82&author=Y.+Liauthor=L.+Qianauthor=J.+Yuan&title=Small+molecule+probes+for+cellular+death+machines&doi=10.1016%2Fj.cbpa.2017.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule probes for cellular death machines</span></div><div class="casAuthors">Li, Ying; Qian, Lihui; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-82</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The past decade has witnessed a significant expansion of our understanding about the regulated cell death mechanisms beyond apoptosis.  The application of chem. biol. approaches had played a major role in driving these exciting discoveries.  The discovery and use of small mol. probes in cell death research has not only revealed significant insights into the regulatory mechanism of cell death but also provided new drug targets and lead drug candidates for developing therapeutics of human diseases with huge unmet need.  Here, we provide an overview of small mol. modulators for necroptosis and ferroptosis, two non-apoptotic cell death mechanisms, and discuss the mol. pathways and relevant pathophysiol. mechanisms revealed by the judicial applications of such small mol. probes.  We suggest that the development and applications of small mol. probes for non-apoptotic cell death mechanisms provide an outstanding example showcasing the power of chem. biol. in exploring novel biol. mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWclFUTaB4dLVg90H21EOLACvtfcHk0lgqd8VCBcKqxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVWqsb7N&md5=b77651a179b4f644dbceef9f32220876</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2017.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2017.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DSmall%2520molecule%2520probes%2520for%2520cellular%2520death%2520machines%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D39%26spage%3D74%26epage%3D82%26doi%3D10.1016%2Fj.cbpa.2017.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vince, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feltham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benetatos, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunduru, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinlay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverkus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tergaonkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callus, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koentgen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaux, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span> <span> </span><span class="NLM_article-title">IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">682</span>– <span class="NLM_lpage">693</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.10.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.cell.2007.10.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18022363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSgur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=682-693&author=J.+E.+Vinceauthor=W.+W.+Wongauthor=N.+Khanauthor=R.+Felthamauthor=D.+Chauauthor=A.+U.+Ahmedauthor=C.+A.+Benetatosauthor=S.+K.+Chunduruauthor=S.+M.+Condonauthor=M.+McKinlayauthor=R.+Brinkauthor=M.+Leverkusauthor=V.+Tergaonkarauthor=P.+Schneiderauthor=B.+A.+Callusauthor=F.+Koentgenauthor=D.+L.+Vauxauthor=J.+Silke&title=IAP+antagonists+target+cIAP1+to+induce+TNFalpha-dependent+apoptosis&doi=10.1016%2Fj.cell.2007.10.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis</span></div><div class="casAuthors">Vince, James E.; Wong, W. Wei-Lynn; Khan, Nufail; Feltham, Rebecca; Chau, Diep; Ahmed, Afsar U.; Benetatos, Christopher A.; Chunduru, Srinivas K.; Condon, Stephen M.; McKinlay, Mark; Brink, Robert; Leverkus, Martin; Tergaonkar, Vinay; Schneider, Pascal; Callus, Bernard A.; Koentgen, Frank; Vaux, David L.; Silke, John</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">682-693</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">XIAP prevents apoptosis by binding to and inhibiting caspases, and this inhibition can be relieved by IAP antagonists, such as Smac/DIABLO.  IAP antagonist compds. (IACs) have therefore been designed to inhibit XIAP to kill tumor cells.  Because XIAP inhibits postmitochondrial caspases, caspase 8 inhibitors should not block killing by IACs.  Instead, the authors show that apoptosis caused by an IAC is blocked by the caspase 8 inhibitor crmA and that IAP antagonists activate NF-κB signaling via inhibition of cIAP1.  In sensitive tumor lines, IAP antagonist induced NF-κB-stimulated prodn. of TNFα that killed cells in an autocrine fashion.  Inhibition of NF-κB reduced TNFα prodn., and blocking NF-κB activation or TNFα allowed tumor cells to survive IAC-induced apoptosis.  Cells treated with an IAC, or those in which cIAP1 was deleted, became sensitive to apoptosis induced by exogenous TNFα, suggesting novel uses of these compds. in treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqNa8nssRGeLVg90H21EOLACvtfcHk0liT2l7ik9GOxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSgur3N&md5=9e973670c472d0612d947a2ffe688d20</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.10.037%26sid%3Dliteratum%253Aachs%26aulast%3DVince%26aufirst%3DJ.%2BE.%26aulast%3DWong%26aufirst%3DW.%2BW.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DChau%26aufirst%3DD.%26aulast%3DAhmed%26aufirst%3DA.%2BU.%26aulast%3DBenetatos%26aufirst%3DC.%2BA.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DMcKinlay%26aufirst%3DM.%26aulast%3DBrink%26aufirst%3DR.%26aulast%3DLeverkus%26aufirst%3DM.%26aulast%3DTergaonkar%26aufirst%3DV.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DCallus%26aufirst%3DB.%2BA.%26aulast%3DKoentgen%26aufirst%3DF.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DIAP%2520antagonists%2520target%2520cIAP1%2520to%2520induce%2520TNFalpha-dependent%2520apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D682%26epage%3D693%26doi%3D10.1016%2Fj.cell.2007.10.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauster, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigenzahn, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stukalov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lardeau, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorzoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruckner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gridling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parapatics, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colinge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubicek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krautwald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span> <span> </span><span class="NLM_article-title">A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1767</span> <span class="refDoi"> DOI: 10.1038/cddis.2015.130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fcddis.2015.130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=25996294" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&author=A.+Fausterauthor=M.+Rebsamenauthor=K.+V.+Huberauthor=J.+W.+Bigenzahnauthor=A.+Stukalovauthor=C.+H.+Lardeauauthor=S.+Scorzoniauthor=M.+Brucknerauthor=M.+Gridlingauthor=K.+Parapaticsauthor=J.+Colingeauthor=K.+L.+Bennettauthor=S.+Kubicekauthor=S.+Krautwaldauthor=A.+Linkermannauthor=G.+Superti-Furga&title=A+cellular+screen+identifies+ponatinib+and+pazopanib+as+inhibitors+of+necroptosis&doi=10.1038%2Fcddis.2015.130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2015.130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2015.130%26sid%3Dliteratum%253Aachs%26aulast%3DFauster%26aufirst%3DA.%26aulast%3DRebsamen%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DK.%2BV.%26aulast%3DBigenzahn%26aufirst%3DJ.%2BW.%26aulast%3DStukalov%26aufirst%3DA.%26aulast%3DLardeau%26aufirst%3DC.%2BH.%26aulast%3DScorzoni%26aufirst%3DS.%26aulast%3DBruckner%26aufirst%3DM.%26aulast%3DGridling%26aufirst%3DM.%26aulast%3DParapatics%26aufirst%3DK.%26aulast%3DColinge%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DK.%2BL.%26aulast%3DKubicek%26aufirst%3DS.%26aulast%3DKrautwald%26aufirst%3DS.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26atitle%3DA%2520cellular%2520screen%2520identifies%2520ponatinib%2520and%2520pazopanib%2520as%2520inhibitors%2520of%2520necroptosis%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2015%26volume%3D6%26doi%3D10.1038%2Fcddis.2015.130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safferthal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of necroptosis by SMAC mimetic bypasses apoptosis resistance in acute myeloid leukemia cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1487</span>– <span class="NLM_lpage">1502</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fonc.2016.310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27869161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvV2ntr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=1487-1502&author=C.+Safferthalauthor=K.+Rohdeauthor=S.+Fulda&title=Therapeutic+targeting+of+necroptosis+by+SMAC+mimetic+bypasses+apoptosis+resistance+in+acute+myeloid+leukemia+cells&doi=10.1038%2Fonc.2016.310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells</span></div><div class="casAuthors">Safferthal, C.; Rohde, K.; Fulda, S.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1487-1502</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Resistance to apoptosis, for example due to overexpression of Inhibitor of Apoptosis (IAP) proteins, is assocd. with poor prognosis in acute myeloid leukemia (AML).  Here, we identify that Smac mimetics such as BV6, which antagonizes IAP proteins, elicit necroptosis in AML cells, in which apoptosis is inhibited pharmacol. by caspase inhibitors or genetically by caspase-8 knockdown.  Importantly, BV6 triggers necroptosis also in apoptosis-resistant patient-derived AML blasts, underlining the clin. relevance of our findings.  Mechanistically, we show that BV6-induced cell death depends on key components of necroptosis signaling such as RIP1, RIP3 and MLKL, since pharmacol. or genetic inhibition of these proteins significantly protects AML cells from BV6-mediated cell death, whereas PGAM5 is dispensable.  Interestingly, we identify constitutive tumor necrosis factor-alpha (TNFα) secretion and an autocrine/paracrine TNFα loop as crit. mediators of BV6-induced necroptosis in AML cell lines and patient-derived blasts, as the TNFα-blocking antibody Enbrel or tumor necrosis factor-alpha receptor 1 (TNFR1) knockdown significantly rescue cell death.  Notably, AML cells exhibit high basal levels of TNFα compared to non-malignant CD34+ cells, which is further increased by BV6.  In conclusion, this is the first report showing that Smac mimetics circumvent apoptosis resistance in AML cells by inducing necroptosis in a TNFα-dependent manner, which has important implications for the development of new strategies to overcome treatment resistance in AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3FlE4mhKWHLVg90H21EOLACvtfcHk0liT2l7ik9GOxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvV2ntr%252FE&md5=f5e560e534db4acf5c098c48d53a70bc</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.310%26sid%3Dliteratum%253Aachs%26aulast%3DSafferthal%26aufirst%3DC.%26aulast%3DRohde%26aufirst%3DK.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DTherapeutic%2520targeting%2520of%2520necroptosis%2520by%2520SMAC%2520mimetic%2520bypasses%2520apoptosis%2520resistance%2520in%2520acute%2520myeloid%2520leukemia%2520cells%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D1487%26epage%3D1502%26doi%3D10.1038%2Fonc.2016.310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinhart, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e802</span> <span class="refDoi"> DOI: 10.1038/cddis.2013.320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fcddis.2013.320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=24030154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWru7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&author=L.+Steinhartauthor=K.+Belzauthor=S.+Fulda&title=SMAC+mimetic+and+demethylating+agents+synergistically+trigger+cell+death+in+acute+myeloid+leukemia+cells+and+overcome+apoptosis+resistance+by+inducing+necroptosis&doi=10.1038%2Fcddis.2013.320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis</span></div><div class="casAuthors">Steinhart, L.; Belz, K.; Fulda, S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Sept.</span>),
    <span class="NLM_cas:pages">e802</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Evasion of apoptosis, for example, by inhibitor of apoptosis (IAP) proteins, contributes to treatment resistance and poor outcome in acute myeloid leukemia (AML).  Here we identify a novel synergistic interaction between the small-mol. second mitochondria-derived activator of caspases (Smac) mimetic BV6, which antagonizes X-linked IAP, cellular IAP (cIAP)1 and cIAP2, and the demethylating agents 5-azacytidine or 5-aza-2'-deoxycytidine (DAC) to induce cell death in AML cells, including apoptosis-resistant cells.  Calcn. of combination index (CI) confirms that this drug combination is highly synergistic (CI 0.02-0.4).  In contrast, BV6 and DAC at equimolar concns. do not cause synergistic toxicity against normal peripheral blood lymphocytes, pointing to some tumor cell selectivity.  Mol. studies reveal that BV6 and DAC cooperate to trigger the activation of caspases, mitochondrial perturbations and DNA fragmentation, consistent with apoptotic cell death.  However, the broad-range caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (zVAD.fmk) fails to protect against BV6/DAC-induced cell death and even significantly increases the percentage of Annexin-V/propidium iodide double-pos. cells.  Importantly, BV6/DAC-induced cell death in the presence of zVAD.fmk is significantly reduced by pharmacol. inhibition of key components of necroptosis signaling, i.e., receptor-interacting protein (RIP) 1 using necrostatin-1 or mixed lineage kinase domain-like protein (MLKL) using necrosulfonamide.  This indicates a switch from BV6/DAC-induced cell death from apoptosis to necroptosis upon caspase inhibition.  Thus, BV6 cooperates with demethylating agents to induce cell death in AML cells and circumvents apoptosis resistance via a switch to necroptosis as an alternative mode of cell death.  The identification of a novel synergism of BV6 and demethylating agents has important implications for the development of new treatment strategies for AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVGaKa7EEAo7Vg90H21EOLACvtfcHk0li_rVwP5VDHBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWru7nO&md5=55db38f2119584b4424d0ee75caba93b</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.320%26sid%3Dliteratum%253Aachs%26aulast%3DSteinhart%26aufirst%3DL.%26aulast%3DBelz%26aufirst%3DK.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DSMAC%2520mimetic%2520and%2520demethylating%2520agents%2520synergistically%2520trigger%2520cell%2520death%2520in%2520acute%2520myeloid%2520leukemia%2520cells%2520and%2520overcome%2520apoptosis%2520resistance%2520by%2520inducing%2520necroptosis%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26doi%3D10.1038%2Fcddis.2013.320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinwascher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugues, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoeneberger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel synergistic induction of cell death by SMAC mimetic and HDAC inhibitors in acute myeloid leukemia cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2015.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.canlet.2015.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=26028172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsVWku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2015&pages=32-43&author=S.+Steinwascherauthor=A.+L.+Nuguesauthor=H.+Schoenebergerauthor=S.+Fulda&title=Identification+of+a+novel+synergistic+induction+of+cell+death+by+SMAC+mimetic+and+HDAC+inhibitors+in+acute+myeloid+leukemia+cells&doi=10.1016%2Fj.canlet.2015.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel synergistic induction of cell death by Smac mimetic and HDAC inhibitors in acute myeloid leukemia cells</span></div><div class="casAuthors">Steinwascher, Sofie; Nugues, Anne-Lucie; Schoeneberger, Hannah; Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-43</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Inhibitor of Apoptosis (IAP) proteins are expressed at high levels in acute myeloid leukemia (AML) and contribute to resistance to programmed cell death.  Here, we report that inhibition of IAP proteins by the small-mol. Smac mimetic BV6 acts together with histone deacetylase (HDAC) inhibitors (HDACIs) such as MS275 or SAHA to trigger cell death in AML cell lines in a synergistic manner, as underscored by calcn. of combination index (CI).  Also, BV6 and HDACIs cooperate to trigger DNA fragmentation, a marker of apoptotic cell death, and to suppress long-term clonogenic survival of AML cells.  In contrast, equimolar concns. of BV6 and MS275 or SAHA do not synergize to elicit cell death in normal peripheral blood lymphocytes (PBLs), emphasizing some tumor cell selectivity of this combination treatment.  Addn. of the tumor necrosis factor (TNF)α-blocking antibody Enbrel significantly reduces BV6/MS275-induced cell death in the majority of AML cell lines, indicating that autocrine/paracrine TNFα signaling contributes to cell death.  Remarkably, the broad-range caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (zVAD.fmk) fails to rescue MV4-11, Molm13 and OCI-AML3 cells and even enhances BV6/MS275-mediated cell death, whereas zVAD.fmk reduces BV6/MS275-induced cell death in NB4 cells.  Annexin-V/propidium iodide (PI) double staining reveals that BV6/MS275 cotreatment predominately increases the percentage of double-pos. cells.  Of note, the Receptor-Interacting Protein (RIP)1 inhibitor necrostatin-1 (Nec-1) or the Mixed Lineage Kinase Domain-Like protein (MLKL) inhibitor necrosulfonamide (NSA) significantly reduce BV6/MS275-induced cell death in the presence of zVAD.fmk, suggesting that BV6/MS275 cotreatment triggers necroptosis when caspases are inhibited.  Thus, BV6 acts in concert with HDACIs to induce cell death in AML cells and can bypass apoptosis resistance, at least in several AML cell lines, by engaging necroptosis as an alternative route of regulated cell death.  The identification of a novel synergism of BV6 and HDACIs has important implications for the development of new treatment strategies for AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyEt2llVRSPrVg90H21EOLACvtfcHk0li_rVwP5VDHBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsVWku7o%253D&md5=6afbf3069ba87555e5b8f0c3ba81678b</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DSteinwascher%26aufirst%3DS.%26aulast%3DNugues%26aufirst%3DA.%2BL.%26aulast%3DSchoeneberger%26aufirst%3DH.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520novel%2520synergistic%2520induction%2520of%2520cell%2520death%2520by%2520SMAC%2520mimetic%2520and%2520HDAC%2520inhibitors%2520in%2520acute%2520myeloid%2520leukemia%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D366%26spage%3D32%26epage%3D43%26doi%3D10.1016%2Fj.canlet.2015.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brumatti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalaoui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanzer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomilio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaser, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Valle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gugasyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurthridge, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaux, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekert, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span> <span> </span><span class="NLM_article-title">The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">339ra69</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aad3099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1126%2Fscitranslmed.aad3099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27194727" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=339ra69&author=G.+Brumattiauthor=C.+Maauthor=N.+Lalaouiauthor=N.+Y.+Nguyenauthor=M.+Navarroauthor=M.+C.+Tanzerauthor=J.+Richmondauthor=M.+Ghisiauthor=J.+M.+Salmonauthor=N.+Silkeauthor=G.+Pomilioauthor=S.+P.+Glaserauthor=E.+de+Valleauthor=R.+Gugasyanauthor=M.+A.+Gurthridgeauthor=S.+M.+Condonauthor=R.+W.+Johnstoneauthor=R.+Lockauthor=G.+Salvesenauthor=A.+Weiauthor=D.+L.+Vauxauthor=P.+G.+Ekertauthor=J.+Silke&title=The+caspase-8+inhibitor+emricasan+combines+with+the+SMAC+mimetic+birinapant+to+induce+necroptosis+and+treat+acute+myeloid+leukemia&doi=10.1126%2Fscitranslmed.aad3099"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad3099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad3099%26sid%3Dliteratum%253Aachs%26aulast%3DBrumatti%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DLalaoui%26aufirst%3DN.%26aulast%3DNguyen%26aufirst%3DN.%2BY.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DTanzer%26aufirst%3DM.%2BC.%26aulast%3DRichmond%26aufirst%3DJ.%26aulast%3DGhisi%26aufirst%3DM.%26aulast%3DSalmon%26aufirst%3DJ.%2BM.%26aulast%3DSilke%26aufirst%3DN.%26aulast%3DPomilio%26aufirst%3DG.%26aulast%3DGlaser%26aufirst%3DS.%2BP.%26aulast%3Dde%2BValle%26aufirst%3DE.%26aulast%3DGugasyan%26aufirst%3DR.%26aulast%3DGurthridge%26aufirst%3DM.%2BA.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DLock%26aufirst%3DR.%26aulast%3DSalvesen%26aufirst%3DG.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DEkert%26aufirst%3DP.%2BG.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DThe%2520caspase-8%2520inhibitor%2520emricasan%2520combines%2520with%2520the%2520SMAC%2520mimetic%2520birinapant%2520to%2520induce%2520necroptosis%2520and%2520treat%2520acute%2520myeloid%2520leukemia%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D339ra69%26doi%3D10.1126%2Fscitranslmed.aad3099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McComb, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguade-Gorgorio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marovca, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cario, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrappe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanulla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Stackelberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourquin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornhauser, B. C.</span></span> <span> </span><span class="NLM_article-title">Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">339ra70</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aad2986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1126%2Fscitranslmed.aad2986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27194728" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=339ra70&author=S.+McCombauthor=J.+Aguade-Gorgorioauthor=L.+Harderauthor=B.+Marovcaauthor=G.+Carioauthor=C.+Eckertauthor=M.+Schrappeauthor=M.+Stanullaauthor=A.+von+Stackelbergauthor=J.+P.+Bourquinauthor=B.+C.+Bornhauser&title=Activation+of+concurrent+apoptosis+and+necroptosis+by+SMAC+mimetics+for+the+treatment+of+refractory+and+relapsed+ALL&doi=10.1126%2Fscitranslmed.aad2986"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad2986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad2986%26sid%3Dliteratum%253Aachs%26aulast%3DMcComb%26aufirst%3DS.%26aulast%3DAguade-Gorgorio%26aufirst%3DJ.%26aulast%3DHarder%26aufirst%3DL.%26aulast%3DMarovca%26aufirst%3DB.%26aulast%3DCario%26aufirst%3DG.%26aulast%3DEckert%26aufirst%3DC.%26aulast%3DSchrappe%26aufirst%3DM.%26aulast%3DStanulla%26aufirst%3DM.%26aulast%3Dvon%2BStackelberg%26aufirst%3DA.%26aulast%3DBourquin%26aufirst%3DJ.%2BP.%26aulast%3DBornhauser%26aufirst%3DB.%2BC.%26atitle%3DActivation%2520of%2520concurrent%2520apoptosis%2520and%2520necroptosis%2520by%2520SMAC%2520mimetics%2520for%2520the%2520treatment%2520of%2520refractory%2520and%2520relapsed%2520ALL%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D339ra70%26doi%3D10.1126%2Fscitranslmed.aad2986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cekay, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuth, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>410</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2017.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.canlet.2017.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=28923396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGhtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2017&pages=228-237&author=M.+J.+Cekayauthor=S.+Roeslerauthor=T.+Frankauthor=A.+K.+Knuthauthor=I.+Eckhardtauthor=S.+Fulda&title=SMAC+mimetics+and+type+II+interferon+synergistically+induce+necroptosis+in+various+cancer+cell+lines&doi=10.1016%2Fj.canlet.2017.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines</span></div><div class="casAuthors">Cekay, Michael John; Roesler, Stefanie; Frank, Tanja; Knuth, Anne-Kathrin; Eckhardt, Ines; Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">410</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">228-237</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Since cancer cells often evade apoptosis, induction of necroptosis as another mode of programmed cell death is considered a promising therapeutic alternative.  Here, we identify a novel synergistic interaction of Smac mimetics that antagonize x-linked Inhibitor of Apoptosis (XIAP), cellular Inhibitor of Apoptosis (cIAP) 1 and 2 with interferon (IFN)γ to induce necroptosis in apoptosis-resistant cancer cells in which caspase activation is blocked.  This synergism is confirmed by calcn. of combination indexes (CIs) and found in both solid and hematol. cancer cell lines as well as for different Smac mimetics (i.e. BV6, Birinapant), pointing to a broader relevance.  Importantly, individual genetic knockdown of key components of necroptosis signaling, i.e. receptor-interacting protein (RIP) 1, RIP3 or mixed lineage kinase domain-like pseudokinase (MLKL), significantly protects from BV6/IFNγ-induced cell death.  Similarly, pharmacol. inhibitors of RIP1 (necrostatin-1(Nec-1)), RIP3 (GSK'872) or MLKL (necrosulfonamide (NSA)) significantly reduce BV6/IFNγ-stimulated cell death.  Of note, IFN-regulatory factor (IRF)1 is required for BV6/IFNγ-mediated necroptosis, as IRF1 silencing provides protection from cell death.  By comparison, antibodies blocking tumor necrosis factor (TNF)α, TNF-related apoptosis-inducing ligand (TRAIL) or CD95 ligand fail to inhibit BV6/IFNγ-induced cell death, pointing to a mechanism independently of death receptor ligands.  This is the first report showing that Smac mimetics synergize with IFNγ to trigger necroptosis in apoptosis-resistant cancer cells with important implications for Smac mimetic-based strategies for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3zPXAKQHzirVg90H21EOLACvtfcHk0lhlYmiMDaiBng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGhtrzO&md5=914c8888c0ad91effdafac9a6ca41dbc</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DCekay%26aufirst%3DM.%2BJ.%26aulast%3DRoesler%26aufirst%3DS.%26aulast%3DFrank%26aufirst%3DT.%26aulast%3DKnuth%26aufirst%3DA.%2BK.%26aulast%3DEckhardt%26aufirst%3DI.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DSMAC%2520mimetics%2520and%2520type%2520II%2520interferon%2520synergistically%2520induce%2520necroptosis%2520in%2520various%2520cancer%2520cell%2520lines%26jtitle%3DCancer%2520Lett.%26date%3D2017%26volume%3D410%26spage%3D228%26epage%3D237%26doi%3D10.1016%2Fj.canlet.2017.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hannes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abhari, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>380</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.05.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.canlet.2016.05.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27267809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28Xptl2msb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2016&pages=31-38&author=S.+Hannesauthor=B.+A.+Abhariauthor=S.+Fulda&title=SMAC+mimetic+triggers+necroptosis+in+pancreatic+carcinoma+cells+when+caspase+activation+is+blocked&doi=10.1016%2Fj.canlet.2016.05.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked</span></div><div class="casAuthors">Hannes, Sabine; Abhari, Behnaz Ahangarian; Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-38</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Evasion of apoptosis represents a key mechanism of treatment resistance of pancreatic cancer (PC) and contributes to the poor prognosis of this cancer type.  Here, we report that induction of necroptosis is an alternative strategy to trigger programmed cell death in apoptosis-resistant PC cells.  We show that the second mitochondrial activator of caspases (Smac) mimetic BV6 that antagonizes inhibitor of apoptosis (IAP) proteins induces necroptosis in PC cells in which apoptosis is blocked by the caspase inhibitor zVAD.fmk.  Intriguingly, BV6 switches autocrine/paracrine prodn. of tumor necrosis factor (TNF)α by PC cells into a death signal and also acts in concert with exogenously supplied TNFα to trigger necroptosis, when caspase activation is simultaneously blocked.  BV6 stimulates TNFα prodn. and formation of the receptor-interacting protein (RIP)1/RIP3-contg. necrosome complex in PC cells.  Knockdown of TNF receptor 1 (TNFR1) protects PC cells from BV6- or BV6/TNFα-mediated cell death, demonstrating that TNFα autocrine/paracrine signaling by PC cells contributes to BV6-induced necroptosis.  Importantly, genetic silencing of receptor interacting protein kinase 3 (RIPK3) or mixed lineage kinase domain-like protein (MLKL) significantly rescues PC cells from BV6- or BV6/TNFα-induced cell death.  Similarly, pharmacol. inhibition of RIP1, RIP3 or MLKL significantly reduces BV6- or BV6/TNFα-stimulated cell death.  By demonstrating that Smac mimetics can bypass resistance to apoptosis by triggering necroptosis as an alternative form of programmed cell death, our findings have important implications for the design of new treatment concepts for PC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprc2H6W9HoZ7Vg90H21EOLACvtfcHk0lhlYmiMDaiBng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xptl2msb4%253D&md5=3019374fa5667c7fd4a01762ebace34d</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.05.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.05.036%26sid%3Dliteratum%253Aachs%26aulast%3DHannes%26aufirst%3DS.%26aulast%3DAbhari%26aufirst%3DB.%2BA.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DSMAC%2520mimetic%2520triggers%2520necroptosis%2520in%2520pancreatic%2520carcinoma%2520cells%2520when%2520caspase%2520activation%2520is%2520blocked%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D380%26spage%3D31%26epage%3D38%26doi%3D10.1016%2Fj.canlet.2016.05.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetic-induced caspase-independent necroptosis requires RIP1 in breast cancer</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.3892/mmr.2015.4542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.3892%2Fmmr.2015.4542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=26573429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsVOqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=359-366&author=G.+Jinauthor=Y.+Lanauthor=F.+Hanauthor=Y.+Sunauthor=Z.+Liuauthor=M.+Zhangauthor=X.+Liuauthor=X.+Zhangauthor=J.+Huauthor=H.+Liuauthor=B.+Wang&title=SMAC+mimetic-induced+caspase-independent+necroptosis+requires+RIP1+in+breast+cancer&doi=10.3892%2Fmmr.2015.4542"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Smac mimetic-induced caspase-independent necroptosis requires RIP1 in breast cancer</span></div><div class="casAuthors">Jin, Gongsheng; Lan, Yadong; Han, Fusheng; Sun, Yiming; Liu, Zhe; Zhang, Mingliang; Liu, Xianfu; Zhang, Xiaojing; Hu, Jianguo; Liu, Hao; Wang, Benzhong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1, Pt. A</span>),
    <span class="NLM_cas:pages">359-366</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-2997</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">There is an urgent requirement for the development of novel targeted therapies to treat breast cancer, which is the most comment type of malignancy among women.  The evasion of apoptosis is a hallmark of cancer, and is often due to the upregulation of inhibitor of apoptosis proteins (IAPs) in tumor cells.  Second mitochondrial-derived activator of caspase/direct IAP-binding protein with low PI is a natural IAP antagonist, which is found in the mitochondrion; this protein has a motif, which binds to a surface groove on the baculovirus IAP repeat domains of the IAPs.  In the present study, the effects of the LCL161 Smac mimetic, a small mol. IAP antagonist, on breast cell lines was examd.  The results from MTT and colony formation assays demonstrated that LCL161 markedly inhibited the proliferation and induced the apoptosis of MDA-MB-231 and MCF-7 cell lines.  As detd. by western blotting, cIAP1 was degraded in the breast cancer cells, which occurred in an LCL161-dependent manner.  Upon caspase activation, LCL161 treatment induced necroptosis, another form of programmed cell death.  The downregulation of receptor-interacting protein kinase-1 via small interfering RNA protected the cells from LCL161-induced necroptosis.  Taken together, the results of the present study showed that LCL161 can induce multiple forms of programmed cell death in breast cancer cells, and may thus offer promise as an anticancer agent in diverse genotypic backgrounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfi2gxJMeSc7Vg90H21EOLACvtfcHk0lhlYmiMDaiBng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsVOqtbc%253D&md5=9bf26552bf3204f95405d580d2afce51</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2015.4542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2015.4542%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DG.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DB.%26atitle%3DSMAC%2520mimetic-induced%2520caspase-independent%2520necroptosis%2520requires%2520RIP1%2520in%2520breast%2520cancer%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2016%26volume%3D13%26spage%3D359%26epage%3D366%26doi%3D10.3892%2Fmmr.2015.4542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chromik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safferthal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serve, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>344</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2013.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.canlet.2013.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=24184825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWksLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2014&pages=101-109&author=J.+Chromikauthor=C.+Safferthalauthor=H.+Serveauthor=S.+Fulda&title=SMAC+mimetic+primes+apoptosis-resistant+acute+myeloid+leukaemia+cells+for+cytarabine-induced+cell+death+by+triggering+necroptosis&doi=10.1016%2Fj.canlet.2013.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis</span></div><div class="casAuthors">Chromik, Joerg; Safferthal, Charlotta; Serve, Hubert; Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-109</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The prognosis for patients with acute myeloid leukemia (AML) is still poor, thus calling for novel treatment strategies.  Here, we report that the small-mol. Smac mimetic BV6, which antagonizes Inhibitor of Apoptosis (IAP) proteins, acts in concert with cytarabine (AraC) to trigger cell death in AML cells in a highly synergistic manner (combination index 0.02-0.27).  Similarly, BV6 cooperates with AraC to trigger cell death in primary AML samples, underscoring the clin. relevance of our findings.  Mol. studies reveal that the TNFα-blocking antibody Enbrel significantly reduces BV6/AraC-induced cell death, demonstrating that an autocrine/paracrine TNFα loop mediates cell death.  Furthermore, BV6 and AraC synergize to induce loss of mitochondrial membrane potential, caspase activation and DNA fragmentation, consistent with apoptotic cell death.  Nevertheless, the caspase inhibitor zVAD.fmk fails to protect against BV6/AraC-induced cell death.  Intriguingly, this cell death upon caspase inhibition is significantly reduced by pharmacol. inhibition of two key components of necroptosis signaling, i.e. by RIP1 kinase inhibitor Necrostatin-1 or MLKL inhibitor NSA.  Thus, BV6 sensitizes AML cells to AraC-induced cell death and overcomes apoptosis resistance by triggering necroptosis as alternative form of cell death.  These findings have important implications for Smac mimetic-based strategies to bypass apoptosis resistance of AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtA4eI6yYN47Vg90H21EOLACvtfcHk0lgo-Nx4q2Am_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWksLrN&md5=2270f71fe315c8591581630b4c871fe3</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2013.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2013.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DChromik%26aufirst%3DJ.%26aulast%3DSafferthal%26aufirst%3DC.%26aulast%3DServe%26aufirst%3DH.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DSMAC%2520mimetic%2520primes%2520apoptosis-resistant%2520acute%2520myeloid%2520leukaemia%2520cells%2520for%2520cytarabine-induced%2520cell%2520death%2520by%2520triggering%2520necroptosis%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D344%26spage%3D101%26epage%3D109%26doi%3D10.1016%2Fj.canlet.2013.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vince, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawlor, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span> <span> </span><span class="NLM_article-title">Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2012.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.immuni.2012.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=22365665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=215-227&author=J.+E.+Vinceauthor=W.+W.+Wongauthor=I.+Gentleauthor=K.+E.+Lawlorauthor=R.+Allamauthor=L.+O%E2%80%99Reillyauthor=K.+Masonauthor=O.+Grossauthor=S.+Maauthor=G.+Guardaauthor=H.+Andertonauthor=R.+Castilloauthor=G.+Hackerauthor=J.+Silkeauthor=J.+Tschopp&title=Inhibitor+of+apoptosis+proteins+limit+RIP3+kinase-dependent+interleukin-1+activation&doi=10.1016%2Fj.immuni.2012.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor of Apoptosis Proteins Limit RIP3 Kinase-Dependent Interleukin-1 Activation</span></div><div class="casAuthors">Vince, James E.; Wong, W. Wei-Lynn; Gentle, Ian; Lawlor, Kate E.; Allam, Ramanjaneyulu; O'Reilly, Lorraine; Mason, Kylie; Gross, Olaf; Ma, Stephen; Guarda, Greta; Anderton, Holly; Castillo, Rosa; Hacker, Georg; Silke, John; Tschopp, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-227</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Interleukin-1β (IL-1β) is a potent inflammatory cytokine that is usually cleaved and activated by inflammasome-assocd. caspase-1.  To det. whether IL-1β activation is regulated by inhibitor of apoptosis (IAP) proteins, we treated macrophages with an IAP-antagonist "Smac mimetic" compd. or genetically deleted the genes that encode the three IAP family members cIAP1, cIAP2, and XIAP.  After Toll-like receptor priming, IAP inhibition triggered cleavage of IL-1β that was mediated not only by the NLRP3-caspase-1 inflammasome, but also by caspase-8 in a caspase-1-independent manner.  In the absence of IAPs, rapid and full generation of active IL-1β by the NLRP3-caspase-1 inflammasome, or by caspase-8, required the kinase RIP3 and reactive oxygen species prodn.  These results demonstrate that activation of the cell death-inducing ripoptosome platform and RIP3 can generate bioactive IL-1β and implicate them as addnl. targets for the treatment of pathol. IL-1-driven inflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraQ4W4rNSHa7Vg90H21EOLACvtfcHk0lgo-Nx4q2Am_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSmsbw%253D&md5=bbc9ccbe0c31918b7350cf3250c801d6</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2012.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2012.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DVince%26aufirst%3DJ.%2BE.%26aulast%3DWong%26aufirst%3DW.%2BW.%26aulast%3DGentle%26aufirst%3DI.%26aulast%3DLawlor%26aufirst%3DK.%2BE.%26aulast%3DAllam%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DL.%26aulast%3DMason%26aufirst%3DK.%26aulast%3DGross%26aufirst%3DO.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DGuarda%26aufirst%3DG.%26aulast%3DAnderton%26aufirst%3DH.%26aulast%3DCastillo%26aufirst%3DR.%26aulast%3DHacker%26aufirst%3DG.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DInhibitor%2520of%2520apoptosis%2520proteins%2520limit%2520RIP3%2520kinase-dependent%2520interleukin-1%2520activation%26jtitle%3DImmunity%26date%3D2012%26volume%3D36%26spage%3D215%26epage%3D227%26doi%3D10.1016%2Fj.immuni.2012.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenneth, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, C. S.</span></span> <span> </span><span class="NLM_article-title">An inactivating caspase 11 passenger mutation originating from the 129 murine strain in mice targeted for c-IAP1</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>443</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1042/BJ20120249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1042%2FBJ20120249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=22332634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvV2qtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=443&publication_year=2012&pages=355-359&author=N.+S.+Kennethauthor=J.+M.+Youngerauthor=E.+D.+Hughesauthor=D.+Marcotteauthor=P.+A.+Barkerauthor=T.+L.+Saundersauthor=C.+S.+Duckett&title=An+inactivating+caspase+11+passenger+mutation+originating+from+the+129+murine+strain+in+mice+targeted+for+c-IAP1&doi=10.1042%2FBJ20120249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">An inactivating caspase 11 passenger mutation originating from the 129 murine strain in mice targeted for c-IAP1</span></div><div class="casAuthors">Kenneth, Niall S.; Younger, J. Michael; Hughes, Elizabeth D.; Marcotte, Danielle; Barker, Philip A.; Saunders, Thomas L.; Duckett, Colin S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">443</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">355-359</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A recent study revealed that ES (embryonic stem) cell lines derived from the 129 murine strain carry an inactivating mutation within the caspase 11 gene (Casp4) locus [Kayagaki, Warming, Lamkanfi, Vande Walle, Louie, Dong, Newton, Qu, Liu, Heldens, Zhang, Lee, Roose-Girma and Dixit (2011) Nature 479, 117-121].  Thus, if 129 ES cells are used to target genes closely linked to caspase 11, the resulting mice might also carry the caspase 11 deficiency as a passenger mutation.  In the present study, we examd. the genetic loci of mice targeted for the closely linked c-IAP (cellular inhibitor of apoptosis) genes, which were generated in 129 ES cells, and found that, despite extensive backcrossing into a C57BL/6 background, c-IAP1-/- animals are also deficient in caspase 11.  Consequently, data obtained from these mice should be re-evaluated in this new context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqjYBOAY4CFLVg90H21EOLACvtfcHk0lgo-Nx4q2Am_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvV2qtrw%253D&md5=471f0b836ca27ef9a60070d0829572da</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1042%2FBJ20120249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20120249%26sid%3Dliteratum%253Aachs%26aulast%3DKenneth%26aufirst%3DN.%2BS.%26aulast%3DYounger%26aufirst%3DJ.%2BM.%26aulast%3DHughes%26aufirst%3DE.%2BD.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DBarker%26aufirst%3DP.%2BA.%26aulast%3DSaunders%26aufirst%3DT.%2BL.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26atitle%3DAn%2520inactivating%2520caspase%252011%2520passenger%2520mutation%2520originating%2520from%2520the%2520129%2520murine%2520strain%2520in%2520mice%2520targeted%2520for%2520c-IAP1%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D443%26spage%3D355%26epage%3D359%26doi%3D10.1042%2FBJ20120249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rickert, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ware, C. F.</span></span> <span> </span><span class="NLM_article-title">Mousing around with caspases and IAPs</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>443</i></span>,  <span class="NLM_fpage">e1</span>– <span class="NLM_lpage">2</span>, <span class="refDoi"> DOI: 10.1042/BJ20120402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1042%2FBJ20120402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=22452818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvV2qtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=443&publication_year=2012&pages=e1-2&author=R.+C.+Rickertauthor=G.+S.+Salvesenauthor=C.+F.+Ware&title=Mousing+around+with+caspases+and+IAPs&doi=10.1042%2FBJ20120402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Mousing around with caspases and IAPs</span></div><div class="casAuthors">Rickert, Robert C.; Salvesen, Guy S.; Ware, Carl F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">443</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1-e2</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">In a paper in this issue of the Biochem. Journal that questions the role of c-IAP1 (cellular inhibitor of apoptosis 1) in inflammation, new results from the Duckett lab. remind us of the importance of truly knowing the mice we depend on.  It turns out that c-IAP1 is tightly linked to caspase 11 and cannot be segregated by recombination.  This disturbing result implies that immune functions ascribed to c-IAP1 may be due to the caspase 11 mutation that is co-inherited with the locus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmmyfYfcoCBbVg90H21EOLACvtfcHk0lhY1QROJtTDnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvV2qtLs%253D&md5=90828413fadde10d506bc0656715c4b3</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1042%2FBJ20120402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20120402%26sid%3Dliteratum%253Aachs%26aulast%3DRickert%26aufirst%3DR.%2BC.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DWare%26aufirst%3DC.%2BF.%26atitle%3DMousing%2520around%2520with%2520caspases%2520and%2520IAPs%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D443%26spage%3De1%26epage%3D2%26doi%3D10.1042%2FBJ20120402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, B.</span></span> <span> </span><span class="NLM_article-title">Research progress of the relationship between pyroptosis and disease</span>. <i>Am. J. Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2213</span>– <span class="NLM_lpage">2219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=30093958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADC%252BB3c7mslantA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=2213-2219&author=Y.+Maauthor=J.+Jiangauthor=Y.+Gaoauthor=T.+Shiauthor=X.+Zhuauthor=K.+Zhangauthor=K.+Luauthor=B.+Xue&title=Research+progress+of+the+relationship+between+pyroptosis+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Research progress of the relationship between pyroptosis and disease</span></div><div class="casAuthors">Ma Yuze; Jiang Jiaxuan; Gao Yuan; Lu Ke; Xue Bin; Shi Tianshu; Zhu Xiaobo; Zhang Kaijia; Lu Ke; Xue Bin; Xue Bin</div><div class="citationInfo"><span class="NLM_cas:title">American journal of translational research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2213-2219</span>
        ISSN:<span class="NLM_cas:issn">1943-8141</span>.
    </div><div class="casAbstract">Pyroptosis, characterized by proinflammation, has been defined as a new type of programmed cell death in recent years.  Inflammasomes are activated by the corresponding pathogen-associated molecular patterns (PAMPS) or damage-associated molecular patterns (DAMPS), followed up by the cleavage of pro-interleukin-1β (pro-IL-1β), pro-interleukin-18 (pro-IL-18) and gasdermin D.  The N-terminal fragment of gasdermin D gives rise to the destruction of cell membrane, leading to cell rupture as well as the efflux of proinflammatory cytokines.  Recent studies have shown that pyroptosis is associated with a variety of diseases due to its proinflammation effect and the dysfunction of related cells.  The relationship between pyroptosis and associated diseases is described in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSReK5aqxQUscvLc4ARHEmzfW6udTcc2eZelz-sVSKv3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7mslantA%253D%253D&md5=2a90a458ac8a2669855b1d3f36e8f2ca</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DXue%26aufirst%3DB.%26atitle%3DResearch%2520progress%2520of%2520the%2520relationship%2520between%2520pyroptosis%2520and%2520disease%26jtitle%3DAm.%2520J.%2520Transl.%2520Res.%26date%3D2018%26volume%3D10%26spage%3D2213%26epage%3D2219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preston, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toe, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojaimi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baschuk, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachbur, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torresi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, M.</span></span> <span> </span><span class="NLM_article-title">Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">5803</span>– <span class="NLM_lpage">5808</span>, <span class="refDoi"> DOI: 10.1073/pnas.1502400112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1073%2Fpnas.1502400112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=25902530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=5803-5808&author=G.+Ebertauthor=C.+Allisonauthor=S.+Prestonauthor=J.+Cooneyauthor=J.+G.+Toeauthor=M.+D.+Stutzauthor=S.+Ojaimiauthor=N.+Baschukauthor=U.+Nachburauthor=J.+Torresiauthor=J.+Silkeauthor=C.+G.+Begleyauthor=M.+Pellegrini&title=Eliminating+hepatitis+B+by+antagonizing+cellular+inhibitors+of+apoptosis&doi=10.1073%2Fpnas.1502400112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis</span></div><div class="casAuthors">Ebert, Gregor; Allison, Cody; Preston, Simon; Cooney, James; Toe, Jesse G.; Stutz, Michael D.; Ojaimi, Samar; Baschuk, Nikola; Nachbur, Ueli; Torresi, Joseph; Silke, John; Begley, C. Glenn; Pellegrini, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5803-5808</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We have shown that cellular inhibitor of apoptosis proteins (cIAPs) impair clearance of hepatitis B virus (HBV) infection by preventing TNF-mediated killing/death of infected cells.  A key question, with profound therapeutic implications, is whether this finding can be translated to the development of drugs that promote elimination of infected cells.  Drug inhibitors of cIAPs were developed as cancer therapeutics to promote TNF-mediated tumor killing.  These drugs are also known as Smac mimetics, because they mimic the action of the endogenous protein Smac/Diablo that antagonizes cIAP function.  Here, we show using an immunocompetent mouse model of chronic HBV infection that birinapant and other Smac mimetics are able to rapidly reduce serum HBV DNA and serum HBV surface antigen, and they promote the elimination of hepatocytes contg. HBV core antigen.  The efficacy of Smac mimetics in treating HBV infection is dependent on their chem., host CD4+ T cells, and TNF.  Birinapant enhances the ability of entecavir, an antiviral nucleoside analog, to reduce viral DNA prodn. in HBV-infected animals.  These results indicate that birinapant and other Smac mimetics may have efficacy in treating HBV infection and perhaps, other intracellular infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6fFsKqFdCAbVg90H21EOLACvtfcHk0liN7iOAivc-wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOrsLk%253D&md5=dd522bba71dfdeba3f9804c680745f78</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1502400112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1502400112%26sid%3Dliteratum%253Aachs%26aulast%3DEbert%26aufirst%3DG.%26aulast%3DAllison%26aufirst%3DC.%26aulast%3DPreston%26aufirst%3DS.%26aulast%3DCooney%26aufirst%3DJ.%26aulast%3DToe%26aufirst%3DJ.%2BG.%26aulast%3DStutz%26aufirst%3DM.%2BD.%26aulast%3DOjaimi%26aufirst%3DS.%26aulast%3DBaschuk%26aufirst%3DN.%26aulast%3DNachbur%26aufirst%3DU.%26aulast%3DTorresi%26aufirst%3DJ.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DBegley%26aufirst%3DC.%2BG.%26aulast%3DPellegrini%26aufirst%3DM.%26atitle%3DEliminating%2520hepatitis%2520B%2520by%2520antagonizing%2520cellular%2520inhibitors%2520of%2520apoptosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D5803%26epage%3D5808%26doi%3D10.1073%2Fpnas.1502400112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preston, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toe, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojaimi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baschuk, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachbur, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torresi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colledge, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revill, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, M.</span></span> <span> </span><span class="NLM_article-title">Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">5797</span>– <span class="NLM_lpage">5802</span>, <span class="refDoi"> DOI: 10.1073/pnas.1502390112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1073%2Fpnas.1502390112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=25902529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=5797-5802&author=G.+Ebertauthor=S.+Prestonauthor=C.+Allisonauthor=J.+Cooneyauthor=J.+G.+Toeauthor=M.+D.+Stutzauthor=S.+Ojaimiauthor=H.+W.+Scottauthor=N.+Baschukauthor=U.+Nachburauthor=J.+Torresiauthor=R.+Chinauthor=D.+Colledgeauthor=X.+Liauthor=N.+Warnerauthor=P.+Revillauthor=S.+Bowdenauthor=J.+Silkeauthor=C.+G.+Begleyauthor=M.+Pellegrini&title=Cellular+inhibitor+of+apoptosis+proteins+prevent+clearance+of+hepatitis+B+virus&doi=10.1073%2Fpnas.1502390112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus</span></div><div class="casAuthors">Ebert, Gregor; Preston, Simon; Allison, Cody; Cooney, James; Toe, Jesse G.; Stutz, Michael D.; Ojaimi, Samar; Scott, Hamish W.; Baschuk, Nikola; Nachbur, Ueli; Torresi, Joseph; Chin, Ruth; Colledge, Danielle; Li, Xin; Warner, Nadia; Revill, Peter; Bowden, Scott; Silke, John; Begley, C. Glenn; Pellegrini, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5797-5802</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Hepatitis B virus (HBV) infection can result in a spectrum of outcomes from immune-mediated control to disease progression, cirrhosis, and liver cancer.  The host mol. pathways that influence and contribute to these outcomes need to be defined.  Using an immunocompetent mouse model of chronic HBV infection, we identified some of the host cellular and mol. factors that impact on infection outcomes.  Here, we show that cellular inhibitor of apoptosis proteins (cIAPs) attenuate TNF signaling during hepatitis B infection, and they restrict the death of infected hepatocytes, thus allowing viral persistence.  Animals with a liver-specific cIAP1 and total cIAP2 deficiency efficiently control HBV infection compared with WT mice.  This phenotype was partly recapitulated in mice that were deficient in cIAP2 alone.  These results indicate that antagonizing the function of cIAPs may promote the clearance of HBV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ5MHwS37sJbVg90H21EOLACvtfcHk0lhP6aZjoYqluQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOrsLg%253D&md5=098384720ec928dc72c3b0c41bb88d02</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1502390112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1502390112%26sid%3Dliteratum%253Aachs%26aulast%3DEbert%26aufirst%3DG.%26aulast%3DPreston%26aufirst%3DS.%26aulast%3DAllison%26aufirst%3DC.%26aulast%3DCooney%26aufirst%3DJ.%26aulast%3DToe%26aufirst%3DJ.%2BG.%26aulast%3DStutz%26aufirst%3DM.%2BD.%26aulast%3DOjaimi%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DH.%2BW.%26aulast%3DBaschuk%26aufirst%3DN.%26aulast%3DNachbur%26aufirst%3DU.%26aulast%3DTorresi%26aufirst%3DJ.%26aulast%3DChin%26aufirst%3DR.%26aulast%3DColledge%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWarner%26aufirst%3DN.%26aulast%3DRevill%26aufirst%3DP.%26aulast%3DBowden%26aufirst%3DS.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DBegley%26aufirst%3DC.%2BG.%26aulast%3DPellegrini%26aufirst%3DM.%26atitle%3DCellular%2520inhibitor%2520of%2520apoptosis%2520proteins%2520prevent%2520clearance%2520of%2520hepatitis%2520B%2520virus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D5797%26epage%3D5802%26doi%3D10.1073%2Fpnas.1502390112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 33 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Emily J. Hanan, Jun Liang, Xiaojing Wang, Robert A. Blake, Nicole Blaquiere, <span class="NLM_string-name hlFld-ContribAuthor">Steven T. Staben</span>. </span><span class="cited-content_cbyCitation_article-title">Monomeric Targeted Protein Degraders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11330-11361. <a href="https://doi.org/10.1021/acs.jmedchem.0c00093" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00093%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMonomeric%252BTargeted%252BProtein%252BDegraders%26aulast%3DHanan%26aufirst%3DEmily%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17012020%26date%3D15062020%26date%3D30042020%26volume%3D63%26issue%3D20%26spage%3D11330%26epage%3D11361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nicole Blaquiere, Elisia Villemure, <span class="NLM_string-name hlFld-ContribAuthor">Steven T. Staben</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry of Inhibiting RING-Type E3 Ubiquitin Ligases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 7957-7985. <a href="https://doi.org/10.1021/acs.jmedchem.9b01451" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01451</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01451%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252BChemistry%252Bof%252BInhibiting%252BRING-Type%252BE3%252BUbiquitin%252BLigases%26aulast%3DBlaquiere%26aufirst%3DNicole%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D31082019%26date%3D02042020%26date%3D06032020%26volume%3D63%26issue%3D15%26spage%3D7957%26epage%3D7985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chunlin Zhuang, <span class="NLM_string-name hlFld-ContribAuthor">Fener Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (4)
                                     , 1490-1510. <a href="https://doi.org/10.1021/acs.jmedchem.9b01317" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01317%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BInhibitors%252Bof%252BNecroptosis%25253A%252BCurrent%252BStatus%252Band%252BPerspectives%26aulast%3DZhuang%26aufirst%3DChunlin%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D11082019%26date%3D31102019%26date%3D17102019%26volume%3D63%26issue%3D4%26spage%3D1490%26epage%3D1510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">N. D. Prasad Atmuri, <span class="NLM_string-name hlFld-ContribAuthor">William D. Lubell</span>. </span><span class="cited-content_cbyCitation_article-title">Stereo- and Regiochemical Transannular Cyclization of a Common Hexahydro-1H-azonine to Afford Three Different Indolizidinone Dipeptide Mimetics. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (3)
                                     , 1340-1351. <a href="https://doi.org/10.1021/acs.joc.9b01861" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01861</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01861%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStereo-%252Band%252BRegiochemical%252BTransannular%252BCyclization%252Bof%252Ba%252BCommon%252BHexahydro-1H-azonine%252Bto%252BAfford%252BThree%252BDifferent%252BIndolizidinone%252BDipeptide%252BMimetics%26aulast%3DAtmuri%26aufirst%3DN.%2BD.%2BPrasad%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D09072019%26date%3D15112019%26date%3D23102019%26volume%3D85%26issue%3D3%26spage%3D1340%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Megan Egbert, Adrian Whitty, György M. Keserű, <span class="NLM_string-name hlFld-ContribAuthor">Sandor Vajda</span>. </span><span class="cited-content_cbyCitation_article-title">Why Some Targets Benefit from beyond Rule of Five Drugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (22)
                                     , 10005-10025. <a href="https://doi.org/10.1021/acs.jmedchem.8b01732" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01732</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01732%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhy%252BSome%252BTargets%252BBenefit%252Bfrom%252Bbeyond%252BRule%252Bof%252BFive%252BDrugs%26aulast%3DEgbert%26aufirst%3DMegan%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D13112018%26date%3D26062019%26date%3D12062019%26volume%3D62%26issue%3D22%26spage%3D10005%26epage%3D10025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Carlo Baggio, Parima Udompholkul, Luca Gambini, Ahmed F. Salem, Jennifer Jossart, J. Jefferson P. Perry, <span class="NLM_string-name hlFld-ContribAuthor">Maurizio Pellecchia</span>. </span><span class="cited-content_cbyCitation_article-title">Aryl-fluorosulfate-based Lysine Covalent Pan-Inhibitors of Apoptosis Protein (IAP) Antagonists with Cellular Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 9188-9200. <a href="https://doi.org/10.1021/acs.jmedchem.9b01108" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01108%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAryl-fluorosulfate-based%252BLysine%252BCovalent%252BPan-Inhibitors%252Bof%252BApoptosis%252BProtein%252B%252528IAP%252529%252BAntagonists%252Bwith%252BCellular%252BEfficacy%26aulast%3DBaggio%26aufirst%3DCarlo%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D09072019%26date%3D08102019%26date%3D24092019%26volume%3D62%26issue%3D20%26spage%3D9188%26epage%3D9200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Luca Gambini, Carlo Baggio, Parima Udompholkul, Jennifer Jossart, Ahmed F. Salem, J. Jefferson P. Perry, <span class="NLM_string-name hlFld-ContribAuthor">Maurizio Pellecchia</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Inhibitors of Protein–Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (11)
                                     , 5616-5627. <a href="https://doi.org/10.1021/acs.jmedchem.9b00561" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00561%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCovalent%252BInhibitors%252Bof%252BProtein%2525E2%252580%252593Protein%252BInteractions%252BTargeting%252BLysine%25252C%252BTyrosine%25252C%252Bor%252BHistidine%252BResidues%26aulast%3DGambini%26aufirst%3DLuca%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D08042019%26date%3D29052019%26date%3D16052019%26volume%3D62%26issue%3D11%26spage%3D5616%26epage%3D5627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Keitou Shu, Naoya Iwamoto, Kaori Honda, Yasumitsu Kondoh, Hiroyuki Hirano, Hiroyuki Osada, Hiroaki Ohno, Nobutaka Fujii, <span class="NLM_string-name hlFld-ContribAuthor">Shinya Oishi</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Mirror-Image Screening Systems for XIAP BIR3 Domain Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2019,</strong> <em>30 </em>
                                    (5)
                                     , 1395-1404. <a href="https://doi.org/10.1021/acs.bioconjchem.9b00154" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.9b00154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.9b00154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.9b00154%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DDevelopment%252Bof%252BMirror-Image%252BScreening%252BSystems%252Bfor%252BXIAP%252BBIR3%252BDomain%252BInhibitors%26aulast%3DShu%26aufirst%3DKeitou%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D27022019%26date%3D19032019%26date%3D17042019%26date%3D19032019%26volume%3D30%26issue%3D5%26spage%3D1395%26epage%3D1404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reyhaneh  Farghadani</span>, <span class="hlFld-ContribAuthor ">Rakesh  Naidu</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Apoptosis as a Double-Edge Sword in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.5772/intechopen.97844" title="DOI URL">https://doi.org/10.5772/intechopen.97844</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.97844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.97844%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BRole%252Bof%252BApoptosis%252Bas%252Ba%252BDouble-Edge%252BSword%252Bin%252BCancer%26aulast%3DFarghadani%26aufirst%3DReyhaneh%26date%3D2021%26date%3D2021%26pub%3DIntechOpen%26atitle%3DRegulation%252Band%252BDysfunction%252Bof%252BApoptosis%252B%25255BWorking%252BTitle%25255D%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  D'Amico</span>, <span class="hlFld-ContribAuthor ">Rishov  Mukhopadhyay</span>, <span class="hlFld-ContribAuthor ">Huib  Ovaa</span>, <span class="hlFld-ContribAuthor ">Monique P. C.  Mulder</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting TRIM Proteins: A Quest towards Drugging an Emerging Protein Class. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2021,</strong> <em>22 </em>
                                    (12)
                                     , 2011-2031. <a href="https://doi.org/10.1002/cbic.202000787" title="DOI URL">https://doi.org/10.1002/cbic.202000787</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.202000787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.202000787%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DTargeting%252BTRIM%252BProteins%25253A%252BA%252BQuest%252Btowards%252BDrugging%252Ban%252BEmerging%252BProtein%252BClass%26aulast%3DD%2527Amico%26aufirst%3DFrancesca%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D12%26spage%3D2011%26epage%3D2031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gayathri R.  Devi</span>, <span class="hlFld-ContribAuthor ">Pascal  Finetti</span>, <span class="hlFld-ContribAuthor ">Michael A.  Morse</span>, <span class="hlFld-ContribAuthor ">Seayoung  Lee</span>, <span class="hlFld-ContribAuthor ">Alexandre  de Nonneville</span>, <span class="hlFld-ContribAuthor ">Steven  Van Laere</span>, <span class="hlFld-ContribAuthor ">Jesse  Troy</span>, <span class="hlFld-ContribAuthor ">Joseph  Geradts</span>, <span class="hlFld-ContribAuthor ">Shannon  McCall</span>, <span class="hlFld-ContribAuthor ">Francois  Bertucci</span>. </span><span class="cited-content_cbyCitation_article-title">Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (11)
                                     , 2807. <a href="https://doi.org/10.3390/cancers13112807" title="DOI URL">https://doi.org/10.3390/cancers13112807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13112807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13112807%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DExpression%252Bof%252BX-Linked%252BInhibitor%252Bof%252BApoptosis%252BProtein%252B%252528XIAP%252529%252Bin%252BBreast%252BCancer%252BIs%252BAssociated%252Bwith%252BShorter%252BSurvival%252Band%252BResistance%252Bto%252BChemotherapy%26aulast%3DDevi%26aufirst%3DGayathri%2BR.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D11%26spage%3D2807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jisook  Kim</span>, <span class="hlFld-ContribAuthor ">Inhwan  Bae</span>, <span class="hlFld-ContribAuthor ">Jiyoung  Song</span>, <span class="hlFld-ContribAuthor ">Younghoon  Kim</span>, <span class="hlFld-ContribAuthor ">Younggil  Ahn</span>, <span class="hlFld-ContribAuthor ">Hyun‐Ju  Park</span>, <span class="hlFld-ContribAuthor ">Ha Hyung  Kim</span>, <span class="hlFld-ContribAuthor ">Dae Kyong  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Imidazopyrazinone Derivatives as Antagonists of
              Inhibitor of Apoptosis Proteins
              (IAPs). </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2021,</strong> <em>42 </em>
                                    (6)
                                     , 847-851. <a href="https://doi.org/10.1002/bkcs.12271" title="DOI URL">https://doi.org/10.1002/bkcs.12271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bkcs.12271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbkcs.12271%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BImidazopyrazinone%252BDerivatives%252Bas%252BAntagonists%252Bof%252BInhibitor%252Bof%252BApoptosis%252BProteins%252B%252528IAPs%252529%26aulast%3DKim%26aufirst%3DJisook%26date%3D2021%26date%3D2021%26volume%3D42%26issue%3D6%26spage%3D847%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zonghui  Ma</span>, <span class="hlFld-ContribAuthor ">Yu  Ji</span>, <span class="hlFld-ContribAuthor ">Yifan  Yu</span>, <span class="hlFld-ContribAuthor ">Dailin  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Specific non-genetic IAP-based protein erasers (SNIPERs) as a potential therapeutic strategy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113247. <a href="https://doi.org/10.1016/j.ejmech.2021.113247" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113247</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113247%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSpecific%252Bnon-genetic%252BIAP-based%252Bprotein%252Berasers%252B%252528SNIPERs%252529%252Bas%252Ba%252Bpotential%252Btherapeutic%252Bstrategy%26aulast%3DMa%26aufirst%3DZonghui%26date%3D2021%26volume%3D216%26spage%3D113247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cassandra  Millet-Boureima</span>, <span class="hlFld-ContribAuthor ">Stephanie  He</span>, <span class="hlFld-ContribAuthor ">Thi Bich Uyen  Le</span>, <span class="hlFld-ContribAuthor ">Chiara  Gamberi</span>. </span><span class="cited-content_cbyCitation_article-title">Modeling Neoplastic Growth in Renal Cell Carcinoma and Polycystic Kidney Disease. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (8)
                                     , 3918. <a href="https://doi.org/10.3390/ijms22083918" title="DOI URL">https://doi.org/10.3390/ijms22083918</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22083918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22083918%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DModeling%252BNeoplastic%252BGrowth%252Bin%252BRenal%252BCell%252BCarcinoma%252Band%252BPolycystic%252BKidney%252BDisease%26aulast%3DMillet-Boureima%26aufirst%3DCassandra%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D8%26spage%3D3918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Supusson  Pengnam</span>, <span class="hlFld-ContribAuthor ">Samarwadee  Plianwong</span>, <span class="hlFld-ContribAuthor ">Prasopchai  Patrojanasophon</span>, <span class="hlFld-ContribAuthor ">Widchaya  Radchatawedchakoon</span>, <span class="hlFld-ContribAuthor ">Boon-ek  Yingyongnarongkul</span>, <span class="hlFld-ContribAuthor ">Praneet  Opanasopit</span>, <span class="hlFld-ContribAuthor ">Purin  Charoensuksai</span>. </span><span class="cited-content_cbyCitation_article-title">Synergistic Effect of Doxorubicin and siRNA-Mediated Silencing of Mcl-1 Using Cationic Niosomes against 3D MCF-7 Spheroids. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 550. <a href="https://doi.org/10.3390/pharmaceutics13040550" title="DOI URL">https://doi.org/10.3390/pharmaceutics13040550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics13040550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics13040550%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DSynergistic%252BEffect%252Bof%252BDoxorubicin%252Band%252BsiRNA-Mediated%252BSilencing%252Bof%252BMcl-1%252BUsing%252BCationic%252BNiosomes%252Bagainst%252B3D%252BMCF-7%252BSpheroids%26aulast%3DPengnam%26aufirst%3DSupusson%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gertrud  Knoll</span>, <span class="hlFld-ContribAuthor ">Martin  Ehrenschwender</span>. </span><span class="cited-content_cbyCitation_article-title">The non‐peptidomimetic IAP antagonist ASTX660 sensitizes colorectal cancer cells for extrinsic apoptosis. </span><span class="cited-content_cbyCitation_journal-name">FEBS Open Bio</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     , 714-723. <a href="https://doi.org/10.1002/2211-5463.13096" title="DOI URL">https://doi.org/10.1002/2211-5463.13096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/2211-5463.13096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F2211-5463.13096%26sid%3Dliteratum%253Aachs%26jtitle%3DFEBS%2520Open%2520Bio%26atitle%3DThe%252Bnon%2525E2%252580%252590peptidomimetic%252BIAP%252Bantagonist%252BASTX660%252Bsensitizes%252Bcolorectal%252Bcancer%252Bcells%252Bfor%252Bextrinsic%252Bapoptosis%26aulast%3DKnoll%26aufirst%3DGertrud%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D3%26spage%3D714%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cassandra  Millet-Boureima</span>, <span class="hlFld-ContribAuthor ">Susannah  Selber-Hnatiw</span>, <span class="hlFld-ContribAuthor ">Chiara  Gamberi</span>. </span><span class="cited-content_cbyCitation_article-title">Drug discovery and chemical probing in
              Drosophila. </span><span class="cited-content_cbyCitation_journal-name">Genome</span><span> <strong>2021,</strong> <em>64 </em>
                                    (2)
                                     , 147-159. <a href="https://doi.org/10.1139/gen-2020-0037" title="DOI URL">https://doi.org/10.1139/gen-2020-0037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1139/gen-2020-0037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1139%2Fgen-2020-0037%26sid%3Dliteratum%253Aachs%26jtitle%3DGenome%26atitle%3DDrug%252Bdiscovery%252Band%252Bchemical%252Bprobing%252Bin%252BDrosophila%26aulast%3DMillet-Boureima%26aufirst%3DCassandra%26date%3D2021%26volume%3D64%26issue%3D2%26spage%3D147%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ömer  Güllülü</span>, <span class="hlFld-ContribAuthor ">Stephanie  Hehlgans</span>, <span class="hlFld-ContribAuthor ">Claus  Rödel</span>, <span class="hlFld-ContribAuthor ">Emmanouil  Fokas</span>, <span class="hlFld-ContribAuthor ">Franz  Rödel</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer—A Promising Signaling Network for Therapeutic Interventions. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 624. <a href="https://doi.org/10.3390/cancers13040624" title="DOI URL">https://doi.org/10.3390/cancers13040624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13040624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13040624%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTumor%252BSuppressor%252BProtein%252Bp53%252Band%252BInhibitor%252Bof%252BApoptosis%252BProteins%252Bin%252BColorectal%252BCancer%2525E2%252580%252594A%252BPromising%252BSignaling%252BNetwork%252Bfor%252BTherapeutic%252BInterventions%26aulast%3DG%25C3%25BCll%25C3%25BCl%25C3%25BC%26aufirst%3D%25C3%2596mer%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damilohun Samuel  Metibemu</span>, <span class="hlFld-ContribAuthor ">Oluseyi Adeboye  Akinloye</span>, <span class="hlFld-ContribAuthor ">Adio Jamiu  Akamo</span>, <span class="hlFld-ContribAuthor ">Jude Ogechukwu  Okoye</span>, <span class="hlFld-ContribAuthor ">David Ajiboye  Ojo</span>, <span class="hlFld-ContribAuthor ">Eric  Morifi</span>, <span class="hlFld-ContribAuthor ">Idowu Olaposi  Omotuyi</span>. </span><span class="cited-content_cbyCitation_article-title">Carotenoid isolates of
              Spondias mombin
              demonstrate anticancer effects in DMBA‐induced breast cancer in Wistar rats through X‐linked inhibitor of apoptosis protein (XIAP) antagonism and anti‐inflammation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Food Biochemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (12)
                                     <a href="https://doi.org/10.1111/jfbc.13523" title="DOI URL">https://doi.org/10.1111/jfbc.13523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jfbc.13523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjfbc.13523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Food%2520Biochemistry%26atitle%3DCarotenoid%252Bisolates%252Bof%252BSpondias%252Bmombin%252Bdemonstrate%252Banticancer%252Beffects%252Bin%252BDMBA%2525E2%252580%252590induced%252Bbreast%252Bcancer%252Bin%252BWistar%252Brats%252Bthrough%252BX%2525E2%252580%252590linked%252Binhibitor%252Bof%252Bapoptosis%252Bprotein%252B%252528XIAP%252529%252Bantagonism%252Band%252Banti%2525E2%252580%252590inflammation%26aulast%3DMetibemu%26aufirst%3DDamilohun%2BSamuel%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Gambini</span>, <span class="hlFld-ContribAuthor ">Parima  Udompholkul</span>, <span class="hlFld-ContribAuthor ">Ahmed F.  Salem</span>, <span class="hlFld-ContribAuthor ">Carlo  Baggio</span>, <span class="hlFld-ContribAuthor ">Maurizio  Pellecchia</span>. </span><span class="cited-content_cbyCitation_article-title">Stability and Cell Permeability of Sulfonyl Fluorides in the Design of Lys‐Covalent Antagonists of Protein‐Protein Interactions. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (22)
                                     , 2176-2184. <a href="https://doi.org/10.1002/cmdc.202000355" title="DOI URL">https://doi.org/10.1002/cmdc.202000355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000355%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStability%252Band%252BCell%252BPermeability%252Bof%252BSulfonyl%252BFluorides%252Bin%252Bthe%252BDesign%252Bof%252BLys%2525E2%252580%252590Covalent%252BAntagonists%252Bof%252BProtein%2525E2%252580%252590Protein%252BInteractions%26aulast%3DGambini%26aufirst%3DLuca%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D22%26spage%3D2176%26epage%3D2184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankita  Srivastava</span>, <span class="hlFld-ContribAuthor ">Kaneez  Fatima</span>, <span class="hlFld-ContribAuthor ">Eram  Fatima</span>, <span class="hlFld-ContribAuthor ">Arjun  Singh</span>, <span class="hlFld-ContribAuthor ">Aastha  Singh</span>, <span class="hlFld-ContribAuthor ">Aparna  Shukla</span>, <span class="hlFld-ContribAuthor ">Suaib  Luqman</span>, <span class="hlFld-ContribAuthor ">Karuna  Shanker</span>, <span class="hlFld-ContribAuthor ">Debabrata  Chanda</span>, <span class="hlFld-ContribAuthor ">Feroz  Khan</span>, <span class="hlFld-ContribAuthor ">Arvind S.  Negi</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorinated benzylidene indanone exhibits antiproliferative activity through modulation of microtubule dynamics and antiangiogenic activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2020,</strong> <em>154 </em>, 105513. <a href="https://doi.org/10.1016/j.ejps.2020.105513" title="DOI URL">https://doi.org/10.1016/j.ejps.2020.105513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2020.105513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2020.105513%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DFluorinated%252Bbenzylidene%252Bindanone%252Bexhibits%252Bantiproliferative%252Bactivity%252Bthrough%252Bmodulation%252Bof%252Bmicrotubule%252Bdynamics%252Band%252Bantiangiogenic%252Bactivity%26aulast%3DSrivastava%26aufirst%3DAnkita%26date%3D2020%26volume%3D154%26spage%3D105513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cassandra  Millet-Boureima</span>, <span class="hlFld-ContribAuthor ">Roman  Rozencwaig</span>, <span class="hlFld-ContribAuthor ">Felix  Polyak</span>, <span class="hlFld-ContribAuthor ">Chiara  Gamberi</span>. </span><span class="cited-content_cbyCitation_article-title">Cyst Reduction by Melatonin in a Novel Drosophila Model of Polycystic Kidney Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (22)
                                     , 5477. <a href="https://doi.org/10.3390/molecules25225477" title="DOI URL">https://doi.org/10.3390/molecules25225477</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25225477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25225477%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DCyst%252BReduction%252Bby%252BMelatonin%252Bin%252Ba%252BNovel%252BDrosophila%252BModel%252Bof%252BPolycystic%252BKidney%252BDisease%26aulast%3DMillet-Boureima%26aufirst%3DCassandra%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D22%26spage%3D5477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swati  Kumar</span>, <span class="hlFld-ContribAuthor ">Ciaran  Fairmichael</span>, <span class="hlFld-ContribAuthor ">Daniel B.  Longley</span>, <span class="hlFld-ContribAuthor ">Richard C.  Turkington</span>. </span><span class="cited-content_cbyCitation_article-title">The Multiple Roles of the IAP Super-family in cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>214 </em>, 107610. <a href="https://doi.org/10.1016/j.pharmthera.2020.107610" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2020.107610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2020.107610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2020.107610%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DThe%252BMultiple%252BRoles%252Bof%252Bthe%252BIAP%252BSuper-family%252Bin%252Bcancer%26aulast%3DKumar%26aufirst%3DSwati%26date%3D2020%26volume%3D214%26spage%3D107610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Łupicka-Słowik</span>, <span class="hlFld-ContribAuthor ">Mateusz  Psurski</span>, <span class="hlFld-ContribAuthor ">Renata  Grzywa</span>, <span class="hlFld-ContribAuthor ">Monika  Cuprych</span>, <span class="hlFld-ContribAuthor ">Jarosław  Ciekot</span>, <span class="hlFld-ContribAuthor ">Waldemar  Goldeman</span>, <span class="hlFld-ContribAuthor ">Elżbieta  Wojaczyńska</span>, <span class="hlFld-ContribAuthor ">Jacek  Wojaczyński</span>, <span class="hlFld-ContribAuthor ">Józef  Oleksyszyn</span>, <span class="hlFld-ContribAuthor ">Marcin  Sieńczyk</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design, synthesis, and evaluation of the biological activity of novel phosphoroorganic small molecule IAP antagonists. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2020,</strong> <em>38 </em>
                                    (5)
                                     , 1350-1364. <a href="https://doi.org/10.1007/s10637-020-00923-4" title="DOI URL">https://doi.org/10.1007/s10637-020-00923-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-020-00923-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-020-00923-4%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DStructure-based%252Bdesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bthe%252Bbiological%252Bactivity%252Bof%252Bnovel%252Bphosphoroorganic%252Bsmall%252Bmolecule%252BIAP%252Bantagonists%26aulast%3D%25C5%2581upicka-S%25C5%2582owik%26aufirst%3DAgnieszka%26date%3D2020%26date%3D2020%26volume%3D38%26issue%3D5%26spage%3D1350%26epage%3D1364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Najoua  Lalaoui</span>, <span class="hlFld-ContribAuthor ">Delphine  Merino</span>, <span class="hlFld-ContribAuthor ">Goknur  Giner</span>, <span class="hlFld-ContribAuthor ">François  Vaillant</span>, <span class="hlFld-ContribAuthor ">Diep  Chau</span>, <span class="hlFld-ContribAuthor ">Lin  Liu</span>, <span class="hlFld-ContribAuthor ">Tobias  Kratina</span>, <span class="hlFld-ContribAuthor ">Bhupinder  Pal</span>, <span class="hlFld-ContribAuthor ">James R.  Whittle</span>, <span class="hlFld-ContribAuthor ">Nima  Etemadi</span>, <span class="hlFld-ContribAuthor ">Jean  Berthelet</span>, <span class="hlFld-ContribAuthor ">Julius  Gräsel</span>, <span class="hlFld-ContribAuthor ">Cathrine  Hall</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Ritchie</span>, <span class="hlFld-ContribAuthor ">Matthias  Ernst</span>, <span class="hlFld-ContribAuthor ">Gordon K.  Smyth</span>, <span class="hlFld-ContribAuthor ">David L.  Vaux</span>, <span class="hlFld-ContribAuthor ">Jane E.  Visvader</span>, <span class="hlFld-ContribAuthor ">Geoffrey J.  Lindeman</span>, <span class="hlFld-ContribAuthor ">John  Silke</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting triple-negative breast cancers with the Smac-mimetic birinapant. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Differentiation</span><span> <strong>2020,</strong> <em>27 </em>
                                    (10)
                                     , 2768-2780. <a href="https://doi.org/10.1038/s41418-020-0541-0" title="DOI URL">https://doi.org/10.1038/s41418-020-0541-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41418-020-0541-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41418-020-0541-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Differentiation%26atitle%3DTargeting%252Btriple-negative%252Bbreast%252Bcancers%252Bwith%252Bthe%252BSmac-mimetic%252Bbirinapant%26aulast%3DLalaoui%26aufirst%3DNajoua%26date%3D2020%26date%3D2020%26volume%3D27%26issue%3D10%26spage%3D2768%26epage%3D2780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heather M.  Lamb</span>. </span><span class="cited-content_cbyCitation_article-title">Double agents of cell death: novel emerging functions of apoptotic regulators. </span><span class="cited-content_cbyCitation_journal-name">The FEBS Journal</span><span> <strong>2020,</strong> <em>287 </em>
                                    (13)
                                     , 2647-2663. <a href="https://doi.org/10.1111/febs.15308" title="DOI URL">https://doi.org/10.1111/febs.15308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/febs.15308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffebs.15308%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FEBS%2520Journal%26atitle%3DDouble%252Bagents%252Bof%252Bcell%252Bdeath%25253A%252Bnovel%252Bemerging%252Bfunctions%252Bof%252Bapoptotic%252Bregulators%26aulast%3DLamb%26aufirst%3DHeather%2BM.%26date%3D2020%26date%3D2020%26volume%3D287%26issue%3D13%26spage%3D2647%26epage%3D2663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Henry G  Smith</span>, <span class="hlFld-ContribAuthor ">Kunzah  Jamal</span>, <span class="hlFld-ContribAuthor ">Jasbani HS  Dayal</span>, <span class="hlFld-ContribAuthor ">Tencho  Tenev</span>, <span class="hlFld-ContribAuthor ">Joan  Kyula‐Currie</span>, <span class="hlFld-ContribAuthor ">Naomi  Guppy</span>, <span class="hlFld-ContribAuthor ">Patrycja  Gazinska</span>, <span class="hlFld-ContribAuthor ">Victoria  Roulstone</span>, <span class="hlFld-ContribAuthor ">Gianmaria  Liccardi</span>, <span class="hlFld-ContribAuthor ">Emma  Davies</span>, <span class="hlFld-ContribAuthor ">Ioannis  Roxanis</span>, <span class="hlFld-ContribAuthor ">Alan A  Melcher</span>, <span class="hlFld-ContribAuthor ">Andrew J  Hayes</span>, <span class="hlFld-ContribAuthor ">Gareth J  Inman</span>, <span class="hlFld-ContribAuthor ">Kevin J  Harrington</span>, <span class="hlFld-ContribAuthor ">Pascal  Meier</span>. </span><span class="cited-content_cbyCitation_article-title">RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma. </span><span class="cited-content_cbyCitation_journal-name">EMBO Molecular Medicine</span><span> <strong>2020,</strong> <em>12 </em>
                                    (6)
                                     <a href="https://doi.org/10.15252/emmm.201910979" title="DOI URL">https://doi.org/10.15252/emmm.201910979</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15252/emmm.201910979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15252%2Femmm.201910979%26sid%3Dliteratum%253Aachs%26jtitle%3DEMBO%2520Molecular%2520Medicine%26atitle%3DRIPK1%2525E2%252580%252590mediated%252Bimmunogenic%252Bcell%252Bdeath%252Bpromotes%252Banti%2525E2%252580%252590tumour%252Bimmunity%252Bagainst%252Bsoft%2525E2%252580%252590tissue%252Bsarcoma%26aulast%3DSmith%26aufirst%3DHenry%2BG%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Yun  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiu-Yun  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Yao  Wei</span>, <span class="hlFld-ContribAuthor ">Yan-Ming  Xu</span>, <span class="hlFld-ContribAuthor ">Andy T. Y.  Lau</span>. </span><span class="cited-content_cbyCitation_article-title">Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (4)
                                     , 1012. <a href="https://doi.org/10.3390/cells9041012" title="DOI URL">https://doi.org/10.3390/cells9041012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9041012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9041012%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DPotency%252Band%252BSelectivity%252Bof%252BSMAC%25252FDIABLO%252BMimetics%252Bin%252BSolid%252BTumor%252BTherapy%26aulast%3DZhao%26aufirst%3DXiao-Yun%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D4%26spage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simone  Jensen</span>, <span class="hlFld-ContribAuthor ">Jakob Benedict  Seidelin</span>, <span class="hlFld-ContribAuthor ">Eric Charles  LaCasse</span>, <span class="hlFld-ContribAuthor ">Ole Haagen  Nielsen</span>. </span><span class="cited-content_cbyCitation_article-title">SMAC mimetics and RIPK inhibitors as therapeutics for chronic inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Science Signaling</span><span> <strong>2020,</strong> <em>13 </em>
                                    (619)
                                     , eaax8295. <a href="https://doi.org/10.1126/scisignal.aax8295" title="DOI URL">https://doi.org/10.1126/scisignal.aax8295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scisignal.aax8295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscisignal.aax8295%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Signaling%26atitle%3DSMAC%252Bmimetics%252Band%252BRIPK%252Binhibitors%252Bas%252Btherapeutics%252Bfor%252Bchronic%252Binflammatory%252Bdiseases%26aulast%3DJensen%26aufirst%3DSimone%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D619%26spage%3Deaax8295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Madsen</span>, <span class="hlFld-ContribAuthor ">Carlos  Azevedo</span>, <span class="hlFld-ContribAuthor ">Iolanda  Micco</span>, <span class="hlFld-ContribAuthor ">Lars Kolster  Petersen</span>, <span class="hlFld-ContribAuthor ">Nils Jakob Vest  Hansen</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of DNA-encoded libraries: A versatile tool for drug discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 181-249. <a href="https://doi.org/10.1016/bs.pmch.2020.03.001" title="DOI URL">https://doi.org/10.1016/bs.pmch.2020.03.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2020.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2020.03.001%26sid%3Dliteratum%253Aachs%26atitle%3DAn%252Boverview%252Bof%252BDNA-encoded%252Blibraries%25253A%252BA%252Bversatile%252Btool%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DMadsen%26aufirst%3DDaniel%26date%3D2020%26spage%3D181%26epage%3D249%26pub%3DElsevier%26date%3D2020%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter D.  Koch</span>, <span class="hlFld-ContribAuthor ">Christopher B.  Rodell</span>, <span class="hlFld-ContribAuthor ">Rainer H.  Kohler</span>, <span class="hlFld-ContribAuthor ">Mikael J.  Pittet</span>, <span class="hlFld-ContribAuthor ">Ralph  Weissleder</span>. </span><span class="cited-content_cbyCitation_article-title">Myeloid Cell-Targeted Nanocarriers Efficiently Inhibit Cellular Inhibitor of Apoptosis for Cancer Immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2020,</strong> <em>27 </em>
                                    (1)
                                     , 94-104.e5. <a href="https://doi.org/10.1016/j.chembiol.2019.12.007" title="DOI URL">https://doi.org/10.1016/j.chembiol.2019.12.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2019.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2019.12.007%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DMyeloid%252BCell-Targeted%252BNanocarriers%252BEfficiently%252BInhibit%252BCellular%252BInhibitor%252Bof%252BApoptosis%252Bfor%252BCancer%252BImmunotherapy%26aulast%3DKoch%26aufirst%3DPeter%2BD.%26date%3D2020%26volume%3D27%26issue%3D1%26spage%3D94%26epage%3D104.e5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cassandra  Millet-Boureima</span>, <span class="hlFld-ContribAuthor ">Ramesh  Chingle</span>, <span class="hlFld-ContribAuthor ">William D.  Lubell</span>, <span class="hlFld-ContribAuthor ">Chiara  Gamberi</span>. </span><span class="cited-content_cbyCitation_article-title">Cyst Reduction in a Polycystic Kidney Disease Drosophila Model Using Smac Mimics. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2019,</strong> <em>7 </em>
                                    (4)
                                     , 82. <a href="https://doi.org/10.3390/biomedicines7040082" title="DOI URL">https://doi.org/10.3390/biomedicines7040082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines7040082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines7040082%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DCyst%252BReduction%252Bin%252Ba%252BPolycystic%252BKidney%252BDisease%252BDrosophila%252BModel%252BUsing%252BSmac%252BMimics%26aulast%3DMillet-Boureima%26aufirst%3DCassandra%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D4%26spage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muñoz</span>, <span class="hlFld-ContribAuthor ">Brucoli</span>, <span class="hlFld-ContribAuthor ">Zecchini</span>, <span class="hlFld-ContribAuthor ">Sandoval-Hernandez</span>, <span class="hlFld-ContribAuthor ">Arboleda</span>, <span class="hlFld-ContribAuthor ">Lopez-Vallejo</span>, <span class="hlFld-ContribAuthor ">Delgado</span>, <span class="hlFld-ContribAuthor ">Giovarelli</span>, <span class="hlFld-ContribAuthor ">Coazzoli</span>, <span class="hlFld-ContribAuthor ">Catalani</span>, <span class="hlFld-ContribAuthor ">De Palma</span>, <span class="hlFld-ContribAuthor ">Perrotta</span>, <span class="hlFld-ContribAuthor ">Cuca</span>, <span class="hlFld-ContribAuthor ">Clementi</span>, <span class="hlFld-ContribAuthor ">Cervia</span>. </span><span class="cited-content_cbyCitation_article-title">XIAP as a Target of New Small Organic Natural Molecules Inducing Human Cancer Cell Death. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (9)
                                     , 1336. <a href="https://doi.org/10.3390/cancers11091336" title="DOI URL">https://doi.org/10.3390/cancers11091336</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11091336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11091336%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DXIAP%252Bas%252Ba%252BTarget%252Bof%252BNew%252BSmall%252BOrganic%252BNatural%252BMolecules%252BInducing%252BHuman%252BCancer%252BCell%252BDeath%26aulast%3DMu%25C3%25B1oz%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D9%26spage%3D1336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Functional domains of mammalian IAPs: typical IAP structure and the structures of XIAP, c-IAP1, and c-IAP2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Regulation of caspase-dependent apoptosis and NF-κB signaling by IAP and SMAC proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1G73">1G73</a>) and detailed interactions of SMAC, XIAP-BIR3 (presented as a surface model and the carbons in gray), and the AVPI peptide (carbons in yellow, nitrogens in blue, and oxygens in red). Blue dashed lines represent hydrogen bonds. The figures were generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Systematic summary for the different regions of the first-generation SMAC-based AVPI peptides and peptidomimetics. Structures with asterisks (∗) contain non-natural substituents. Chemical structures of representative potent and cell-permeable SMAC peptidomimetics as IAP antagonists. Substituents in different regions are colored as follows: alanine (blue), valine (pink), proline (black), and isoleucine (red). # indicates that the compound has been advanced into clinical evaluations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structure optimization workflow for the bicyclic monovalent IAP antagonists developed by Dr. Shaomeng Wang and colleagues. The bicyclic parts are colored in orange, and the side chains are colored in black. # indicates that the compound has been advanced into clinical evaluations. The crystal structure of the complex is generated by PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Other representative bicyclic monovalent IAP antagonists obtained using different cyclization strategies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) First reported bivalent SMAC mimetic. The corresponding monovalent mimetic is highlighted in blue. (B) Common design strategies of the bivalent IAP antagonists, highlighted in different colors. Ala = P1, Val = P2, Pro = P3, Ile = P4. Linker 1: P4–P4 strategy. Linker 2: P2–P2 strategy. Linker 3: P3–P3 strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Bivalent antagonists linked using the P4–P4 strategy, highlighted in red. # indicates that the compound has been advanced into clinical evaluations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Bivalent antagonists linked using the P2–P2 strategy, highlighted in pink.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Bivalent antagonists linked using the P3–P3 strategy, highlighted in orange.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structure optimization workflow of nonalanine IAP antagonists (A) and their cocrystal complexes with the XIAP BIR3 protein: (B) fragment <b>43</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5C7B">5C7B</a>); (C) AT-IAP (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M6L">5M6L</a>); (D) ASTX660 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQW">5OQW</a>). The red dots represent water molecules in the crystal complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structure optimization workflow for benzoxazepinone and benzodiazepinone synthesis (A) and the cocrystal complexes of these compounds with the XIAP BIR2 protein: (B) compound <b>50</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJV">4KJV</a>); (C) compound <b>52</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJU">4KJU</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Macrocyclic molecules as IAP antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. IAP antagonists with disclosed structures that have been advanced into clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/medium/jm-2018-01668b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Representative conjugates with an IAP antagonist moiety for target protein degradation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01668/20190621/images/large/jm-2018-01668b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01668&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70373" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70373" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 160 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, A. R.</span></span> <span> </span><span class="NLM_article-title">Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1038/bjc.1972.33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fbjc.1972.33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=4561027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADyaE3s%252FgsFSksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1972&pages=239-257&author=J.+F.+Kerrauthor=A.+H.+Wyllieauthor=A.+R.+Currie&title=Apoptosis%3A+a+basic+biological+phenomenon+with+wide-ranging+implications+in+tissue+kinetics&doi=10.1038%2Fbjc.1972.33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics</span></div><div class="casAuthors">Kerr J F; Wyllie A H; Currie A R</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-57</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">The term apoptosis is proposed for a hitherto little recognized mechanism of controlled cell deletion, which appears to play a complementary but opposite role to mitosis in the regulation of animal cell populations.  Its morphological features suggest that it is an active, inherently programmed phenomenon, and it has been shown that it can be initiated or inhibited by a variety of environmental stimuli, both physiological and pathological.The structural changes take place in two discrete stages.  The first comprises nuclear and cytoplasmic condensation and breaking up of the cell into a number of membrane-bound, ultrastructurally well-preserved fragments.  In the second stage these apoptotic bodies are shed from epithelial-lined surfaces or are taken up by other cells, where they undergo a series of changes resembling in vitro autolysis within phagosomes, and are rapidly degraded by lysosomal enzymes derived from the ingesting cells.Apoptosis seems to be involved in cell turnover in many healthy adult tissues and is responsible for focal elimination of cells during normal embryonic development.  It occurs spontaneously in untreated malignant neoplasms, and participates in at least some types of therapeutically induced tumour regression.  It is implicated in both physiological involution and atrophy of various tissues and organs.  It can also be triggered by noxious agents, both in the embryo and adult animal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNWEBcjRkVZzW1zwg2yUK5fW6udTcc2eYVWTV23PG5lrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3s%252FgsFSksw%253D%253D&md5=60211d4b22f18156fa64206b2cad983d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1972.33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1972.33%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DJ.%2BF.%26aulast%3DWyllie%26aufirst%3DA.%2BH.%26aulast%3DCurrie%26aufirst%3DA.%2BR.%26atitle%3DApoptosis%253A%2520a%2520basic%2520biological%2520phenomenon%2520with%2520wide-ranging%2520implications%2520in%2520tissue%2520kinetics%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1972%26volume%3D26%26spage%3D239%26epage%3D257%26doi%3D10.1038%2Fbjc.1972.33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, J. M.</span></span> <span> </span><span class="NLM_article-title">Apoptosis and disease</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1254</span>, <span class="refDoi"> DOI: 10.1016/0140-6736(93)91154-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2F0140-6736%2893%2991154-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=8098400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADyaK3s3mtFSqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1993&pages=1251-1254&author=D.+A.+Carsonauthor=J.+M.+Ribeiro&title=Apoptosis+and+disease&doi=10.1016%2F0140-6736%2893%2991154-E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis and disease</span></div><div class="casAuthors">Carson D A; Ribeiro J M</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">8855</span>),
    <span class="NLM_cas:pages">1251-4</span>
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    </div><div class="casAbstract">The intercellular connections that characterise advanced forms of life would not be possible without a mechanism to remove individual cells that are no longer needed, or that function abnormally.  Such physiological cell death, in the absence of inflammation, is achieved by apoptosis, a structurally distinct programmed cell death pathway.  Defective regulation of programmed cell death may play a part in the aetiology of cancer, AIDS, autoimmune diseases, and degenerative diseases of the central nervous system.  The pharmacological manipulation of apoptosis offers new possibilities for the prevention and treatment of these illnesses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5_BzorppnLgxyojvcjibhfW6udTcc2ebzLV20SUMZVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s3mtFSqsQ%253D%253D&md5=c163cc42fac31d9c0d2b17afcc351109</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0140-6736%2893%2991154-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0140-6736%252893%252991154-E%26sid%3Dliteratum%253Aachs%26aulast%3DCarson%26aufirst%3DD.%2BA.%26aulast%3DRibeiro%26aufirst%3DJ.%2BM.%26atitle%3DApoptosis%2520and%2520disease%26jtitle%3DLancet%26date%3D1993%26volume%3D341%26spage%3D1251%26epage%3D1254%26doi%3D10.1016%2F0140-6736%2893%2991154-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solary, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubrez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eymin, B.</span></span> <span> </span><span class="NLM_article-title">The role of apoptosis in the pathogenesis and treatment of diseases</span>. <i>Eur. Respir. J.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1293</span>– <span class="NLM_lpage">1305</span>, <span class="refDoi"> DOI: 10.1183/09031936.96.09061293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1183%2F09031936.96.09061293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=8804951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADyaK28zpvVSltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1996&pages=1293-1305&author=E.+Solaryauthor=L.+Dubrezauthor=B.+Eymin&title=The+role+of+apoptosis+in+the+pathogenesis+and+treatment+of+diseases&doi=10.1183%2F09031936.96.09061293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The role of apoptosis in the pathogenesis and treatment of diseases</span></div><div class="casAuthors">Solary E; Dubrez L; Eymin B</div><div class="citationInfo"><span class="NLM_cas:title">The European respiratory journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1293-305</span>
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    </div><div class="casAbstract">In adult multicellular organisms, homeostasis is determined in each cell lineage by a balance between cell death and cell growth.  Dysregulation of cell death mechanisms is involved in the pathogenesis of an increasing number of diseases.  Defective apoptosis can participate in malignant transformation, viral latency and autoimmune diseases.  Excessive apoptotic cell death is involved in CD4+ T-cell depletion observed in acquired immune deficiency syndrome, in fulminant hepatitis associated with infection by hepatitis B and C viruses, in some neurodegenerative disorders and haematological diseases, in polycystic kidney disease and ischaemia.  Three steps can be distinguished in the pathway that leads to cell death.  The first step involves interactions between the extracellular and intracellular signals that decide whether a cell should live or die.  When death is chosen, a common pathway that involves at least the Bcl-2- family of proteins and the interleukin-1 beta (IL-1 beta)-converting enzyme-related cysteine proteases confirms whether or not the cell should die.  Finally, if death is allowed to occur, the apoptotic process itself is characterized by deoxyribonucleic acid (DNA) fragmentation, proteolysis and morphological changes that precede the engulfment of apoptotic cells by neighbouring cells and phagocytes.  Several inducers and inhibitors of apoptosis acting on one or several of these three steps that characterize the apoptotic process have been identified in vitro.  Their potential usefulness in improving the current therapeutic strategies and designing new strategies in several different diseases is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSstdFlp_TrSMyail4HZd-ifW6udTcc2ebzLV20SUMZVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zpvVSltQ%253D%253D&md5=d297625b8ca78684e2fa14dc36e24605</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1183%2F09031936.96.09061293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.96.09061293%26sid%3Dliteratum%253Aachs%26aulast%3DSolary%26aufirst%3DE.%26aulast%3DDubrez%26aufirst%3DL.%26aulast%3DEymin%26aufirst%3DB.%26atitle%3DThe%2520role%2520of%2520apoptosis%2520in%2520the%2520pathogenesis%2520and%2520treatment%2520of%2520diseases%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D1996%26volume%3D9%26spage%3D1293%26epage%3D1305%26doi%3D10.1183%2F09031936.96.09061293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of cancer: the next generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+the+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lic2-uKkBOrvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520the%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span> <span> </span><span class="NLM_article-title">The inhibitor of apoptosis proteins as therapeutic targets in cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">5995</span>– <span class="NLM_lpage">6000</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-07-0729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1078-0432.CCR-07-0729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=17947460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFygs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=5995-6000&author=D.+Vucicauthor=W.+J.+Fairbrother&title=The+inhibitor+of+apoptosis+proteins+as+therapeutic+targets+in+cancer&doi=10.1158%2F1078-0432.CCR-07-0729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer</span></div><div class="casAuthors">Vucic, Domagoj; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5995-6000</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Apoptosis is a cell suicide process with a major role in development and homeostasis in vertebrates and invertebrates.  Inhibition of apoptosis enhances the survival of cancer cells and facilitates their escape from immune surveillance and cytotoxic therapies.  Among the principal mols. contributing to this phenomenon are the inhibitor of apoptosis (IAP) proteins, a family of antiapoptotic regulators that block cell death in response to diverse stimuli through interactions with inducers and effectors of apoptosis.  IAP proteins are expressed in the majority of human malignancies at elevated levels and play an active role in promoting tumor maintenance through the inhibition of cellular death and participation in signaling pathways assocd. with malignancies.  Here, we discuss the role of IAP proteins in cancer and options for targeting IAP proteins for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosUyky7YXEnLVg90H21EOLACvtfcHk0li_0_eBp3zx5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFygs7vP&md5=bff042bce2006a510abb6814d43c6dc5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-0729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-0729%26sid%3Dliteratum%253Aachs%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520inhibitor%2520of%2520apoptosis%2520proteins%2520as%2520therapeutic%2520targets%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D5995%26epage%3D6000%26doi%3D10.1158%2F1078-0432.CCR-07-0729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, C. S.</span></span> <span> </span><span class="NLM_article-title">IAP proteins: blocking the road to death’s door</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1038/nrm830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnrm830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=12042762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=401-410&author=G.+S.+Salvesenauthor=C.+S.+Duckett&title=IAP+proteins%3A+blocking+the+road+to+death%E2%80%99s+door&doi=10.1038%2Fnrm830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: IAP proteins: blocking the road to death's door</span></div><div class="casAuthors">Salvesen, Guy S.; Duckett, Colin S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-410</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The 'inhibitor of apoptosis' (IAP) gene family, which was discovered less than a decade ago, encodes a group of structurally related proteins that, in addn. to their ability to suppress apoptotic cell death, are involved in an increasing no. of seemingly unrelated cellular functions.  Here, we review the functional and structural properties of this fascinating group of proteins, and of several recently identified IAP-binding factors that regulate IAP function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofMWLW8mAr_LVg90H21EOLACvtfcHk0li_0_eBp3zx5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D&md5=0f967aad318a34d988ad40486950ed62</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm830%26sid%3Dliteratum%253Aachs%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26atitle%3DIAP%2520proteins%253A%2520blocking%2520the%2520road%2520to%2520death%25E2%2580%2599s%2520door%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2002%26volume%3D3%26spage%3D401%26epage%3D410%26doi%3D10.1038%2Fnrm830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deveraux, Q.
L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span> <span> </span><span class="NLM_article-title">IAP family proteins--suppressors of apoptosis</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1101/gad.13.3.239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1101%2Fgad.13.3.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=9990849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADyaK1MXht1KgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=239-252&author=Q.%0AL.+Deverauxauthor=J.+C.+Reed&title=IAP+family+proteins%2D%2Dsuppressors+of+apoptosis&doi=10.1101%2Fgad.13.3.239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">IAP family proteins-suppressors of apoptosis</span></div><div class="casAuthors">Deveraux, Quinn L.; Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-252</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review with 98 refs.  Apoptosis is a physiol. cell suicide program that is crit. for the development and maintenance of healthy tissues.  Dysregulation of cell death pathways occur in cancer, autoimmune and immunodeficiency diseases, reperfusion injury after ischemic episodes, and in neurodegenerative disorders.  Thus, proteins involved in apoptosis regulation are of intense biol. interest and many are attractive therapeutic targets.  This review discusses the Inhibitor of Apoptosis (IAP) family of proteins.  First discovered in baculoviruses, IAPs were shown to be involved in suppressing the host cell death response to viral infection.  Interestingly, ectopic expression of some baculoviral IAPs blocks apoptosis in mammalian cells, suggesting conservation of the cell death program among diverse species and commonalities in the mechanism used by the IAPs to inhibit apoptosis.  Although the mechanism used by the IAPs to suppress cell death remains debated, several studies have provided insights into the biochem. functions of these intriguing proteins.  Moreover, a variety of reports have suggested an important role for the IAPs in some human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSDPMG453K_LVg90H21EOLACvtfcHk0li_0_eBp3zx5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1KgsL0%253D&md5=a1a71b281cb401c9580e48a7e8f1ccee</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.3.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.3.239%26sid%3Dliteratum%253Aachs%26aulast%3DDeveraux%26aufirst%3DQ.%2BL.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DIAP%2520family%2520proteins--suppressors%2520of%2520apoptosis%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D239%26epage%3D252%26doi%3D10.1101%2Fgad.13.3.239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clem, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. K.</span></span> <span> </span><span class="NLM_article-title">An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">2521</span>– <span class="NLM_lpage">2528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=8139034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADyaK2cXksFSqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1994&pages=2521-2528&author=M.+J.+Birnbaumauthor=R.+J.+Clemauthor=L.+K.+Miller&title=An+apoptosis-inhibiting+gene+from+a+nuclear+polyhedrosis+virus+encoding+a+polypeptide+with+Cys%2FHis+sequence+motifs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs</span></div><div class="casAuthors">Birnbaum, Mark J.; Clem, Rollie J.; Miller, Lois K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2521-8</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    </div><div class="casAbstract">Two different baculovirus genes are known to be able to block apoptosis triggered upon infection of Spodoptera frugiperda cells with p35 mutants of the insect baculovirus Autographa californica nuclear polyhedrosis virus (AcMNPV):p35 (P35-encoding gene) of AcMNPV and iap (inhibitor of apoptosis gene) of Cydia pomonella granulosis virus (CpGV).  Using a genetic complementation assay to identify addnl. genes which inhibit apoptosis during infection with a p35 mutant, the authors have isolated a gene from Orgyia pseudotsugata NPV (OpMNPV) that was able to functionally substitute for AcMPNV p35.  The nucleotide sequence of this gene, Op-iap, predicted a 30-kDa polypeptide product with approx. 58% amino acid sequence identity to the product of CpGV iap, Cp-IAP.  Like Cp-IAP, the predicted product of Op-iap has a carboxy-terminal C3HC4 zinc finger-like motif.  In addn., a pair of addnl. cysteine/histidine motifs were found in the N-terminal regions of both polypeptide sequences.  Recombinant p35 mutant viruses carrying either Op-iap or Cp-iap appeared to have a normal phenotype in S. frugiperda cells.  Thus, Cp-IAP and Op-IAP appear to be functionally analogous to P35 but are likely to block apoptosis by a different mechanism which may involve direct interaction with DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOzymcROFQ6LVg90H21EOLACvtfcHk0li_0_eBp3zx5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksFSqurg%253D&md5=e391d3cedb2dbdff2c8b7a584cd92293</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirnbaum%26aufirst%3DM.%2BJ.%26aulast%3DClem%26aufirst%3DR.%2BJ.%26aulast%3DMiller%26aufirst%3DL.%2BK.%26atitle%3DAn%2520apoptosis-inhibiting%2520gene%2520from%2520a%2520nuclear%2520polyhedrosis%2520virus%2520encoding%2520a%2520polypeptide%2520with%2520Cys%252FHis%2520sequence%2520motifs%26jtitle%3DJ.%2520Virol%26date%3D1994%26volume%3D68%26spage%3D2521%26epage%3D2528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crook, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clem, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. K.</span></span> <span> </span><span class="NLM_article-title">An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">2168</span>– <span class="NLM_lpage">2174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=8445726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADyaK3sXisVyqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1993&pages=2168-2174&author=N.+E.+Crookauthor=R.+J.+Clemauthor=L.+K.+Miller&title=An+apoptosis-inhibiting+baculovirus+gene+with+a+zinc+finger-like+motif"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif</span></div><div class="casAuthors">Crook, Norman E.; Clem, Rollie J.; Miller, Lois K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2168-74</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    </div><div class="casAbstract">Spodoptera frugiperda SF-21 cells infected with Autographa californica nuclear polyhedrosis virus mutants which lack a functional p35 gene undergo apoptosis, a type of programmed cell death.  To identify p35-homologous genes in other baculoviruses, A. californica nuclear polyhedrosis virus DNA contg. a deletion in p35 was contransfected into SF-21 cells along with genomic DNAs from other baculoviruses.  One of the viral DNAs which were able to rescue wild-type infection was from Cydia pomonella granulosis virus (CpGV).  The CpGV gene responsible for the effect was mapped to a 1.6-kb SalI-SstI subclone of the SalI B fragment of CpGV.  The sequence of the SalI-SstI subclone revealed an open reading frame capable of encoding a polypeptide of 31 kDa which was sufficient to rescue wild-type infection; this gene was thus called iap (inhibitor of apoptosis).  The predicted sequence of the IAP polypeptide exhibited no significant homol. to P35 but contained a zinc finger-like motif which is also found in other genes with the potential to regulate apoptosis, including several mammalian proto-oncogenes and two insect genes involved in embryonic development.  In the context of the viral genome, both iap and p35 were able to block apoptosis induced by actinomycin D, indicating that these genes act by blocking cellular apoptosis rather than by preventing viral stimulation of apoptosis.  Several independent recombinant viruses derived from cotransfections with either the entire CpGV genome or the 1.6-kb subclone were characterized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9wL9F0FrRUbVg90H21EOLACvtfcHk0lilkF4gGsDBvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXisVyqtbg%253D&md5=cdd2b2488b2416f2ec84e79a4311ec92</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrook%26aufirst%3DN.%2BE.%26aulast%3DClem%26aufirst%3DR.%2BJ.%26aulast%3DMiller%26aufirst%3DL.%2BK.%26atitle%3DAn%2520apoptosis-inhibiting%2520baculovirus%2520gene%2520with%2520a%2520zinc%2520finger-like%2520motif%26jtitle%3DJ.%2520Virol%26date%3D1993%26volume%3D67%26spage%3D2168%26epage%3D2174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varfolomeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span> <span> </span><span class="NLM_article-title">Targeting inhibitor of apoptosis proteins for therapeutic intervention</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1509</span>– <span class="NLM_lpage">1525</span>, <span class="refDoi"> DOI: 10.4155/fmc.09.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.4155%2Ffmc.09.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21426063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFSit7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1509-1525&author=C.+Ndubakuauthor=F.+Cohenauthor=E.+Varfolomeevauthor=D.+Vucic&title=Targeting+inhibitor+of+apoptosis+proteins+for+therapeutic+intervention&doi=10.4155%2Ffmc.09.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting inhibitor of apoptosis proteins for therapeutic intervention</span></div><div class="casAuthors">Ndubaku, Chudi; Cohen, Frederick; Varfolomeev, Eugene; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1509-1525</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The inhibitors of apoptosis (IAP) proteins have emerged over the last decade as important targets for therapeutic intervention in human malignancies.  Overexpression of IAPs was implicated in cell survival and resistance against stress-induced apoptosis brought on by radiation and/or chemotherapeutics (currently the std.-of-care in a variety of different cancer diseases).  In addn., evasion from death receptor-mediated apoptosis and regulation of NF-κB pathways and cell division were also assocd. with IAP proteins.  Efforts to target IAP proteins in tumors have focused mainly on designing small mols. that mimic the IAP-binding motif of the endogenous IAP antagonist, second mitochondrial activator of caspases.  In addn., several other IAP-targeting strategies, including antisense oligonucleotides and transcriptional repression, were also initiated, with the hope of providing therapeutic benefit to cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZV1K372WKh7Vg90H21EOLACvtfcHk0lilkF4gGsDBvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFSit7%252FI&md5=40f037c635256749e6a78a71a98c7d9d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.116%26sid%3Dliteratum%253Aachs%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DTargeting%2520inhibitor%2520of%2520apoptosis%2520proteins%2520for%2520therapeutic%2520intervention%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D1509%26epage%3D1525%26doi%3D10.4155%2Ffmc.09.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, W. C.</span></span> <span> </span><span class="NLM_article-title">Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">6815</span>– <span class="NLM_lpage">6824</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=14583479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosVGnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=6815-6824&author=L.+Yangauthor=Z.+Caoauthor=H.+Yanauthor=W.+C.+Wood&title=Coexistence+of+high+levels+of+apoptotic+signaling+and+inhibitor+of+apoptosis+proteins+in+human+tumor+cells%3A+implication+for+cancer+specific+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Coexistence of High Levels of Apoptotic Signaling and Inhibitor of Apoptosis Proteins in Human Tumor Cells: Implication for Cancer Specific Therapy</span></div><div class="casAuthors">Yang, Lily; Cao, Zehong; Yan, Hui; Wood, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6815-6824</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">It is well known that dysfunction of the apoptotic pathway confers apoptosis resistance and results in a low sensitivity of human cancer cells to therapeutic agents.  A novel strategy to overcome the resistance is to target the apoptotic pathway directly.  To identify mol. targets in the apoptotic pathway that are differentially regulated in cancer and normal cells, we have examd. the levels of apoptotic effectors and inhibitors in human tumor and normal cell lines as well as in cancer and normal tissues.  These include three pancreatic cancer lines (BXPC-3, MIA PaCa-2, and Panc-1), four breast cancer cell lines (MDA-MB-231, MDA-MB-435, MDA-MB-361, and MCF-7), and colon carcinoma line (SW620).  Addnl., breast carcinoma tissue specimens were examd.  Compared with normal human fibroblast and mammary epithelial cell lines, we detected high basal levels of caspase-3 and caspase-8 activities and active caspase-3 fragments in the tumor cell lines and cancer tissues in the absence of apoptotic stimuli.  Furthermore, the tumor cells expressed high levels of survivin and XIAP, two members of the inhibitor of apoptosis (IAP) protein family.  When the activity of these IAPs was blocked by expression of dominant-neg. mutant survivin (survivinT34A) and XIAP-assocd. factor 1, resp., apoptosis was induced in tumor but not normal cell lines.  Moreover, down-regulation of both survivin and XIAP significantly enhanced tumor-cell apoptosis as compared with inhibition of either survivin or XIAP alone.  These results suggest that up-regulated IAP expression counteracts the high basal caspase-3 activity obsd. in these tumor cells and that apoptosis in tumor cells but not normal cells can be induced by blocking IAP activity.  Therefore, IAPs are important mol. targets for the development of cancer-specific therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrnkSWDJOSCbVg90H21EOLACvtfcHk0lilkF4gGsDBvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosVGnsrk%253D&md5=f8b94616c5ddba25d9ac4ecd1e17eba8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DWood%26aufirst%3DW.%2BC.%26atitle%3DCoexistence%2520of%2520high%2520levels%2520of%2520apoptotic%2520signaling%2520and%2520inhibitor%2520of%2520apoptosis%2520proteins%2520in%2520human%2520tumor%2520cells%253A%2520implication%2520for%2520cancer%2520specific%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D6815%26epage%3D6824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornblau, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segall, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scudiero, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudor, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qui, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monks, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreeff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span> <span> </span><span class="NLM_article-title">Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1796</span>– <span class="NLM_lpage">1803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10815900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktVWis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=1796-1803&author=I.+Tammauthor=S.+M.+Kornblauauthor=H.+Segallauthor=S.+Krajewskiauthor=K.+Welshauthor=S.+Kitadaauthor=D.+A.+Scudieroauthor=G.+Tudorauthor=Y.+H.+Quiauthor=A.+Monksauthor=M.+Andreeffauthor=J.+C.+Reed&title=Expression+and+prognostic+significance+of+IAP-family+genes+in+human+cancers+and+myeloid+leukemias"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias</span></div><div class="casAuthors">Tamm, Ingo; Kornblau, Steven M.; Segall, Harry; Krajewski, Stanislaw; Welsh, Kate; Kitada, Shinichi; Scudiero, Dominic A.; Tudor, Gabriela; Qui, Yi Hua; Monks, Anne; Andreeff, Michael; Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1796-1803</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Expression of several inhibitor of apoptosis proteins (IAPs) was investigated in the National Cancer Institute panel of 60 human tumor cell lines, and the expression and prognostic significance of one of these, XIAP, was evaluated in 78 previously untreated patients with acute myelogenous leukemia (AML).  XIAP and cIAP1 were expressed in most cancer lines analyzed, with substantial variability in their relative levels.  In contrast, NAIP mRNA was not detectable, and cIAP2 was found at the mRNA and protein levels in only 34 (56%) and 5 (8%) of the 60 tumor cell lines analyzed, resp.  Interestingly, XIAP, cIAP1, and cIAP2 mRNA levels did not correlate with protein levels in the tumor lines, indicating posttranscriptional regulation of expression.  High levels of XIAP protein in tumor cell lines were unexpectedly correlated with sensitivity to some anticancer drugs, particularly cytarabine and other nucleosides, whereas higher levels of cIAP1 protein levels were assocd. with resistance to several anticancer drugs.  The relevance of XIAP to in vivo responses to cytarabine was explored in AML, making correlations with patient outcome.  Patients with lower levels of XIAP protein had longer survival and a tendency toward longer remission duration than those with higher levels of XIAP.  Altogether, IAPs are widely but differentially expressed in human cancers and leukemias, and higher XIAP protein levels may have adverse prognostic significance for patients with AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPBpTFu0KAgrVg90H21EOLACvtfcHk0lh7VVfbwXfrfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVWis7k%253D&md5=08ea4dd16cfe6106339fbe7ee7e47a77</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamm%26aufirst%3DI.%26aulast%3DKornblau%26aufirst%3DS.%2BM.%26aulast%3DSegall%26aufirst%3DH.%26aulast%3DKrajewski%26aufirst%3DS.%26aulast%3DWelsh%26aufirst%3DK.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DTudor%26aufirst%3DG.%26aulast%3DQui%26aufirst%3DY.%2BH.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DAndreeff%26aufirst%3DM.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DExpression%2520and%2520prognostic%2520significance%2520of%2520IAP-family%2520genes%2520in%2520human%2520cancers%2520and%2520myeloid%2520leukemias%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D1796%26epage%3D1803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Small-molecule SMAC mimetics as new cancer therapeutics</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2014.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.pharmthera.2014.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=24841289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosl2ju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2014&pages=82-95&author=L.+Baiauthor=D.+C.+Smithauthor=S.+Wang&title=Small-molecule+SMAC+mimetics+as+new+cancer+therapeutics&doi=10.1016%2Fj.pharmthera.2014.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule SMAC mimetics as new cancer therapeutics</span></div><div class="casAuthors">Bai, Longchuan; Smith, David C.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-95</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Apoptosis is a tightly regulated cellular process and faulty regulation of apoptosis is a hallmark of human cancers.  Targeting key apoptosis regulators with the goal to restore apoptosis in tumor cells has been pursued as a new cancer therapeutic strategy.  XIAP, cIAP1, and cIAP2, members of inhibitor of apoptosis (IAP) proteins, are crit. regulators of cell death and survival and are attractive targets for new cancer therapy.  The SMAC/DIABLO protein is an endogenous antagonist of XIAP, cIAP1, and cIAP2.  In the last decade, intense research efforts have resulted in the design and development of several small-mol. SMAC mimetics now in clin. trials for cancer treatment.  In this review, we will discuss the roles of XIAP, cIAP1, and cIAP2 in regulation of cell death and survival, and the design and development of small-mol. SMAC mimetics as novel cancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLJ1zuCJO_xrVg90H21EOLACvtfcHk0lh7VVfbwXfrfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosl2ju7k%253D&md5=92404daa1b37f65bee87fa699858a5bf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DSmall-molecule%2520SMAC%2520mimetics%2520as%2520new%2520cancer%2520therapeutics%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D144%26spage%3D82%26epage%3D95%26doi%3D10.1016%2Fj.pharmthera.2014.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lober, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Togo, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zapata, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span> <span> </span><span class="NLM_article-title">Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">1080</span>– <span class="NLM_lpage">1090</span>, <span class="refDoi"> DOI: 10.1074/jbc.M509381200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.M509381200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=16282325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD28XitF2kug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=1080-1090&author=T.+Samuelauthor=K.+Welshauthor=T.+Loberauthor=S.+H.+Togoauthor=J.+M.+Zapataauthor=J.+C.+Reed&title=Distinct+BIR+domains+of+cIAP1+mediate+binding+to+and+ubiquitination+of+tumor+necrosis+factor+receptor-associated+factor+2+and+second+mitochondrial+activator+of+caspases&doi=10.1074%2Fjbc.M509381200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct BIR Domains of cIAP1 Mediate Binding to and Ubiquitination of Tumor Necrosis Factor Receptor-associated Factor 2 and Second Mitochondrial Activator of Caspases</span></div><div class="casAuthors">Samuel, Temesgen; Welsh, Kate; Lober, Thomas; Togo, Summanuna H.; Zapata, Juan M.; Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1080-1090</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis proteins (IAPs) regulate apoptosis primarily by inhibiting caspase-family proteases.  However, many IAPs also possess E3 ligase (ubiquitin-protein isopeptide ligase) activities implicated in both caspase-dependent and -independent functions of these proteins.  Here, the authors compared the structural features of cIAP1 responsible for its interactions with two known target proteins, TRAF2 and SMAC.  The N-terminal (BIR1) and C-terminal (BIR3) BIR domains of cIAP1 were detd. to be necessary and sufficient for binding TRAF2 and SMAC, resp.  Mutational anal. of the BIR1 and BIR3 domains identified crit. residues required for TRAF2 and SMAC binding.  Using these mutants, cIAP1-mediated ubiquitination of TRAF2 and SMAC in vitro was detd. to be correspondingly dependent on intact binding sites on BIR1 and BIR3.  Because TRAF2 regulates NF-κB activation, the effects of cIAP1 on TRAF2-mediated induction of NF-κB transcriptional activity were studied using reporter gene assays.  Expression of a fragment of cIAP1 encompassing the three BIR domains (but not full-length cIAP1) greatly enhanced TRAF2-induced increases in NF-κB activity, providing a convenient assay for monitoring BIR-dependent effects of cIAP1 on TRAF2 in cells.  BIR1 mutants of the BIR1-3 fragment of cIAP1 that failed to bind TRAF2 lost the ability to modulate NF-κB activity, demonstrating a requirement for BIR1-mediated interactions with TRAF2.  Altogether, these findings demonstrate the modularity and diversification of BIR domains, showing that a single cIAP can direct its E3 ligase activity toward different substrates and can alter the cellular functions of different protein targets in accordance with differences in the specificity of individual BIR domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_mIKWzl6NzLVg90H21EOLACvtfcHk0lh7VVfbwXfrfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitF2kug%253D%253D&md5=6c675e45e0175fa52e2eeaed19fdd805</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M509381200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M509381200%26sid%3Dliteratum%253Aachs%26aulast%3DSamuel%26aufirst%3DT.%26aulast%3DWelsh%26aufirst%3DK.%26aulast%3DLober%26aufirst%3DT.%26aulast%3DTogo%26aufirst%3DS.%2BH.%26aulast%3DZapata%26aufirst%3DJ.%2BM.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DDistinct%2520BIR%2520domains%2520of%2520cIAP1%2520mediate%2520binding%2520to%2520and%2520ubiquitination%2520of%2520tumor%2520necrosis%2520factor%2520receptor-associated%2520factor%25202%2520and%2520second%2520mitochondrial%2520activator%2520of%2520caspases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D1080%26epage%3D1090%26doi%3D10.1074%2Fjbc.M509381200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varfolomeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wayson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span> <span> </span><span class="NLM_article-title">The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">29022</span>– <span class="NLM_lpage">29029</span>, <span class="refDoi"> DOI: 10.1074/jbc.M605116200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.M605116200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=16891304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFamsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=29022-29029&author=E.+Varfolomeevauthor=S.+M.+Waysonauthor=V.+M.+Dixitauthor=W.+J.+Fairbrotherauthor=D.+Vucic&title=The+inhibitor+of+apoptosis+protein+fusion+c-IAP2.MALT1+stimulates+NF-kappaB+activation+independently+of+TRAF1+AND+TRAF2&doi=10.1074%2Fjbc.M605116200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-κB activation independently of TRAF1 AND TRAF2</span></div><div class="casAuthors">Varfolomeev, Eugene; Wayson, Sarah M.; Dixit, Vishva M.; Fairbrother, Wayne J.; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">29022-29029</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The inhibitors of apoptosis (IAPs) are a family of cell death inhibitors found in viruses and metazoans.  All members of the IAP family have at least one baculovirus IAP repeat (BIR) motif that is essential for their anti-apoptotic activity.  The t(11, 18)(q21;q21) translocation fuses the BIR domains of c-IAP2 with the paracaspase/MALT1 (mucosa-assocd. lymphoid tissue) protein, a crit. mediator of T cell receptor-stimulated activation of NF-κB.  The c-IAP2.MALT1 fusion protein constitutively activates the NF-κB pathway, and this is considered crit. to malignant B cell transformation and lymphoma progression.  The BIR domains of c-IAP1 and c-IAP2 interact with tumor necrosis factor receptor-assocd. factors 1 and 2 (TRAF1 and TRAF2).  Here we investigated the importance of TRAF1 and TRAF2 for c-IAP2.MALT1-stimulated NF-κB activation.  We identified a novel epitope within the BIR1 domains of c-IAP1 and c-IAP2 that is crucial for their phys. interaction with TRAF1 and TRAF2.  The c-IAP2.MALT1 fusion protein assocs. with TRAF1 and TRAF2 using the same binding site.  We explored the functional relevance of this interaction and established that binding to TRAF1 and TRAF2 is not required for c-IAP2.MALT1-stimulated NF-κB activation.  Furthermore, gene ablation of TRAF2 or combined down-regulation of TRAF1 and TRAF2 did not affect c-IAP2.MALT1-stimulated signaling.  However, TRAF1/2-binding mutants of c-IAP2.MALT1 still oligomerize and activate NF-κB, suggesting that oligomerization might be important for signaling of the fusion protein.  Therefore, the t(11, 18)(q21;q21) translocation creating the c-IAP2.MALT1 fusion protein activates NF-κB and contributes to human malignancy in the absence of signaling adaptors that might otherwise regulate its activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrt_4xav-jLrVg90H21EOLACvtfcHk0li4y7Bd0g-uZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFamsrw%253D&md5=79aa3ec008da4e8d5b05854ed04ed2bf</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M605116200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M605116200%26sid%3Dliteratum%253Aachs%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DWayson%26aufirst%3DS.%2BM.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DThe%2520inhibitor%2520of%2520apoptosis%2520protein%2520fusion%2520c-IAP2.MALT1%2520stimulates%2520NF-kappaB%2520activation%2520independently%2520of%2520TRAF1%2520AND%2520TRAF2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D29022%26epage%3D29029%26doi%3D10.1074%2Fjbc.M605116200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, K. L.</span></span> <span> </span><span class="NLM_article-title">A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">37297</span>– <span class="NLM_lpage">37305</span>, <span class="refDoi"> DOI: 10.1074/jbc.M303389200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.M303389200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=12867425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2mu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=37297-37305&author=E.+D.+Tangauthor=C.+Y.+Wangauthor=Y.+Xiongauthor=K.+L.+Guan&title=A+role+for+NF-kappaB+essential+modifier%2FIkappaB+kinase-gamma+%28NEMO%2FIKKgamma%29+ubiquitination+in+the+activation+of+the+IkappaB+kinase+complex+by+tumor+necrosis+factor-alpha&doi=10.1074%2Fjbc.M303389200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A Role for NF-κB Essential Modifier/IκB Kinase-γ (NEMO/IKKγ) Ubiquitination in the Activation of the IκB Kinase Complex by Tumor Necrosis Factor-α</span></div><div class="casAuthors">Tang, Eric D.; Wang, Cun-Yu; Xiong, Yue; Guan, Kun-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">37297-37305</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">NEMO (NF-κB essential modifier)/IKKγ (IκB kinase-γ) is required for the activation of the IκB kinase complex (IKK) by inflammatory stimuli such as tumor necrosis factor (TNF-α).  Here we show that TNF-α stimulates the ubiquitination of NEMO in a manner that does not appear to target it for degrdn. and that is impaired by mutations in the NEMO zinc finger.  Mutations of the zinc finger are found in patients with hypohidrotic ectodermal dysplasia with immunodeficiency (HED-ID) and lead to the impairment of TNF-α-stimulated IKK phosphorylation and activation.  In addn., the ubiquitination of NEMO is mediated by c-IAP1, an inhibitor of apoptosis protein that is a component of the TNF receptor signaling complex.  Thus, the ubiquitination of NEMO mediated by c-IAP1 likely plays an important role in the activation of IKK by TNF-α.  Also, defective NEMO ubiquitination may be responsible for the impaired cellular NF-κB signaling found in patients with HED-ID.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX7WoCOLR0gbVg90H21EOLACvtfcHk0li4y7Bd0g-uZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2mu7g%253D&md5=2cb7eea0ca7f100822190d36a9a81a26</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M303389200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M303389200%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DE.%2BD.%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26atitle%3DA%2520role%2520for%2520NF-kappaB%2520essential%2520modifier%252FIkappaB%2520kinase-gamma%2520%2528NEMO%252FIKKgamma%2529%2520ubiquitination%2520in%2520the%2520activation%2520of%2520the%2520IkappaB%2520kinase%2520complex%2520by%2520tumor%2520necrosis%2520factor-alpha%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D37297%26epage%3D37305%26doi%3D10.1074%2Fjbc.M303389200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eckelman, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, F. L.</span></span> <span> </span><span class="NLM_article-title">Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">988</span>– <span class="NLM_lpage">994</span>, <span class="refDoi"> DOI: 10.1038/sj.embor.7400795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fsj.embor.7400795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=17016456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVajtr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=988-994&author=B.+P.+Eckelmanauthor=G.+S.+Salvesenauthor=F.+L.+Scott&title=Human+inhibitor+of+apoptosis+proteins%3A+why+XIAP+is+the+black+sheep+of+the+family&doi=10.1038%2Fsj.embor.7400795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family</span></div><div class="casAuthors">Eckelman, Brendan P.; Salvesen, Guy S.; Scott, Fiona L.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">988-994</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Several of the inhibitor of apoptosis protein (IAP) family members regulate apoptosis in response to various cellular assaults.  Some members are also involved in cell signaling, mitosis and targeting proteins to the ubiquitin-proteasome degrdn. machinery.  The most intensively studied family member, X-linked IAP (XIAP), is a potent inhibitor of caspase activity; hence, it is generally assumed that direct caspase inhibition is an important conserved function of most members of the family.  Biochem. and structural studies have precisely mapped the elements of XIAP required for caspase inhibition.  Intriguingly, these elements are not conserved among IAPs.  Here, we review current knowledge of the caspase-inhibitory potential of the human IAPs and show that XIAP is probably the only bona fide caspase inhibitor, suggesting that the other family members never gained the ability to directly inhibit caspase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi2WCkDI8Vs7Vg90H21EOLACvtfcHk0li4y7Bd0g-uZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVajtr7K&md5=7db7a68e171e0303dd25ba6e2a97be34</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsj.embor.7400795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.embor.7400795%26sid%3Dliteratum%253Aachs%26aulast%3DEckelman%26aufirst%3DB.%2BP.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DScott%26aufirst%3DF.%2BL.%26atitle%3DHuman%2520inhibitor%2520of%2520apoptosis%2520proteins%253A%2520why%2520XIAP%2520is%2520the%2520black%2520sheep%2520of%2520the%2520family%26jtitle%3DEMBO%2520Rep.%26date%3D2006%26volume%3D7%26spage%3D988%26epage%3D994%26doi%3D10.1038%2Fsj.embor.7400795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eckelman, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span> <span> </span><span class="NLM_article-title">The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">3254</span>– <span class="NLM_lpage">3260</span>, <span class="refDoi"> DOI: 10.1074/jbc.M510863200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.M510863200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=16339151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=3254-3260&author=B.+P.+Eckelmanauthor=G.+S.+Salvesen&title=The+human+anti-apoptotic+proteins+cIAP1+and+cIAP2+bind+but+do+not+inhibit+caspases&doi=10.1074%2Fjbc.M510863200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Anti-apoptotic Proteins cIAP1 and cIAP2 Bind but Do Not Inhibit Caspases</span></div><div class="casAuthors">Eckelman, Brendan P.; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3254-3260</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">CIAPs (cellular inhibitor of apoptosis proteins) 1 and 2 are able to regulate apoptosis when ectopically expressed in recipient cells and probably also in vivo.  Previous work suggested that this is at least partially due to direct caspase inhibition, mediated by two of the three baculovirus IAP repeat (BIR) domains that are contained in these proteins.  In support of this we show that the BIR domains 2 and 3 of the two cIAPs are able to bind caspases-7 and -9.  However, we demonstrate that neither of these BIR domains is able to inhibit caspases because of crit. substitutions in the regions that target caspase inhibition in the X-linked IAP, a tight binding caspase inhibitor.  The cIAP BIR domains can be converted to tight binding caspase inhibitors by substituting these crit. residues with XIAP residues.  Thus, cIAPs maintain protein scaffolds suitable for direct caspase inhibition but have lost or never acquired specific caspase inhibitory interaction sites.  Consequently, although the binding function of the cIAP BIRs may be important for their physiol. function, caspase inhibition is not.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7nmRzBWNlZrVg90H21EOLACvtfcHk0lhOsBvx8rScRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSmsrk%253D&md5=b7375d7fb6c76c0a4ce99b9a9dc14972</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M510863200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M510863200%26sid%3Dliteratum%253Aachs%26aulast%3DEckelman%26aufirst%3DB.%2BP.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DThe%2520human%2520anti-apoptotic%2520proteins%2520cIAP1%2520and%2520cIAP2%2520bind%2520but%2520do%2520not%2520inhibit%2520caspases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D3254%26epage%3D3260%26doi%3D10.1074%2Fjbc.M510863200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gyrd-Hansen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miasari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoro, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zender, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Fonseca, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvelebil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bujnicki, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, P.</span></span> <span> </span><span class="NLM_article-title">IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1309</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1038/ncb1789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fncb1789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18931663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlais7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=1309-1317&author=M.+Gyrd-Hansenauthor=M.+Dardingauthor=M.+Miasariauthor=M.+M.+Santoroauthor=L.+Zenderauthor=W.+Xueauthor=T.+Tenevauthor=P.+C.+da+Fonsecaauthor=M.+Zvelebilauthor=J.+M.+Bujnickiauthor=S.+Loweauthor=J.+Silkeauthor=P.+Meier&title=IAPs+contain+an+evolutionarily+conserved+ubiquitin-binding+domain+that+regulates+NF-kappaB+as+well+as+cell+survival+and+oncogenesis&doi=10.1038%2Fncb1789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-κB as well as cell survival and oncogenesis</span></div><div class="casAuthors">Gyrd-Hansen, Mads; Darding, Maurice; Miasari, Maria; Santoro, Massimo M.; Zender, Lars; Xue, Wen; Tenev, Tencho; da Fonseca, Paula C. A.; Zvelebil, Marketa; Bujnicki, Janusz M.; Lowe, Scott; Silke, John; Meier, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1309-1317</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The covalent attachment of ubiquitin to target proteins influences various cellular processes, including DNA repair, NF-κB signaling and cell survival.  The most common mode of regulation by ubiquitin-conjugation involves specialized ubiquitin-binding proteins that bind to ubiquitylated proteins and link them to downstream biochem. processes.  Unravelling how the ubiquitin-message is recognized is essential because aberrant ubiquitin-mediated signaling contributes to tumor formation.  Recent evidence indicates that inhibitor of apoptosis (IAP) proteins are frequently overexpressed in cancer and their expression level is implicated in contributing to tumorigenesis, chemoresistance, disease progression and poor patient-survival.  Here, we have identified an evolutionarily conserved ubiquitin-assocd. (UBA) domain in IAPs, which enables them to bind to Lys 63-linked polyubiquitin.  We found that the UBA domain is essential for the oncogenic potential of cIAP1, to maintain endothelial cell survival and to protect cells from TNF-α-induced apoptosis.  Moreover, the UBA domain is required for XIAP and cIAP2-MALT1 to activate NF-κB.  Our data suggest that the UBA domain of cIAP2-MALT1 stimulates NF-κB signaling by binding to polyubiquitylated NEMO.  Significantly, 98% of all cIAP2-MALT1 fusion proteins retain the UBA domain, suggesting that ubiquitin-binding contributes to the oncogenic potential of cIAP2-MALT1 in MALT lymphoma.  Our data identify IAPs as ubiquitin-binding proteins that contribute to ubiquitin-mediated cell survival, NF-κB signaling and oncogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1bPlCkVUl3LVg90H21EOLACvtfcHk0lhOsBvx8rScRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlais7jJ&md5=ad243bd52582b4e40f58eccd369bc2d4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fncb1789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1789%26sid%3Dliteratum%253Aachs%26aulast%3DGyrd-Hansen%26aufirst%3DM.%26aulast%3DDarding%26aufirst%3DM.%26aulast%3DMiasari%26aufirst%3DM.%26aulast%3DSantoro%26aufirst%3DM.%2BM.%26aulast%3DZender%26aufirst%3DL.%26aulast%3DXue%26aufirst%3DW.%26aulast%3DTenev%26aufirst%3DT.%26aulast%3Dda%2BFonseca%26aufirst%3DP.%2BC.%26aulast%3DZvelebil%26aufirst%3DM.%26aulast%3DBujnicki%26aufirst%3DJ.%2BM.%26aulast%3DLowe%26aufirst%3DS.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DIAPs%2520contain%2520an%2520evolutionarily%2520conserved%2520ubiquitin-binding%2520domain%2520that%2520regulates%2520NF-kappaB%2520as%2520well%2520as%2520cell%2520survival%2520and%2520oncogenesis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2008%26volume%3D10%26spage%3D1309%26epage%3D1317%26doi%3D10.1038%2Fncb1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaux, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span> <span> </span><span class="NLM_article-title">IAPs, RINGs and ubiquitylation</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1038/nrm1621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnrm1621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=15803136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVaktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=287-297&author=D.+L.+Vauxauthor=J.+Silke&title=IAPs%2C+RINGs+and+ubiquitylation&doi=10.1038%2Fnrm1621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">IAPs, RINGs and ubiquitylation</span></div><div class="casAuthors">Vaux, David L.; Silke, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">287-297</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Here, the authors review the function of the RING domain of inhibitor of apoptosis proteins (IAPs), provide an overview of the biol. of E3 ubiquitin ligases, the enzymes which conjugate ubiquitin to substrate proteins, and its application to IAPs, and examine evidence for substrate ubiquitination by IAPs and for the importance of these ubiquitination events in the prevention of apoptosis.  The IAPs all contain one or more baculoviral IAP repeat motifs, through which they interact with various other proteins.  Many IAPs also have another Zn-binding motif, the RING domain, which can recruit E2 ubiquitin-conjugating enzymes and catalyze the transfer of ubiquitin onto target proteins.  The no. of targets of IAP-mediated ubiquitination is increasing, and recent results indicate that outcomes following ubiquitination are tantalizingly complex.  As well as regulating other proteins, the IAPs themselves are controlled by ubiquitin-mediated degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8gh0_du1aY7Vg90H21EOLACvtfcHk0lhOsBvx8rScRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVaktb8%253D&md5=4d3040429bbac085dd33b46c8c74d955</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrm1621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1621%26sid%3Dliteratum%253Aachs%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DIAPs%252C%2520RINGs%2520and%2520ubiquitylation%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2005%26volume%3D6%26spage%3D287%26epage%3D297%26doi%3D10.1038%2Fnrm1621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rautureau, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francalanci, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broemer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoro, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, P.</span></span> <span> </span><span class="NLM_article-title">CARD-mediated autoinhibition of cIAP1’s E3 ligase activity suppresses cell proliferation and migration</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">569</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2011.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.molcel.2011.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21549626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsV2jtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2011&pages=569-583&author=J.+Lopezauthor=S.+W.+Johnauthor=T.+Tenevauthor=G.+J.+Rautureauauthor=M.+G.+Hindsauthor=F.+Francalanciauthor=R.+Wilsonauthor=M.+Broemerauthor=M.+M.+Santoroauthor=C.+L.+Dayauthor=P.+Meier&title=CARD-mediated+autoinhibition+of+cIAP1%E2%80%99s+E3+ligase+activity+suppresses+cell+proliferation+and+migration&doi=10.1016%2Fj.molcel.2011.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">CARD-Mediated Autoinhibition of cIAP1's E3 Ligase Activity Suppresses Cell Proliferation and Migration</span></div><div class="casAuthors">Lopez, Juanita; John, Sidonie Wicky; Tenev, Tencho; Rautureau, Gilles J. P.; Hinds, Mark G.; Francalanci, Floriana; Wilson, Rebecca; Broemer, Meike; Santoro, Massimo M.; Day, Catherine L.; Meier, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">569-583</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">E3 ligases mediate the covalent attachment of ubiquitin to target proteins thereby enabling ubiquitin-dependent signaling.  Unraveling how E3 ligases are regulated is important because miscontrolled ubiquitylation can lead to disease.  Cellular inhibitor of apoptosis (cIAP) proteins are E3 ligases that modulate diverse biol. processes such as cell survival, proliferation, and migration.  Here, the authors have solved the structure of the caspase recruitment domain (CARD) of cIAP1 and identified that it is required for cIAP1 autoregulation.  The CARD inhibits activation of cIAP1's E3 activity by preventing RING dimerization, E2 binding, and E2 activation.  Moreover, the CARD is required to suppress cell proliferation and migration.  Further, CARD-mediated autoregulation is also necessary to maximally suppress caspase-8-dependent apoptosis and vascular tree degeneration in vivo.  Taken together, the authors' data reveal mechanisms by which the E3 ligase activity of cIAP1 is controlled, and how its deregulation impacts on cell proliferation, migration and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEuBA3RY1Np7Vg90H21EOLACvtfcHk0lhActhxYhIQMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsV2jtb0%253D&md5=5ffa96aa585d6c4468951d01b1f76d52</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DJ.%26aulast%3DJohn%26aufirst%3DS.%2BW.%26aulast%3DTenev%26aufirst%3DT.%26aulast%3DRautureau%26aufirst%3DG.%2BJ.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DFrancalanci%26aufirst%3DF.%26aulast%3DWilson%26aufirst%3DR.%26aulast%3DBroemer%26aufirst%3DM.%26aulast%3DSantoro%26aufirst%3DM.%2BM.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DCARD-mediated%2520autoinhibition%2520of%2520cIAP1%25E2%2580%2599s%2520E3%2520ligase%2520activity%2520suppresses%2520cell%2520proliferation%2520and%2520migration%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D42%26spage%3D569%26epage%3D583%26doi%3D10.1016%2Fj.molcel.2011.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varfolomeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blankenship, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wayson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorova, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayagaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dynek, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span> <span> </span><span class="NLM_article-title">IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">681</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.cell.2007.10.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18022362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSgurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=669-681&author=E.+Varfolomeevauthor=J.+W.+Blankenshipauthor=S.+M.+Waysonauthor=A.+V.+Fedorovaauthor=N.+Kayagakiauthor=P.+Gargauthor=K.+Zobelauthor=J.+N.+Dynekauthor=L.+O.+Elliottauthor=H.+J.+Wallweberauthor=J.+A.+Flygareauthor=W.+J.+Fairbrotherauthor=K.+Deshayesauthor=V.+M.+Dixitauthor=D.+Vucic&title=IAP+antagonists+induce+autoubiquitination+of+c-IAPs%2C+NF-kappaB+activation%2C+and+TNFalpha-dependent+apoptosis&doi=10.1016%2Fj.cell.2007.10.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis</span></div><div class="casAuthors">Varfolomeev, Eugene; Blankenship, John W.; Wayson, Sarah M.; Fedorova, Anna V.; Kayagaki, Nobuhiko; Garg, Parie; Zobel, Kerry; Dynek, Jasmin N.; Elliott, Linda O.; Wallweber, Heidi J. A.; Flygare, John A.; Fairbrother, Wayne J.; Deshayes, Kurt; Dixit, Vishva M.; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">669-681</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis (IAP) proteins are antiapoptotic regulators that block cell death in response to diverse stimuli.  They are expressed at elevated levels in human malignancies and are attractive targets for the development of novel cancer therapeutics.  Herein, the authors demonstrate that small-mol. IAP antagonists bind to select baculovirus IAP repeat (BIR) domains resulting in dramatic induction of autoubiquitination activity and rapid proteasomal degrdn. of c-IAPs.  The IAP antagonists also induce cell death that is dependent on TNF signaling and de novo protein biosynthesis.  Addnl., the c-IAP proteins were found to function as regulators of NF-κB signaling.  Through their ubiquitin E3 ligase activities c-IAP1 and c-IAP2 promote proteasomal degrdn. of NIK, the central ser/thr kinase in the noncanonical NF-κB pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV7cKeBeR_hrVg90H21EOLACvtfcHk0lhActhxYhIQMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSgurzF&md5=c9a255030cc26db0519680d170ba91f9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DBlankenship%26aufirst%3DJ.%2BW.%26aulast%3DWayson%26aufirst%3DS.%2BM.%26aulast%3DFedorova%26aufirst%3DA.%2BV.%26aulast%3DKayagaki%26aufirst%3DN.%26aulast%3DGarg%26aufirst%3DP.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DDynek%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DIAP%2520antagonists%2520induce%2520autoubiquitination%2520of%2520c-IAPs%252C%2520NF-kappaB%2520activation%252C%2520and%2520TNFalpha-dependent%2520apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D669%26epage%3D681%26doi%3D10.1016%2Fj.cell.2007.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holcik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korneluk, R. G.</span></span> <span> </span><span class="NLM_article-title">XIAP: apoptotic brake and promising therapeutic target</span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1023/A:1011379307472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1023%2FA%3A1011379307472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=11445667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsF2qu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=253-261&author=M.+Holcikauthor=H.+Gibsonauthor=R.+G.+Korneluk&title=XIAP%3A+apoptotic+brake+and+promising+therapeutic+target&doi=10.1023%2FA%3A1011379307472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">XIAP: apoptotic brake and promising therapeutic target</span></div><div class="casAuthors">Holcik, Martin; Gibson, Hilary; Korneluk, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-261</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  The X-linked Inhibitor of Apoptosis, XIAP, is a key member of the newly discovered family of intrinsic inhibitors of apoptosis (IAP) proteins.  IAPs block cell death both in vitro and in vivo by virtue of inhibition of distinct caspases.  Although other proteins were identified which inhibit upstream caspases, only the IAPs were demonstrated to be endogenous repressors of the terminal caspase cascade.  In turn, the caspase inhibiting activity of XIAP is neg. regulated by at least 2 XIAP-interacting proteins, XAF1 and Smac/DIABLO.  In addn. to the inhibition of caspases, recent discoveries from several labs. suggest that XIAP is also involved in a no. of other biol. significant cellular activities including modulation of receptor-mediated signal transduction and protein ubiquitination.  XIAP is also translated by a rare cap-independent mechanism mediated by a specific sequence called IRES (for Internal Ribosome Entry Site) which is found in the XIAP 5' UTR.  XIAP protein is thus synthesized under various conditions of cellular stress such as serum starvation and low dose γ-irradn. induced apoptosis, conditions that lead to the inhibition of cellular protein synthesis.  The multiple biol. activities of XIAP, its unique translational and post-translational control and the centrality of the caspase cascade make the control of XIAP expression an exceptionally promising mol. target for modulating apoptosis.  Therapeutic benefits can be derived from both the suppression of inappropriate cell death such as in neurodegenerative disorders and ischemic injury or in the activation of latent cell death pathways such as in autoimmune disease and cancer where apoptosis induction is the desired outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqewyDCMlelK7Vg90H21EOLACvtfcHk0lhActhxYhIQMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsF2qu7g%253D&md5=fa50ae4bab9721c40942d0268085e5a4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1023%2FA%3A1011379307472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1011379307472%26sid%3Dliteratum%253Aachs%26aulast%3DHolcik%26aufirst%3DM.%26aulast%3DGibson%26aufirst%3DH.%26aulast%3DKorneluk%26aufirst%3DR.%2BG.%26atitle%3DXIAP%253A%2520apoptotic%2520brake%2520and%2520promising%2520therapeutic%2520target%26jtitle%3DApoptosis%26date%3D2001%26volume%3D6%26spage%3D253%26epage%3D261%26doi%3D10.1023%2FA%3A1011379307472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Brabander, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harran, P. G.</span></span> <span> </span><span class="NLM_article-title">A small molecule SMAC mimic potentiates TRAIL- and TNFalpha-mediated cell death</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>305</i></span>,  <span class="NLM_fpage">1471</span>– <span class="NLM_lpage">1474</span>, <span class="refDoi"> DOI: 10.1126/science.1098231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1126%2Fscience.1098231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=15353805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFartL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1471-1474&author=L.+Liauthor=R.+M.+Thomasauthor=H.+Suzukiauthor=J.+K.+De+Brabanderauthor=X.+Wangauthor=P.+G.+Harran&title=A+small+molecule+SMAC+mimic+potentiates+TRAIL-+and+TNFalpha-mediated+cell+death&doi=10.1126%2Fscience.1098231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death</span></div><div class="casAuthors">Li, Lin; Thomas, Ranny Mathew; Suzuki, Hidetaka; De Brabander, Jef K.; Wang, Xiaodong; Harran, Patrick G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">5689</span>),
    <span class="NLM_cas:pages">1471-1474</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We describe the synthesis and properties of a small mol. mimic of Smac, a pro-apoptotic protein that functions by relieving inhibitor-of-apoptosis protein (IAP)-mediated suppression of caspase activity.  The compd. binds to X chromosome-encoded IAP (XIAP), cellular IAP 1 (cIAP-1), and cellular IAP 2 (cIAP-2) and synergizes with both tumor necrosis factor α (TNFα) and TNF-related apoptosis-inducing ligand (TRAIL) to potently induce caspase activation and apoptosis in human cancer cells.  The mol. has allowed a temporal, unbiased evaluation of the roles that IAP proteins play during signaling from TRAIL and TNF receptors.  The compd. is also a lead structure for the development of IAP antagonists potentially useful as therapy for cancer and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri19S7A9uW8bVg90H21EOLACvtfcHk0ljBh2cDelawKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFartL8%253D&md5=75945f9e8637c8ce303e15f95395f449</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscience.1098231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1098231%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DR.%2BM.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DDe%2BBrabander%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHarran%26aufirst%3DP.%2BG.%26atitle%3DA%2520small%2520molecule%2520SMAC%2520mimic%2520potentiates%2520TRAIL-%2520and%2520TNFalpha-mediated%2520cell%2520death%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1471%26epage%3D1474%26doi%3D10.1126%2Fscience.1098231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">SMAC, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)00008-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2FS0092-8674%2800%2900008-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10929711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=33-42&author=C.+Duauthor=M.+Fangauthor=Y.+Liauthor=L.+Liauthor=X.+Wang&title=SMAC%2C+a+mitochondrial+protein+that+promotes+cytochrome+c-dependent+caspase+activation+by+eliminating+IAP+inhibition&doi=10.1016%2FS0092-8674%2800%2900008-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition</span></div><div class="casAuthors">Du, Chunying; Fang, Min; Li, Yucheng; Li, Lily; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-42</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We report here the identification of a novel protein, Smac, which promotes caspase activation in the cytochrome c/Apaf-1/caspase-9 pathway.  Smac promotes caspase-9 activation by binding to inhibitor of apoptosis proteins, IAPs, and removing their inhibitory activity.  Smac is normally a mitochondrial protein but is released into the cytosol when cells undergo apoptosis.  Mitochondrial import and cleavage of its signal peptide are required for Smac to gain its apoptotic activity.  Overexpression of Smac increases cells' sensitivity to apoptotic stimuli.  Smac is the second mitochondrial protein, along with cytochrome c, that promotes apoptosis by activating caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEUyaGmAsnprVg90H21EOLACvtfcHk0ljBh2cDelawKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCrsbc%253D&md5=8321d44bed77ff7c2da398e1b02f9e20</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900008-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900008-8%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DC.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DSMAC%252C%2520a%2520mitochondrial%2520protein%2520that%2520promotes%2520cytochrome%2520c-dependent%2520caspase%2520activation%2520by%2520eliminating%2520IAP%2520inhibition%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D33%26epage%3D42%26doi%3D10.1016%2FS0092-8674%2800%2900008-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verhagen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekert, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pakusch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritz, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaux, D. L.</span></span> <span> </span><span class="NLM_article-title">Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)00009-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2FS0092-8674%2800%2900009-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10929712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=43-53&author=A.+M.+Verhagenauthor=P.+G.+Ekertauthor=M.+Pakuschauthor=J.+Silkeauthor=L.+M.+Connollyauthor=G.+E.+Reidauthor=R.+L.+Moritzauthor=R.+J.+Simpsonauthor=D.+L.+Vaux&title=Identification+of+DIABLO%2C+a+mammalian+protein+that+promotes+apoptosis+by+binding+to+and+antagonizing+IAP+proteins&doi=10.1016%2FS0092-8674%2800%2900009-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins</span></div><div class="casAuthors">Verhagen, Anne M.; Ekert, Paul G.; Pakusch, Miha; Silke, John; Connolly, Lisa M.; Reid, Gavin E.; Moritz, Robert L.; Simpson, Richard J.; Vaux, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">To identify proteins that bind mammalian IAP homolog A (MIHA, also known as XIAP), we used coimmunopptn. and 2D immobilized pH gradient/SDS-PAGE, followed by electrospray ionization tandem mass spectrometry.  DIABLO (direct IAP binding protein with low pI) is a novel protein that can bind MIHA and can also interact with MIHB and MIHC and the baculoviral IAP, OpIAP.  The N-terminally processed, IAP-interacting form of DIABLO is concd. in membrane fractions in healthy cells but released into the MIHA-contg. cytosolic fractions upon UV irradn.  As transfection of cells with DIABLO was able to counter the protection afforded by MIHA against UV irradn., DIABLO may promote apoptosis by binding to IAPs and preventing them from inhibiting caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-TYWHjxeE7Vg90H21EOLACvtfcHk0ljBh2cDelawKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr4%253D&md5=475519bd43e9d625b06b0293895d9693</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900009-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900009-X%26sid%3Dliteratum%253Aachs%26aulast%3DVerhagen%26aufirst%3DA.%2BM.%26aulast%3DEkert%26aufirst%3DP.%2BG.%26aulast%3DPakusch%26aufirst%3DM.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DConnolly%26aufirst%3DL.%2BM.%26aulast%3DReid%26aufirst%3DG.%2BE.%26aulast%3DMoritz%26aufirst%3DR.%2BL.%26aulast%3DSimpson%26aufirst%3DR.%2BJ.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26atitle%3DIdentification%2520of%2520DIABLO%252C%2520a%2520mammalian%2520protein%2520that%2520promotes%2520apoptosis%2520by%2520binding%2520to%2520and%2520antagonizing%2520IAP%2520proteins%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D43%26epage%3D53%26doi%3D10.1016%2FS0092-8674%2800%2900009-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structural and biochemical basis of apoptotic activation by SMAC/DIABLO</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>406</i></span>,  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1038/35022514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2F35022514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10972280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVCrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2000&pages=855-862&author=J.+Chaiauthor=C.+Duauthor=J.+W.+Wuauthor=S.+Kyinauthor=X.+Wangauthor=Y.+Shi&title=Structural+and+biochemical+basis+of+apoptotic+activation+by+SMAC%2FDIABLO&doi=10.1038%2F35022514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and biochemical basis of apoptotic activation by Smac/DIABLO</span></div><div class="casAuthors">Chai, Jijie; Du, Chunying; Wu, Jia-Wei; Kyin, Saw; Wang, Xiaodong; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">406</span>
        (<span class="NLM_cas:issue">6798</span>),
    <span class="NLM_cas:pages">855-862</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis (programmed cell death), an essential process in the development and homeostasis of metazoans, is carried out by caspases.  The mitochondrial protein Smac/DIABLO performs a crit. function in apoptosis by eliminating the inhibitory effect of IAPs (inhibitor of apoptosis proteins) on caspases.  Here we show that Smac/DIABLO promotes not only the proteolytic activation of procaspase-3 but also the enzymic activity of mature caspase-3, both of which depend upon its ability to interact phys. with IAPs.  The crystal structure of Smac/DIABLO at 2.2Å resoln. reveals that it homodimerizes through an extensive hydrophobic interface.  Missense mutations inactivating this dimeric interface significantly compromise the function of Smac/DIABLO.  As in the Drosophila proteins Reaper, Grim and Hid, the amino-terminal amino acids of Smac/DIABLO are indispensable for its function, and a seven-residue peptide derived from the amino terminus promotes procaspase-3 activation in vitro.  These results establish an evolutionarily conserved structural and biochem. basis for the activation of apoptosis by Smac/DIABLO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ4zPSamJORbVg90H21EOLACvtfcHk0liiFzY9TTdoLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVCrsLk%253D&md5=e3e65405a679b11556fa875b7c5dc9fa</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2F35022514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35022514%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%2BW.%26aulast%3DKyin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520and%2520biochemical%2520basis%2520of%2520apoptotic%2520activation%2520by%2520SMAC%252FDIABLO%26jtitle%3DNature%26date%3D2000%26volume%3D406%26spage%3D855%26epage%3D862%26doi%3D10.1038%2F35022514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oost, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Structural basis for binding of SMAC/DIABLO to the XIAP BIR3 domain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">1004</span>– <span class="NLM_lpage">1008</span>, <span class="refDoi"> DOI: 10.1038/35050006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2F35050006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=11140637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1004-1008&author=Z.+Liuauthor=C.+Sunauthor=E.+T.+Olejniczakauthor=R.+P.+Meadowsauthor=S.+F.+Betzauthor=T.+Oostauthor=J.+Herrmannauthor=J.+C.+Wuauthor=S.+W.+Fesik&title=Structural+basis+for+binding+of+SMAC%2FDIABLO+to+the+XIAP+BIR3+domain&doi=10.1038%2F35050006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain</span></div><div class="casAuthors">Liu, Zhlhong; Sun, Chaohong; Olejniczak, Edward T.; Meadows, Robert P.; Betz, Stephen F.; Oost, Thorsten; Hemnann, Julia; Wu, Joe C.; Feslk, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1004-1008</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The inhibitor-of-apoptosis proteins (IAPs) regulate programmed cell death by inhibiting members of the caspase family of enzymes.  Recently, a mammalian protein called Smac (also named DIABLO) was identified that binds to the LAPs and promotes caspase activation.  Although undefined in the x-ray structure, the amino-terminal residues of Smac are crit. for its function.  To understand the structural basis for mol. recognition between Smac and the IAPs, we detd. the soln. structure of the BIR3 domain of X-linked IAP (XIAP) complexed with a functionally active nine-residue peptide derived from the N terminus of Smac.  The peptide binds across the third β-strand of the BIR3 domain in an extended conformation with only the first four residues contacting the protein.  The complex is stabilized by four intermol. hydrogen bonds, an electrostatic interaction involving the N terminus of the peptide, and several hydrophobic interactions.  This structural information, along with the binding data from BIR3 and Smac peptide mutants reported here, should aid in the design of small mols. that may be used for the treatment of cancers that overexpress IAPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM4pZbM96xmrVg90H21EOLACvtfcHk0liiFzY9TTdoLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D&md5=d81bd94ecd9cf9c11d96ee228ff371aa</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2F35050006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DBetz%26aufirst%3DS.%2BF.%26aulast%3DOost%26aufirst%3DT.%26aulast%3DHerrmann%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DStructural%2520basis%2520for%2520binding%2520of%2520SMAC%252FDIABLO%2520to%2520the%2520XIAP%2520BIR3%2520domain%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1004%26epage%3D1008%26doi%3D10.1038%2F35050006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suber, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis of IAP recognition by SMAC/DIABLO</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">1008</span>– <span class="NLM_lpage">1012</span>, <span class="refDoi"> DOI: 10.1038/35050012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2F35050012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=11140638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1008-1012&author=G.+Wuauthor=J.+Chaiauthor=T.+L.+Suberauthor=J.+W.+Wuauthor=C.+Duauthor=X.+Wangauthor=Y.+Shi&title=Structural+basis+of+IAP+recognition+by+SMAC%2FDIABLO&doi=10.1038%2F35050012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of IAP recognition by Smac/DIABLO</span></div><div class="casAuthors">Wu, Geng; Chai, Jijie; Suber, Tomeka L.; Wu, Jia-Wel; Du, Chunying; Wang, Xiaodong; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1008-1012</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is an essential process in the development and homeostasis of all metazoans.  The inhibitor-of-apoptosis (IAP) proteins suppress cell death by inhibiting the activity of caspases; this inhibition is performed by the zinc-binding BIR domains of the IAP proteins.  The mitochondrial protein Smac/DIABLO promotes apoptosis by eliminating the inhibitory effect of IAPs through phys. interactions.  Amino-terminal sequences in Smac/DIABLO are required for this function, as mutation of the very first amino acid leads to loss of interaction with LAPs and concomitant loss of Smac/DIABLO function.  Here we report the high-resoln. crystal structure of Smac/DIABLO complexed with the third BIR domain (BIR3) of XIAP.  Our results show that the N-terminal four residues (Ala-Val-Pro-Ile) in Smac/DIABLO recognize a surface groove on BIR3, with the first residue Ala binding a hydrophobic pocket and making five hydrogen bonds to neighboring residues on BIR3.  These observations provide a structural explanation for the roles of the Smac N terminus as well as the conserved N-terminal sequences in the Drosophila proteins Hid/Grim/Reaper.  In conjunction with other observations, our results reveal how Smac may relieve IAP inhibition of caspase-9 activity.  In addn. to explaining a no. of biol. observations, our structural anal. identifies potential targets for drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3qy8uKazsrVg90H21EOLACvtfcHk0liiFzY9TTdoLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D&md5=fab609edfb1833053eeb78dd2d4ed536</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2F35050012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DSuber%26aufirst%3DT.%2BL.%26aulast%3DWu%26aufirst%3DJ.%2BW.%26aulast%3DDu%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520IAP%2520recognition%2520by%2520SMAC%252FDIABLO%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1008%26epage%3D1012%26doi%3D10.1038%2F35050012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocina, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structural analysis of a functional DIAP1 fragment bound to grim and hid peptides</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(01)00282-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2FS1097-2765%2801%2900282-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=11511363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1Wnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=95-104&author=J.+W.+Wuauthor=A.+E.+Cocinaauthor=J.+Chaiauthor=B.+A.+Hayauthor=Y.+Shi&title=Structural+analysis+of+a+functional+DIAP1+fragment+bound+to+grim+and+hid+peptides&doi=10.1016%2FS1097-2765%2801%2900282-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analysis of a functional DIAP1 fragment bound to grim and hid peptides</span></div><div class="casAuthors">Wu, Jia-Wei; Cocina, Amy E.; Chai, Jijie; Hay, Bruce A.; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-104</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis protein DIAP1 suppresses apoptosis in Drosophila, with the second BIR domain (BIR2) playing an important role.  Three proteins, Hid, Grim, and Reaper, promote apoptosis, in part by binding to DIAP1 through their conserved N-terminal sequences.  The crystal structures of DIAP1-BIR2 by itself and in complex with the N-terminal peptides from Hid and Grim reveal that these peptides bind a surface groove on DIAP1, with the first four amino acids mimicking the binding of the Smac tetrapeptide to XIAP.  The next 3 residues also contribute to binding through hydrophobic interactions.  Interestingly, peptide binding induces the formation of an addnl. α helix in DIAP1.  Our study reveals the structural conservation and diversity necessary for the binding of IAPs by the Drosophila Hid/Grim/Reaper and the mammalian Smac proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK8y5_Rd5rLrVg90H21EOLACvtfcHk0liiFzY9TTdoLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1Wnu70%253D&md5=7f65cfee4e8ff7e5cff9ee603117a522</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2801%2900282-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252801%252900282-9%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%2BW.%26aulast%3DCocina%26aufirst%3DA.%2BE.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DHay%26aufirst%3DB.%2BA.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520analysis%2520of%2520a%2520functional%2520DIAP1%2520fragment%2520bound%2520to%2520grim%2520and%2520hid%2520peptides%26jtitle%3DMol.%2520Cell%26date%3D2001%26volume%3D8%26spage%3D95%26epage%3D104%26doi%3D10.1016%2FS1097-2765%2801%2900282-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">A structural view of mitochondria-mediated apoptosis</span>. <i>Nat. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">394</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1038/87548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2F87548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=11323712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1ersbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=394-401&author=Y.+Shi&title=A+structural+view+of+mitochondria-mediated+apoptosis&doi=10.1038%2F87548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A structural view of mitochondria-mediated apoptosis</span></div><div class="casAuthors">Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">394-401</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A review, with 87 refs.  Mitochondria-mediated apoptosis plays a central role in animal development and tissue homeostasis, and its alteration results in a range of malignant disorders including cancer.  Upon apoptotic stimuli, the mitochondrial proteins cytochrome c and Smac/DIABLO are released into the cytosol, where they synergistically activate caspases by activating Apaf-1 and relieving the apoptotic inhibition by IAPs.  Recent biochem. and structural studies reveal a mol. basis for these important events and identify an evolutionarily conserved mechanism of apoptosis from fruit flies to mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4gpcowzOjsbVg90H21EOLACvtfcHk0lgc_7zYo6wf1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1ersbY%253D&md5=c052658166d2b7a0b35d7eb00a02bc6d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2F87548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F87548%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.%26atitle%3DA%2520structural%2520view%2520of%2520mitochondria-mediated%2520apoptosis%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D394%26epage%3D401%26doi%3D10.1038%2F87548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kipp, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wist, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cresson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albiniak, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semmelhack, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLendon, G. L.</span></span> <span> </span><span class="NLM_article-title">Molecular targeting of inhibitor of apoptosis proteins based on small molecule mimics of natural binding partners</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">7344</span>– <span class="NLM_lpage">7349</span>, <span class="refDoi"> DOI: 10.1021/bi0121454</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0121454" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjs1egsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=7344-7349&author=R.+A.+Kippauthor=M.+A.+Caseauthor=A.+D.+Wistauthor=C.+M.+Cressonauthor=M.+Carrellauthor=E.+Grinerauthor=A.+Wiitaauthor=P.+A.+Albiniakauthor=J.+Chaiauthor=Y.+Shiauthor=M.+F.+Semmelhackauthor=G.+L.+McLendon&title=Molecular+targeting+of+inhibitor+of+apoptosis+proteins+based+on+small+molecule+mimics+of+natural+binding+partners&doi=10.1021%2Fbi0121454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Targeting of Inhibitor of Apoptosis Proteins Based on Small Molecule Mimics of Natural Binding Partners</span></div><div class="casAuthors">Kipp, Rachael A.; Case, Martin A.; Wist, Aislyn D.; Cresson, Catherine M.; Carrell, Maria; Griner, Erin; Wiita, Arun; Albiniak, Philip A.; Chai, Jijie; Shi, Yigong; Semmelhack, Martin F.; McLendon, George L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7344-7349</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An assay based on a solvent-sensitive fluorogenic dye mol., badan, is used to test the binding affinity of a library of tetrapeptide mols. for the BIR3 (baculovirus IAP repeat) domain of XIAP (X-linked inhibitor of apoptosis protein).  The fluorophore is attached to a tetrapeptide, Ala-Val-Pro-Cys-NH2, through a thiol linkage and, upon binding to XIAP, undergoes a solvatochromic shift in fluorescence emission.  When a mol. (e.g., a natural protein known to bind to XIAP or a tetrapeptide mimic) displaces the dye, the emission shifts back to the spectrum obsd. in water.  As emission intensity is related to the binding of the tetrapeptide, the intensity can be used to det. the equil. const., K, for the displacement of the dye by the tetrapeptide.  The results permit residue-specific anal. of the interaction.  Furthermore, we show that hydrophobic effects in the fourth position are general and can effectively increase overall affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2jRD1J251H7Vg90H21EOLACvtfcHk0lgc_7zYo6wf1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjs1egsL4%253D&md5=ce6f8ed9b3a195523b98dc4943142312</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fbi0121454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0121454%26sid%3Dliteratum%253Aachs%26aulast%3DKipp%26aufirst%3DR.%2BA.%26aulast%3DCase%26aufirst%3DM.%2BA.%26aulast%3DWist%26aufirst%3DA.%2BD.%26aulast%3DCresson%26aufirst%3DC.%2BM.%26aulast%3DCarrell%26aufirst%3DM.%26aulast%3DGriner%26aufirst%3DE.%26aulast%3DWiita%26aufirst%3DA.%26aulast%3DAlbiniak%26aufirst%3DP.%2BA.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSemmelhack%26aufirst%3DM.%2BF.%26aulast%3DMcLendon%26aufirst%3DG.%2BL.%26atitle%3DMolecular%2520targeting%2520of%2520inhibitor%2520of%2520apoptosis%2520proteins%2520based%2520on%2520small%2520molecule%2520mimics%2520of%2520natural%2520binding%2520partners%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D7344%26epage%3D7349%26doi%3D10.1021%2Fbi0121454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design of small-molecule SMAC mimetics as IAP antagonists</span>. <i>Curr. Top. Microbiol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1007/82_2010_111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1007%2F82_2010_111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2010&pages=89-113&author=S.+Wang&title=Design+of+small-molecule+SMAC+mimetics+as+IAP+antagonists&doi=10.1007%2F82_2010_111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2F82_2010_111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F82_2010_111%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%2520of%2520small-molecule%2520SMAC%2520mimetics%2520as%2520IAP%2520antagonists%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2010%26volume%3D348%26spage%3D89%26epage%3D113%26doi%3D10.1007%2F82_2010_111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oost, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Assaad, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deckwerth, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oltersdorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaselli, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">4417</span>– <span class="NLM_lpage">4426</span>, <span class="refDoi"> DOI: 10.1021/jm040037k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040037k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFOltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4417-4426&author=T.+K.+Oostauthor=C.+Sunauthor=R.+C.+Armstrongauthor=A.+S.+Al-Assaadauthor=S.+F.+Betzauthor=T.+L.+Deckwerthauthor=H.+Dingauthor=S.+W.+Elmoreauthor=R.+P.+Meadowsauthor=E.+T.+Olejniczakauthor=A.+Oleksijewauthor=T.+Oltersdorfauthor=S.+H.+Rosenbergauthor=A.+R.+Shoemakerauthor=K.+J.+Tomaselliauthor=H.+Zouauthor=S.+W.+Fesik&title=Discovery+of+potent+antagonists+of+the+antiapoptotic+protein+XIAP+for+the+treatment+of+cancer&doi=10.1021%2Fjm040037k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer</span></div><div class="casAuthors">Oost, Thorsten K.; Sun, Chaohong; Armstrong, Robert C.; Al-Assaad, Ali-Samer; Betz, Stephen F.; Deckwerth, Thomas L.; Ding, Hong; Elmore, Steven W.; Meadows, Robert P.; Olejniczak, Edward T.; Oleksijew, Andrew; Oltersdorf, Tilman; Rosenberg, Saul H.; Shoemaker, Alexander R.; Tomaselli, Kevin J.; Zou, Hua; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4417-4426</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis (IAP) proteins are overexpressed in many cancers and have been implicated in tumor growth, pathogenesis, and resistance to chemo- or radiotherapy.  On the basis of the NMR structure of a SMAC peptide complexed with the BIR3 domain of X-linked IAP (XIAP), a novel series of XIAP antagonists was discovered.  The most potent compds. in this series bind to the baculovirus IAP repeat 3 (BIR3) domain of XIAP with single-digit nanomolar affinity and promote cell death in several human cancer cell lines.  In a MDA-MB-231 breast cancer mouse xenograft model, these XIAP antagonists inhibited the growth of tumors.  Close structural analogs that showed only weak binding to the XIAP-BIR3 domain were inactive in the cellular assays and showed only marginal in vivo activity.  Our results are consistent with a mechanism in which ligands for the BIR3 domain of XIAP induce apoptosis by freeing up caspases.  The present study validates the BIR3 domain of XIAP as a target and supports the use of small mol. XIAP antagonists as a potential therapy for cancers that overexpress XIAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzSXHFufBtZbVg90H21EOLACvtfcHk0lgc_7zYo6wf1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFOltbo%253D&md5=ccd77135a42ab84cd36f221abdb4fee7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm040037k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040037k%26sid%3Dliteratum%253Aachs%26aulast%3DOost%26aufirst%3DT.%2BK.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DAl-Assaad%26aufirst%3DA.%2BS.%26aulast%3DBetz%26aufirst%3DS.%2BF.%26aulast%3DDeckwerth%26aufirst%3DT.%2BL.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DTomaselli%26aufirst%3DK.%2BJ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520potent%2520antagonists%2520of%2520the%2520antiapoptotic%2520protein%2520XIAP%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4417%26epage%3D4426%26doi%3D10.1021%2Fjm040037k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varfolomeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorova, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dynek, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span> <span> </span><span class="NLM_article-title">Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1021/cb900083m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb900083m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Sjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=557-566&author=C.+Ndubakuauthor=E.+Varfolomeevauthor=L.+Wangauthor=K.+Zobelauthor=K.+Lauauthor=L.+O.+Elliottauthor=B.+Maurerauthor=A.+V.+Fedorovaauthor=J.+N.+Dynekauthor=M.+Koehlerauthor=S.+G.+Hymowitzauthor=V.+Tsuiauthor=K.+Deshayesauthor=W.+J.+Fairbrotherauthor=J.+A.+Flygareauthor=D.+Vucic&title=Antagonism+of+c-IAP+and+XIAP+proteins+is+required+for+efficient+induction+of+cell+death+by+small-molecule+IAP+antagonists&doi=10.1021%2Fcb900083m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of c-IAP and XIAP Proteins Is Required for Efficient Induction of Cell Death by Small-Molecule IAP Antagonists</span></div><div class="casAuthors">Ndubaku, Chudi; Varfolomeev, Eugene; Wang, Lan; Zobel, Kerry; Lau, Kevin; Elliott, Linda O.; Maurer, Brigitte; Fedorova, Anna V.; Dynek, Jasmin N.; Koehler, Michael; Hymowitz, Sarah G.; Tsui, Vickie; Deshayes, Kurt; Fairbrother, Wayne J.; Flygare, John A.; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">557-566</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins are crit. regulators of cancer cell survival, which makes them attractive targets for therapeutic intervention in cancers.  Herein, the structure-based design of IAP antagonists with high affinities and selectivity (>2000-fold) for c-IAP1 over XIAP and their functional characterization as activators of apoptosis in tumor cells are described.  Although capable of inducing cell death and preventing clonogenic survival, c-IAP-selective antagonists are significantly less potent in promoting apoptosis when compared to pan-selective compds.  However, both pan-IAP- and c-IAP-selective antagonists stimulate c-IAP1 and c-IAP2 degrdn. and activation of NF-κB pathways with comparable potencies.  Therefore, although compds. that specifically target c-IAP1 and c-IAP2 are capable of inducing apoptosis, antagonism of the c-IAP proteins and XIAP is required for efficient induction of cancer cell death by IAP antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7xO3yZNCyz7Vg90H21EOLACvtfcHk0ljqNWuH0QDd5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Sjur4%253D&md5=f1c82b7c5632453ba36e039441f039c9</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fcb900083m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb900083m%26sid%3Dliteratum%253Aachs%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DMaurer%26aufirst%3DB.%26aulast%3DFedorova%26aufirst%3DA.%2BV.%26aulast%3DDynek%26aufirst%3DJ.%2BN.%26aulast%3DKoehler%26aufirst%3DM.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DAntagonism%2520of%2520c-IAP%2520and%2520XIAP%2520proteins%2520is%2520required%2520for%2520efficient%2520induction%2520of%2520cell%2520death%2520by%2520small-molecule%2520IAP%2520antagonists%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2009%26volume%3D4%26spage%3D557%26epage%3D566%26doi%3D10.1021%2Fcb900083m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheeti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisner, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazzard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halladay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoRusso, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Um, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varfolomeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ware, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4101</span>– <span class="NLM_lpage">4113</span>, <span class="refDoi"> DOI: 10.1021/jm300060k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300060k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4101-4113&author=J.%0AA.+Flygareauthor=M.+Beresiniauthor=N.+Budhaauthor=H.+Chanauthor=I.+T.+Chanauthor=S.+Cheetiauthor=F.+Cohenauthor=K.+Deshayesauthor=K.+Doernerauthor=S.+G.+Eckhardtauthor=L.+O.+Elliottauthor=B.+Fengauthor=M.+C.+Franklinauthor=S.+F.+Reisnerauthor=L.+Gazzardauthor=J.+Halladayauthor=S.+G.+Hymowitzauthor=H.+Laauthor=P.+LoRussoauthor=B.+Maurerauthor=L.+Murrayauthor=E.+Pliseauthor=C.+Quanauthor=J.+P.+Stephanauthor=S.+G.+Youngauthor=J.+Tomauthor=V.+Tsuiauthor=J.+Umauthor=E.+Varfolomeevauthor=D.+Vucicauthor=A.+J.+Wagnerauthor=H.+J.+Wallweberauthor=L.+Wangauthor=J.+Wareauthor=Z.+Wenauthor=H.+Wongauthor=J.+M.+Wongauthor=M.+Wongauthor=S.+Wongauthor=R.+Yuauthor=K.+Zobelauthor=W.+J.+Fairbrother&title=Discovery+of+a+potent+small-molecule+antagonist+of+inhibitor+of+apoptosis+%28IAP%29+proteins+and+clinical+candidate+for+the+treatment+of+cancer+%28GDC-0152%29&doi=10.1021%2Fjm300060k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)</span></div><div class="casAuthors">Flygare, John A.; Beresini, Maureen; Budha, Nageshwar; Chan, Helen; Chan, Iris T.; Cheeti, Sravanthi; Cohen, Frederick; Deshayes, Kurt; Doerner, Karl; Eckhardt, S. Gail; Elliott, Linda O.; Feng, Bainian; Franklin, Matthew C.; Reisner, Stacy Frankovitz; Gazzard, Lewis; Halladay, Jason; Hymowitz, Sarah G.; La, Hank; LoRusso, Patricia; Maurer, Brigitte; Murray, Lesley; Plise, Emile; Quan, Clifford; Stephan, Jean-Philippe; Young, Shin G.; Tom, Jeffrey; Tsui, Vickie; Um, Joanne; Varfolomeev, Eugene; Vucic, Domagoj; Wagner, Andrew J.; Wallweber, Heidi J. A.; Wang, Lan; Ware, Joseph; Wen, Zhaoyang; Wong, Harvey; Wong, Jonathan M.; Wong, Melisa; Wong, Susan; Yu, Ron; Zobel, Kerry; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4101-4113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of compds. were designed and synthesized as antagonists of cIAP1/2, ML-IAP, and XIAP based on the N-terminus, AVPI, of mature Smac.  Compd. (I) (GDC-0152) has the best profile of these compds.; it binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domains of cIAP1 and cIAP2 with Ki values of 28, 14, 17, and 43 nM, resp.  These compds. promote degrdn. of cIAP1, induce activation of caspase-3/7, and lead to decreased viability of breast cancer cells without affecting normal mammary epithelial cells.  Compd. I inhibits tumor growth when dosed orally in the MDA-MB-231 breast cancer xenograft model.  Compd. I was advanced to human clin. trials, and it exhibited linear pharmacokinetics over the dose range (0.049 to 1.48 mg/kg) tested.  Mean plasma clearance in humans was 9 ± 3 mL/min/kg, and the vol. of distribution was 0.6 ± 0.2 L/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZSPNVJ5gVWrVg90H21EOLACvtfcHk0ljqNWuH0QDd5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D&md5=19452878ea834d3c324d567b39a78fb2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm300060k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300060k%26sid%3Dliteratum%253Aachs%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DBudha%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DI.%2BT.%26aulast%3DCheeti%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDoerner%26aufirst%3DK.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DReisner%26aufirst%3DS.%2BF.%26aulast%3DGazzard%26aufirst%3DL.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLoRusso%26aufirst%3DP.%26aulast%3DMaurer%26aufirst%3DB.%26aulast%3DMurray%26aufirst%3DL.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DStephan%26aufirst%3DJ.%2BP.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DTom%26aufirst%3DJ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DUm%26aufirst%3DJ.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWare%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DJ.%2BM.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520small-molecule%2520antagonist%2520of%2520inhibitor%2520of%2520apoptosis%2520%2528IAP%2529%2520proteins%2520and%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520cancer%2520%2528GDC-0152%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4101%26epage%3D4113%26doi%3D10.1021%2Fjm300060k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baggio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udompholkul, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salem, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aronson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dona, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troadec, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichiorri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">Design of potent pan-IAP and Lys-covalent XIAP selective inhibitors using a thermodynamics driven approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6350</span>– <span class="NLM_lpage">6363</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00810</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00810" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6350-6363&author=C.+Baggioauthor=L.+Gambiniauthor=P.+Udompholkulauthor=A.+F.+Salemauthor=A.+Aronsonauthor=A.+Donaauthor=E.+Troadecauthor=F.+Pichiorriauthor=M.+Pellecchia&title=Design+of+potent+pan-IAP+and+Lys-covalent+XIAP+selective+inhibitors+using+a+thermodynamics+driven+approach&doi=10.1021%2Facs.jmedchem.8b00810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach</span></div><div class="casAuthors">Baggio, Carlo; Gambini, Luca; Udompholkul, Parima; Salem, Ahmed F.; Aronson, Alexander; Dona, Ada; Troadec, Estelle; Pichiorri, Flavia; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6350-6363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently we reported that rapid detn. of enthalpy of binding can be achieved for a large no. of congeneric agents or in combinatorial libraries fairly efficiently.  We show that using a thermodn. Craig plot can be very useful in dissecting the enthalpy and entropy contribution of different substituents on a common scaffold, in order to design potent, selective, or pan-active compds.  In our implementation, the approach identified a crit. Lys residue in the BIR3 domain of XIAP.  We report for the first time that it is possible to target such residue covalently to attain potent and selective agents.  Preliminary cellular studies in various models of leukemia, multiple myeloma, and pancreatic cancers suggest that the derived agents possess a potentially intriguing pattern of activity, esp. for cell lines that are resistant to the pan-IAP antagonist and clin. candidate LCL161.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHXO3jixcQVbVg90H21EOLACvtfcHk0lj4Y7_WtVz_Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7nJ&md5=825ecb56c2a2e7d7b92ef9f1601f3df8</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00810%26sid%3Dliteratum%253Aachs%26aulast%3DBaggio%26aufirst%3DC.%26aulast%3DGambini%26aufirst%3DL.%26aulast%3DUdompholkul%26aufirst%3DP.%26aulast%3DSalem%26aufirst%3DA.%2BF.%26aulast%3DAronson%26aufirst%3DA.%26aulast%3DDona%26aufirst%3DA.%26aulast%3DTroadec%26aufirst%3DE.%26aulast%3DPichiorri%26aufirst%3DF.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DDesign%2520of%2520potent%2520pan-IAP%2520and%2520Lys-covalent%2520XIAP%2520selective%2520inhibitors%2520using%2520a%2520thermodynamics%2520driven%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6350%26epage%3D6363%26doi%3D10.1021%2Facs.jmedchem.8b00810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiokawa, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oguro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosugi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">7938</span>– <span class="NLM_lpage">7954</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.09.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.bmc.2013.09.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=24169315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs12ltb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=7938-7954&author=Z.+Shiokawaauthor=K.+Hashimotoauthor=B.+Saitoauthor=Y.+Oguroauthor=H.+Sumiauthor=M.+Yabukiauthor=M.+Yoshimatsuauthor=Y.+Kosugiauthor=Y.+Deboriauthor=N.+Morishitaauthor=D.+R.+Douganauthor=G.+P.+Snellauthor=S.+Yoshidaauthor=T.+Ishikawa&title=Design%2C+synthesis%2C+and+biological+activities+of+novel+hexahydropyrazino%5B1%2C2-a%5Dindole+derivatives+as+potent+inhibitors+of+apoptosis+%28IAP%29+proteins+antagonists+with+improved+membrane+permeability+across+MDR1+expressing+cells&doi=10.1016%2Fj.bmc.2013.09.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells</span></div><div class="casAuthors">Shiokawa, Zenyu; Hashimoto, Kentaro; Saito, Bunnai; Oguro, Yuya; Sumi, Hiroyuki; Yabuki, Masato; Yoshimatsu, Mie; Kosugi, Yohei; Debori, Yasuyuki; Morishita, Nao; Dougan, Douglas R.; Snell, Gyorgy P.; Yoshida, Sei; Ishikawa, Tomoyasu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7938-7954</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors previously reported octahydropyrrolo[1,2-a]pyrazine deriv. (T-3256336) as a potent antagonist for inhibitors of apoptosis (IAP) proteins.  Because compd. T-3256336 was susceptible to MDR1 mediated efflux, the authors developed another scaffold, hexahydropyrazino[1,2-a]indole, using structure-based drug design.  The fused benzene ring of this scaffold was aimed at increasing the lipophilicity and decreasing the basicity of the scaffold to improve the membrane permeability across MDR1 expressing cells.  The authors established a chiral pool synthetic route to yield the desired tricyclic chiral isomers.  Chem. modification of the core scaffold led to a representative compd. I, which showed strong inhibition of IAP binding (X chromosome-linked IAP [XIAP]: IC50 23 nM and cellular IAP [cIAP]: IC50 1.1 nM) and cell growth inhibition (MDA-MB-231 cells: GI50 2.8 nM) with high permeability and low potential of MDR1 substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMPcB0ZZBVPLVg90H21EOLACvtfcHk0lj4Y7_WtVz_Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs12ltb3J&md5=9287b57136ba62eaf138e12b1fdb6af4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.09.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.09.067%26sid%3Dliteratum%253Aachs%26aulast%3DShiokawa%26aufirst%3DZ.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DB.%26aulast%3DOguro%26aufirst%3DY.%26aulast%3DSumi%26aufirst%3DH.%26aulast%3DYabuki%26aufirst%3DM.%26aulast%3DYoshimatsu%26aufirst%3DM.%26aulast%3DKosugi%26aufirst%3DY.%26aulast%3DDebori%26aufirst%3DY.%26aulast%3DMorishita%26aufirst%3DN.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activities%2520of%2520novel%2520hexahydropyrazino%255B1%252C2-a%255Dindole%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520apoptosis%2520%2528IAP%2529%2520proteins%2520antagonists%2520with%2520improved%2520membrane%2520permeability%2520across%2520MDR1%2520expressing%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D7938%26epage%3D7954%26doi%3D10.1016%2Fj.bmc.2013.09.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oguro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiokawa, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosugi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of potent inhibitor of apoptosis (IAP) proteins antagonists bearing an octahydropyrrolo[1,2-a]pyrazine scaffold as a novel proline mimetic</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1228</span>– <span class="NLM_lpage">1246</span>, <span class="refDoi"> DOI: 10.1021/jm301674z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301674z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkt1Okug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1228-1246&author=K.+Hashimotoauthor=B.+Saitoauthor=N.+Miyamotoauthor=Y.+Oguroauthor=D.+Tomitaauthor=Z.+Shiokawaauthor=M.+Asanoauthor=H.+Kakeiauthor=N.+Tayaauthor=M.+Kawasakiauthor=H.+Sumiauthor=M.+Yabukiauthor=K.+Iwaiauthor=S.+Yoshidaauthor=M.+Yoshimatsuauthor=K.+Aoyamaauthor=Y.+Kosugiauthor=T.+Kojimaauthor=N.+Morishitaauthor=D.+R.+Douganauthor=G.+P.+Snellauthor=S.+Imamuraauthor=T.+Ishikawa&title=Design+and+synthesis+of+potent+inhibitor+of+apoptosis+%28IAP%29+proteins+antagonists+bearing+an+octahydropyrrolo%5B1%2C2-a%5Dpyrazine+scaffold+as+a+novel+proline+mimetic&doi=10.1021%2Fjm301674z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of potent inhibitor of apoptosis (IAP) proteins antagonists bearing an octahydropyrrolo[1,2-a]pyrazine scaffold as a novel proline mimetic</span></div><div class="casAuthors">Hashimoto, Kentaro; Saito, Bunnai; Miyamoto, Naoki; Oguro, Yuya; Tomita, Daisuke; Shiokawa, Zenyu; Asano, Moriteru; Kakei, Hiroyuki; Taya, Naohiro; Kawasaki, Masanori; Sumi, Hiroyuki; Yabuki, Masato; Iwai, Kenichi; Yoshida, Sei; Yoshimatsu, Mie; Aoyama, Kazunobu; Kosugi, Yohei; Kojima, Takashi; Morishita, Nao; Dougan, Douglas R.; Snell, Gyorgy P.; Imamura, Shinichi; Ishikawa, Tomoyasu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1228-1246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To develop novel inhibitor of apoptosis (IAP) proteins antagonists, we designed a bicyclic octahydropyrrolo[1,2-a]pyrazine scaffold as a novel proline bioisostere.  This design was based on the X-ray co-crystal structure of four N-terminal amino acid residues (AVPI) of the second mitochondria-derived activator of caspase (Smac) with the X-chromosome-linked IAP (XIAP) protein.  Lead optimization of this scaffold to improve oral absorption yielded compd. (I), which showed potent cellular IAP1 (cIAP1 IC50: 1.3 nM) and XIAP (IC50: 200 nM) inhibitory activity, in addn. to potent tumor growth inhibitory activity (GI50: 1.8 nM) in MDA-MB-231 breast cancer cells.  X-ray crystallog. anal. of compd. I bound to XIAP and to cIAP1 was achieved, revealing the various key interactions that contribute to the higher cIAPI affinity of compd. I over XIAP.  Because of its potent IAP inhibitory activities, compd. I (T-3256336) caused tumor regression in a MDA-MB-231 tumor xenograft model (T/C: -53% at 30 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0yTXJd7mdobVg90H21EOLACvtfcHk0lgY-rJ3WQXQDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkt1Okug%253D%253D&md5=e015021a842d92ceca267ab2ef78f752</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301674z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301674z%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DB.%26aulast%3DMiyamoto%26aufirst%3DN.%26aulast%3DOguro%26aufirst%3DY.%26aulast%3DTomita%26aufirst%3DD.%26aulast%3DShiokawa%26aufirst%3DZ.%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DKakei%26aufirst%3DH.%26aulast%3DTaya%26aufirst%3DN.%26aulast%3DKawasaki%26aufirst%3DM.%26aulast%3DSumi%26aufirst%3DH.%26aulast%3DYabuki%26aufirst%3DM.%26aulast%3DIwai%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DYoshimatsu%26aufirst%3DM.%26aulast%3DAoyama%26aufirst%3DK.%26aulast%3DKosugi%26aufirst%3DY.%26aulast%3DKojima%26aufirst%3DT.%26aulast%3DMorishita%26aufirst%3DN.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DImamura%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520inhibitor%2520of%2520apoptosis%2520%2528IAP%2529%2520proteins%2520antagonists%2520bearing%2520an%2520octahydropyrrolo%255B1%252C2-a%255Dpyrazine%2520scaffold%2520as%2520a%2520novel%2520proline%2520mimetic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1228%26epage%3D1246%26doi%3D10.1021%2Fjm301674z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of potent, conformationally constrained SMAC mimetics</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">16686</span>– <span class="NLM_lpage">16687</span>, <span class="refDoi"> DOI: 10.1021/ja047438+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja047438%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCru7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=16686-16687&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=C.+Y.+Yangauthor=L.+Xuauthor=M.+Liuauthor=Y.+Tomitaauthor=H.+Panauthor=Y.+Yoshiokaauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=S.+Wang&title=Structure-based+design+of+potent%2C+conformationally+constrained+SMAC+mimetics&doi=10.1021%2Fja047438%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of potent, conformationally constrained Smac mimetics</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Yang, Chao-Yie; Xu, Liang; Liu, Meilan; Tomita, York; Pan, Hongguang; Yoshioka, Yoshiko; Krajewski, Krzysztof; Roller, Peter P.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">16686-16687</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A successful structure-based design and synthesis of a class of highly potent conformationally constrained Smac mimetics is described.  The most potent compd. has a Ki value of 25 nM binding to the XIAP BIR3 protein and is 23 times more potent than natural Smac peptides.  These potent Smac mimetics can serve as powerful chem. and pharmacol. tools to further elucidate the role of Smac and its cellular binding partners in apoptosis regulation and may be developed as a new class of anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVqjV4v0Bp27Vg90H21EOLACvtfcHk0lgY-rJ3WQXQDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCru7zJ&md5=3b29591968a51e0b5fdfc42c81aae5de</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja047438%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja047438%252B%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DYoshioka%26aufirst%3DY.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520of%2520potent%252C%2520conformationally%2520constrained%2520SMAC%2520mimetics%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D16686%26epage%3D16687%26doi%3D10.1021%2Fja047438%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">4147</span>– <span class="NLM_lpage">4150</span>, <span class="refDoi"> DOI: 10.1021/jm0499108</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0499108" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1Kqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4147-4150&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=C.+Y.+Yangauthor=L.+Xuauthor=Y.+Tomitaauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=S.+Wang&title=Structure-based+design%2C+synthesis%2C+and+evaluation+of+conformationally+constrained+mimetics+of+the+second+mitochondria-derived+activator+of+caspase+that+target+the+X-linked+inhibitor+of+apoptosis+protein%2Fcaspase-9+interaction+site&doi=10.1021%2Fjm0499108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design, Synthesis, and Evaluation of Conformationally Constrained Mimetics of the Second Mitochondria-Derived Activator of Caspase That Target the X-Linked Inhibitor of Apoptosis Protein/Caspase-9 Interaction Site</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Yang, Chao-Yie; Xu, Liang; Tomita, York; Krajewski, Krzysztof; Roller, Peter P.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4147-4150</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A successful structure-based design of conformationally constrained second mitochondria-derived activator of caspase (Smac) mimetics that target the XIAP/caspase-9 interaction site is described.  The most potent Smac mimetic (12d) has a Ki of 350 nM for binding to the XIAP BIR3 domain protein.  The compd. 12d is found to be effective in enhancing apoptosis induced by cisplatin in PC-3 human prostate cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmBYVDWMeKvrVg90H21EOLACvtfcHk0lgY-rJ3WQXQDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1Kqsbc%253D&md5=e64491c5a63afbdc6832334034692c99</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm0499108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0499108%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520conformationally%2520constrained%2520mimetics%2520of%2520the%2520second%2520mitochondria-derived%2520activator%2520of%2520caspase%2520that%2520target%2520the%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%252Fcaspase-9%2520interaction%2520site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4147%26epage%3D4150%26doi%3D10.1021%2Fjm0499108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of a potent, cell-permeable, conformationally constrained second mitochondria derived activator of caspase (SMAC) mimetic</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">7916</span>– <span class="NLM_lpage">7920</span>, <span class="refDoi"> DOI: 10.1021/jm061108d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061108d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Ghs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7916-7920&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=J.+Luauthor=S.+Qiuauthor=C.+Y.+Yangauthor=W.+Gaoauthor=J.+Meagherauthor=J.+Stuckeyauthor=S.+Wang&title=Design%2C+synthesis%2C+and+evaluation+of+a+potent%2C+cell-permeable%2C+conformationally+constrained+second+mitochondria+derived+activator+of+caspase+%28SMAC%29+mimetic&doi=10.1021%2Fjm061108d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of a Potent, Cell-Permeable, Conformationally Constrained Second Mitochondria Derived Activator of Caspase (Smac) Mimetic</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Lu, Jianfeng; Qiu, Su; Yang, Chao-Yie; Gao, Wei; Meagher, Jennifer; Stuckey, Jeanne; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7916-7920</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A potent, cell-permeable, conformationally constrained second mitochondria derived activator of caspase mimetic (SM-131, 2) has been designed, synthesized, and evaluated.  Compd. 2 binds to X-linked inhibitors of apoptosis proteins (XIAP) with a Ki of 61 nM in a competitive binding assay and directly antagonizes the XIAP inhibition of caspase-9 activity in a cell-free functional assay.  Compd. 2 achieves an IC50 of 100 nM in inhibition of cell growth and effectively induces cell death in the MDA-MB-231 human breast cancer cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxw5s6_ZlkCrVg90H21EOLACvtfcHk0lj3Kr3i_Ur9iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Ghs7rF&md5=6964976131c6fbb1ae76d89885538e8c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm061108d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061108d%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DMeagher%26aufirst%3DJ.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520a%2520potent%252C%2520cell-permeable%252C%2520conformationally%2520constrained%2520second%2520mitochondria%2520derived%2520activator%2520of%2520caspase%2520%2528SMAC%2529%2520mimetic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7916%26epage%3D7920%26doi%3D10.1021%2Fjm061108d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis, evaluation, and crystallographic studies of conformationally constrained SMAC mimetics as inhibitors of the X-linked inhibitor of apoptosis protein (XIAP)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7169</span>– <span class="NLM_lpage">7180</span>, <span class="refDoi"> DOI: 10.1021/jm8006849</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8006849" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWgsr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7169-7180&author=H.+Sunauthor=J.+A.+Stuckeyauthor=Z.+Nikolovska-Coleskaauthor=D.+Qinauthor=J.+L.+Meagherauthor=S.+Qiuauthor=J.+Luauthor=C.+Y.+Yangauthor=N.+G.+Saitoauthor=S.+Wang&title=Structure-based+design%2C+synthesis%2C+evaluation%2C+and+crystallographic+studies+of+conformationally+constrained+SMAC+mimetics+as+inhibitors+of+the+X-linked+inhibitor+of+apoptosis+protein+%28XIAP%29&doi=10.1021%2Fjm8006849"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design, Synthesis, Evaluation, and Crystallographic Studies of Conformationally Constrained Smac Mimetics as Inhibitors of the X-linked Inhibitor of Apoptosis Protein (XIAP)</span></div><div class="casAuthors">Sun, Haiying; Stuckey, Jeanne A.; Nikolovska-Coleska, Zaneta; Qin, Dongguang; Meagher, Jennifer L.; Qiu, Su; Lu, Jianfeng; Yang, Chao-Yie; Saito, Naoyuki G.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7169-7180</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small mols. designed to mimic the binding of Smac protein to X-linked inhibitor of apoptosis protein (XIAP) are being pursued as a promising new class of anticancer drugs.  Herein, we report the design, synthesis, and comprehensive structure-activity relationship studies of a series of conformationally constrained bicyclic Smac mimetics.  Our studies led to the discovery of a no. of highly potent and cell-permeable Smac mimetics and yielded important new insights into their structure-activity relationship for their binding to XIAP and for their activity in inhibition of cancer cell growth.  Detn. of the crystal structure of one potent Smac mimetic, compd. 21, in complex with XIAP BIR3 provides the structural basis for its high-affinity binding to XIAP and for the design of highly potent Smac mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgt5ivzgNCObVg90H21EOLACvtfcHk0lj3Kr3i_Ur9iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWgsr7J&md5=515d5c4e791d37f83d2e32b6234aa66b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm8006849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8006849%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DSaito%26aufirst%3DN.%2BG.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520evaluation%252C%2520and%2520crystallographic%2520studies%2520of%2520conformationally%2520constrained%2520SMAC%2520mimetics%2520as%2520inhibitors%2520of%2520the%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528XIAP%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7169%26epage%3D7180%26doi%3D10.1021%2Fjm8006849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Potent, orally bioavailable diazabicyclic small-molecule mimetics of second mitochondria-derived activator of caspases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">8158</span>– <span class="NLM_lpage">8162</span>, <span class="refDoi"> DOI: 10.1021/jm801254r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801254r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOjs7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=8158-8162&author=Y.+Pengauthor=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=S.+Qiuauthor=C.+Y.+Yangauthor=J.+Luauthor=Q.+Caiauthor=H.+Yiauthor=S.+Kangauthor=D.+Yangauthor=S.+Wang&title=Potent%2C+orally+bioavailable+diazabicyclic+small-molecule+mimetics+of+second+mitochondria-derived+activator+of+caspases&doi=10.1021%2Fjm801254r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Potent, Orally Bioavailable Diazabicyclic Small-Molecule Mimetics of Second Mitochondria-Derived Activator of Caspases</span></div><div class="casAuthors">Peng, Yuefeng; Sun, Haiying; Nikolovska-Coleska, Zaneta; Qiu, Su; Yang, Chao-Yie; Lu, Jianfeng; Cai, Qian; Yi, Han; Kang, Sanmao; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8158-8162</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of small-mol. Smac mimetics contg. a diazabicyclic core structure have been designed, synthesized, and evaluated.  The most potent compd. I binds to XIAP, cIAP-1, and cIAP-2 with Ki values of 8.4, 1.5, and 4.2 nM, resp., directly antagonizes XIAP in a cell-free functional assay and induces cIAP-1 degrdn. in cancer cells.  It inhibits cell growth with an IC50 value of 31 nM, effectively induces apoptosis in the MDA-MB-231 cancer cell line, and has a good oral bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsvyGFa0RL1rVg90H21EOLACvtfcHk0lj3Kr3i_Ur9iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOjs7vF&md5=21d7e471c3e97eeef3413294bdc9e779</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm801254r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801254r%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPotent%252C%2520orally%2520bioavailable%2520diazabicyclic%2520small-molecule%2520mimetics%2520of%2520second%2520mitochondria-derived%2520activator%2520of%2520caspases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D8158%26epage%3D8162%26doi%3D10.1021%2Fjm801254r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of tricyclic, conformationally constrained small-molecule mimetics of second mitochondria-derived activator of caspases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7352</span>– <span class="NLM_lpage">7355</span>, <span class="refDoi"> DOI: 10.1021/jm801146d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801146d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2jsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7352-7355&author=B.+Zhangauthor=Z.+Nikolovska-Coleskaauthor=Y.+Zhangauthor=L.+Baiauthor=S.+Qiuauthor=C.+Y.+Yangauthor=H.+Sunauthor=S.+Wangauthor=Y.+Wu&title=Design%2C+synthesis%2C+and+evaluation+of+tricyclic%2C+conformationally+constrained+small-molecule+mimetics+of+second+mitochondria-derived+activator+of+caspases&doi=10.1021%2Fjm801146d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Tricyclic, Conformationally Constrained Small-Molecule Mimetics of Second Mitochondria-Derived Activator of Caspases</span></div><div class="casAuthors">Zhang, Bin; Nikolovska-Coleska, Zaneta; Zhang, Yan; Bai, Longchuan; Qiu, Su; Yang, Chao-Yie; Sun, Haiying; Wang, Shaomeng; Wu, Yikang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7352-7355</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of tricyclic, conformationally constrained Smac mimetics have been designed, synthesized, and evaluated.  The most potent compd. 6 (WS-5) binds to XIAP, cIAP-1, and cIAP-2 with Ki of 18, 1.1, and 4.2 nM, resp.  Compd. 6 antagonizes XIAP in a functional assay, induces cIAP-1 degrdn., inhibits cell growth with an IC50 of 68 nM in the MDA-MB-231 cancer cell line, and effectively induces cancer cells to undergo apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojd9U5P-xipLVg90H21EOLACvtfcHk0liFeEJCt5Zdvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2jsLnK&md5=b6a69cd39881fd868e822042261090a5</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm801146d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801146d%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520tricyclic%252C%2520conformationally%2520constrained%2520small-molecule%2520mimetics%2520of%2520second%2520mitochondria-derived%2520activator%2520of%2520caspases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7352%26epage%3D7355%26doi%3D10.1021%2Fjm801146d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of potent, nonpeptidic mimetics of second mitochondria-derived activator of caspases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">593</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1021/jm801101z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801101z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksV2juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=593-596&author=W.+Sunauthor=Z.+Nikolovska-Coleskaauthor=D.+Qinauthor=H.+Sunauthor=C.+Y.+Yangauthor=L.+Baiauthor=S.+Qiuauthor=Y.+Wangauthor=D.+Maauthor=S.+Wang&title=Design%2C+synthesis%2C+and+evaluation+of+potent%2C+nonpeptidic+mimetics+of+second+mitochondria-derived+activator+of+caspases&doi=10.1021%2Fjm801101z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Potent, Nonpeptidic Mimetics of Second Mitochondria-Derived Activator of Caspases</span></div><div class="casAuthors">Sun, Wei; Nikolovska-Coleska, Zaneta; Qin, Dongguang; Sun, Haiying; Yang, Chao-Yie; Bai, Longchuang; Qiu, Su; Wang, You; Ma, Dawei; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">593-596</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of new Smac mimetics have been designed, synthesized, and evaluated.  The most potent compd. 10 (I) binds to XIAP, cIAP-1, and cIAP-2 BIR3 proteins with Ki of 3.9, 0.37, and 0.25 nM, resp.  Compd. 10 antagonizes XIAP in a cell-free functional assay and induces rapid cIAP-1 degrdn. in cancer cells.  Compd. 10 inhibits cell growth in the MDA-MB-231 cancer cell line with an IC50 of 8.9 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcSkEaskJVSbVg90H21EOLACvtfcHk0liFeEJCt5Zdvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksV2juw%253D%253D&md5=d2318c41357a62386273a82986222e9f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm801101z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801101z%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DW.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520potent%252C%2520nonpeptidic%2520mimetics%2520of%2520second%2520mitochondria-derived%2520activator%2520of%2520caspases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D593%26epage%3D596%26doi%3D10.1021%2Fjm801101z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deschamps, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Nonpeptidic and potent small-molecule inhibitors of cIAP-1/2 and XIAP proteins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6361</span>– <span class="NLM_lpage">6367</span>, <span class="refDoi"> DOI: 10.1021/jm100487z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100487z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslCgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6361-6367&author=H.+Sunauthor=J.+Luauthor=L.+Liuauthor=H.+Yiauthor=S.+Qiuauthor=C.+Y.+Yangauthor=J.+R.+Deschampsauthor=S.+Wang&title=Nonpeptidic+and+potent+small-molecule+inhibitors+of+cIAP-1%2F2+and+XIAP+proteins&doi=10.1021%2Fjm100487z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptidic and Potent Small-Molecule Inhibitors of cIAP-1/2 and XIAP Proteins</span></div><div class="casAuthors">Sun, Haiying; Lu, Jianfeng; Liu, Liu; Yi, Han; Qiu, Su; Yang, Chao-Yie; Deschamps, Jeffrey R.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6361-6367</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of compds. were designed and synthesized as antagonists of cIAP-1/2 and XIAP based upon our previously identified lead compd. SM-122 (I).  The most potent of these II binds to XIAP, cIAP-1, and cIAP-2 proteins with Ki values of 36, <1, and <1.9 nM, resp.  Consistent with its potent binding affinities to IAPs, II effectively antagonizes XIAP in a cell-free caspase-9 functional assay, efficiently induces cIAP-1 degrdn. in cells at concns. as low as 10 nM, and triggers activation of caspases and PARP cleavage in the MDA-MB-231 breast cancer cell line.  Compd. II potently inhibits cell growth in the MDA-MB-231 cancer cell line with an IC50 value of 200 nM and is 9 times more potent than compd. I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJAD9rnga8p7Vg90H21EOLACvtfcHk0liFeEJCt5Zdvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslCgsr4%253D&md5=0b38acbc17c4ba3dcd5b81eeaef9e1a2</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm100487z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100487z%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DNonpeptidic%2520and%2520potent%2520small-molecule%2520inhibitors%2520of%2520cIAP-1%252F2%2520and%2520XIAP%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6361%26epage%3D6367%26doi%3D10.1021%2Fjm100487z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leopold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2714</span>– <span class="NLM_lpage">2726</span>, <span class="refDoi"> DOI: 10.1021/jm101505d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101505d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2714-2726&author=Q.+Caiauthor=H.+Sunauthor=Y.+Pengauthor=J.+Luauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=L.+Liuauthor=S.+Qiuauthor=C.+Y.+Yangauthor=R.+Millerauthor=H.+Yiauthor=T.+Zhangauthor=D.+Sunauthor=S.+Kangauthor=M.+Guoauthor=L.+Leopoldauthor=D.+Yangauthor=S.+Wang&title=A+potent+and+orally+active+antagonist+%28SM-406%2FAT-406%29+of+multiple+inhibitor+of+apoptosis+proteins+%28IAPs%29+in+clinical+development+for+cancer+treatment&doi=10.1021%2Fjm101505d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span></div><div class="casAuthors">Cai, Qian; Sun, Haiying; Peng, Yuefeng; Lu, Jianfeng; Nikolovska-Coleska, Zaneta; McEachern, Donna; Liu, Liu; Qiu, Su; Yang, Chao-Yie; Miller, Rebecca; Yi, Han; Zhang, Tao; Sun, Duxin; Kang, Sanmao; Guo, Ming; Leopold, Lance; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2714-2726</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery and characterization of SM-406 (compd. 2), a potent and orally bioavailable Smac mimetic and an antagonist of the inhibitor of apoptosis proteins (IAPs).  This compd. binds to XIAP, cIAP1, and cIAP2 proteins with Ki of 66.4, 1.9, and 5.1 nM, resp.  Compd. 2 effectively antagonizes XIAP BIR3 protein in a cell-free functional assay, induces rapid degrdn. of cellular cIAP1 protein, and inhibits cancer cell growth in various human cancer cell lines.  It has good oral bioavailability in mice, rats, non-human primates, and dogs, is highly effective in induction of apoptosis in xenograft tumors, and is capable of complete inhibition of tumor growth.  Compd. 2 is currently in phase I clin. trials for the treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgYOZBCwfnLrVg90H21EOLACvtfcHk0lhP6-aLp-FVyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D&md5=5b73a2ea1a5a2a6b3e3f4c978b49706f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm101505d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101505d%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DLeopold%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520potent%2520and%2520orally%2520active%2520antagonist%2520%2528SM-406%252FAT-406%2529%2520of%2520multiple%2520inhibitor%2520of%2520apoptosis%2520proteins%2520%2528IAPs%2529%2520in%2520clinical%2520development%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2714%26epage%3D2726%26doi%3D10.1021%2Fjm101505d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Potent and selective small-molecule inhibitors of cIAP1/2 proteins reveal that the binding of Smac mimetics to XIAP BIR3 is not required for their effective induction of cell death in tumor cells</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">994</span>– <span class="NLM_lpage">1002</span>, <span class="refDoi"> DOI: 10.1021/cb400889a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400889a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2cXit1yls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=994-1002&author=H.+Sunauthor=J.+Luauthor=L.+Liuauthor=C.+Y.+Yangauthor=S.+Wang&title=Potent+and+selective+small-molecule+inhibitors+of+cIAP1%2F2+proteins+reveal+that+the+binding+of+Smac+mimetics+to+XIAP+BIR3+is+not+required+for+their+effective+induction+of+cell+death+in+tumor+cells&doi=10.1021%2Fcb400889a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective Small-Molecule Inhibitors of cIAP1/2 Proteins Reveal That the Binding of Smac Mimetics to XIAP BIR3 Is Not Required for Their Effective Induction of Cell Death in Tumor Cells</span></div><div class="casAuthors">Sun, Haiying; Lu, Jianfeng; Liu, Liu; Yang, Chao-Yie; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">994-1002</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cellular inhibitor of apoptosis protein 1 and 2 (cIAP1/2) and X-linked inhibitor of apoptosis protein (XIAP) are key apoptosis regulators and promising new cancer therapeutic targets.  This study describes a set of non-peptide, small-mol. Smac (second mitochondria-derived activator of caspases) mimetics that are selective inhibitors of cIAP1/2 over XIAP.  The most potent and most selective compds. bind to cIAP1/2 with affinities in the low nanomolar range and show >1,000-fold selectivity for cIAP1 over XIAP.  These selective cIAP inhibitors effectively induce degrdn. of the cIAP1 protein in cancer cells at low nanomolar concns. and do not antagonize XIAP in a cell-free functional assay.  They potently inhibit cell growth and effectively induce apoptosis at low nanomolar concns. in cancer cells with a mechanism of action similar to that of other known Smac mimetics.  Our study shows that binding of Smac mimetics to XIAP BIR3 is not required for effective induction of apoptosis in tumor cells by Smac mimetics.  These potent and highly selective cIAP1/2 inhibitors are powerful tools in the investigation of the role of these IAP proteins in the regulation of apoptosis and other cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVFuPpODQgO7Vg90H21EOLACvtfcHk0lhP6-aLp-FVyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXit1yls74%253D&md5=c0aadbda28ed4e14aa31b58cb995b8af</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fcb400889a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400889a%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPotent%2520and%2520selective%2520small-molecule%2520inhibitors%2520of%2520cIAP1%252F2%2520proteins%2520reveal%2520that%2520the%2520binding%2520of%2520Smac%2520mimetics%2520to%2520XIAP%2520BIR3%2520is%2520not%2520required%2520for%2520their%2520effective%2520induction%2520of%2520cell%2520death%2520in%2520tumor%2520cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D994%26epage%3D1002%26doi%3D10.1021%2Fcb400889a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varfolomeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okawa, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of a potent SMAC mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">533</span>, <span class="refDoi"> DOI: 10.1021/cb600276q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb600276q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps12jsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=525-533&author=K.+Zobelauthor=L.+Wangauthor=E.+Varfolomeevauthor=M.+C.+Franklinauthor=L.+O.+Elliottauthor=H.+J.+Wallweberauthor=D.+C.+Okawaauthor=J.+A.+Flygareauthor=D.+Vucicauthor=W.+J.+Fairbrotherauthor=K.+Deshayes&title=Design%2C+synthesis%2C+and+biological+activity+of+a+potent+SMAC+mimetic+that+sensitizes+cancer+cells+to+apoptosis+by+antagonizing+IAPs&doi=10.1021%2Fcb600276q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs</span></div><div class="casAuthors">Zobel, Kerry; Wang, Lan; Varfolomeev, Eugene; Franklin, Matthew C.; Elliott, Linda O.; Wallweber, Heide J. A.; Okawa, David C.; Flygare, John A.; Vucic, Domagoj; Fairbrother, Wayne J.; Deshayes, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">525-533</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Designed second mitochondrial activator of caspases (Smac) mimetics based on an accessible [7,5]-bicyclic scaffold bind to and antagonize protein interactions involving the inhibitor of apoptosis (IAP) proteins, X-chromosome-linked IAP (XIAP), melanoma IAP (ML-IAP), and c-IAPs 1 and 2 (cIAP2 and cIAP2).  The design rationale is based on a combination of phage-panning data, peptide binding studies, and a survey of potential isosteres.  The synthesis of two scaffolds is described.  These compds. bind the XIAP-baculoviral IAP repeat 3 (BIR3), cIAP1-BIR3, cIAP2-BIR3, and ML-IAP-BIR domains with submicromolar affinities.  The most potent Smac mimetic binds the cIAP-1-BIR3 and ML-IAP-BIR domains with a Ki of 5 nM.  THe X-ray crystal structure of this compd. bound to an ML-IAP/XIAP chimeric BIR domain protein is compared with that of a complex with a phage-derived tetrapeptide, AVPW.  The structures show that these compds. bind to the Smac-binding site on ML0IAP with identical hydrogen-bonding patterns and similar hydrophobic interactions.  Consistent with the structural data, coimmunopptn. expts. demonstrate that the compds. can effectively block Smac interactions with ML0IAP.  The compds. are further demonstrated to activate caspase-3 and -7, to reduce cell viability in assays using MDA-MB-231 breast cancer cells and A2058 melanoma cells, and to enhance doxorubicin-induced apoptosis in MDA-MB-231 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxz4Cro0vW9rVg90H21EOLACvtfcHk0lhP6-aLp-FVyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps12jsbk%253D&md5=48b9613b3bbde6a1164281919e00e173</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fcb600276q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb600276q%26sid%3Dliteratum%253Aachs%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DOkawa%26aufirst%3DD.%2BC.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DDeshayes%26aufirst%3DK.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520a%2520potent%2520SMAC%2520mimetic%2520that%2520sensitizes%2520cancer%2520cells%2520to%2520apoptosis%2520by%2520antagonizing%2520IAPs%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2006%26volume%3D1%26spage%3D525%26epage%3D533%26doi%3D10.1021%2Fcb600276q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncharov, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keteltas, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankovitz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span> <span> </span><span class="NLM_article-title">Orally bioavailable antagonists of inhibitor of apoptosis proteins based on an azabicyclooctane scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1723</span>– <span class="NLM_lpage">1730</span>, <span class="refDoi"> DOI: 10.1021/jm801450c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801450c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1ektb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1723-1730&author=F.+Cohenauthor=B.+Alickeauthor=L.+O.+Elliottauthor=J.+A.+Flygareauthor=T.+Goncharovauthor=S.+F.+Keteltasauthor=M.+C.+Franklinauthor=S.+Frankovitzauthor=J.+P.+Stephanauthor=V.+Tsuiauthor=D.+Vucicauthor=H.+Wongauthor=W.+J.+Fairbrother&title=Orally+bioavailable+antagonists+of+inhibitor+of+apoptosis+proteins+based+on+an+azabicyclooctane+scaffold&doi=10.1021%2Fjm801450c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Bioavailable Antagonists of Inhibitor of Apoptosis Proteins Based on an Azabicyclooctane Scaffold</span></div><div class="casAuthors">Cohen, Frederick; Alicke, Bruno; Elliott, Linda O.; Flygare, John A.; Goncharov, Tatiana; Keteltas, Stephen F.; Franklin, Matthew C.; Frankovitz, Stacy; Stephan, Jean-Philippe; Tsui, Vickie; Vucic, Domagoj; Wong, Harvey; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1723-1730</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of IAP antagonists based on an azabicyclooctane scaffold was designed and synthesized.  The most potent of these compds., I, binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domain of c-IAP1 with Ki values of 140, 38, and 33 nM, resp.  These compds. promote degrdn. of c-IAP1, activate caspases, and lead to decreased viability of breast cancer cells without affecting normal mammary epithelial cells.  Finally, I inhibits tumor growth when dosed orally in a breast cancer xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkDNRJcxvb2bVg90H21EOLACvtfcHk0lhRbaV2TfvzWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1ektb4%253D&md5=f6f414daa4174a3449c44442cb944a4a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm801450c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801450c%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DGoncharov%26aufirst%3DT.%26aulast%3DKeteltas%26aufirst%3DS.%2BF.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DFrankovitz%26aufirst%3DS.%26aulast%3DStephan%26aufirst%3DJ.%2BP.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DOrally%2520bioavailable%2520antagonists%2520of%2520inhibitor%2520of%2520apoptosis%2520proteins%2520based%2520on%2520an%2520azabicyclooctane%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1723%26epage%3D1730%26doi%3D10.1021%2Fjm801450c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velankar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulciniti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tassone, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raje, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsiades, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsiades, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span> <span> </span><span class="NLM_article-title">Targeting mitochondrial factor SMAC/DIABLO as therapy for multiple myeloma (MM)</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">1220</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.1182/blood-2006-04-015149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1182%2Fblood-2006-04-015149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=17032924" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2006&pages=1220-1227&author=D.+Chauhanauthor=P.+Neriauthor=M.+Velankarauthor=K.+Podarauthor=T.+Hideshimaauthor=M.+Fulcinitiauthor=P.+Tassoneauthor=N.+Rajeauthor=C.+Mitsiadesauthor=N.+Mitsiadesauthor=P.+Richardsonauthor=L.+Zawelauthor=M.+Tranauthor=N.+Munshiauthor=K.+C.+Anderson&title=Targeting+mitochondrial+factor+SMAC%2FDIABLO+as+therapy+for+multiple+myeloma+%28MM%29&doi=10.1182%2Fblood-2006-04-015149"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-04-015149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-04-015149%26sid%3Dliteratum%253Aachs%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DNeri%26aufirst%3DP.%26aulast%3DVelankar%26aufirst%3DM.%26aulast%3DPodar%26aufirst%3DK.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DFulciniti%26aufirst%3DM.%26aulast%3DTassone%26aufirst%3DP.%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DMitsiades%26aufirst%3DC.%26aulast%3DMitsiades%26aufirst%3DN.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DZawel%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DTargeting%2520mitochondrial%2520factor%2520SMAC%252FDIABLO%2520as%2520therapy%2520for%2520multiple%2520myeloma%2520%2528MM%2529%26jtitle%3DBlood%26date%3D2006%26volume%3D109%26spage%3D1220%26epage%3D1227%26doi%3D10.1182%2Fblood-2006-04-015149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hird, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquila, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennessy, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasbinder, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitor of apoptosis proteins antagonists: a patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1517/13543776.2015.1041922</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1517%2F13543776.2015.1041922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=25980951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSru7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=755-774&author=A.+W.+Hirdauthor=B.+M.+Aquilaauthor=E.+J.+Hennessyauthor=M.+M.+Vasbinderauthor=B.+Yang&title=Small+molecule+inhibitor+of+apoptosis+proteins+antagonists%3A+a+patent+review&doi=10.1517%2F13543776.2015.1041922"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitor of apoptosis proteins antagonists: a patent review</span></div><div class="casAuthors">Hird, Alexander W.; Aquila, Brian M.; Hennessy, Edward J.; Vasbinder, Melissa M.; Yang, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">755-774</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The family of inhibitor of apoptosis proteins (IAPs) plays a key role in the suppression of proapoptotic signaling; hence, a small mol. that disrupts the binding of IAPs with their functional partner should restore apoptotic response to proapoptotic stimuli in cells.  The continued publication of new patent applications of IAP antagonists over the past 4 years is a testament to the continued interest surrounding the IAP family of proteins.  Areas covered: This review summarizes the IAP antagonist patent literature from 2010 to 2014.  Monovalent and bivalent Smac mimetics will be covered as well as two new developments in the field: IAP antagonists coupled to or merged with other targeted agents and new BIR2 selective IAP antagonists.  Expert opinion: In addn. to the well-explored scaffolds for monovalent and bivalent Smac-mimetics, some companies have taken more drastic approaches to explore new chem. space - for example, fragment-based approaches and macrocyclic inhibitors.  Furthermore, other companies have designed compds. with alternative biol. profiles - tethering to known kinase binding structures, trying to target to the mitochondria or introducing selective binding to the BIR2 domain.  An overview of the status for the four small mol. IAP antagonists being evaluated in active human clin. trials is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5iwIpEHoA9LVg90H21EOLACvtfcHk0lhRbaV2TfvzWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSru7jM&md5=318208dc0a860b64cc385c32ff4b8bf0</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1517%2F13543776.2015.1041922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2015.1041922%26sid%3Dliteratum%253Aachs%26aulast%3DHird%26aufirst%3DA.%2BW.%26aulast%3DAquila%26aufirst%3DB.%2BM.%26aulast%3DHennessy%26aufirst%3DE.%2BJ.%26aulast%3DVasbinder%26aufirst%3DM.%2BM.%26aulast%3DYang%26aufirst%3DB.%26atitle%3DSmall%2520molecule%2520inhibitor%2520of%2520apoptosis%2520proteins%2520antagonists%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2015%26volume%3D25%26spage%3D755%26epage%3D774%26doi%3D10.1517%2F13543776.2015.1041922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span> <span> </span><span class="NLM_article-title">Small-molecule pan-IAP antagonists: a patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1517/13543770903567077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1517%2F13543770903567077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=20100005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=251-267&author=J.+A.+Flygareauthor=W.+J.+Fairbrother&title=Small-molecule+pan-IAP+antagonists%3A+a+patent+review&doi=10.1517%2F13543770903567077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule pan-IAP antagonists: a patent review</span></div><div class="casAuthors">Flygare, John A.; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-267</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The inhibitor of apoptosis (IAP) proteins are crit. regulators of cancer cell survival that have become important targets for therapeutic intervention in human malignancies.  One strategy for targeting IAP proteins involves agents that mimic the amino terminus of the endogenous IAP protein antagonist second mitochondria-derived activator of caspases (Smac)/direct IAP-binding protein with low pI (DIABLO) and thus block crit. IAP protein interactions.  Areas covered in this review: This review of the IAP antagonist patent literature covers the period from 2000 to mid-2009.  Over 50 patents and patent applications pertaining to IAP antagonists have been published over the past 10 years.  In the case of several filings, only the original source is reviewed in this anal.  What the reader will gain: Readers will gain an overview of IAP protein antagonist scaffolds, with representative examples including monovalent and bivalent Smac mimetics, and an understanding of their structure-activity relationships.  Take home message: The feasibility of disrupting IAP protein interactions with pro-apoptotic proteins using monovalent and bivalent Smac-derived peptidomimetic compds. has been broadly established.  Four such compds. have entered or been approved to enter human clin. trials, which will hopefully allow the utility of this potential therapeutic approach to be evaluated in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN1K-xLSDlXrVg90H21EOLACvtfcHk0ljrDFixycvJLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb0%253D&md5=9017c8266da17502a6c081d5ca2955ac</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1517%2F13543770903567077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903567077%26sid%3Dliteratum%253Aachs%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DSmall-molecule%2520pan-IAP%2520antagonists%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D251%26epage%3D267%26doi%3D10.1517%2F13543770903567077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent SMAC mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">15279</span>– <span class="NLM_lpage">15294</span>, <span class="refDoi"> DOI: 10.1021/ja074725f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja074725f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1yrur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=15279-15294&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=J.+Luauthor=J.+L.+Meagherauthor=C.+Y.+Yangauthor=S.+Qiuauthor=Y.+Tomitaauthor=Y.+Uedaauthor=S.+Jiangauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Design%2C+synthesis%2C+and+characterization+of+a+potent%2C+nonpeptide%2C+cell-permeable%2C+bivalent+SMAC+mimetic+that+concurrently+targets+both+the+BIR2+and+BIR3+domains+in+XIAP&doi=10.1021%2Fja074725f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Characterization of a Potent, Nonpeptide, Cell-Permeable, Bivalent Smac Mimetic That Concurrently Targets Both the BIR2 and BIR3 Domains in XIAP</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Lu, Jianfeng; Meagher, Jennifer L.; Yang, Chao-Yie; Qiu, Su; Tomita, York; Ueda, Yumi; Jiang, Sheng; Krajewski, Krzysztof; Roller, Peter P.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">15279-15294</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">XIAP is a central apoptosis regulator that inhibits apoptosis by binding to and inhibiting the effectors caspase-3/-7 and an initiator caspase-9 through its BIR2 and BIR3 domains, resp.  Smac protein in its dimeric form effectively antagonizes XIAP by concurrently targeting both its BIR2 and BIR3 domains.  We report the design, synthesis, and characterization of a nonpeptide, cell-permeable, bivalent small-mol. (SM-164) which mimics Smac protein for targeting XIAP.  Our study shows that SM-164 binds to XIAP contg. both BIR domains with an IC50 value of 1.39 nM, being 300 and 7000 times more potent than its monovalent counterparts and the natural Smac AVPI peptide, resp.  SM-164 concurrently interacts with both BIR domains in XIAP and functions as an ultrapotent antagonist of XIAP in both cell-free functional and cell-based assays.  SM-164 targets cellular XIAP and effectively induces apoptosis at concns. as low as 1 nM in the HL-60 leukemia cell line.  The potency of bivalent SM-164 in binding, functional, and cellular assays is 2-3 orders of magnitude higher than its corresponding monovalent Smac mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNGBGUOFcArLVg90H21EOLACvtfcHk0ljrDFixycvJLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1yrur%252FI&md5=11b7028aa71b875e07b80f7a3d952b46</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fja074725f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja074725f%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520a%2520potent%252C%2520nonpeptide%252C%2520cell-permeable%252C%2520bivalent%2520SMAC%2520mimetic%2520that%2520concurrently%2520targets%2520both%2520the%2520BIR2%2520and%2520BIR3%2520domains%2520in%2520XIAP%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D15279%26epage%3D15294%26doi%3D10.1021%2Fja074725f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design of small-molecule peptidic and nonpeptidic SMAC mimetics</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1264</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1021/ar8000553</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar8000553" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kiur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=1264-1277&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=C.+Y.+Yangauthor=D.+Qianauthor=J.+Luauthor=S.+Qiuauthor=L.+Baiauthor=Y.+Pengauthor=Q.+Caiauthor=S.+Wang&title=Design+of+small-molecule+peptidic+and+nonpeptidic+SMAC+mimetics&doi=10.1021%2Far8000553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Small-Molecule Peptidic and Nonpeptidic Smac Mimetics</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Yang, Chao-Yie; Qian, Dongguang; Lu, Jianfeng; Qiu, Su; Bai, Longchuan; Peng, Yuefeng; Cai, Qian; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1264-1277</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Smac/DIABLO is a protein released from mitochondria into the cytosol in response to apoptotic stimuli.  Smac promotes apoptosis at least in part through antagonizing inhibitor of apoptosis proteins (IAPs), including XIAP, cIAP-1, and cIAP-2.  Smac interacts with these IAPs via its N-terminal AVPI binding motif.  There has been an enormous interest in academic labs. and pharmaceutical companies in the design of small-mol. Smac mimetics as potential anticancer agents.  This task is particularly challenging because it involves targeting protein-protein interactions.  Nevertheless, intense research has now generated potent, specific, cell-permeable small-mol. peptidomimetics and nonpeptidic mimetics.  To date, two types of Smac mimetics have been reported, namely, monovalent and bivalent Smac mimetics.  The monovalent compds. are designed to mimic the binding of a single AVPI binding motif to IAP proteins, whereas the bivalent compds. contain two AVPI binding motif mimetics tethered together through a linker.  Studies from several groups have clearly demonstrated that both monovalent and bivalent Smac mimetics not only enhance the antitumor activity of other anticancer agents but also can induce apoptosis as single agents in a subset of human cancer cell lines in vitro and are capable of achieving tumor regression in animal models of human cancer.  In general, bivalent Smac mimetics are 100-1000 times more potent than their corresponding monovalent Smac mimetics in induction of apoptosis in tumor cells.  However, properly designed monovalent Smac mimetics can achieve oral bioavailability and may have major advantages over bivalent Smac mimetics as potential drug candidates.  In-depth insights on the mol. mechanism of action of Smac mimetics have been provided by several independent studies.  It was shown that Smac mimetics induce apoptosis in tumor cells by targeting cIAP-1/-2 for the rapid degrdn. of these proteins, which leads to activation of nuclear factor κB (NF-κB) and prodn. and secretion of tumor necrosis factor α (TNFα).  TNFα promotes formation of a receptor-interacting serine-threonine kinase 1 (RIPK1)-dependent caspase-8-activating complex, leading to activation of caspase-8 and -3/-7 and ultimately to apoptosis.  For the most efficient apoptosis induction, Smac mimetics also need to remove the inhibition of XIAP to caspase-3/-7.  Hence, Smac mimetics induce apoptosis in tumor cells by targeting not only cIAP-1/-2 but also XIAP.  The employment of potent, cell-permeable, small-mol. Smac mimetics has yielded important insights into the regulation of apoptosis by IAP proteins.  To date, at least one Smac mimetic has been advanced into clin. development.  Several other Smac mimetics are in an advanced preclin. development stage and are expected to enter human clin. testing for the treatment of cancer in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF2ORbmgx5q7Vg90H21EOLACvtfcHk0ljrDFixycvJLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kiur3L&md5=434530329024b75e59f7f88e29ea0de1</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Far8000553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far8000553%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DQian%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%2520of%2520small-molecule%2520peptidic%2520and%2520nonpeptidic%2520SMAC%2520mimetics%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D1264%26epage%3D1277%26doi%3D10.1021%2Far8000553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shangary, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1/2 and XIAP</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">9384</span>– <span class="NLM_lpage">9393</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-2655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F0008-5472.CAN-08-2655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=19010913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOmt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=9384-9393&author=J.+Luauthor=L.+Baiauthor=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=S.+Qiuauthor=R.+S.+Millerauthor=H.+Yiauthor=S.+Shangaryauthor=Y.+Sunauthor=J.+L.+Meagherauthor=J.+A.+Stuckeyauthor=S.+Wang&title=SM-164%3A+a+novel%2C+bivalent+Smac+mimetic+that+induces+apoptosis+and+tumor+regression+by+concurrent+removal+of+the+blockade+of+cIAP-1%2F2+and+XIAP&doi=10.1158%2F0008-5472.CAN-08-2655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">SM-164: A Novel, Bivalent Smac Mimetic That Induces Apoptosis and Tumor Regression by Concurrent Removal of the Blockade of cIAP-1/2 and XIAP</span></div><div class="casAuthors">Lu, Jianfeng; Bai, Longchuan; Sun, Haiying; Nikolovska-Coleska, Zaneta; McEachern, Donna; Qiu, Su; Miller, Rebecca S.; Yi, Han; Shangary, Sanjeev; Sun, Yi; Meagher, Jennifer L.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9384-9393</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Small-mol. Smac mimetics are being developed as a novel class of anticancer drugs.  Recent studies have shown that Smac mimetics target cellular inhibitor of apoptosis protein (cIAP)-1/2 for degrdn. and induce tumor necrosis factor-α (TNFα)-dependent apoptosis in tumor cells.  In this study, we have investigated the mechanism of action and therapeutic potential of two different types of novel Smac mimetics, monovalent SM-122 and bivalent SM-164.  Our data showed that removal of cIAP-1/2 by Smac mimetics or small interfering RNA is not sufficient for robust TNFα-dependent apoptosis induction, and X-linked inhibitor of apoptosis protein (XIAP) plays a crit. role in inhibiting apoptosis induction.  Although SM-164 is modestly more effective than SM-122 in induction of cIAP-1/2 degrdn., SM-164 is 1,000 times more potent than SM-122 as an inducer of apoptosis in tumor cells, which is attributed to its much higher potency in binding to and antagonizing XIAP.  SM-164 induces rapid cIAP-1 degrdn. and strong apoptosis in the MDA-MB-231 xenograft tumor tissues and achieves tumor regression, but has no toxicity in normal mouse tissues.  Our study provides further insights into the mechanism of action for Smac mimetics and regulation of apoptosis by inhibitor of apoptosis proteins.  Furthermore, our data provide evidence that SM-164 is a promising new anticancer drug for further evaluation and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlLbn79J0ygLVg90H21EOLACvtfcHk0ljDec-1N_I3iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOmt7vE&md5=2d33887357ef44ef9aa997c8021814ec</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-2655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-2655%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DR.%2BS.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DSM-164%253A%2520a%2520novel%252C%2520bivalent%2520Smac%2520mimetic%2520that%2520induces%2520apoptosis%2520and%2520tumor%2520regression%2520by%2520concurrent%2520removal%2520of%2520the%2520blockade%2520of%2520cIAP-1%252F2%2520and%2520XIAP%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D9384%26epage%3D9393%26doi%3D10.1158%2F0008-5472.CAN-08-2655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellail, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, SMAC mimetic SM-164 in combination with TRAIL for cancer treatment</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">902</span>– <span class="NLM_lpage">914</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-10-0864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1535-7163.MCT-10-0864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21372226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlslKgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=902-914&author=J.+Luauthor=D.+McEachernauthor=H.+Sunauthor=L.+Baiauthor=Y.+Pengauthor=S.+Qiuauthor=R.+Millerauthor=J.+Liaoauthor=H.+Yiauthor=M.+Liuauthor=A.+Bellailauthor=C.+Haoauthor=S.+Y.+Sunauthor=A.+T.+Tingauthor=S.+Wang&title=Therapeutic+potential+and+molecular+mechanism+of+a+novel%2C+potent%2C+nonpeptide%2C+SMAC+mimetic+SM-164+in+combination+with+TRAIL+for+cancer+treatment&doi=10.1158%2F1535-7163.MCT-10-0864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment</span></div><div class="casAuthors">Lu, Jianfeng; McEachern, Donna; Sun, Haiying; Bai, Longchuan; Peng, Yuefeng; Qiu, Su; Miller, Rebecca; Liao, Jinhui; Yi, Han; Liu, Meilan; Bellail, Anita; Hao, Chunhai; Sun, Shi-Yong; Ting, Adrian T.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">902-914</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Smac mimetics are being developed as a new class of anticancer therapies.  Because the single-agent activity of Smac mimetics is very limited, rational combinations represent a viable strategy for their clin. development.  The combination of Smac mimetics with TNF-related apoptosis inducing ligand (TRAIL) may be particularly attractive because of the low toxicity of TRAIL to normal cells and the synergistic antitumor activity obsd. for the combination.  In this study, we have investigated the combination synergy between TRAIL and a potent Smac mimetic, SM-164, in vitro and in vivo and the underlying mol. mechanism of action for the synergy.  Our study shows that SM-164 is highly synergistic with TRAIL in vitro in both TRAIL-sensitive and TRAIL-resistant cancer cell lines of breast, prostate, and colon cancer.  Furthermore, the combination of SM-164 with TRAIL induces rapid tumor regression in vivo in a breast cancer xenograft model in which either agent is ineffective.  Our data show that X-linked IAP (XIAP) and cellular IAP 1 (cIAP1), but not cIAP2, work in concert to attenuate the activity of TRAIL; SM-164 strongly enhances TRAIL activity by concurrently targeting XIAP and cIAP1.  Moreover, although RIP1 plays a minimal role in the activity of TRAIL as a single agent, it is required for the synergistic interaction between TRAIL and SM-164.  This study provides a strong rationale to develop the combination of SM-164 and TRAIL as a new therapeutic strategy for the treatment of human cancer.  Mol Cancer Ther; 10(5); 902-14.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ3TvDUPiQaLVg90H21EOLACvtfcHk0ljDec-1N_I3iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlslKgt7Y%253D&md5=4c6f2df52cdcd0d4ad87d39b36ff9ddd</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0864%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DBellail%26aufirst%3DA.%26aulast%3DHao%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DS.%2BY.%26aulast%3DTing%26aufirst%3DA.%2BT.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DTherapeutic%2520potential%2520and%2520molecular%2520mechanism%2520of%2520a%2520novel%252C%2520potent%252C%2520nonpeptide%252C%2520SMAC%2520mimetic%2520SM-164%2520in%2520combination%2520with%2520TRAIL%2520for%2520cancer%2520treatment%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D902%26epage%3D914%26doi%3D10.1158%2F1535-7163.MCT-10-0864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Potent bivalent SMAC mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">3306</span>– <span class="NLM_lpage">3318</span>, <span class="refDoi"> DOI: 10.1021/jm101651b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101651b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3306-3318&author=H.+Sunauthor=L.+Liuauthor=J.+Luauthor=L.+Baiauthor=X.+Liauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=C.+Y.+Yangauthor=S.+Qiuauthor=H.+Yiauthor=D.+Sunauthor=S.+Wang&title=Potent+bivalent+SMAC+mimetics%3A+effect+of+the+linker+on+binding+to+inhibitor+of+apoptosis+proteins+%28IAPs%29+and+anticancer+activity&doi=10.1021%2Fjm101651b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Bivalent Smac Mimetics: Effect of the Linker on Binding to Inhibitor of Apoptosis Proteins (IAPs) and Anticancer Activity</span></div><div class="casAuthors">Sun, Haiying; Liu, Liu; Lu, Jianfeng; Bai, Longchuan; Li, Xiaoqin; Nikolovska-Coleska, Zaneta; McEachern, Donna; Yang, Chao-Yie; Qiu, Su; Yi, Han; Sun, Duxin; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3306-3318</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized and evaluated a series of nonpeptidic, bivalent Smac mimetics as antagonists of the inhibitor of apoptosis proteins and new anticancer agents.  All these bivalent Smac mimetics bind to full-length XIAP with low nanomolar affinities and function as ultrapotent antagonists of XIAP.  While these Smac mimetics bind to cIAP1/2 with similar low nanomolar affinities, their potencies to induce degrdn. of cIAP1/2 proteins in cells differ by more than 100-fold.  The most potent bivalent Smac mimetics inhibit cell growth with IC50 from 1 to 3 nM in the MDA-MB-231 breast cancer cell line and are 100 times more potent than the least potent compds.  Detn. of intracellular concns. for several representative compds. showed that the linkers in these bivalent Smac mimetics significantly affect their intracellular concns. and hence the overall cellular activity.  Compd. 27 completely inhibits tumor growth in the MDA-MB-231 xenografts while causing no signs of toxicity in the animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHDLE3fRizsbVg90H21EOLACvtfcHk0ljDec-1N_I3iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSqs74%253D&md5=cff3236e7f91333d13edd4093aa6f634</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm101651b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101651b%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPotent%2520bivalent%2520SMAC%2520mimetics%253A%2520effect%2520of%2520the%2520linker%2520on%2520binding%2520to%2520inhibitor%2520of%2520apoptosis%2520proteins%2520%2528IAPs%2529%2520and%2520anticancer%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3306%26epage%3D3318%26doi%3D10.1021%2Fjm101651b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hennessy, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquila, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castriotta, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattersley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hird, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huntington, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamhi, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laing, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oza, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeh, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sha, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasbinder, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitston, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9897</span>– <span class="NLM_lpage">9919</span>, <span class="refDoi"> DOI: 10.1021/jm401075x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401075x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9897-9919&author=E.+J.+Hennessyauthor=A.+Adamauthor=B.+M.+Aquilaauthor=L.+M.+Castriottaauthor=D.+Cookauthor=M.+Hattersleyauthor=A.+W.+Hirdauthor=C.+Huntingtonauthor=V.+M.+Kamhiauthor=N.+M.+Laingauthor=D.+Liauthor=T.+MacIntyreauthor=C.+A.+Omerauthor=V.+Ozaauthor=T.+Pattersonauthor=G.+Repikauthor=M.+T.+Rooneyauthor=J.+C.+Saehauthor=L.+Shaauthor=M.+M.+Vasbinderauthor=H.+Wangauthor=D.+Whitston&title=Discovery+of+a+novel+class+of+dimeric+Smac+mimetics+as+potent+IAP+antagonists+resulting+in+a+clinical+candidate+for+the+treatment+of+cancer+%28AZD5582%29&doi=10.1021%2Fjm401075x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582)</span></div><div class="casAuthors">Hennessy, Edward J.; Adam, Ammar; Aquila, Brian M.; Castriotta, Lillian M.; Cook, Donald; Hattersley, Maureen; Hird, Alexander W.; Huntington, Christopher; Kamhi, Victor M.; Laing, Naomi M.; Li, Danyang; MacIntyre, Terry; Omer, Charles A.; Oza, Vibha; Patterson, Troy; Repik, Galina; Rooney, Michael T.; Saeh, Jamal C.; Sha, Li; Vasbinder, Melissa M.; Wang, Haiyun; Whitston, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9897-9919</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of dimeric compds. based on the AVPI motif of Smac (second mitochondrial activator of caspases) were designed and prepd. as antagonists of the inhibitor of apoptosis proteins (IAPs).  Optimization of cellular potency, phys. properties, and pharmacokinetic parameters led to the identification of compd. 14 (AZD5582), which binds potently to the BIR3 domains of cIAP1, cIAP2, and XIAP (IC50 = 15, 21, and 15 nM, resp.).  This compd. causes cIAP1 degrdn. and induces apoptosis in the MDA-MB-231 breast cancer cell line at subnanomolar concns. in vitro.  When administered i.v. to MDA-MB-231 xenograft-bearing mice, 14 results in cIAP1 degrdn. and caspase-3 cleavage within tumor cells and causes substantial tumor regressions following two weekly doses of 3.0 mg/kg.  Antiproliferative effects are obsd. with 14 in only a small subset of the over 200 cancer cell lines examd., consistent with other published IAP inhibitors.  As a result of its in vitro and in vivo profile, 14 was nominated as a candidate for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppmeDH06Y5lLVg90H21EOLACvtfcHk0lgtdQM6-YLIbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltrjM&md5=9b4a5f7b89ebf74737d86c86acdf9c77</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm401075x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401075x%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DE.%2BJ.%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DAquila%26aufirst%3DB.%2BM.%26aulast%3DCastriotta%26aufirst%3DL.%2BM.%26aulast%3DCook%26aufirst%3DD.%26aulast%3DHattersley%26aufirst%3DM.%26aulast%3DHird%26aufirst%3DA.%2BW.%26aulast%3DHuntington%26aufirst%3DC.%26aulast%3DKamhi%26aufirst%3DV.%2BM.%26aulast%3DLaing%26aufirst%3DN.%2BM.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DOza%26aufirst%3DV.%26aulast%3DPatterson%26aufirst%3DT.%26aulast%3DRepik%26aufirst%3DG.%26aulast%3DRooney%26aufirst%3DM.%2BT.%26aulast%3DSaeh%26aufirst%3DJ.%2BC.%26aulast%3DSha%26aufirst%3DL.%26aulast%3DVasbinder%26aufirst%3DM.%2BM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWhitston%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520dimeric%2520Smac%2520mimetics%2520as%2520potent%2520IAP%2520antagonists%2520resulting%2520in%2520a%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520cancer%2520%2528AZD5582%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9897%26epage%3D9919%26doi%3D10.1021%2Fjm401075x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Condon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPorte, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rippin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haimowitz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendi, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benetatos, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neiman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seipel, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinlay, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feltham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettjeman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vince, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunduru, S. K.</span></span> <span> </span><span class="NLM_article-title">Birinapant, a SMAC-mimetic with improved tolerability for the treatment of solid tumors and hematological malignancies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3666</span>– <span class="NLM_lpage">3677</span>, <span class="refDoi"> DOI: 10.1021/jm500176w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500176w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltF2msrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3666-3677&author=S.+M.+Condonauthor=Y.+Mitsuuchiauthor=Y.+Dengauthor=M.+G.+LaPorteauthor=S.+R.+Rippinauthor=T.+Haimowitzauthor=M.+D.+Alexanderauthor=P.+T.+Kumarauthor=M.+S.+Hendiauthor=Y.+H.+Leeauthor=C.+A.+Benetatosauthor=G.+Yuauthor=G.+S.+Kapoorauthor=E.+Neimanauthor=M.+E.+Seipelauthor=J.+M.+Burnsauthor=M.+A.+Grahamauthor=M.+A.+McKinlayauthor=X.+Liauthor=J.+Wangauthor=Y.+Shiauthor=R.+Felthamauthor=B.+Bettjemanauthor=M.+H.+Cummingauthor=J.+E.+Vinceauthor=N.+Khanauthor=J.+Silkeauthor=C.+L.+Dayauthor=S.+K.+Chunduru&title=Birinapant%2C+a+SMAC-mimetic+with+improved+tolerability+for+the+treatment+of+solid+tumors+and+hematological+malignancies&doi=10.1021%2Fjm500176w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Birinapant, a Smac-Mimetic with Improved Tolerability for the Treatment of Solid Tumors and Hematological Malignancies</span></div><div class="casAuthors">Condon, Stephen M.; Mitsuuchi, Yasuhiro; Deng, Yijun; LaPorte, Matthew G.; Rippin, Susan R.; Haimowitz, Thomas; Alexander, Matthew D.; Kumar, Pavan Tirunahari; Hendi, Mukta S.; Lee, Yu-Hua; Benetatos, Christopher A.; Yu, Guangyao; Kapoor, Gurpreet Singh; Neiman, Eric; Seipel, Martin E.; Burns, Jennifer M.; Graham, Martin A.; McKinlay, Mark A.; Li, Xiaochun; Wang, Jiawei; Shi, Yigong; Feltham, Rebecca; Bettjeman, Bodhi; Cumming, Mathew H.; Vince, James E.; Khan, Nufail; Silke, John; Day, Catherine L.; Chunduru, Srinivas K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3666-3677</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Birinapant (1) is a second-generation bivalent antagonist of IAP proteins that is currently undergoing clin. development for the treatment of cancer.  Using a range of assays that evaluated cIAP1 stability and oligomeric state, we demonstrated that 1 stabilized the cIAP1-BUCR (BIR3-UBA-CARD-RING) dimer and promoted autoubiquitylation of cIAP1 in vitro.  Smac-mimetic 1-induced loss of cIAPs correlated with inhibition of TNF-mediated NF-κB activation, caspase activation, and tumor cell killing.  Many first-generation Smac-mimetics such as compd. A (2) were poorly tolerated.  Notably, animals that lack functional cIAP1, cIAP2, and XIAP are not viable, and 2 mimicked features of triple IAP knockout cells in vitro.  The improved tolerability of 1 was assocd. with (i) decreased potency against cIAP2 and affinity for XIAP BIR3 and (ii) decreased ability to inhibit XIAP-dependent signaling pathways.  The P2' position of 1 was crit. to this differential activity, and this improved tolerability has allowed 1 to proceed into clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMoeegQjyMH7Vg90H21EOLACvtfcHk0lgtdQM6-YLIbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltF2msrc%253D&md5=585857357c81b517de327eed450421b0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm500176w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500176w%26sid%3Dliteratum%253Aachs%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DMitsuuchi%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DLaPorte%26aufirst%3DM.%2BG.%26aulast%3DRippin%26aufirst%3DS.%2BR.%26aulast%3DHaimowitz%26aufirst%3DT.%26aulast%3DAlexander%26aufirst%3DM.%2BD.%26aulast%3DKumar%26aufirst%3DP.%2BT.%26aulast%3DHendi%26aufirst%3DM.%2BS.%26aulast%3DLee%26aufirst%3DY.%2BH.%26aulast%3DBenetatos%26aufirst%3DC.%2BA.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DKapoor%26aufirst%3DG.%2BS.%26aulast%3DNeiman%26aufirst%3DE.%26aulast%3DSeipel%26aufirst%3DM.%2BE.%26aulast%3DBurns%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DMcKinlay%26aufirst%3DM.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DBettjeman%26aufirst%3DB.%26aulast%3DCumming%26aufirst%3DM.%2BH.%26aulast%3DVince%26aufirst%3DJ.%2BE.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26atitle%3DBirinapant%252C%2520a%2520SMAC-mimetic%2520with%2520improved%2520tolerability%2520for%2520the%2520treatment%2520of%2520solid%2520tumors%2520and%2520hematological%2520malignancies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3666%26epage%3D3677%26doi%3D10.1021%2Fjm500176w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benetatos, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haimowitz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnone, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seipel, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunduru, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinlay, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condon, S. M.</span></span> <span> </span><span class="NLM_article-title">Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-kappaB signaling by degrading TRAF2-associated cIAP1 in cancer cells</span>. <i>Cell Death Discov</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">16046</span>, <span class="refDoi"> DOI: 10.1038/cddiscovery.2016.46</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fcddiscovery.2016.46" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=28149532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADC%252BC1c3hvFCmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=16046&author=Y.+Mitsuuchiauthor=C.+A.+Benetatosauthor=Y.+Dengauthor=T.+Haimowitzauthor=S.+C.+Beckauthor=M.+R.+Arnoneauthor=G.+S.+Kapoorauthor=M.+E.+Seipelauthor=S.+K.+Chunduruauthor=M.+A.+McKinlayauthor=C.+G.+Begleyauthor=S.+M.+Condon&title=Bivalent+IAP+antagonists%2C+but+not+monovalent+IAP+antagonists%2C+inhibit+TNF-mediated+NF-kappaB+signaling+by+degrading+TRAF2-associated+cIAP1+in+cancer+cells&doi=10.1038%2Fcddiscovery.2016.46"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-κB signaling by degrading TRAF2-associated cIAP1 in cancer cells</span></div><div class="casAuthors">Mitsuuchi Y; Benetatos C A; Deng Y; Haimowitz T; Beck S C; Arnone M R; Kapoor G S; Seipel M E; Chunduru S K; McKinlay M A; Begley C G; Condon S M</div><div class="citationInfo"><span class="NLM_cas:title">Cell death discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16046</span>
        ISSN:<span class="NLM_cas:issn">2058-7716</span>.
    </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins have pivotal roles in cell proliferation and differentiation, and antagonizing IAPs in certain cancer cell lines results in induction of cell death.  A variety of IAP antagonist compounds targeting the baculovirus IAP protein repeat 3 (BIR3) domain of cIAP1have advanced into clinical trials.  Here we sought to compare and contrast the biochemical activities of selected monovalent and bivalent IAP antagonists with the intent of identifying functional differences between these two classes of IAP antagonist drug candidates.  The anti-cellular IAP1 (cIAP1) and pro-apoptotic activities of monovalent IAP antagonists were increased by using a single covalent bond to combine the monovalent moieties at the P4 position.  In addition, regardless of drug concentration, treatment with monovalent compounds resulted in consistently higher levels of residual cIAP1 compared with that seen following bivalent compound treatment.  We found that the remaining residual cIAP1 following monovalent compound treatment was predominantly tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2)-associated cIAP1.  As a consequence, bivalent compounds were more effective at inhibiting TNF-induced activation of p65/NF-κB compared with monovalent compounds.  Moreover, extension of the linker chain at the P4 position of bivalent compounds resulted in a decreased ability to degrade TRAF2-associated cIAP1 in a manner similar to monovalent compounds.  This result implied that specific bivalent IAP antagonists but not monovalent compounds were capable of inducing formation of a cIAP1 E3 ubiquitin ligase complex with the capacity to effectively degrade TRAF2-associated cIAP1.  These results further suggested that only certain bivalent IAP antagonists are preferred for the targeting of TNF-dependent signaling for the treatment of cancer or infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTweo5XuUOxT4YPsCkJIw00fW6udTcc2eawYQTaF56zDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3hvFCmsg%253D%253D&md5=d451111fb7d800e0207454ec4309bbce</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fcddiscovery.2016.46&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddiscovery.2016.46%26sid%3Dliteratum%253Aachs%26aulast%3DMitsuuchi%26aufirst%3DY.%26aulast%3DBenetatos%26aufirst%3DC.%2BA.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DHaimowitz%26aufirst%3DT.%26aulast%3DBeck%26aufirst%3DS.%2BC.%26aulast%3DArnone%26aufirst%3DM.%2BR.%26aulast%3DKapoor%26aufirst%3DG.%2BS.%26aulast%3DSeipel%26aufirst%3DM.%2BE.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DMcKinlay%26aufirst%3DM.%2BA.%26aulast%3DBegley%26aufirst%3DC.%2BG.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26atitle%3DBivalent%2520IAP%2520antagonists%252C%2520but%2520not%2520monovalent%2520IAP%2520antagonists%252C%2520inhibit%2520TNF-mediated%2520NF-kappaB%2520signaling%2520by%2520degrading%2520TRAF2-associated%2520cIAP1%2520in%2520cancer%2520cells%26jtitle%3DCell%2520Death%2520Discov%26date%3D2017%26volume%3D3%26spage%3D16046%26doi%3D10.1038%2Fcddiscovery.2016.46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayly, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skidmore, J.</span></span> <span> </span><span class="NLM_article-title">Small molecules, big targets: drug discovery faces the protein-protein interaction challenge</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnrd.2016.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27050677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=533-550&author=D.+E.+Scottauthor=A.+R.+Baylyauthor=C.+Abellauthor=J.+Skidmore&title=Small+molecules%2C+big+targets%3A+drug+discovery+faces+the+protein-protein+interaction+challenge&doi=10.1038%2Fnrd.2016.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules, big targets: drug discovery faces the protein-protein interaction challenge</span></div><div class="casAuthors">Scott, Duncan E.; Bayly, Andrew R.; Abell, Chris; Skidmore, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">533-550</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein-protein interactions (PPIs) are of pivotal importance in the regulation of biol. systems and are consequently implicated in the development of disease states.  Recent work has begun to show that, with the right tools, certain classes of PPI can yield to the efforts of medicinal chemists to develop inhibitors, and the first PPI inhibitors have reached clin. development.  In this Review, we describe the research leading to these breakthroughs and highlight the existence of groups of structurally related PPIs within the PPI target class.  For each of these groups, we use examples of successful discovery efforts to illustrate the research strategies that have proved most useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK-aGzHa9mP7Vg90H21EOLACvtfcHk0liQH1OX2DBjWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D&md5=9f0953567ae9338b8b36aa78b8160655</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.29%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BE.%26aulast%3DBayly%26aufirst%3DA.%2BR.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DSkidmore%26aufirst%3DJ.%26atitle%3DSmall%2520molecules%252C%2520big%2520targets%253A%2520drug%2520discovery%2520faces%2520the%2520protein-protein%2520interaction%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D533%26epage%3D550%26doi%3D10.1038%2Fnrd.2016.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Bivalent SMAC mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1021/jm201072x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201072x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=106-114&author=Y.+Pengauthor=H.+Sunauthor=J.+Luauthor=L.+Liuauthor=Q.+Caiauthor=R.+Shenauthor=C.+Y.+Yangauthor=H.+Yiauthor=S.+Wang&title=Bivalent+SMAC+mimetics+with+a+diazabicyclic+core+as+highly+potent+antagonists+of+XIAP+and+cIAP1%2F2+and+novel+anticancer+agents&doi=10.1021%2Fjm201072x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Bivalent Smac Mimetics with a Diazabicyclic Core as Highly Potent Antagonists of XIAP and cIAP1/2 and Novel Anticancer Agents</span></div><div class="casAuthors">Peng, Yuefeng; Sun, Haiying; Lu, Jianfeng; Liu, Liu; Cai, Qian; Shen, Rong; Yang, Chao-Yie; Yi, Han; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">106-114</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonpeptidic, bivalent Smac mimetics designed based upon monovalent Smac mimetics with a diazabicyclic core structure bind to XIAP, cIAP1, and cIAP2 with low to subnanomolar affinities and are highly effective in antagonizing XIAP in cell-free functional assays.  They efficiently induce the degrdn. of cIAP1 and cIAP2 in cancer cells at concns. as low as 1 nM, activate caspase-3 and -8, and cleave PARP at 3-10 nM.  The most potent compds. in the series have IC50 of 3-5 nM in inhibition of cell growth in both MDA-MB-231 and SK-OV-3 cell lines and are promising lead compds. for the development of a new class of cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF3qkUBx1I87Vg90H21EOLACvtfcHk0liQH1OX2DBjWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurvI&md5=217458cb832862fa7fbd09262f6f7b2f</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm201072x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201072x%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DBivalent%2520SMAC%2520mimetics%2520with%2520a%2520diazabicyclic%2520core%2520as%2520highly%2520potent%2520antagonists%2520of%2520XIAP%2520and%2520cIAP1%252F2%2520and%2520novel%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D106%26epage%3D114%26doi%3D10.1021%2Fjm201072x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">A potent bivalent SMAC mimetic (SM-1200) achieving rapid, complete, and durable tumor regression in mice</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3969</span>– <span class="NLM_lpage">3979</span>, <span class="refDoi"> DOI: 10.1021/jm400216d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400216d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3969-3979&author=R.+Shengauthor=H.+Sunauthor=L.+Liuauthor=J.+Luauthor=D.+McEachernauthor=G.+Wangauthor=J.+Wenauthor=P.+Minauthor=Z.+Duauthor=H.+Luauthor=S.+Kangauthor=M.+Guoauthor=D.+Yangauthor=S.+Wang&title=A+potent+bivalent+SMAC+mimetic+%28SM-1200%29+achieving+rapid%2C+complete%2C+and+durable+tumor+regression+in+mice&doi=10.1021%2Fjm400216d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent Bivalent Smac Mimetic (SM-1200) Achieving Rapid, Complete, and Durable Tumor Regression in Mice</span></div><div class="casAuthors">Sheng, Rong; Sun, Haiying; Liu, Liu; Lu, Jianfeng; McEachern, Donna; Wang, Guanfeng; Wen, Jianfeng; Min, Ping; Du, Zhenyun; Lu, Huirong; Kang, Sanmao; Guo, Ming; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3969-3979</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors have designed, synthesized, and evaluated a series of new compds. based upon the authors' previously reported bivalent Smac mimetics.  This led to the identification of compd. SM-1200, which binds to XIAP, cIAP1, and cIAP2 with Ki values of 0.5, 3.7, and 5.4 nM, resp., inhibits cell growth in the MDA-MB-231 breast cancer and SK-OV-3 ovarian cancer cell lines with IC50 values of 11.0 and 28.2 nM, resp.  Compd. SM-1200 has a much improved pharmacokinetic profile over the authors' previously reported bivalent Smac mimetics and is highly effective in induction of rapid and durable tumor regression in the MDA-MB-231 xenograft model.  These data indicate that compd. SM-1200 is a promising Smac mimetic and warrants extensive evaluation as a potential candidate for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlWWEgSvmyrVg90H21EOLACvtfcHk0liOLnpSXxf-8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtr0%253D&md5=5610e9a8cc40939434a77e5840a50110</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm400216d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400216d%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DMin%26aufirst%3DP.%26aulast%3DDu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520potent%2520bivalent%2520SMAC%2520mimetic%2520%2528SM-1200%2529%2520achieving%2520rapid%252C%2520complete%252C%2520and%2520durable%2520tumor%2520regression%2520in%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3969%26epage%3D3979%26doi%3D10.1021%2Fjm400216d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milutinovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudreault, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillard, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaquith, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, P. A.</span></span> <span> </span><span class="NLM_article-title">cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">700</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2008.05.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.molcel.2008.05.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18570872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFWnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=689-700&author=M.+J.+Bertrandauthor=S.+Milutinovicauthor=K.+M.+Dicksonauthor=W.+C.+Hoauthor=A.+Boudreaultauthor=J.+Durkinauthor=J.+W.+Gillardauthor=J.+B.+Jaquithauthor=S.+J.+Morrisauthor=P.+A.+Barker&title=cIAP1+and+cIAP2+facilitate+cancer+cell+survival+by+functioning+as+E3+ligases+that+promote+RIP1+ubiquitination&doi=10.1016%2Fj.molcel.2008.05.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination</span></div><div class="casAuthors">Bertrand, Mathieu J. M.; Milutinovic, Snezana; Dickson, Kathleen M.; Ho, Wai Chi; Boudreault, Alain; Durkin, Jon; Gillard, John W.; Jaquith, James B.; Morris, Stephen J.; Barker, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">689-700</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) family of proteins enhances cell survival through mechanisms that remain uncertain.  In this report, we show that cIAP1 and cIAP2 promote cancer cell survival by functioning as E3 ubiquitin ligases that maintain constitutive ubiquitination of the RIP1 adaptor protein.  We demonstrate that AEG40730, a compd. modeled on BIR-binding tetrapeptides, binds to cIAP1 and cIAP2, facilitates their autoubiquitination and proteosomal degrdn., and causes a dramatic redn. in RIP1 ubiquitination.  We show that cIAP1 and cIAP2 directly ubiquitinate RIP1 and induce constitutive RIP1 ubiquitination in cancer cells and demonstrate that constitutively ubiquitinated RIP1 assocs. with the prosurvival kinase TAK1.  When deubiquitinated by AEG40730 treatment, RIP1 binds caspase-8 and induces apoptosis.  These findings provide insights into the function of the IAPs and provide new therapeutic opportunities in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd_y6j1lTyc7Vg90H21EOLACvtfcHk0liOLnpSXxf-8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFWnt74%253D&md5=89f7538f6a7f253b5ca1e80bd7b11d8b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2008.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2008.05.014%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DM.%2BJ.%26aulast%3DMilutinovic%26aufirst%3DS.%26aulast%3DDickson%26aufirst%3DK.%2BM.%26aulast%3DHo%26aufirst%3DW.%2BC.%26aulast%3DBoudreault%26aufirst%3DA.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DGillard%26aufirst%3DJ.%2BW.%26aulast%3DJaquith%26aufirst%3DJ.%2BB.%26aulast%3DMorris%26aufirst%3DS.%2BJ.%26aulast%3DBarker%26aufirst%3DP.%2BA.%26atitle%3DcIAP1%2520and%2520cIAP2%2520facilitate%2520cancer%2520cell%2520survival%2520by%2520functioning%2520as%2520E3%2520ligases%2520that%2520promote%2520RIP1%2520ubiquitination%26jtitle%3DMol.%2520Cell%26date%3D2008%26volume%3D30%26spage%3D689%26epage%3D700%26doi%3D10.1016%2Fj.molcel.2008.05.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbott, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of tetrahydroisoquinoline-based bivalent heterodimeric IAP antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5022</span>– <span class="NLM_lpage">5029</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.09.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.bmcl.2014.09.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=25278234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOltbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5022-5029&author=K.+S.+Kimauthor=L.+Zhangauthor=D.+Williamsauthor=H.+L.+Perezauthor=E.+Stangauthor=R.+M.+Borzilleriauthor=S.+Posyauthor=M.+Leiauthor=C.+Chaudhryauthor=S.+Emanuelauthor=R.+Talbott&title=Discovery+of+tetrahydroisoquinoline-based+bivalent+heterodimeric+IAP+antagonists&doi=10.1016%2Fj.bmcl.2014.09.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of tetrahydroisoquinoline-based bivalent heterodimeric IAP antagonists</span></div><div class="casAuthors">Kim, Kyoung Soon; Zhang, Liping; Williams, David; Perez, Heidi L.; Stang, Erik; Borzilleri, Robert M.; Posy, Shana; Lei, Ming; Chaudhry, Charu; Emanuel, Stuart; Talbott, Randy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5022-5029</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bivalent heterodimeric IAP antagonists that incorporate (R)-tetrahydroisoquinoline in the P3' subunit show high affinity for the BIR2 domain and demonstrated potent IAP inhibitory activities in biochem. and cellular assays.  Potent in vivo efficacy was obsd. in a variety of human tumor xenograft models.  The bivalent heterodimeric mol. I with a P3-P3' benzamide linker induced pharmacodynamic markers of apoptosis and was efficacious when administered i.v. at a dose of 1 mg/kg to mice harboring A875 human melanoma tumors.  An analog with a polyamine group incorporated at the P2' thiovaline side chain of I exhibited antiproliferative activity against the P-gp expressing HCT116/VM46 cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGmx42606d97Vg90H21EOLACvtfcHk0liOLnpSXxf-8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOltbvN&md5=63b2a7041057d80aeddd4ef08ad2d599</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.09.022%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DD.%26aulast%3DPerez%26aufirst%3DH.%2BL.%26aulast%3DStang%26aufirst%3DE.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DPosy%26aufirst%3DS.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DChaudhry%26aufirst%3DC.%26aulast%3DEmanuel%26aufirst%3DS.%26aulast%3DTalbott%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520tetrahydroisoquinoline-based%2520bivalent%2520heterodimeric%2520IAP%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5022%26epage%3D5029%26doi%3D10.1016%2Fj.bmcl.2014.09.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuel, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanslau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fargnoli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naglich, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traeger, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuppugalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vite, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbott, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, R. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent heterodimeric antagonists of inhibitor of apoptosis proteins (IAPs) with sustained antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1556</span>– <span class="NLM_lpage">1562</span>, <span class="refDoi"> DOI: 10.1021/jm501482t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501482t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVygsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1556-1562&author=H.+L.+Perezauthor=C.+Chaudhryauthor=S.+L.+Emanuelauthor=C.+Fanslauauthor=J.+Fargnoliauthor=J.+Ganauthor=K.+S.+Kimauthor=M.+Leiauthor=J.+G.+Naglichauthor=S.+C.+Traegerauthor=R.+Vuppugallaauthor=D.+D.+Weiauthor=G.+D.+Viteauthor=R.+L.+Talbottauthor=R.+M.+Borzilleri&title=Discovery+of+potent+heterodimeric+antagonists+of+inhibitor+of+apoptosis+proteins+%28IAPs%29+with+sustained+antitumor+activity&doi=10.1021%2Fjm501482t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Heterodimeric Antagonists of Inhibitor of Apoptosis Proteins (IAPs) with Sustained Antitumor Activity</span></div><div class="casAuthors">Perez, Heidi L.; Chaudhry, Charu; Emanuel, Stuart L.; Fanslau, Caroline; Fargnoli, Joseph; Gan, Jinping; Kim, Kyoung S.; Lei, Ming; Naglich, Joseph G.; Traeger, Sarah C.; Vuppugalla, Ragini; Wei, Donna D.; Vite, Gregory D.; Talbott, Randy L.; Borzilleri, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1556-1562</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The prominent role of IAPs in controlling cell death and their overexpression in a variety of cancers has prompted the development of IAP antagonists as potential antitumor therapies.  The authors describe the identification of a series of heterodimeric antagonists with highly potent antiproliferative activities in cIAP- and XIAP-dependent cell lines.  Compds. I (L = none) and I (L = NH) further demonstrate curative efficacy in human melanoma and lung cancer xenograft models and are promising candidates for advanced studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9jI4A3_S8CbVg90H21EOLACvtfcHk0lgz4vLrIpUwEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVygsQ%253D%253D&md5=890b77928df9afc7d03ba0a50724d430</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm501482t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501482t%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DH.%2BL.%26aulast%3DChaudhry%26aufirst%3DC.%26aulast%3DEmanuel%26aufirst%3DS.%2BL.%26aulast%3DFanslau%26aufirst%3DC.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DGan%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DNaglich%26aufirst%3DJ.%2BG.%26aulast%3DTraeger%26aufirst%3DS.%2BC.%26aulast%3DVuppugalla%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DD.%2BD.%26aulast%3DVite%26aufirst%3DG.%2BD.%26aulast%3DTalbott%26aufirst%3DR.%2BL.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520potent%2520heterodimeric%2520antagonists%2520of%2520inhibitor%2520of%2520apoptosis%2520proteins%2520%2528IAPs%2529%2520with%2520sustained%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1556%26epage%3D1562%26doi%3D10.1021%2Fjm501482t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamanini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitorino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsher, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.</span></span> <span> </span><span class="NLM_article-title">Fragment-based drug discovery targeting inhibitor of apoptosis proteins: discovery of a non-alanine lead series with dual activity against cIAP1 and XIAP</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6574</span>– <span class="NLM_lpage">6588</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00706</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00706" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1CitLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6574-6588&author=G.+Chessariauthor=I.+M.+Buckauthor=J.+E.+Dayauthor=P.+J.+Dayauthor=A.+Iqbalauthor=C.+N.+Johnsonauthor=E.+J.+Lewisauthor=V.+Martinsauthor=D.+Millerauthor=M.+Readerauthor=D.+C.+Reesauthor=S.+J.+Richauthor=E.+Tamaniniauthor=M.+Vitorinoauthor=G.+A.+Wardauthor=P.+A.+Williamsauthor=G.+Williamsauthor=N.+E.+Wilsherauthor=A.+J.+Woolford&title=Fragment-based+drug+discovery+targeting+inhibitor+of+apoptosis+proteins%3A+discovery+of+a+non-alanine+lead+series+with+dual+activity+against+cIAP1+and+XIAP&doi=10.1021%2Facs.jmedchem.5b00706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAP</span></div><div class="casAuthors">Chessari, Gianni; Buck, Ildiko M.; Day, James E. H.; Day, Philip J.; Iqbal, Aman; Johnson, Christopher N.; Lewis, Edward J.; Martins, Vanessa; Miller, Darcey; Reader, Michael; Rees, David C.; Rich, Sharna J.; Tamanini, Emiliano; Vitorino, Marc; Ward, George A.; Williams, Pamela A.; Williams, Glyn; Wilsher, Nicola E.; Woolford, Alison J.-A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6574-6588</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis proteins (IAPs) are important regulators of apoptosis and pro-survival signaling pathways whose deregulation is often assocd. with tumor genesis and tumor growth.  IAPs have been proposed as targets for anticancer therapy, and a no. of peptidomimetic IAP antagonists have entered clin. trials.  Using the fragment-based screening approach, the authors identified nonpeptidic fragments binding with millimolar affinities to both cellular inhibitor of apoptosis protein 1 (cIAP1) and X-linked inhibitor of apoptosis protein (XIAP).  Structure-based hit optimization together with an anal. of protein-ligand electrostatic potential complementarity allowed us to significantly increase binding affinity of the starting hits.  Subsequent optimization gave a potent nonalanine IAP antagonist I structurally distinct from all IAP antagonists previously reported.  The lead compd. had activity in cell-based assays and in a mouse xenograft efficacy model and represents a highly promising start point for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXRpw0ZQNug7Vg90H21EOLACvtfcHk0lgz4vLrIpUwEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1CitLrL&md5=70a9c10527791ce2cedd0a74e0bbeebb</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00706%26sid%3Dliteratum%253Aachs%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DBuck%26aufirst%3DI.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DIqbal%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMiller%26aufirst%3DD.%26aulast%3DReader%26aufirst%3DM.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DTamanini%26aufirst%3DE.%26aulast%3DVitorino%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DG.%2BA.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DWilsher%26aufirst%3DN.%2BE.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26atitle%3DFragment-based%2520drug%2520discovery%2520targeting%2520inhibitor%2520of%2520apoptosis%2520proteins%253A%2520discovery%2520of%2520a%2520non-alanine%2520lead%2520series%2520with%2520dual%2520activity%2520against%2520cIAP1%2520and%2520XIAP%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6574%26epage%3D6588%26doi%3D10.1021%2Facs.jmedchem.5b00706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamanini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths-Jones, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heightman, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsher, N. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent Nonpeptidomimetic, small-molecule antagonist of cellular inhibitor of apoptosis protein 1 (cIAP1) and X-linked inhibitor of apoptosis protein (XIAP)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4611</span>– <span class="NLM_lpage">4625</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01877</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01877" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Wntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4611-4625&author=E.+Tamaniniauthor=I.+M.+Buckauthor=G.+Chessariauthor=E.+Chiarparinauthor=J.+E.+H.+Dayauthor=M.+Fredericksonauthor=C.+M.+Griffiths-Jonesauthor=K.+Hearnauthor=T.+D.+Heightmanauthor=A.+Iqbalauthor=C.+N.+Johnsonauthor=E.+J.+Lewisauthor=V.+Martinsauthor=T.+Peakmanauthor=M.+Readerauthor=S.+J.+Richauthor=G.+A.+Wardauthor=P.+A.+Williamsauthor=N.+E.+Wilsher&title=Discovery+of+a+Potent+Nonpeptidomimetic%2C+small-molecule+antagonist+of+cellular+inhibitor+of+apoptosis+protein+1+%28cIAP1%29+and+X-linked+inhibitor+of+apoptosis+protein+%28XIAP%29&doi=10.1021%2Facs.jmedchem.6b01877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP)</span></div><div class="casAuthors">Tamanini, Emiliano; Buck, Ildiko M.; Chessari, Gianni; Chiarparin, Elisabetta; Day, James E. H.; Frederickson, Martyn; Griffiths-Jones, Charlotte M.; Hearn, Keisha; Heightman, Tom D.; Iqbal, Aman; Johnson, Christopher N.; Lewis, Edward J.; Martins, Vanessa; Peakman, Torren; Reader, Michael; Rich, Sharna J.; Ward, George A.; Williams, Pamela A.; Wilsher, Nicola E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4611-4625</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">XIAP and cIAP1 are members of the inhibitor of apoptosis protein (IAP) family and are key regulators of anti-apoptotic and pro-survival signaling pathways.  Overexpression of IAPs occurs in various cancers and has been assocd. with tumor progression and resistance to treatment.  Structure-based drug design (SBDD) guided by structural information from X-ray crystallog., computational studies, and NMR soln. conformational anal. was successfully applied to a fragment-derived lead resulting in AT-IAP, a potent, orally bioavailable, dual antagonist of XIAP and cIAP1 and a structurally novel chem. probe for IAP biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMIPJYPfW1ubVg90H21EOLACvtfcHk0lgz4vLrIpUwEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Wntb0%253D&md5=2e00e53298df3ebe16bc02ad7cd7bf65</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01877%26sid%3Dliteratum%253Aachs%26aulast%3DTamanini%26aufirst%3DE.%26aulast%3DBuck%26aufirst%3DI.%2BM.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DDay%26aufirst%3DJ.%2BE.%2BH.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DGriffiths-Jones%26aufirst%3DC.%2BM.%26aulast%3DHearn%26aufirst%3DK.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DIqbal%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DPeakman%26aufirst%3DT.%26aulast%3DReader%26aufirst%3DM.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DWard%26aufirst%3DG.%2BA.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DWilsher%26aufirst%3DN.%2BE.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520Nonpeptidomimetic%252C%2520small-molecule%2520antagonist%2520of%2520cellular%2520inhibitor%2520of%2520apoptosis%2520protein%25201%2520%2528cIAP1%2529%2520and%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528XIAP%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4611%26epage%3D4625%26doi%3D10.1021%2Facs.jmedchem.6b01877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsher, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span> <span> </span><span class="NLM_article-title">ASTX660, a novel non-peptidomimetic antagonist of cIAP1/2 and XIAP, potently induces TNFalpha-dependent apoptosis in cancer cell lines and inhibits tumor growth</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1381</span>– <span class="NLM_lpage">1391</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-17-0848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1535-7163.MCT-17-0848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=29695633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1alur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=1381-1391&author=G.+A.+Wardauthor=E.+J.+Lewisauthor=J.+S.+Ahnauthor=C.+N.+Johnsonauthor=J.+F.+Lyonsauthor=V.+Martinsauthor=J.+M.+Munckauthor=S.+J.+Richauthor=T.+Smythauthor=N.+T.+Thompsonauthor=P.+A.+Williamsauthor=N.+E.+Wilsherauthor=N.+G.+Wallisauthor=G.+Chessari&title=ASTX660%2C+a+novel+non-peptidomimetic+antagonist+of+cIAP1%2F2+and+XIAP%2C+potently+induces+TNFalpha-dependent+apoptosis+in+cancer+cell+lines+and+inhibits+tumor+growth&doi=10.1158%2F1535-7163.MCT-17-0848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth</span></div><div class="casAuthors">Ward, George A.; Lewis, Edward J.; Ahn, Jong Sook; Johnson, Christopher N.; Lyons, John F.; Martins, Vanessa; Munck, Joanne M.; Rich, Sharna J.; Smyth, Tomoko; Thompson, Neil T.; Williams, Pamela A.; Wilsher, Nicola E.; Wallis, Nicola G.; Chessari, Gianni</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1381-1391</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Because of their roles in the evasion of apoptosis, inhibitor of apoptosis proteins (IAP) are considered attractive targets for anticancer therapy.  Antagonists of these proteins have the potential to switch prosurvival signaling pathways in cancer cells toward cell death.  Various SMAC-peptidomimetics with inherent cIAP selectivity have been tested clin. and demonstrated minimal single-agent efficacy.  ASTX660 is a potent, non-peptidomimetic antagonist of cIAP1/2 and XIAP, discovered using fragment-based drug design.  The antagonism of XIAP and cIAP1 by ASTX660 was demonstrated on purified proteins, cells, and in vivo in xenograft models.  The compd. binds to the isolated BIR3 domains of both XIAP and cIAP1 with nanomolar potencies.  In cells and xenograft tissue, direct antagonism of XIAP was demonstrated by measuring its displacement from caspase-9 or SMAC.  Compd.-induced proteasomal degrdn. of cIAP1 and 2, resulting in downstream effects of NIK stabilization and activation of noncanonical NF-κB signaling, demonstrated cIAP1/2 antagonism.  Treatment with ASTX660 led to TNFα-dependent induction of apoptosis in various cancer cell lines in vitro, whereas dosing in mice bearing breast and melanoma tumor xenografts inhibited tumor growth.  ASTX660 is currently being tested in a phase I-II clin. trial (NCT02503423), and we propose that its antagonism of cIAP1/2 and XIAP may offer improved efficacy over first-generation antagonists that are more cIAP1/2 selective.  Mol Cancer Ther; 17(7); 1381-91. ©2018 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA6bD-2Q28tLVg90H21EOLACvtfcHk0lhbmxbidLmujA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1alur7J&md5=0fad3f7bf0870ef4566b182d4719a5d6</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-17-0848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-17-0848%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DG.%2BA.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DAhn%26aufirst%3DJ.%2BS.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DLyons%26aufirst%3DJ.%2BF.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMunck%26aufirst%3DJ.%2BM.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DSmyth%26aufirst%3DT.%26aulast%3DThompson%26aufirst%3DN.%2BT.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DWilsher%26aufirst%3DN.%2BE.%26aulast%3DWallis%26aufirst%3DN.%2BG.%26aulast%3DChessari%26aufirst%3DG.%26atitle%3DASTX660%252C%2520a%2520novel%2520non-peptidomimetic%2520antagonist%2520of%2520cIAP1%252F2%2520and%2520XIAP%252C%2520potently%2520induces%2520TNFalpha-dependent%2520apoptosis%2520in%2520cancer%2520cell%2520lines%2520and%2520inhibits%2520tumor%2520growth%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26spage%3D1381%26epage%3D1391%26doi%3D10.1158%2F1535-7163.MCT-17-0848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millemaggi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsher, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span> <span> </span><span class="NLM_article-title">A fragment-derived clinical candidate for antagonism of X-linked and cellular inhibitor of apoptosis proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1 H,2 H,3 H-pyrrolo[3,2- b]pyridin-1-yl)-2-[(2 R,5 R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7314</span>– <span class="NLM_lpage">7329</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00900</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00900" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVKhtr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7314-7329&author=C.+N.+Johnsonauthor=J.+S.+Ahnauthor=I.+M.+Buckauthor=E.+Chiarparinauthor=J.+E.+H.+Dayauthor=A.+Hopkinsauthor=S.+Howardauthor=E.+J.+Lewisauthor=V.+Martinsauthor=A.+Millemaggiauthor=J.+M.+Munckauthor=L.+W.+Pageauthor=T.+Peakmanauthor=M.+Readerauthor=S.+J.+Richauthor=G.+Saxtyauthor=T.+Smythauthor=N.+T.+Thompsonauthor=G.+A.+Wardauthor=P.+A.+Williamsauthor=N.+E.+Wilsherauthor=G.+Chessari&title=A+fragment-derived+clinical+candidate+for+antagonism+of+X-linked+and+cellular+inhibitor+of+apoptosis+proteins%3A+1-%286-%5B%284-Fluorophenyl%29methyl%5D-5-%28hydroxymethyl%29-3%2C3-dimethyl-1+H%2C2+H%2C3+H-pyrrolo%5B3%2C2-+b%5Dpyridin-1-yl%29-2-%5B%282+R%2C5+R%29-5-methyl-2-%28%5B%283R%29-3-methylmorpholin-4-yl%5Dmethyl%29piperazin-1-yl%5Dethan-1-one+%28ASTX660%29&doi=10.1021%2Facs.jmedchem.8b00900"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1H,2H,3H-pyrrolo[3,2-b]pyridin-1-yl)-2-[(2R,5R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660)</span></div><div class="casAuthors">Johnson, Christopher N.; Ahn, Jong Sook; Buck, Ildiko M.; Chiarparin, Elisabetta; Day, James E. H.; Hopkins, Anna; Howard, Steven; Lewis, Edward J.; Martins, Vanessa; Millemaggi, Alessia; Munck, Joanne M.; Page, Lee W.; Peakman, Torren; Reader, Michael; Rich, Sharna J.; Saxty, Gordon; Smyth, Tomoko; Thompson, Neil T.; Ward, George A.; Williams, Pamela A.; Wilsher, Nicola E.; Chessari, Gianni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7314-7329</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis proteins (IAPs) are promising anticancer targets, given their roles in the evasion of apoptosis.  Several peptidomimetic IAP antagonists, with inherent selectivity for cellular IAP (cIAP) over X-linked IAP (XIAP), have been tested in the clinic.  A fragment screening approach followed by structure-based optimization has previously been reported that resulted in a low-nanomolar cIAP1 and XIAP antagonist lead mol. with a more balanced cIAP-XIAP profile.  We now report the further structure-guided optimization of the lead, with a view to improving the metabolic stability and cardiac safety profile, to give the nonpeptidomimetic antagonist clin. candidate (ASTX660), currently being tested in a phase 1/2 clin. trial (NCT02503423).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBj2OOs5EG-7Vg90H21EOLACvtfcHk0lhbmxbidLmujA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVKhtr7P&md5=9c7ca5775f42441c971ad8459bb129c2</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00900%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DAhn%26aufirst%3DJ.%2BS.%26aulast%3DBuck%26aufirst%3DI.%2BM.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DDay%26aufirst%3DJ.%2BE.%2BH.%26aulast%3DHopkins%26aufirst%3DA.%26aulast%3DHoward%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMillemaggi%26aufirst%3DA.%26aulast%3DMunck%26aufirst%3DJ.%2BM.%26aulast%3DPage%26aufirst%3DL.%2BW.%26aulast%3DPeakman%26aufirst%3DT.%26aulast%3DReader%26aufirst%3DM.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DSmyth%26aufirst%3DT.%26aulast%3DThompson%26aufirst%3DN.%2BT.%26aulast%3DWard%26aufirst%3DG.%2BA.%26aulast%3DWilliams%26aufirst%3DP.%2BA.%26aulast%3DWilsher%26aufirst%3DN.%2BE.%26aulast%3DChessari%26aufirst%3DG.%26atitle%3DA%2520fragment-derived%2520clinical%2520candidate%2520for%2520antagonism%2520of%2520X-linked%2520and%2520cellular%2520inhibitor%2520of%2520apoptosis%2520proteins%253A%25201-%25286-%255B%25284-Fluorophenyl%2529methyl%255D-5-%2528hydroxymethyl%2529-3%252C3-dimethyl-1%2520H%252C2%2520H%252C3%2520H-pyrrolo%255B3%252C2-%2520b%255Dpyridin-1-yl%2529-2-%255B%25282%2520R%252C5%2520R%2529-5-methyl-2-%2528%255B%25283R%2529-3-methylmorpholin-4-yl%255Dmethyl%2529piperazin-1-yl%255Dethan-1-one%2520%2528ASTX660%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7314%26epage%3D7329%26doi%3D10.1021%2Facs.jmedchem.8b00900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donnell, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michoud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupert, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fretland, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kester, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukacs, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mischke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moliterni, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polonskaia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutt, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solis, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Specian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiszewski, S. W.</span></span> <span> </span><span class="NLM_article-title">Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7772</span>– <span class="NLM_lpage">7787</span>, <span class="refDoi"> DOI: 10.1021/jm400731m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400731m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFGku7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7772-7787&author=A.+F.+Donnellauthor=C.+Michoudauthor=K.+C.+Rupertauthor=X.+Hanauthor=D.+Aguilarauthor=K.+B.+Frankauthor=A.+J.+Fretlandauthor=L.+Gaoauthor=B.+Gogginauthor=J.+H.+Hoggauthor=K.+Hongauthor=C.+A.+Jansonauthor=R.+F.+Kesterauthor=N.+Kongauthor=K.+Leauthor=S.+Liauthor=W.+Liangauthor=L.+J.+Lombardoauthor=Y.+Louauthor=C.+M.+Lukacsauthor=S.+Mischkeauthor=J.+A.+Moliterniauthor=A.+Polonskaiaauthor=A.+D.+Schuttauthor=D.+S.+Solisauthor=A.+Specianauthor=R.+T.+Taylorauthor=M.+Weiselauthor=S.+W.+Remiszewski&title=Benzazepinones+and+benzoxazepinones+as+antagonists+of+inhibitor+of+apoptosis+proteins+%28IAPs%29+selective+for+the+second+baculovirus+IAP+repeat+%28BIR2%29+domain&doi=10.1021%2Fjm400731m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Benzazepinones and Benzoxazepinones as Antagonists of Inhibitor of Apoptosis Proteins (IAPs) Selective for the Second Baculovirus IAP Repeat (BIR2) Domain</span></div><div class="casAuthors">Donnell, Andrew F.; Michoud, Christophe; Rupert, Kenneth C.; Han, Xiaochun; Aguilar, Douglas; Frank, Karl B.; Fretland, Adrian J.; Gao, Lin; Goggin, Barry; Hogg, J. Heather; Hong, Kyoungja; Janson, Cheryl A.; Kester, Robert F.; Kong, Norman; Le, Kang; Li, Shirley; Liang, Weiling; Lombardo, Louis J.; Lou, Yan; Lukacs, Christine M.; Mischke, Steven; Moliterni, John A.; Polonskaia, Ann; Schutt, Andrew D.; Solis, Dave S.; Specian, Anthony; Taylor, Robert T.; Weisel, Martin; Remiszewski, Stacy W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7772-7787</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">XIAP is a key regulator of apoptosis, and its overexpression in cancer cells may contribute to their survival.  The antiapoptotic function of XIAP derives from its BIR domains, which bind to and inhibit pro-apoptotic caspases.  Most known IAP inhibitors are selective for the BIR3 domain and bind to cIAP1 and cIAP2 as well as XIAP.  Pathways activated upon cIAP binding contribute to the function of these compds.  Inhibitors selective for XIAP should exert pro-apoptotic effects through competition with the terminal caspases.  This paper details our synthetic explorations of a novel XIAP BIR2-selective benzazepinone screening hit with a focus on increasing BIR2 potency and overcoming high in vivo clearance.  These efforts led to the discovery of benzoxazepinone 40, a potent BIR2-selective inhibitor with good in vivo pharmacokinetic properties which potentiates apoptotic signaling in a manner mechanistically distinct from that of known pan-IAP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqR1SV1L6CSrVg90H21EOLACvtfcHk0lg_Z-szK8rWKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFGku7rM&md5=7ae7bebecf9f779ce42bd29b7312652b</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm400731m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400731m%26sid%3Dliteratum%253Aachs%26aulast%3DDonnell%26aufirst%3DA.%2BF.%26aulast%3DMichoud%26aufirst%3DC.%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DAguilar%26aufirst%3DD.%26aulast%3DFrank%26aufirst%3DK.%2BB.%26aulast%3DFretland%26aufirst%3DA.%2BJ.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DGoggin%26aufirst%3DB.%26aulast%3DHogg%26aufirst%3DJ.%2BH.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DKester%26aufirst%3DR.%2BF.%26aulast%3DKong%26aufirst%3DN.%26aulast%3DLe%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DW.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DLukacs%26aufirst%3DC.%2BM.%26aulast%3DMischke%26aufirst%3DS.%26aulast%3DMoliterni%26aufirst%3DJ.%2BA.%26aulast%3DPolonskaia%26aufirst%3DA.%26aulast%3DSchutt%26aufirst%3DA.%2BD.%26aulast%3DSolis%26aufirst%3DD.%2BS.%26aulast%3DSpecian%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DR.%2BT.%26aulast%3DWeisel%26aufirst%3DM.%26aulast%3DRemiszewski%26aufirst%3DS.%2BW.%26atitle%3DBenzazepinones%2520and%2520benzoxazepinones%2520as%2520antagonists%2520of%2520inhibitor%2520of%2520apoptosis%2520proteins%2520%2528IAPs%2529%2520selective%2520for%2520the%2520second%2520baculovirus%2520IAP%2520repeat%2520%2528BIR2%2529%2520domain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7772%26epage%3D7787%26doi%3D10.1021%2Fjm400731m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kester, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnell, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiszewski, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moliterni, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michoud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupert, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mischke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukacs, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fretland, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polonskaia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solis, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tardell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvorozniak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutt, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggin, B.</span></span> <span> </span><span class="NLM_article-title">Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7788</span>– <span class="NLM_lpage">7803</span>, <span class="refDoi"> DOI: 10.1021/jm400732v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400732v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOjur3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7788-7803&author=R.+F.+Kesterauthor=A.+F.+Donnellauthor=Y.+Louauthor=S.+W.+Remiszewskiauthor=L.+J.+Lombardoauthor=S.+Chenauthor=N.+T.+Leauthor=J.+Loauthor=J.+A.+Moliterniauthor=X.+Hanauthor=J.+H.+Hoggauthor=W.+Liangauthor=C.+Michoudauthor=K.+C.+Rupertauthor=S.+Mischkeauthor=K.+Leauthor=M.+Weiselauthor=C.+A.+Jansonauthor=C.+M.+Lukacsauthor=A.+J.+Fretlandauthor=K.+Hongauthor=A.+Polonskaiaauthor=L.+Gaoauthor=S.+Liauthor=D.+S.+Solisauthor=D.+Aguilarauthor=C.+Tardellauthor=M.+Dvorozniakauthor=S.+Tannuauthor=E.+C.+Leeauthor=A.+D.+Schuttauthor=B.+Goggin&title=Optimization+of+benzodiazepinones+as+selective+inhibitors+of+the+X-linked+inhibitor+of+apoptosis+protein+%28XIAP%29+second+baculovirus+IAP+repeat+%28BIR2%29+domain&doi=10.1021%2Fjm400732v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Benzodiazepinones as Selective Inhibitors of the X-Linked Inhibitor of Apoptosis Protein (XIAP) Second Baculovirus IAP Repeat (BIR2) Domain</span></div><div class="casAuthors">Kester, Robert F.; Donnell, Andrew F.; Lou, Yan; Remiszewski, Stacy W.; Lombardo, Louis J.; Chen, Shaoqing; Le, Nam T.; Lo, Jennifer; Moliterni, John A.; Han, Xiaochun; Hogg, J. Heather; Liang, Weiling; Michoud, Christophe; Rupert, Kenneth C.; Mischke, Steven; Le, Kang; Weisel, Martin; Janson, Cheryl A.; Lukacs, Christine M.; Fretland, Adrian J.; Hong, Kyoungja; Polonskaia, Ann; Gao, Lin; Li, Shirley; Solis, Dave S.; Aguilar, Doug; Tardell, Christine; Dvorozniak, Mark; Tannu, Shahid; Lee, Edmund C.; Schutt, Andy D.; Goggin, Barry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7788-7803</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The IAPs are key regulators of the apoptotic pathways and are commonly overexpressed in many cancer cells.  IAPs contain one to three BIR domains that are crucial for their inhibitory function.  The pro-survival properties of XIAP come from binding of the BIR domains to the pro-apoptotic caspases.  The BIR3 domain of XIAP binds and inhibits caspase 9, while the BIR2 domain binds and inhibits the terminal caspases 3 and 7.  While XIAP BIR3 inhibitors have previously been reported, they also inhibit cIAP1/2 and promote the release of TNFα, potentially limiting their therapeutic utility.  This paper will focus on the optimization of selective XIAP BIR2 inhibitors leading to the discovery of highly potent benzodiazepinone 36 (IC50 = 45 nM), which has high levels of selectivity over XIAP BIR3 and cIAP1 BIR2/3 and shows efficacy in a xenograft pharmacodynamic model monitoring caspase activity while not promoting the release of TNFα in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGkZy4tzatPrVg90H21EOLACvtfcHk0lg_Z-szK8rWKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOjur3M&md5=5260aeb14bf75a3754bd1720c2512a8a</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm400732v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400732v%26sid%3Dliteratum%253Aachs%26aulast%3DKester%26aufirst%3DR.%2BF.%26aulast%3DDonnell%26aufirst%3DA.%2BF.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DRemiszewski%26aufirst%3DS.%2BW.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLe%26aufirst%3DN.%2BT.%26aulast%3DLo%26aufirst%3DJ.%26aulast%3DMoliterni%26aufirst%3DJ.%2BA.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DHogg%26aufirst%3DJ.%2BH.%26aulast%3DLiang%26aufirst%3DW.%26aulast%3DMichoud%26aufirst%3DC.%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DMischke%26aufirst%3DS.%26aulast%3DLe%26aufirst%3DK.%26aulast%3DWeisel%26aufirst%3DM.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DLukacs%26aufirst%3DC.%2BM.%26aulast%3DFretland%26aufirst%3DA.%2BJ.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DPolonskaia%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DSolis%26aufirst%3DD.%2BS.%26aulast%3DAguilar%26aufirst%3DD.%26aulast%3DTardell%26aufirst%3DC.%26aulast%3DDvorozniak%26aufirst%3DM.%26aulast%3DTannu%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DE.%2BC.%26aulast%3DSchutt%26aufirst%3DA.%2BD.%26aulast%3DGoggin%26aufirst%3DB.%26atitle%3DOptimization%2520of%2520benzodiazepinones%2520as%2520selective%2520inhibitors%2520of%2520the%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528XIAP%2529%2520second%2520baculovirus%2520IAP%2520repeat%2520%2528BIR2%2529%2520domain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7788%26epage%3D7803%26doi%3D10.1021%2Fjm400732v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lukacs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belunis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowther, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danho, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiszewski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamath, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span> <span> </span><span class="NLM_article-title">The structure of XIAP BIR2: understanding the selectivity of the BIR domains</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1717</span>– <span class="NLM_lpage">1725</span>, <span class="refDoi"> DOI: 10.1107/S0907444913016284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1107%2FS0907444913016284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=23999295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlKrsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1717-1725&author=C.+Lukacsauthor=C.+Belunisauthor=R.+Crowtherauthor=W.+Danhoauthor=L.+Gaoauthor=B.+Gogginauthor=C.+A.+Jansonauthor=S.+Liauthor=S.+Remiszewskiauthor=A.+Schuttauthor=M.+K.+Thakurauthor=S.+K.+Singhauthor=S.+Swaminathanauthor=R.+Pandeyauthor=R.+Tyagiauthor=R.+Gosuauthor=A.+V.+Kamathauthor=A.+Kuglstatter&title=The+structure+of+XIAP+BIR2%3A+understanding+the+selectivity+of+the+BIR+domains&doi=10.1107%2FS0907444913016284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of XIAP BIR2: understanding the selectivity of the BIR domains</span></div><div class="casAuthors">Lukacs, Christine; Belunis, Charles; Crowther, Robert; Danho, Waleed; Gao, Lin; Goggin, Barry; Janson, Cheryl A.; Li, Shirley; Remiszewski, Stacy; Schutt, Andrew; Thakur, Manish K.; Singh, Saroj K.; Swaminathan, Srinivasan; Pandey, Rajat; Tyagi, Rajiv; Gosu, Ramachandraiah; Kamath, Ajith V.; Kuglstatter, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1717-1725</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">XIAP, a member of the inhibitor of apoptosis family of proteins, is a crit. regulator of apoptosis.  Inhibition of the BIR domain-caspase interaction is a promising approach towards treating cancer.  Previous work has been directed towards inhibiting the BIR3-caspase-9 interaction, which blocks the intrinsic apoptotic pathway; selectively inhibiting the BIR2-caspase-3 interaction would also block the extrinsic pathway.  The BIR2 domain of XIAP has successfully been crystd.; peptides and small-mol. inhibitors can be soaked into these crystals, which diffract to high resoln.  Here, the BIR2 apo crystal structure and the structures of five BIR2-tetrapeptide complexes are described.  The structural flexibility obsd. on comparing these structures, along with a comparison with XIAP BIR3, affords an understanding of the structural elements that drive selectivity between BIR2 and BIR3 and which can be used to design BIR2-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6-upk5-drzbVg90H21EOLACvtfcHk0ljK3xsbAPJ_Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlKrsLnK&md5=deebf6694f2e53929d7c6ec4e763cf14</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1107%2FS0907444913016284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913016284%26sid%3Dliteratum%253Aachs%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DBelunis%26aufirst%3DC.%26aulast%3DCrowther%26aufirst%3DR.%26aulast%3DDanho%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DGoggin%26aufirst%3DB.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DRemiszewski%26aufirst%3DS.%26aulast%3DSchutt%26aufirst%3DA.%26aulast%3DThakur%26aufirst%3DM.%2BK.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DPandey%26aufirst%3DR.%26aulast%3DTyagi%26aufirst%3DR.%26aulast%3DGosu%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%2BV.%26aulast%3DKuglstatter%26aufirst%3DA.%26atitle%3DThe%2520structure%2520of%2520XIAP%2520BIR2%253A%2520understanding%2520the%2520selectivity%2520of%2520the%2520BIR%2520domains%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1717%26epage%3D1725%26doi%3D10.1107%2FS0907444913016284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Interaction of a cyclic, bivalent SMAC mimetic with the x-linked inhibitor of apoptosis protein</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">9811</span>– <span class="NLM_lpage">9824</span>, <span class="refDoi"> DOI: 10.1021/bi800785y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi800785y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=9811-9824&author=Z.+Nikolovska-Coleskaauthor=J.+L.+Meagherauthor=S.+Jiangauthor=C.+Y.+Yangauthor=S.+Qiuauthor=P.+P.+Rollerauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Interaction+of+a+cyclic%2C+bivalent+SMAC+mimetic+with+the+x-linked+inhibitor+of+apoptosis+protein&doi=10.1021%2Fbi800785y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of a Cyclic, Bivalent Smac Mimetic with the X-Linked Inhibitor of Apoptosis Protein</span></div><div class="casAuthors">Nikolovska-Coleska, Zaneta; Meagher, Jennifer L.; Jiang, Sheng; Yang, Chao-Yie; Qiu, Su; Roller, Peter P.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">9811-9824</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed and synthesized a cyclic, bivalent Smac mimetic (compd. 3) and characterized its interaction with the X-linked inhibitor of apoptosis protein (XIAP).  Compd. 3 binds to XIAP contg. both BIR2 and BIR3 domains with a biphasic dose-response curve representing two binding sites with IC50 values of 0.5 and 406 nM, resp.  Compd. 3 binds to XIAPs contg. the BIR3-only and BIR2-only domain with Ki values of 4 nM and 4.4 μM, resp.  Gel filtration expts. using wild-type and mutated XIAPs showed that 3 forms a 1:2 stoichiometric complex with XIAP contg. the BIR3-only domain.  However, it forms a 1:1 stoichiometric complex with XIAP contg. both BIR2 and BIR3 domains, and both BIR domains are involved in the binding.  Compd. 3 efficiently antagonizes inhibition of XIAP in a cell-free functional assay and is >200 times more potent than its corresponding monovalent compd. 2.  Detn. of the crystal structure of 3 in complex with the XIAP BIR3 domain confirms that 3 induces homodimerization of the XIAP BIR3 domain and provides a structural basis for the cooperative binding of one mol. of compd. 3 to two XIAP BIR3 mols.  On the basis of this crystal structure, a binding model of XIAP contg. both BIR2 and BIR3 domains and 3 was constructed, which sheds light on the ability of 3 to relieve the inhibition of XIAP with not only caspase-9 but also caspase-3/-7.  Compd. 3 is cell-permeable, effectively activates caspases in whole cells, and potently inhibits cancer cell growth.  Compd. 3 is a useful biochem. and pharmacol. tool for further elucidating the role of XIAP in regulation of apoptosis and represents a promising lead compd. for the design of potent, cell-permeable Smac mimetics for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSEyxJPGLGNLVg90H21EOLACvtfcHk0ljK3xsbAPJ_Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmu7vK&md5=e4bc922befd427c343f908017286d6f7</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fbi800785y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi800785y%26sid%3Dliteratum%253Aachs%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DInteraction%2520of%2520a%2520cyclic%252C%2520bivalent%2520SMAC%2520mimetic%2520with%2520the%2520x-linked%2520inhibitor%2520of%2520apoptosis%2520protein%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D9811%26epage%3D9824%26doi%3D10.1021%2Fbi800785y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Cyclopeptide SMAC mimetics as antagonists of IAP proteins</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3043</span>– <span class="NLM_lpage">3046</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.bmcl.2010.03.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=20443226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFGnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3043-3046&author=H.+Sunauthor=L.+Liuauthor=J.+Luauthor=S.+Qiuauthor=C.+Y.+Yangauthor=H.+Yiauthor=S.+Wang&title=Cyclopeptide+SMAC+mimetics+as+antagonists+of+IAP+proteins&doi=10.1016%2Fj.bmcl.2010.03.114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclopeptide Smac mimetics as antagonists of IAP proteins</span></div><div class="casAuthors">Sun, Haiying; Liu, Liu; Lu, Jianfeng; Qiu, Su; Yang, Chao-Yie; Yi, Han; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3043-3046</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two cyclopeptidic Smac mimetics (I) (R1 = Ph and CH2Ph) were designed and synthesized.  These two compds. bind to XIAP and cIAP-1/2 with low nanomolar affinities, and restore the activities of caspase-9 and caspase-3/-7 inhibited by XIAP.  Compd. I (R1 = Ph) potently inhibits cancer cell growth and is 5-8 times more potent than the initial lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbEjNhyQ7ZgbVg90H21EOLACvtfcHk0ljK3xsbAPJ_Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFGnsrs%253D&md5=e32ead150e03ba70be0c41ecd82fa6e7</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.114%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DCyclopeptide%2520SMAC%2520mimetics%2520as%2520antagonists%2520of%2520IAP%2520proteins%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3043%26epage%3D3046%26doi%3D10.1016%2Fj.bmcl.2010.03.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seigal, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connors, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuel, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fargnoli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naglich, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokross, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbott, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrett, N. K.</span></span> <span> </span><span class="NLM_article-title">The discovery of macrocyclic XIAP antagonists from a DNA-programmed chemistry library, and their optimization to give lead compounds with in vivo antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2855</span>– <span class="NLM_lpage">2861</span>, <span class="refDoi"> DOI: 10.1021/jm501892g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501892g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivF2qu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2855-2861&author=B.+A.+Seigalauthor=W.+H.+Connorsauthor=A.+Fraleyauthor=R.+M.+Borzilleriauthor=P.+H.+Carterauthor=S.+L.+Emanuelauthor=J.+Fargnoliauthor=K.+Kimauthor=M.+Leiauthor=J.+G.+Naglichauthor=M.+E.+Pokrossauthor=S.+L.+Posyauthor=H.+Shenauthor=N.+Surtiauthor=R.+Talbottauthor=Y.+Zhangauthor=N.+K.+Terrett&title=The+discovery+of+macrocyclic+XIAP+antagonists+from+a+DNA-programmed+chemistry+library%2C+and+their+optimization+to+give+lead+compounds+with+in+vivo+antitumor+activity&doi=10.1021%2Fjm501892g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of Macrocyclic XIAP Antagonists from a DNA-Programmed Chemistry Library, and Their Optimization To Give Lead Compounds with in Vivo Antitumor Activity</span></div><div class="casAuthors">Seigal, Benjamin A.; Connors, William H.; Fraley, Andrew; Borzilleri, Robert M.; Carter, Percy H.; Emanuel, Stuart L.; Fargnoli, Joseph; Kim, Kyoung; Lei, Ming; Naglich, Joseph G.; Pokross, Matthew E.; Posy, Shana L.; Shen, Henry; Surti, Neha; Talbott, Randy; Zhang, Yong; Terrett, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2855-2861</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Affinity selection screening of macrocycle libraries derived from DNA-programmed chem. identified XIAP BIR2 and BIR3 domain inhibitors that displace bound pro-apoptotic caspases.  X-ray cocrystal structures of key compds. with XIAP BIR2 suggested potency-enhancing structural modifications.  Optimization of dimeric macrocycles with similar affinity for both domains were potent pro-apoptotic agents in cancer cell lines and efficacious in shrinking tumors in a mouse xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlB6i1KOFJjrVg90H21EOLACvtfcHk0lgiVESUyAkiYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivF2qu78%253D&md5=9bd53cc3ed014796248e8048cecea0d1</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm501892g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501892g%26sid%3Dliteratum%253Aachs%26aulast%3DSeigal%26aufirst%3DB.%2BA.%26aulast%3DConnors%26aufirst%3DW.%2BH.%26aulast%3DFraley%26aufirst%3DA.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DEmanuel%26aufirst%3DS.%2BL.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DNaglich%26aufirst%3DJ.%2BG.%26aulast%3DPokross%26aufirst%3DM.%2BE.%26aulast%3DPosy%26aufirst%3DS.%2BL.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DSurti%26aufirst%3DN.%26aulast%3DTalbott%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTerrett%26aufirst%3DN.%2BK.%26atitle%3DThe%2520discovery%2520of%2520macrocyclic%2520XIAP%2520antagonists%2520from%2520a%2520DNA-programmed%2520chemistry%2520library%252C%2520and%2520their%2520optimization%2520to%2520give%2520lead%2520compounds%2520with%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2855%26epage%3D2861%26doi%3D10.1021%2Fjm501892g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seigal, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrett, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbott, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fargnoli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naglich, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuppugalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vite, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, R. M.</span></span> <span> </span><span class="NLM_article-title">Dimeric macrocyclic antagonists of inhibitor of apoptosis proteins for the treatment of cancer</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">770</span>– <span class="NLM_lpage">775</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00091</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00091" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVGlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=770-775&author=Y.+Zhangauthor=B.+A.+Seigalauthor=N.+K.+Terrettauthor=R.+L.+Talbottauthor=J.+Fargnoliauthor=J.+G.+Naglichauthor=C.+Chaudhryauthor=S.+L.+Posyauthor=R.+Vuppugallaauthor=G.+Corneliusauthor=M.+Leiauthor=C.+Wangauthor=Y.+Zhangauthor=R.+J.+Schmidtauthor=D.+D.+Weiauthor=M.+M.+Millerauthor=M.+P.+Allenauthor=L.+Liauthor=P.+H.+Carterauthor=G.+D.+Viteauthor=R.+M.+Borzilleri&title=Dimeric+macrocyclic+antagonists+of+inhibitor+of+apoptosis+proteins+for+the+treatment+of+cancer&doi=10.1021%2Facsmedchemlett.5b00091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Dimeric Macrocyclic Antagonists of Inhibitor of Apoptosis Proteins for the Treatment of Cancer</span></div><div class="casAuthors">Zhang, Yong; Seigal, Benjamin A.; Terrett, Nicholas K.; Talbott, Randy L.; Fargnoli, Joseph; Naglich, Joseph G.; Chaudhry, Charu; Posy, Shana L.; Vuppugalla, Ragini; Cornelius, Georgia; Lei, Ming; Wang, Chunlei; Zhang, Yingru; Schmidt, Robert J.; Wei, Donna D.; Miller, Michael M.; Allen, Martin P.; Li, Ling; Carter, Percy H.; Vite, Gregory D.; Borzilleri, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">770-775</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of dimeric macrocyclic compds. were prepd. and evaluated as antagonists for inhibitor of apoptosis proteins.  The most potent analog I, which binds to XIAP and c-IAP proteins with high affinity and induces caspase-3 activation and ultimately cell apoptosis, inhibits growth of human melanoma and colorectal cell lines at low nanomolar concns.  Furthermore, compd. I demonstrated significant antitumor activity in the A875 human melanoma xenograft model at doses as low as 2 mg/kg on a q3d schedule.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBzbs9VSlJ47Vg90H21EOLACvtfcHk0lgiVESUyAkiYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVGlsLs%253D&md5=0e734d3be3ee9f36d4d3f0f10686b978</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00091%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSeigal%26aufirst%3DB.%2BA.%26aulast%3DTerrett%26aufirst%3DN.%2BK.%26aulast%3DTalbott%26aufirst%3DR.%2BL.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DNaglich%26aufirst%3DJ.%2BG.%26aulast%3DChaudhry%26aufirst%3DC.%26aulast%3DPosy%26aufirst%3DS.%2BL.%26aulast%3DVuppugalla%26aufirst%3DR.%26aulast%3DCornelius%26aufirst%3DG.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSchmidt%26aufirst%3DR.%2BJ.%26aulast%3DWei%26aufirst%3DD.%2BD.%26aulast%3DMiller%26aufirst%3DM.%2BM.%26aulast%3DAllen%26aufirst%3DM.%2BP.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DVite%26aufirst%3DG.%2BD.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDimeric%2520macrocyclic%2520antagonists%2520of%2520inhibitor%2520of%2520apoptosis%2520proteins%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D770%26epage%3D775%26doi%3D10.1021%2Facsmedchemlett.5b00091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span>U.S.
National Library of Medicine. Clinicaltrials.gov. <a href="https://www.clinicaltrials.gov/" class="extLink">https://www.clinicaltrials.gov/</a> (accessed Oct 15, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=U.S.%0ANational+Library+of+Medicine.+Clinicaltrials.gov.+https%3A%2F%2Fwww.clinicaltrials.gov%2F+%28accessed+Oct+15%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amaravadi, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilder, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adjei, A. A.</span></span> <span> </span><span class="NLM_article-title">A phase I study of the SMAC-mimetic birinapant in adults with refractory solid tumors or lymphoma</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2569</span>– <span class="NLM_lpage">2575</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-15-0475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1535-7163.MCT-15-0475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=26333381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOgt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=2569-2575&author=R.+K.+Amaravadiauthor=R.+J.+Schilderauthor=L.+P.+Martinauthor=M.+Levinauthor=M.+A.+Grahamauthor=D.+E.+Wengauthor=A.+A.+Adjei&title=A+phase+I+study+of+the+SMAC-mimetic+birinapant+in+adults+with+refractory+solid+tumors+or+lymphoma&doi=10.1158%2F1535-7163.MCT-15-0475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma</span></div><div class="casAuthors">Amaravadi, Ravi K.; Schilder, Russell J.; Martin, Lainie P.; Levin, Myron; Graham, Martin A.; Weng, David E.; Adjei, Alex A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2569-2575</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) family of antiapoptotic proteins has been identified as a target for small mol. inhibitors in cancer.  Second mitochondrial-derived activator of caspases (SMAC) efficiently and naturally antagonizes IAPs, and preclin. studies have detd. that SMAC mimetics have potent anticancer properties.  Here, we report a first-in-human trial designed to det. the max. tolerated dose (MTD), safety, and pharmacokinetics/pharmacodynamics (PK/PD) of birinapant, a novel SMAC mimetic.  Patients with advanced solid tumors or lymphoma were enrolled in a 3+3 dose escalation design with birinapant administered i.v. from 0.18 to 63 mg/m2 once weekly every 3 of 4 wk.  Fifty patients were enrolled to 12 dose cohorts.  Birinapant 47 mg/m2 was detd. to be the MTD.  At 63 mg/m2, dose-limiting toxicities included headache, nausea, and vomiting.  Two cases of Bell's palsy (grade 2) also occurred at 63 mg/m2.  Birinapant had a plasma half-life of 30 to 35 h and accumulated in tumor tissue.  Birinapant suppressed cIAP1 and increased apoptosis in peripheral blood mononuclear cells and tumor tissue.  Prolonged stable disease was obsd. in 3 patients: non-small cell lung cancer (5 mo), colorectal cancer (5 mo), and liposarcoma (9 mo).  Two patients with colorectal cancer had radiog. evidence of tumor shrinkage.  In conclusion, birinapant was well tolerated with an MTD of 47 mg/m2 and exhibited favorable PK and PD properties.  Several patients demonstrated stable disease and evidence of antitumor activity.  These results support the ongoing clin. trials of birinapant in patients with cancer.  Mol Cancer Ther; 14(11); 2569-75. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5J9EHx3GGObVg90H21EOLACvtfcHk0lgXX0gSqVHtZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOgt7zI&md5=f40e5be7890545adbe2ff475a8d43d1d</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0475%26sid%3Dliteratum%253Aachs%26aulast%3DAmaravadi%26aufirst%3DR.%2BK.%26aulast%3DSchilder%26aufirst%3DR.%2BJ.%26aulast%3DMartin%26aufirst%3DL.%2BP.%26aulast%3DLevin%26aufirst%3DM.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DWeng%26aufirst%3DD.%2BE.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520the%2520SMAC-mimetic%2520birinapant%2520in%2520adults%2520with%2520refractory%2520solid%2520tumors%2520or%2520lymphoma%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D2569%26epage%3D2575%26doi%3D10.1158%2F1535-7163.MCT-15-0475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noonan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunch, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, C.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takebe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinders, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annunziata, C. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer</span>. <i>Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">588</span>– <span class="NLM_lpage">597</span>, <span class="refDoi"> DOI: 10.1002/cncr.29783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1002%2Fcncr.29783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=26566079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XitF2kurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2016&pages=588-597&author=A.+M.+Noonanauthor=K.+P.+Bunchauthor=J.+Q.+Chenauthor=M.+A.+Herrmannauthor=J.+M.+Leeauthor=E.+C.+Kohnauthor=C.%0AC.+O%E2%80%99Sullivanauthor=E.+Jordanauthor=N.+Houstonauthor=N.+Takebeauthor=R.+J.+Kindersauthor=L.+Caoauthor=C.+J.+Peerauthor=W.+D.+Figgauthor=C.+M.+Annunziata&title=Pharmacodynamic+markers+and+clinical+results+from+the+phase+2+study+of+the+SMAC+mimetic+birinapant+in+women+with+relapsed+platinum-resistant+or+-refractory+epithelial+ovarian+cancer&doi=10.1002%2Fcncr.29783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer</span></div><div class="casAuthors">Noonan, Anne M.; Bunch, Kristen P.; Chen, Jin-Qiu; Herrmann, Michelle A.; Lee, Jung-Min; Kohn, Elise C.; O'Sullivan, Ciara C.; Jordan, Elizabeth; Houston, Nicole; Takebe, Naoko; Kinders, Robert J.; Cao, Liang; Peer, Cody J.; Figg, W. Douglas; Annunziata, Christina M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">588-597</span>CODEN:
                <span class="NLM_cas:coden">CANCAR</span>;
        ISSN:<span class="NLM_cas:issn">0008-543X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">BACKGROUND : Inhibitors of apoptosis proteins (IAPs) are key regulators of apoptosis and are frequently dysregulated in ovarian cancer.  It was hypothesized that blocking IAPs with birinapant would increase tumor cell death and result in objective responses for women with platinum-refractory and -resistant ovarian cancer.  METHODS : In this phase 2, Cancer Therapy Evaluation Program-sponsored study, patients received birinapant at 47 mg/m2 on days 1, 8, and 15 of 28-day cycles.  Pharmacokinetics were obtained during cycle 1.  Plasma, peripheral blood mononuclear cells (PBMCs), and percutaneous tumor biopsy samples were collected before cycle 1 and after 6 wk.  The primary endpoint was an objective response or progression-free survival lasting greater than 6 mo in a mini-max design.  RESULTS : Eleven patients received birinapant; after this, accrual was terminated for lack of a clin. benefit.  Birinapant was well tolerated, with predominantly grade 2 adverse events and 1 case of grade 3 lymphopenia.  Pretreatment biopsy samples and PBMCs were collected; paired posttreatment biopsy samples and PBMCs were collected from 7 and 10 patients, resp.  There was consistent downregulation of cellular inhibitor of apoptosis protein 1 in tumors (P = .016) and PBMCs (P < .01).  Procaspase 3 also decreased in tumors (P = .031) and PBMCs (P < .01); cleaved caspase 3 colocalized with H2A histone family member X (γ-H2AX) in tumors after birinapant exposure.  Peripheral T and B cells decreased significantly after treatment, but natural killer cells did not (P = .04, P = .05, and P = .43, resp.).  CONCLUSIONS : Birinapant shows consistent target suppression in vivo without single-agent antitumor activity in this small population.  Single-agent pharmacodynamics are necessary to understand the drug's mechanism of action and set the stage for rational combination therapy.  Preclin. studies are ongoing to identify optimal synergistic combinations for future clin. trials.  Cancer 2016;122:588-597. © 2015 American Cancer Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHWiFa-PLcgbVg90H21EOLACvtfcHk0lgXX0gSqVHtZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitF2kurg%253D&md5=2fa896daa52417c39dcda0e3b6d5aeed</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fcncr.29783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcncr.29783%26sid%3Dliteratum%253Aachs%26aulast%3DNoonan%26aufirst%3DA.%2BM.%26aulast%3DBunch%26aufirst%3DK.%2BP.%26aulast%3DChen%26aufirst%3DJ.%2BQ.%26aulast%3DHerrmann%26aufirst%3DM.%2BA.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DKohn%26aufirst%3DE.%2BC.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DC.%2BC.%26aulast%3DJordan%26aufirst%3DE.%26aulast%3DHouston%26aufirst%3DN.%26aulast%3DTakebe%26aufirst%3DN.%26aulast%3DKinders%26aufirst%3DR.%2BJ.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DPeer%26aufirst%3DC.%2BJ.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DAnnunziata%26aufirst%3DC.%2BM.%26atitle%3DPharmacodynamic%2520markers%2520and%2520clinical%2520results%2520from%2520the%2520phase%25202%2520study%2520of%2520the%2520SMAC%2520mimetic%2520birinapant%2520in%2520women%2520with%2520relapsed%2520platinum-resistant%2520or%2520-refractory%2520epithelial%2520ovarian%2520cancer%26jtitle%3DCancer%26date%3D2016%26volume%3D122%26spage%3D588%26epage%3D597%26doi%3D10.1002%2Fcncr.29783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Q. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Y. X.</span></span> <span> </span><span class="NLM_article-title">A novel SMAC mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.canlet.2016.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27424523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFyms7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2016&pages=14-22&author=N.+Liauthor=L.+Fengauthor=H.+Q.+Hanauthor=J.+Yuanauthor=X.+K.+Qiauthor=Y.+F.+Lianauthor=B.+H.+Kuangauthor=Y.+C.+Zhangauthor=C.+C.+Dengauthor=H.+J.+Zhangauthor=Y.+Y.+Yaoauthor=M.+Xuauthor=G.+P.+Heauthor=B.+C.+Zhaoauthor=L.+Gaoauthor=Q.+S.+Fengauthor=L.+Z.+Chenauthor=L.+Yangauthor=D.+Yangauthor=Y.+X.+Zeng&title=A+novel+SMAC+mimetic+APG-1387+demonstrates+potent+antitumor+activity+in+nasopharyngeal+carcinoma+cells+by+inducing+apoptosis&doi=10.1016%2Fj.canlet.2016.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis</span></div><div class="casAuthors">Li, Ning; Feng, Lin; Han, Hui-Qiong; Yuan, Jing; Qi, Xue-Kang; Lian, Yi-Fan; Kuang, Bo-Hua; Zhang, Yu-Chen; Deng, Cheng-Cheng; Zhang, Hao-Jiong; Yao, You-Yuan; Xu, Miao; He, Gui-Ping; Zhao, Bing-Chun; Gao, Ling; Feng, Qi-Sheng; Chen, Li-Zhen; Yang, Lu; Yang, Dajun; Zeng, Yi-Xin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-22</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Despite advances in the development of radiation against nasopharyngeal carcinoma (NPC), the management of advanced NPC remains a challenge.  Smac mimetics are designed to neutralize inhibitor of apoptosis (IAP) proteins, thus reactivating the apoptotic program in cancer cells.  In this study, we investigated the effect of a novel bivalent Smac mimetic APG-1387 in NPC.  In vitro, APG-1387 in combination with TNF-α potently decreased NPC cell viability by inducing apoptosis in majority of NPC cell lines.  The in vitro antitumor effect was RIPK1-dependent, whereas it was independent on IAPs, USP11, or EBV.  Of note, the inhibition of NF-κB or AKT pathway rendered resistant NPC cells responsive to the treatment of APG-1387/TNF-α.  In vivo, APG-1387 displayed antitumor activity as a single agent at well-tolerated doses, even in an in vitro resistant cell line.  In summary, our results demonstrate that APG-1387 exerts a potent antitumor effect on NPC.  These findings support clin. evaluation of APG-1387 as a potential treatment for advanced NPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxgw98S18Ux7Vg90H21EOLACvtfcHk0lgXX0gSqVHtZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFyms7zJ&md5=06a99be3d888ddacea48da463055e625</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DH.%2BQ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DQi%26aufirst%3DX.%2BK.%26aulast%3DLian%26aufirst%3DY.%2BF.%26aulast%3DKuang%26aufirst%3DB.%2BH.%26aulast%3DZhang%26aufirst%3DY.%2BC.%26aulast%3DDeng%26aufirst%3DC.%2BC.%26aulast%3DZhang%26aufirst%3DH.%2BJ.%26aulast%3DYao%26aufirst%3DY.%2BY.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DG.%2BP.%26aulast%3DZhao%26aufirst%3DB.%2BC.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DQ.%2BS.%26aulast%3DChen%26aufirst%3DL.%2BZ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DZeng%26aufirst%3DY.%2BX.%26atitle%3DA%2520novel%2520SMAC%2520mimetic%2520APG-1387%2520demonstrates%2520potent%2520antitumor%2520activity%2520in%2520nasopharyngeal%2520carcinoma%2520cells%2520by%2520inducing%2520apoptosis%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D381%26spage%3D14%26epage%3D22%26doi%3D10.1016%2Fj.canlet.2016.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D. J.</span></span> <span> </span><span class="NLM_article-title">A novel SMAC mimetic APG-1387 exhibits dual antitumor effect on HBV-positive hepatocellular carcinoma with high expression of cIAP2 by inducing apoptosis and enhancing innate anti-tumor immunity</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2018.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.bcp.2018.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=29679556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotlGjsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2018&pages=127-135&author=W.+Panauthor=Q.+Luoauthor=X.+Yanauthor=L.+Yuanauthor=H.+Yiauthor=L.+Zhangauthor=B.+Liauthor=Y.+Zhangauthor=J.+Sunauthor=M.+Z.+Qiuauthor=D.+J.+Yang&title=A+novel+SMAC+mimetic+APG-1387+exhibits+dual+antitumor+effect+on+HBV-positive+hepatocellular+carcinoma+with+high+expression+of+cIAP2+by+inducing+apoptosis+and+enhancing+innate+anti-tumor+immunity&doi=10.1016%2Fj.bcp.2018.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">A novel SMAC mimetic APG-1387 exhibits dual antitumor effect on HBV-positive hepatocellular carcinoma with high expression of cIAP2 by inducing apoptosis and enhancing innate anti-tumor immunity</span></div><div class="casAuthors">Pan, Wentao; Luo, Qiuyun; Yan, Xianglei; Yuan, Luping; Yi, Hanjie; Zhang, Lin; Li, Baoxia; Zhang, Yuxin; Sun, Jian; Qiu, Miao-Zhen; Yang, Da-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-135</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Check point inhibitor anti-PD1 antibody produced some efficacy in Hepatocellular Carcinoma (HCC) patients previously treated with sorafenib.  Unfortunately, HCC patients with hepatitis B virus (HBV) infection did not respond as well as uninfected patients.  Previously, Second mitochondria-derived activator of caspases (SMAC) mimetics-the antagonist for inhibitor of apoptosis proteins (IAPs) can rapidly reduce serum hepatitis B virus DNA in animal model.  APG-1387 is a novel SMAC-mimetic, small mol. inhibitor targeting inhibitor of apoptosis proteins (IAPs).  In our study, firstly, we found that HCC patients with copy no. alteration of cIAP1, cIAP2, and XIAP had a dismal prognosis.  Then, we discovered that APG-1387 alone could induce apoptosis of PLC/PRF/5 which was HBV pos. both in-vitro and in-vivo.  Furthermore, we found that APG-1387 significantly up-regulated the expression of calreticulin and HLA-DR in PLC/PRF/5 via activating non-classic NF-κB pathway.  Also, compared to vehicle group, APG-1387 increased NK cell counts by 5 folds in PLC/PRF/5 xenograft model.  In-vitro, APG-1387 pos. regulated T cells by reducing Treg differentiation and down-regulating PD1 expression in CD4 T cell.  Moreover, APG-1387 had no impact on memory T cells.  Consequently, our results suggest that APG1387 could be a good candidate to combine with anti-PD1 antibody treatment to overcome low responds of check point inhibitors in HBV pos. HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdnVcQu-xYbbVg90H21EOLACvtfcHk0lj6uUJ_3rjKjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotlGjsLk%253D&md5=0f3fa0b8ddaa67243bb3b0c8be88b7f7</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2018.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2018.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DM.%2BZ.%26aulast%3DYang%26aufirst%3DD.%2BJ.%26atitle%3DA%2520novel%2520SMAC%2520mimetic%2520APG-1387%2520exhibits%2520dual%2520antitumor%2520effect%2520on%2520HBV-positive%2520hepatocellular%2520carcinoma%2520with%2520high%2520expression%2520of%2520cIAP2%2520by%2520inducing%2520apoptosis%2520and%2520enhancing%2520innate%2520anti-tumor%2520immunity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D154%26spage%3D127%26epage%3D135%26doi%3D10.1016%2Fj.bcp.2018.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sikic, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallant, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camidge, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colevas, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messersmith, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakelee, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminker, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J. R.</span></span> <span> </span><span class="NLM_article-title">Safety, pharmacokinetics (PK), and pharmacodynamics (PD) of HGS1029, an inhibitor of apoptosis protein (IAP) inhibitor, in patients (Pts) with advanced solid tumors: Results of a phase I study</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">3008</span>– <span class="NLM_lpage">3008</span>, <span class="refDoi"> DOI: 10.1200/jco.2011.29.15_suppl.3008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1200%2Fjco.2011.29.15_suppl.3008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21709188" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=3008-3008&author=B.+I.+Sikicauthor=S.+G.+Eckhardtauthor=G.+Gallantauthor=H.+A.+Burrisauthor=D.+R.+Camidgeauthor=A.+D.+Colevasauthor=S.+F.+Jonesauthor=W.+A.+Messersmithauthor=H.+A.+Wakeleeauthor=H.+Liauthor=P.+G.+Kaminkerauthor=S.+Morrisauthor=J.+R.+Infante&title=Safety%2C+pharmacokinetics+%28PK%29%2C+and+pharmacodynamics+%28PD%29+of+HGS1029%2C+an+inhibitor+of+apoptosis+protein+%28IAP%29+inhibitor%2C+in+patients+%28Pts%29+with+advanced+solid+tumors%3A+Results+of+a+phase+I+study&doi=10.1200%2Fjco.2011.29.15_suppl.3008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1200%2Fjco.2011.29.15_suppl.3008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252Fjco.2011.29.15_suppl.3008%26sid%3Dliteratum%253Aachs%26aulast%3DSikic%26aufirst%3DB.%2BI.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DGallant%26aufirst%3DG.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DCamidge%26aufirst%3DD.%2BR.%26aulast%3DColevas%26aufirst%3DA.%2BD.%26aulast%3DJones%26aufirst%3DS.%2BF.%26aulast%3DMessersmith%26aufirst%3DW.%2BA.%26aulast%3DWakelee%26aufirst%3DH.%2BA.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DKaminker%26aufirst%3DP.%2BG.%26aulast%3DMorris%26aufirst%3DS.%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26atitle%3DSafety%252C%2520pharmacokinetics%2520%2528PK%2529%252C%2520and%2520pharmacodynamics%2520%2528PD%2529%2520of%2520HGS1029%252C%2520an%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528IAP%2529%2520inhibitor%252C%2520in%2520patients%2520%2528Pts%2529%2520with%2520advanced%2520solid%2520tumors%253A%2520Results%2520of%2520a%2520phase%2520I%2520study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3D3008%26epage%3D3008%26doi%3D10.1200%2Fjco.2011.29.15_suppl.3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Cytochrome C-mediated apoptosis</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.73.011303.073706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1146%2Fannurev.biochem.73.011303.073706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=15189137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslagsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2004&pages=87-106&author=X.+Jiangauthor=X.+Wang&title=Cytochrome+C-mediated+apoptosis&doi=10.1146%2Fannurev.biochem.73.011303.073706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome C-mediated apoptosis</span></div><div class="casAuthors">Jiang, Xuejun; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-106</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Apoptosis, or programmed cell death, is involved in development, elimination of damaged cells, and maintenance of cell homeostasis.  Deregulation of apoptosis may cause diseases, such as cancers, immune diseases, and neurodegenerative disorders.  Apoptosis is executed by a subfamily of cysteine proteases known as caspases.  In mammalian cells, a major caspase activation pathway is the cytochrome c-initiated pathway.  In this pathway, a variety of apoptotic stimuli cause cytochrome c release from mitochondria, which in turn induces a series of biochem. reactions that result in caspase activation and subsequent cell death.  This review focused on the recent progress in understanding the biochem. mechanisms and regulation of the pathway, the roles of the pathway in physiol. and disease, and their potential therapeutic values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaXd15zPESYLVg90H21EOLACvtfcHk0lj6uUJ_3rjKjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslagsrY%253D&md5=a8e668a41a4b4d0994a128019967f28d</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.73.011303.073706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.73.011303.073706%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DCytochrome%2520C-mediated%2520apoptosis%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2004%26volume%3D73%26spage%3D87%26epage%3D106%26doi%3D10.1146%2Fannurev.biochem.73.011303.073706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashkenazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Death receptors: signaling and modulation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">1305</span>– <span class="NLM_lpage">1308</span>, <span class="refDoi"> DOI: 10.1126/science.281.5381.1305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1126%2Fscience.281.5381.1305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=9721089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADyaK1cXlvVegsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=1305-1308&author=A.+Ashkenaziauthor=V.+M.+Dixit&title=Death+receptors%3A+signaling+and+modulation&doi=10.1126%2Fscience.281.5381.1305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Death receptors: Signaling and modulation</span></div><div class="casAuthors">Ashkenazi, Avi; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">5381</span>),
    <span class="NLM_cas:pages">1305-1308</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review, with 61 refs.  Apoptosis is a cell suicide mechanism that enables metazoans to control cell no. in tissues and to eliminate individual cells that threaten the animal's survival.  Certain cells have unique sensors, termed death receptors, on their surface.  Death receptors detect the presence of extracellular death signals and, in response, they rapidly ignite the cell's intrinsic apoptosis machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql5qJid4f9QLVg90H21EOLACvtfcHk0lj1LWWZin-HVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvVegsL0%253D&md5=9bd9f0e6b358e7cfa3b509dec7fbbe8f</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1126%2Fscience.281.5381.1305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.281.5381.1305%26sid%3Dliteratum%253Aachs%26aulast%3DAshkenazi%26aufirst%3DA.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DDeath%2520receptors%253A%2520signaling%2520and%2520modulation%26jtitle%3DScience%26date%3D1998%26volume%3D281%26spage%3D1305%26epage%3D1308%26doi%3D10.1126%2Fscience.281.5381.1305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tchoghandjian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennewein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajalingam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Identification of non-canonical NF-kappaB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e564</span> <span class="refDoi"> DOI: 10.1038/cddis.2013.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fcddis.2013.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=23538445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVykur%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&author=A.+Tchoghandjianauthor=C.+Jenneweinauthor=I.+Eckhardtauthor=K.+Rajalingamauthor=S.+Fulda&title=Identification+of+non-canonical+NF-kappaB+signaling+as+a+critical+mediator+of+Smac+mimetic-stimulated+migration+and+invasion+of+glioblastoma+cells&doi=10.1038%2Fcddis.2013.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells</span></div><div class="casAuthors">Tchoghandjian, A.; Jennewein, C.; Eckhardt, I.; Rajalingam, K.; Fulda, S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">March</span>),
    <span class="NLM_cas:pages">e564</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">As inhibitor of apoptosis (IAP) proteins can regulate addnl. signaling pathways beyond apoptosis, we investigated the effect of the second mitochondrial activator of caspases (Smac) mimetic BV6, which antagonizes IAP proteins, on non-apoptotic functions in glioblastoma (GBM).  Here, we identify non-canonical nuclear factor-κB (NF-κB) signaling and a tumor necrosis factor-α (TNFα)/TNF receptor 1 (TNFR1) autocrine/paracrine loop as crit. mediators of BV6-stimulated migration and invasion of GBM cells.  In addn. to GBM cell lines, BV6 triggers cell elongation, migration and invasion in primary, patient-derived GBM cells at non-toxic concns., which do not affect cell viability or proliferation, and also increases infiltrative tumor growth in vivo underscoring the relevance of these findings.  Mol. studies reveal that BV6 causes rapid degrdn. of cellular IAP proteins, accumulation of NIK, processing of p100 to p52, translocation of p52 into the nucleus, increased NF-κB DNA binding and enhanced NF-κB transcriptional activity.  Electrophoretic mobility shift assay supershift shows that the NF-κB DNA-binding subunits consist of p50, p52 and RelB further confirming the activation of the non-canonical NF-κB pathway.  BV6-stimulated NF-κB activation leads to elevated mRNA levels of TNFα and addnl. NF-κB target genes involved in migration (i.e., interleukin 8, monocyte chemoattractant protein 1, CXC chemokine receptor 4) and invasion (i.e., matrix metalloproteinase-9).  Importantly, inhibition of NF-κB by overexpression of dominant-neg. IκBα superrepressor prevents the BV6-stimulated cell elongation, migration and invasion.  Similarly, specific inhibition of non-canonical NF-κB signaling by RNA interference-mediated silencing of NIK suppresses the BV6-induced cell elongation, migration and invasion as well as upregulation of NF-κB target genes.  Intriguingly, pharmacol. or genetic inhibition of the BV6-stimulated TNFα autocrine/paracrine loop by the TNFα-blocking antibody Enbrel or by knockdown of TNFR1 abrogates BV6-induced cell elongation, migration and invasion.  By demonstrating that the Smac mimetic BV6 at non-toxic concns. promotes migration and invasion of GBM cells via non-canonical NF-κB signaling, our findings have important implications for the use of Smac mimetics as cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrnI_do1XXrbVg90H21EOLACvtfcHk0lj1LWWZin-HVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVykur%252FE&md5=76b270768bd9b2f54644cf5482e788d8</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.70%26sid%3Dliteratum%253Aachs%26aulast%3DTchoghandjian%26aufirst%3DA.%26aulast%3DJennewein%26aufirst%3DC.%26aulast%3DEckhardt%26aufirst%3DI.%26aulast%3DRajalingam%26aufirst%3DK.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520non-canonical%2520NF-kappaB%2520signaling%2520as%2520a%2520critical%2520mediator%2520of%2520Smac%2520mimetic-stimulated%2520migration%2520and%2520invasion%2520of%2520glioblastoma%2520cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26doi%3D10.1038%2Fcddis.2013.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarrant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin-Koh, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dybdal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steigerwalt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamounas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amemiya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dambach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span> <span> </span><span class="NLM_article-title">Toxicity profile of small-molecule IAP antagonist GDC-0152 is linked to TNF-alpha pharmacology</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfs265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1093%2Ftoxsci%2Fkfs265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=22956632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFamsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2013&pages=247-258&author=R.+I.+Ericksonauthor=J.+Tarrantauthor=G.+Cainauthor=S.+C.+Lewin-Kohauthor=N.+Dybdalauthor=H.+Wongauthor=E.+Blackwoodauthor=K.+Westauthor=R.+Steigerwaltauthor=M.+Mamounasauthor=J.+A.+Flygareauthor=K.+Amemiyaauthor=D.+Dambachauthor=W.+J.+Fairbrotherauthor=D.+Diaz&title=Toxicity+profile+of+small-molecule+IAP+antagonist+GDC-0152+is+linked+to+TNF-alpha+pharmacology&doi=10.1093%2Ftoxsci%2Fkfs265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity Profile of Small-Molecule IAP Antagonist GDC-0152 Is Linked to TNF-α Pharmacology</span></div><div class="casAuthors">Erickson, Rebecca I.; Tarrant, Jacqueline; Cain, Gary; Lewin-Koh, Sock-Cheng; Dybdal, Noel; Wong, Harvey; Blackwood, Elizabeth; West, Kristina; Steigerwalt, Ronald; Mamounas, Michael; Flygare, John A.; Amemiya, Kenjie; Dambach, Donna; Fairbrother, Wayne J.; Diaz, Dolores</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">247-258</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-0929</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Inhibitor-of-apoptosis (IAP) proteins suppress apoptosis and are overexpressed in a variety of cancers.  Small-mol. IAP antagonists are currently being tested in clin. trials as novel cancer therapeutics.  GDC-0152 is a small-mol. drug that triggers tumor cell apoptosis by selectively antagonizing IAPs.  GDC-0152 induces NF-κB transcriptional activity leading to expression of several chemokines and cytokines, of which tumor necrosis factor alpha (TNF-α) is the most important for single-agent tumor activity.  TNF-α is a pleiotropic cytokine that drives a variety of cellular responses, comprising inflammation, proliferation, and cell survival or death depending on the cellular context.  As malignant and normal cells produce TNF-α upon IAP antagonism, increased TNF-α could drive both efficacy and toxicity.  The toxicity profile of GDC-0152 in dogs and rats was characterized after iv dose administration once every 2 wk for four doses.  Findings in both species consisted of a dose-related, acute, systemic inflammatory response, and hepatic injury.  Lab. findings included elevated plasma cytokines, an inflammatory leukogram, and increased liver transaminases with histopathol. findings of inflammatory infiltrates and apoptosis/necrosis in multiple tissues; a toxicol. profile consistent with TNF-α-mediated toxicity.  Dogs exhibited more severe findings than rats, and humans did not exhibit these findings, at comparable exposures across species.  Furthermore, elevations in blood neutrophil count, serum monocyte chemoattractant protein-1, and other markers of inflammation corresponded to GDC-0152 exposure and toxicity and thus may have utility as safety biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoC4-WYAFUa7Vg90H21EOLACvtfcHk0lj1LWWZin-HVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFamsg%253D%253D&md5=78209395dfc2e757baf6a3f91c45c4dc</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfs265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfs265%26sid%3Dliteratum%253Aachs%26aulast%3DErickson%26aufirst%3DR.%2BI.%26aulast%3DTarrant%26aufirst%3DJ.%26aulast%3DCain%26aufirst%3DG.%26aulast%3DLewin-Koh%26aufirst%3DS.%2BC.%26aulast%3DDybdal%26aufirst%3DN.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DBlackwood%26aufirst%3DE.%26aulast%3DWest%26aufirst%3DK.%26aulast%3DSteigerwalt%26aufirst%3DR.%26aulast%3DMamounas%26aufirst%3DM.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DAmemiya%26aufirst%3DK.%26aulast%3DDambach%26aufirst%3DD.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DDiaz%26aufirst%3DD.%26atitle%3DToxicity%2520profile%2520of%2520small-molecule%2520IAP%2520antagonist%2520GDC-0152%2520is%2520linked%2520to%2520TNF-alpha%2520pharmacology%26jtitle%3DToxicol.%2520Sci.%26date%3D2013%26volume%3D131%26spage%3D247%26epage%3D258%26doi%3D10.1093%2Ftoxsci%2Fkfs265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vora, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vangveravong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwnica-Worms, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weilbaecher, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faccio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novack, D. V.</span></span> <span> </span><span class="NLM_article-title">Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-12-0271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F2159-8290.CD-12-0271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=23269702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Wktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=212-223&author=C.+Yangauthor=J.+L.+Davisauthor=R.+Zengauthor=P.+Voraauthor=X.+Suauthor=L.+I.+Collinsauthor=S.+Vangveravongauthor=R.+H.+Machauthor=D.+Piwnica-Wormsauthor=K.+N.+Weilbaecherauthor=R.+Faccioauthor=D.+V.+Novack&title=Antagonism+of+inhibitor+of+apoptosis+proteins+increases+bone+metastasis+via+unexpected+osteoclast+activation&doi=10.1158%2F2159-8290.CD-12-0271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of Inhibitor of Apoptosis Proteins Increases Bone Metastasis via Unexpected Osteoclast Activation</span></div><div class="casAuthors">Yang, Chang; Davis, Jennifer L.; Zeng, Rong; Vora, Paras; Su, Xinming; Collins, Lynne I.; Vangveravong, Suwanna; Mach, Robert H.; Piwnica-Worms, David; Weilbaecher, Katherine N.; Faccio, Roberta; Veis Novack, Deborah</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-223</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis (IAP) proteins play a central role in many types of cancer, and IAP antagonists are in development as anticancer agents.  IAP antagonists cause apoptosis in many cells, but they also activate alternative NF-κB signaling through NF-ΚB-inducing kinase (NIK), which regulates osteoclasts.  In bone metastasis, a pos. feedback loop between tumors and osteoclasts promotes tumor growth and osteolysis.  We therefore tested the effect of IAP antagonists on the bone microenvironment for metastasis.  In both drug-sensitive and drug-resistant tumors, growth in bone was favored, as compared with other sites during IAP antagonist treatment.  These drugs also caused osteoporosis and increased osteoclastogenesis, mediated by NIK, and enhanced tumor-assocd. osteolysis.  Cotreatment with zoledronic acid, a potent osteoclast inhibitor, reduced IAP antagonist-enhanced tumor growth in bone and osteolysis.  Thus, IAP antagonist-based cancer treatment may be compromised by osteoporosis and enhanced skeletal metastasis, which may be prevented by antiresorptive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2R6FAPQouhrVg90H21EOLACvtfcHk0ljl_I_vDz7sWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Wktrs%253D&md5=8fcc317509bf6008b705d8b769f1edb7</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-12-0271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-12-0271%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DJ.%2BL.%26aulast%3DZeng%26aufirst%3DR.%26aulast%3DVora%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DCollins%26aufirst%3DL.%2BI.%26aulast%3DVangveravong%26aufirst%3DS.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DPiwnica-Worms%26aufirst%3DD.%26aulast%3DWeilbaecher%26aufirst%3DK.%2BN.%26aulast%3DFaccio%26aufirst%3DR.%26aulast%3DNovack%26aufirst%3DD.%2BV.%26atitle%3DAntagonism%2520of%2520inhibitor%2520of%2520apoptosis%2520proteins%2520increases%2520bone%2520metastasis%2520via%2520unexpected%2520osteoclast%2520activation%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D212%26epage%3D223%26doi%3D10.1158%2F2159-8290.CD-12-0271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalcin-Chin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Autocrine TNFalpha signaling renders human cancer cells susceptible to SMAC-mimetic-induced apoptosis</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">456</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2007.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.ccr.2007.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=17996648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtl2nurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=445-456&author=S.+L.+Petersenauthor=L.+Wangauthor=A.+Yalcin-Chinauthor=L.+Liauthor=M.+Peytonauthor=J.+Minnaauthor=P.+Harranauthor=X.+Wang&title=Autocrine+TNFalpha+signaling+renders+human+cancer+cells+susceptible+to+SMAC-mimetic-induced+apoptosis&doi=10.1016%2Fj.ccr.2007.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Autocrine TNFα signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis</span></div><div class="casAuthors">Petersen, Sean L.; Wang, Lai; Yalcin-Chin, Asligul; Li, Lin; Peyton, Michael; Minna, John; Harran, Patrick; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">445-456</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A small-mol. mimetic of Smac/Diablo that specifically counters the apoptosis-inhibiting activity of IAP proteins has been shown to enhance apoptosis induced by cell surface death receptors as well as chemotherapeutic drugs.  Survey of a panel of 50 human non-small-cell lung cancer cell lines has revealed, surprisingly, that roughly one-quarter of these lines are sensitive to the treatment of Smac mimetic alone, suggesting that an apoptotic signal has been turned on in these cells and is held in check by IAP proteins.  This signal has now been identified as the autocrine-secreted cytokine tumor necrosis factor alpha (TNFα).  In response to autocrine TNFα signaling, the Smac mimetic promotes formation of a RIPK1-dependent caspase-8-activating complex, leading to apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_J544Om3crLVg90H21EOLACvtfcHk0ljl_I_vDz7sWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtl2nurrN&md5=c5bf1e83b408cf61e8413dce35d0cc59</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2007.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2007.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYalcin-Chin%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%26aulast%3DHarran%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DAutocrine%2520TNFalpha%2520signaling%2520renders%2520human%2520cancer%2520cells%2520susceptible%2520to%2520SMAC-mimetic-induced%2520apoptosis%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D445%26epage%3D456%26doi%3D10.1016%2Fj.ccr.2007.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span> <span> </span><span class="NLM_article-title">Targeting IAP proteins for therapeutic intervention in cancer</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1038/nrd3627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnrd3627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=22293567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=109-124&author=S.+Fuldaauthor=D.+Vucic&title=Targeting+IAP+proteins+for+therapeutic+intervention+in+cancer&doi=10.1038%2Fnrd3627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IAP proteins for therapeutic intervention in cancer</span></div><div class="casAuthors">Fulda, Simone; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-124</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Evasion of apoptosis is one of the crucial acquired capabilities used by cancer cells to fend off anticancer therapies.  Inhibitor of apoptosis (IAP) proteins exert a range of biol. activities that promote cancer cell survival and proliferation.  X chromosome-linked IAP is a direct inhibitor of caspases - pro-apoptotic executioner proteases - whereas cellular IAP proteins block the assembly of pro-apoptotic protein signalling complexes and mediate the expression of anti-apoptotic mols.  Furthermore, mutations, amplifications and chromosomal translocations of IAP genes are assocd. with various malignancies.  Among the therapeutic strategies that have been designed to target IAP proteins, the most widely used approach is based on mimicking the IAP-binding motif of second mitochondria-derived activator of caspase (SMAC), which functions as an endogenous IAP antagonist.  Alternative strategies include transcriptional repression and the use of antisense oligonucleotides.  This Review provides an update on IAP protein biol. as well as current and future perspectives on targeting IAP proteins for therapeutic intervention in human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-R51O_sZcdLVg90H21EOLACvtfcHk0ljl_I_vDz7sWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GgsLo%253D&md5=219506817f8526ba0bbd27117ed4f290</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1038%2Fnrd3627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3627%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DTargeting%2520IAP%2520proteins%2520for%2520therapeutic%2520intervention%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D109%26epage%3D124%26doi%3D10.1038%2Fnrd3627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoeneberger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristofanon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanlangenakker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeremias, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1020</span>– <span class="NLM_lpage">1029</span>, <span class="refDoi"> DOI: 10.1038/leu.2011.353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fleu.2011.353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=22173242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADC%252BC38zovFagsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1020-1029&author=S.+Loderauthor=M.+Faklerauthor=H.+Schoenebergerauthor=S.+Cristofanonauthor=J.+Leibacherauthor=N.+Vanlangenakkerauthor=M.+J.+Bertrandauthor=P.+Vandenabeeleauthor=I.+Jeremiasauthor=K.+M.+Debatinauthor=S.+Fulda&title=RIP1+is+required+for+IAP+inhibitor-mediated+sensitization+of+childhood+acute+leukemia+cells+to+chemotherapy-induced+apoptosis&doi=10.1038%2Fleu.2011.353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis</span></div><div class="casAuthors">Loder S; Fakler M; Schoeneberger H; Cristofanon S; Leibacher J; Vanlangenakker N; Bertrand M J M; Vandenabeele P; Jeremias I; Debatin K-M; Fulda S</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1020-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Evasion of apoptosis may contribute to poor treatment response in pediatric acute lymphoblastic leukemia (ALL), calling for novel treatment strategies.  Here, we report that inhibitors of apoptosis (IAPs) at subtoxic concentrations cooperate with various anticancer drugs (that is, AraC, Gemcitabine, Cyclophosphamide, Doxorubicin, Etoposide, Vincristine and Taxol) to induce apoptosis in ALL cells in a synergistic manner as calculated by combination index and to reduce long-term clonogenic survival.  Importantly, we identify RIP1 as a critical regulator of this synergism of IAP inhibitors and AraC that mediates the formation of a RIP1/FADD/caspase-8 complex via an autocrine/paracrine loop of tumor necrosis factor-α (TNFα).  Knockdown of RIP1 abolishes formation of this complex and subsequent activation of caspase-8 and -3, mitochondrial perturbations and apoptosis.  Similarly, inhibition of RIP1 kinase activity by Necrostatin-1 or blockage of TNFα by Enbrel inhibits IAP inhibitor- and AraC-triggered interaction of RIP1, FADD and caspase-8 and apoptosis.  In contrast to malignant cells, IAP inhibitors and AraC at equimolar concentrations are non-toxic to normal peripheral blood lymphocytes or mesenchymal stromal cells.  Thus, our findings provide first evidence that IAP inhibitors present a promising strategy to prime childhood ALL cells for chemotherapy-induced apoptosis in a RIP1-dependent manner.  These data have important implications for developing apoptosis-targeted therapies in childhood leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTa70MZXGWiVYqdXsLcGTEUfW6udTcc2ebtiMMv3d3X0rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zovFagsg%253D%253D&md5=04c10a36ff79b391c2ac597725b2fc67</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1038%2Fleu.2011.353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2011.353%26sid%3Dliteratum%253Aachs%26aulast%3DLoder%26aufirst%3DS.%26aulast%3DFakler%26aufirst%3DM.%26aulast%3DSchoeneberger%26aufirst%3DH.%26aulast%3DCristofanon%26aufirst%3DS.%26aulast%3DLeibacher%26aufirst%3DJ.%26aulast%3DVanlangenakker%26aufirst%3DN.%26aulast%3DBertrand%26aufirst%3DM.%2BJ.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DJeremias%26aufirst%3DI.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DRIP1%2520is%2520required%2520for%2520IAP%2520inhibitor-mediated%2520sensitization%2520of%2520childhood%2520acute%2520leukemia%2520cells%2520to%2520chemotherapy-induced%2520apoptosis%26jtitle%3DLeukemia%26date%3D2012%26volume%3D26%26spage%3D1020%26epage%3D1029%26doi%3D10.1038%2Fleu.2011.353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Probst, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetics increase cancer cell response to chemotherapeutics in a TNF-alpha-dependent manner</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1645</span>– <span class="NLM_lpage">1654</span>, <span class="refDoi"> DOI: 10.1038/cdd.2010.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fcdd.2010.44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=20431601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFChsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1645-1654&author=B.+L.+Probstauthor=L.+Liuauthor=V.+Rameshauthor=L.+Liauthor=H.+Sunauthor=J.+D.+Minnaauthor=L.+Wang&title=SMAC+mimetics+increase+cancer+cell+response+to+chemotherapeutics+in+a+TNF-alpha-dependent+manner&doi=10.1038%2Fcdd.2010.44"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent manner</span></div><div class="casAuthors">Probst, B. L.; Liu, L.; Ramesh, V.; Li, L.; Sun, H.; Minna, J. D.; Wang, L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1645-1654</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Second mitochondria-derived activator of caspase (Smac) is a mitochondrial protein released into the cytosol during apoptosis.  Smac mimetics have recently been touted as a novel therapeutic to induce apoptosis in cancer cells.  The ability of Smac mimetics to induce apoptosis in vitro has been shown to be dependent upon both XIAP neutralization and cancer cell autocrine tumor necrosis factor-α (TNF-α) prodn.  In this study we provide new evidence for the utility of Smac mimetics in combination with conventional chemotherapy agents to exacerbate caspase activation and induce cancer cell death.  Furthermore, we find that the combination effect is because of a multifaceted mechanism involving both inhibition of cell proliferation by the chemotherapy agents and an enhanced autocrine TNF-α feedback loop by the Smac mimetic/chemotherapy agent combination.  Surprisingly, although genotoxic agents typically induce apoptosis through the mitochondrial intrinsic pathway, we show that this synergism is mediated through a TNF-α/RIP1-dependent pathway, leading to activation of the extrinsic apoptotic pathway.  Finally, we report that autocrine TNF-α contributes to Smac mimetic-induced tumor regression as a single agent or in combination with chemotherapeutics in xenograft mouse models.  Collectively, we provide mechanistic and applicable data to support translational studies in the use of a Smac mimetic/chemotherapy antineoplasm modality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTaxGVjKencLVg90H21EOLACvtfcHk0ljhyOI1FMCFpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFChsLnO&md5=10924e8e08d725d40270cd663cbcc744</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2010.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2010.44%26sid%3Dliteratum%253Aachs%26aulast%3DProbst%26aufirst%3DB.%2BL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DRamesh%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DWang%26aufirst%3DL.%26atitle%3DSMAC%2520mimetics%2520increase%2520cancer%2520cell%2520response%2520to%2520chemotherapeutics%2520in%2520a%2520TNF-alpha-dependent%2520manner%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2010%26volume%3D17%26spage%3D1645%26epage%3D1654%26doi%3D10.1038%2Fcdd.2010.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fandy, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, R. K.</span></span> <span> </span><span class="NLM_article-title">SMAC/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">60</span>, <span class="refDoi"> DOI: 10.1186/1476-4598-7-60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1186%2F1476-4598-7-60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18590557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADC%252BD1cvlsFWrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=60&author=T.+E.+Fandyauthor=S.+Shankarauthor=R.+K.+Srivastava&title=SMAC%2FDIABLO+enhances+the+therapeutic+potential+of+chemotherapeutic+drugs+and+irradiation%2C+and+sensitizes+TRAIL-resistant+breast+cancer+cells&doi=10.1186%2F1476-4598-7-60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells</span></div><div class="casAuthors">Fandy Tamer E; Shankar Sharmila; Srivastava Rakesh K</div><div class="citationInfo"><span class="NLM_cas:title">Molecular cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Drug resistance is a major concern in cancer therapy.  Here, we investigate the clinical potential of the second mitochondria-derived activator of caspase (Smac/DIABLO) in enhancing the apoptosis-inducing potential of commonly used anticancer drugs (paclitaxel, doxorubicin, etoposide, tamoxifen), irradiation and TRAIL in breast carcinoma.  METHODS:  Breast cancer cells were overexpressed with Smac/DIABLO gene (full-length or Delta55 Smac/DIABLO) or treated with Smac/DIABLO peptide to enhance the apoptosis-inducing potential of chemotherapeutic drugs and irradiation, and sensitize TRAIL-resistant cells.  Cell viability and apoptosis were measured by XTT assay and DAPI staining, respectively.  Protein-protein interaction was determined by immunoprecipitation followed by the Western blot analysis.  RESULTS:  Overexpression of Smac/DIABLO gene (full-length or Delta55 Smac/DIABLO) or treatment with Smac/DIABLO peptide enhances apoptosis induced by paclitaxel, doxorubicin, etoposide, tamoxifen, and irradiation in breast cancer cells.  Overexpression of Smac/DIABLO resulted in an increased interaction of Smac/DIABLO with IAPs, which correlated with an increase in caspase-3 activity and apoptosis.  Furthermore, Smac/DIABLO sensitized TRAIL-resistant breast cancer cell lines to undergo apoptosis through caspase-3 activation.  These data suggest that apoptotic events down-stream of mitochondria were intact in TRAIL-resistant cells since ectopic expression of Smac/DIABLO or pretreatment of cells with Smac/DIABLO peptide completely restored TRAIL sensitivity.  CONCLUSION:  The ability of Smac/DIABLO agonists to enhance the apoptosis-inducing potential of chemotherapeutic drugs and irradiation, and sensitize TRAIL-resistant tumor cells suggests that Smac/DIABLO may induce fundamental alterations in cell signaling pathways.  Thus, Smac/DIABLO agonists can be used as promising new candidates for cancer treatment by potentiating cytotoxic therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVDgSbnz1HggHqQV89nF-2fW6udTcc2ebtiMMv3d3X0rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvlsFWrtg%253D%253D&md5=e64d7666130d6893668b449fc085d8fb</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-7-60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-7-60%26sid%3Dliteratum%253Aachs%26aulast%3DFandy%26aufirst%3DT.%2BE.%26aulast%3DShankar%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DR.%2BK.%26atitle%3DSMAC%252FDIABLO%2520enhances%2520the%2520therapeutic%2520potential%2520of%2520chemotherapeutic%2520drugs%2520and%2520irradiation%252C%2520and%2520sensitizes%2520TRAIL-resistant%2520breast%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%26date%3D2008%26volume%3D7%26spage%3D60%26doi%3D10.1186%2F1476-4598-7-60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terragni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffer, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tullai, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, G. M.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factors</span>. <i>BMC Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">6</span>, <span class="refDoi"> DOI: 10.1186/1471-2121-9-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1186%2F1471-2121-9-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18226221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADC%252BD1c3gslentQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=6&author=J.+Terragniauthor=J.+R.+Grahamauthor=K.+W.+Adamsauthor=M.+E.+Schafferauthor=J.+W.+Tullaiauthor=G.+M.+Cooper&title=Phosphatidylinositol+3-kinase+signaling+in+proliferating+cells+maintains+an+anti-apoptotic+transcriptional+program+mediated+by+inhibition+of+FOXO+and+non-canonical+activation+of+NFkappaB+transcription+factors&doi=10.1186%2F1471-2121-9-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factors</span></div><div class="casAuthors">Terragni Jolyon; Graham Julie R; Adams Kenneth W; Schaffer Michael E; Tullai John W; Cooper Geoffrey M</div><div class="citationInfo"><span class="NLM_cas:title">BMC cell biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Phosphatidylinositol (PI) 3-kinase is activated by a variety of growth factor receptors and the PI 3-kinase/Akt signaling pathway is a key regulator of cell proliferation and survival.  The downstream targets of PI 3-kinase/Akt signaling include direct regulators of cell cycle progression and apoptosis as well as a number of transcription factors.  Growth factor stimulation of quiescent cells leads to robust activation of PI 3-kinase, induction of immediate-early genes, and re-entry into the cell cycle.  A lower level of PI 3-kinase signaling is also required for the proliferation and survival of cells maintained in the presence of growth factors, but the gene expression program controlled by PI 3-kinase signaling in proliferating cells has not been elucidated.  RESULTS:  We used microarray analyses to characterize the changes in gene expression resulting from inhibition of PI 3-kinase in proliferating cells.  The genes regulated by inhibition of PI 3-kinase in proliferating cells were distinct from genes induced by growth factor stimulation of quiescent cells and highly enriched in genes that regulate programmed cell death.  Computational analyses followed by chromatin immunoprecipitations demonstrated FOXO binding to both previously known and novel sites in promoter regions of approximately one-third of the up-regulated genes, consistent with activation of FOXO1 and FOXO3a in response to inhibition of PI 3-kinase.  NFkappaB binding sites were similarly identified in promoter regions of over one-third of the down-regulated genes.  RelB was constitutively bound to promoter regions in cells maintained in serum, however binding decreased following PI 3-kinase inhibition, indicating that PI 3-kinase signaling activates NFkappaB via the non-canonical pathway in proliferating cells.  Approximately 70% of the genes targeted by FOXO and NFkappaB regulate cell proliferation and apoptosis, including several regulators of apoptosis that were not previously known to be targeted by these transcription factors.  CONCLUSION:  PI 3-kinase signaling in proliferating cells regulates a novel transcriptional program that is highly enriched in genes that regulate apoptosis.  At least one-third of these genes are regulated either by FOXO transcription factors, which are activated following PI 3-kinase inhibition, or by RelB, which is activated by PI 3-kinase via the non-canonical pathway in proliferating cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkhXGPmX20psyail4HZd-ifW6udTcc2eYh69LMrnVjz7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3gslentQ%253D%253D&md5=342cfd9cf9842f1316eb89d642cf3d05</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1186%2F1471-2121-9-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2121-9-6%26sid%3Dliteratum%253Aachs%26aulast%3DTerragni%26aufirst%3DJ.%26aulast%3DGraham%26aufirst%3DJ.%2BR.%26aulast%3DAdams%26aufirst%3DK.%2BW.%26aulast%3DSchaffer%26aufirst%3DM.%2BE.%26aulast%3DTullai%26aufirst%3DJ.%2BW.%26aulast%3DCooper%26aufirst%3DG.%2BM.%26atitle%3DPhosphatidylinositol%25203-kinase%2520signaling%2520in%2520proliferating%2520cells%2520maintains%2520an%2520anti-apoptotic%2520transcriptional%2520program%2520mediated%2520by%2520inhibition%2520of%2520FOXO%2520and%2520non-canonical%2520activation%2520of%2520NFkappaB%2520transcription%2520factors%26jtitle%3DBMC%2520Cell%2520Biol.%26date%3D2008%26volume%3D9%26spage%3D6%26doi%3D10.1186%2F1471-2121-9-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seol, D. W.</span></span> <span> </span><span class="NLM_article-title">Up-regulation of IAPs by PI-3K: a cell survival signal-mediated anti-apoptotic mechanism</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>377</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2008.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.bbrc.2008.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18929542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlykt7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2008&pages=508-511&author=D.+W.+Seol&title=Up-regulation+of+IAPs+by+PI-3K%3A+a+cell+survival+signal-mediated+anti-apoptotic+mechanism&doi=10.1016%2Fj.bbrc.2008.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of IAPs by PI-3K: A cell survival signal-mediated anti-apoptotic mechanism</span></div><div class="casAuthors">Seol, Dai-Wu</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">508-511</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Under normal cell physiol., a balance between cell survival and apoptosis is crucial for homeostasis.  Many studies have demonstrated that apoptosis is modulated by cell survival stimuli.  Active Akt, a common mediator of cell survival signals, has been shown to inhibit apoptosis by attenuating activity of pro-apoptotic factors Bad and caspase-9.  However, the anti-apoptotic mechanisms mediated by various cell survival signals are poorly understood.  Human prostate cancer LNCaP cells, known to contain constitutively activated Akt as a result of a frame-shift mutation in PTEN, an inhibitor of PI-3K/Akt pathway, were obsd. to be completely resistant to TRAIL-induced apoptosis.  In agreement with the known action of Akt, blockade of the PI-3K/Akt pathway rendered LNCaP cells highly susceptible to TRAIL.  Importantly, active PI-3K/Akt prevented processing/activation of caspase-3, a phenomenon assocd. with the function of inhibitor of apoptosis proteins (IAPs).  In fact, inhibition of PI-3K activity using Wortmannin significantly decreased the protein levels of IAPs, concomitantly promoting processing/activation of caspase-3 and TRAIL-induced apoptosis.  My data indicate that in addn. to blocking Bad and caspase-9 through Akt, PI-3K also inhibits caspase-3 through up-regulating IAPs, thereby attenuates apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoasoEra137nLVg90H21EOLACvtfcHk0lgVtqM47W9r1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlykt7vK&md5=d2e1f79043702e3d66b2a15d3076b0ee</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2008.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2008.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DSeol%26aufirst%3DD.%2BW.%26atitle%3DUp-regulation%2520of%2520IAPs%2520by%2520PI-3K%253A%2520a%2520cell%2520survival%2520signal-mediated%2520anti-apoptotic%2520mechanism%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D377%26spage%3D508%26epage%3D511%26doi%3D10.1016%2Fj.bbrc.2008.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Overcoming cancer cell resistance to SMAC mimetic induced apoptosis by modulating cIAP-2 expression</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">11936</span>– <span class="NLM_lpage">11941</span>, <span class="refDoi"> DOI: 10.1073/pnas.1005667107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1073%2Fpnas.1005667107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=20547836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVartLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=11936-11941&author=S.+L.+Petersenauthor=M.+Peytonauthor=J.+D.+Minnaauthor=X.+Wang&title=Overcoming+cancer+cell+resistance+to+SMAC+mimetic+induced+apoptosis+by+modulating+cIAP-2+expression&doi=10.1073%2Fpnas.1005667107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression</span></div><div class="casAuthors">Petersen, Sean L.; Peyton, Michael; Minna, John D.; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">11936-11941, S11936/1-S11936/3</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Smac mimetics target cancer cells in a TNFα-dependent manner, partly via proteasome degrdn. of cellular inhibitor of apoptosis 1 (cIAP1) and cIAP2.  Degrdn. of cIAPs triggers the release of receptor interacting protein kinase (RIPK1) from TNF receptor 1 (TNFR1) to form a caspase-8 activating complex together with the adaptor protein Fas-assocd. death domain (FADD).  We report here a means through which cancer cells mediate resistance to Smac mimetic/TNFα-induced apoptosis and corresponding strategies to overcome such resistance.  These human cancer cell lines evades Smac mimetic-induced apoptosis by up-regulation of cIAP2, which although initially degraded, rebounds and is refractory to subsequent degrdn. clAP2 is induced by TNFa via NF-κB and modulation of the NF-κB signal renders otherwise resistant cells sensitive to Smac mimetics.  In addn., other signaling pathways, including phosphatidyl inositol-3 kinase (PI3K), have the potential to concurrently regulate cIAP2.  Using the P13K inhibitor, LY294002, dAP2 up-regulation was suppressed and resistance to Smac mimetics-induced apoptosis was also overcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp5NQOxkS-wLVg90H21EOLACvtfcHk0lgVtqM47W9r1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVartLg%253D&md5=278c84b651abd7af0357a7023977d54b</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1005667107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1005667107%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DS.%2BL.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DOvercoming%2520cancer%2520cell%2520resistance%2520to%2520SMAC%2520mimetic%2520induced%2520apoptosis%2520by%2520modulating%2520cIAP-2%2520expression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D11936%26epage%3D11941%26doi%3D10.1073%2Fpnas.1005667107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stirewalt, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radich, J. P.</span></span> <span> </span><span class="NLM_article-title">The role of FLT3 in haematopoietic malignancies</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">665</span>, <span class="refDoi"> DOI: 10.1038/nrc1169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnrc1169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=12951584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVWlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=650-665&author=D.+L.+Stirewaltauthor=J.+P.+Radich&title=The+role+of+FLT3+in+haematopoietic+malignancies&doi=10.1038%2Fnrc1169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">The role of FLT3 in hematopoietic malignancies</span></div><div class="casAuthors">Stirewalt, Derek L.; Radich, Jerald P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">650-665</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Normal haematopoietic cells use complex systems to control proliferation, differentiation and cell death.  The control of proliferation is, in part, accomplished through the ligand-induced stimulation of receptor tyrosine kinases, which signal to downstream effectors through the RAS pathway.  Recently, mutations in the FMS-like tyrosine kinase 3 (FLT3) gene, which encodes a receptor tyrosine kinase, have been found to be the most common genetic lesion in acute myeloid leukemia (AML), occurring in ∼25% of cases.  Exploring the mechanism by which these FLT3 mutations cause uncontrolled proliferation might lead to a better understanding of how cells become cancerous and provide insights for the development of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRONPQkpemorVg90H21EOLACvtfcHk0lgVtqM47W9r1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVWlu7c%253D&md5=97183b7a6087fafe20bfc695f403825b</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1038%2Fnrc1169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1169%26sid%3Dliteratum%253Aachs%26aulast%3DStirewalt%26aufirst%3DD.%2BL.%26aulast%3DRadich%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520role%2520of%2520FLT3%2520in%2520haematopoietic%2520malignancies%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D650%26epage%3D665%26doi%3D10.1038%2Fnrc1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weisberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cools, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsiades, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMillin, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall-Meyers, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, J. D.</span></span> <span> </span><span class="NLM_article-title">Potentiation of antileukemic therapies by SMAC mimetic, LBW242: effects on mutant FLT3-expressing cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1951</span>– <span class="NLM_lpage">1961</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-06-0810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1535-7163.MCT-06-0810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=17620426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsV2jsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1951-1961&author=E.+Weisbergauthor=A.+L.+Kungauthor=R.+D.+Wrightauthor=D.+Morenoauthor=L.+Catleyauthor=A.+Rayauthor=L.+Zawelauthor=M.+Tranauthor=J.+Coolsauthor=G.+Gillilandauthor=C.+Mitsiadesauthor=D.+W.+McMillinauthor=J.+Jiangauthor=E.+Hall-Meyersauthor=J.+D.+Griffin&title=Potentiation+of+antileukemic+therapies+by+SMAC+mimetic%2C+LBW242%3A+effects+on+mutant+FLT3-expressing+cells&doi=10.1158%2F1535-7163.MCT-06-0810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells</span></div><div class="casAuthors">Weisberg, Ellen; Kung, Andrew L.; Wright, Renee D.; Moreno, Daisy; Catley, Laurie; Ray, Arghya; Zawel, Leigh; Tran, Mary; Cools, Jan; Gilliland, Gary; Mitsiades, Constantine; McMillin, Douglas W.; Jiang, Jingrui; Hall-Meyers, Elizabeth; Griffin, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1951-1961</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Members of the inhibitor of apoptosis protein (IAP) family play a role in mediating apoptosis.  Studies suggest that these proteins may be a viable target in leukemia because they have been found to be variably expressed in acute leukemias and are assocd. with chemosensitivity, chemoresistance, disease progression, remission, and patient survival.  Another promising therapeutic target, FLT3, is mutated in about one third of acute myelogenous leukemia (AML) patients; promising results have recently been achieved in clin. trials investigating the effects of the protein tyrosine kinase inhibitor PKC412 on AML patients harboring mutations in the FLT3 protein.  Of growing concern, however, is the development of drug resistance resulting from the emergence of point mutations in targeted tyrosine kinases used for treatment of acute leukemia patients.  One approach to overriding resistance is to combine structurally unrelated inhibitors and/or inhibitors of different signaling pathways.  The proapoptotic IAP inhibitor, LBW242, was shown in proliferation studies done in vitro to enhance the killing of PKC412-sensitive and PKC412-resistant cell lines expressing mutant FLT3 when combined with either PKC412 or std. cytotoxic agents (doxorubicin and Ara-c).  In addn., in an in vivo imaging assay using bioluminescence as a measure of tumor burden, a total of 12 male NCr-nude mice were treated for 10 days with p.o. administration of vehicle, LBW242 (50 mg/kg/day), PKC412 (40 mg/kg/day), or a combination of LBW242 and PKC412; the lowest tumor burden was obsd. in the drug combination group.  Finally, the combination of LBW242 and PKC412 was sufficient to override stromal-mediated viability signaling conferring resistance to PKC412.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqob_oR49wsRbVg90H21EOLACvtfcHk0lj8WegSraR8zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsV2jsr8%253D&md5=7c4baf35a3a07a29c59fdb18294922af</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0810%26sid%3Dliteratum%253Aachs%26aulast%3DWeisberg%26aufirst%3DE.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DWright%26aufirst%3DR.%2BD.%26aulast%3DMoreno%26aufirst%3DD.%26aulast%3DCatley%26aufirst%3DL.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DZawel%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DM.%26aulast%3DCools%26aufirst%3DJ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DMitsiades%26aufirst%3DC.%26aulast%3DMcMillin%26aufirst%3DD.%2BW.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DHall-Meyers%26aufirst%3DE.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26atitle%3DPotentiation%2520of%2520antileukemic%2520therapies%2520by%2520SMAC%2520mimetic%252C%2520LBW242%253A%2520effects%2520on%2520mutant%2520FLT3-expressing%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1951%26epage%3D1961%26doi%3D10.1158%2F1535-7163.MCT-06-0810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weisberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straub, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazo-Kallanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galinsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, J. D.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetics: implications for enhancement of targeted therapies in leukemia</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2100</span>– <span class="NLM_lpage">2109</span>, <span class="refDoi"> DOI: 10.1038/leu.2010.212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fleu.2010.212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=20844561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FivF2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=2100-2109&author=E.+Weisbergauthor=A.+Rayauthor=R.+Barrettauthor=E.+Nelsonauthor=A.+L.+Christieauthor=D.+Porterauthor=C.+Straubauthor=L.+Zawelauthor=J.+F.+Daleyauthor=S.+Lazo-Kallanianauthor=R.+Stoneauthor=I.+Galinskyauthor=D.+Frankauthor=A.+L.+Kungauthor=J.+D.+Griffin&title=SMAC+mimetics%3A+implications+for+enhancement+of+targeted+therapies+in+leukemia&doi=10.1038%2Fleu.2010.212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Smac mimetics: implications for enhancement of targeted therapies in leukemia</span></div><div class="casAuthors">Weisberg E; Ray A; Barrett R; Nelson E; Christie A L; Porter D; Straub C; Zawel L; Daley J F; Lazo-Kallanian S; Stone R; Galinsky I; Frank D; Kung A L; Griffin J D</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2100-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Drug resistance is a growing concern with clinical use of tyrosine kinase inhibitors.  Utilizing in vitro models of intrinsic drug resistance and stromal-mediated chemoresistance, as well as functional mouse models of progressive and residual disease, we attempted to develop a potential therapeutic approach designed to suppress leukemia recurrence following treatment with selective kinase inhibitors.  The novel IAP inhibitor, LCL161, [corrected] was observed to potentiate the effects of tyrosine kinase inhibition against leukemic disease both in the absence and presence of a stromal-protected [corrected] environment.  LCL161 enhanced the proapoptotic effects of nilotinib and PKC412, against leukemic disease in vitro and potentiated the activity of both kinase inhibitors against leukemic disease in vivo.  In addition, LCL161 synergized in vivo with nilotinib to reduce leukemia burden significantly below the baseline level suppression exhibited by a moderate-to-high dose of nilotinib.  Finally, LCL161 displayed antiproliferative effects against cells characterized by intrinsic resistance to tyrosine kinase inhibitors as a result of expression of point mutations in the protein targets of drug inhibition.  These results support the idea of using IAP inhibitors in conjunction with targeted tyrosine kinase inhibition to override drug resistance and suppress or eradicate residual disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXlc9eyWdycoUSrryheKE6fW6udTcc2ebmVsMIDe-Qprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FivF2htA%253D%253D&md5=b0305435b043feacfbe32df84b094ccd</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1038%2Fleu.2010.212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2010.212%26sid%3Dliteratum%253Aachs%26aulast%3DWeisberg%26aufirst%3DE.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DBarrett%26aufirst%3DR.%26aulast%3DNelson%26aufirst%3DE.%26aulast%3DChristie%26aufirst%3DA.%2BL.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DStraub%26aufirst%3DC.%26aulast%3DZawel%26aufirst%3DL.%26aulast%3DDaley%26aufirst%3DJ.%2BF.%26aulast%3DLazo-Kallanian%26aufirst%3DS.%26aulast%3DStone%26aufirst%3DR.%26aulast%3DGalinsky%26aufirst%3DI.%26aulast%3DFrank%26aufirst%3DD.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26atitle%3DSMAC%2520mimetics%253A%2520implications%2520for%2520enhancement%2520of%2520targeted%2520therapies%2520in%2520leukemia%26jtitle%3DLeukemia%26date%3D2010%26volume%3D24%26spage%3D2100%26epage%3D2109%26doi%3D10.1038%2Fleu.2010.212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wick, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span> <span> </span><span class="NLM_article-title">Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">808</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.1038/nm735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnm735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=12118245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls12msbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=808-815&author=S.+Fuldaauthor=W.+Wickauthor=M.+Wellerauthor=K.+M.+Debatin&title=Smac+agonists+sensitize+for+Apo2L%2FTRAIL-+or+anticancer+drug-induced+apoptosis+and+induce+regression+of+malignant+glioma+in+vivo&doi=10.1038%2Fnm735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo</span></div><div class="casAuthors">Fulda, Simone; Wick, Wolfgang; Weller, Michael; Debatin, Klaus-Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">808-815</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A major concern in cancer therapy is resistance of tumors such as glioblastoma to current treatment protocols.  Here, we report that transfer of the gene encoding second mitochondria-derived activator of caspase (Smac) or Smac peptides sensitized various tumor cells in vitro and malignant glioma cells in vivo for apoptosis induced by death-receptor ligation or cytotoxic drugs.  Expression of a cytosolic active form of Smac or cell-permeable Smac peptides bypassed the Bcl-2 block, which prevented the release of Smac from mitochondria, and also sensitized resistant neuroblastoma or melanoma cells and patient-derived primary neuroblastoma cells ex vivo.  Most importantly, Smac peptides strongly enhanced the antitumor activity of Apo-2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in an intracranial malignant glioma xenograft model in vivo.  Complete eradication of established tumors and survival of mice was only achieved upon combined treatment with Smac peptides and Apo2L/TRAIL without detectable toxicity to normal brain tissue.  Thus, Smac agonists are promising candidates for cancer therapy by potentiating cytotoxic therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAiJY7qJmypLVg90H21EOLACvtfcHk0lj8WegSraR8zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls12msbw%253D&md5=6718e2999db2730ad0cdf51046e718ef</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1038%2Fnm735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm735%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26atitle%3DSmac%2520agonists%2520sensitize%2520for%2520Apo2L%252FTRAIL-%2520or%2520anticancer%2520drug-induced%2520apoptosis%2520and%2520induce%2520regression%2520of%2520malignant%2520glioma%2520in%2520vivo%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D808%26epage%3D815%26doi%3D10.1038%2Fnm735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giagkousiklidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westhoff, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperczyk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspase</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">10502</span>– <span class="NLM_lpage">10513</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-0866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F0008-5472.CAN-05-0866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=16288043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Wgu7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=10502-10513&author=S.+Giagkousiklidisauthor=M.+Voglerauthor=M.+A.+Westhoffauthor=H.+Kasperczykauthor=K.+M.+Debatinauthor=S.+Fulda&title=Sensitization+for+gamma-irradiation-induced+apoptosis+by+second+mitochondria-derived+activator+of+caspase&doi=10.1158%2F0008-5472.CAN-05-0866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitization for γ-Irradiation-Induced Apoptosis by Second Mitochondria-Derived Activator of Caspase</span></div><div class="casAuthors">Giagkousiklidis, Stavros; Vogler, Meike; Westhoff, Mike-Andrew; Kasperczyk, Hubert; Debatin, Klaus-Michael; Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10502-10513</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Resistance to current treatment regimens, such as radiation therapy, remains a major concern in oncol. and may be caused by defects in apoptosis programs.  Because inhibitor of apoptosis proteins (IAPs), which are expressed at high levels in many tumors, block apoptosis at the core of the apoptotic machinery by inhibiting caspases, therapeutic modulation of IAPs could target a key control point in resistance.  Here, we report for the first time that full-length or mature second mitochondria-derived activator of caspase (Smac), an inhibitor of IAPs, significantly enhanced γ-irradn.-induced apoptosis and reduced clonogenic survival in neuroblastoma, glioblastoma, or pancreatic carcinoma cells.  Notably, Smac had no effect on DNA damage/DNA repair, activation of nuclear factor-κB, up-regulation of p53 and p21 proteins, or cell cycle arrest following γ-irradn., indicating that Smac did not alter the initial damage and/or cellular stress response.  Smac enhanced activation of caspase-2, caspase-3, caspase-8, and caspase-9, loss of mitochondrial membrane potential, and cytochrome c release on γ-irradn.  Inhibition of caspases also blocked γ-irradn.-induced mitochondrial perturbations, indicating that Smac facilitated caspase activation, which in turn triggered a mitochondrial amplification loop.  Interestingly, mitochondrial perturbations were completely blocked by the broad-range caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone or the relatively selective caspase-2 inhibitor N-benzyloxycarbonyl-Val-Asp-Val-Ala-Asp-fluoromethylketone, whereas caspase-8 or caspase-3 inhibitors only inhibited the increased drop of mitochondrial membrane potential provided by Smac, suggesting that caspase-2 was acting upstream of mitochondria after γ-irradn.  In conclusion, our findings provide evidence that targeting IAPs (e.g., by Smac agonists) is a promising strategy to enhance radiosensitivity in human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPnrHw079U5LVg90H21EOLACvtfcHk0lhsZvjlbf85Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Wgu7%252FF&md5=5395fd5ac885392c07ae68b0dd3a3cc7</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-0866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-0866%26sid%3Dliteratum%253Aachs%26aulast%3DGiagkousiklidis%26aufirst%3DS.%26aulast%3DVogler%26aufirst%3DM.%26aulast%3DWesthoff%26aufirst%3DM.%2BA.%26aulast%3DKasperczyk%26aufirst%3DH.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DSensitization%2520for%2520gamma-irradiation-induced%2520apoptosis%2520by%2520second%2520mitochondria-derived%2520activator%2520of%2520caspase%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D10502%26epage%3D10513%26doi%3D10.1158%2F0008-5472.CAN-05-0866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holcik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korneluk, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, T.</span></span> <span> </span><span class="NLM_article-title">Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4174</span>– <span class="NLM_lpage">4177</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1203765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fsj.onc.1203765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10962579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVKlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=4174-4177&author=M.+Holcikauthor=C.+Yehauthor=R.+G.+Kornelukauthor=T.+Chow&title=Translational+upregulation+of+X-linked+inhibitor+of+apoptosis+%28XIAP%29+increases+resistance+to+radiation+induced+cell+death&doi=10.1038%2Fsj.onc.1203765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death</span></div><div class="casAuthors">Holcik, Martin; Yeh, Chiaoli; Korneluk, Robert G.; Chow, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">4174-4177</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibitory regulators of apoptosis play a crit. role in the responsiveness of tumor cells to cytotoxic agents.  The X-linked inhibitor of apoptosis protein (XIAP) is a member of a novel family of Inhibitor of Apoptosis (IAP) proteins.  Here we show that acute low dose ionizing irradn. results in the translational upregulation of XIAP that correlates with an increased resistance to radiation in non-small cell lung carcinoma.  This upregulation is mediated by an internal ribosome binding mechanism via an IRES element located within a XIAP 5' UTR.  Transient overexpression of XIAP rendered human carcinoma cells resistant to low dose γ-irradn.  By contrast, the antisense targeting of XIAP resulted in increased cell death following irradn. advocating a distinct role for XIAP in radiation resistant phenotype of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLacZN8mYro7Vg90H21EOLACvtfcHk0lhsZvjlbf85Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVKlsLc%253D&md5=3caa8ba6c997cb3750e50b96970c7c99</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1203765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1203765%26sid%3Dliteratum%253Aachs%26aulast%3DHolcik%26aufirst%3DM.%26aulast%3DYeh%26aufirst%3DC.%26aulast%3DKorneluk%26aufirst%3DR.%2BG.%26aulast%3DChow%26aufirst%3DT.%26atitle%3DTranslational%2520upregulation%2520of%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520%2528XIAP%2529%2520increases%2520resistance%2520to%2520radiation%2520induced%2520cell%2520death%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D4174%26epage%3D4177%26doi%3D10.1038%2Fsj.onc.1203765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giagkousiklidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellanki, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Sensitization of pancreatic carcinoma cells for gamma-irradiation-induced apoptosis by XIAP inhibition</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">7006</span>– <span class="NLM_lpage">7016</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1210502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fsj.onc.1210502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=17471230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Wgt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=7006-7016&author=S.+Giagkousiklidisauthor=S.+H.+Vellankiauthor=K.+M.+Debatinauthor=S.+Fulda&title=Sensitization+of+pancreatic+carcinoma+cells+for+gamma-irradiation-induced+apoptosis+by+XIAP+inhibition&doi=10.1038%2Fsj.onc.1210502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitization of pancreatic carcinoma cells for γ-irradiation-induced apoptosis by XIAP inhibition</span></div><div class="casAuthors">Giagkousiklidis, S.; Vellanki, S. H.; Debatin, K-M.; Fulda, S.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">7006-7016</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Resistance of pancreatic cancer to current treatments including radiotherapy remains a major challenge in oncol. and may be caused by defects in apoptosis programs.  Since 'inhibitor of apoptosis proteins' (IAPs) block apoptosis at the core of the apoptotic machinery by inhibiting caspases, therapeutic modulation of IAPs could tackle a key resistance mechanism.  Here, we report that targeting X-linked inhibitor of apoptosis (XIAP) by RNA-interference-mediated knockdown or overexpression of second mitochondria-derived activator of caspase significantly enhanced apoptosis and markedly reduced clonogenic growth of pancreatic carcinoma cells upon γ-irradn.  Anal. of signaling pathways revealed that antagonizing XIAP increased activation of caspase-2, -3, -8 and -9 and loss of mitochondrial membrane potential upon γ-irradn.  Interestingly, inhibition of caspases also reduced the cooperative effect of XIAP targeting and γ-irradn. to trigger mitochondrial perturbations, suggesting that XIAP controls a feedback mitochondrial amplification loop by regulating caspase activity.  Importantly, our data demonstrate for the first time that small mol. XIAP inhibitors sensitized pancreatic carcinoma cells for γ-irradn.-induced apoptosis, whereas they had no effect on γ-irradn.-mediated apoptosis of non-malignant fibroblasts indicating some tumor specificity.  In conclusion, targeting XIAP, for example by small mols., is a promising novel approach to enhance radiosensitivity of pancreatic cancer that warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocEFY0jlGoJ7Vg90H21EOLACvtfcHk0lhsZvjlbf85Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Wgt7rF&md5=84f692e7521dfe4140e383c8dfd6e67a</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210502%26sid%3Dliteratum%253Aachs%26aulast%3DGiagkousiklidis%26aufirst%3DS.%26aulast%3DVellanki%26aufirst%3DS.%2BH.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DSensitization%2520of%2520pancreatic%2520carcinoma%2520cells%2520for%2520gamma-irradiation-induced%2520apoptosis%2520by%2520XIAP%2520inhibition%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D7006%26epage%3D7016%26doi%3D10.1038%2Fsj.onc.1210502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span> <span> </span><span class="NLM_article-title">Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21804946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXms1Knsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=128-143&author=Y.+Daiauthor=J.+Desanoauthor=Y.+Quauthor=W.+Tangauthor=Y.+Mengauthor=T.+S.+Lawrenceauthor=L.+Xu&title=Natural+IAP+inhibitor+Embelin+enhances+therapeutic+efficacy+of+ionizing+radiation+in+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Natural IAP inhibitor embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer</span></div><div class="casAuthors">Dai, Yao; DeSano, Jeffrey; Qu, Yang; Tang, Wenhua; Meng, Yang; Lawrence, Theodore S.; Xu, Liang</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">128-143</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Embelin is an active ingredient of traditional herbal medicine that exhibits anti-tumor effects in human prostate cancer cells.  However, therapeutic effect of embelin in combination with conventional radiation therapy is not yet detd.  In this study, we evaluate the sensitizing potential of embelin on ionizing radiation (IR) in a human prostate cancer model.  In vitro, embelin combined with radiation potently suppressed prostate cancer PC-3 cell proliferation that was assocd. with S and G2/M arrest in cell cycle.  Moreover, the combination treatment promoted caspase-independent apoptosis, as evidenced by the increased apoptotic cell death without caspase-3 activation, but not autophagy.  Clonogenic survival assay showed that S-phase arrest was required for embelin-mediated radiosensitization.  In vivo, embelin significantly improved tumor response to X-ray radiation in the PC-3 xenograft model.  Combination therapy produced enhanced tumor growth delay and prolonged time to progression, with minimal systemic toxicity.  Immunohistochem. studies showed that embelin plus IR significantly inhibited cell proliferation, induced apoptosis, and decreased microvessel d. in tumors as compared with either treatment alone, suggesting an enhanced combinatory inhibition on tumor suppression and angiogenesis.  Our results demonstrate that embelin significantly facilitates tumor suppression by radiation therapy both in vitro and in vivo in the prostate cancer model.  This finding warrants embelin as a novel adjuvant therapeutic candidate for the treatment of hormone-refractory prostate cancer that is resistant to radiation therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaR72PSf0Ix7Vg90H21EOLACvtfcHk0lhsEI6b3C5xCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXms1Knsbo%253D&md5=4a4c379504790fb542eda1f04b406ae5</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DDesano%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DMeng%26aufirst%3DY.%26aulast%3DLawrence%26aufirst%3DT.%2BS.%26aulast%3DXu%26aufirst%3DL.%26atitle%3DNatural%2520IAP%2520inhibitor%2520Embelin%2520enhances%2520therapeutic%2520efficacy%2520of%2520ionizing%2520radiation%2520in%2520prostate%2520cancer%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2011%26volume%3D1%26spage%3D128%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeSano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burstein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pienta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span> <span> </span><span class="NLM_article-title">Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7701</span>– <span class="NLM_lpage">7710</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-0188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1078-0432.CCR-08-0188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=19047096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVegtrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=7701-7710&author=Y.+Daiauthor=M.+Liuauthor=W.+Tangauthor=J.+DeSanoauthor=E.+Bursteinauthor=M.+Davisauthor=K.+Pientaauthor=T.+Lawrenceauthor=L.+Xu&title=Molecularly+targeted+radiosensitization+of+human+prostate+cancer+by+modulating+inhibitor+of+apoptosis&doi=10.1158%2F1078-0432.CCR-08-0188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Molecularly Targeted Radiosensitization of Human Prostate Cancer by Modulating Inhibitor of Apoptosis</span></div><div class="casAuthors">Dai, Yao; Liu, Meilan; Tang, Wenhua; DeSano, Jeffrey; Burstein, Ezra; Davis, Mary; Pienta, Kenneth; Lawrence, Theodore; Xu, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7701-7710</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The inhibitor of apoptosis proteins (IAP) are overexpressed in hormone-refractory prostate cancer, rendering the cancer cells resistant to radiation.  This study aims to investigate the radiosensitizing effect of small-mol. IAP inhibitor both in vitro and in vivo in androgen-independent prostate cancer and the possible mechanism of radiosensitization.  Exptl. Design: Radiosensitization of SH-130 in human prostate cancer DU-145 cells was detd. by clonogenic survival assay.  Combination effect of SH-130 and ionizing radiation was evaluated by apoptosis assays.  Pull-down and immunopptn. assays were employed to investigate the interaction between SH-130 and IAPs.  DU-145 xenografts in nude mice were treated with SH-130, radiation, or combination, and tumor suppression effect was detd. by caliper measurement or bioluminescence imaging.  Nuclear factor-κB activation was detected by luciferase reporter assay and quant. real-time PCR.  RESULTS: SH-130 potently enhanced radiation-induced caspase activation and apoptosis in DU-145 cells.  Both X-linked IAP and cIAP-1 can be pulled down by SH-130 but not by inactive SH-123.  Moreover, SH-130 interrupted interaction between X-linked IAP/cIAP-1 and Smac.  In a nude mouse xenograft model, SH-130 potently sensitized the DU-145 tumors to X-ray radiation without increasing systemic toxicity.  The combination therapy suppressed tumor growth more significantly than either treatment alone, with over 80% of complete tumor regression.  Furthermore, SH-130 partially blocked tumor necrosis factor-α- and radiation-induced nuclear factor-κB activation in DU-145 cells.  CONCLUSIONS: Our results show that small-mol. inhibitors of IAPs can overcome apoptosis resistance and radiosensitize human prostate cancer with high levels of IAPs.  Mol. modulation of IAPs may improve the outcome of prostate cancer radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMkV6mpPRNdrVg90H21EOLACvtfcHk0lhsEI6b3C5xCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVegtrbI&md5=e17e9cc73ae39e2505b06ddc9c300e83</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0188%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DDeSano%26aufirst%3DJ.%26aulast%3DBurstein%26aufirst%3DE.%26aulast%3DDavis%26aufirst%3DM.%26aulast%3DPienta%26aufirst%3DK.%26aulast%3DLawrence%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DL.%26atitle%3DMolecularly%2520targeted%2520radiosensitization%2520of%2520human%2520prostate%2520cancer%2520by%2520modulating%2520inhibitor%2520of%2520apoptosis%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D7701%26epage%3D7710%26doi%3D10.1158%2F1078-0432.CCR-08-0188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vellanki, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabrucker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proepper, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eramo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeckers, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Small-molecule XIAP inhibitors enhance gamma-irradiation-induced apoptosis in glioblastoma</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1593/neo.09436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1593%2Fneo.09436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=19649204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1MXoslKiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=743-752&author=S.+H.+Vellankiauthor=A.+Grabruckerauthor=S.+Liebauauthor=C.+Proepperauthor=A.+Eramoauthor=V.+Braunauthor=T.+Boeckersauthor=K.+M.+Debatinauthor=S.+Fulda&title=Small-molecule+XIAP+inhibitors+enhance+gamma-irradiation-induced+apoptosis+in+glioblastoma&doi=10.1593%2Fneo.09436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule XIAP inhibitors enhance γ-irradiation-induced apoptosis in glioblastoma</span></div><div class="casAuthors">Vellanki, Sri Hari Krishna; Grabrucker, Andreas; Liebau, Stefan; Proepper, Christian; Eramo, Adriana; Braun, Veit; Boeckers, Tobias; Debatin, Klaus-Michael; Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Ann Arbor, MI, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">743-752</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">Because evasion of apoptosis can cause radioresistance of glioblastoma, there is a need to design rational strategies that counter apoptosis resistance.  In the present study, we investigated the potential of targeting the antiapoptotic protein XIAP for the radiosensitization of glioblastoma.  Here, we report that small-mol. XIAP inhibitors significantly enhance γ-irradn.-induced loss of viability and apoptosis and cooperate with γ-irradn. to suppress clonogenic survival of glioblastoma cells.  Anal. of mol. mechanisms reveals that XIAP inhibitors act in concert with γ-irradn. to cause mitochondrial outer membrane permeabilization, caspase activation, and caspase-dependent apoptosis.  Importantly, XIAP inhibitors also sensitize primary cultured glioblastoma cells derived from surgical specimens as well as glioblastoma-initiating stemlike cancer stem cells for γ-irradn.  In contrast, they do not increase the toxicity of γ-irradn. on some nonmalignant cells of the central nervous system, including rat neurons or glial cells, pointing to some tumor selectivity.  In conclusion, by demonstrating for the first time that small-mol. XIAP inhibitors increase the radiosensitivity of glioblastoma cells while sparing normal cells of the central nervous system, our findings build the rationale for further (pre)clin. development of XIAP inhibitors in combination with γ-irradn. in glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHqZM_Mi9OOLVg90H21EOLACvtfcHk0lhsEI6b3C5xCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXoslKiur4%253D&md5=903abf6952c79563b01bf32211c81cee</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1593%2Fneo.09436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.09436%26sid%3Dliteratum%253Aachs%26aulast%3DVellanki%26aufirst%3DS.%2BH.%26aulast%3DGrabrucker%26aufirst%3DA.%26aulast%3DLiebau%26aufirst%3DS.%26aulast%3DProepper%26aufirst%3DC.%26aulast%3DEramo%26aufirst%3DA.%26aulast%3DBraun%26aufirst%3DV.%26aulast%3DBoeckers%26aufirst%3DT.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DSmall-molecule%2520XIAP%2520inhibitors%2520enhance%2520gamma-irradiation-induced%2520apoptosis%2520in%2520glioblastoma%26jtitle%3DNeoplasia%26date%3D2009%26volume%3D11%26spage%3D743%26epage%3D752%26doi%3D10.1593%2Fneo.09436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennewein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marschall, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristofanon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellanki, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hehlgans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludolph, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">NF-kappaB is required for Smac mimetic-mediated sensitization of glioblastoma cells for gamma-irradiation-induced apoptosis</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1867</span>– <span class="NLM_lpage">1875</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1535-7163.MCT-11-0218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21859841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yls77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=1867-1875&author=R.+Bergerauthor=C.+Jenneweinauthor=V.+Marschallauthor=S.+Karlauthor=S.+Cristofanonauthor=L.+Wagnerauthor=S.+H.+Vellankiauthor=S.+Hehlgansauthor=F.+Rodelauthor=K.+M.+Debatinauthor=A.+C.+Ludolphauthor=S.+Fulda&title=NF-kappaB+is+required+for+Smac+mimetic-mediated+sensitization+of+glioblastoma+cells+for+gamma-irradiation-induced+apoptosis&doi=10.1158%2F1535-7163.MCT-11-0218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB Is Required for Smac Mimetic-Mediated Sensitization of Glioblastoma Cells for γ-Irradiation-Induced Apoptosis</span></div><div class="casAuthors">Berger, Rebecca; Jennewein, Claudia; Marschall, Viola; Karl, Sabine; Cristofanon, Silvia; Wagner, Liane; Vellanki, Sri Hari Krishna; Hehlgans, Stephanie; Roedel, Franz; Debatin, Klaus-Michael; Ludolph, Albert C.; Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1867-1875</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Evasion of apoptosis contributes to radioresistance of glioblastoma, calling for novel strategies to overcome apoptosis resistance.  In this study, we investigated the potential of the small mol. Smac mimetic BV6 to modulate radiosensitivity of glioblastoma cells.  Here, we identify a novel proapoptotic function of NF-κB in γ-irradn.-induced apoptosis of glioblastoma cells by showing, for the first time, that NF-κB is critically required for Smac mimetic-mediated radiosensitization.  BV6 significantly increases γ-irradn.-triggered apoptosis in several glioblastoma cell lines in a dose- and time-dependent manner.  Calcn. of combination index (CI) reveals that the interaction of BV6 and γ-irradn. is highly synergistic (CI < 0.3).  Mol. studies show that BV6 stimulates NF-κB activation, which is crit. for radiosensitization, because genetic inhibition of NF-κB by overexpression of the dominant-neg. superrepressor IκBα-SR significantly decreases BV6- and γ-irradn.-induced apoptosis.  Also, the BV6-mediated enhancement of γ-irradn.-triggered caspase activation, drop of mitochondrial membrane potential, and cytochrome c release is abolished in cells overexpressing IκBα-SR.  Similarly, NF-κB inhibition by ectopic expression of a kinase dead mutant of IKKβ prevents the BV6-mediated sensitization for γ-irradn.  The clin. relevance is underscored by expts. with primary tumor samples showing that BV6 sensitizes primary cultured glioma cells as well as glioblastoma-initiating cancer stem cells derived from surgical specimens for γ-irradn.  In conclusion, we identify NF-κB as a crit. mediator of Smac mimetic-conferred radiosensitization of glioblastoma cells.  These results have important implications for the development of Smac mimetic-based combination protocols for radiosensitization of glioblastoma.  Mol Cancer Ther; 10(10); 1867-75.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDgz47LnLOQ7Vg90H21EOLACvtfcHk0lje3L1LjVb3ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yls77J&md5=35bf683c1a4316871b29b41848f5fadb</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0218%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DJennewein%26aufirst%3DC.%26aulast%3DMarschall%26aufirst%3DV.%26aulast%3DKarl%26aufirst%3DS.%26aulast%3DCristofanon%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DL.%26aulast%3DVellanki%26aufirst%3DS.%2BH.%26aulast%3DHehlgans%26aufirst%3DS.%26aulast%3DRodel%26aufirst%3DF.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26aulast%3DLudolph%26aufirst%3DA.%2BC.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DNF-kappaB%2520is%2520required%2520for%2520Smac%2520mimetic-mediated%2520sensitization%2520of%2520glioblastoma%2520cells%2520for%2520gamma-irradiation-induced%2520apoptosis%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D1867%26epage%3D1875%26doi%3D10.1158%2F1535-7163.MCT-11-0218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebolt, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span> <span> </span><span class="NLM_article-title">Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-10-0643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F1535-7163.MCT-10-0643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21282353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=658-669&author=J.+Yangauthor=D.+McEachernauthor=W.+Liauthor=M.+A.+Davisauthor=H.+Liauthor=M.+A.+Morganauthor=L.+Baiauthor=J.+T.+Seboltauthor=H.+Sunauthor=T.+S.+Lawrenceauthor=S.+Wangauthor=Y.+Sun&title=Radiosensitization+of+head+and+neck+squamous+cell+carcinoma+by+a+SMAC-mimetic+compound%2C+SM-164%2C+requires+activation+of+caspases&doi=10.1158%2F1535-7163.MCT-10-0643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosensitization of Head and Neck Squamous Cell Carcinoma by a SMAC-Mimetic Compound, SM-164, Requires Activation of Caspases</span></div><div class="casAuthors">Yang, Jie; McEachern, Donna; Li, Wenyan; Davis, Mary A.; Li, Hua; Morgan, Meredith A.; Bai, Longchuan; Sebolt, Jonathan T.; Sun, Haiying; Lawrence, Theodore S.; Wang, Shaomeng; Sun, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-669</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Chemoradiation is the treatment of choice for locally advanced head and neck squamous cell carcinoma (HNSCC).  However, radioresistance, which contributes to local recurrence, remains a significant therapeutic problem.  In this study, we characterized SM-164, a small second mitochondria-derived activator of caspase -mimetic compd. that promotes degrdn. of cellular inhibitor of apoptosis-1 (cIAP-1; also known as baculoviral IAP repeat-contg. protein 2, BIRC2) and releases active caspases from the X-linked inhibitor of apoptosis inhibitory binding as a radiosensitizing agent in HNSCC cells.  We found that SM-164 at nanomolar concns. induced radiosensitization in some HNSCC cell lines in a manner dependent on intrinsic sensitivity to caspase activation and apoptosis induction.  Blockage of caspase activation via short interfering RNA knockdown or a pan-caspase inhibitor, z-VAD-fmk, largely abrogated SM-164 radiosensitization.  On the other hand, the resistant lines with a high level of Bcl-2 that blocks caspase activation and apoptosis induction became sensitive to radiation on Bcl-2 knockdown.  Mechanistic studies revealed that SM-164 radiosensitization in sensitive cells was assocd. with NF-κB activation and TNFα secretion, followed by activation of caspase-8 and -9, leading to enhanced apoptosis.  Finally, SM-164 also radiosensitized human tumor xenograft while causing minimal toxicity.  Thus, SM-164 is a potent radiosensitizer via a mechanism involving caspase activation and holds promise for future clin. development as a novel class of radiosensitizer for the treatment of a subset of head and neck cancer patients.  Mol Cancer Ther; 10(4); 658-69.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNverk0aII4rVg90H21EOLACvtfcHk0lje3L1LjVb3ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSrtLg%253D&md5=956ac9aa378b66847abb94bd8f1911be</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0643%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DDavis%26aufirst%3DM.%2BA.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMorgan%26aufirst%3DM.%2BA.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DSebolt%26aufirst%3DJ.%2BT.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLawrence%26aufirst%3DT.%2BS.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DRadiosensitization%2520of%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%2520by%2520a%2520SMAC-mimetic%2520compound%252C%2520SM-164%252C%2520requires%2520activation%2520of%2520caspases%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D658%26epage%3D669%26doi%3D10.1158%2F1535-7163.MCT-10-0643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matzinger, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viertl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsoutsou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedemann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vozenin, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuagniaux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourhis, J.</span></span> <span> </span><span class="NLM_article-title">The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFalpha-mediated in head and neck squamous cell carcinoma</span>. <i>Radiother. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1016/j.radonc.2015.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.radonc.2015.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=26096848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVegs7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2015&pages=495-503&author=O.+Matzingerauthor=D.+Viertlauthor=P.+Tsoutsouauthor=L.+Kadiauthor=S.+Rigottiauthor=C.+Zannaauthor=N.+Wiedemannauthor=M.+C.+Vozeninauthor=G.+Vuagniauxauthor=J.+Bourhis&title=The+radiosensitizing+activity+of+the+SMAC-mimetic%2C+Debio+1143%2C+is+TNFalpha-mediated+in+head+and+neck+squamous+cell+carcinoma&doi=10.1016%2Fj.radonc.2015.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma</span></div><div class="casAuthors">Matzinger, Oscar; Viertl, David; Tsoutsou, Pelagia; Kadi, Linda; Rigotti, Stefania; Zanna, Claudio; Wiedemann, Norbert; Vozenin, Marie-Catherine; Vuagniaux, Gregoire; Bourhis, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Radiotherapy and Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">495-503</span>CODEN:
                <span class="NLM_cas:coden">RAONDT</span>;
        ISSN:<span class="NLM_cas:issn">0167-8140</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Second mitochondria-derived activator of caspase (SMAC)-mimetics are a new class of targeted drugs that specifically induce apoptotic cancer cell death and block pro-survival signaling by antagonizing selected members of the inhibitor of apoptosis protein (IAP) family.  The present study was designed to investigate the radiosensitizing effect and optimal sequence of administration of the novel SMAC-mimetic Debio 1143 in vitro and in vivo.  Apoptosis, alteration of DNA damage repair (DDR), and tumor necrosis factor-alpha (TNF-α) signaling were examd.  In vitro, Debio 1143 displayed anti-proliferative activity and enhanced intrinsic radiation sensitivity in 5/6 head and neck squamous cell carcinoma (HNSCC) cell lines in a synergistic manner.  In vivo, Debio 1143 dose-dependently radio-sensitized FaDu and SQ20B xenografts, resulting in complete tumor regression in 8/10 FaDu-xenografted mice at the high dose level.  At the mol. level, Debio 1143 combined with radiotherapy (RT) induced enhancement of caspase-3 activity, increase in Annexin V-pos. cells and karyopyknosis, and increase in TNF-α mRNA levels.  Finally, in a neutralization expt. using a TNF-α-blocking antibody and a caspase inhibitor, it was shown that the radiosensitizing effect of Debio 1143 is mediated by caspases and TNF-α.  These results demonstrate that the novel SMAC-mimetic Debio 1143 is a radiosensitizing agent that is worthy of further investigation in clin. trials in combination with radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDXg5haORedrVg90H21EOLACvtfcHk0lhxYj64UE-JQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVegs7rM&md5=632f084b345194b4140826f076162f1d</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.radonc.2015.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.radonc.2015.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DMatzinger%26aufirst%3DO.%26aulast%3DViertl%26aufirst%3DD.%26aulast%3DTsoutsou%26aufirst%3DP.%26aulast%3DKadi%26aufirst%3DL.%26aulast%3DRigotti%26aufirst%3DS.%26aulast%3DZanna%26aufirst%3DC.%26aulast%3DWiedemann%26aufirst%3DN.%26aulast%3DVozenin%26aufirst%3DM.%2BC.%26aulast%3DVuagniaux%26aufirst%3DG.%26aulast%3DBourhis%26aufirst%3DJ.%26atitle%3DThe%2520radiosensitizing%2520activity%2520of%2520the%2520SMAC-mimetic%252C%2520Debio%25201143%252C%2520is%2520TNFalpha-mediated%2520in%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%26jtitle%3DRadiother.%2520Oncol.%26date%3D2015%26volume%3D116%26spage%3D495%26epage%3D503%26doi%3D10.1016%2Fj.radonc.2015.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span> <span> </span><span class="NLM_article-title">SMAC-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis</span>. <i>Breast Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1007/s10549-011-1752-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1007%2Fs10549-011-1752-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21901386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlOlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2012&pages=189-199&author=D.+Yangauthor=Y.+Zhaoauthor=A.+Y.+Liauthor=S.+Wangauthor=G.+Wangauthor=Y.+Sun&title=SMAC-mimetic+compound+SM-164+induces+radiosensitization+in+breast+cancer+cells+through+activation+of+caspases+and+induction+of+apoptosis&doi=10.1007%2Fs10549-011-1752-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Smac-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis</span></div><div class="casAuthors">Yang, Dong; Zhao, Yongchao; Li, Amy Y.; Wang, Shaomeng; Wang, Gongxian; Sun, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">189-199</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Radiotherapy is a treatment choice for local control of breast cancer, particularly after the removal of tumor tissues by surgery.  However, intrinsic radioresistance of cancer cells limits therapeutic efficacy.  Here, we detd. in breast cancer cells the potential radiosensitizing activity of SM-164, a small mol. compd., that mimics the activity of SMAC, a mitochondrial protein released during apoptosis to activate caspases by inhibiting cellular inhibitor of apoptosis proteins, cIAP-1, and XIAP.  We found that SM-164 at nanomolar concns. promoted degrdn. of cIAP-1, disrupted the inhibitory binding of XIAP to active caspase-9, and sensitized breast cancer cells to radiation with a sensitization enhancement ratio (SER) of 1.7-1.8.  In one line of breast cancer cells resistant to SM-164 as a single agent, SM-164 radiosensitization was mediated by intrinsic apoptosis pathway through activation of caspases-9 and -3.  In a line of breast cancer cells sensitive to SM-164 as a single agent, SM-164 radiosensitization was mediated by both extrinsic and intrinsic apoptosis pathways through activation of caspases-9, -8, and -3.  Consistently, blockage of caspase activation, through siRNA knockdown or treatment with a pan-caspase inhibitor z-VAD-fmk, inhibited apoptosis and abrogated SM-164 radiosensitization.  Our study demonstrates that IAPs are valid radiosensitizing targets in breast cancer cells and SM-164 could be further developed as a novel class of radiosensitizers for the treatment of radioresistant breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQN0rWHmKu-LVg90H21EOLACvtfcHk0lhxYj64UE-JQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlOlu7k%253D&md5=61941e8b55a1a5dca83c836a19188558</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1007%2Fs10549-011-1752-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-011-1752-3%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DA.%2BY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DSMAC-mimetic%2520compound%2520SM-164%2520induces%2520radiosensitization%2520in%2520breast%2520cancer%2520cells%2520through%2520activation%2520of%2520caspases%2520and%2520induction%2520of%2520apoptosis%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2012%26volume%3D133%26spage%3D189%26epage%3D199%26doi%3D10.1007%2Fs10549-011-1752-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peery, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. T.</span></span> <span> </span><span class="NLM_article-title">Targeting survivin for therapeutic discovery: past, present, and future promises</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1466</span>– <span class="NLM_lpage">1477</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2017.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.drudis.2017.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=28577912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlSgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1466-1477&author=R.+C.+Peeryauthor=J.+Y.+Liuauthor=J.+T.+Zhang&title=Targeting+survivin+for+therapeutic+discovery%3A+past%2C+present%2C+and+future+promises&doi=10.1016%2Fj.drudis.2017.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting survivin for therapeutic discovery: past, present, and future promises</span></div><div class="casAuthors">Peery, Robert C.; Liu, Jing-Yuan; Zhang, Jian-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1466-1477</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Survivin, the smallest member of the inhibitor of apoptosis protein (IAP) family, is overexpressed in cells of almost all cancers but not in most normal tissues in adults.  Survivin expression is required for cancer cell survival and knocking down its expression or inhibiting its function using mol. approaches results in spontaneous apoptosis.  Thus, survivin is an attractive and perhaps ideal target for cancer drug discovery.  However, a US Food and Drug Administration (FDA)-approved drug targeting survivin has yet to emerge.  In this Foundation Review, we examine and evaluate various strategies that have been used to target survivin and the stages of each survivin inhibitor to help understand this lack of success.  We also provide future perspectives moving forward in targeting survivin for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAjdIclTWikbVg90H21EOLACvtfcHk0lhxYj64UE-JQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlSgsrk%253D&md5=e0c67912f0c8fbd96ba9bd3d454dc879</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2017.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2017.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DPeery%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DZhang%26aufirst%3DJ.%2BT.%26atitle%3DTargeting%2520survivin%2520for%2520therapeutic%2520discovery%253A%2520past%252C%2520present%252C%2520and%2520future%2520promises%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2017%26volume%3D22%26spage%3D1466%26epage%3D1477%26doi%3D10.1016%2Fj.drudis.2017.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">Livin/ML-IAP as a new target for cancer treatment</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>250</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2006.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.canlet.2006.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=17218055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=2007&pages=168-176&author=B.+Liuauthor=M.+Hanauthor=J.+K.+Wenauthor=L.+Wang&title=Livin%2FML-IAP+as+a+new+target+for+cancer+treatment&doi=10.1016%2Fj.canlet.2006.09.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Livin/ML-IAP as a new target for cancer treatment</span></div><div class="casAuthors">Liu, Bin; Han, Mei; Wen, Jin-Kun; Wang, Ling</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">250</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-176</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Livin is a member of the inhibitors of apoptosis protein (IAP) gene family, which encodes neg. regulatory proteins that prevent cell apoptosis.  Livin is selectively expressed in the most common human neoplasms and appears to be involved in tumor cell resistance to chemotherapeutic agents.  Several studies in vitro and in vivo have demonstrated that down-regulation of Livin expression increases the apoptotic rate, reduces tumor growth potential and sensitized tumor cells to chemotherapeutic drugs.  This review will focus on the role of this protein during cancer development and progression and will demonstrate possible targets for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4SSDnWWgHJLVg90H21EOLACvtfcHk0lgcrrkPH7U_Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFGqtLk%253D&md5=7af14b77b7c348e8d39bdfc3d9c74e2c</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2006.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2006.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DM.%26aulast%3DWen%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DL.%26atitle%3DLivin%252FML-IAP%2520as%2520a%2520new%2520target%2520for%2520cancer%2520treatment%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D250%26spage%3D168%26epage%3D176%26doi%3D10.1016%2Fj.canlet.2006.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feltham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettjeman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budhidarmo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mace, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunduru, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinlay, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaux, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, C. L.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">17015</span>– <span class="NLM_lpage">17028</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.222919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.M111.222919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21393245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlslKlur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=17015-17028&author=R.+Felthamauthor=B.+Bettjemanauthor=R.+Budhidarmoauthor=P.+D.+Maceauthor=S.+Shirleyauthor=S.+M.+Condonauthor=S.+K.+Chunduruauthor=M.+A.+McKinlayauthor=D.+L.+Vauxauthor=J.+Silkeauthor=C.+L.+Day&title=SMAC+mimetics+activate+the+E3+ligase+activity+of+cIAP1+protein+by+promoting+RING+domain+dimerization&doi=10.1074%2Fjbc.M111.222919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Smac Mimetics Activate the E3 Ligase Activity of cIAP1 Protein by Promoting RING Domain Dimerization</span></div><div class="casAuthors">Feltham, Rebecca; Bettjeman, Bodhi; Budhidarmo, Rhesa; Mace, Peter D.; Shirley, Sarah; Condon, Stephen M.; Chunduru, Srinivas K.; McKinlay, Mark A.; Vaux, David L.; Silke, John; Day, Catherine L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">17015-17028</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins are important ubiquitin E3 ligases that regulate cell survival and oncogenesis.  The cIAP1 and cIAP2 paralogs bear three N-terminal baculoviral IAP repeat (BIR) domains and a C-terminal E3 ligase RING domain.  IAP antagonist compds., also known as Smac mimetics, bind the BIR domains of IAPs and trigger rapid RING-dependent autoubiquitylation, but the mechanism is unknown.  We show that RING dimerization is essential for the E3 ligase activity of cIAP1 and cIAP2 because monomeric RING mutants could not interact with the ubiquitin-charged E2 enzyme and were resistant to Smac mimetic-induced autoubiquitylation.  Unexpectedly, the BIR domains inhibited cIAP1 RING dimerization, and cIAP1 existed predominantly as an inactive monomer.  However, addn. of either mono- or bivalent Smac mimetics relieved this inhibition, thereby allowing dimer formation and promoting E3 ligase activation.  In contrast, the cIAP2 dimer was more stable, had higher intrinsic E3 ligase activity, and was not highly activated by Smac mimetics.  These results explain how Smac mimetics promote rapid destruction of cIAP1 and suggest mechanisms for activating cIAP1 in other pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4sfaFqS3EFbVg90H21EOLACvtfcHk0lgcrrkPH7U_Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlslKlur4%253D&md5=94c17984105fe3a51bb9c797c82702fa</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.222919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.222919%26sid%3Dliteratum%253Aachs%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DBettjeman%26aufirst%3DB.%26aulast%3DBudhidarmo%26aufirst%3DR.%26aulast%3DMace%26aufirst%3DP.%2BD.%26aulast%3DShirley%26aufirst%3DS.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DMcKinlay%26aufirst%3DM.%2BA.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DC.%2BL.%26atitle%3DSMAC%2520mimetics%2520activate%2520the%2520E3%2520ligase%2520activity%2520of%2520cIAP1%2520protein%2520by%2520promoting%2520RING%2520domain%2520dimerization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D17015%26epage%3D17028%26doi%3D10.1074%2Fjbc.M111.222919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Induced protein degradation: an emerging drug discovery paradigm</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnrd.2016.211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27885283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCit7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=101-114&author=A.+C.+Laiauthor=C.+M.+Crews&title=Induced+protein+degradation%3A+an+emerging+drug+discovery+paradigm&doi=10.1038%2Fnrd.2016.211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Induced protein degradation: an emerging drug discovery paradigm</span></div><div class="casAuthors">Lai, Ashton C.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-114</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. drug discovery has traditionally focused on occupancy of a binding site that directly affects protein function, and this approach typically precludes targeting proteins that lack such amenable sites.  Furthermore, high systemic drug exposures may be needed to maintain sufficient target inhibition in vivo, increasing the risk of undesirable off-target effects.  Induced protein degrdn. is an alternative approach that is event-driven: upon drug binding, the target protein is tagged for elimination.  Emerging technologies based on proteolysis-targeting chimaeras (PROTACs) that exploit cellular quality control machinery to selectively degrade target proteins are attracting considerable attention in the pharmaceutical industry owing to the advantages they could offer over traditional small-mol. strategies.  These advantages include the potential to reduce systemic drug exposure, the ability to counteract increased target protein expression that often accompanies inhibition of protein function and the potential ability to target proteins that are not currently therapeutically tractable, such as transcription factors, scaffolding and regulatory proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj-O7zXGOpXLVg90H21EOLACvtfcHk0lgcrrkPH7U_Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCit7rP&md5=a01ff43e9b696fe4dc03f0815158a98f</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.211%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DA.%2BC.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DInduced%2520protein%2520degradation%253A%2520an%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D101%26epage%3D114%26doi%3D10.1038%2Fnrd.2016.211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Development of protein degradation inducers of androgen receptor by conjugation of androgen receptor ligands and inhibitor of apoptosis protein ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">575</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00168</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00168" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslSlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=543-575&author=N.+Shibataauthor=K.+Nagaiauthor=Y.+Moritaauthor=O.+Ujikawaauthor=N.+Ohokaauthor=T.+Hattoriauthor=R.+Koyamaauthor=O.+Sanoauthor=Y.+Imaedaauthor=H.+Naraauthor=N.+Choauthor=M.+Naito&title=Development+of+protein+degradation+inducers+of+androgen+receptor+by+conjugation+of+androgen+receptor+ligands+and+inhibitor+of+apoptosis+protein+ligands&doi=10.1021%2Facs.jmedchem.7b00168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands</span></div><div class="casAuthors">Shibata, Norihito; Nagai, Katsunori; Morita, Yoko; Ujikawa, Osamu; Ohoka, Nobumichi; Hattori, Takayuki; Koyama, Ryokichi; Sano, Osamu; Imaeda, Yasuhiro; Nara, Hiroshi; Cho, Nobuo; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">543-575</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeted protein degrdn. using small mols. is a novel strategy for drug development.  The authors have developed hybrid mols. named specific and nongenetic inhibitor of apoptosis protein [IAP]-dependent protein erasers (SNIPERs) that recruit IAP ubiquitin ligases to degrade target proteins.  Here, the authors show novel SNIPERs capable of inducing proteasomal degrdn. of the androgen receptor (AR).  Through derivatization of the SNIPER(AR) mol. at the AR ligand and IAP ligand and linker, the authors developed SNIPER(AR)-51 (I), which shows effective protein knockdown activity against AR.  Consistent with the degrdn. of the AR protein, I inhibits AR-mediated gene expression and proliferation of androgen-dependent prostate cancer cells.  In addn., I efficiently induces caspase activation and apoptosis in prostate cancer cells, which was not obsd. in the cells treated with AR antagonists.  These results suggest that SNIPER(AR)s could be leads for an anticancer drug against prostate cancers that exhibit AR-dependent proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW6OG4BZYg1rVg90H21EOLACvtfcHk0lgbEiyW0myy7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslSlu7k%253D&md5=eeefbe187f2f93ca32518f6a3258b903</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00168%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DNagai%26aufirst%3DK.%26aulast%3DMorita%26aufirst%3DY.%26aulast%3DUjikawa%26aufirst%3DO.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DKoyama%26aufirst%3DR.%26aulast%3DSano%26aufirst%3DO.%26aulast%3DImaeda%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DH.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520protein%2520degradation%2520inducers%2520of%2520androgen%2520receptor%2520by%2520conjugation%2520of%2520androgen%2520receptor%2520ligands%2520and%2520inhibitor%2520of%2520apoptosis%2520protein%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D543%26epage%3D575%26doi%3D10.1021%2Facs.jmedchem.7b00168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sameshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the allosteric site of oncoprotein BCR-ABL as an alternative strategy for effective target protein degradation</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1042</span>– <span class="NLM_lpage">1047</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00247</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00247" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2js7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1042-1047&author=K.+Shimokawaauthor=N.+Shibataauthor=T.+Sameshimaauthor=N.+Miyamotoauthor=O.+Ujikawaauthor=H.+Naraauthor=N.+Ohokaauthor=T.+Hattoriauthor=N.+Choauthor=M.+Naito&title=Targeting+the+allosteric+site+of+oncoprotein+BCR-ABL+as+an+alternative+strategy+for+effective+target+protein+degradation&doi=10.1021%2Facsmedchemlett.7b00247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Allosteric Site of Oncoprotein BCR-ABL as an Alternative Strategy for Effective Target Protein Degradation</span></div><div class="casAuthors">Shimokawa, Kenichiro; Shibata, Norihito; Sameshima, Tomoya; Miyamoto, Naoki; Ujikawa, Osamu; Nara, Hiroshi; Ohoka, Nobumichi; Hattori, Takayuki; Cho, Nobuo; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1042-1047</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein degrdn. technol. based on hybrid small mols. is an emerging drug modality that has significant potential in drug discovery and as a unique method of post-translational protein knockdown in the field of chem. biol.  Here, we report the first example of a novel and potent protein degrdn. inducer that binds to an allosteric site of the oncogenic BCR-ABL protein.  BCR-ABL allosteric ligands were incorporated into the SNIPER (Specific and Nongenetic inhibitor of apoptosis protein [IAP]-dependent Protein Erasers) platform, and a series of in vitro biol. assays of binding affinity, target protein modulation, signal transduction, and growth inhibition were carried out.  One of the designed compds., I (SNIPER(ABL)-062), showed desirable binding affinities against ABL1, cIAP1/2, and XIAP and consequently caused potent BCR-ABL degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH-F9T_RIbVbVg90H21EOLACvtfcHk0lgbEiyW0myy7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2js7fI&md5=2500e7d9129934033f969721141a8c1b</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00247%26sid%3Dliteratum%253Aachs%26aulast%3DShimokawa%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DSameshima%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DN.%26aulast%3DUjikawa%26aufirst%3DO.%26aulast%3DNara%26aufirst%3DH.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520allosteric%2520site%2520of%2520oncoprotein%2520BCR-ABL%2520as%2520an%2520alternative%2520strategy%2520for%2520effective%2520target%2520protein%2520degradation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1042%26epage%3D1047%26doi%3D10.1021%2Facsmedchemlett.7b00247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span> <span> </span><span class="NLM_article-title">Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">5820</span>– <span class="NLM_lpage">5826</span>, <span class="refDoi"> DOI: 10.1021/ja100691p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja100691p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1Gktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=5820-5826&author=Y.+Itohauthor=M.+Ishikawaauthor=M.+Naitoauthor=Y.+Hashimoto&title=Protein+knockdown+using+methyl+bestatin-ligand+hybrid+molecules%3A+design+and+synthesis+of+inducers+of+ubiquitination-mediated+degradation+of+cellular+retinoic+acid-binding+proteins&doi=10.1021%2Fja100691p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Knockdown Using Methyl Bestatin-Ligand Hybrid Molecules: Design and Synthesis of Inducers of Ubiquitination-Mediated Degradation of Cellular Retinoic Acid-Binding Proteins</span></div><div class="casAuthors">Itoh, Yukihiro; Ishikawa, Minoru; Naito, Mikihiko; Hashimoto, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5820-5826</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Induction of selective degrdn. of target proteins by small mols. (protein knockdown) would be useful for biol. research and treatment of various diseases.  To achieve protein knockdown, we utilized the ubiquitin ligase activity of cellular inhibitor of apoptosis protein 1 (cIAP1), which is activated by Me bestatin (MeBS, 2).  We speculated that formation of an artificial (nonphysiol.) complex of cIAP1 and a target protein would be induced by a hybrid mol. consisting of MeBS (2) linked to a ligand of the target protein, and this would lead to cIAP1-mediated ubiquitination and subsequent proteasomal degrdn. of the target protein.  To verify this hypothesis, we focused on cellular retinoic acid-binding proteins (CRABP-I and -II) and designed hybrid mols. (compds. 4) consisting of MeBS (2) coupled via spacers of various lengths to all-trans retinoic acid (ATRA, 3), a ligand of CRABPs.  Compds. 4 induced selective loss of CRABP-I and -II proteins in cells.  We confirmed that 4b induced formation of a complex of cIAP1 and CRABP-II in vitro and induced proteasomal degrdn. of CRABP-II in cells.  When neuroblastoma IMR-32 cells were treated with 4b, the level of CRABP-II was reduced and cell migration was inhibited, suggesting potential value of CRABP-II-targeting therapy for controlling tumor metastasis.  Our results indicate that 4b possesses sufficient activity, permeability, and stability in cells to be employed in cellular assays.  Hybrid mols. such as 4 should be useful not only as chem. tools for studying the biol./physiol. functions of CRABPs but also as candidate therapeutic agents targeting CRABPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUZurgNT02VLVg90H21EOLACvtfcHk0lgbEiyW0myy7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1Gktb0%253D&md5=96c56bb081695a00b6fa6c269aaeef1b</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fja100691p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja100691p%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DNaito%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26atitle%3DProtein%2520knockdown%2520using%2520methyl%2520bestatin-ligand%2520hybrid%2520molecules%253A%2520design%2520and%2520synthesis%2520of%2520inducers%2520of%2520ubiquitination-mediated%2520degradation%2520of%2520cellular%2520retinoic%2520acid-binding%2520proteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D5820%26epage%3D5826%26doi%3D10.1021%2Fja100691p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okuhira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimaki-Mogami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>585</i></span>,  <span class="NLM_fpage">1147</span>– <span class="NLM_lpage">1152</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2011.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.febslet.2011.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21414315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVGjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2011&pages=1147-1152&author=K.+Okuhiraauthor=N.+Ohokaauthor=K.+Saiauthor=T.+Nishimaki-Mogamiauthor=Y.+Itohauthor=M.+Ishikawaauthor=Y.+Hashimotoauthor=M.+Naito&title=Specific+degradation+of+CRABP-II+via+cIAP1-mediated+ubiquitylation+induced+by+hybrid+molecules+that+crosslink+cIAP1+and+the+target+protein&doi=10.1016%2Fj.febslet.2011.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein</span></div><div class="casAuthors">Okuhira, Keiichiro; Ohoka, Nobumichi; Sai, Kimie; Nishimaki-Mogami, Tomoko; Itoh, Yukihiro; Ishikawa, Minoru; Hashimoto, Yuichi; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1147-1152</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Manipulation of protein stability with small mols. is a challenge in the field of drug discovery.  Here we show that cellular retinoic acid binding protein-II (CRABP-II) can be specifically degraded by a novel compd., SNIPER-4, consisting of (-)-N-[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butyryl]-L-leucine Me ester and all-trans retinoic acid that are ligands for cellular inhibitor of apoptosis protein 1 (cIAP1) and CRABP-II, resp.  Mechanistic anal. revealed that SNIPER-4 induces cIAP1-mediated ubiquitylation of CRABP-II, resulting in the proteasomal degrdn.  The protein knockdown strategy employing the structure of SNIPER-4 could be applicable to other target proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5g-lBn9EFJrVg90H21EOLACvtfcHk0lgbEiyW0myy7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVGjtLk%253D&md5=5f56939c9c2a68efb08283b68a570af1</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2011.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2011.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DOkuhira%26aufirst%3DK.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DSai%26aufirst%3DK.%26aulast%3DNishimaki-Mogami%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DSpecific%2520degradation%2520of%2520CRABP-II%2520via%2520cIAP1-mediated%2520ubiquitylation%2520induced%2520by%2520hybrid%2520molecules%2520that%2520crosslink%2520cIAP1%2520and%2520the%2520target%2520protein%26jtitle%3DFEBS%2520Lett.%26date%3D2011%26volume%3D585%26spage%3D1147%26epage%3D1152%26doi%3D10.1016%2Fj.febslet.2011.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okuhira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimaki-Mogami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">1492</span>– <span class="NLM_lpage">1498</span>, <span class="refDoi"> DOI: 10.1111/cas.12272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1111%2Fcas.12272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=23992566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ylu7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2013&pages=1492-1498&author=K.+Okuhiraauthor=Y.+Demizuauthor=T.+Hattoriauthor=N.+Ohokaauthor=N.+Shibataauthor=T.+Nishimaki-Mogamiauthor=H.+Okudaauthor=M.+Kuriharaauthor=M.+Naito&title=Development+of+hybrid+small+molecules+that+induce+degradation+of+estrogen+receptor-alpha+and+necrotic+cell+death+in+breast+cancer+cells&doi=10.1111%2Fcas.12272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells</span></div><div class="casAuthors">Okuhira, Keiichiro; Demizu, Yosuke; Hattori, Takayuki; Ohoka, Nobumichi; Shibata, Norihito; Nishimaki-Mogami, Tomoko; Okuda, Haruhiro; Kurihara, Masaaki; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1492-1498</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Manipulation of protein stability with small mols. has a great potential for both basic research and clin. therapy.  Recently, we have developed a series of hybrid small mols. named SNIPER (Specific and Non-genetic IAP-dependent Protein ERaser) that induces degrdn. of target proteins via ubiquitin-proteasome system.  Here we report the activities of SNIPER(ER) that targets estrogen receptor alpha (ERα) for degrdn.  SNIPER(ER) induced degrdn. of ERα and inhibited estrogen-dependent expression of pS2 gene in an estrogen-dependent breast cancer cell line MCF-7.  A proteasome inhibitor MG132 and siRNA-mediated downregulation of cIAP1 abrogated the SNIPER(ER)-induced ERα degrdn., suggesting that the ERα is degraded by proteasome subsequent to cIAP1-mediated ubiquitylation.  Intriguingly, after the ERα degrdn., the SNIPER(ER)-treated MCF-7 cells undergo rapid cell death.  Detailed anal. indicated that SNIPER(ER) caused necrotic cell death accompanied by a release of HMGB1, a marker of necrosis, from the cells.  Following the ERα degrdn., reactive oxygen species (ROS) was produced in the SNIPER(ER)-treated MCF-7 cells, and an anti-oxidant N-acetylcysteine inhibited the necrotic cell death.  These results indicate that SNIPER(ER) induces ERα degrdn., ROS prodn. and necrotic cell death, implying a therapeutic potential of SNIPER(ER) as a lead for the treatment of ERα-pos. breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpckyKeS1C4ZrVg90H21EOLACvtfcHk0lgVrHN-kRUd-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ylu7fM&md5=dc35aee47ea4cd9554a663eb077137b5</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1111%2Fcas.12272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12272%26sid%3Dliteratum%253Aachs%26aulast%3DOkuhira%26aufirst%3DK.%26aulast%3DDemizu%26aufirst%3DY.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DNishimaki-Mogami%26aufirst%3DT.%26aulast%3DOkuda%26aufirst%3DH.%26aulast%3DKurihara%26aufirst%3DM.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520hybrid%2520small%2520molecules%2520that%2520induce%2520degradation%2520of%2520estrogen%2520receptor-alpha%2520and%2520necrotic%2520cell%2520death%2520in%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Sci.%26date%3D2013%26volume%3D104%26spage%3D1492%26epage%3D1498%26doi%3D10.1111%2Fcas.12272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuhira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e1513</span> <span class="refDoi"> DOI: 10.1038/cddis.2014.471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fcddis.2014.471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=25375378" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=N.+Ohokaauthor=K.+Nagaiauthor=T.+Hattoriauthor=K.+Okuhiraauthor=N.+Shibataauthor=N.+Choauthor=M.+Naito&title=Cancer+cell+death+induced+by+novel+small+molecules+degrading+the+TACC3+protein+via+the+ubiquitin-proteasome+pathway&doi=10.1038%2Fcddis.2014.471"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.471%26sid%3Dliteratum%253Aachs%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DNagai%26aufirst%3DK.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DOkuhira%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DCancer%2520cell%2520death%2520induced%2520by%2520novel%2520small%2520molecules%2520degrading%2520the%2520TACC3%2520protein%2520via%2520the%2520ubiquitin-proteasome%2520pathway%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26doi%3D10.1038%2Fcddis.2014.471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Protein knockdown technology: application of ubiquitin ligase to cancer therapy</span>. <i>Curr. Cancer Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.2174/1568009616666151112122502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.2174%2F1568009616666151112122502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=26560118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFOqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=136-146&author=N.+Ohokaauthor=N.+Shibataauthor=T.+Hattoriauthor=M.+Naito&title=Protein+knockdown+technology%3A+application+of+ubiquitin+ligase+to+cancer+therapy&doi=10.2174%2F1568009616666151112122502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy</span></div><div class="casAuthors">Ohoka, Nobumichi; Shibata, Norihito; Hattori, Takayuki; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">136-146</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Selective degrdn. of pathogenic proteins by small mols. in cells is a novel approach for development of therapeutic agents against various diseases, including cancer.  We and others have developed a protein knockdown technol. with a series of hybrid small compds., called SNIPERs (Specific and Nongenetic IAP-dependent Protein ERasers); and peptidic chimeric mols., called PROTACs (proteolysis-targeting chimeric mols.), which induce selective degrdn. of target proteins via the ubiquitin-proteasome pathway.  These compds. include two different ligands connected by a linker; one is a ligand for a ubiquitin ligase and the other is a ligand for the target protein, which are expected to crosslink these proteins in cells.  Theor., any cytosolic protein can be targeted for degrdn. by this technol.  To date, several SNIPERs and PROTACs against various oncogenic proteins have been developed, which specifically induce polyubiquitylation and proteasomal degrdn. of the oncogenic proteins, resulting in cell death, growth arrest, or impaired migration of cancer cells.  Thus, this protein knockdown technol. has a great potential for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmS_kGOWfeuLVg90H21EOLACvtfcHk0lgVrHN-kRUd-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFOqtw%253D%253D&md5=d78f1ae70ea89843d9f946454cc95058</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.2174%2F1568009616666151112122502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009616666151112122502%26sid%3Dliteratum%253Aachs%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DProtein%2520knockdown%2520technology%253A%2520application%2520of%2520ubiquitin%2520ligase%2520to%2520cancer%2520therapy%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2016%26volume%3D16%26spage%3D136%26epage%3D146%26doi%3D10.2174%2F1568009616666151112122502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okuhira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Molecular design, synthesis, and evaluation of SNIPER(ER) that induces proteasomal degradation of ERalpha</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1366</i></span>,  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-3127-9_42</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1007%2F978-1-4939-3127-9_42" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=26585163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntV2iuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1366&publication_year=2016&pages=549-560&author=K.+Okuhiraauthor=Y.+Demizuauthor=T.+Hattoriauthor=N.+Ohokaauthor=N.+Shibataauthor=M.+Kuriharaauthor=M.+Naito&title=Molecular+design%2C+synthesis%2C+and+evaluation+of+SNIPER%28ER%29+that+induces+proteasomal+degradation+of+ERalpha&doi=10.1007%2F978-1-4939-3127-9_42"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Design, Synthesis, and Evaluation of SNIPER(ER) That Induces Proteasomal Degradation of ERα</span></div><div class="casAuthors">Okuhira, Keiichiro; Demizu, Yosuke; Hattori, Takayuki; Ohoka, Nobumichi; Shibata, Norihito; Kurihara, Masaaki; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1366</span>
        (<span class="NLM_cas:issue">Estrogen Receptors</span>),
    <span class="NLM_cas:pages">549-560</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Manipulation of protein stability using small mols. has a great potential for both basic research and clin. therapy.  Based on our protein knockdown technol., we recently developed a novel small mol. SNIPER(ER) that targets the estrogen receptor alpha (ERα) for degrdn. via the ubiquitin-proteasome system.  This chapter describes the design and synthesis of SNIPER(ER) compds., and methods for the evaluation of their activity in cellular system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw8q6LETjkkLVg90H21EOLACvtfcHk0lhJcPvbHYl_EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntV2iuro%253D&md5=ece40d5d502601cdd67d104533d497bc</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-3127-9_42&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-3127-9_42%26sid%3Dliteratum%253Aachs%26aulast%3DOkuhira%26aufirst%3DK.%26aulast%3DDemizu%26aufirst%3DY.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DKurihara%26aufirst%3DM.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DMolecular%2520design%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520SNIPER%2528ER%2529%2520that%2520induces%2520proteasomal%2520degradation%2520of%2520ERalpha%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2016%26volume%3D1366%26spage%3D549%26epage%3D560%26doi%3D10.1007%2F978-1-4939-3127-9_42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motoi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, M.</span></span> <span> </span><span class="NLM_article-title">Development of BCR-ABL degradation inducers via the conjugation of an imatinib derivative and a cIAP1 ligand</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4865</span>– <span class="NLM_lpage">4869</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.bmcl.2016.09.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27666635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOntbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4865-4869&author=Y.+Demizuauthor=N.+Shibataauthor=T.+Hattoriauthor=N.+Ohokaauthor=H.+Motoiauthor=T.+Misawaauthor=T.+Shodaauthor=M.+Naitoauthor=M.+Kurihara&title=Development+of+BCR-ABL+degradation+inducers+via+the+conjugation+of+an+imatinib+derivative+and+a+cIAP1+ligand&doi=10.1016%2Fj.bmcl.2016.09.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Development of BCR-ABL degradation inducers via the conjugation of an imatinib derivative and a cIAP1 ligand</span></div><div class="casAuthors">Demizu, Yosuke; Shibata, Norihito; Hattori, Takayuki; Ohoka, Nobumichi; Motoi, Hiromi; Misawa, Takashi; Shoda, Takuji; Naito, Mikihiko; Kurihara, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4865-4869</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The manipulation of protein stability with small mols. has great potential as a technique for aiding the development of clin. therapies, including treatments for cancer.  In this study, BCR-ABL protein degrdn. inducers called SNIPER(ABL) (Specific and Nongenetic inhibitors of apoptosis protein [IAP]-dependent Protein Erasers) were developed.  The designed mols. contained two biol. active scaffolds: one was an imatinib deriv. that binds to BCL-ABL and the other was a Me bestatin that binds to cellular IAP 1 (cIAP1).  The hybrid mols., SNIPER(ABL), were expected to recruit BCR-ABL to cIAP1 for removal by proteasomes.  In fact, SNIPER(ABL) induced the degrdn. of BCR-ABL protein and a subsequent redn. in cell growth.  Thus, the degrdn. of BCR-ABL by SNIPER(ABL) is one potential strategy for treating BCR-ABL driven chronic myelogenous leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLT6dtmVPL47Vg90H21EOLACvtfcHk0lhJcPvbHYl_EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOntbnK&md5=31c045087293acf60932a9d6c4f38504</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DDemizu%26aufirst%3DY.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DMotoi%26aufirst%3DH.%26aulast%3DMisawa%26aufirst%3DT.%26aulast%3DShoda%26aufirst%3DT.%26aulast%3DNaito%26aufirst%3DM.%26aulast%3DKurihara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520BCR-ABL%2520degradation%2520inducers%2520via%2520the%2520conjugation%2520of%2520an%2520imatinib%2520derivative%2520and%2520a%2520cIAP1%2520ligand%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4865%26epage%3D4869%26doi%3D10.1016%2Fj.bmcl.2016.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okuhira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawahara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Targeted degradation of proteins localized in subcellular compartments by hybrid small molecules</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1124/mol.116.105569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1124%2Fmol.116.105569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27965304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsFajtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2017&pages=159-166&author=K.+Okuhiraauthor=T.+Shodaauthor=R.+Omuraauthor=N.+Ohokaauthor=T.+Hattoriauthor=N.+Shibataauthor=Y.+Demizuauthor=R.+Sugiharaauthor=A.+Ichinoauthor=H.+Kawaharaauthor=Y.+Itohauthor=M.+Ishikawaauthor=Y.+Hashimotoauthor=M.+Kuriharaauthor=S.+Itohauthor=H.+Saitoauthor=M.+Naito&title=Targeted+degradation+of+proteins+localized+in+subcellular+compartments+by+hybrid+small+molecules&doi=10.1124%2Fmol.116.105569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted degradation of proteins localized in subcellular compartments by hybrid small molecules</span></div><div class="casAuthors">Okuhira, Keiichiro; Shoda, Takuji; Omura, Risa; Ohoka, Nobumichi; Hattori, Takayuki; Shibata, Norihito; Demizu, Yosuke; Sugihara, Ryo; Ichino, Asato; Kawahara, Haruka; Itoh, Yukihiro; Ishikawa, Minoru; Hashimoto, Yuichi; Kurihara, Masaaki; Itoh, Susumu; Saito, Hiroyuki; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-169</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Development of novel small mols. that selectively degrade pathogenic proteins would provide an important advance in targeted therapy.  Recently, we have devised a series of hybrid small mols. named SNIPER (specific and nongenetic IAPdependent protein ERaser) that induces the degrdn. of target proteins via the ubiquitin-proteasome system.  To understand the localization of proteins that can be targeted by this protein knockdown technol., we examd. whether SNIPER mols. are able to induce degrdn. of cellular retinoic acid binding protein II (CRABP-II) proteins localized in subcellular compartments of cells.  CRABP-II is genetically fused with subcellular localization signals, and they are expressed in the cells.  SNIPER(CRABP) with different IAP-ligands, SNIPER(CRABP)- 4 with bestatin and SNIPER(CRABP)-11 with MV1 compd., induce the proteasomal degrdn. of wild-type (WT), cytosolic, nuclear, and membrane-localized CRABP-II proteins, whereas only SNIPER(CRABP)-11 displayed degrdn. activity toward the mitochondrial CRABP-II protein.  The small interfering RNA- mediated silencing of cIAP1 expression attenuated the knockdown activity of SNIPER(CRABP) against WT and cytosolic CRABP-II proteins, indicating that cIAP1 is the E3 ligase responsible for degrdn. of these proteins.  Against membrane-localized CRABP- II protein, cIAP1 is also a primary E3 ligase in the cells, but another E3 ligase distinct from cIAP2 and X-linked inhibitor of apoptosis protein (XIAP) could also be involved in the SNIPER(CRABP)-11- induced degrdn.  However, for the degrdn. of nuclear and mitochondrial CRABP-II proteins, E3 ligases other than cIAP1, cIAP2, and XIAP play a role in the SNIPER-mediated protein knockdown.  These results indicate that SNIPER can target cytosolic, nuclear, membrane-localized, and mitochondrial proteins for degrdn., but the responsible E3 ligase is different, depending on the localization of the target protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhA3S1phDgcbVg90H21EOLACvtfcHk0lhJcPvbHYl_EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsFajtbw%253D&md5=640d098e0247d9241e3eca20a1491126</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1124%2Fmol.116.105569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.116.105569%26sid%3Dliteratum%253Aachs%26aulast%3DOkuhira%26aufirst%3DK.%26aulast%3DShoda%26aufirst%3DT.%26aulast%3DOmura%26aufirst%3DR.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DDemizu%26aufirst%3DY.%26aulast%3DSugihara%26aufirst%3DR.%26aulast%3DIchino%26aufirst%3DA.%26aulast%3DKawahara%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DKurihara%26aufirst%3DM.%26aulast%3DItoh%26aufirst%3DS.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DTargeted%2520degradation%2520of%2520proteins%2520localized%2520in%2520subcellular%2520compartments%2520by%2520hybrid%2520small%2520molecules%26jtitle%3DMol.%2520Pharmacol.%26date%3D2017%26volume%3D91%26spage%3D159%26epage%3D166%26doi%3D10.1124%2Fmol.116.105569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuhira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teratani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">In vivo knockdown of pathogenic proteins via specific and nongenetic inhibitor of apoptosis protein (IAP)-dependent protein erasers (SNIPERs)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">4556</span>– <span class="NLM_lpage">4570</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.768853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.M116.768853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=28154167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksVClur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=4556-4570&author=N.+Ohokaauthor=K.+Okuhiraauthor=M.+Itoauthor=K.+Nagaiauthor=N.+Shibataauthor=T.+Hattoriauthor=O.+Ujikawaauthor=K.+Shimokawaauthor=O.+Sanoauthor=R.+Koyamaauthor=H.+Fujitaauthor=M.+Terataniauthor=H.+Matsumotoauthor=Y.+Imaedaauthor=H.+Naraauthor=N.+Choauthor=M.+Naito&title=In+vivo+knockdown+of+pathogenic+proteins+via+specific+and+nongenetic+inhibitor+of+apoptosis+protein+%28IAP%29-dependent+protein+erasers+%28SNIPERs%29&doi=10.1074%2Fjbc.M116.768853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs)</span></div><div class="casAuthors">Ohoka, Nobumichi; Okuhira, Keiichiro; Ito, Masahiro; Nagai, Katsunori; Shibata, Norihito; Hattori, Takayuki; Ujikawa, Osamu; Shimokawa, Kenichiro; Sano, Osamu; Koyama, Ryokichi; Fujita, Hisashi; Teratani, Mika; Matsumoto, Hirokazu; Imaeda, Yasuhiro; Nara, Hiroshi; Cho, Nobuo; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4556-4570</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Many diseases, esp. cancers, result from aberrant or overexpression of pathogenic proteins.  Specific inhibitors against these proteins have shown remarkable therapeutic effects, but these are limited mainly to enzymes.  An alternative approach that may have utility in drug development relies on selective degrdn. of pathogenic proteins via small chimeric mols. linking an E3 ubiquitin ligase to the targeted protein for proteasomal degrdn.  To this end, the authors recently developed a protein knockdown system based on hybrid small mol. SNIPERs (Specific and Nongenetic IAP-dependent Protein Erasers) that recruit inhibitor of the apoptosis protein (IAP) ubiquitin ligases to specifically degrade targeted proteins.  Here, the authors extend the authors' previous study to show a proof of concept of the SNIPER technol. in vivo.  By incorporating a high affinity IAP ligand, the authors developed a novel SNIPER against estrogen receptor α (ERα), SNIPER(ER)-87, that has a potent protein knockdown activity.  The SNIPER(ER) reduced ERα levels in tumor xenografts and suppressed the growth of ERα-pos. breast tumors in mice.  Mechanistically, it preferentially recruits X-linked IAP (XIAP) rather than cellular IAP1, to degrade ERα via the ubiquitin-proteasome pathway.  With this IAP ligand, potent SNIPERs against other pathogenic proteins, BCR-ABL, bromodomain-contg. protein 4 (BRD4), and phosphodiesterase-4 (PDE4) could also be developed.  These results indicate that forced ubiquitylation by SNIPERs is a useful method to achieve efficient protein knockdown with potential therapeutic activities and could also be applied to study the role of ubiquitylation in many cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEzH5uNeAFabVg90H21EOLACvtfcHk0ljzmymI0UcLmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksVClur8%253D&md5=b09264d53c47c54343ed92d5a6d0eb79</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.768853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.768853%26sid%3Dliteratum%253Aachs%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DOkuhira%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DNagai%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DUjikawa%26aufirst%3DO.%26aulast%3DShimokawa%26aufirst%3DK.%26aulast%3DSano%26aufirst%3DO.%26aulast%3DKoyama%26aufirst%3DR.%26aulast%3DFujita%26aufirst%3DH.%26aulast%3DTeratani%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DH.%26aulast%3DImaeda%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DH.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DIn%2520vivo%2520knockdown%2520of%2520pathogenic%2520proteins%2520via%2520specific%2520and%2520nongenetic%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528IAP%2529-dependent%2520protein%2520erasers%2520%2528SNIPERs%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D4556%26epage%3D4570%26doi%3D10.1074%2Fjbc.M116.768853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1041</span>, <span class="refDoi"> DOI: 10.1111/cas.13198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1111%2Fcas.13198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=28192613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFGkt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2017&pages=1032-1041&author=N.+Ohokaauthor=K.+Nagaiauthor=N.+Shibataauthor=T.+Hattoriauthor=H.+Naraauthor=N.+Choauthor=M.+Naito&title=SNIPER%28TACC3%29+induces+cytoplasmic+vacuolization+and+sensitizes+cancer+cells+to+Bortezomib&doi=10.1111%2Fcas.13198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib</span></div><div class="casAuthors">Ohoka, Nobumichi; Nagai, Katsunori; Shibata, Norihito; Hattori, Takayuki; Nara, Hiroshi; Cho, Nobuo; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1032-1041</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">We previously developed a hybrid small mol. SNIPER (Specific and Nongenetic IAP-dependent Protein ERaser) against transforming acidic coiled-coil-3 (TACC3), SNIPER(TACC3), that induces proteasomal degrdn. of TACC3 protein.  In this study, we found that SNIPER(TACC3) induces cytoplasmic vacuolization derived from endoplasmic reticulum (ER) and paraptosis-like cell death selectively in cancer cells.  Mechanistic anal. suggests that accumulation of ubiquitylated protein aggregates that requires X-linked inhibitor of apoptosis protein (XIAP) induces ER stress, which results in ER-stress responses involving X-box binding protein-1 (XBP-1) and ER-derived vacuolization in cancer cells.  Importantly, inhibition of proteasome enhanced the SNIPER(TACC3)-induced vacuolization, and the combination treatment of SNIPER(TACC3) and bortezomib exhibited a synergistic anticancer activity in several cancer cell lines.  The induction of paraptosis-like cell death in cancer cells by SNIPER(TACC3) could be applied to treat cancer cells resistant to undergo apoptosis by overexpression of XIAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzpVKQdkRrQrVg90H21EOLACvtfcHk0ljzmymI0UcLmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFGkt7g%253D&md5=8cadd012e1983f47ff426289a33e92cb</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1111%2Fcas.13198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13198%26sid%3Dliteratum%253Aachs%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DNagai%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DNara%26aufirst%3DH.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DSNIPER%2528TACC3%2529%2520induces%2520cytoplasmic%2520vacuolization%2520and%2520sensitizes%2520cancer%2520cells%2520to%2520Bortezomib%26jtitle%3DCancer%2520Sci.%26date%3D2017%26volume%3D108%26spage%3D1032%26epage%3D1041%26doi%3D10.1111%2Fcas.13198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sameshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Development of protein degradation inducers of oncogenic BCR-ABL protein by conjugation of ABL kinase inhibitors and IAP ligands</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1657</span>– <span class="NLM_lpage">1666</span>, <span class="refDoi"> DOI: 10.1111/cas.13284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1111%2Fcas.13284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=28556300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVWmt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2017&pages=1657-1666&author=N.+Shibataauthor=N.+Miyamotoauthor=K.+Nagaiauthor=K.+Shimokawaauthor=T.+Sameshimaauthor=N.+Ohokaauthor=T.+Hattoriauthor=Y.+Imaedaauthor=H.+Naraauthor=N.+Choauthor=M.+Naito&title=Development+of+protein+degradation+inducers+of+oncogenic+BCR-ABL+protein+by+conjugation+of+ABL+kinase+inhibitors+and+IAP+ligands&doi=10.1111%2Fcas.13284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Development of protein degradation inducers of oncogenic BCR-ABL protein by conjugation of ABL kinase inhibitors and IAP ligands</span></div><div class="casAuthors">Shibata, Norihito; Miyamoto, Naoki; Nagai, Katsunori; Shimokawa, Kenichiro; Sameshima, Tomoya; Ohoka, Nobumichi; Hattori, Takayuki; Imaeda, Yasuhiro; Nara, Hiroshi; Cho, Nobuo; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1657-1666</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Chromosomal translocation occurs in some cancer cells, which results in the expression of aberrant oncogenic fusion proteins that include BCR-ABL in chronic myelogenous leukemia (CML).  Inhibitors of ABL tyrosine kinase, such as imatinib and dasatinib, exhibit remarkable therapeutic effects, although emergence of drug resistance hampers the therapy during long-term treatment.  An alternative approach to treat CML is to downregulate the BCR-ABL protein.  We have devised a protein knockdown system by hybrid mols. named Specific and Non-genetic inhibitor of apoptosis protein [IAP]-dependent Protein Erasers (SNIPER), which is designed to induce IAP-mediated ubiquitylation and proteasomal degrdn. of target proteins, and a couple of SNIPER(ABL) against BCR-ABL protein have been developed recently.  In this study, we tested various combinations of ABL inhibitors and IAP ligands, and the linker was optimized for protein knockdown activity of SNIPER(ABL).  The resulting SNIPER(ABL)-39, in which dasatinib is conjugated to an IAP ligand LCL161 deriv. by polyethylene glycol (PEG) × 3 linker, shows a potent activity to degrade the BCR-ABL protein.  Mechanistic anal. suggested that both cellular inhibitor of apoptosis protein 1 (cIAP1) and X-linked inhibitor of apoptosis protein (XIAP) play a role in the degrdn. of BCR-ABL protein.  Consistent with the degrdn. of BCR-ABL protein, the SNIPER(ABL)-39 inhibited the phosphorylation of signal transducer and activator of transcription 5 (STAT5) and Crk like proto-oncogene (CrkL), and suppressed the growth of BCR-ABL-pos. CML cells.  These results suggest that SNIPER(ABL)-39 could be a candidate for a degrdn.-based novel anti-cancer drug against BCR-ABL-pos. CML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwfgAQFIWa0LVg90H21EOLACvtfcHk0ljzmymI0UcLmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVWmt7fP&md5=ac6370b8855fb6a0a53c2e0506eb4491</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1111%2Fcas.13284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13284%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DMiyamoto%26aufirst%3DN.%26aulast%3DNagai%26aufirst%3DK.%26aulast%3DShimokawa%26aufirst%3DK.%26aulast%3DSameshima%26aufirst%3DT.%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DImaeda%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DH.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520protein%2520degradation%2520inducers%2520of%2520oncogenic%2520BCR-ABL%2520protein%2520by%2520conjugation%2520of%2520ABL%2520kinase%2520inhibitors%2520and%2520IAP%2520ligands%26jtitle%3DCancer%2520Sci.%26date%3D2017%26volume%3D108%26spage%3D1657%26epage%3D1666%26doi%3D10.1111%2Fcas.13284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshaies, R. J.</span></span> <span> </span><span class="NLM_article-title">Development of PROTACS to target cancer-promoting proteins for ubiquitination and degradation</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1358</span>, <span class="refDoi"> DOI: 10.1074/mcp.T300009-MCP200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fmcp.T300009-MCP200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=14525958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVShu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=1350-1358&author=K.+M.+Sakamotoauthor=K.+B.+Kimauthor=R.+Vermaauthor=A.+Ransickauthor=B.+Steinauthor=C.+M.+Crewsauthor=R.+J.+Deshaies&title=Development+of+PROTACS+to+target+cancer-promoting+proteins+for+ubiquitination+and+degradation&doi=10.1074%2Fmcp.T300009-MCP200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Protacs to target cancer-promoting proteins for ubiquitination and degradation</span></div><div class="casAuthors">Sakamoto, Kathleen M.; Kim, Kyung B.; Verma, Rati; Ransick, Andy; Stein, Bernd; Crews, Craig M.; Deshaies, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Proteomics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1350-1358</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9476</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The proteome contains hundreds of proteins that in theory could be excellent therapeutic targets for the treatment of human diseases.  However, many of these proteins are from functional classes that have never been validated as viable candidates for the development of small mol. inhibitors.  Thus, to exploit fully the potential of the Human Genome Project to advance human medicine, there is a need to develop generic methods of inhibiting protein activity that do not rely on the target protein's function.  The authors previously demonstrated that a normally stable protein, methionine aminopeptidase-2 or MetAP-2, could be artificially targeted to an Skp1-Cullin-F-box (SCF) ubiquitin ligase complex for ubiquitination and degrdn. through a chimeric bridging mol. or Protac (proteolysis targeting chimeric mol.).  This Protac consisted of an SCFβ-TRCP-binding phosphopeptide derived from IκBα linked to ovalicin, which covalently binds MetAP-2.  In this study, the authors employed this approach to target two different proteins, the estrogen (ER) and androgen (AR) receptors, which have been implicated in the progression of breast and prostate cancer, resp.  The authors show here that an estradiol-based Protac can enforce the ubiquitination and degrdn. of the α isoform of ER in vitro, and a dihydroxytestosterone-based Protac introduced into cells promotes the rapid disappearance of AR in a proteasome-dependent manner.  Future improvements to this technol. may yield a general approach to treat a no. of human diseases, including cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3SZSMptsCorVg90H21EOLACvtfcHk0lifzMV1Rcwp8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVShu7jE&md5=5a9f4cf5d5cc1d990bf59ac824902111</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1074%2Fmcp.T300009-MCP200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.T300009-MCP200%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DK.%2BM.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DVerma%26aufirst%3DR.%26aulast%3DRansick%26aufirst%3DA.%26aulast%3DStein%26aufirst%3DB.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26atitle%3DDevelopment%2520of%2520PROTACS%2520to%2520target%2520cancer-promoting%2520proteins%2520for%2520ubiquitination%2520and%2520degradation%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2003%26volume%3D2%26spage%3D1350%26epage%3D1358%26doi%3D10.1074%2Fmcp.T300009-MCP200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimori, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuhira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sameshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, M.</span></span> <span> </span><span class="NLM_article-title">Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor alpha degradation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">6776</span>– <span class="NLM_lpage">6790</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA117.001091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.RA117.001091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=29545311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVOktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2018&pages=6776-6790&author=N.+Ohokaauthor=Y.+Moritaauthor=K.+Nagaiauthor=K.+Shimokawaauthor=O.+Ujikawaauthor=I.+Fujimoriauthor=M.+Itoauthor=Y.+Hayaseauthor=K.+Okuhiraauthor=N.+Shibataauthor=T.+Hattoriauthor=T.+Sameshimaauthor=O.+Sanoauthor=R.+Koyamaauthor=Y.+Imaedaauthor=H.+Naraauthor=N.+Choauthor=M.+Naito&title=Derivatization+of+inhibitor+of+apoptosis+protein+%28IAP%29+ligands+yields+improved+inducers+of+estrogen+receptor+alpha+degradation&doi=10.1074%2Fjbc.RA117.001091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor α degradation</span></div><div class="casAuthors">Ohoka, Nobumichi; Morita, Yoko; Nagai, Katsunori; Shimokawa, Kenichiro; Ujikawa, Osamu; Fujimori, Ikuo; Ito, Masahiro; Hayase, Youji; Okuhira, Keiichiro; Shibata, Norihito; Hattori, Takayuki; Sameshima, Tomoya; Sano, Osamu; Koyama, Ryokichi; Imaeda, Yasuhiro; Nara, Hiroshi; Cho, Nobuo; Naito, Mikihiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6776-6790</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aberrant expression of proteins often underlies many diseases, including cancer.  A recently developed approach in drug development is small mol.-mediated, selective degrdn. of dysregulated proteins.  The authors have devised a protein-knockdown system that utilizes chimeric mols. termed specific and nongenetic IAP-dependent protein erasers (SNIPERs) to induce ubiquitylation and proteasomal degrdn. of various target proteins.  SNIPER(ER)-87 consists of an inhibitor of apoptosis protein (IAP) ligand LCL161 deriv. that is conjugated to the estrogen receptor α (ERα) ligand 4-hydroxytamoxifen by a PEG linker, and the authors have previously reported that this SNIPER efficiently degrades the ERα protein.  Here, the authors report that derivatization of the IAP ligand module yields SNIPER(ER)s with superior protein-knockdown activity.  These improved SNIPER(ER)s exhibited higher binding affinities to IAPs and induced more potent degrdn. of ERα than does SNIPER(ER)-87.  Further, they induced simultaneous degrdn. of cellular inhibitor of apoptosis protein 1 (cIAP1) and delayed degrdn. of X-linked IAP (XIAP).  Notably, these reengineered SNIPER(ER)s efficiently induced apoptosis in MCF-7 human breast cancer cells that require IAPs for continued cellular survival.  The authors found that one of these mols., SNIPER(ER)-110, inhibits the growth of MCF-7 tumor xenografts in mice more potently than the previously characterized SNIPER(ER)-87.  Mechanistic anal. revealed that the authors' novel SNIPER(ER)s preferentially recruit XIAP, rather than cIAP1, to degrade ERα.  The authors' results suggest that derivatized IAP ligands could facilitate further development of SNIPERs with potent protein-knockdown and cytocidal activities against cancer cells requiring IAPs for survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj30BS7yI2dLVg90H21EOLACvtfcHk0lifzMV1Rcwp8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVOktb4%253D&md5=5800916097e83ecb4692cdc0e0c13525</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA117.001091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA117.001091%26sid%3Dliteratum%253Aachs%26aulast%3DOhoka%26aufirst%3DN.%26aulast%3DMorita%26aufirst%3DY.%26aulast%3DNagai%26aufirst%3DK.%26aulast%3DShimokawa%26aufirst%3DK.%26aulast%3DUjikawa%26aufirst%3DO.%26aulast%3DFujimori%26aufirst%3DI.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DHayase%26aufirst%3DY.%26aulast%3DOkuhira%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DN.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DSameshima%26aufirst%3DT.%26aulast%3DSano%26aufirst%3DO.%26aulast%3DKoyama%26aufirst%3DR.%26aulast%3DImaeda%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DH.%26aulast%3DCho%26aufirst%3DN.%26aulast%3DNaito%26aufirst%3DM.%26atitle%3DDerivatization%2520of%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528IAP%2529%2520ligands%2520yields%2520improved%2520inducers%2520of%2520estrogen%2520receptor%2520alpha%2520degradation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26spage%3D6776%26epage%3D6790%26doi%3D10.1074%2Fjbc.RA117.001091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasula, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashwell, J. D.</span></span> <span> </span><span class="NLM_article-title">IAPs: what’s in a name?</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2008.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.molcel.2008.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18439892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsFentLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=123-135&author=S.+M.+Srinivasulaauthor=J.+D.+Ashwell&title=IAPs%3A+what%E2%80%99s+in+a+name%3F&doi=10.1016%2Fj.molcel.2008.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">IAPs: What's in a name?</span></div><div class="casAuthors">Srinivasula, Srinivasa M.; Ashwell, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-135</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Originally described in insect viruses, cellular proteins with baculoviral IAP repeat (BIR) motifs have been thought to function primarily as inhibitors of apoptosis.  The subsequent finding that a subset of inhibitor of apoptosis proteins (IAPs) that contain a RING domain have ubiquitin protein ligase (E3) activity implied the presence of other functions.  It is now known that IAPs are involved in mitotic chromosome segregation, cellular morphogenesis, Cu homeostasis, and intracellular signaling.  Here, the authors review the current understanding of the roles of IAPs in apoptotic and nonapoptotic processes and explore the notion that the latter represents the primary physiol. activities of IAPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWWLYuSWt6U7Vg90H21EOLACvtfcHk0lifzMV1Rcwp8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsFentLY%253D&md5=762b696e69868dcd7714f63a0f622e3a</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2008.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2008.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DSrinivasula%26aufirst%3DS.%2BM.%26aulast%3DAshwell%26aufirst%3DJ.%2BD.%26atitle%3DIAPs%253A%2520what%25E2%2580%2599s%2520in%2520a%2520name%253F%26jtitle%3DMol.%2520Cell%26date%3D2008%26volume%3D30%26spage%3D123%26epage%3D135%26doi%3D10.1016%2Fj.molcel.2008.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uegaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mon, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohbayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of IAP (inhibitor of apoptosis) proteins represses inflammatory status via nuclear factor-kappa B pathway in murine endometriosis lesions</span>. <i>Am. J. Reprod. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">e12780</span>, <span class="refDoi"> DOI: 10.1111/aji.12780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1111%2Faji.12780" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2018&pages=e12780&author=F.+Taniguchiauthor=T.+Uegakiauthor=K.+Nakamuraauthor=K.+Y.+Monauthor=T.+Haradaauthor=T.+Ohbayashiauthor=T.+Harada&title=Inhibition+of+IAP+%28inhibitor+of+apoptosis%29+proteins+represses+inflammatory+status+via+nuclear+factor-kappa+B+pathway+in+murine+endometriosis+lesions&doi=10.1111%2Faji.12780"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1111%2Faji.12780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Faji.12780%26sid%3Dliteratum%253Aachs%26aulast%3DTaniguchi%26aufirst%3DF.%26aulast%3DUegaki%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DMon%26aufirst%3DK.%2BY.%26aulast%3DHarada%26aufirst%3DT.%26aulast%3DOhbayashi%26aufirst%3DT.%26aulast%3DHarada%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520IAP%2520%2528inhibitor%2520of%2520apoptosis%2529%2520proteins%2520represses%2520inflammatory%2520status%2520via%2520nuclear%2520factor-kappa%2520B%2520pathway%2520in%2520murine%2520endometriosis%2520lesions%26jtitle%3DAm.%2520J.%2520Reprod.%2520Immunol.%26date%3D2018%26volume%3D79%26spage%3De12780%26doi%3D10.1111%2Faji.12780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenneth, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, C. S.</span></span> <span> </span><span class="NLM_article-title">IAP proteins: regulators of cell migration and development</span>. <i>Curr. Opin. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">871</span>– <span class="NLM_lpage">875</span>, <span class="refDoi"> DOI: 10.1016/j.ceb.2012.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.ceb.2012.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=23219152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhsl2ju7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=871-875&author=N.+S.+Kennethauthor=C.+S.+Duckett&title=IAP+proteins%3A+regulators+of+cell+migration+and+development&doi=10.1016%2Fj.ceb.2012.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">IAP proteins: regulators of cell migration and development</span></div><div class="casAuthors">Kenneth, Niall S.; Duckett, Colin S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">871-875</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The cytoprotective properties of vertebrate inhibitor of apoptosis (IAP) proteins have been the subject of much study.  These proteins have, however, emerged as key signaling intermediates modulating a variety of cellular functions through their ability to act as E3 ubiquitin ligases.  This review will focus on the cell death-independent roles of the IAP proteins, focusing on recent reports indicating that c-IAPs and XIAP are key mols. involved in modulating cell migration and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEHaeAe_26qbVg90H21EOLACvtfcHk0lgrR28yhMKxxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhsl2ju7jI&md5=bc7cc2a38c5a577b9e308339a82a5324</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2012.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2012.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DKenneth%26aufirst%3DN.%2BS.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26atitle%3DIAP%2520proteins%253A%2520regulators%2520of%2520cell%2520migration%2520and%2520development%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2012%26volume%3D24%26spage%3D871%26epage%3D875%26doi%3D10.1016%2Fj.ceb.2012.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosas-Acosta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span> <span> </span><span class="NLM_article-title">X-linked inhibitor of apoptosis protein (XIAP) mediates cancer cell motility via Rho GDP dissociation inhibitor (RhoGDI)-dependent regulation of the cytoskeleton</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">15630</span>– <span class="NLM_lpage">15640</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.176982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1074%2Fjbc.M110.176982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=21402697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVWjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=15630-15640&author=J.+Liuauthor=D.+Zhangauthor=W.+Luoauthor=Y.+Yuauthor=J.+Yuauthor=J.+Liauthor=X.+Zhangauthor=B.+Zhangauthor=J.+Chenauthor=X.+R.+Wuauthor=G.+Rosas-Acostaauthor=C.+Huang&title=X-linked+inhibitor+of+apoptosis+protein+%28XIAP%29+mediates+cancer+cell+motility+via+Rho+GDP+dissociation+inhibitor+%28RhoGDI%29-dependent+regulation+of+the+cytoskeleton&doi=10.1074%2Fjbc.M110.176982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">X-linked inhibitor of apoptosis protein (XIAP) mediates cancer cell motility via Rho GDP dissociation inhibitor (RhoGDI)-dependent regulation of the cytoskeleton</span></div><div class="casAuthors">Liu, Jin-Yi; Zhang, Dong-Yun; Luo, Wen-Jing; Yu, Yong-Hui; Yu, Jian-Xiu; Li, Jing-Xia; Zhang, Xin-Hai; Zhang, Bao-Lin; Chen, Jing-Yuan; Wu, Xue-Ru; Rosas-Acosta, German; Huang, Chuan-Shu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">15630-15640</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">X-linked inhibitor of apoptosis protein (XIAP) overexpression has been found to be assocd. with malignant cancer progression and aggression in individuals with many types of cancers.  However, the mol. basis of XIAP in the regulation of cancer cell biol. behavior remains largely unknown.  In this study, we found that a deficiency of XIAP expression in human cancer cells by either knock-out or knockdown leads to a marked redn. in β-actin polymn. and cytoskeleton formation.  Consistently, cell migration and invasion were also decreased in XIAP-deficient cells compared with parental wild-type cells.  Subsequent studies demonstrated that the regulation of cell motility by XIAP depends on its interaction with the Rho GDP dissocn. inhibitor (RhoGDI) via the XIAP RING domain.  Furthermore, XIAP was found to neg. regulate RhoGDI SUMOylation, which might affect its activity in controlling cell motility.  Collectively, our studies provide novel insights into the mol. mechanisms by which XIAP regulates cancer invasion and offer a further theor. basis for setting XIAP as a potential prognostic marker and specific target for treatment of cancers with metastatic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKnYyFLCELwLVg90H21EOLACvtfcHk0liVR-KSmD6Ezg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVWjtL4%253D&md5=d595cd4a97c0b13801be94ca938483bd</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.176982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.176982%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%2BR.%26aulast%3DRosas-Acosta%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DC.%26atitle%3DX-linked%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528XIAP%2529%2520mediates%2520cancer%2520cell%2520motility%2520via%2520Rho%2520GDP%2520dissociation%2520inhibitor%2520%2528RhoGDI%2529-dependent%2520regulation%2520of%2520the%2520cytoskeleton%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D15630%26epage%3D15640%26doi%3D10.1074%2Fjbc.M110.176982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oberoi, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocking, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholz, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mooz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karreman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer zu
Heringdorf, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruonala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macek, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koster, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajalingam, K.</span></span> <span> </span><span class="NLM_article-title">IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1038/emboj.2011.423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Femboj.2011.423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=22117219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeit7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=14-28&author=T.+K.+Oberoiauthor=T.+Doganauthor=J.+C.+Hockingauthor=R.+P.+Scholzauthor=J.+Moozauthor=C.+L.+Andersonauthor=C.+Karremanauthor=D.+Meyer+zu%0AHeringdorfauthor=G.+Schmidtauthor=M.+Ruonalaauthor=K.+Namikawaauthor=G.+S.+Harmsauthor=A.+Carpyauthor=B.+Macekauthor=R.+W.+Kosterauthor=K.+Rajalingam&title=IAPs+regulate+the+plasticity+of+cell+migration+by+directly+targeting+Rac1+for+degradation&doi=10.1038%2Femboj.2011.423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation</span></div><div class="casAuthors">Oberoi, Tripat Kaur; Dogan, Taner; Hocking, Jennifer C.; Scholz, Rolf-Peter; Mooz, Juliane; Anderson, Carrie L.; Karreman, Christiaan; Meyer zu Heringdorf, Dagmar; Schmidt, Gudula; Ruonala, Mika; Namikawa, Kazuhiko; Harms, Gregory S.; Carpy, Alejandro; Macek, Boris; Koester, Reinhard W.; Rajalingam, Krishnaraj</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-28</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibitors of apoptosis proteins (IAPs) are a highly conserved class of multifunctional proteins.  Rac1 is a well-studied Rho GTPase that controls numerous basic cellular processes.  While the regulation of nucleotide binding to Rac1 is well understood, the mol. mechanisms controlling Rac1 degrdn. are not known.  Here, the authors demonstrate X-linked IAP (XIAP) and cellular IAP1 (c-IAP1), which function as E3 ubiquitin ligases, directly bind to Rac1 in a nucleotide-independent manner to promote its polyubiquitination at Lys-147 and proteasomal degrdn.  These IAPs were also required for the degrdn. of Rac1 upon CNF1 toxin treatment or RhoGDI depletion.  Consistently, down-regulation of XIAP or c-IAP1 by various strategies led to an increase in Rac1 protein levels in primary and tumor cells, leading to an elongated morphol. and enhanced cell migration.  Further, XIAP counteracted Rac1-dependent cellular polarization in the developing zebrafish hindbrain and promoted the delamination of neurons from the normal tissue architecture.  These observations unveiled an evolutionarily conserved role of IAPs in controlling Rac1 stability, thereby regulating the plasticity of cell migration and morphogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdklbqF_Nl9bVg90H21EOLACvtfcHk0liVR-KSmD6Ezg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeit7rO&md5=8e71e043f962700c411bd61a77ecd6a7</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1038%2Femboj.2011.423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2011.423%26sid%3Dliteratum%253Aachs%26aulast%3DOberoi%26aufirst%3DT.%2BK.%26aulast%3DDogan%26aufirst%3DT.%26aulast%3DHocking%26aufirst%3DJ.%2BC.%26aulast%3DScholz%26aufirst%3DR.%2BP.%26aulast%3DMooz%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DC.%2BL.%26aulast%3DKarreman%26aufirst%3DC.%26aulast%3DMeyer%2Bzu%2BHeringdorf%26aufirst%3DD.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DRuonala%26aufirst%3DM.%26aulast%3DNamikawa%26aufirst%3DK.%26aulast%3DHarms%26aufirst%3DG.%2BS.%26aulast%3DCarpy%26aufirst%3DA.%26aulast%3DMacek%26aufirst%3DB.%26aulast%3DKoster%26aufirst%3DR.%2BW.%26aulast%3DRajalingam%26aufirst%3DK.%26atitle%3DIAPs%2520regulate%2520the%2520plasticity%2520of%2520cell%2520migration%2520by%2520directly%2520targeting%2520Rac1%2520for%2520degradation%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D14%26epage%3D28%26doi%3D10.1038%2Femboj.2011.423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slisz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanneman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draganov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacohen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dranoff, G.</span></span> <span> </span><span class="NLM_article-title">IAP inhibitors enhance co-stimulation to promote tumor immunity</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">2195</span>– <span class="NLM_lpage">2206</span>, <span class="refDoi"> DOI: 10.1084/jem.20101123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1084%2Fjem.20101123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=20837698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Cms73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2010&pages=2195-2206&author=M.+Douganauthor=S.+Douganauthor=J.+Sliszauthor=B.+Firestoneauthor=M.+Vannemanauthor=D.+Draganovauthor=G.+Goyalauthor=W.+Liauthor=D.+Neubergauthor=R.+Blumbergauthor=N.+Hacohenauthor=D.+Porterauthor=L.+Zawelauthor=G.+Dranoff&title=IAP+inhibitors+enhance+co-stimulation+to+promote+tumor+immunity&doi=10.1084%2Fjem.20101123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">IAP inhibitors enhance co-stimulation to promote tumor immunity</span></div><div class="casAuthors">Dougan, Michael; Dougan, Stephanie; Slisz, Joanna; Firestone, Brant; Vanneman, Matthew; Draganov, Dobrin; Goyal, Girija; Li, Weibo; Neuberg, Donna; Blumberg, Richard; Hacohen, Nir; Porter, Dale; Zawel, Leigh; Dranoff, Glenn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2195-2206</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis proteins (IAPs) have recently been shown to modulate nuclear factor κB (NF-κB) signaling downstream of tumor necrosis factor (TNF) family receptors, positioning them as essential survival factors in several cancer cell lines, as indicated by the cytotoxic activity of several novel small mol. IAP antagonists.  In addn. to roles in cancer, increasing evidence suggests that IAPs have an important function in immunity; however, the impact of IAP antagonists on antitumor immune responses is unknown.  In this study, the authors examine the consequences of IAP antagonism on T cell function in vitro and in the context of a tumor vaccine in vivo.  The authors find that IAP antagonists can augment human and mouse T cell responses to physiol. relevant stimuli.  The activity of IAP antagonists depends on the activation of NF-κB2 signaling, a mechanism paralleling that responsible for the cytotoxic activity in cancer cells.  The authors further show that IAP antagonists can augment both prophylactic and therapeutic antitumor vaccines in vivo.  These findings indicate an important role for the IAPs in regulating T cell-dependent responses and suggest that targeting IAPs using small mol. antagonists may be a strategy for developing novel immunomodulating therapies against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmv-vLXjlFDbVg90H21EOLACvtfcHk0liVR-KSmD6Ezg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Cms73P&md5=6e49336c9cac37d0f1be08f65014cd0f</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1084%2Fjem.20101123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20101123%26sid%3Dliteratum%253Aachs%26aulast%3DDougan%26aufirst%3DM.%26aulast%3DDougan%26aufirst%3DS.%26aulast%3DSlisz%26aufirst%3DJ.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DVanneman%26aufirst%3DM.%26aulast%3DDraganov%26aufirst%3DD.%26aulast%3DGoyal%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DNeuberg%26aufirst%3DD.%26aulast%3DBlumberg%26aufirst%3DR.%26aulast%3DHacohen%26aufirst%3DN.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DZawel%26aufirst%3DL.%26aulast%3DDranoff%26aufirst%3DG.%26atitle%3DIAP%2520inhibitors%2520enhance%2520co-stimulation%2520to%2520promote%2520tumor%2520immunity%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2010%26volume%3D207%26spage%3D2195%26epage%3D2206%26doi%3D10.1084%2Fjem.20101123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, M.</span></span> <span> </span><span class="NLM_article-title">Regulation of innate and adaptive antitumor immunity by IAP antagonists</span>. <i>Immunotherapy</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.2217/imt-2017-0185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.2217%2Fimt-2017-0185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=29807457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlWqsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=787-796&author=S.+K.+Douganauthor=M.+Dougan&title=Regulation+of+innate+and+adaptive+antitumor+immunity+by+IAP+antagonists&doi=10.2217%2Fimt-2017-0185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of innate and adaptive antitumor immunity by IAP antagonists</span></div><div class="casAuthors">Dougan, Stephanie K.; Dougan, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Immunotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">787-796</span>CODEN:
                <span class="NLM_cas:coden">IMMUCO</span>;
        ISSN:<span class="NLM_cas:issn">1750-7448</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Inhibition of the T-cell co-inhibitory checkpoint receptors or their ligands CTLA-4, PD-1 and PD-L1 using monoclonal antibodies has proven to be highly effective against many cancers.  Yet many cancers remain resistant to checkpoint blockade, and durable remissions occur in only a minority of patients.  Novel approaches to enhancing antitumor responses are thus necessary in order to expand the reach of these treatments.  The inhibitor of apoptosis (IAP) protein family comprises a diverse group of proteins, many of which have immunoregulatory roles.  Small mol. IAP antagonists have been developed and are undergoing early phase clin. testing.  These drugs were initially developed to promote tumor cell apoptosis; however, a considerable body of work now indicates that IAP antagonists induce antitumor activity through modulation of innate and adaptive immunity.  Primarily through inhibition of cellular (c)-IAP1 and c-IAP2, IAP antagonists can activate alternative NF-κB signaling, promoting B-cell survival, activation of dendritic cells and delivering a broad co-stimulatory signal to T cells.  At the same time, IAP antagonists can promote tumor cell intrinsic sensitization to innate immune signals, and enhance tumor cell killing by inflammatory cytokines and phagocytic macrophages.  These drugs thus represent an attractive investigational approach to immunotherapy, providing a pos. signaling counterpart to the relief of signal inhibition conferred by checkpoint blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCDoHKW4B6TbVg90H21EOLACvtfcHk0lhKJ363sja8QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlWqsrzE&md5=98f73cd2f999007630043823f6ea38c0</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.2217%2Fimt-2017-0185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fimt-2017-0185%26sid%3Dliteratum%253Aachs%26aulast%3DDougan%26aufirst%3DS.%2BK.%26aulast%3DDougan%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520innate%2520and%2520adaptive%2520antitumor%2520immunity%2520by%2520IAP%2520antagonists%26jtitle%3DImmunotherapy%26date%3D2018%26volume%3D10%26spage%3D787%26epage%3D796%26doi%3D10.2217%2Fimt-2017-0185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbitt, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharik, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dueck, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asmann, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhmetzyanova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosiorek, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calcinotto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggs, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keane, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmann, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacy, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ailawadhi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dispenzieri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buadi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeder, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanan-Khan, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fooksman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergsagel, P. L.</span></span> <span> </span><span class="NLM_article-title">IAP antagonists induce anti-tumor immunity in multiple myeloma</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1411</span>– <span class="NLM_lpage">1420</span>, <span class="refDoi"> DOI: 10.1038/nm.4229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnm.4229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27841872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVGgtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=1411-1420&author=M.+Chesiauthor=N.+N.+Mirzaauthor=V.+M.+Garbittauthor=M.+E.+Sharikauthor=A.+C.+Dueckauthor=Y.+W.+Asmannauthor=I.+Akhmetzyanovaauthor=H.+E.+Kosiorekauthor=A.+Calcinottoauthor=D.+L.+Riggsauthor=N.+Keaneauthor=G.+J.+Ahmannauthor=K.+M.+Morrisonauthor=R.+Fonsecaauthor=M.+Q.+Lacyauthor=D.+Dingliauthor=S.+K.+Kumarauthor=S.+Ailawadhiauthor=A.+Dispenzieriauthor=F.+Buadiauthor=M.+A.+Gertzauthor=C.+B.+Reederauthor=Y.+Linauthor=A.+A.+Chanan-Khanauthor=A.+K.+Stewartauthor=D.+Fooksmanauthor=P.+L.+Bergsagel&title=IAP+antagonists+induce+anti-tumor+immunity+in+multiple+myeloma&doi=10.1038%2Fnm.4229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">IAP antagonists induce anti-tumor immunity in multiple myeloma</span></div><div class="casAuthors">Chesi, Marta; Mirza, Noweeda N.; Garbitt, Victoria M.; Sharik, Meaghen E.; Dueck, Amylou C.; Asmann, Yan W.; Akhmetzyanova, Ilseyar; Kosiorek, Heidi E.; Calcinotto, Arianna; Riggs, Daniel L.; Keane, Niamh; Ahmann, Gregory J.; Morrison, Kevin M.; Fonseca, Rafael; Lacy, Martha Q.; Dingli, David; Kumar, Shaji K.; Ailawadhi, Sikander; Dispenzieri, Angela; Buadi, Francis; Gertz, Morie A.; Reeder, Craig B.; Lin, Yi; Chanan-Khan, Asher A.; Stewart, A. Keith; Fooksman, David; Bergsagel, P. Leif</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1411-1420</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The cellular inhibitors of apoptosis (cIAP) 1 and 2 are amplified in about 3% of cancers and have been identified in multiple malignancies as being potential therapeutic targets as a result of their role in the evasion of apoptosis.  Consequently, small-mol. IAP antagonists, such as LCL161, have entered clin. trials for their ability to induce tumor necrosis factor (TNF)-mediated apoptosis of cancer cells.  However, cIAP1 and cIAP2 are recurrently homozygously deleted in multiple myeloma (MM), resulting in constitutive activation of the noncanonical nuclear factor (NF)-κB pathway.  To our surprise, we obsd. robust in vivo anti-myeloma activity of LCL161 in a transgenic myeloma mouse model and in patients with relapsed-refractory MM, where the addn. of cyclophosphamide resulted in a median progression-free-survival of 10 mo.  This effect was not a result of direct induction of tumor cell death, but rather of upregulation of tumor-cell-autonomous type I interferon (IFN) signaling and a strong inflammatory response that resulted in the activation of macrophages and dendritic cells, leading to phagocytosis of tumor cells.  Treatment of a MM mouse model with LCL161 established long-term anti-tumor protection and induced regression in a fraction of the mice.  Notably, combination of LCL161 with the immune-checkpoint inhibitor anti-PD1 was curative in all of the treated mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLwOgDYr44NbVg90H21EOLACvtfcHk0lhKJ363sja8QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVGgtL3N&md5=cb7f2d3f3cc01efe48ed29cfd281ef57</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1038%2Fnm.4229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4229%26sid%3Dliteratum%253Aachs%26aulast%3DChesi%26aufirst%3DM.%26aulast%3DMirza%26aufirst%3DN.%2BN.%26aulast%3DGarbitt%26aufirst%3DV.%2BM.%26aulast%3DSharik%26aufirst%3DM.%2BE.%26aulast%3DDueck%26aufirst%3DA.%2BC.%26aulast%3DAsmann%26aufirst%3DY.%2BW.%26aulast%3DAkhmetzyanova%26aufirst%3DI.%26aulast%3DKosiorek%26aufirst%3DH.%2BE.%26aulast%3DCalcinotto%26aufirst%3DA.%26aulast%3DRiggs%26aufirst%3DD.%2BL.%26aulast%3DKeane%26aufirst%3DN.%26aulast%3DAhmann%26aufirst%3DG.%2BJ.%26aulast%3DMorrison%26aufirst%3DK.%2BM.%26aulast%3DFonseca%26aufirst%3DR.%26aulast%3DLacy%26aufirst%3DM.%2BQ.%26aulast%3DDingli%26aufirst%3DD.%26aulast%3DKumar%26aufirst%3DS.%2BK.%26aulast%3DAilawadhi%26aufirst%3DS.%26aulast%3DDispenzieri%26aufirst%3DA.%26aulast%3DBuadi%26aufirst%3DF.%26aulast%3DGertz%26aufirst%3DM.%2BA.%26aulast%3DReeder%26aufirst%3DC.%2BB.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DChanan-Khan%26aufirst%3DA.%2BA.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26aulast%3DFooksman%26aufirst%3DD.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26atitle%3DIAP%2520antagonists%2520induce%2520anti-tumor%2520immunity%2520in%2520multiple%2520myeloma%26jtitle%3DNat.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D1411%26epage%3D1420%26doi%3D10.1038%2Fnm.4229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clancy-Thompson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruck, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Exley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumberg, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dranoff, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, S. K.</span></span> <span> </span><span class="NLM_article-title">IAP antagonists enhance cytokine production from mouse and human iNKT cells</span>. <i>Cancer Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1158/2326-6066.CIR-17-0490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1158%2F2326-6066.CIR-17-0490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=29187357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVSltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=25-35&author=E.+Clancy-Thompsonauthor=L.+Aliauthor=P.+T.+Bruckauthor=M.+A.+Exleyauthor=R.+S.+Blumbergauthor=G.+Dranoffauthor=M.+Douganauthor=S.+K.+Dougan&title=IAP+antagonists+enhance+cytokine+production+from+mouse+and+human+iNKT+cells&doi=10.1158%2F2326-6066.CIR-17-0490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells</span></div><div class="casAuthors">Clancy-Thompson, Eleanor; Ali, Lestat; Bruck, Patrick T.; Exley, Mark A.; Blumberg, Richard S.; Dranoff, Glenn; Dougan, Michael; Dougan, Stephanie K.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-35</span>CODEN:
                <span class="NLM_cas:coden">CIRACV</span>;
        ISSN:<span class="NLM_cas:issn">2326-6066</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis protein (IAP) antagonists are in clin. trials for a variety of cancers, and mouse models show synergism between IAP antagonists and anti-PD-1 immunotherapy.  Although IAP antagonists affect the intrinsic signaling of tumor cells, their most pronounced effects are on immune cells and the generation of antitumor immunity.  Here, we examd. the effects of IAP antagonism on T-cell development using mouse fetal thymic organ culture and obsd. a selective loss of iNKT cells, an effector cell type of potential importance for cancer immunotherapy.  Thymic iNKT-cell development probably failed due to increased strength of TCR signal leading to neg. selection, given that mature iNKT cells treated with IAP antagonists were not depleted, but had enhanced cytokine prodn. in both mouse and human ex vivo cultures.  Consistent with this, mature mouse primary iNKT cells and iNKT hybridomas increased prodn. of effector cytokines in the presence of IAP antagonists.  In vivo administration of IAP antagonists and α-GalCer resulted in increased IFNγ and IL-2 prodn. from iNKT cells and decreased tumor burden in a mouse model of melanoma lung metastasis.  Human iNKT cells also proliferated and increased IFNγ prodn. dramatically in the presence of IAP antagonists, demonstrating the utility of these compds. in adoptive therapy of iNKT cells.  Cancer Immunol Res; 6(1); 25-35. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ZRHeL8HNz7Vg90H21EOLACvtfcHk0lhKJ363sja8QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVSltQ%253D%253D&md5=e0979ec634d8723cfaa43063c6074dc5</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1158%2F2326-6066.CIR-17-0490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2326-6066.CIR-17-0490%26sid%3Dliteratum%253Aachs%26aulast%3DClancy-Thompson%26aufirst%3DE.%26aulast%3DAli%26aufirst%3DL.%26aulast%3DBruck%26aufirst%3DP.%2BT.%26aulast%3DExley%26aufirst%3DM.%2BA.%26aulast%3DBlumberg%26aufirst%3DR.%2BS.%26aulast%3DDranoff%26aufirst%3DG.%26aulast%3DDougan%26aufirst%3DM.%26aulast%3DDougan%26aufirst%3DS.%2BK.%26atitle%3DIAP%2520antagonists%2520enhance%2520cytokine%2520production%2520from%2520mouse%2520and%2520human%2520iNKT%2520cells%26jtitle%3DCancer%2520Immunol.%2520Res.%26date%3D2018%26volume%3D6%26spage%3D25%26epage%3D35%26doi%3D10.1158%2F2326-6066.CIR-17-0490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vince, J.</span></span> <span> </span><span class="NLM_article-title">IAPs and cell death</span>. <i>Curr. Top. Microbiol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>403</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1007/82_2016_507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1007%2F82_2016_507" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=2016&pages=95-117&author=J.+Silkeauthor=J.+Vince&title=IAPs+and+cell+death&doi=10.1007%2F82_2016_507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1007%2F82_2016_507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F82_2016_507%26sid%3Dliteratum%253Aachs%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DVince%26aufirst%3DJ.%26atitle%3DIAPs%2520and%2520cell%2520death%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2016%26volume%3D403%26spage%3D95%26epage%3D117%26doi%3D10.1007%2F82_2016_507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of necroptosis: an ordered cellular explosion</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">700</span>– <span class="NLM_lpage">714</span>, <span class="refDoi"> DOI: 10.1038/nrm2970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fnrm2970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=20823910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFajsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=700-714&author=P.+Vandenabeeleauthor=L.+Galluzziauthor=T.+Vanden+Bergheauthor=G.+Kroemer&title=Molecular+mechanisms+of+necroptosis%3A+an+ordered+cellular+explosion&doi=10.1038%2Fnrm2970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of necroptosis: an ordered cellular explosion</span></div><div class="casAuthors">Vandenabeele, Peter; Galluzzi, Lorenzo; Vanden Berghe, Tom; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">700-714</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  For a long time, apoptosis was considered the sole form of programmed cell death during development, homeostasis and disease, whereas necrosis was regarded as an unregulated and uncontrollable process.  Evidence now reveals that necrosis can also occur in a regulated manner.  The initiation of programmed necrosis, 'necroptosis', by death receptors (such as tumor necrosis factor receptor 1) requires the kinase activity of receptor-interacting protein 1 (RIP1; also known as RIPK1) and RIP3 (also known as RIPK3), and its execution involves the active disintegration of mitochondrial, lysosomal and plasma membranes.  Necroptosis participates in the pathogenesis of diseases, including ischemic injury, neurodegeneration and viral infection, thereby representing an attractive target for the avoidance of unwarranted cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvEe8vjo9AoLVg90H21EOLACvtfcHk0lirHc87QRzUXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFajsL7P&md5=bc7798f807de31771d8e620acf754b92</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1038%2Fnrm2970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2970%26sid%3Dliteratum%253Aachs%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMolecular%2520mechanisms%2520of%2520necroptosis%253A%2520an%2520ordered%2520cellular%2520explosion%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D700%26epage%3D714%26doi%3D10.1038%2Fnrm2970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Small molecule probes for cellular death machines</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2017.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.cbpa.2017.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=28628894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVWqsb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2017&pages=74-82&author=Y.+Liauthor=L.+Qianauthor=J.+Yuan&title=Small+molecule+probes+for+cellular+death+machines&doi=10.1016%2Fj.cbpa.2017.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule probes for cellular death machines</span></div><div class="casAuthors">Li, Ying; Qian, Lihui; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-82</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The past decade has witnessed a significant expansion of our understanding about the regulated cell death mechanisms beyond apoptosis.  The application of chem. biol. approaches had played a major role in driving these exciting discoveries.  The discovery and use of small mol. probes in cell death research has not only revealed significant insights into the regulatory mechanism of cell death but also provided new drug targets and lead drug candidates for developing therapeutics of human diseases with huge unmet need.  Here, we provide an overview of small mol. modulators for necroptosis and ferroptosis, two non-apoptotic cell death mechanisms, and discuss the mol. pathways and relevant pathophysiol. mechanisms revealed by the judicial applications of such small mol. probes.  We suggest that the development and applications of small mol. probes for non-apoptotic cell death mechanisms provide an outstanding example showcasing the power of chem. biol. in exploring novel biol. mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWclFUTaB4dLVg90H21EOLACvtfcHk0lirHc87QRzUXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVWqsb7N&md5=b77651a179b4f644dbceef9f32220876</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2017.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2017.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DSmall%2520molecule%2520probes%2520for%2520cellular%2520death%2520machines%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D39%26spage%3D74%26epage%3D82%26doi%3D10.1016%2Fj.cbpa.2017.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vince, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feltham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benetatos, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunduru, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinlay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverkus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tergaonkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callus, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koentgen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaux, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span> <span> </span><span class="NLM_article-title">IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">682</span>– <span class="NLM_lpage">693</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.10.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.cell.2007.10.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=18022363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSgur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=682-693&author=J.+E.+Vinceauthor=W.+W.+Wongauthor=N.+Khanauthor=R.+Felthamauthor=D.+Chauauthor=A.+U.+Ahmedauthor=C.+A.+Benetatosauthor=S.+K.+Chunduruauthor=S.+M.+Condonauthor=M.+McKinlayauthor=R.+Brinkauthor=M.+Leverkusauthor=V.+Tergaonkarauthor=P.+Schneiderauthor=B.+A.+Callusauthor=F.+Koentgenauthor=D.+L.+Vauxauthor=J.+Silke&title=IAP+antagonists+target+cIAP1+to+induce+TNFalpha-dependent+apoptosis&doi=10.1016%2Fj.cell.2007.10.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis</span></div><div class="casAuthors">Vince, James E.; Wong, W. Wei-Lynn; Khan, Nufail; Feltham, Rebecca; Chau, Diep; Ahmed, Afsar U.; Benetatos, Christopher A.; Chunduru, Srinivas K.; Condon, Stephen M.; McKinlay, Mark; Brink, Robert; Leverkus, Martin; Tergaonkar, Vinay; Schneider, Pascal; Callus, Bernard A.; Koentgen, Frank; Vaux, David L.; Silke, John</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">682-693</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">XIAP prevents apoptosis by binding to and inhibiting caspases, and this inhibition can be relieved by IAP antagonists, such as Smac/DIABLO.  IAP antagonist compds. (IACs) have therefore been designed to inhibit XIAP to kill tumor cells.  Because XIAP inhibits postmitochondrial caspases, caspase 8 inhibitors should not block killing by IACs.  Instead, the authors show that apoptosis caused by an IAC is blocked by the caspase 8 inhibitor crmA and that IAP antagonists activate NF-κB signaling via inhibition of cIAP1.  In sensitive tumor lines, IAP antagonist induced NF-κB-stimulated prodn. of TNFα that killed cells in an autocrine fashion.  Inhibition of NF-κB reduced TNFα prodn., and blocking NF-κB activation or TNFα allowed tumor cells to survive IAC-induced apoptosis.  Cells treated with an IAC, or those in which cIAP1 was deleted, became sensitive to apoptosis induced by exogenous TNFα, suggesting novel uses of these compds. in treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqNa8nssRGeLVg90H21EOLACvtfcHk0lirHc87QRzUXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSgur3N&md5=9e973670c472d0612d947a2ffe688d20</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.10.037%26sid%3Dliteratum%253Aachs%26aulast%3DVince%26aufirst%3DJ.%2BE.%26aulast%3DWong%26aufirst%3DW.%2BW.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DChau%26aufirst%3DD.%26aulast%3DAhmed%26aufirst%3DA.%2BU.%26aulast%3DBenetatos%26aufirst%3DC.%2BA.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DMcKinlay%26aufirst%3DM.%26aulast%3DBrink%26aufirst%3DR.%26aulast%3DLeverkus%26aufirst%3DM.%26aulast%3DTergaonkar%26aufirst%3DV.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DCallus%26aufirst%3DB.%2BA.%26aulast%3DKoentgen%26aufirst%3DF.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DIAP%2520antagonists%2520target%2520cIAP1%2520to%2520induce%2520TNFalpha-dependent%2520apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D682%26epage%3D693%26doi%3D10.1016%2Fj.cell.2007.10.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauster, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigenzahn, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stukalov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lardeau, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorzoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruckner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gridling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parapatics, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colinge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubicek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krautwald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span> <span> </span><span class="NLM_article-title">A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1767</span> <span class="refDoi"> DOI: 10.1038/cddis.2015.130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fcddis.2015.130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=25996294" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&author=A.+Fausterauthor=M.+Rebsamenauthor=K.+V.+Huberauthor=J.+W.+Bigenzahnauthor=A.+Stukalovauthor=C.+H.+Lardeauauthor=S.+Scorzoniauthor=M.+Brucknerauthor=M.+Gridlingauthor=K.+Parapaticsauthor=J.+Colingeauthor=K.+L.+Bennettauthor=S.+Kubicekauthor=S.+Krautwaldauthor=A.+Linkermannauthor=G.+Superti-Furga&title=A+cellular+screen+identifies+ponatinib+and+pazopanib+as+inhibitors+of+necroptosis&doi=10.1038%2Fcddis.2015.130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2015.130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2015.130%26sid%3Dliteratum%253Aachs%26aulast%3DFauster%26aufirst%3DA.%26aulast%3DRebsamen%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DK.%2BV.%26aulast%3DBigenzahn%26aufirst%3DJ.%2BW.%26aulast%3DStukalov%26aufirst%3DA.%26aulast%3DLardeau%26aufirst%3DC.%2BH.%26aulast%3DScorzoni%26aufirst%3DS.%26aulast%3DBruckner%26aufirst%3DM.%26aulast%3DGridling%26aufirst%3DM.%26aulast%3DParapatics%26aufirst%3DK.%26aulast%3DColinge%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DK.%2BL.%26aulast%3DKubicek%26aufirst%3DS.%26aulast%3DKrautwald%26aufirst%3DS.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26atitle%3DA%2520cellular%2520screen%2520identifies%2520ponatinib%2520and%2520pazopanib%2520as%2520inhibitors%2520of%2520necroptosis%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2015%26volume%3D6%26doi%3D10.1038%2Fcddis.2015.130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safferthal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of necroptosis by SMAC mimetic bypasses apoptosis resistance in acute myeloid leukemia cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1487</span>– <span class="NLM_lpage">1502</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fonc.2016.310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27869161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvV2ntr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=1487-1502&author=C.+Safferthalauthor=K.+Rohdeauthor=S.+Fulda&title=Therapeutic+targeting+of+necroptosis+by+SMAC+mimetic+bypasses+apoptosis+resistance+in+acute+myeloid+leukemia+cells&doi=10.1038%2Fonc.2016.310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells</span></div><div class="casAuthors">Safferthal, C.; Rohde, K.; Fulda, S.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1487-1502</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Resistance to apoptosis, for example due to overexpression of Inhibitor of Apoptosis (IAP) proteins, is assocd. with poor prognosis in acute myeloid leukemia (AML).  Here, we identify that Smac mimetics such as BV6, which antagonizes IAP proteins, elicit necroptosis in AML cells, in which apoptosis is inhibited pharmacol. by caspase inhibitors or genetically by caspase-8 knockdown.  Importantly, BV6 triggers necroptosis also in apoptosis-resistant patient-derived AML blasts, underlining the clin. relevance of our findings.  Mechanistically, we show that BV6-induced cell death depends on key components of necroptosis signaling such as RIP1, RIP3 and MLKL, since pharmacol. or genetic inhibition of these proteins significantly protects AML cells from BV6-mediated cell death, whereas PGAM5 is dispensable.  Interestingly, we identify constitutive tumor necrosis factor-alpha (TNFα) secretion and an autocrine/paracrine TNFα loop as crit. mediators of BV6-induced necroptosis in AML cell lines and patient-derived blasts, as the TNFα-blocking antibody Enbrel or tumor necrosis factor-alpha receptor 1 (TNFR1) knockdown significantly rescue cell death.  Notably, AML cells exhibit high basal levels of TNFα compared to non-malignant CD34+ cells, which is further increased by BV6.  In conclusion, this is the first report showing that Smac mimetics circumvent apoptosis resistance in AML cells by inducing necroptosis in a TNFα-dependent manner, which has important implications for the development of new strategies to overcome treatment resistance in AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3FlE4mhKWHLVg90H21EOLACvtfcHk0ljNw2OtI_SIlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvV2ntr%252FE&md5=f5e560e534db4acf5c098c48d53a70bc</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.310%26sid%3Dliteratum%253Aachs%26aulast%3DSafferthal%26aufirst%3DC.%26aulast%3DRohde%26aufirst%3DK.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DTherapeutic%2520targeting%2520of%2520necroptosis%2520by%2520SMAC%2520mimetic%2520bypasses%2520apoptosis%2520resistance%2520in%2520acute%2520myeloid%2520leukemia%2520cells%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D1487%26epage%3D1502%26doi%3D10.1038%2Fonc.2016.310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinhart, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e802</span> <span class="refDoi"> DOI: 10.1038/cddis.2013.320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1038%2Fcddis.2013.320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=24030154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWru7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&author=L.+Steinhartauthor=K.+Belzauthor=S.+Fulda&title=SMAC+mimetic+and+demethylating+agents+synergistically+trigger+cell+death+in+acute+myeloid+leukemia+cells+and+overcome+apoptosis+resistance+by+inducing+necroptosis&doi=10.1038%2Fcddis.2013.320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis</span></div><div class="casAuthors">Steinhart, L.; Belz, K.; Fulda, S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Sept.</span>),
    <span class="NLM_cas:pages">e802</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Evasion of apoptosis, for example, by inhibitor of apoptosis (IAP) proteins, contributes to treatment resistance and poor outcome in acute myeloid leukemia (AML).  Here we identify a novel synergistic interaction between the small-mol. second mitochondria-derived activator of caspases (Smac) mimetic BV6, which antagonizes X-linked IAP, cellular IAP (cIAP)1 and cIAP2, and the demethylating agents 5-azacytidine or 5-aza-2'-deoxycytidine (DAC) to induce cell death in AML cells, including apoptosis-resistant cells.  Calcn. of combination index (CI) confirms that this drug combination is highly synergistic (CI 0.02-0.4).  In contrast, BV6 and DAC at equimolar concns. do not cause synergistic toxicity against normal peripheral blood lymphocytes, pointing to some tumor cell selectivity.  Mol. studies reveal that BV6 and DAC cooperate to trigger the activation of caspases, mitochondrial perturbations and DNA fragmentation, consistent with apoptotic cell death.  However, the broad-range caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (zVAD.fmk) fails to protect against BV6/DAC-induced cell death and even significantly increases the percentage of Annexin-V/propidium iodide double-pos. cells.  Importantly, BV6/DAC-induced cell death in the presence of zVAD.fmk is significantly reduced by pharmacol. inhibition of key components of necroptosis signaling, i.e., receptor-interacting protein (RIP) 1 using necrostatin-1 or mixed lineage kinase domain-like protein (MLKL) using necrosulfonamide.  This indicates a switch from BV6/DAC-induced cell death from apoptosis to necroptosis upon caspase inhibition.  Thus, BV6 cooperates with demethylating agents to induce cell death in AML cells and circumvents apoptosis resistance via a switch to necroptosis as an alternative mode of cell death.  The identification of a novel synergism of BV6 and demethylating agents has important implications for the development of new treatment strategies for AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVGaKa7EEAo7Vg90H21EOLACvtfcHk0ljNw2OtI_SIlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWru7nO&md5=55db38f2119584b4424d0ee75caba93b</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.320%26sid%3Dliteratum%253Aachs%26aulast%3DSteinhart%26aufirst%3DL.%26aulast%3DBelz%26aufirst%3DK.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DSMAC%2520mimetic%2520and%2520demethylating%2520agents%2520synergistically%2520trigger%2520cell%2520death%2520in%2520acute%2520myeloid%2520leukemia%2520cells%2520and%2520overcome%2520apoptosis%2520resistance%2520by%2520inducing%2520necroptosis%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26doi%3D10.1038%2Fcddis.2013.320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinwascher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugues, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoeneberger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel synergistic induction of cell death by SMAC mimetic and HDAC inhibitors in acute myeloid leukemia cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2015.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.canlet.2015.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=26028172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsVWku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2015&pages=32-43&author=S.+Steinwascherauthor=A.+L.+Nuguesauthor=H.+Schoenebergerauthor=S.+Fulda&title=Identification+of+a+novel+synergistic+induction+of+cell+death+by+SMAC+mimetic+and+HDAC+inhibitors+in+acute+myeloid+leukemia+cells&doi=10.1016%2Fj.canlet.2015.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel synergistic induction of cell death by Smac mimetic and HDAC inhibitors in acute myeloid leukemia cells</span></div><div class="casAuthors">Steinwascher, Sofie; Nugues, Anne-Lucie; Schoeneberger, Hannah; Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-43</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Inhibitor of Apoptosis (IAP) proteins are expressed at high levels in acute myeloid leukemia (AML) and contribute to resistance to programmed cell death.  Here, we report that inhibition of IAP proteins by the small-mol. Smac mimetic BV6 acts together with histone deacetylase (HDAC) inhibitors (HDACIs) such as MS275 or SAHA to trigger cell death in AML cell lines in a synergistic manner, as underscored by calcn. of combination index (CI).  Also, BV6 and HDACIs cooperate to trigger DNA fragmentation, a marker of apoptotic cell death, and to suppress long-term clonogenic survival of AML cells.  In contrast, equimolar concns. of BV6 and MS275 or SAHA do not synergize to elicit cell death in normal peripheral blood lymphocytes (PBLs), emphasizing some tumor cell selectivity of this combination treatment.  Addn. of the tumor necrosis factor (TNF)α-blocking antibody Enbrel significantly reduces BV6/MS275-induced cell death in the majority of AML cell lines, indicating that autocrine/paracrine TNFα signaling contributes to cell death.  Remarkably, the broad-range caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (zVAD.fmk) fails to rescue MV4-11, Molm13 and OCI-AML3 cells and even enhances BV6/MS275-mediated cell death, whereas zVAD.fmk reduces BV6/MS275-induced cell death in NB4 cells.  Annexin-V/propidium iodide (PI) double staining reveals that BV6/MS275 cotreatment predominately increases the percentage of double-pos. cells.  Of note, the Receptor-Interacting Protein (RIP)1 inhibitor necrostatin-1 (Nec-1) or the Mixed Lineage Kinase Domain-Like protein (MLKL) inhibitor necrosulfonamide (NSA) significantly reduce BV6/MS275-induced cell death in the presence of zVAD.fmk, suggesting that BV6/MS275 cotreatment triggers necroptosis when caspases are inhibited.  Thus, BV6 acts in concert with HDACIs to induce cell death in AML cells and can bypass apoptosis resistance, at least in several AML cell lines, by engaging necroptosis as an alternative route of regulated cell death.  The identification of a novel synergism of BV6 and HDACIs has important implications for the development of new treatment strategies for AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyEt2llVRSPrVg90H21EOLACvtfcHk0lgqyTkUqzZdBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsVWku7o%253D&md5=6afbf3069ba87555e5b8f0c3ba81678b</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DSteinwascher%26aufirst%3DS.%26aulast%3DNugues%26aufirst%3DA.%2BL.%26aulast%3DSchoeneberger%26aufirst%3DH.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520novel%2520synergistic%2520induction%2520of%2520cell%2520death%2520by%2520SMAC%2520mimetic%2520and%2520HDAC%2520inhibitors%2520in%2520acute%2520myeloid%2520leukemia%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D366%26spage%3D32%26epage%3D43%26doi%3D10.1016%2Fj.canlet.2015.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brumatti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalaoui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanzer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomilio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaser, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Valle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gugasyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurthridge, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaux, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekert, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span> <span> </span><span class="NLM_article-title">The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">339ra69</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aad3099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1126%2Fscitranslmed.aad3099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27194727" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=339ra69&author=G.+Brumattiauthor=C.+Maauthor=N.+Lalaouiauthor=N.+Y.+Nguyenauthor=M.+Navarroauthor=M.+C.+Tanzerauthor=J.+Richmondauthor=M.+Ghisiauthor=J.+M.+Salmonauthor=N.+Silkeauthor=G.+Pomilioauthor=S.+P.+Glaserauthor=E.+de+Valleauthor=R.+Gugasyanauthor=M.+A.+Gurthridgeauthor=S.+M.+Condonauthor=R.+W.+Johnstoneauthor=R.+Lockauthor=G.+Salvesenauthor=A.+Weiauthor=D.+L.+Vauxauthor=P.+G.+Ekertauthor=J.+Silke&title=The+caspase-8+inhibitor+emricasan+combines+with+the+SMAC+mimetic+birinapant+to+induce+necroptosis+and+treat+acute+myeloid+leukemia&doi=10.1126%2Fscitranslmed.aad3099"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad3099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad3099%26sid%3Dliteratum%253Aachs%26aulast%3DBrumatti%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DLalaoui%26aufirst%3DN.%26aulast%3DNguyen%26aufirst%3DN.%2BY.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DTanzer%26aufirst%3DM.%2BC.%26aulast%3DRichmond%26aufirst%3DJ.%26aulast%3DGhisi%26aufirst%3DM.%26aulast%3DSalmon%26aufirst%3DJ.%2BM.%26aulast%3DSilke%26aufirst%3DN.%26aulast%3DPomilio%26aufirst%3DG.%26aulast%3DGlaser%26aufirst%3DS.%2BP.%26aulast%3Dde%2BValle%26aufirst%3DE.%26aulast%3DGugasyan%26aufirst%3DR.%26aulast%3DGurthridge%26aufirst%3DM.%2BA.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DLock%26aufirst%3DR.%26aulast%3DSalvesen%26aufirst%3DG.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DEkert%26aufirst%3DP.%2BG.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DThe%2520caspase-8%2520inhibitor%2520emricasan%2520combines%2520with%2520the%2520SMAC%2520mimetic%2520birinapant%2520to%2520induce%2520necroptosis%2520and%2520treat%2520acute%2520myeloid%2520leukemia%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D339ra69%26doi%3D10.1126%2Fscitranslmed.aad3099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McComb, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguade-Gorgorio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marovca, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cario, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrappe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanulla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Stackelberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourquin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornhauser, B. C.</span></span> <span> </span><span class="NLM_article-title">Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">339ra70</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aad2986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1126%2Fscitranslmed.aad2986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27194728" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=339ra70&author=S.+McCombauthor=J.+Aguade-Gorgorioauthor=L.+Harderauthor=B.+Marovcaauthor=G.+Carioauthor=C.+Eckertauthor=M.+Schrappeauthor=M.+Stanullaauthor=A.+von+Stackelbergauthor=J.+P.+Bourquinauthor=B.+C.+Bornhauser&title=Activation+of+concurrent+apoptosis+and+necroptosis+by+SMAC+mimetics+for+the+treatment+of+refractory+and+relapsed+ALL&doi=10.1126%2Fscitranslmed.aad2986"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad2986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad2986%26sid%3Dliteratum%253Aachs%26aulast%3DMcComb%26aufirst%3DS.%26aulast%3DAguade-Gorgorio%26aufirst%3DJ.%26aulast%3DHarder%26aufirst%3DL.%26aulast%3DMarovca%26aufirst%3DB.%26aulast%3DCario%26aufirst%3DG.%26aulast%3DEckert%26aufirst%3DC.%26aulast%3DSchrappe%26aufirst%3DM.%26aulast%3DStanulla%26aufirst%3DM.%26aulast%3Dvon%2BStackelberg%26aufirst%3DA.%26aulast%3DBourquin%26aufirst%3DJ.%2BP.%26aulast%3DBornhauser%26aufirst%3DB.%2BC.%26atitle%3DActivation%2520of%2520concurrent%2520apoptosis%2520and%2520necroptosis%2520by%2520SMAC%2520mimetics%2520for%2520the%2520treatment%2520of%2520refractory%2520and%2520relapsed%2520ALL%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D339ra70%26doi%3D10.1126%2Fscitranslmed.aad2986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cekay, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuth, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>410</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2017.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.canlet.2017.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=28923396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGhtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2017&pages=228-237&author=M.+J.+Cekayauthor=S.+Roeslerauthor=T.+Frankauthor=A.+K.+Knuthauthor=I.+Eckhardtauthor=S.+Fulda&title=SMAC+mimetics+and+type+II+interferon+synergistically+induce+necroptosis+in+various+cancer+cell+lines&doi=10.1016%2Fj.canlet.2017.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines</span></div><div class="casAuthors">Cekay, Michael John; Roesler, Stefanie; Frank, Tanja; Knuth, Anne-Kathrin; Eckhardt, Ines; Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">410</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">228-237</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Since cancer cells often evade apoptosis, induction of necroptosis as another mode of programmed cell death is considered a promising therapeutic alternative.  Here, we identify a novel synergistic interaction of Smac mimetics that antagonize x-linked Inhibitor of Apoptosis (XIAP), cellular Inhibitor of Apoptosis (cIAP) 1 and 2 with interferon (IFN)γ to induce necroptosis in apoptosis-resistant cancer cells in which caspase activation is blocked.  This synergism is confirmed by calcn. of combination indexes (CIs) and found in both solid and hematol. cancer cell lines as well as for different Smac mimetics (i.e. BV6, Birinapant), pointing to a broader relevance.  Importantly, individual genetic knockdown of key components of necroptosis signaling, i.e. receptor-interacting protein (RIP) 1, RIP3 or mixed lineage kinase domain-like pseudokinase (MLKL), significantly protects from BV6/IFNγ-induced cell death.  Similarly, pharmacol. inhibitors of RIP1 (necrostatin-1(Nec-1)), RIP3 (GSK'872) or MLKL (necrosulfonamide (NSA)) significantly reduce BV6/IFNγ-stimulated cell death.  Of note, IFN-regulatory factor (IRF)1 is required for BV6/IFNγ-mediated necroptosis, as IRF1 silencing provides protection from cell death.  By comparison, antibodies blocking tumor necrosis factor (TNF)α, TNF-related apoptosis-inducing ligand (TRAIL) or CD95 ligand fail to inhibit BV6/IFNγ-induced cell death, pointing to a mechanism independently of death receptor ligands.  This is the first report showing that Smac mimetics synergize with IFNγ to trigger necroptosis in apoptosis-resistant cancer cells with important implications for Smac mimetic-based strategies for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3zPXAKQHzirVg90H21EOLACvtfcHk0lgqyTkUqzZdBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGhtrzO&md5=914c8888c0ad91effdafac9a6ca41dbc</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DCekay%26aufirst%3DM.%2BJ.%26aulast%3DRoesler%26aufirst%3DS.%26aulast%3DFrank%26aufirst%3DT.%26aulast%3DKnuth%26aufirst%3DA.%2BK.%26aulast%3DEckhardt%26aufirst%3DI.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DSMAC%2520mimetics%2520and%2520type%2520II%2520interferon%2520synergistically%2520induce%2520necroptosis%2520in%2520various%2520cancer%2520cell%2520lines%26jtitle%3DCancer%2520Lett.%26date%3D2017%26volume%3D410%26spage%3D228%26epage%3D237%26doi%3D10.1016%2Fj.canlet.2017.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hannes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abhari, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>380</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.05.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.canlet.2016.05.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=27267809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28Xptl2msb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2016&pages=31-38&author=S.+Hannesauthor=B.+A.+Abhariauthor=S.+Fulda&title=SMAC+mimetic+triggers+necroptosis+in+pancreatic+carcinoma+cells+when+caspase+activation+is+blocked&doi=10.1016%2Fj.canlet.2016.05.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked</span></div><div class="casAuthors">Hannes, Sabine; Abhari, Behnaz Ahangarian; Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-38</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Evasion of apoptosis represents a key mechanism of treatment resistance of pancreatic cancer (PC) and contributes to the poor prognosis of this cancer type.  Here, we report that induction of necroptosis is an alternative strategy to trigger programmed cell death in apoptosis-resistant PC cells.  We show that the second mitochondrial activator of caspases (Smac) mimetic BV6 that antagonizes inhibitor of apoptosis (IAP) proteins induces necroptosis in PC cells in which apoptosis is blocked by the caspase inhibitor zVAD.fmk.  Intriguingly, BV6 switches autocrine/paracrine prodn. of tumor necrosis factor (TNF)α by PC cells into a death signal and also acts in concert with exogenously supplied TNFα to trigger necroptosis, when caspase activation is simultaneously blocked.  BV6 stimulates TNFα prodn. and formation of the receptor-interacting protein (RIP)1/RIP3-contg. necrosome complex in PC cells.  Knockdown of TNF receptor 1 (TNFR1) protects PC cells from BV6- or BV6/TNFα-mediated cell death, demonstrating that TNFα autocrine/paracrine signaling by PC cells contributes to BV6-induced necroptosis.  Importantly, genetic silencing of receptor interacting protein kinase 3 (RIPK3) or mixed lineage kinase domain-like protein (MLKL) significantly rescues PC cells from BV6- or BV6/TNFα-induced cell death.  Similarly, pharmacol. inhibition of RIP1, RIP3 or MLKL significantly reduces BV6- or BV6/TNFα-stimulated cell death.  By demonstrating that Smac mimetics can bypass resistance to apoptosis by triggering necroptosis as an alternative form of programmed cell death, our findings have important implications for the design of new treatment concepts for PC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprc2H6W9HoZ7Vg90H21EOLACvtfcHk0lhhyc8YFLD90A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xptl2msb4%253D&md5=3019374fa5667c7fd4a01762ebace34d</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.05.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.05.036%26sid%3Dliteratum%253Aachs%26aulast%3DHannes%26aufirst%3DS.%26aulast%3DAbhari%26aufirst%3DB.%2BA.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DSMAC%2520mimetic%2520triggers%2520necroptosis%2520in%2520pancreatic%2520carcinoma%2520cells%2520when%2520caspase%2520activation%2520is%2520blocked%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D380%26spage%3D31%26epage%3D38%26doi%3D10.1016%2Fj.canlet.2016.05.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetic-induced caspase-independent necroptosis requires RIP1 in breast cancer</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.3892/mmr.2015.4542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.3892%2Fmmr.2015.4542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=26573429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsVOqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=359-366&author=G.+Jinauthor=Y.+Lanauthor=F.+Hanauthor=Y.+Sunauthor=Z.+Liuauthor=M.+Zhangauthor=X.+Liuauthor=X.+Zhangauthor=J.+Huauthor=H.+Liuauthor=B.+Wang&title=SMAC+mimetic-induced+caspase-independent+necroptosis+requires+RIP1+in+breast+cancer&doi=10.3892%2Fmmr.2015.4542"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Smac mimetic-induced caspase-independent necroptosis requires RIP1 in breast cancer</span></div><div class="casAuthors">Jin, Gongsheng; Lan, Yadong; Han, Fusheng; Sun, Yiming; Liu, Zhe; Zhang, Mingliang; Liu, Xianfu; Zhang, Xiaojing; Hu, Jianguo; Liu, Hao; Wang, Benzhong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1, Pt. A</span>),
    <span class="NLM_cas:pages">359-366</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-2997</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">There is an urgent requirement for the development of novel targeted therapies to treat breast cancer, which is the most comment type of malignancy among women.  The evasion of apoptosis is a hallmark of cancer, and is often due to the upregulation of inhibitor of apoptosis proteins (IAPs) in tumor cells.  Second mitochondrial-derived activator of caspase/direct IAP-binding protein with low PI is a natural IAP antagonist, which is found in the mitochondrion; this protein has a motif, which binds to a surface groove on the baculovirus IAP repeat domains of the IAPs.  In the present study, the effects of the LCL161 Smac mimetic, a small mol. IAP antagonist, on breast cell lines was examd.  The results from MTT and colony formation assays demonstrated that LCL161 markedly inhibited the proliferation and induced the apoptosis of MDA-MB-231 and MCF-7 cell lines.  As detd. by western blotting, cIAP1 was degraded in the breast cancer cells, which occurred in an LCL161-dependent manner.  Upon caspase activation, LCL161 treatment induced necroptosis, another form of programmed cell death.  The downregulation of receptor-interacting protein kinase-1 via small interfering RNA protected the cells from LCL161-induced necroptosis.  Taken together, the results of the present study showed that LCL161 can induce multiple forms of programmed cell death in breast cancer cells, and may thus offer promise as an anticancer agent in diverse genotypic backgrounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfi2gxJMeSc7Vg90H21EOLACvtfcHk0lhhyc8YFLD90A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsVOqtbc%253D&md5=9bf26552bf3204f95405d580d2afce51</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2015.4542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2015.4542%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DG.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DB.%26atitle%3DSMAC%2520mimetic-induced%2520caspase-independent%2520necroptosis%2520requires%2520RIP1%2520in%2520breast%2520cancer%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2016%26volume%3D13%26spage%3D359%26epage%3D366%26doi%3D10.3892%2Fmmr.2015.4542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chromik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safferthal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serve, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span> <span> </span><span class="NLM_article-title">SMAC mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>344</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2013.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.canlet.2013.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=24184825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWksLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2014&pages=101-109&author=J.+Chromikauthor=C.+Safferthalauthor=H.+Serveauthor=S.+Fulda&title=SMAC+mimetic+primes+apoptosis-resistant+acute+myeloid+leukaemia+cells+for+cytarabine-induced+cell+death+by+triggering+necroptosis&doi=10.1016%2Fj.canlet.2013.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis</span></div><div class="casAuthors">Chromik, Joerg; Safferthal, Charlotta; Serve, Hubert; Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-109</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The prognosis for patients with acute myeloid leukemia (AML) is still poor, thus calling for novel treatment strategies.  Here, we report that the small-mol. Smac mimetic BV6, which antagonizes Inhibitor of Apoptosis (IAP) proteins, acts in concert with cytarabine (AraC) to trigger cell death in AML cells in a highly synergistic manner (combination index 0.02-0.27).  Similarly, BV6 cooperates with AraC to trigger cell death in primary AML samples, underscoring the clin. relevance of our findings.  Mol. studies reveal that the TNFα-blocking antibody Enbrel significantly reduces BV6/AraC-induced cell death, demonstrating that an autocrine/paracrine TNFα loop mediates cell death.  Furthermore, BV6 and AraC synergize to induce loss of mitochondrial membrane potential, caspase activation and DNA fragmentation, consistent with apoptotic cell death.  Nevertheless, the caspase inhibitor zVAD.fmk fails to protect against BV6/AraC-induced cell death.  Intriguingly, this cell death upon caspase inhibition is significantly reduced by pharmacol. inhibition of two key components of necroptosis signaling, i.e. by RIP1 kinase inhibitor Necrostatin-1 or MLKL inhibitor NSA.  Thus, BV6 sensitizes AML cells to AraC-induced cell death and overcomes apoptosis resistance by triggering necroptosis as alternative form of cell death.  These findings have important implications for Smac mimetic-based strategies to bypass apoptosis resistance of AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtA4eI6yYN47Vg90H21EOLACvtfcHk0lhhyc8YFLD90A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWksLrN&md5=2270f71fe315c8591581630b4c871fe3</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2013.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2013.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DChromik%26aufirst%3DJ.%26aulast%3DSafferthal%26aufirst%3DC.%26aulast%3DServe%26aufirst%3DH.%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DSMAC%2520mimetic%2520primes%2520apoptosis-resistant%2520acute%2520myeloid%2520leukaemia%2520cells%2520for%2520cytarabine-induced%2520cell%2520death%2520by%2520triggering%2520necroptosis%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D344%26spage%3D101%26epage%3D109%26doi%3D10.1016%2Fj.canlet.2013.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vince, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawlor, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span> <span> </span><span class="NLM_article-title">Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2012.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1016%2Fj.immuni.2012.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=22365665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=215-227&author=J.+E.+Vinceauthor=W.+W.+Wongauthor=I.+Gentleauthor=K.+E.+Lawlorauthor=R.+Allamauthor=L.+O%E2%80%99Reillyauthor=K.+Masonauthor=O.+Grossauthor=S.+Maauthor=G.+Guardaauthor=H.+Andertonauthor=R.+Castilloauthor=G.+Hackerauthor=J.+Silkeauthor=J.+Tschopp&title=Inhibitor+of+apoptosis+proteins+limit+RIP3+kinase-dependent+interleukin-1+activation&doi=10.1016%2Fj.immuni.2012.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor of Apoptosis Proteins Limit RIP3 Kinase-Dependent Interleukin-1 Activation</span></div><div class="casAuthors">Vince, James E.; Wong, W. Wei-Lynn; Gentle, Ian; Lawlor, Kate E.; Allam, Ramanjaneyulu; O'Reilly, Lorraine; Mason, Kylie; Gross, Olaf; Ma, Stephen; Guarda, Greta; Anderton, Holly; Castillo, Rosa; Hacker, Georg; Silke, John; Tschopp, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-227</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Interleukin-1β (IL-1β) is a potent inflammatory cytokine that is usually cleaved and activated by inflammasome-assocd. caspase-1.  To det. whether IL-1β activation is regulated by inhibitor of apoptosis (IAP) proteins, we treated macrophages with an IAP-antagonist "Smac mimetic" compd. or genetically deleted the genes that encode the three IAP family members cIAP1, cIAP2, and XIAP.  After Toll-like receptor priming, IAP inhibition triggered cleavage of IL-1β that was mediated not only by the NLRP3-caspase-1 inflammasome, but also by caspase-8 in a caspase-1-independent manner.  In the absence of IAPs, rapid and full generation of active IL-1β by the NLRP3-caspase-1 inflammasome, or by caspase-8, required the kinase RIP3 and reactive oxygen species prodn.  These results demonstrate that activation of the cell death-inducing ripoptosome platform and RIP3 can generate bioactive IL-1β and implicate them as addnl. targets for the treatment of pathol. IL-1-driven inflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraQ4W4rNSHa7Vg90H21EOLACvtfcHk0ljcSdFKBQCtVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSmsbw%253D&md5=bbc9ccbe0c31918b7350cf3250c801d6</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2012.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2012.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DVince%26aufirst%3DJ.%2BE.%26aulast%3DWong%26aufirst%3DW.%2BW.%26aulast%3DGentle%26aufirst%3DI.%26aulast%3DLawlor%26aufirst%3DK.%2BE.%26aulast%3DAllam%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DL.%26aulast%3DMason%26aufirst%3DK.%26aulast%3DGross%26aufirst%3DO.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DGuarda%26aufirst%3DG.%26aulast%3DAnderton%26aufirst%3DH.%26aulast%3DCastillo%26aufirst%3DR.%26aulast%3DHacker%26aufirst%3DG.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DInhibitor%2520of%2520apoptosis%2520proteins%2520limit%2520RIP3%2520kinase-dependent%2520interleukin-1%2520activation%26jtitle%3DImmunity%26date%3D2012%26volume%3D36%26spage%3D215%26epage%3D227%26doi%3D10.1016%2Fj.immuni.2012.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenneth, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, C. S.</span></span> <span> </span><span class="NLM_article-title">An inactivating caspase 11 passenger mutation originating from the 129 murine strain in mice targeted for c-IAP1</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>443</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1042/BJ20120249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1042%2FBJ20120249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=22332634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvV2qtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=443&publication_year=2012&pages=355-359&author=N.+S.+Kennethauthor=J.+M.+Youngerauthor=E.+D.+Hughesauthor=D.+Marcotteauthor=P.+A.+Barkerauthor=T.+L.+Saundersauthor=C.+S.+Duckett&title=An+inactivating+caspase+11+passenger+mutation+originating+from+the+129+murine+strain+in+mice+targeted+for+c-IAP1&doi=10.1042%2FBJ20120249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">An inactivating caspase 11 passenger mutation originating from the 129 murine strain in mice targeted for c-IAP1</span></div><div class="casAuthors">Kenneth, Niall S.; Younger, J. Michael; Hughes, Elizabeth D.; Marcotte, Danielle; Barker, Philip A.; Saunders, Thomas L.; Duckett, Colin S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">443</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">355-359</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A recent study revealed that ES (embryonic stem) cell lines derived from the 129 murine strain carry an inactivating mutation within the caspase 11 gene (Casp4) locus [Kayagaki, Warming, Lamkanfi, Vande Walle, Louie, Dong, Newton, Qu, Liu, Heldens, Zhang, Lee, Roose-Girma and Dixit (2011) Nature 479, 117-121].  Thus, if 129 ES cells are used to target genes closely linked to caspase 11, the resulting mice might also carry the caspase 11 deficiency as a passenger mutation.  In the present study, we examd. the genetic loci of mice targeted for the closely linked c-IAP (cellular inhibitor of apoptosis) genes, which were generated in 129 ES cells, and found that, despite extensive backcrossing into a C57BL/6 background, c-IAP1-/- animals are also deficient in caspase 11.  Consequently, data obtained from these mice should be re-evaluated in this new context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqjYBOAY4CFLVg90H21EOLACvtfcHk0ljcSdFKBQCtVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvV2qtrw%253D&md5=471f0b836ca27ef9a60070d0829572da</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1042%2FBJ20120249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20120249%26sid%3Dliteratum%253Aachs%26aulast%3DKenneth%26aufirst%3DN.%2BS.%26aulast%3DYounger%26aufirst%3DJ.%2BM.%26aulast%3DHughes%26aufirst%3DE.%2BD.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DBarker%26aufirst%3DP.%2BA.%26aulast%3DSaunders%26aufirst%3DT.%2BL.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26atitle%3DAn%2520inactivating%2520caspase%252011%2520passenger%2520mutation%2520originating%2520from%2520the%2520129%2520murine%2520strain%2520in%2520mice%2520targeted%2520for%2520c-IAP1%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D443%26spage%3D355%26epage%3D359%26doi%3D10.1042%2FBJ20120249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rickert, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ware, C. F.</span></span> <span> </span><span class="NLM_article-title">Mousing around with caspases and IAPs</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>443</i></span>,  <span class="NLM_fpage">e1</span>– <span class="NLM_lpage">2</span>, <span class="refDoi"> DOI: 10.1042/BJ20120402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1042%2FBJ20120402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=22452818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvV2qtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=443&publication_year=2012&pages=e1-2&author=R.+C.+Rickertauthor=G.+S.+Salvesenauthor=C.+F.+Ware&title=Mousing+around+with+caspases+and+IAPs&doi=10.1042%2FBJ20120402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Mousing around with caspases and IAPs</span></div><div class="casAuthors">Rickert, Robert C.; Salvesen, Guy S.; Ware, Carl F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">443</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1-e2</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">In a paper in this issue of the Biochem. Journal that questions the role of c-IAP1 (cellular inhibitor of apoptosis 1) in inflammation, new results from the Duckett lab. remind us of the importance of truly knowing the mice we depend on.  It turns out that c-IAP1 is tightly linked to caspase 11 and cannot be segregated by recombination.  This disturbing result implies that immune functions ascribed to c-IAP1 may be due to the caspase 11 mutation that is co-inherited with the locus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmmyfYfcoCBbVg90H21EOLACvtfcHk0ljcSdFKBQCtVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvV2qtLs%253D&md5=90828413fadde10d506bc0656715c4b3</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1042%2FBJ20120402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20120402%26sid%3Dliteratum%253Aachs%26aulast%3DRickert%26aufirst%3DR.%2BC.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DWare%26aufirst%3DC.%2BF.%26atitle%3DMousing%2520around%2520with%2520caspases%2520and%2520IAPs%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D443%26spage%3De1%26epage%3D2%26doi%3D10.1042%2FBJ20120402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, B.</span></span> <span> </span><span class="NLM_article-title">Research progress of the relationship between pyroptosis and disease</span>. <i>Am. J. Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2213</span>– <span class="NLM_lpage">2219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=30093958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A280%3ADC%252BB3c7mslantA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=2213-2219&author=Y.+Maauthor=J.+Jiangauthor=Y.+Gaoauthor=T.+Shiauthor=X.+Zhuauthor=K.+Zhangauthor=K.+Luauthor=B.+Xue&title=Research+progress+of+the+relationship+between+pyroptosis+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Research progress of the relationship between pyroptosis and disease</span></div><div class="casAuthors">Ma Yuze; Jiang Jiaxuan; Gao Yuan; Lu Ke; Xue Bin; Shi Tianshu; Zhu Xiaobo; Zhang Kaijia; Lu Ke; Xue Bin; Xue Bin</div><div class="citationInfo"><span class="NLM_cas:title">American journal of translational research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2213-2219</span>
        ISSN:<span class="NLM_cas:issn">1943-8141</span>.
    </div><div class="casAbstract">Pyroptosis, characterized by proinflammation, has been defined as a new type of programmed cell death in recent years.  Inflammasomes are activated by the corresponding pathogen-associated molecular patterns (PAMPS) or damage-associated molecular patterns (DAMPS), followed up by the cleavage of pro-interleukin-1β (pro-IL-1β), pro-interleukin-18 (pro-IL-18) and gasdermin D.  The N-terminal fragment of gasdermin D gives rise to the destruction of cell membrane, leading to cell rupture as well as the efflux of proinflammatory cytokines.  Recent studies have shown that pyroptosis is associated with a variety of diseases due to its proinflammation effect and the dysfunction of related cells.  The relationship between pyroptosis and associated diseases is described in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSReK5aqxQUscvLc4ARHEmzfW6udTcc2eZHD7dlpjlT3bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7mslantA%253D%253D&md5=2a90a458ac8a2669855b1d3f36e8f2ca</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DXue%26aufirst%3DB.%26atitle%3DResearch%2520progress%2520of%2520the%2520relationship%2520between%2520pyroptosis%2520and%2520disease%26jtitle%3DAm.%2520J.%2520Transl.%2520Res.%26date%3D2018%26volume%3D10%26spage%3D2213%26epage%3D2219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preston, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toe, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojaimi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baschuk, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachbur, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torresi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, M.</span></span> <span> </span><span class="NLM_article-title">Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">5803</span>– <span class="NLM_lpage">5808</span>, <span class="refDoi"> DOI: 10.1073/pnas.1502400112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1073%2Fpnas.1502400112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=25902530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=5803-5808&author=G.+Ebertauthor=C.+Allisonauthor=S.+Prestonauthor=J.+Cooneyauthor=J.+G.+Toeauthor=M.+D.+Stutzauthor=S.+Ojaimiauthor=N.+Baschukauthor=U.+Nachburauthor=J.+Torresiauthor=J.+Silkeauthor=C.+G.+Begleyauthor=M.+Pellegrini&title=Eliminating+hepatitis+B+by+antagonizing+cellular+inhibitors+of+apoptosis&doi=10.1073%2Fpnas.1502400112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis</span></div><div class="casAuthors">Ebert, Gregor; Allison, Cody; Preston, Simon; Cooney, James; Toe, Jesse G.; Stutz, Michael D.; Ojaimi, Samar; Baschuk, Nikola; Nachbur, Ueli; Torresi, Joseph; Silke, John; Begley, C. Glenn; Pellegrini, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5803-5808</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We have shown that cellular inhibitor of apoptosis proteins (cIAPs) impair clearance of hepatitis B virus (HBV) infection by preventing TNF-mediated killing/death of infected cells.  A key question, with profound therapeutic implications, is whether this finding can be translated to the development of drugs that promote elimination of infected cells.  Drug inhibitors of cIAPs were developed as cancer therapeutics to promote TNF-mediated tumor killing.  These drugs are also known as Smac mimetics, because they mimic the action of the endogenous protein Smac/Diablo that antagonizes cIAP function.  Here, we show using an immunocompetent mouse model of chronic HBV infection that birinapant and other Smac mimetics are able to rapidly reduce serum HBV DNA and serum HBV surface antigen, and they promote the elimination of hepatocytes contg. HBV core antigen.  The efficacy of Smac mimetics in treating HBV infection is dependent on their chem., host CD4+ T cells, and TNF.  Birinapant enhances the ability of entecavir, an antiviral nucleoside analog, to reduce viral DNA prodn. in HBV-infected animals.  These results indicate that birinapant and other Smac mimetics may have efficacy in treating HBV infection and perhaps, other intracellular infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6fFsKqFdCAbVg90H21EOLACvtfcHk0lgFjdLgbjKVAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOrsLk%253D&md5=dd522bba71dfdeba3f9804c680745f78</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1502400112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1502400112%26sid%3Dliteratum%253Aachs%26aulast%3DEbert%26aufirst%3DG.%26aulast%3DAllison%26aufirst%3DC.%26aulast%3DPreston%26aufirst%3DS.%26aulast%3DCooney%26aufirst%3DJ.%26aulast%3DToe%26aufirst%3DJ.%2BG.%26aulast%3DStutz%26aufirst%3DM.%2BD.%26aulast%3DOjaimi%26aufirst%3DS.%26aulast%3DBaschuk%26aufirst%3DN.%26aulast%3DNachbur%26aufirst%3DU.%26aulast%3DTorresi%26aufirst%3DJ.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DBegley%26aufirst%3DC.%2BG.%26aulast%3DPellegrini%26aufirst%3DM.%26atitle%3DEliminating%2520hepatitis%2520B%2520by%2520antagonizing%2520cellular%2520inhibitors%2520of%2520apoptosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D5803%26epage%3D5808%26doi%3D10.1073%2Fpnas.1502400112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preston, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toe, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojaimi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baschuk, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachbur, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torresi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colledge, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revill, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, M.</span></span> <span> </span><span class="NLM_article-title">Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">5797</span>– <span class="NLM_lpage">5802</span>, <span class="refDoi"> DOI: 10.1073/pnas.1502390112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=10.1073%2Fpnas.1502390112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=25902529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=5797-5802&author=G.+Ebertauthor=S.+Prestonauthor=C.+Allisonauthor=J.+Cooneyauthor=J.+G.+Toeauthor=M.+D.+Stutzauthor=S.+Ojaimiauthor=H.+W.+Scottauthor=N.+Baschukauthor=U.+Nachburauthor=J.+Torresiauthor=R.+Chinauthor=D.+Colledgeauthor=X.+Liauthor=N.+Warnerauthor=P.+Revillauthor=S.+Bowdenauthor=J.+Silkeauthor=C.+G.+Begleyauthor=M.+Pellegrini&title=Cellular+inhibitor+of+apoptosis+proteins+prevent+clearance+of+hepatitis+B+virus&doi=10.1073%2Fpnas.1502390112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus</span></div><div class="casAuthors">Ebert, Gregor; Preston, Simon; Allison, Cody; Cooney, James; Toe, Jesse G.; Stutz, Michael D.; Ojaimi, Samar; Scott, Hamish W.; Baschuk, Nikola; Nachbur, Ueli; Torresi, Joseph; Chin, Ruth; Colledge, Danielle; Li, Xin; Warner, Nadia; Revill, Peter; Bowden, Scott; Silke, John; Begley, C. Glenn; Pellegrini, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5797-5802</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Hepatitis B virus (HBV) infection can result in a spectrum of outcomes from immune-mediated control to disease progression, cirrhosis, and liver cancer.  The host mol. pathways that influence and contribute to these outcomes need to be defined.  Using an immunocompetent mouse model of chronic HBV infection, we identified some of the host cellular and mol. factors that impact on infection outcomes.  Here, we show that cellular inhibitor of apoptosis proteins (cIAPs) attenuate TNF signaling during hepatitis B infection, and they restrict the death of infected hepatocytes, thus allowing viral persistence.  Animals with a liver-specific cIAP1 and total cIAP2 deficiency efficiently control HBV infection compared with WT mice.  This phenotype was partly recapitulated in mice that were deficient in cIAP2 alone.  These results indicate that antagonizing the function of cIAPs may promote the clearance of HBV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ5MHwS37sJbVg90H21EOLACvtfcHk0lgFjdLgbjKVAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOrsLg%253D&md5=098384720ec928dc72c3b0c41bb88d02</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1502390112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1502390112%26sid%3Dliteratum%253Aachs%26aulast%3DEbert%26aufirst%3DG.%26aulast%3DPreston%26aufirst%3DS.%26aulast%3DAllison%26aufirst%3DC.%26aulast%3DCooney%26aufirst%3DJ.%26aulast%3DToe%26aufirst%3DJ.%2BG.%26aulast%3DStutz%26aufirst%3DM.%2BD.%26aulast%3DOjaimi%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DH.%2BW.%26aulast%3DBaschuk%26aufirst%3DN.%26aulast%3DNachbur%26aufirst%3DU.%26aulast%3DTorresi%26aufirst%3DJ.%26aulast%3DChin%26aufirst%3DR.%26aulast%3DColledge%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWarner%26aufirst%3DN.%26aulast%3DRevill%26aufirst%3DP.%26aulast%3DBowden%26aufirst%3DS.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DBegley%26aufirst%3DC.%2BG.%26aulast%3DPellegrini%26aufirst%3DM.%26atitle%3DCellular%2520inhibitor%2520of%2520apoptosis%2520proteins%2520prevent%2520clearance%2520of%2520hepatitis%2520B%2520virus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D5797%26epage%3D5802%26doi%3D10.1073%2Fpnas.1502390112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1G73" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1G73','PDB','1G73'); return false;">PDB: 1G73</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1G3F" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1G3F','PDB','1G3F'); return false;">PDB: 1G3F</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JK7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JK7','PDB','2JK7'); return false;">PDB: 2JK7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5C7B" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5C7B','PDB','5C7B'); return false;">PDB: 5C7B</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M6L" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M6L','PDB','5M6L'); return false;">PDB: 5M6L</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQW','PDB','5OQW'); return false;">PDB: 5OQW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJV','PDB','4KJV'); return false;">PDB: 4KJV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJU','PDB','4KJU'); return false;">PDB: 4KJU</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01668&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01668%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-12" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01668" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b36f25aeda34e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
